PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rubin, R				Rubin, Rita			US Share of Funding Toward Global Tobacco Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1133	1133		10.1001/jama.2019.14752	http://dx.doi.org/10.1001/jama.2019.14752			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550014				2022-12-28	WOS:000488822800006
J	Zeng, QQ; Michael, IP; Zhang, P; Saghafinia, S; Knott, G; Jiao, W; McCabe, BD; Galvan, JA; Robinson, HPC; Zlobec, I; Ciriello, G; Hanahan, D				Zeng, Qiqun; Michael, Iacovos P.; Zhang, Peng; Saghafinia, Sadegh; Knott, Graham; Jiao, Wei; McCabe, Brian D.; Galvan, Jose A.; Robinson, Hugh P. C.; Zlobec, Inti; Ciriello, Giovanni; Hanahan, Douglas			Synaptic proximity enables NMDAR signalling to promote brain metastasis	NATURE			English	Article							GLUTAMATE RELEASE; RECEPTOR; PHOSPHORYLATION; NEUROLIGIN; SURVIVAL; GROWTH	Metastasis-the disseminated growth of tumours in distant organs-underlies cancer mortality. Breast-to-brain metastasis (B2BM) is a common and disruptive form of cancer and is prevalent in the aggressive basal-like subtype, but is also found at varying frequencies in all cancer subtypes. Previous studies revealed parameters of breast cancer metastasis to the brain, but its preference for this site remains an enigma. Here we show that B2BM cells co-opt a neuronal signalling pathway that was recently implicated in invasive tumour growth, involving activation by glutamate ligands of N-methyl-D-aspartate receptors (NMDARs), which is key in model systems for metastatic colonization of the brain and is associated with poor prognosis. Whereas NMDAR activation is autocrine in some primary tumour types, human and mouse B2BM cells express receptors but secrete insufficient glutamate to induce signalling, which is instead achieved by the formation of pseudo-tripartite synapses between cancer cells and glutamatergic neurons, presenting a rationale for brain metastasis.	[Zeng, Qiqun; Michael, Iacovos P.; Saghafinia, Sadegh; Hanahan, Douglas] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland; [Zeng, Qiqun; Michael, Iacovos P.; Saghafinia, Sadegh; Ciriello, Giovanni; Hanahan, Douglas] SCCL, Lausanne, Switzerland; [Zhang, Peng] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Washington, DC 20010 USA; [Saghafinia, Sadegh; Ciriello, Giovanni] Univ Lausanne UNIL, Dept Computat Biol, Lausanne, Switzerland; [Saghafinia, Sadegh; Ciriello, Giovanni] Swiss Inst Bioinformat, Lausanne, Switzerland; [Knott, Graham] Swiss Fed Inst Technol Lausanne EPFL, Sch Life Sci, BioEM Facil, Lausanne, Switzerland; [Jiao, Wei; McCabe, Brian D.] Swiss Fed Inst Technol Lausanne EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Galvan, Jose A.; Zlobec, Inti] Univ Bern, Inst Pathol, Bern, Switzerland; [Robinson, Hugh P. C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Children's National Health System; University of Lausanne; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bern; University of Cambridge	Hanahan, D (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland.; Hanahan, D (corresponding author), SCCL, Lausanne, Switzerland.	douglas.hanahan@epfl.ch	Michael, Iacovos P/C-8695-2016; /C-7753-2013	Michael, Iacovos P/0000-0001-7674-1233; Saghafinia, Sadegh/0000-0001-5695-9825; McCabe, Brian/0000-0003-1620-0501; /0000-0003-3138-7642; Robinson, Hugh/0000-0002-5048-9954; Zhang, Peng/0000-0002-6218-1885; Zlobec, Inti/0000-0001-6741-3000	Swiss National Science Foundation; European Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank: J. Massague and J. Joyce for, respectively, providing the MDA231 and TS1 parental and derivative B2BM cell lines; J. Massague, K. Pietras and M. De Palma for comments on the manuscript; S. Grant for suggestions; M. W. Peng, A. F. Dubois, S. Lamy and L. Drori for technical support; J. Scotton for providing mouse glioma samples; W. Tang and all the members of the Hanahan laboratory for discussions. This work was principally supported by grants from the Swiss National Science Foundation and the European Research Council, and by a gift from the Biltema Foundation that was administered by the ISREC Foundation, Lausanne, Switzerland.	Amit M, 2016, NAT REV CANCER, V16, P399, DOI 10.1038/nrc.2016.38; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; FONNUM F, 1981, NEUROSCIENCE, V6, P863, DOI 10.1016/0306-4522(81)90168-8; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Harris KM, 2012, COLD SPRING HARB PER, V4, P5, DOI DOI 10.1101/CSHPERSPECT.A005587; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kim NK, 2011, EUR J NEUROSCI, V34, P199, DOI 10.1111/j.1460-9568.2011.07768.x; Knox R, 2014, STROKE, V45, P3040, DOI 10.1161/STROKEAHA.114.006170; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Levy AD, 2018, CELL REP, V24, P1523, DOI 10.1016/j.celrep.2018.07.006; Li L, 2018, CANCER CELL, V33, P736, DOI 10.1016/j.ccell.2018.02.011; Li L, 2013, CELL, V153, P86, DOI 10.1016/j.cell.2013.02.051; Lin NU, 2013, CLIN CANCER RES, V19, P6404, DOI 10.1158/1078-0432.CCR-13-0790; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Matsumura S, 2010, EUR J NEUROSCI, V32, P798, DOI 10.1111/j.1460-9568.2010.07348.x; Michael IP, 2019, DEV CELL, V49, P409, DOI 10.1016/j.devcel.2019.04.015; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; Neman J, 2014, P NATL ACAD SCI USA, V111, P984, DOI 10.1073/pnas.1322098111; Pacifici M, 2012, JOVE-J VIS EXP, DOI 10.3791/3965; Park ES, 2011, P NATL ACAD SCI USA, V108, P17456, DOI 10.1073/pnas.1114210108; Robinson HPC, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170221; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Shchors K, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.012; Stogsdill JA, 2017, NATURE, V551, P192, DOI 10.1038/nature24638; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vargas-Caballero M, 2004, J NEUROSCI, V24, P6171, DOI 10.1523/JNEUROSCI.1380-04.2004; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236	42	186	192	12	94	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					526	+		10.1038/s41586-019-1576-6	http://dx.doi.org/10.1038/s41586-019-1576-6			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31534217	Green Accepted, Green Submitted			2022-12-28	WOS:000488247600048
J	Kim, S; Beltran, B; Irnov, I; Jacobs-Wagner, C				Kim, Sangjin; Beltran, Bruno; Irnov, Irnov; Jacobs-Wagner, Christine			Long-Distance Cooperative and Antagonistic RNA Polymerase Dynamics via DNA Supercoiling	CELL			English	Article							ESCHERICHIA-COLI; SINGLE-MOLECULE; TRANSCRIPTION TERMINATION; RIFAMPICIN INHIBITION; TRYPTOPHAN OPERON; ELONGATION RATE; MESSENGER-RNA; RIBOSOMAL-RNA; ILVYC OPERON; EXPRESSION	Genes are often transcribed by multiple RNA polymerases (RNAPs) at densities that can vary widely across genes and environmental conditions. Here, we provide in vitro and in vivo evidence for a built-in mechanism by which co-transcribing RNAPs display either collaborative or antagonistic dynamics over long distances (>2 kb) through transcription-induced DNA supercoiling. In Escherichia coli, when the promoter is active, co-transcribing RNAPs translocate faster than a single RNAP, but their average speed is not altered by large variations in promoter strength and thus RNAP density. Environmentally induced promoter repression reduces the elongation efficiency of already-loaded RNAPs, causing premature termination and quick synthesis arrest of no-longerneeded proteins. This negative effect appears independent of RNAP convoy formation and is abrogated by topoisomerase I activity. Antagonistic dynamics can also occur between RNAPs from divergently transcribed gene pairs. Our findings may be broadly applicable given that transcription on topologically constrained DNA is the norm across organisms.	[Kim, Sangjin; Beltran, Bruno; Irnov, Irnov; Jacobs-Wagner, Christine] Yale Univ, Microbial Sci Inst, West Haven, CT 06516 USA; [Kim, Sangjin; Irnov, Irnov; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Kim, Sangjin; Beltran, Bruno; Irnov, Irnov; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06536 USA; [Jacobs-Wagner, Christine] Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Kim, Sangjin] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Kim, Sangjin] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Beltran, Bruno] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Jacobs-Wagner, Christine] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Jacobs-Wagner, Christine] Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Stanford University; Stanford University; Stanford University	Kim, S; Jacobs-Wagner, C (corresponding author), Yale Univ, Microbial Sci Inst, West Haven, CT 06516 USA.; Kim, S; Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.; Kim, S; Jacobs-Wagner, C (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06536 USA.; Jacobs-Wagner, C (corresponding author), Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA.; Kim, S (corresponding author), Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA.; Kim, S (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Jacobs-Wagner, C (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Jacobs-Wagner, C (corresponding author), Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA.	sangjin@illinois.edu; christine.jacobs-wagner@yale.edu		Kim, Sangjin/0000-0002-8444-7891; Jacobs-Wagner, Christine/0000-0003-0980-5334				ADESNIK M, 1970, COLD SPRING HARB SYM, V35, P451, DOI 10.1101/SQB.1970.035.01.059; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Bai L, 2006, ANNU REV BIOPH BIOM, V35, P343, DOI 10.1146/annurev.biophys.35.010406.150153; Bon M, 2006, FASEB J, V20, P1721, DOI 10.1096/fj.06-6087fje; Booker BM, 2010, MOL MICROBIOL, V78, P1348, DOI 10.1111/j.1365-2958.2010.07394.x; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Brutzer H, 2010, BIOPHYS J, V98, P1267, DOI 10.1016/j.bpj.2009.12.4292; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x; Crut A, 2007, P NATL ACAD SCI USA, V104, P11957, DOI 10.1073/pnas.0700333104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; DUNAWAY M, 1993, NATURE, V361, P746, DOI 10.1038/361746a0; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; FISHER RF, 1983, J BIOL CHEM, V258, P8146; Forte G, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.052503; Ganji M, 2016, NANO LETT, V16, P4699, DOI 10.1021/acs.nanolett.6b02213; GIAEVER GN, 1988, CELL, V55, P849, DOI 10.1016/0092-8674(88)90140-7; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; GUARENTE LP, 1978, P NATL ACAD SCI USA, V75, P294, DOI 10.1073/pnas.75.1.294; Guptasarma P, 1996, BIOESSAYS, V18, P325, DOI 10.1002/bies.950180411; Heberling T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005069; Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697; Irnov I, 2010, MOL MICROBIOL, V76, P559, DOI 10.1111/j.1365-2958.2010.07131.x; Ivenso ID, 2016, BIOPHYS J, V110, P2176, DOI 10.1016/j.bpj.2016.03.041; Iyer Sukanya, 2016, Nucleic Acids Res, V44, pe142; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Jones DL, 2014, SCIENCE, V346, P1533, DOI 10.1126/science.1255301; Joo Chirlmin, 2012, Cold Spring Harb Protoc, V2012, P1005, DOI 10.1101/pdb.prot071027; Kepes A, 1969, Prog Biophys Mol Biol, V19, P199, DOI 10.1016/0079-6107(69)90006-6; Kim S, 2018, BIOPHYS J, V114, P1718, DOI 10.1016/j.bpj.2018.02.010; Kohler R, 2017, SCIENCE, V356, P194, DOI 10.1126/science.aal3059; Koster DA, 2010, CELL, V142, P519, DOI 10.1016/j.cell.2010.08.001; Kotlajich MV, 2015, ELIFE, V4, DOI 10.7554/eLife.04970; Kouzine F, 2014, NUCLEUS-PHILA, V5, P195, DOI 10.4161/nucl.28909; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Larson MH, 2011, MOL CELL, V41, P249, DOI 10.1016/j.molcel.2011.01.008; Le TT, 2018, J MOL BIOL, V430, P4513, DOI 10.1016/j.jmb.2018.08.006; Leng FF, 2011, P NATL ACAD SCI USA, V108, P19973, DOI 10.1073/pnas.1109854108; Lionberger TA, 2010, BIOPHYS J, V99, P1139, DOI 10.1016/j.bpj.2010.04.074; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Meyer S, 2018, CURR GENET, V64, P555, DOI 10.1007/s00294-017-0785-5; Meyer S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003785; Miller J. H, 1972, EXPT MOL GENETICS; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mokry M, 2012, NUCLEIC ACIDS RES, V40, P148, DOI 10.1093/nar/gkr720; Monod J., 1956, ENZYMES UNITS BIOL S, P7; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; MOSTELLER RD, 1970, J MOL BIOL, V48, P525, DOI 10.1016/0022-2836(70)90064-1; Naughton C, 2013, TRANSCR-AUSTIN, V4, P162, DOI 10.4161/trns.25554; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Nelson P, 1999, P NATL ACAD SCI USA, V96, P14342, DOI 10.1073/pnas.96.25.14342; Noel RJ, 2000, J BIOL CHEM, V275, P7708, DOI 10.1074/jbc.275.11.7708; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Opel ML, 2001, MOL MICROBIOL, V39, P191, DOI 10.1046/j.1365-2958.2001.02249.x; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pelechano V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015442; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Rhee KY, 1999, P NATL ACAD SCI USA, V96, P14294, DOI 10.1073/pnas.96.25.14294; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Sawitzke JA, 2013, METHOD ENZYMOL, V533, P79, DOI 10.1016/B978-0-12-420067-8.00007-6; SCHLEIF R, 1973, J BACTERIOL, V115, P9, DOI 10.1128/JB.115.1.9-14.1973; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sevier SA, 2018, NUCLEIC ACIDS RES, V46, P5924, DOI 10.1093/nar/gky382; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Sobetzko P, 2016, NUCLEIC ACIDS RES, V44, P1514, DOI 10.1093/nar/gkw007; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tantale K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12248; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; van Loenhout MTJ, 2012, SCIENCE, V338, P94, DOI 10.1126/science.1225810; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Vogel U, 1997, J BIOL CHEM, V272, P12265, DOI 10.1074/jbc.272.19.12265; VOGEL U, 1994, J BIOL CHEM, V269, P16236; Voulgaris J, 1999, J BACTERIOL, V181, P4170, DOI 10.1128/JB.181.14.4170-4175.1999; Wade JT, 2004, P NATL ACAD SCI USA, V101, P17777, DOI 10.1073/pnas.0404305101; Wang ZY, 1997, J MOL BIOL, V271, P499, DOI 10.1006/jmbi.1997.1197; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; YANOFSKY C, 1981, J BACTERIOL, V145, P1334, DOI 10.1128/JB.145.3.1334-1341.1981	99	37	37	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					106	+		10.1016/j.cell.2019.08.033	http://dx.doi.org/10.1016/j.cell.2019.08.033			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539491	Bronze			2022-12-28	WOS:000486618500017
J	Naci, H; Davis, C; Savovic, J; Higgins, JPT; Sterne, JAC; Gyawali, B; Romo-Sandoval, X; Handley, N; Booth, CM				Naci, Huseyin; Davis, Courtney; Savovic, Jelena; Higgins, Julian P. T.; Sterne, Jonathan A. C.; Gyawali, Bishal; Romo-Sandoval, Xochitl; Handley, Nicola; Booth, Christopher M.			Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROGRESSION-FREE SURVIVAL; SURROGATE END-POINTS; CLINICAL-TRIALS; METHODOLOGICAL QUALITY; THERAPEUTIC AGENTS; EMPIRICAL-EVIDENCE; ONCOLOGY; MEANINGFUL; OUTCOMES; ASSOCIATION	OBJECTIVE To examine the design characteristics, risk of bias, and reporting adequacy of pivotal randomised controlled trials of cancer drugs approved by the European Medicines Agency (EMA). DESIGN Cross sectional analysis. SETTING European regulatory documents, clinical trial registry records, protocols, journal publications, and supplementary appendices. ELIGIBILITY CRITERIA Pivotal randomised controlled trials of new cancer drugs approved by the EMA between 2014 and 2016. MAIN OUTCOME MEASURES Study design characteristics (randomisation, comparators, and endpoints); risk of bias using the revised Cochrane tool (bias arising from the randomisation process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of the reported result); and reporting adequacy (completeness and consistency of information in trial protocols, publications, supplementary appendices, clinical trial registry records, and regulatory documents). RESULTS Between 2014 and 2016, the EMA approved 32 new cancer drugs on the basis of 54 pivotal studies. Of these, 41 (76%) were randomised controlled trials and 13 (24%) were either non-randomised studies or single arm studies. 39/41 randomised controlled trials had available publications and were included in our study. Only 10 randomised controlled trials (26%) measured overall survival as either a primary or coprimary endpoint, with the remaining trials evaluating surrogate measures such as progression free survival and response rates. Overall, 19 randomised controlled trials (49%) were judged to be at high risk of bias for their primary outcome. Concerns about missing outcome data (n= 10) and measurement of the outcome (n= 7) were the most common domains leading to high risk of bias judgments. Fewer randomised controlled trials that evaluated overall survival as the primary endpoint were at high risk of bias than those that evaluated surrogate efficacy endpoints (2/10 (20%) v 16/29 (55%), respectively). When information available in regulatory documents and the scientific literature was considered separately, overall risk of bias judgments differed for eight randomised controlled trials (21%), which reflects reporting inadequacies in both sources of information. Regulators identified additional deficits beyond the domains captured in risk of bias assessments for 10 drugs (31%). These deficits included magnitude of clinical benefit, inappropriate comparators, and nonpreferred study endpoints, which were not disclosed as limitations in scientific publications. CONCLUSIONS Most pivotal studies forming the basis of EMA approval of new cancer drugs between 2014 and 2016 were randomised controlled trials. However, almost half of these were judged to be at high risk of bias based on their design, conduct, or analysis, some of which might be unavoidable because of the complexity of cancer trials. Regulatory documents and the scientific literature had gaps in their reporting. Journal publications did not acknowledge the key limitations of the available evidence identified in regulatory documents.	[Naci, Huseyin; Romo-Sandoval, Xochitl] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Naci, Huseyin; Gyawali, Bishal] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA; [Davis, Courtney; Handley, Nicola] Kings Coll London, Dept Global Hlth & Social Med, London, England; [Savovic, Jelena; Higgins, Julian P. T.; Sterne, Jonathan A. C.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Savovic, Jelena; Higgins, Julian P. T.] Univ Hosp Bristol NHS Fdn Trust, NIHR CLAHRC West, Bristol, Avon, England; [Higgins, Julian P. T.; Sterne, Jonathan A. C.] Natl Inst Hlth, Bristol Biomed Res Ctr, Bristol, Avon, England; [Gyawali, Bishal; Booth, Christopher M.] Queens Univ Kingston, Canc Res Inst, Kingston, ON, Canada	University of London; London School Economics & Political Science; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; King's College London; University of Bristol; University of Bristol; Queens University - Canada	Naci, H (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.; Naci, H (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA.	h.naci@lse.ac.uk	Gyawali, Bishal/H-6653-2019; Savović, Jelena/O-4107-2019; Higgins, Julian PT/H-4008-2011	Gyawali, Bishal/0000-0001-7444-8594; Savović, Jelena/0000-0002-2861-0578; Higgins, Julian PT/0000-0002-8323-2514; Romo Sandoval, Xochitl Citlalli/0000-0001-5798-4512; Sterne, Jonathan/0000-0001-8496-6053	Commonwealth Fund; Higher Education Funding Council in England; Health Action International; NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust; University of Bristol; NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust; Arnold Ventures; Canada Research Chair in Population Cancer Care; MRC [MR/K025643/1] Funding Source: UKRI	Commonwealth Fund; Higher Education Funding Council in England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Health Action International; NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust; University of Bristol; NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust; Arnold Ventures; Canada Research Chair in Population Cancer Care; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HN is 2018-19 UK Harkness Fellow in Health Care Policy and Practice, funded by the Commonwealth Fund. HN and CD are supported by the Higher Education Funding Council in England. XRS and NH were funded in part by Health Action International. JPTH and JACS are National Institute for Health Research (NIHR) senior investigators, are supported by NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol, and are members of the Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol. JS and JPTH were supported by the NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health and Social Care. BG's fellowship at the Program on Regulation, Therapeutics, and Law (PORTAL) was funded by Arnold Ventures. CMB is supported as the Canada Research Chair in Population Cancer Care. Funders did not have any role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication. All authors had full access to all of the data in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Abraha I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2445; Aggarwal A, 2017, ANN ONCOL, V28, P1738, DOI 10.1093/annonc/mdx110; Amir E, 2012, EUR J CANCER, V48, P385, DOI 10.1016/j.ejca.2011.10.028; Banzi R, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2062; Banzi R, 2015, EUR J INTERN MED, V26, P572, DOI 10.1016/j.ejim.2015.08.008; Barbui C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2291; Bell ML, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8668; Bello S, 2017, J CLIN EPIDEMIOL, V81, P42, DOI 10.1016/j.jclinepi.2016.08.002; Bello S, 2014, J CLIN EPIDEMIOL, V67, P1059, DOI 10.1016/j.jclinepi.2014.05.007; Berntgen M, 2014, VALUE HEALTH, V17, P634, DOI 10.1016/j.jval.2014.04.006; Bhattacharya S, 2009, J CLIN ONCOL, V27, P5958, DOI 10.1200/JCO.2009.22.4329; Booth CM, 2008, J CLIN ONCOL, V26, P6, DOI 10.1200/JCO.2007.13.8156; Booth CM, 2012, J CLIN ONCOL, V30, P1030, DOI 10.1200/JCO.2011.38.7571; Booth CM, 2008, J CLIN ONCOL, V26, P5458, DOI 10.1200/JCO.2008.16.5456; Boutron I, 2006, PLOS MED, V3, P1931, DOI 10.1371/journal.pmed.0030425; Bylicki O, 2015, ANN ONCOL, V26, P231, DOI 10.1093/annonc/mdu489; Chen EY, 2019, JAMA INTERN MED, V179, P642, DOI 10.1001/jamainternmed.2018.8351; CLARK L, 2016, BMJ-BRIT MED J, V355, DOI DOI 10.1136/BMJ.I5663; Corbett MS, 2014, RES SYNTH METHODS, V5, P79, DOI 10.1002/jrsm.1090; Davis C., 2013, UNHEALTHY PHARM REGU, DOI [10.1057/9781137349477, DOI 10.1057/9781137349477]; Davis C, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4530; Dechartres A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2490; Del Paggio JC, 2017, ANN ONCOL, V28, P157, DOI 10.1093/annonc/mdw538; Del Paggio JC, 2017, LANCET ONCOL, V18, P887, DOI 10.1016/S1470-2045(17)30415-1; DOSHI P, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1991; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; European Medicines Agency, HUMAN MEDICINES HIGH; European Medicines Agency, 2017, EMA CHMP 205 95 REV; Fallowfield LJ, 2017, SUPPORT CARE CANCER, V25, P237, DOI 10.1007/s00520-016-3408-7; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Fleming TR, 2009, J CLIN ONCOL, V27, P2874, DOI 10.1200/JCO.2008.20.4107; Fojo T, 2014, JAMA OTOLARYNGOL, V140, P1225, DOI 10.1001/jamaoto.2014.1570; Food and Drug Administration, CLINICAL TRIAL ENDPO; Goodman SN, 2007, ANN INTERN MED, V146, P882, DOI 10.7326/0003-4819-146-12-200706190-00010; Gyawali B, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4383; Gyawali B, 2017, NEW BIOETH, V23, P95, DOI 10.1080/20502877.2017.1314885; Haslam A, 2019, EUR J CANCER, V106, P196, DOI 10.1016/j.ejca.2018.11.012; Hatswell AJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011666; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2016, COCHRANE DB SYST REV, V10, P29; Hodkinson A, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0766-x; Hoekman J, 2019, SOC SCI MED, V222, P76, DOI 10.1016/j.socscimed.2018.12.025; Hrobjartsson A, 2007, INT J EPIDEMIOL, V36, P654, DOI 10.1093/ije/dym020; Hrobjartsson A, 2014, INT J EPIDEMIOL, V43, P937, DOI 10.1093/ije/dyt270; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Hwang TJ, 2019, INT J CANCER, V144, P1746, DOI 10.1002/ijc.31957; Ioannides SJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004324; Jenkins V, 2018, SUPPORT CARE CANCER, V26, P3941, DOI 10.1007/s00520-018-4273-3; Jones DS, 2015, LANCET, V385, P1502, DOI 10.1016/S0140-6736(15)60742-5; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Kim C, 2015, JAMA INTERN MED, V175, P1992, DOI 10.1001/jamainternmed.2015.5868; Kohler M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h796; Kordecka A, 2019, VALUE HEALTH, V22, P884, DOI 10.1016/j.jval.2019.03.007; Kovic B, 2018, JAMA INTERN MED, V178, P1586, DOI 10.1001/jamainternmed.2018.4710; Kumar H, 2016, JAMA ONCOL, V2, P1238, DOI 10.1001/jamaoncol.2016.0931; Kumar S, 2019, LANCET, V394, P281, DOI 10.1016/S0140-6736(19)31711-8; Lenzer J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4244; Light DW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2068; Mansournia MA, 2017, EPIDEMIOLOGY, V28, P54, DOI 10.1097/EDE.0000000000000564; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Morant AV, 2018, CLIN PHARMACOL THER, V104, P169, DOI 10.1002/cpt.900; Morissette K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000025.pub2; Mullard A, 2018, NAT REV DRUG DISCOV, V17, P234, DOI 10.1038/nrd.2018.41; Mullard A, 2018, NAT REV DRUG DISCOV, V17, P86, DOI 10.1038/nrd.2018.17; Naci H, 2017, JAMA-J AM MED ASSOC, V318, P626, DOI 10.1001/jama.2017.9415; Naci H, 2017, MILBANK Q, V95, P261, DOI 10.1111/1468-0009.12261; Naci H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5542; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Page MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159267; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Pignatti F, 2011, EUR J CANCER, V47, P1759, DOI 10.1016/j.ejca.2011.05.009; Prasad V, 2015, EUR J CANCER, V51, P2269, DOI 10.1016/j.ejca.2015.07.005; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Reveiz L, 2015, J CLIN EPIDEMIOL, V68, P1036, DOI 10.1016/j.jclinepi.2014.06.001; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schroll JB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2231; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Schumock GT, 2017, AM J HEALTH-SYST PH, V74, P1158, DOI 10.2146/ajhp170164; Sivendran S, 2014, J CLIN ONCOL, V32, P83, DOI 10.1200/JCO.2013.52.2219; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Sorenson C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4849; Sridhara R, 2013, CLIN CANCER RES, V19, P2613, DOI 10.1158/1078-0432.CCR-12-2938; Tafuri G, 2014, ANN ONCOL, V25, P265, DOI 10.1093/annonc/mdt512; Tannock IF, 2016, LANCET ONCOL, V17, pE560, DOI 10.1016/S1470-2045(16)30572-1; Templeton AJ, 2015, EUR J CANCER, V51, P721, DOI 10.1016/j.ejca.2014.12.016; Tibau A, 2018, JAMA ONCOL, V4, P1610, DOI 10.1001/jamaoncol.2018.4300; Tse T, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1452; Turner Lucy, 2012, Syst Rev, V1, P60, DOI 10.1186/2046-4053-1-60; Vale CL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1798; Vera-Badillo FE, 2013, ANN ONCOL, V24, P1238, DOI 10.1093/annonc/mds636; Vera-Badillo FE, 2016, EUR J CANCER, V61, P29, DOI 10.1016/j.ejca.2016.03.066; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526; Wieseler B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8141; Woloshin S, 2018, JAMA-J AM MED ASSOC, V319, P404, DOI 10.1001/jama.2017.20653; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yordanov Y, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h809, 10.1136/bmj.h809]; Zhang JR, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017240	100	60	61	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2019	366								l5221	10.1136/bmj.l5221	http://dx.doi.org/10.1136/bmj.l5221			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VZ	31533922	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000487759000003
J	Bibby, J; Briggs, A				Bibby, Jo; Briggs, Adam			Cheap fags and booze	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bibby, Jo; Briggs, Adam] Hlth Fdn, London, England		Bibby, J (corresponding author), Hlth Fdn, London, England.	Jo.Bibby@health.org.uk		Briggs, Adam/0000-0002-2314-1039				Burton R., 2016, PUBLIC HLTH BURDEN A; Cabinet Office Department of Health and Social Care, 2019, ADV OUR HLTH PREV 20; Centre for Public Impact, 2019, SMOK BAN UK; Davies SC., 2018, ANN REPORT CHIEF MED; NHS England, 2019, NHS LONG TERM PLAN; Office for National Statistics, 2019, EC IN REAS SEAS ADJ; PHE (Public Health England), 2019, PHE STRAT 2020 2025; Public Health England, PUBL HLTH PROF; Public Health England, 2018, TOB COMM SUPP 2019 2	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l5563	10.1136/bmj.l5563	http://dx.doi.org/10.1136/bmj.l5563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VP	31527066				2022-12-28	WOS:000487758000007
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on... data hubs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l5581	10.1136/bmj.l5581	http://dx.doi.org/10.1136/bmj.l5581			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VP	31527137				2022-12-28	WOS:000487758000011
J	Kelso, MV; Mahenderkar, NK; Chen, QZ; Tubbesing, JZ; Switzer, JA				Kelso, Meagan V.; Mahenderkar, Naveen K.; Chen, Qingzhi; Tubbesing, John Z.; Switzer, Jay A.			Response to Comment on "Spin coating epitaxial films"	SCIENCE			English	Editorial Material									[Kelso, Meagan V.; Mahenderkar, Naveen K.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA; [Kelso, Meagan V.; Mahenderkar, Naveen K.; Chen, Qingzhi; Tubbesing, John Z.; Switzer, Jay A.] Missouri Univ Sci & Technol, Grad Ctr Mat Res, Rolla, MO 65409 USA; [Chen, Qingzhi; Tubbesing, John Z.; Switzer, Jay A.] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA; [Mahenderkar, Naveen K.] Lam Res Corp, 4650 Cushing Pkwy, Fremont, CA 94538 USA	University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; Lam Research Corporation	Switzer, JA (corresponding author), Missouri Univ Sci & Technol, Grad Ctr Mat Res, Rolla, MO 65409 USA.; Switzer, JA (corresponding author), Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA.	jswitzer@mst.edu			U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering [DE-FG02-08ER46518]	U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE))	The material is based on work supported by the U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering, under grant DE-FG02-08ER46518.	Kelso MV, 2019, SCIENCE, V364, P166, DOI 10.1126/science.aaw6184; Lu C., 2019, SCIENCE, V365	2	2	2	4	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI					10.1126/science.aay3966	http://dx.doi.org/10.1126/science.aay3966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515358				2022-12-28	WOS:000485780800002
J	Lu, CJ; Tang, LL				Lu, Chaojing; Tang, Lingli			Comment on "Spin coating epitaxial films"	SCIENCE			English	Editorial Material							BI3.15ND0.85TI3O12 THIN-FILMS		[Lu, Chaojing; Tang, Lingli] Qingdao Univ, Coll Phys, State Key Lab Biofibers & Ecotext, Qingdao 266071, Shandong, Peoples R China	Qingdao University	Lu, CJ (corresponding author), Qingdao Univ, Coll Phys, State Key Lab Biofibers & Ecotext, Qingdao 266071, Shandong, Peoples R China.	cjlu@qdu.edu.cn		Lu, Chaojing/0000-0002-4706-6619	National Natural Science Foundation of China [51472131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: Supported by National Natural Science Foundation of China grant 51472131.	Jones JL, 2004, J MATER RES, V19, P3414, DOI 10.1557/JMR.2004.0440; Kelso MV, 2019, SCIENCE, V364, P166, DOI 10.1126/science.aaw6184; Lu CJ, 2008, PHYS STATUS SOLIDI A, V205, P2711, DOI 10.1002/pssa.200824043; Ye WN, 2008, APPL PHYS A-MATER, V91, P323, DOI 10.1007/s00339-008-4406-5	4	6	6	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI					10.1126/science.aay3894	http://dx.doi.org/10.1126/science.aay3894			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515357				2022-12-28	WOS:000485780800001
J	Saurer, M; Ramrath, DJF; Niemann, M; Calderaro, S; Prange, C; Mattei, S; Scaiola, A; Leitner, A; Bieri, P; Horn, EK; Leibundgut, M; Boehringer, D; Schneider, A; Ban, N				Saurer, Martin; Ramrath, David J. F.; Niemann, Moritz; Calderaro, Salvatore; Prange, Celine; Mattei, Simone; Scaiola, Alain; Leitner, Alexander; Bieri, Philipp; Horn, Elke K.; Leibundgut, Marc; Boehringer, Daniel; Schneider, Andre; Ban, Nenad			Mitoribosomal small subunit biogenesis in trypanosomes involves an extensive assembly machinery	SCIENCE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; MITOCHONDRIAL RIBOSOME; ESCHERICHIA-COLI; CRYO-EM; PURIFICATION; BRUCEI; SYSTEM; IDENTIFICATION; VISUALIZATION; TRANSPORT	Mitochondrial ribosomes (mitoribosomes) are large ribonucleoprotein complexes that synthesize proteins encoded by the mitochondrial genome. An extensive cellular machinery responsible for ribosome assembly has been described only for eukaryotic cytosolic ribosomes. Here we report that the assembly of the small mitoribosomal subunit in Trypanosoma brucei involves a large number of factors and proceeds through the formation of assembly intermediates, which we analyzed by using cryo-electron microscopy. One of them is a 4-megadalton complex, referred to as the small subunit assemblosome, in which we identified 34 factors that interact with immature ribosomal RNA (rRNA) and recognize its functionally important regions. The assembly proceeds through large-scale conformational changes in rRNA coupled with successive incorporation of mitoribosomal proteins, providing an example for the complexity of the ribosomal assembly process in mitochondria.	[Saurer, Martin; Ramrath, David J. F.; Prange, Celine; Mattei, Simone; Scaiola, Alain; Bieri, Philipp; Leibundgut, Marc; Boehringer, Daniel; Ban, Nenad] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, Otto Stern Weg 5, CH-8093 Zurich, Switzerland; [Niemann, Moritz; Calderaro, Salvatore; Horn, Elke K.; Schneider, Andre] Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland; [Leitner, Alexander] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, Otto Stern Weg 3, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Dept Biol, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.; Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@dcb.unibe.ch; ban@mol.biol.ethz.ch	Leitner, Alexander/U-1601-2019	Leitner, Alexander/0000-0003-4126-0725; Scaiola, Alain/0000-0003-3233-3910; Mattei, Simone/0000-0002-2005-8977; Bieri, Philipp/0000-0001-9031-2945; Saurer, Martin/0000-0001-8181-6711	Swiss National Science Foundation (SNSF); National Center of Competence in Research (NCCR) RNA & Disease Program of the SNSF; FEBS long-term fellowship; EMBO long-term fellowship [ALTF 793-2017]; Human Frontier Science Program long-term fellowship [LT000008/2018-L]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Competence in Research (NCCR) RNA & Disease Program of the SNSF(Swiss National Science Foundation (SNSF)); FEBS long-term fellowship; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program long-term fellowship(Human Frontier Science Program)	This work was supported by the Swiss National Science Foundation (SNSF) and the National Center of Competence in Research (NCCR) RNA & Disease Program of the SNSF. D.J.F.R. was supported by a FEBS long-term fellowship. S. M. was supported by an EMBO long-term fellowship (ALTF 793-2017) and by a Human Frontier Science Program long-term fellowship (LT000008/2018-L).	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aphasizheva I, 2016, MOL MICROBIOL, V99, P1043, DOI 10.1111/mmi.13287; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bieri P, 2018, CURR OPIN STRUC BIOL, V49, P44, DOI 10.1016/j.sbi.2017.12.009; Brown A, 2017, NAT STRUCT MOL BIOL, V24, P866, DOI 10.1038/nsmb.3464; BRUN R, 1979, ACTA TROP, V36, P289; Chaharbakhshi E, 2016, GENESIS, V54, P505, DOI 10.1002/dvg.22964; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conrad J, 1999, RNA, V5, P751, DOI 10.1017/S1355838299990167; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Davis JH, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0181; De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Hauser R, 1996, J CELL SCI, V109, P517; Holzer S, 2013, J MOL BIOL, V425, P4154, DOI 10.1016/j.jmb.2013.08.022; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; Koch B, 2012, J BIOL CHEM, V287, P21806, DOI 10.1074/jbc.M112.365791; Kressler D, 2017, TRENDS BIOCHEM SCI, V42, P640, DOI 10.1016/j.tibs.2017.05.005; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Pena C, 2017, NAT STRUCT MOL BIOL, V24, P689, DOI 10.1038/nsmb.3454; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Ramrath DJF, 2018, SCIENCE, V362, DOI 10.1126/science.aau7735; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sergiev PV, 2018, NAT CHEM BIOL, V14, P226, DOI [10.1038/nchembio.2569, 10.1038/NCHEMBIO.2569]; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Shen CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11285; Spahr H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04388-1; Tyc J, 2017, MITOCHONDRION, V34, P67, DOI 10.1016/j.mito.2017.01.003; Van Vranken JG, 2018, MOL CELL, V71, P567, DOI 10.1016/j.molcel.2018.06.039; Wei Y, 2012, J STRUCT BIOL, V179, P29, DOI 10.1016/j.jsb.2012.04.011; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WRZESINSKI J, 1995, BIOCHEMISTRY-US, V34, P8904, DOI 10.1021/bi00027a043; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200	50	32	32	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1144	+		10.1126/science.aaw5570	http://dx.doi.org/10.1126/science.aaw5570			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515389				2022-12-28	WOS:000485780800042
J	Masuda, T; Yoshimi, A; Fujieda, A; Fujimoto, H; Haba, H; Hara, H; Hiraki, T; Kaino, H; Kasamatsu, Y; Kitao, S; Konashi, K; Miyamoto, Y; Okai, K; Okubo, S; Sasao, N; Seto, M; Schumm, T; Shigekawa, Y; Suzuki, K; Stellmer, S; Tamasaku, K; Uetake, S; Watanabe, M; Watanabe, T; Yasuda, Y; Yamaguchi, A; Yoda, Y; Yokokita, T; Yoshimura, M; Yoshimura, K				Masuda, Takahiko; Yoshimi, Akihiro; Fujieda, Akira; Fujimoto, Hiroyuki; Haba, Hiromitsu; Hara, Hideaki; Hiraki, Takahiro; Kaino, Hiroyuki; Kasamatsu, Yoshitaka; Kitao, Shinji; Konashi, Kenji; Miyamoto, Yuki; Okai, Koichi; Okubo, Sho; Sasao, Noboru; Seto, Makoto; Schumm, Thorsten; Shigekawa, Yudai; Suzuki, Kenta; Stellmer, Simon; Tamasaku, Kenji; Uetake, Satoshi; Watanabe, Makoto; Watanabe, Tsukasa; Yasuda, Yuki; Yamaguchi, Atsushi; Yoda, Yoshitaka; Yokokita, Takuya; Yoshimura, Motohiko; Yoshimura, Koji			X-ray pumping of the Th-229 nuclear clock isomer	NATURE			English	Article							SILICON; COEFFICIENTS; TRANSITION; CONSTANT	The metastable first excited state of thorium-229, Th-229m, is just a few electronvolts above the nuclear ground state(1-4) and is accessible by vacuum ultraviolet lasers. The ability to manipulate the Th-229 nuclear states with the precision of atomic laser spectroscopy(5) opens up several prospects(6), from studies of fundamental interactions in physics(7,8) to applications such as a compact and robust nuclear clock(5,9,10). However, direct optical excitation of the isomer and its radiative decay to the ground state have not yet been observed, and several key nuclear structure parameters-such as the exact energies and half-lives of the low-lying nuclear levels of Th-229-remain unknown(11). Here we present active optical pumping into Th-229m, achieved using narrow-band 29-kiloelectronvolt synchrotron radiation to resonantly excite the second excited state of Th-229, which then decays predominantly into the isomer. We determine the resonance energy with an accuracy of 0.07 electronvolts, measure a half-life of 82.2 picoseconds and an excitation linewidth of 1.70 nanoelectronvolts, and extract the branching ratio of the second excited state into the ground and isomeric state. These measurements allow us to constrain the Th-229m isomer energy by combining them with gamma-spectroscopy data collected over the past 40 years.	[Masuda, Takahiko; Yoshimi, Akihiro; Fujieda, Akira; Hara, Hideaki; Hiraki, Takahiro; Kaino, Hiroyuki; Miyamoto, Yuki; Okai, Koichi; Okubo, Sho; Sasao, Noboru; Suzuki, Kenta; Uetake, Satoshi; Yoshimura, Motohiko; Yoshimura, Koji] Okayama Univ, Res Inst Interdisciplinary Sci, Okayama, Japan; [Fujimoto, Hiroyuki; Watanabe, Tsukasa] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Haba, Hiromitsu; Yamaguchi, Atsushi; Yokokita, Takuya] RIKEN, Wako, Saitama, Japan; [Kasamatsu, Yoshitaka; Shigekawa, Yudai; Yasuda, Yuki] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka, Japan; [Kitao, Shinji; Seto, Makoto] Kyoto Univ, Inst Integrated Radiat & Nucl Sci, Kumatori Cho, Kyoto, Japan; [Konashi, Kenji; Watanabe, Makoto] Tohoku Univ, Inst Mat Res, Sendai, Miyagi, Japan; [Schumm, Thorsten; Stellmer, Simon] TU Wien, Inst Atom & Subat Phys, Vienna, Austria; [Tamasaku, Kenji] RIKEN SPring 8 Ctr, Sayo Cho, Wako, Saitama, Japan; [Yoda, Yoshitaka] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan	Okayama University; National Institute of Advanced Industrial Science & Technology (AIST); RIKEN; Osaka University; Kyoto University; Tohoku University; Technische Universitat Wien; RIKEN; Japan Synchrotron Radiation Research Institute	Sasao, N; Yoshimura, K (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci, Okayama, Japan.	sasao@okayama-u.ac.jp; yosimura@okayama-u.ac.jp	Schumm, Thorsten/B-8565-2008; Fujimoto, Hiroyuki/M-4902-2018; masuda, takahiko/R-6510-2019; Hiraki, Takahiro/T-1153-2019; Yoshimi, Akihiro/C-8539-2015	Schumm, Thorsten/0000-0002-1066-202X; Fujimoto, Hiroyuki/0000-0001-6656-7147; masuda, takahiko/0000-0001-8122-5145; Yoshimi, Akihiro/0000-0002-2438-1384; Hiraki, Takahiro/0000-0002-6235-5830; , Atsushi/0000-0002-3981-3872	JSPS KAKENHI [JP15H03661, JP17K14291, JP18H01230, JP18H04353]; EU FET-Open project [664732]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EU FET-Open project	The synchrotron radiation experiments were performed at the BL09XU and BL19LXU lines of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposals 2016B1232, 2017B1335, 2018A1326 and 2018B1436) and RIKEN (proposal number 20180045). We thank all members of the SPring-8 operation and supporting teams. The experiment received support from the KEK Photon Factory (proposal number 2017G085) and the Institute for Materials Research, Tohoku University (18F0014), where indispensable detector tests and target preparation were performed. We especially thank S. Kishimoto for support at KEK, T. Kobayashi for technical assistance at SPring-8 and K. Beeks for discussion during the preparation of the manuscript. This work was supported by JSPS KAKENHI grants JP15H03661, JP17K14291, JP18H01230 and JP18H04353. T. S. and S. S. gratefully acknowledge funding by the EU FET-Open project, grant number 664732 (nuClock). A. Yoshimi and A. Yamaguchi acknowledge the MATSUO foundation and Technology Pioneering Projects in RIKEN, respectively.	Barci V, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.034329; Beck BR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.142501; Beck B. R., 2009, LLNLPROC415170; Berengut JC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.210801; Berger M. J, 2010, NIST PHOTON CROSS SE; BOND WL, 1960, ACTA CRYSTALLOGR, V13, P814, DOI 10.1107/S0365110X60001941; Browne E, 2008, NUCL DATA SHEETS, V109, P2657, DOI 10.1016/j.nds.2008.10.001; Campbell CJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120802; Cavagnero G, 2004, METROLOGIA, V41, P56, DOI 10.1088/0026-1394/41/1/008; Cavagnero G, 2004, METROLOGIA, V41, P445, DOI 10.1088/0026-1394/41/6/C01; Firestone RB, 1996, TABLE ISOTOPES; Flambaum VV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.092502; Flambaum VV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.072501; Fujimoto H, 2011, METROLOGIA, V48, pS55, DOI 10.1088/0026-1394/48/2/S09; HALL JJ, 1967, PHYS REV, V161, P756, DOI 10.1103/PhysRev.161.756; Hayes AC, 2007, PHYS LETT B, V650, P229, DOI 10.1016/j.physletb.2007.05.021; HELMER RG, 1994, PHYS REV C, V49, P1845, DOI 10.1103/PhysRevC.49.1845; Jeet J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.253001; Kazakov GA, 2014, NUCL INSTRUM METH A, V735, P229, DOI 10.1016/j.nima.2013.09.012; Kazakov GA, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083019; Kibedi T, 2008, NUCL INSTRUM METH A, V589, P202, DOI 10.1016/j.nima.2008.02.051; KROGER LA, 1976, NUCL PHYS A, V259, P29, DOI 10.1016/0375-9474(76)90494-2; Krywka C, 2016, AIP CONF PROC, V1764, DOI 10.1063/1.4961129; LYON KG, 1977, J APPL PHYS, V48, P865, DOI 10.1063/1.323747; Masuda T, 2019, NUCL INSTRUM METH A, V913, P72, DOI 10.1016/j.nima.2018.10.029; Masuda T, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4989405; Matinyan S, 1998, PHYS REP, V298, P200; Peik E, 2003, EUROPHYS LETT, V61, P181, DOI 10.1209/epl/i2003-00210-x; Peik E, 2015, CR PHYS, V16, P516, DOI 10.1016/j.crhy.2015.02.007; Raboud P. A., 1999, PHYS REV A, V61; Schodel R, 2001, P SOC PHOTO-OPT INS, V4401, P54, DOI 10.1117/12.445624; Scofield J.H., 1973, UCRL51326 LAWR LIV L; Seiferle B, 2019, NATURE, V573, P243, DOI 10.1038/s41586-019-1533-4; Seiferle B, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.042501; Seto M, 2000, PHYS REV LETT, V84, P566, DOI 10.1103/PhysRevLett.84.566; Seto M, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.021016; Stellmer S, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.062506; Tanabashi M, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.030001; Thielking J, 2018, NATURE, V556, P321, DOI 10.1038/s41586-018-0011-8; Tkalya EV, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.054324; von der Wense L, 2016, NATURE, V533, P47, DOI 10.1038/nature17669; Watanabe T, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/6/065002; Yabashi M, 2001, NUCL INSTRUM METH A, V467, P678, DOI 10.1016/S0168-9002(01)00444-2; Yamaguchi A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/5/053053; Yoshimi A, 2018, PHYS REV C, V97, DOI 10.1103/PhysRevC.97.024607	46	37	38	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					238	+		10.1038/s41586-019-1542-3	http://dx.doi.org/10.1038/s41586-019-1542-3			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31511686	Green Submitted			2022-12-28	WOS:000485415400050
J	Dyer, O				Dyer, Owen			Trump administration restricts dietary science in new food guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Teicholz N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4962; US Department of Agriculture, TOP QUEST BE EX COMM	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5490	10.1136/bmj.l5490	http://dx.doi.org/10.1136/bmj.l5490			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501086				2022-12-28	WOS:000486648500012
J	Findeisen, M; Allen, TL; Henstridge, DC; Kammoun, H; Brandon, AE; Baggio, LL; Watt, KI; Pal, M; Cron, L; Estevez, E; Yang, C; Kowalski, GM; O'Reilly, L; Egan, C; Sun, E; Thai, LM; Krippner, G; Adams, TE; Lee, RS; Grotzinger, J; Garbers, C; Risis, S; Kraakman, MJ; Mellet, NA; Sligar, J; Kimber, ET; Young, RL; Cowley, MA; Bruce, CR; Meikle, PJ; Baldock, PA; Gregorevic, P; Biden, TJ; Cooney, GJ; Keating, DJ; Drucker, DJ; Rose-John, S; Febbraio, MA				Findeisen, Maria; Allen, Tamara L.; Henstridge, Darren C.; Kammoun, Helene; Brandon, Amanda E.; Baggio, Laurie L.; Watt, Kevin I.; Pal, Martin; Cron, Lena; Estevez, Emma; Yang, Christine; Kowalski, Greg M.; O'Reilly, Liam; Egan, Casey; Sun, Emily; Le May Thai; Krippner, Guy; Adams, Timothy E.; Lee, Robert S.; Groetzinger, Joachim; Garbers, Christoph; Risis, Steve; Kraakman, Michael J.; Mellet, Natalie A.; Sligar, James; Kimber, Erica T.; Young, Richard L.; Cowley, Michael A.; Bruce, Clinton R.; Meikle, Peter J.; Baldock, Paul A.; Gregorevic, Paul; Biden, Trevor J.; Cooney, Gregory J.; Keating, Damien J.; Drucker, Daniel J.; Rose-John, Stefan; Febbraio, Mark A.			Treatment of type 2 diabetes with the designer cytokine IC7Fc	NATURE			English	Article							CILIARY NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; REVEALS INSIGHTS; MUSCLE MASS; INTERLEUKIN-6; MICE; GLUCOSE; INFLAMMATION; PREVALENCE; EXERCISE	The gp130 receptor cytokines IL-6 and CNTF improve metabolic homeostasis but have limited therapeutic use for the treatment of type 2 diabetes. Accordingly, we engineered the gp130 ligand IC7Fc, in which one gp130-binding site is removed from IL-6 and replaced with the LIF-receptor-binding site from CNTF, fused with the Fc domain of immunoglobulin G, creating a cytokine with CNTF-like, but IL-6-receptor-dependent, signalling. Here we show that IC7Fc improves glucose tolerance and hyperglycaemia and prevents weight gain and liver steatosis in mice. In addition, IC7Fc either increases, or prevents the loss of, skeletal muscle mass by activation of the transcriptional regulator YAP1. In human-cell-based assays, and in non-human primates, IC7Fc treatment results in no signs of inflammation or immunogenicity. Thus, IC7Fc is a realistic next-generation biological agent for the treatment of type 2 diabetes and muscle atrophy, disorders that are currently pandemic.	[Findeisen, Maria; Brandon, Amanda E.; Pal, Martin; Cron, Lena; Estevez, Emma; O'Reilly, Liam; Le May Thai; Sligar, James; Kimber, Erica T.; Baldock, Paul A.; Gregorevic, Paul; Biden, Trevor J.; Cooney, Gregory J.; Febbraio, Mark A.] Garvan Inst Med Res, Sydney, NSW, Australia; [Allen, Tamara L.; Henstridge, Darren C.; Kammoun, Helene; Yang, Christine; Kowalski, Greg M.; Krippner, Guy; Lee, Robert S.; Risis, Steve; Kraakman, Michael J.; Mellet, Natalie A.; Bruce, Clinton R.; Meikle, Peter J.; Febbraio, Mark A.] Baker Heart Diabet Inst, Melbourne, Vic, Australia; [Brandon, Amanda E.; Cooney, Gregory J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Baggio, Laurie L.; Drucker, Daniel J.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Mt Sinai Hosp, Dept Med, Toronto, ON, Canada; [Watt, Kevin I.; Gregorevic, Paul] Univ Melbourne, Dept Physiol, Ctr Muscle Res, Melbourne, Vic, Australia; [Pal, Martin] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Dept Med Biol, Melbourne, Vic, Australia; [Kowalski, Greg M.; Bruce, Clinton R.] Deakin Univ, Inst Phys Act & Nutr, Melbourne, Vic, Australia; [Egan, Casey; Febbraio, Mark A.] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia; [Sun, Emily; Keating, Damien J.] Flinders Univ S Australia, Mol & Cellular Physiol Lab, Adelaide, SA, Australia; [Adams, Timothy E.] CSIRO Mfg, Melbourne, Vic, Australia; [Groetzinger, Joachim; Rose-John, Stefan] Christian Albrechts Univ Kiel, Dept Biochem, Kiel, Germany; [Garbers, Christoph] Otto von Guericke Univ, Inst Pathol, Magdeburg, Germany; [Young, Richard L.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Findeisen, Maria; Allen, Tamara L.; Cowley, Michael A.] Monash Univ, Dept Physiol, Melbourne, Vic, Australia	Garvan Institute of Medical Research; Baker Heart and Diabetes Institute; University of Sydney; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Melbourne; University of Melbourne; Deakin University; Monash University; Flinders University South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Kiel; Otto von Guericke University; University of Adelaide; Monash University	Febbraio, MA (corresponding author), Garvan Inst Med Res, Sydney, NSW, Australia.; Febbraio, MA (corresponding author), Baker Heart Diabet Inst, Melbourne, Vic, Australia.; Febbraio, MA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia.	mark.febbraio@monash.edu	Drucker, Daniel J/A-4092-2010; Watt, Kevin I./AAF-6703-2021; Baldock, Paul/B-3840-2012; Garbers, Christoph/D-9932-2015; Gregorevic, Paul/AAH-6040-2021; Biden, Trevor/AAW-2829-2021; Pal, Martin/AAL-8685-2020; Febbraio, Mark/AAE-9632-2019; Adams, Timothy/I-6231-2012	Watt, Kevin I./0000-0001-7475-4487; Garbers, Christoph/0000-0003-4939-6950; Gregorevic, Paul/0000-0002-7418-8945; Pal, Martin/0000-0002-1563-5426; Adams, Timothy/0000-0003-3436-0066; Estevez, Emma/0000-0002-5125-2190; Sun, Emily Wai-Ling/0000-0001-5484-918X; Thai, Le May/0000-0002-9630-2446; Bruce, Clinton/0000-0002-0515-3343; Febbraio, Mark/0000-0002-9296-4418; Biden, Trevor/0000-0001-5211-0234; Young, Richard/0000-0001-5116-4951; Lee, Robert/0000-0002-8166-142X; Kowalski, Greg/0000-0002-1599-017X; Meikle, Peter/0000-0002-2593-4665; Keating, Damien/0000-0002-0154-8305; Kraakman, Michael/0000-0002-5755-0447	National Health AMP; Medical Research Council of Australia [526606, APP1156511, APP1039502, 445302, APP1021168, APP1116936]; CASS Foundation; CIHR [164321]; Victorian Government's OIS Program; DFG [PA-2459/1-1]; Deutsche Forschungsgemeinschaft (DFG), Bonn [SFB841, SFB877]; Cluster of Excellence 'Inflammation at Interfaces'	National Health AMP; Medical Research Council of Australia; CASS Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Victorian Government's OIS Program; DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG), Bonn(German Research Foundation (DFG)); Cluster of Excellence 'Inflammation at Interfaces'	This study was funded, in part, by the National Health & Medical Research Council of Australia (project grant 526606 and APP1156511 to M.A.F. and S.R.-J.; project grant APP1039502 to M.A.F.; development grant APP1039502 to M.A.F., T.E.A. and M.A.C.; principal research fellowship 445302 to M.A.F., senior principal research fellowship (SPRF) APP1021168 to M.A.F. and SPRF APP1116936 to M.A.F. This project was also funded, in part, by a CASS Foundation grant awarded to T.L.A. and M.A.F. and CIHR foundation grant 164321 to D.J.D. The project was also supported in part by the Victorian Government's OIS Program. We thank F.T. Wunderlich and C.M. Wunderlich for providing reagents to generate the ROSA26-IC7Fc mouse, as well as A. Nenci and J. Gonzales from the Monash Gene Targeting Facility. M.P. was supported by a research fellowship (DFG, PA-2459/1-1). We thank J. Scoble and L. Sparrow for their help in preparing PEGylated forms of IC7, J. Bentley for help with europium assays, X. Xiao and G. Lovrecz for mammalian cell line development and scale-up, L. Pontes-Braz for protein purification and the Burnet ImmunoMonitoring Facility for conducting the human PBMC experiments. The work of S.R.-J. was funded by the Deutsche Forschungsgemeinschaft (DFG), Bonn (grant no.: SFB841, project C1; grant no.: SFB877, project A1), and by the Cluster of Excellence 'Inflammation at Interfaces'.	Askmyr M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15529; Brandon AE, 2019, CELL METAB, V29, P183, DOI 10.1016/j.cmet.2018.09.013; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Duff E, 2003, NUTR REV, V61, P423, DOI 10.1301/nr.2003.dec.423-426; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826; Febbraio MA, 2007, J CLIN INVEST, V117, P841, DOI 10.1172/JCI30453; Febbraio MA, 2014, TRENDS ENDOCRIN MET, V25, P312, DOI 10.1016/j.tem.2014.02.004; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; Grey A, 2009, DIABETES OBES METAB, V11, P275, DOI 10.1111/j.1463-1326.2008.00931.x; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Henstridge DC, 2015, CELL STRESS CHAPERON, V20, P461, DOI 10.1007/s12192-015-0571-6; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Jazayeri JA, 2008, BIODRUGS, V22, P11, DOI 10.2165/00063030-200822010-00002; Jordy AB, 2015, AM J PHYSIOL-ENDOC M, V308, pE778, DOI 10.1152/ajpendo.00547.2014; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; Kowalski GM, 2015, BBA-MOL CELL BIOL L, V1851, P210, DOI 10.1016/j.bbalip.2014.12.002; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Lotz B, 1996, NEUROLOGY, V46, P1244; Ma C, 2018, CLIN OBES, V8, P131, DOI 10.1111/cob.12240; Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Pal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054247; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rakemann T, 1999, J BIOL CHEM, V274, P1257, DOI 10.1074/jbc.274.3.1257; Scheidt-Nave C, 2001, J CLIN ENDOCR METAB, V86, P2032, DOI 10.1210/jc.86.5.2032; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Steinberg GR, 2006, ENDOCRINOLOGY, V147, P3906, DOI 10.1210/en.2005-1587; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Tibble CA, 2013, EXPERT REV ENDOCRINO, V8, P247, DOI [10.1586/eem.13.20, 10.1586/EEM.13.20]; Watt KI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7048; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Whitham M, 2016, NAT REV DRUG DISCOV, V15, P719, DOI 10.1038/nrd.2016.153; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie D, 2007, BONE, V40, P1352, DOI 10.1016/j.bone.2007.01.007	41	31	31	2	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					63	+		10.1038/s41586-019-1601-9	http://dx.doi.org/10.1038/s41586-019-1601-9			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31554967				2022-12-28	WOS:000488832500030
J	Parikh, RB; Adamson, BJS; Khozin, S; Galsky, MD; Baxi, SS; Cohen, A; Mamtani, R				Parikh, Ravi B.; Adamson, Blythe J. S.; Khozin, Sean; Galsky, Matthew D.; Baxi, Shrujal S.; Cohen, Aaron; Mamtani, Ronac			Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CISPLATIN-INELIGIBLE PATIENTS; SINGLE-ARM; MULTICENTER	This research letter discusses the association between label restrictions by the US Food and Drug Administration on first-line immunotherapy for advanced bladder cancer and subsequent changes in practice.	[Parikh, Ravi B.; Mamtani, Ronac] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Adamson, Blythe J. S.; Baxi, Shrujal S.; Cohen, Aaron] Flatiron Hlth, New York, NY USA; [Khozin, Sean] US FDA, Silver Spring, MD USA; [Galsky, Matthew D.] Icahn Sch Med, Tisch Canc Inst, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; US Food & Drug Administration (FDA); Icahn School of Medicine at Mount Sinai	Parikh, RB (corresponding author), Abramson Canc Ctr, 3400 Civ Ctr Blvd,Twelfth Floor, Philadelphia, PA 19104 USA.	ravi.parikh@pennmedicine.upenn.edu			Conquer Cancer Foundation from the National Cancer Institute of the National Institutes of Health [5-T32-CA009615, K23-CA187185]; NATIONAL CANCER INSTITUTE [T32CA009615, K23CA187185] Funding Source: NIH RePORTER	Conquer Cancer Foundation from the National Cancer Institute of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Conquer Cancer Foundation (Dr Parikh) and grants 5-T32-CA009615 (Dr Parikh) and K23-CA187185 (Dr Mamtani) from the National Cancer Institute of the National Institutes of Health.	Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Beaver JA, 2018, JAMA ONCOL, V4, P849, DOI 10.1001/jamaoncol.2017.5618; Curtis MD, 2018, HEALTH SERV RES, V53, P4460, DOI 10.1111/1475-6773.12872; O'Connor JM, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0798; Zettler M, 2018, JAMA ONCOL, V4, P993, DOI 10.1001/jamaoncol.2018.0610	6	14	14	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1209	1211		10.1001/jama.2019.10650	http://dx.doi.org/10.1001/jama.2019.10650			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550019	Bronze, Green Published			2022-12-28	WOS:000488822800028
J	Hopkins, J				Hopkins, Janice			Two proposed bills aim to cut drug costs for retired Americans	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5673	10.1136/bmj.l5673	http://dx.doi.org/10.1136/bmj.l5673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WS	31548361				2022-12-28	WOS:000488488000015
J	Salinas-Botran, A; Guarin-Corredor, MJ				Salinas-Botran, Alejandro; Guarin-Corredor, Maria J.			Orbital Metastasis in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Salinas-Botran, Alejandro; Guarin-Corredor, Maria J.] Hosp Denia, Denia, Spain		Salinas-Botran, A (corresponding author), Hosp Denia, Denia, Spain.	asalinasbotran@yahoo.es							0	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					E26	E26		10.1056/NEJMicm1814570	http://dx.doi.org/10.1056/NEJMicm1814570			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4PY	31532964				2022-12-28	WOS:000487066900001
J	Lipscombe, LL				Lipscombe, Lorraine L.			Inpatients >= 50 years with type 2 diabetes and CV disease or risk factors, oral semaglutide did not increase CV events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In patients >= 50 years of age with type 2 diabetes and cardiovascular (CV) disease or risk factors, does oral semaglutide increase risk for CV events? Methods Design: Randomized placebo-controlled trial (Peptide Innovation for Early Diabetes Treatment [PIONEER] 6 trial). ClinicalTrials. gov NCT02692716. Allocation: Concealed.* Blinding: Blinded* (patients, clinicians, and outcome adjudicators). Follow-up period: Median 16 months. Setting: 214 clinical centers in 21 countries. Patients: 3183 adults who had type 2 diabetes (mean age 66 y, 68% men) and were =>= 50 years of age with established CV disease or chronic kidney disease or were >= 60 years of age with CV risk factors only. Exclusion criteria included New York Heart Association class 4 heart failure; long-term or intermittent hemodialysis or peritoneal dialysis, or severe renal impairment; planned coronary-, carotid-, or peripheral artery revascularization; proliferative retinopathy or maculopathy resulting in active treatment; treatment with a glucagon-like peptide-1 receptor agonist (GLP-1RA), dipeptidyl peptidase 4 inhibitor, or pramlintide in the past 90 days; or myocardial infarction (MI), stroke, or hospitalization for unstable angina or transient ischemic attack in the past 60 days. Intervention: Oral semaglutide, target dose 14 mg/d, achieved using a dose-escalation schedule (n = 1591), or placebo (n = 1592). Outcomes: Major adverse cardiac events (composite of death from CV or undetermined causes, nonfatal MI, or nonfatal stroke). Secondary outcomes included components of the primary composite outcome, hospitalization for unstable angina, hospitalization for heart failure, and death from any cause. The prespecified noninferiority limit for the primary outcome was 1.8 (upper boundary of the 2-sided 95% CI around the hazard ratio). Patient follow-up: > 99% (intention-to-treat analysis). Main results The results are in the Table. Conclusion In patients >= 50 years of age with type 2 diabetes and cardiovascular (CV) disease or risk factors, oral semaglutide did not increase risk for CV events compared with placebo.	[Lipscombe, Lorraine L.] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada.			Lipscombe, Lorraine/0000-0001-7412-7993					0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC28	JC28		10.7326/ACPJ201909170-028	http://dx.doi.org/10.7326/ACPJ201909170-028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525762				2022-12-28	WOS:000486101400004
J	Tanne, JH				Tanne, Janice Hopkins			Trump pledges to ban flavoured e-cigarettes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Centers for Disease Control and Prevention, 2019, OUTBR LUNG DIS ASS E; Food and Drug Administration, 2019, FDA IS REG E CIG; Food and Drug Administration, 2019, TRUMP ADM COMB EP YO; Food and Drug Administration, 2019, YOUTH TOB US RES NAT; Food and Drug Administration, 2019, WARN LETT; RIMMER A, 2019, BMJ-BRIT MED J, V366, P67143, DOI DOI 10.1136/BMJ.L5320	6	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5562	10.1136/bmj.l5562	http://dx.doi.org/10.1136/bmj.l5562			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519645				2022-12-28	WOS:000486649800013
J	Abbott, S; Grewal, S; Mehdi, H; Rafferty, M				Abbott, Sarah; Grewal, Sukhmeet; Mehdi, Hassan; Rafferty, Michael			A painful shoulder after a fall	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROXIMAL HUMERUS; FRACTURE		[Abbott, Sarah] West Middlesex Univ Hosp, London, England; [Grewal, Sukhmeet; Mehdi, Hassan] Northwest London NHS Trust, London, England; [Rafferty, Michael] Hillingdon Hosp NHS Trust, London, England	Brunel University; Imperial College London	Abbott, S (corresponding author), West Middlesex Univ Hosp, London, England.	sarah.abbott9@nhs.net						Hohloch L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183157; Hwang RW, 2008, J ORTHOP TRAUMA, V22, P286, DOI 10.1097/BOT.0b013e31816b7898; Landin LA, 1997, J PEDIATR ORTHOP B, V6, P79, DOI 10.1097/01202412-199704000-00002; Neer C S 2nd, 1965, Clin Orthop Relat Res, V41, P24; Pahlavan S, 2011, J CHILD ORTHOP, V5, P187, DOI 10.1007/s11832-011-0328-4; Pandya NK, 2010, J PEDIATR ORTHOP B, V19, P535, DOI 10.1097/BPB.0b013e32833ce424; Popkin CA, 2015, J AM ACAD ORTHOP SUR, V23, P77, DOI 10.5435/JAAOS-D-14-00033; Ryan LM, 2017, PROXIMAL HUMERAL FRA; Wera GD, 2006, J BONE JOINT SURG BR, V88B, P1521, DOI 10.1302/0301-620X.88B11.18164	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l2155	10.1136/bmj.l2155	http://dx.doi.org/10.1136/bmj.l2155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506271				2022-12-28	WOS:000486648900001
J	Kar, P				Kar, Partha			Partha Kar: The NHS really isn't a bad place to work	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Diabet & Endocrinol, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Diabet & Endocrinol, Portsmouth, Hants, England.	drparthakar@gmail.com	Kar, Partha/AAT-4839-2020						0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5451	10.1136/bmj.l5451	http://dx.doi.org/10.1136/bmj.l5451			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506274	Bronze			2022-12-28	WOS:000486648900008
J	Rubin, R				Rubin, Rita			High Unintended Pregnancy Rate Spurs Efforts to Ease Contraceptive Access	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News story discusses efforts to remove barriers faced by women seeking birth control pills and other hormonal contraceptives.					Rubin, Rita/AAD-1259-2020						0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2019	322	15					1434	1436		10.1001/jama.2019.15237	http://dx.doi.org/10.1001/jama.2019.15237			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI4ST	31553401				2022-12-28	WOS:000493458400001
J	Huber, F; Berwanger, J; Polesya, S; Mankovsky, S; Ebert, H; Giessibl, FJ				Huber, Ferdinand; Berwanger, Julian; Polesya, Svitlana; Mankovsky, Sergiy; Ebert, Hubert; Giessibl, Franz J.			Chemical bond formation showing a transition from physisorption to chemisorption	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; ADSORPTION; RESOLUTION; SURFACE; CO; MOLECULE; ENERGY; ORDER	Surface molecules can transition from physisorption through weak van der Waals forces to a strongly bound chemisorption state by overcoming an energy barrier. We show that a carbon monoxide (CO) molecule adsorbed to the tip of an atomic force microscope enables a controlled observation of bond formation, including its potential transition from physisorption to chemisorption. During imaging of copper (Cu) and iron (Fe) adatoms on a Cu(111) surface, the CO was not chemically inert but transited through a physisorbed local energy minimum into a chemisorbed global minimum, and an energy barrier was seen for the Fe adatom. Density functional theory reveals that the transition occurs through a hybridization of the electronic states of the CO molecule mainly with s-, p(z)-, and d(z)(2)-type states of the Fe and Cu adatoms, leading to chemical bonding.	[Huber, Ferdinand; Berwanger, Julian; Giessibl, Franz J.] Univ Regensburg, Dept Phys, Inst Expt & Appl Phys, D-93040 Regensburg, Germany; [Polesya, Svitlana; Mankovsky, Sergiy; Ebert, Hubert] Ludwig Maximilians Univ Munchen, Dept Chem, D-81377 Munich, Germany	University of Regensburg; University of Munich	Giessibl, FJ (corresponding author), Univ Regensburg, Dept Phys, Inst Expt & Appl Phys, D-93040 Regensburg, Germany.	franz.giessibl@ur.de	Giessibl, Franz J/K-8022-2013	Giessibl, Franz J/0000-0002-5585-1326; Berwanger, Julian/0000-0003-1279-1658; Mankovskyy, Sergiy/0000-0002-6716-6094; Huber, Ferdinand/0000-0001-8647-6971	Deutsche Forschungsgemeinschaft [CRC1277]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the Deutsche Forschungsgemeinschaft for funding under research project CRC1277, project A02.	ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Bartels L, 1997, APPL PHYS LETT, V71, P213, DOI 10.1063/1.119503; BEDNORZ JG, 1988, ANGEW CHEM INT EDIT, V27, P735, DOI 10.1002/anie.198807351; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Boneschanscher MP, 2012, ACS NANO, V6, P10216, DOI 10.1021/nn3040155; BRODEN G, 1976, SURF SCI, V59, P593, DOI 10.1016/0039-6028(76)90038-8; Cocker TL, 2016, NATURE, V539, P263, DOI 10.1038/nature19816; DURIG U, 1992, J APPL PHYS, V72, P1778, DOI 10.1063/1.352348; Emmrich M, 2015, SCIENCE, V348, P308, DOI 10.1126/science.aaa5329; Ertl G, 2008, ANGEW CHEM INT EDIT, V47, P3524, DOI 10.1002/anie.200800480; Feynman R. P., 1963, FEYNMAN LECT PHYS, V1, DOI 10.1201/9780429502859-1; Gajdos M, 2005, SURF SCI, V590, P117, DOI 10.1016/j.susc.2005.04.047; Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; Giessibl FJ, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5052264; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Hapala P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.226101; Hapala P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085421; HOFFMANN R, 1988, REV MOD PHYS, V60, P601, DOI 10.1103/RevModPhys.60.601; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Ibach H, 2006, PHYS SURFACES INTERF; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; Lennard-Jones JE, 1932, T FARADAY SOC, V28, P0333, DOI 10.1039/tf9322800333; Mohn F, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793200; Moll N, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083023; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Pacchioni GE, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.235426; Pauling L., 1960, NATURE CHEM BOND; Pavlicek N, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-016-0005; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Perez R, 1997, PHYS REV LETT, V78, P678, DOI 10.1103/PhysRevLett.78.678; PROPST FM, 1967, J VAC SCI TECHNOL, V4, P53, DOI 10.1116/1.1492522; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Sader JE, 2018, NAT NANOTECHNOL, V13, P1088, DOI 10.1038/s41565-018-0277-x; Schneiderbauer M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.166102; STILLINGER FH, 1985, PHYS REV B, V31, P5262, DOI 10.1103/PhysRevB.31.5262; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; SUNG SS, 1985, J AM CHEM SOC, V107, P578, DOI 10.1021/ja00289a009; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850; Weymouth AJ, 2014, SCIENCE, V343, P1120, DOI 10.1126/science.1249502; Zangwill A., 1988, PHYS SURFACES	45	41	42	14	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2019	366	6462					235	+		10.1126/science.aay3444	http://dx.doi.org/10.1126/science.aay3444			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD5HS	31515246				2022-12-28	WOS:000490014700042
J	Xu, L; Wang, J; Liu, YL; Xie, LF; Su, B; Mou, DL; Wang, LT; Liu, TT; Wang, XB; Zhang, B; Zhao, L; Hu, LD; Ning, HM; Zhang, YF; Deng, K; Liu, LF; Lu, XF; Zhang, T; Xu, J; Li, C; Wu, H; Deng, HK; Chen, H				Xu, Lei; Wang, Jun; Liu, Yulin; Xie, Liangfu; Su, Bin; Mou, Danlei; Wang, Longteng; Liu, Tingting; Wang, Xiaobao; Zhang, Bin; Zhao, Long; Hu, Liangding; Ning, Hongmei; Zhang, Yufeng; Deng, Kai; Liu, Lifeng; Lu, Xiaofan; Zhang, Tong; Xu, Jun; Li, Cheng; Wu, Hao; Deng, Hongkui; Chen, Hu			CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-THERAPY; CCR5; CORECEPTOR; RNA; DNA	The safety of CRISPR (clustered regularly interspaced short palindromic repeats)-based genome editing in the context of human gene therapy is largely unknown. CCR5 is a reasonable but not absolutely protective target for a cure of human immunodeficiency virus type 1 (HIV-1) infection, because CCR5-null blood cells are largely resistant to HIV-1 entry. We transplanted CRISPR-edited CCR5-ablated hematopoietic stem and progenitor cells (HSPCs) into a patient with HIV-1 infection and acute lymphoblastic leukemia. The acute lymphoblastic leukemia was in complete remission with full donor chimerism, and donor cells carrying the ablated CCR5 persisted for more than 19 months without gene editing-related adverse events. The percentage of CD4+ cells with CCR5 ablation increased by a small degree during a period of antiretroviral-therapy interruption. Although we achieved successful transplantation and long-term engraftment of CRISPR-edited HSPCs, the percentage of CCR5 disruption in lymphocytes was only approximately 5%, which indicates the need for further research into this approach. (Funded by the Beijing Municipal Science and Technology Commission and others; ClinicalTrials.gov number, NCT03164135.)	[Xu, Lei; Wang, Jun; Liu, Tingting; Zhang, Bin; Hu, Liangding; Ning, Hongmei; Zhang, Yufeng; Chen, Hu] Peking Univ, Hlth Sci Ctr, State Key Lab Nat & Biomimet Drugs, Dept Hematopoiet Stem Cell Transplantat,Stem Cell, Beijing, Peoples R China; [Zhang, Bin; Zhao, Long; Hu, Liangding; Chen, Hu] Peking Univ, Hlth Sci Ctr, Cell & Gene Therapy Ctr,307 Hosp Peoples Liberat, Stem Cell Res Ctr,State Key Lab Nat & Biomimet Dr, Beijing, Peoples R China; [Zhang, Bin; Zhao, Long; Hu, Liangding; Chen, Hu] Peking Univ, Hlth Sci Ctr, Med Ctr 5,Peoples Liberat Army Gen Hosp, Stem Cell Res Ctr,State Key Lab Nat & Biomimet Dr, Beijing, Peoples R China; [Zhang, Bin; Zhao, Long; Hu, Liangding; Chen, Hu] Peking Univ, Hlth Sci Ctr, Dept Cell Biol,Sch Basic Med Sci, Stem Cell Res Ctr,State Key Lab Nat & Biomimet Dr, Beijing, Peoples R China; [Liu, Yulin; Xie, Liangfu; Wang, Xiaobao; Xu, Jun; Deng, Hongkui] Peking Univ, Minist Educ, Key Lab Cell Proliferat & Differentiat, Coll Life Sci,Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Wang, Longteng; Li, Cheng] Peking Univ, Sch Life Sci, Ctr Stat Sci, Beijing, Peoples R China; [Wang, Longteng; Li, Cheng] Peking Univ, Ctr Bioinformat, Beijing, Peoples R China; [Su, Bin; Mou, Danlei; Liu, Lifeng; Lu, Xiaofan; Zhang, Tong; Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing Key Lab HIV AIDS Res, Beijing, Peoples R China; [Deng, Kai] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou, Guangdong, Peoples R China	Peking University; Peking University; Chinese People's Liberation Army General Hospital; Peking University; Peking University; Peking University; Peking University; Peking University; Capital Medical University; Sun Yat Sen University	Deng, HK (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Cell Biol,Sch Basic Med Sci, State Key Lab Nat & Biomimet Drugs,Stem Cell Res, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.; Deng, HK (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	hongkui_deng@pku.edu.cn	X, Eric/ABF-1777-2020; Zhang, Tong/HGC-1090-2022; Xu, Lei/I-5238-2013; Zhang, Yufeng/GZL-1973-2022; Deng, Kai/AAK-4404-2020	Xu, Lei/0000-0002-3573-8334; Deng, Kai/0000-0002-9973-8130; Wang, Longteng/0000-0002-0904-8081; Su, Bin/0000-0001-5140-0440	Beijing Municipal Science and Technology Commission	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	Funded by the Beijing Municipal Science and Technology Commission and others	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Chiusa L, 2006, HAEMATOL-HEMATOL J, V91, P270; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Du PW, 2016, MICROBIOL IMMUNOL, V60, P187, DOI 10.1111/1348-0421.12361; Gupta RK, 2019, NATURE, V568, P244, DOI 10.1038/s41586-019-1027-4; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Heesch S, 2010, HAEMATOL-HEMATOL J, V95, P942, DOI 10.3324/haematol.2009.016386; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jiao YM, 2012, VIRAL IMMUNOL, V25, P262, DOI 10.1089/vim.2012.0035; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Peterson CW, 2016, BLOOD, V127, P2416, DOI 10.1182/blood-2015-09-672337; Porteus MH, 2019, NEW ENGL J MED, V380, P947, DOI 10.1056/NEJMra1800729; Roberto A, 2015, BLOOD, V125, P2855, DOI 10.1182/blood-2014-11-608406; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Wei XZ, 2019, NAT MED, V25, P909, DOI 10.1038/s41591-019-0459-6; Wroblewska L, 2015, NAT BIOTECHNOL, V33, P839, DOI 10.1038/nbt.3301; Xu L, 2017, MOL THER, V25, P1782, DOI 10.1016/j.ymthe.2017.04.027; 2014, REG ANESTH PAIN MED, V9, pE1084	22	206	230	20	218	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1240	1247		10.1056/NEJMoa1817426	http://dx.doi.org/10.1056/NEJMoa1817426			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OT	31509667	Bronze			2022-12-28	WOS:000489333500008
J	Dyer, C				Dyer, Clare			Registrar who left emergency department while pregnant woman was in cardiac arrest is struck off after showing no "convincing remorse"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2019	366								l5717	10.1136/bmj.l5717	http://dx.doi.org/10.1136/bmj.l5717			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WY	31554614				2022-12-28	WOS:000488488700010
J	Iacobucci, G				Iacobucci, Gareth			Class A drugs: use by young adults is at 16 year high, figures show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Home Office, 2019, DRUG MIS FIND 2018 2	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5685	10.1136/bmj.l5685	http://dx.doi.org/10.1136/bmj.l5685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WS	31548284				2022-12-28	WOS:000488488000017
J	Nicholson, BD; Aveyard, P; Hamilton, W; Hobbs, FDR				Nicholson, Brian D.; Aveyard, Paul; Hamilton, Willie; Hobbs, F. D. Richard			When should unexpected weight loss warrant further investigation to exclude cancer?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE PATIENTS; CLINICAL-FEATURES; IDENTIFYING PATIENTS; EXTERNAL VALIDATION; COLORECTAL-CANCER; PANCREATIC-CANCER; SYMPTOMATIC PATIENTS; LUNG-CANCER; RISK; DIAGNOSIS		[Nicholson, Brian D.; Aveyard, Paul; Hobbs, F. D. Richard] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Hamilton, Willie] Univ Exeter, Med Sch, Exeter, Devon, England	University of Oxford; University of Exeter	Nicholson, BD (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	brian.nicholson@phc.ox.ac.uk		Aveyard, Paul/0000-0002-1802-4217; Hamilton, William/0000-0003-1611-1373	National Institute for Health Research (NIHR) Doctoral Research Fellowship [DRF-2015-08-18]; Cancer Research UK Population Research Catalyst award [C8640/A23385]; NIHR Oxford Biomedical Research Centre; NIHR School for Primary Care Research; NIHR Collaboration for Leadership in Health Research and Care (CLARHC) Oxford; NIHR Oxford Biomedical Research Centre (BRC,) UHT); NIHR Oxford Medtech and In-Vitro Diagnostics Co-operative (MIC); CLAHRC	National Institute for Health Research (NIHR) Doctoral Research Fellowship(National Institute for Health Research (NIHR)); Cancer Research UK Population Research Catalyst award; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR School for Primary Care Research; NIHR Collaboration for Leadership in Health Research and Care (CLARHC) Oxford; NIHR Oxford Biomedical Research Centre (BRC,) UHT); NIHR Oxford Medtech and In-Vitro Diagnostics Co-operative (MIC); CLAHRC	BDN is funded as part of the National Institute for Health Research (NIHR) Doctoral Research Fellowship (DRF-2015-08-18). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. WH is co-principal investigator of the multi-institutional CanTest Research Collaborative funded by a Cancer Research UK Population Research Catalyst award (C8640/A23385). PA is an NIHR senior investigator and funded by the NIHR Oxford Biomedical Research Centre and CLAHRC. FDRH has part funding from the NIHR School for Primary Care Research, the NIHR Collaboration for Leadership in Health Research and Care (CLARHC) Oxford, the NIHR Oxford Biomedical Research Centre (BRC,) UHT), and the NIHR Oxford Medtech and In-Vitro Diagnostics Co-operative (MIC).	Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Caan BJ, 2018, JAMA ONCOL, V4, P798, DOI 10.1001/jamaoncol.2018.0137; Caan BJ, 2017, CANCER EPIDEM BIOMAR, V26, P1008, DOI [10.1158/1055-9965.epi-17-0200, 10.1158/1055-9965.EPI-17-0200]; Collins GS, 2013, EUR J CANCER CARE, V22, P423, DOI 10.1111/ecc.12015; Collins GS, 2012, BRIT J CANCER, V107, P260, DOI 10.1038/bjc.2012.266; Collins GS, 2013, BRIT J GEN PRACT, V63, pE636, DOI 10.3399/bjgp13X671623; Collins GS, 2013, EUR J CANCER, V49, P1040, DOI 10.1016/j.ejca.2012.10.023; Collins GS, 2013, CANCER EPIDEMIOL, V37, P115, DOI 10.1016/j.canep.2012.11.005; CURLESS R, 1994, GUT, V35, P1267, DOI 10.1136/gut.35.9.1267; Ewing M, 2016, BRIT J GEN PRACT, V66, pE880, DOI 10.3399/bjgp16X687985; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Forster AS, 2018, CANCER EPIDEMIOL, V54, P101, DOI 10.1016/j.canep.2018.03.011; Gaddey HL, 2014, AM FAM PHYSICIAN, V89, P718; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Hamilton W, 2006, BRIT J GEN PRACT, V56, P756; Hamilton W, 2015, BRIT J GEN PRACT, V65, pE516, DOI 10.3399/bjgp15X686077; Hamilton William, 2015, BMJ, V350, ph3044, DOI 10.1136/bmj.h3044; Hamilton W, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-17; Hippisley-Cox J, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660724; Hippisley-Cox J, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660733; Hippisley-Cox J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X616346; Hippisley-Cox J, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606609; HIPPISLEYCOX J, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.D8009; Hippsley-Cox J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636074; Holly EA, 2004, CLIN GASTROENTEROL H, V2, P510, DOI 10.1016/S1542-3565(04)00171-5; Iyen-Omofoman B, 2013, THORAX, V68, P451, DOI 10.1136/thoraxjnl-2012-202348; Keane MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005720; Koo MM, 2018, NEOPLASIA, V20, P165, DOI 10.1016/j.neo.2017.11.005; Lim AWW, 2012, JNCI-J NATL CANCER I, V104, P114, DOI 10.1093/jnci/djr486; Loumaye A, 2017, CLIN BIOCHEM, V50, P1281, DOI 10.1016/j.clinbiochem.2017.07.011; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; Nicholson BD, 2019, CLIN EPIDEMIOL, V11, P145, DOI 10.2147/CLEP.S189989; Nicholson BD, 2018, BRIT J GEN PRACT, V68, pE311, DOI 10.3399/bjgp18X695801; NIHR PROSPERO, 2018, SYSTEMATIC REV SCREE; Olson SH, 2016, PANCREAS, V45, P986, DOI 10.1097/MPA.0000000000000590; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Rolland Y, 2006, AM J MED, V119, P1019, DOI 10.1016/j.amjmed.2006.02.039; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Shephard EA, 2016, BRIT J GEN PRACT, V66, pE182, DOI 10.3399/bjgp16X683989; Shephard EA, 2015, BRIT J GEN PRACT, V65, pE289, DOI 10.3399/bjgp15X684805; Shephard EA, 2015, BRIT J GEN PRACT, V65, pE106, DOI 10.3399/bjgp15X683545; Stapley S, 2013, BRIT J CANCER, V108, P25, DOI 10.1038/bjc.2012.551; Stapley S, 2012, BRIT J CANCER, V106, P1940, DOI 10.1038/bjc.2012.190; Vanderschueren Steven, 2005, Eur J Intern Med, V16, P160, DOI 10.1016/j.ejim.2005.01.004; Wallace JI, 2002, INT J CARDIOL, V85, P15, DOI 10.1016/S0167-5273(02)00246-2; Walter FM, 2016, LANCET GASTROENTEROL, V1, P298, DOI 10.1016/S2468-1253(16)30079-6; Wong CJ, 2014, MED CLIN N AM, V98, P625, DOI 10.1016/j.mcna.2014.01.012	49	8	8	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5271	10.1136/bmj.l5271	http://dx.doi.org/10.1136/bmj.l5271			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WS	31548272	Green Published			2022-12-28	WOS:000488488000003
J	Iacobucci, G				Iacobucci, Gareth			Huge increase in hospital activity should be "wake-up call," says acute medicine leader	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Digital, 2019, HOSP ADM PAT CAR AD	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2019	366								l5661	10.1136/bmj.l5661	http://dx.doi.org/10.1136/bmj.l5661			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WG	31540908				2022-12-28	WOS:000487759700007
J	Lopez, VA; Park, BC; Nowak, D; Sreelatha, A; Zembek, P; Fernandez, J; Servage, KA; Gradowski, M; Hennig, J; Tomchick, DR; Pawlowski, K; Krzymowska, M; Tagliabracci, VS				Lopez, Victor A.; Park, Brenden C.; Nowak, Dominika; Sreelatha, Anju; Zembek, Patrycja; Fernandez, Jessie; Servage, Kelly A.; Gradowski, Marcin; Hennig, Jacek; Tomchick, Diana R.; Pawlowski, Krzysztof; Krzymowska, Magdalena; Tagliabracci, Vincent S.			A Bacterial Effector Mimics a Host HSP90 Client to Undermine Immunity	CELL			English	Article							PSEUDOMONAS-SYRINGAE; DISEASE RESISTANCE; CRYSTAL-STRUCTURE; III EFFECTOR; PROTEIN; KINASE; PLANT; SGT1; PATHOGEN; RAR1	The molecular chaperone HSP90 facilitates the folding of several client proteins, including innate immune receptors and protein kinases. HSP90 is an essential component of plant and animal immunity, yet pathogenic strategies that directly target the chaperone have not been described. Here, we identify the HopBF1 family of bacterial effectors as eukaryotic-specific HSP90 protein kinases. Hop BF1 adopts a minimal protein kinase fold that is recognized by HSP90 as a host client. As a result, HopBF1 phosphoryiates HSP90 to completely inhibit the chaperone's ATPase activity. We demonstrate that phosphorylation of HSP90 prevents activation of immune receptors that trigger the hypersensitive response in plants. Consequently, HopBF1 -dependent phosphorylation of HSP90 is sufficient to induce severe disease symptoms in plants infected with the bacterial pathogen, Pseudomonas syringae. Collectively, our results uncover a family of bacterial effector kinases with toxin-like properties and reveal a previously unrecognized betrayal mechanism by which bacterial pathogens modulate host immunity.	[Lopez, Victor A.; Park, Brenden C.; Sreelatha, Anju; Fernandez, Jessie; Servage, Kelly A.; Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Nowak, Dominika; Zembek, Patrycja; Hennig, Jacek; Krzymowska, Magdalena] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Servage, Kelly A.] Howard Hughes Med Inst, Dallas, TX 75390 USA; [Gradowski, Marcin; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Warsaw, Poland; [Tomchick, Diana R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Pawlowski, Krzysztof] Lund Univ, Lund, Sweden	University of Texas System; University of Texas Southwestern Medical Center Dallas; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Howard Hughes Medical Institute; Warsaw University of Life Sciences; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Lund University	Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	vincent.tagliabracci@utsouthwestern.edu	Krzymowska, Magdalena/GXZ-6495-2022; Gradowski, Marcin/AHC-8195-2022; Tomchick, Diana/HGV-2018-2022; Fernandez, Jessie/AAR-3477-2021; Pawlowski, Krzysztof/C-2949-2013	Gradowski, Marcin/0000-0001-7695-5434; Hennig, Jacek/0000-0003-0156-1320; Nowak, Dominika/0000-0002-6639-233X; Tomchick, Diana/0000-0002-7529-4643; Krzymowska, Magdalena/0000-0001-9016-9165; Fernandez, Jessie/0000-0002-0897-2707; Zembek, Patrycja Beata/0000-0002-7079-3902; Pawlowski, Krzysztof/0000-0002-5367-0935; Lopez, Victor Antonio/0000-0003-1618-5786; Servage, Kelly/0000-0001-7183-2865	Centre for Preclinical Research and Technology (CePT); European Regional Development Fund; Innovative Economy Programme, The National Cohesion Strategy of Poland; NIH [R00DK099254, T32DK007257-37, T32GM008203-29]; Welch Foundation [I-1911]; Cancer Prevention Research Institute of Texas (CPRIT) [RP170674]; Polish National Science Centre [2014/15/B/NZ1/03359, 2017/25/B/NZ1/01883]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK099254, T32DK007257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	Centre for Preclinical Research and Technology (CePT); European Regional Development Fund(European Commission); Innovative Economy Programme, The National Cohesion Strategy of Poland; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention Research Institute of Texas (CPRIT); Polish National Science Centre; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Kim Orth, Neal Alto, Melanie Cobb, Greg Taylor, Dor Salomon, and members of the Tagliabracci laboratory for insightful discussions. We also thank Dr. Farid El Kasmi for providing RPM1 constructs. Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by the European Regional Development Fund and the Innovative Economy Programme, The National Cohesion Strategy of Poland. This work was supported by the NIH (R00DK099254 to V.S.T., T32DK007257-37 to A.S., and T32GM008203-29 to V.A.L.), the Welch Foundation (I-1911 to V.S.T), Cancer Prevention Research Institute of Texas (CPRIT) (RP170674 to V.S.T), and the Polish National Science Centre (2014/15/B/NZ1/03359 to K.P. and 2017/25/B/NZ1/01883 to M.K.). V.S.T. is the Michael L. Rosenberg Scholar in Medical Research, CPRIT Scholar (RR150033), and Searle Scholar.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Baltrus D. A., 2011, PLOS ONE, V7, P1; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Cunnac S, 2011, P NATL ACAD SCI USA, V108, P2975, DOI 10.1073/pnas.1013031108; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Dangl JL, 2006, P NATL ACAD SCI USA, V103, P8575, DOI 10.1073/pnas.0603183103; de Oliveira PSL, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4016; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Gao X., 2009, PLOS PATHOG, V5, P1; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giska F, 2013, PLANT PHYSIOL, V161, P2049, DOI 10.1104/pp.112.209023; Golisz A, 2013, NUCLEIC ACIDS RES, V41, P6232, DOI 10.1093/nar/gkt296; Grishin AM, 2014, STRUCTURE, V22, P250, DOI 10.1016/j.str.2013.11.006; Hassan S, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/730720; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Hubert DA, 2009, P NATL ACAD SCI USA, V106, P9556, DOI 10.1073/pnas.0904877106; Hulin MT, 2018, NEW PHYTOL, V219, P672, DOI 10.1111/nph.15182; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Kadota Y, 2012, BBA-MOL CELL RES, V1823, P689, DOI 10.1016/j.bbamcr.2011.09.016; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller CJ, 2018, TRENDS BIOCHEM SCI, V43, P380, DOI 10.1016/j.tibs.2018.02.009; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Nguyen KB, 2016, P NATL ACAD SCI USA, V113, pE3482, DOI 10.1073/pnas.1605917113; O'Brien HE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-141; Otwinowski Z, 1991, CCP4 STUD WEEK DAR L; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piechocki M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01060; Pruneda JN, 2014, EMBO J, V33, P437, DOI 10.1002/embj.201386386; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Verba KA, 2017, TRENDS BIOCHEM SCI, V42, P799, DOI 10.1016/j.tibs.2017.07.002; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Xin XF, 2018, NAT REV MICROBIOL, V16, P316, DOI 10.1038/nrmicro.2018.17; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Xu D, 2014, BIOINFORMATICS, V30, P660, DOI 10.1093/bioinformatics/btt578; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Zembek P, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00978; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057558; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	103	26	28	2	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					205	+		10.1016/j.cell.2019.08.020	http://dx.doi.org/10.1016/j.cell.2019.08.020			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31522888	Bronze, Green Accepted			2022-12-28	WOS:000486618500024
J	Savage, N				Savage, Neil			A bigger arsenal	NATURE			English	Editorial Material																			0	3	3	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					S54	S55		10.1038/d41586-019-02753-8	http://dx.doi.org/10.1038/d41586-019-02753-8			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534252				2022-12-28	WOS:000486647800006
J	Takemata, N; Samson, RY; Bell, SD				Takemata, Naomichi; Samson, Rachel Y.; Bell, Stephen D.			Physical and Functional Compartmentalization of Archaeal Chromosomes	CELL			English	Article							CELL-DIVISION; HYPERTHERMOPHILIC ARCHAEA; REPLICATION ORIGINS; FACTOR REQUIREMENTS; DNA TOPOLOGY; HI-C; SULFOLOBUS; CONDENSIN; ORGANIZATION; SMC	The three-dimensional organization of chromosomes can have a profound impact on their replication and expression. The chromosomes of higher eukaryotes possess discrete compartments that are characterized by differing transcriptional activities. Contrastingly, most bacterial chromosomes have simpler organization with local domains, the boundaries of which are influenced by gene expression. Numerous studies have revealed that the higher-order architectures of bacterial and eukaryotic chromosomes are dependent on the actions of structural maintenance of chromosomes (SMC) superfamily protein complexes, in particular, the near-universal condensin complex. Intriguingly, however, many archaea, including members of the genus Sulfolobus do not encode canonical condensin. We describe chromosome conformation capture experiments on Sulfolobus species. These reveal the presence of distinct domains along Sulfolobus chromosomes that undergo discrete and specific higher-order interactions, thus defining two compartment types. We observe causal linkages between compartment identity, gene expression, and binding of a uncharacterized SMC superfamily protein that we term "coalescin."	[Takemata, Naomichi; Samson, Rachel Y.; Bell, Stephen D.] Indiana Univ, Mol & Cellular Biochem Dept, Bloomington, IN 47405 USA; [Takemata, Naomichi; Bell, Stephen D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bell, SD (corresponding author), Indiana Univ, Mol & Cellular Biochem Dept, Bloomington, IN 47405 USA.; Bell, SD (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	stedbell@indiana.edu		Takemata, Naomichi/0000-0003-1902-3766; Bell, Stephen/0000-0002-8474-6592	JSPS Overseas Research Fellowship (Japan Society for the Promotion of Science); NIH [R01GM125579]; College of Arts and Science, Indiana University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125579] Funding Source: NIH RePORTER	JSPS Overseas Research Fellowship (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Arts and Science, Indiana University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.T. is funded by a JSPS Overseas Research Fellowship (Japan Society for the Promotion of Science). R.Y.S. and S.D.B.' s laboratory is funded by the College of Arts and Science, Indiana University and NIH grant R01GM125579. We are indebted to Qunxin She (University of Copenhagen) and Norio Kurosawa (Soka University) for agmatine auxotroph strains and Eveline Peeters (Vrije Universiteit Brussel) for her kind gift of the fadR deletion strain. We are indebted to all the staff of the Center for Genomics and Bioinformatics, Indiana University and Dave Miller in particular for help and advice. We thank Christiane Hassel of the Indiana University Flow Cytometry Core Facility for assistance with flow cytometry.	Andersson AF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r99; Andersson AF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-454; Bell SD, 1998, P NATL ACAD SCI USA, V95, P15218, DOI 10.1073/pnas.95.26.15218; Bernander R, 1997, J BACTERIOL, V179, P4963, DOI 10.1128/jb.179.16.4963-4969.1997; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Diebold-Durand ML, 2017, MOL CELL, V67, P334, DOI 10.1016/j.molcel.2017.06.010; Duggin IG, 2008, P NATL ACAD SCI USA, V105, P16737, DOI 10.1073/pnas.0806414105; Duggin IG, 2011, EMBO J, V30, P145, DOI 10.1038/emboj.2010.301; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Haug-Baltzell A, 2017, BIOINFORMATICS, V33, P2197, DOI 10.1093/bioinformatics/btx144; Hirano T, 2016, CELL, V164, P847, DOI 10.1016/j.cell.2016.01.033; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kalliomaa-Sanford AK, 2012, P NATL ACAD SCI USA, V109, P3754, DOI 10.1073/pnas.1113384109; Kamada K, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700166; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Lesne A, 2014, NAT METHODS, V11, P1141, DOI [10.1038/nmeth.3104, 10.1038/NMETH.3104]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindas AC, 2013, NAT REV MICROBIOL, V11, P627, DOI 10.1038/nrmicro3077; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lioy VS, 2018, CELL, V172, P771, DOI 10.1016/j.cell.2017.12.027; Lopez-Garcia P, 1999, MOL MICROBIOL, V33, P766, DOI 10.1046/j.1365-2958.1999.01524.x; LopezGarcia P, 1997, MOL MICROBIOL, V23, P1267, DOI 10.1046/j.1365-2958.1997.3051668.x; Lundgren M, 2004, P NATL ACAD SCI USA, V101, P7046, DOI 10.1073/pnas.0400656101; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Nolivos S, 2014, FEMS MICROBIOL REV, V38, P380, DOI 10.1111/1574-6976.12045; Nuebler J, 2018, P NATL ACAD SCI USA, V115, pE6697, DOI 10.1073/pnas.1717730115; Oh J, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120589; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Poplawski A, 1997, J BACTERIOL, V179, P7625; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson NP, 2007, P NATL ACAD SCI USA, V104, P5806, DOI 10.1073/pnas.0700206104; Robinson NP, 2007, EMBO J, V26, P816, DOI 10.1038/sj.emboj.7601529; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Samson RY, 2013, CELL REP, V3, P485, DOI 10.1016/j.celrep.2013.01.002; Samson RY, 2011, CURR OPIN MICROBIOL, V14, P350, DOI 10.1016/j.mib.2011.04.005; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Seeber A, 2016, MOL CELL, V64, P951, DOI 10.1016/j.molcel.2016.10.032; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Servant N, 2012, BIOINFORMATICS, V28, P2843, DOI 10.1093/bioinformatics/bts521; Spang A, 2017, SCIENCE, V357, DOI 10.1126/science.aaf3883; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Tran NT, 2017, CELL REP, V20, P2057, DOI 10.1016/j.celrep.2017.08.026; Trussart M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14665; van Ruiten MS, 2018, TRENDS GENET, V34, P477, DOI 10.1016/j.tig.2018.03.003; Varani AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r30; Vickridge E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14618; Wang K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09479-1; Wang XD, 2017, SCIENCE, V355, P524, DOI 10.1126/science.aai8982; Wang XD, 2015, GENE DEV, V29, P1661, DOI 10.1101/gad.265876.115; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Zhang C., 2017, APPL ENVIRON MICROB, V84; Zhang CY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07379-4; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng T, 2012, APPL ENVIRON MICROB, V78, P568, DOI 10.1128/AEM.06095-11	64	30	32	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					165	+		10.1016/j.cell.2019.08.036	http://dx.doi.org/10.1016/j.cell.2019.08.036			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539494	Green Accepted, Bronze			2022-12-28	WOS:000486618500021
J	Oliver, D				Oliver, David			David Oliver: 25m pound for hospices won't go far	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2014, ONE CHANCE GET IT RI; Dunhill L., 2019, HLTH SERV J; Economist Intelligence Unit, 2015, 2015 QUAL DEATH IND; Hewitt D., 2019, ITV NEWS; Hospice UK, FACTAND FIG; King's Fund, 2019, NHS BUDG IT HAS CHAN; National Association of Hospice Fundraisers, HIST HOSP MOV; Prime Minister's Office, 2019, 10 DOWN STREET JOHNS; Public Health England, ATL VAR PALL END LIF; Public Health England, 2019, OFF STAT END LIF CAR; Royal College of Physicians, 2016, NEW RCP END LIF CAR; Royal College of Physicians, 2015, CENS CONS PHYS HIGH; Royal College of Physicians, SPEC SPOTL PALL MED	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2019	366								l5520	10.1136/bmj.l5520	http://dx.doi.org/10.1136/bmj.l5520			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VZ	31533916	Bronze			2022-12-28	WOS:000487759000006
J	Cutler, DM				Cutler, David M.			Nursing Our Way to Better Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Cutler, David M.] Harvard Univ, Appl Econ, Dept Econ, Cambridge, MA 02138 USA; [Cutler, David M.] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard University	Cutler, DM (corresponding author), Harvard Univ, Appl Econ, Dept Econ, Cambridge, MA 02138 USA.; Cutler, DM (corresponding author), Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA.	dcutler@fas.harvard.edu		Cutler, David/0000-0002-4949-8917					0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1033	1034		10.1001/jama.2019.13834	http://dx.doi.org/10.1001/jama.2019.13834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31528996	Bronze			2022-12-28	WOS:000488821100003
J	Kamerow, D				Kamerow, Douglas			Are e-cigarettes killing people in the US? Two issues need to be disentangled	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA.; Kamerow, D (corresponding author), Georgetown Univ, Family Med, Washington, DC 20057 USA.	dkamerow@aafp.org						Centers for Disease Control and Prevention, 2019, OUTBR LUNG DIS ASS E; Christiani DC, 2019, N ENGL J MED; Doward J, 2019, GUARDIAN; Kaplan S, 2019, NY TIMES; Maddock SD, 2019, NEW ENGL J MED, DOI [10.1056/NEJMc1912038.31491073, DOI 10.1056/NEJMC1912038.31491073]; RIMMER A, 2019, BMJ-BRIT MED J, V366, P67143, DOI DOI 10.1136/BMJ.L5320; Tanne JH, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5562	7	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5591	10.1136/bmj.l5591	http://dx.doi.org/10.1136/bmj.l5591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530535				2022-12-28	WOS:000487758600011
J	Bosurgi, R				Bosurgi, Raffaella			Climate crisis: healthcare is a major contributor, global report finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health Care Without Harm, 2019, HEALTHC CLIM FOOTPR	1	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5560	10.1136/bmj.l5560	http://dx.doi.org/10.1136/bmj.l5560			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519554				2022-12-28	WOS:000486649800012
J	Nogrady, B				Nogrady, Bianca			Operating without opioids	NATURE			English	Editorial Material							SURGERY											Alam A, 2012, ARCH INTERN MED, V172, P425, DOI 10.1001/archinternmed.2011.1827; Brat GA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5790; Ladha KS, 2018, JAMA-J AM MED ASSOC, V320, P502, DOI 10.1001/jama.2018.6933; Lou I, 2017, ANN SURG ONCOL, V24, P1951, DOI 10.1245/s10434-017-5781-y; Mark J, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5452; Roughead EE, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023990; Trabulsi EJ, 2010, UROLOGY, V76, P1122, DOI 10.1016/j.urology.2010.03.052	7	0	0	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					S8	S9		10.1038/d41586-019-02685-3	http://dx.doi.org/10.1038/d41586-019-02685-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511675	Bronze			2022-12-28	WOS:000485415400006
J	Wise, J				Wise, Jacqui			Cancer survival improves in UK but still lags behind other high income countries	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Arnold M, 2019, LANCET ONCOL, V20, P1493, DOI 10.1016/S1470-2045(19)30456-5	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2019	366								l5508	10.1136/bmj.l5508	http://dx.doi.org/10.1136/bmj.l5508			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MQ	31511229				2022-12-28	WOS:000486649100005
J	Gander, JC; Zhang, X; Ross, K; Wilk, AS; McPherson, L; Browne, T; Pastan, SO; Walker, E; Wang, Z; Patzer, RE				Gander, Jennifer C.; Zhang, Xingyu; Ross, Katherine; Wilk, Adam S.; McPherson, Laura; Browne, Teri; Pastan, Stephen O.; Walker, Elizabeth; Wang, Zhensheng; Patzer, Rachel E.			Association Between Dialysis Facility Ownership and Access to Kidney Transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; PATIENT; INFORMATION; DISPARITIES; PROVISION; EDUCATION; BARRIERS; SURVIVAL; DISEASE; RATES	ImportanceFor-profit (vs nonprofit) dialysis facilities have historically had lower kidney transplantation rates, but it is unknown if the pattern holds for living donor and deceased donor kidney transplantation, varies by facility ownership, or has persisted over time in a nationally representative population. ObjectiveTo determine the association between dialysis facility ownership and placement on the deceased donor kidney transplantation waiting list, receipt of a living donor kidney transplant, or receipt of a deceased donor kidney transplant. Design, Setting, and ParticipantsRetrospective cohort study that included 1478564 patients treated at 6511 US dialysis facilities. Adult patients with incident end-stage kidney disease from the US Renal Data System (2000-2016) were linked with facility ownership (Dialysis Facility Compare) and characteristics (Dialysis Facility Report). ExposuresThe primary exposure was dialysis facility ownership, which was categorized as nonprofit small chains, nonprofit independent facilities, for-profit large chains (>1000 facilities), for-profit small chains (<1000 facilities), and for-profit independent facilities. Main Outcomes and MeasuresAccess to kidney transplantation was defined as time from initiation of dialysis to placement on the deceased donor kidney transplantation waiting list, receipt of a living donor kidney transplant, or receipt of a deceased donor kidney transplant. Cumulative incidence differences and multivariable Cox models assessed the association between dialysis facility ownership and each outcome. ResultsAmong 1478564 patients, the median age was 66 years (interquartile range, 55-76 years), with 55.3% male, and 28.1% non-Hispanic black patients. Eighty-seven percent of patients received care at a for-profit dialysis facility. A total of 109030 patients (7.4%) received care at 435 nonprofit small chain facilities; 78287 (5.3%) at 324 nonprofit independent facilities; 483988 (32.7%) at 2239 facilities of large for-profit chain 1; 482689 (32.6%) at 2082 facilities of large for-profit chain 2; 225890 (15.3%) at 997 for-profit small chain facilities; and 98680 (6.7%) at 434 for-profit independent facilities. During the study period, 121680 patients (8.2%) were placed on the deceased donor waiting list, 23762 (1.6%) received a living donor kidney transplant, and 49290 (3.3%) received a deceased donor kidney transplant. For-profit facilities had lower 5-year cumulative incidence differences for each outcome vs nonprofit facilities (deceased donor waiting list: -13.2% [95% CI, -13.4% to -13.0%]; receipt of a living donor kidney transplant: -2.3% [95% CI, -2.4% to -2.3%]; and receipt of a deceased donor kidney transplant: -4.3% [95% CI, -4.4% to -4.2%]). Adjusted Cox analyses showed lower relative rates for each outcome among patients treated at all for-profit vs all nonprofit dialysis facilities: deceased donor waiting list (hazard ratio [HR], 0.36 [95% CI, 0.35 to 0.36]); receipt of a living donor kidney transplant (HR, 0.52 [95% CI, 0.51 to 0.54]); and receipt of a deceased donor kidney transplant (HR, 0.44 [95% CI, 0.44 to 0.45]). Conclusions and RelevanceAmong US patients with end-stage kidney disease, receiving dialysis at for-profit facilities compared with nonprofit facilities was associated with a lower likelihood of accessing kidney transplantation. Further research is needed to understand the mechanisms behind this association.	[Gander, Jennifer C.] Kaiser Permanente Georgia, Ctr Res & Evaluat, Atlanta, GA USA; [Zhang, Xingyu] Univ Michigan, Sch Nursing, Appl Biostat Lab, Ann Arbor, MI 48109 USA; [Ross, Katherine; McPherson, Laura; Walker, Elizabeth; Wang, Zhensheng; Patzer, Rachel E.] Emory Univ, Sch Med, Dept Surg, Div Transplantat, Atlanta, GA 30322 USA; [Ross, Katherine; Patzer, Rachel E.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Wilk, Adam S.] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA; [Browne, Teri] Univ South Carolina, Coll Social Work, Columbia, SC 29208 USA; [Pastan, Stephen O.] Emory Univ, Sch Med, Dept Med, Renal Div, Atlanta, GA USA; [Wang, Zhensheng; Patzer, Rachel E.] Emory Univ, Sch Med, Hlth Serv Res Ctr, Atlanta, GA USA	Kaiser Permanente; University of Michigan System; University of Michigan; Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of South Carolina System; University of South Carolina Columbia; Emory University; Emory University	Patzer, RE (corresponding author), Emory Univ, Sch Med, Dept Surg, 101 Woodruff Cir,5101 Woodruff Mem Res Bldg, Atlanta, GA 30322 USA.; Patzer, RE (corresponding author), Emory Univ, Sch Med, Dept Med, 101 Woodruff Cir,5101 Woodruff Mem Res Bldg, Atlanta, GA 30322 USA.	rpatzer@emory.edu	Browne, Teri/ABF-8338-2020; Pastan, Stephen/AAC-6622-2022	Browne, Teri/0000-0002-5104-4332; Zhang, Xingyu/0000-0001-8108-1997; Wilk, Adam/0000-0003-4831-0692; Walker, Elizabeth/0000-0002-1907-9906	National Institute of Diabetes and Digestive and Kidney Diseases [F32DK107191]; National Institute on Minority Health and Health Disparities [R01MD010290, U01MD010611]; National Center for Advancing Translational Sciences [UL1TR002378, TL1TR002382]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported in part by grant F32DK107191 from the National Institute of Diabetes and Digestive and Kidney Diseases, grants R01MD010290 and U01MD010611 from the National Institute on Minority Health and Health Disparities, and grants UL1TR002378 and TL1TR002382 from the National Center for Advancing Translational Sciences.	[Anonymous], 2018, US REN DAT SYST 2018; Ashby VB, 2007, AM J TRANSPLANT, V7, P1412, DOI 10.1111/j.1600-6143.2007.01785.x; Ayanian JZ, 2004, AM J KIDNEY DIS, V43, P350, DOI 10.1053/j.ajkd.2003.10.022; Balhara KS, 2012, AM J TRANSPLANT, V12, P3104, DOI 10.1111/j.1600-6143.2012.04207.x; Browne T, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0326-3; Center for Medicare & Medicaid Services, 2018, DIAL FAC COMP; Centers for Medicare & Medicaid Services, 2016, IN CTR HEM CAHPS; Centers for Medicare & Medicaid Services, 2019, ESRD TREATM CHOIC MO; Department of Health and Human Services; Centers for Medicare & Medicaid Services, 2005, END STAG REN DIS MED; Edwards Jessie K, 2016, Curr Epidemiol Rep, V3, P285, DOI 10.1007/s40471-016-0089-1; Farley DO, 1993, EFFECTS COMPETITION; Fowler KJ, 2018, CLIN J AM SOC NEPHRO, V13, P193, DOI 10.2215/CJN.13741217; Friedman B S, 1990, Adv Health Econ Health Serv Res, V11, P131; Gander J, 2015, AM J NEPHROL, V41, P504, DOI 10.1159/000438463; Gander Jennifer C, 2017, Curr Transplant Rep, V4, P1, DOI 10.1007/s40472-017-0133-1; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; Gordon EJ, 2001, MED ANTHROPOL Q, V15, P245, DOI 10.1525/maq.2001.15.2.245; Hanson CS, 2016, TRANSPLANTATION, V100, P943, DOI 10.1097/TP.0000000000000921; HELD PJ, 1990, AM J KIDNEY DIS, V15, P441, DOI 10.1016/S0272-6386(12)70362-1; Hirth RA, 2000, INQUIRY-J HEALTH CAR, V37, P282; Issa Naim, 2012, Adv Perit Dial, V28, P89; Kucirka LM, 2012, AM J TRANSPLANT, V12, P351, DOI 10.1111/j.1600-6143.2011.03865.x; Kucirka LM, 2015, CLIN J AM SOC NEPHRO, V10, P1507, DOI 10.2215/CJN.08280815; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; Patzer RE, 2014, AM J TRANSPLANT, V14, P1562, DOI 10.1111/ajt.12749; Patzer RE, 2015, JAMA-J AM MED ASSOC, V314, P582, DOI 10.1001/jama.2015.8897; Purnell TS, 2012, ADV CHRONIC KIDNEY D, V19, P244, DOI 10.1053/j.ackd.2012.01.008; Reese PP, 2011, TRANSPLANTATION, V91, P1357, DOI 10.1097/TP.0b013e31821bf138; Roach JL, 2010, AM J KIDNEY DIS, V56, P928, DOI 10.1053/j.ajkd.2010.08.006; Salter ML, 2014, J AM SOC NEPHROL, V25, P2871, DOI 10.1681/ASN.2013121298; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; United Network of Organ Sharing, TRANSPL TRENDS 2018; van Buuren S, 2011, J STAT SOFTW, V45, P1; de Luijtgaarden MWM, 2016, NEPHROL DIAL TRANSPL, V31, P120, DOI 10.1093/ndt/gfv295; Vanholder R, 2017, NAT REV NEPHROL, V13, P393, DOI 10.1038/nrneph.2017.63; Weng FL, 2005, AM J KIDNEY DIS, V46, P734, DOI 10.1053/j.ajkd.2005.06.011; Zhang XY, 2018, AM J TRANSPLANT, V18, P1936, DOI 10.1111/ajt.14748; Zhang Y, 2014, TRANSPLANTATION, V98, P543, DOI 10.1097/TP.0000000000000106	38	49	49	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					957	973		10.1001/jama.2019.12803	http://dx.doi.org/10.1001/jama.2019.12803			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY6YZ	31503308	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000486543500017
J	Meester, RGS; Lansdorp-Vogelaar, I; Winawer, SJ; Zauber, AG; Knudsen, AB; Ladabaum, U				Meester, R. G. S.; Lansdorp-Vogelaar, I; Winawer, S. J.; Zauber, A. G.; Knudsen, A. B.; Ladabaum, U.			High-Intensity or Low-Intensity Surveillance for Patients With Colorectal Tumors	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2019	171	9					I20	I20		10.7326/P19-0012	http://dx.doi.org/10.7326/P19-0012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JK6WN	31546254				2022-12-28	WOS:000494983000001
J	Shihoya, W; Inoue, K; Singh, M; Konno, M; Hososhima, S; Yamashita, K; Ikeda, K; Higuchi, A; Izume, T; Okazaki, S; Hashimoto, M; Mizutori, R; Tomida, S; Yamauchi, Y; Abe-Yoshizumi, R; Katayama, K; Tsunoda, SP; Shibata, M; Furutani, Y; Pushkarev, A; Beja, O; Uchihashi, T; Kandori, H; Nureki, O				Shihoya, Wataru; Inoue, Keiichi; Singh, Manish; Konno, Masae; Hososhima, Shoko; Yamashita, Keitaro; Ikeda, Kento; Higuchi, Akimitsu; Izume, Tamaki; Okazaki, Sae; Hashimoto, Masanori; Mizutori, Ritsu; Tomida, Sahoko; Yamauchi, Yumeka; Abe-Yoshizumi, Rei; Katayama, Kota; Tsunoda, Satoshi P.; Shibata, Mikihiro; Furutani, Yuji; Pushkarev, Alina; Beja, Oded; Uchihashi, Takayuki; Kandori, Hideki; Nureki, Osamu			Crystal structure of heliorhodopsin	NATURE			English	Article							ENDOTHELIN ETB-RECEPTOR; CRYSTALLOGRAPHIC STRUCTURE; RHODOPSIN; WATER; FTIR; REFINEMENT; MECHANISM	Heliorhodopsins (HeRs) are a family of rhodopsins that was recently discovered using functional metagenomics(1). They are widely present in bacteria, archaea, algae and algal viruses(2,3). Although HeRs have seven predicted transmembrane helices and an all-trans retinal chromophore as in the type-1 (microbial) rhodopsin, they display less than 15% sequence identity with type-1 and type-2 (animal) rhodopsins. HeRs also exhibit the reverse orientation in the membrane compared with the other rhodopsins. Owing to the lack of structural information, little is known about the overall fold and the photoactivation mechanism of HeRs. Here we present the 2.4-angstrom-resolution structure of HeR from an uncultured Therm oplasmatales archaeon SG8-52-1 (GenBank sequence ID LSSD01000000). Structural and biophysical analyses reveal the similarities and differences between HeRs and type-1 microbial rhodopsins. The overall fold of HeR is similar to that of bacteriorhodopsin. A linear hydrophobic pocket in HeR accommodates a retinal configuration and isomerization as in the type-1 rhodopsin, although most of the residues constituting the pocket are divergent. Hydrophobic residues fill the space in the extracellular half of HeR, preventing the permeation of protons and ions. The structure reveals an unexpected lateral fenestration above the beta-ionone ring of the retinal chromophore, which has a critical role in capturing retinal from environment sources. Our study increases the understanding of the functions of HeRs, and the structural similarity and diversity among the microbial rhodopsins.	[Shihoya, Wataru; Yamashita, Keitaro; Higuchi, Akimitsu; Izume, Tamaki; Okazaki, Sae; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Inoue, Keiichi; Singh, Manish; Konno, Masae; Hososhima, Shoko; Hashimoto, Masanori; Mizutori, Ritsu; Tomida, Sahoko; Yamauchi, Yumeka; Abe-Yoshizumi, Rei; Katayama, Kota; Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Nagoya, Aichi, Japan; [Inoue, Keiichi; Katayama, Kota; Furutani, Yuji; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi, Japan; [Inoue, Keiichi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan; [Inoue, Keiichi; Tsunoda, Satoshi P.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Yamashita, Keitaro] RIKEN SPring 8 Ctr, Sayo, Japan; [Ikeda, Kento] Kanazawa Univ, Grad Sch Nat Sci & Technol, Sch Math & Phys Sci, Kanazawa, Ishikawa, Japan; [Shibata, Mikihiro] Kanazawa Univ, Nano Life Sci Inst WPI NanoLSI, Kanazawa, Ishikawa, Japan; [Shibata, Mikihiro] Kanazawa Univ, Inst Frontier Sci Initiat, High Speed AFM Biol Applicat Unit, Kanazawa, Ishikawa, Japan; [Furutani, Yuji] Natl Inst Nat Sci, Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi, Japan; [Furutani, Yuji] Grad Univ Adv Studies SOKENDAI, Dept Struct Mol Sci, Okazaki, Aichi, Japan; [Pushkarev, Alina; Beja, Oded] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Uchihashi, Takayuki] Nagoya Univ, Dept Phys, Nagoya, Aichi, Japan; [Uchihashi, Takayuki] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi, Japan	University of Tokyo; Nagoya Institute of Technology; Nagoya Institute of Technology; University of Tokyo; Japan Science & Technology Agency (JST); RIKEN; Kanazawa University; Kanazawa University; Kanazawa University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Technion Israel Institute of Technology; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS)	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan.; Kandori, H (corresponding author), Nagoya Inst Technol, Dept Life Sci & Appl Chem, Nagoya, Aichi, Japan.; Kandori, H (corresponding author), Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi, Japan.	kandori@nitech.ac.jp; nureki@bs.s.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; Furutani, Yuji/J-8337-2019; Inoue, Keiichi/AEO-3337-2022; Tsunoda, Satoshi/AAN-7023-2021; Konno, Masae/C-1066-2009; Uchihashi, Takayuki/D-5209-2011; Shibata, Mikihiro/R-2263-2019	Furutani, Yuji/0000-0001-5284-8773; Inoue, Keiichi/0000-0002-6898-4347; Konno, Masae/0000-0002-0605-1816; Uchihashi, Takayuki/0000-0002-0263-5312; Shibata, Mikihiro/0000-0001-5041-3979; Yamashita, Keitaro/0000-0002-5442-7582; Pushkarev, Alina/0000-0002-5536-9193; Tsunoda, Satoshi/0000-0003-3636-1521	AMED [JP19am0101070, 1627]; JSPS KAKENHI [16H06294, 17J30010, 30809421, 25104009, 18H03986, 19H04959, 17H03007, 19H05389, 18H04512, 18H01837, 18K06109]; JST PRESTO [JPMJPR15P2, JPMJPR1688]; JST CREST [JPMJCR1753, JPMJCR17N5]; Louis and Lyra Richmond Memorial Chair in Life Sciences	AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO(Japan Science & Technology Agency (JST)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Louis and Lyra Richmond Memorial Chair in Life Sciences	The diffraction experiments were performed at SPring-8 BL32XU (proposal 2017B2578). We thank the members of the Nureki laboratory and the beamline staff at BL32XU of SPring-8 (Sayo, Japan) for technical assistance during data collection, R. Nakamura and for technical assistance, S. Sugita for help with confocal microscopy. This research was partially supported by Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under grant number JP19am0101070 (support number 1627). This work was supported by JSPS KAKENHI grants 16H06294 (O.N.), 17J30010, 30809421 (W.S.), 25104009, 18H03986, 19H04959 (H.K.), 17H03007 (K. Inoue), 19H05389, 18H04512, 18H01837 (T.U.), 18K06109 (S.P.T.) and by JST PRESTO (JPMJPR15P2 to K. Inoue and JPMJPR1688 to S.P.T.) and CREST (JPMJCR1753 to H.K. and JPMJCR17N5 to Y.F.). O.B. is supported by the Louis and Lyra Richmond Memorial Chair in Life Sciences.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Flores-Uribe J, 2019, ENV MICROBIOL REP, V11, P419, DOI 10.1111/1758-2229.12730; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943; Gerwert K, 2014, BBA-BIOENERGETICS, V1837, P606, DOI 10.1016/j.bbabio.2013.09.006; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Hashimoto K, 2010, BIOCHEMISTRY-US, V49, P3343, DOI 10.1021/bi100184k; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; Inoue K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13415; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Ito S, 2018, J PHYS CHEM B, V122, P165, DOI 10.1021/acs.jpcb.7b11064; Ito S, 2017, PHOTOCHEM PHOTOBIOL, V93, P1381, DOI 10.1111/php.12771; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato HE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8177; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Keffer JL, 2015, J BACTERIOL, V197, P2704, DOI 10.1128/JB.00386-15; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagiri C, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0482-7; Otomo A, 2018, J PHYS CHEM LETT, V9, P6431, DOI 10.1021/acs.jpclett.8b02741; Pushkarev A, 2018, NATURE, V558, P595, DOI 10.1038/s41586-018-0225-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shibata M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26606-y; Shibukawa A, 2019, BIOCHEMISTRY-US, V58, P2934, DOI 10.1021/acs.biochem.9b00257; Shihoya W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07094-0; Shihoya W, 2017, NAT STRUCT MOL BIOL, V24, P758, DOI 10.1038/nsmb.3450; Shihoya W, 2016, NATURE, V537, P363, DOI 10.1038/nature19319; Singh M, 2018, BIOCHEMISTRY-US, V57, P5041, DOI 10.1021/acs.biochem.8b00637; Tahara S, 2019, J PHYS CHEM B, V123, P2507, DOI 10.1021/acs.jpcb.9b00887; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yamashita K, 2018, ACTA CRYSTALLOGR D, V74, P441, DOI 10.1107/S2059798318004576; Yamauchi Y, 2017, BIOPHYS PHYSICOBIOL, V14, P57, DOI 10.2142/biophysico.14.0_57	39	37	37	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					132	+		10.1038/s41586-019-1604-6	http://dx.doi.org/10.1038/s41586-019-1604-6			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31554965				2022-12-28	WOS:000488832500045
J	Venkataramani, V; Tanev, DI; Strahle, C; Studier-Fischer, A; Fankhauser, L; Kessler, T; Korber, C; Kardorff, M; Ratliff, M; Xie, RF; Horstmann, H; Messer, M; Paik, SP; Knabbe, J; Sahm, F; Kurz, FT; Acikgoz, AA; Herrmannsdorfer, F; Agarwal, A; Bergles, DE; Chalmers, A; Miletic, H; Turcan, S; Mawrin, C; Hanggi, D; Liu, HK; Wick, W; Winkler, F; Kuner, T				Venkataramani, Varun; Tanev, Dimitar Ivanov; Strahle, Christopher; Studier-Fischer, Alexander; Fankhauser, Laura; Kessler, Tobias; Koerber, Christoph; Kardorff, Markus; Ratliff, Miriam; Xie, Ruifan; Horstmann, Heinz; Messer, Mirko; Paik, Sang Peter; Knabbe, Johannes; Sahm, Felix; Kurz, Felix T.; Acikgoez, Azer Aylin; Herrmannsdoerfer, Frank; Agarwal, Amit; Bergles, Dwight E.; Chalmers, Anthony; Miletic, Hrvoje; Turcan, Sevin; Mawrin, Christian; Haenggi, Daniel; Liu, Hai-Kun; Wick, Wolfgang; Winkler, Frank; Kuner, Thomas			Glutamatergic synaptic input to glioma cells drives brain tumour progression	NATURE			English	Article							RNA; GROWTH; DETERMINANT; MIGRATION; EPILEPSY; SEIZURES; RELEASE	A network of communicating tumour cells that is connected by tumour microtubes mediates the progression of incurable gliomas. Moreover, neuronal activity can foster malignant behaviour of glioma cells by non-synaptic paracrine and autocrine mechanisms. Here we report a direct communication channel between neurons and glioma cells in different disease models and human tumours: functional bona fide chemical synapses between presynaptic neurons and postsynaptic glioma cells. These neurogliomal synapses show a typical synaptic ultrastructure, are located on tumour microtubes, and produce postsynaptic currents that are mediated by glutamate receptors of the AMPA subtype. Neuronal activity including epileptic conditions generates synchronised calcium transients in tumour-microtube-connected glioma networks. Glioma-cell-specific genetic perturbation of AMPA receptors reduces calcium-related invasiveness of tumour-microtube-positive tumour cells and glioma growth. Invasion and growth are also reduced by anaesthesia and the AMPA receptor antagonist perampanel, respectively. These findings reveal a biologically relevant direct synaptic communication between neurons and glioma cells with potential clinical implications.	[Venkataramani, Varun; Tanev, Dimitar Ivanov; Strahle, Christopher; Koerber, Christoph; Kardorff, Markus; Horstmann, Heinz; Paik, Sang Peter; Knabbe, Johannes; Herrmannsdoerfer, Frank; Kuner, Thomas] Heidelberg Univ, Dept Funct Neuroanat, Inst Anat & Cell Biol, Heidelberg, Germany; [Venkataramani, Varun; Tanev, Dimitar Ivanov; Studier-Fischer, Alexander; Fankhauser, Laura; Kessler, Tobias; Xie, Ruifan; Messer, Mirko; Turcan, Sevin; Wick, Wolfgang; Winkler, Frank] Univ Heidelberg Hosp, Neurol Clin & Natl Ctr Tumor Dis, Heidelberg, Germany; [Venkataramani, Varun; Tanev, Dimitar Ivanov; Studier-Fischer, Alexander; Fankhauser, Laura; Kessler, Tobias; Ratliff, Miriam; Xie, Ruifan; Messer, Mirko; Wick, Wolfgang; Winkler, Frank] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, German Canc Consortium DKTK, Heidelberg, Germany; [Ratliff, Miriam; Haenggi, Daniel] Univ Hosp Mannheim, Neurosurg Clin, Mannheim, Germany; [Sahm, Felix] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Sahm, Felix] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, German Canc Consortium DKTK, Heidelberg, Germany; [Sahm, Felix; Kurz, Felix T.] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [Acikgoez, Azer Aylin; Liu, Hai-Kun] German Canc Res Ctr, Div Mol Neurogenet, DKFZ ZMBH Alliance, Heidelberg, Germany; [Agarwal, Amit] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD USA; [Agarwal, Amit; Bergles, Dwight E.] Heidelberg Univ, Inst Anat & Cell Biol, Res Grp, Heidelberg, Germany; [Chalmers, Anthony] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway; [Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Mawrin, Christian] Otto von Guericke Univ, Inst Neuropathol, Magdeburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Johns Hopkins University; Ruprecht Karls University Heidelberg; University of Glasgow; University of Bergen; University of Bergen; Haukeland University Hospital; Otto von Guericke University	Venkataramani, V; Kuner, T (corresponding author), Heidelberg Univ, Dept Funct Neuroanat, Inst Anat & Cell Biol, Heidelberg, Germany.; Winkler, F (corresponding author), Univ Heidelberg Hosp, Neurol Clin & Natl Ctr Tumor Dis, Heidelberg, Germany.	varun.venkataramani@med.uni-heidelberg.de; frank.winkler@med.uni-heidelberg.de; thomas.kuner@uni-heidelberg.de	Turcan, Sevin/AAF-1095-2019; Wick, Wolfgang/AAA-2545-2020; Sahm, Felix/GQY-8202-2022; Agarwal, Amit/B-7735-2008	Turcan, Sevin/0000-0002-0885-5607; Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Knabbe, Johannes/0000-0003-3170-111X; Ratliff, Miriam/0000-0002-9464-6544; Venkataramani, Varun/0000-0002-2927-0886; Korber, Christoph/0000-0003-1418-9724; Kessler, Tobias/0000-0001-8350-7074; Winkler, Frank/0000-0003-4892-6104; liu, hai-kun/0000-0003-3338-4066; Agarwal, Amit/0000-0001-7948-4498	Chica and Heinz Schaller research foundation; Deutsche Forschungsgemeinschaft [AG 287/1-1, SFB 1389, WI 1930/6]; MD/PhD program of the Medical Faculty Heidelberg; Stiftung fur Krebs-und Scharlachforschung; Deutsche Krebshilfe; CellNetworks Excellence Cluster [EXC 81]; MRC [MR/R009473/1] Funding Source: UKRI	Chica and Heinz Schaller research foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MD/PhD program of the Medical Faculty Heidelberg; Stiftung fur Krebs-und Scharlachforschung; Deutsche Krebshilfe(Deutsche Krebshilfe); CellNetworks Excellence Cluster; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Kaiser, S. Hoppe, J. Grosch, S. Weil, I. Sonntag, M. Osswald, K. Gunkel, C. Kocksch, I. Frommer, A. Schlicksupp, R. Rosauer, H.-Y. Nguyen, L. Doerner, M. Schmitt, U. Lindenberger, H. Zheng and S. Wendler for scientific discussion, support and assistance. We thank A. Hotz-Wagenblatt for help with bioinformatic analysis pipelines. We thank M. Suva and I. Tirosh for support with the analysis of single-cell RNA-seq databases from human gliomas, C. Steinhauser and R. Jabs for advice on how to perform electrophysiological recordings from non-neuronal postsynaptic cells and the EM Core Facility of University Heidelberg for general support. We thank M. Monje for stably transducing our S24 glioma cell line with ChR2(H134R). We thank C. Watts for generating and providing the E2 primary glioblastoma cell line. A. A. was supported by the Chica and Heinz Schaller research foundation and the grant from the Deutsche Forschungsgemeinschaft (AG 287/1-1). V.V. was supported by the MD/PhD program of the Medical Faculty Heidelberg and the Stiftung fur Krebs-und Scharlachforschung. D.I.T. was supported by the Deutsche Krebshilfe. W.W. and F.W. were supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 1389). F.W. was supported by a grant from the Deutsche Forschungsgemeinschaft (WI 1930/6). T. Kuner was supported by the CellNetworks Excellence Cluster (EXC 81). F.W. and T. Kuner acknowledge their children Jakob and Manili, respectively, for seeding this collaboration.	Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chaichana KL, 2009, J NEUROSURG, V111, P282, DOI 10.3171/2009.2.JNS081132; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; GRAY EG, 1959, J ANAT, V93, P420; Harris Kristen M, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a005587; Huberfeld G, 2016, NAT REV NEUROL, V12, P204, DOI 10.1038/nrneurol.2016.26; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Izumoto S, 2018, ANTICANCER RES, V38, P4361, DOI 10.21873/anticanres.12737; Jung E, 2017, J NEUROSCI, V37, P6837, DOI 10.1523/JNEUROSCI.3532-16.2017; Korber V, 2019, CANCER CELL, V35, P692, DOI 10.1016/j.ccell.2019.02.007; Li L, 2018, CANCER CELL, V33, P736, DOI 10.1016/j.ccell.2018.02.011; Li L, 2013, CELL, V153, P86, DOI 10.1016/j.cell.2013.02.051; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Ohtaka-Maruyama C, 2018, SCIENCE, V360, P313, DOI 10.1126/science.aar2866; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Scherer HJ, 1940, J NEUROL PSYCHIATRY, V3, P147, DOI 10.1136/jnnp.3.2.147; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Venkatesh HS, 2019, NATURE, V573, P539, DOI 10.1038/s41586-019-1563-y; Venkatesh HS, 2017, NATURE, V549, P533, DOI 10.1038/nature24014; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weil S, 2017, NEURO-ONCOLOGY, V19, P1316, DOI 10.1093/neuonc/nox070; Weller M, 2012, LANCET ONCOL, V13, pE375, DOI 10.1016/S1470-2045(12)70266-8; Zhu Z, 2014, CELL STEM CELL, V15, P185, DOI 10.1016/j.stem.2014.04.007	37	318	323	28	142	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					532	+		10.1038/s41586-019-1564-x	http://dx.doi.org/10.1038/s41586-019-1564-x			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31534219				2022-12-28	WOS:000488247600049
J	Wechsler, ME; Szefler, SJ; Ortega, VE; Pongracic, JA; Chinchilli, V; Lima, JJ; Krishnan, JA; Kunselman, SJ; Mauger, D; Bleecker, ER; Bacharier, LB; Beigelman, A; Benson, M; Blake, KV; Cabana, MD; Cardet, JC; Castro, M; Chmiel, JF; Covar, R; Denlinger, L; DiMango, E; Fitzpatrick, AM; Gentile, D; Grossman, N; Holguin, F; Jackson, DJ; Kumar, H; Kraft, M; LaForce, CF; Lang, J; Lazarus, SC; Lemanske, RF; Long, D; Lugogo, N; Martinez, F; Meyers, DA; Moore, WC; Moy, J; Naureckas, E; Olin, JT; Peters, SP; Phipatanakul, W; Que, L; Raissy, H; Robison, RG; Ross, K; Sheehan, W; Smith, LJ; Solway, J; Sorkness, CA; Sullivan-Vedder, L; Wenzel, S; White, S; Israel, E				Wechsler, Michael E.; Szefler, Stanley J.; Ortega, Victor E.; Pongracic, Jacqueline A.; Chinchilli, Vernon; Lima, John J.; Krishnan, Jerry A.; Kunselman, Susan J.; Mauger, David; Bleecker, Eugene R.; Bacharier, Leonard B.; Beigelman, Avraham; Benson, Mindy; Blake, Kathryn, V; Cabana, Michael D.; Cardet, Juan-Carlos; Castro, Mario; Chmiel, James F.; Covar, Ronina; Denlinger, Loren; DiMango, Emily; Fitzpatrick, Anne M.; Gentile, Deborah; Grossman, Nicole; Holguin, Fernando; Jackson, Daniel J.; Kumar, Harsha; Kraft, Monica; LaForce, Craig F.; Lang, Jason; Lazarus, Stephen C.; Lemanske, Robert F., Jr.; Long, Dayna; Lugogo, Njira; Martinez, Fernando; Meyers, Deborah A.; Moore, Wendy C.; Moy, James; Naureckas, Edward; Olin, J. Tod; Peters, Stephen P.; Phipatanakul, Wanda; Que, Loretta; Raissy, Hengameh; Robison, Rachel G.; Ross, Kristie; Sheehan, William; Smith, Lewis J.; Solway, Julian; Sorkness, Christine A.; Sullivan-Vedder, Lisa; Wenzel, Sally; White, Steven; Israel, Elliot		NHLBI AsthmaNet	Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; MILD PERSISTENT ASTHMA; GENETIC ANCESTRY; LUNG-FUNCTION; RACE; EXACERBATIONS; BUDESONIDE; FORMOTEROL; IMPACT; RISK	BackgroundMorbidity from asthma is disproportionately higher among black patients than among white patients, and black patients constitute the minority of participants in trials informing treatment. Data indicate that patients with inadequately controlled asthma benefit more from addition of a long-acting beta-agonist (LABA) than from increased glucocorticoids; however, these data may not be informative for treatment in black patients. MethodsWe conducted two prospective, randomized, double-blind trials: one involving children and the other involving adolescents and adults. In both trials, the patients had at least one grandparent who identified as black and had asthma that was inadequately controlled with low-dose inhaled glucocorticoids. We compared combinations of therapy, which included the addition of a LABA (salmeterol) to an inhaled glucocorticoid (fluticasone propionate), a step-up to double to quintuple the dose of fluticasone, or both. The treatments were compared with the use of a composite measure that evaluated asthma exacerbations, asthma-control days, and lung function; data were stratified according to genotypic African ancestry. ResultsWhen quintupling the dose of fluticasone (to 250 mu g twice a day) was compared with adding salmeterol (50 mu g twice a day) and doubling the fluticasone (to 100 mu g twice a day), a superior response occurred in 46% of the children with quintupling the fluticasone and in 46% of the children with doubling the fluticasone and adding salmeterol (P=0.99). In contrast, more adolescents and adults had a superior response to added salmeterol than to an increase in fluticasone (salmeterol-low-dose fluticasone vs. medium-dose fluticasone, 49% vs. 28% [P=0.003]; salmeterol-medium-dose fluticasone vs. high-dose fluticasone, 49% vs. 31% [P=0.02]). Neither the degree of African ancestry nor baseline biomarkers predicted a superior response to specific treatments. The increased dose of inhaled glucocorticoids was associated with a decrease in the ratio of urinary cortisol to creatinine in children younger than 8 years of age. ConclusionsIn contrast to black adolescents and adults, almost half the black children with poorly controlled asthma had a superior response to an increase in the dose of an inhaled glucocorticoid and almost half had a superior response to the addition of a LABA. (Funded by the National Heart, Lung, and Blood Institute; BARD ClinicalTrials.gov number, NCT01967173.)	[Wechsler, Michael E.; Covar, Ronina; Olin, J. Tod] Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA; [Cardet, Juan-Carlos; Grossman, Nicole; Israel, Elliot] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Wechsler, Michael E.; Szefler, Stanley J.; Covar, Ronina; Holguin, Fernando; Olin, J. Tod] Univ Colorado, Sch Med, Aurora, CO USA; [Szefler, Stanley J.] Childrens Hosp Colorado, Aurora, CO USA; [Ortega, Victor E.; Moore, Wendy C.; Peters, Stephen P.] Wake Forest Sch Med, Winston Salem, NC USA; [LaForce, Craig F.] North Carolina Clin Res, Raleigh, NC USA; [Lugogo, Njira; Que, Loretta] Duke Univ, Med Ctr, Durham, NC USA; [Pongracic, Jacqueline A.; Robison, Rachel G.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Krishnan, Jerry A.; Kumar, Harsha] Univ Illinois, Chicago, IL USA; [Moy, James] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Naureckas, Edward; Solway, Julian; White, Steven] Univ Chicago, Chicago, IL 60637 USA; [Smith, Lewis J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Chinchilli, Vernon; Kunselman, Susan J.; Mauger, David] Penn State Univ, Hershey, PA USA; [Gentile, Deborah] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA; [Wenzel, Sally] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Lima, John J.; Blake, Kathryn, V; Lang, Jason] Nemours Childrens Hlth Syst, Jacksonville, FL USA; [Cardet, Juan-Carlos] Univ S Florida, Morsani Coll Med, Tampa, FL USA; [Bleecker, Eugene R.; Kraft, Monica; Martinez, Fernando; Meyers, Deborah A.] Univ Arizona Hlth Sci, Tucson, AZ USA; [Bacharier, Leonard B.; Beigelman, Avraham; Castro, Mario] Washington Univ, Sch Med, St Louis, MO USA; [Benson, Mindy; Cabana, Michael D.; Lazarus, Stephen C.; Long, Dayna] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Benson, Mindy; Long, Dayna] UCSF Benioff Childrens Hosp, Oakland, CA USA; [Cardet, Juan-Carlos; Grossman, Nicole; Israel, Elliot] Harvard Med Sch, Boston, MA 02115 USA; [Phipatanakul, Wanda; Sheehan, William] Boston Childrens Hosp, Boston, MA USA; [Chmiel, James F.; Ross, Kristie] Case Western Reserve Univ, Univ Hosp Rainbow Babies, Cleveland, OH 44106 USA; [Chmiel, James F.; Ross, Kristie] Case Western Reserve Univ, Childrens Hosp, Cleveland, OH 44106 USA; [Denlinger, Loren; Jackson, Daniel J.; Lemanske, Robert F., Jr.; Sorkness, Christine A.] Univ Wisconsin, Madison, WI USA; [Sullivan-Vedder, Lisa] Aurora Sinai Med Ctr, Milwaukee, WI USA; [DiMango, Emily] Columbia Univ, Irving Med Ctr, New York, NY USA; [Fitzpatrick, Anne M.] Emory Univ, Atlanta, GA 30322 USA; [Raissy, Hengameh] Univ New Mexico, Albuquerque, NM 87131 USA	National Jewish Health; Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Wake Forest University; Duke University; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; University of Chicago; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Allegheny General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of South Florida; University of Arizona; University of Arizona Health Sciences; Washington University (WUSTL); University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; University of Wisconsin System; University of Wisconsin Madison; Columbia University; NewYork-Presbyterian Hospital; Emory University; University of New Mexico	Wechsler, ME (corresponding author), Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA.; Israel, E (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	wechslerm@njhealth.org; eisrael@partners.org		Wenzel, Sally/0000-0002-4242-0164; Robison, Rachel/0000-0003-0160-0529; Bacharier, Leonard/0000-0003-0432-2704	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL118128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI125785] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Heart, Lung, and Blood Institute	Adams N. P., 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD3534.PUB3; Adams RJ, 2000, THORAX, V55, P566, DOI 10.1136/thorax.55.7.566; Akinbami, 2006, STATE CHILDHOOD ASTH, V381; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Boulet LP, 2009, RESP MED, V103, P1554, DOI 10.1016/j.rmed.2009.02.015; Cooper RS, 2018, JAMA-J AM MED ASSOC, V320, P1531, DOI 10.1001/jama.2018.10960; Davidian M, 1995, NONLINEAR MODELS REP; Drake KA, 2014, J ALLERGY CLIN IMMUN, V133, P370, DOI 10.1016/j.jaci.2013.06.043; Eisner MD, 2001, RESP RES, V2, P53, DOI 10.1186/rr37; El-Ekiaby A, 2006, AM J RESP CRIT CARE, V174, P508, DOI 10.1164/rccm.200603-431OC; Federico MJ, 2005, CHEST, V127, P571, DOI 10.1378/chest.127.2.571; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Griswold SK, 2005, CHEST, V127, P1579, DOI 10.1378/chest.127.5.1579; Himes BE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002824; Homa DM, 2000, AM J RESP CRIT CARE, V161, P504, DOI 10.1164/ajrccm.161.2.9906025; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Israel E, 2015, AM J RESP CRIT CARE, V191, P530, DOI 10.1164/rccm.201408-1426OC; Jackson DJ, 2018, NEW ENGL J MED, V378, P891, DOI 10.1056/NEJMoa1710988; Keet CA, 2015, J ALLERGY CLIN IMMUN, V135, P655, DOI 10.1016/j.jaci.2014.11.022; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Malka J, 2014, J ALLERGY CLIN IMMUN, V134, P483, DOI 10.1016/j.jaci.2014.03.039; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; Nyenhuis SM, 2017, J ALLERGY CLIN IMMUN, V140, P257, DOI 10.1016/j.jaci.2016.10.024; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Ortega VE, 2014, LANCET RESP MED, V2, P204, DOI 10.1016/S2213-2600(13)70289-3; Ortega VE, 2014, J ALLERGY CLIN IMMUN, V133, P16, DOI 10.1016/j.jaci.2013.10.040; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; Rumpel JA, 2012, J ALLERGY CLIN IMMUN, V130, P1302, DOI 10.1016/j.jaci.2012.09.001; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; Wechsler ME, 2011, AM J RESP CRIT CARE, V184, P1247, DOI 10.1164/rccm.201103-0514OC	38	33	33	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1227	1239		10.1056/NEJMoa1905560	http://dx.doi.org/10.1056/NEJMoa1905560			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OT	31553835	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000489333500007
J	Butler, SM				Butler, Stuart M.			Federalism as an Antidote to Polarization Over Health Care Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Butler, Stuart M.] Brookings Inst, Econ Studies, Washington, DC 20036 USA	Brookings Institution	Butler, SM (corresponding author), Brookings Inst, Econ Studies, Washington, DC 20036 USA.	smbutler@brookings.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1131	1132		10.1001/jama.2019.14114	http://dx.doi.org/10.1001/jama.2019.14114			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550017	Bronze			2022-12-28	WOS:000488822800003
J	Horton, R				Horton, Richard			Offline: Why we must listen to critical friends	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					904	904		10.1016/S0140-6736(19)32130-0	http://dx.doi.org/10.1016/S0140-6736(19)32130-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX7CE	31526724	Bronze			2022-12-28	WOS:000485840600008
J	Makrides, M; Best, K; Yelland, L; McPhee, A; Zhou, S; Quinlivan, J; Dodd, J; Atkinson, E; Safa, H; van Dam, J; Khot, N; Dekker, G; Skubisz, M; Anderson, A; Kean, B; Bowman, A; McCallum, C; Cashman, K; Gibson, R				Makrides, Maria; Best, Karen; Yelland, Lisa; McPhee, Andrew; Zhou, Shao; Quinlivan, Julie; Dodd, Jodie; Atkinson, Elinor; Safa, Huda; van Dam, Jacqueline; Khot, Nisha; Dekker, Gustaaf; Skubisz, Monika; Anderson, Amanda; Kean, Beth; Bowman, Anneka; McCallum, Carly; Cashman, Kara; Gibson, Robert			A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DHA SUPPLEMENTATION; FISH-OIL; PREGNANCY	Background Previous studies have suggested that maternal supplementation with n-3 long-chain polyunsaturated fatty acids may reduce the incidence of preterm delivery but may also prolong gestation beyond term; however, more data are needed regarding the role of n-3 long-chain polyunsaturated fatty acids in pregnancy. Methods We performed a multicenter, double-blind, randomized trial in which women who were pregnant with single or multiple fetuses were assigned to receive either fish-oil capsules that contained 900 mg of n-3 long-chain polyunsaturated fatty acids (n-3 group) or vegetable-oil capsules that contained trace n-3 long-chain polyunsaturated fatty acids (control group) daily, beginning before 20 weeks of gestation and continuing to 34 weeks of gestation or delivery, whichever occurred first. The primary outcome was early preterm delivery, defined as delivery before 34 completed weeks of gestation. Other pregnancy and neonatal outcomes were also assessed. Results A total of 5544 pregnancies in 5517 women were randomly assigned at six centers in Australia; 5486 pregnancies were included in the primary analysis. Early preterm delivery occurred in the case of 61 of 2734 pregnancies (2.2%) in the n-3 group and 55 of 2752 pregnancies (2.0%) in the control group; the between-group difference was not significant (adjusted relative risk, 1.13; 95% confidence interval [CI], 0.79 to 1.63; P=0.50). There were no significant differences between the groups in the incidence of interventions in post-term (>41 weeks of gestation) deliveries, in adverse events, or in other pregnancy or neonatal outcomes, except that a higher percentage of infants born to women in the n-3 group than in the control group were very large for gestational age at birth (adjusted relative risk, 1.30; 95% CI, 1.02 to 1.65). Percentages of serious adverse events did not differ between the groups. Minor gastrointestinal disturbances were more commonly reported in the n-3 group than in the control group. Conclusions Supplementation with n-3 long-chain polyunsaturated fatty acids from early pregnancy (<20 weeks of gestation) until 34 weeks of gestation did not result in a lower incidence of early preterm delivery or a higher incidence of interventions in post-term deliveries than control. (Funded by the Australian National Health and Medical Research Council and the Thyne Reid Foundation; ORIP Australian New Zealand Clinical Trials Registry number, .) In this randomized, double-blind trial, supplementation with n-3 long-chain polyunsaturated fatty acids from early pregnancy (<20 weeks of gestation) until 34 weeks did not result in a lower risk of early preterm delivery or a higher incidence of interventions in post-term deliveries than control.	[Makrides, Maria; Best, Karen; Yelland, Lisa; McPhee, Andrew; Skubisz, Monika; Anderson, Amanda; Kean, Beth; Bowman, Anneka; McCallum, Carly; Gibson, Robert] Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Makrides, Maria; Best, Karen] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Yelland, Lisa; Cashman, Kara] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Zhou, Shao; Gibson, Robert] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [McPhee, Andrew] Womens & Childrens Hosp, Neonatal Serv, Adelaide, SA, Australia; [Dodd, Jodie; Skubisz, Monika] Womens & Childrens Hosp, Dept Obstet & Gynaecol, Adelaide, SA, Australia; [Atkinson, Elinor] Flinders Med Ctr, Dept Obstet, Adelaide, SA, Australia; [Atkinson, Elinor] Flinders Med Ctr, Dept Gynaecol, Adelaide, SA, Australia; [Dekker, Gustaaf] Northern Adelaide Local Hlth Network, Adelaide, SA, Australia; [Quinlivan, Julie] Univ Notre Dame, Fremantle, WA, Australia; [Safa, Huda] Mater Mothers Hosp, Brisbane, Qld, Australia; [van Dam, Jacqueline; Khot, Nisha] Werribee Mercy Hlth, Melbourne, Vic, Australia	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; Womens & Childrens Hospital Australia; Flinders Medical Centre; Flinders Medical Centre; University of Notre Dame Australia	Makrides, M (corresponding author), Womens & Childrens Hosp, South Australian Hlth & Med Res Inst, Level 7, North Adelaide, SA 5006, Australia.	maria.makrides@sahmri.com	Yelland, Lisa N/GPP-4533-2022; Best, Karen P/E-3293-2016; Dodd, Jodie/Y-6849-2019	Yelland, Lisa N/0000-0003-3803-8728; Best, Karen P/0000-0002-7653-5074; Dodd, Jodie/0000-0002-6363-4874	Australian National Health and Medical Research Council [1050468, 1061704, 1046207, 1052388]; Thyne Reid Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Thyne Reid Foundation	Supported by a grant (1050468) and fellowships (1061704, to Dr. Makrides; 1046207, to Dr. Gibson; and 1052388, to Dr. Yelland) from the Australian National Health and Medical Research Council and by a grant from the Thyne Reid Foundation. The trial capsules were donated by Croda UK, which provided the oils, and Efamol/Wassen UK, which provided the encapsulation.	Beeby PJ, 1996, J PAEDIATR CHILD H, V32, P512, DOI 10.1111/j.1440-1754.1996.tb00965.x; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Collins CT, 2017, NEW ENGL J MED, V376, P1245, DOI 10.1056/NEJMoa1611942; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; Kar S, 2016, EUR J OBSTET GYN R B, V198, P40, DOI 10.1016/j.ejogrb.2015.11.033; Leventakou V, 2014, AM J CLIN NUTR, V99, P506, DOI 10.3945/ajcn.113.067421; Liu G, 2014, PROSTAG LEUKOTR ESS, V91, P251, DOI 10.1016/j.plefa.2014.09.009; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; March of Dimes, 2012, PARTN MAT NEWB CHILD; Martin Joyce A, 2018, NCHS Data Brief, P1; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Middleton P, 2018, COCHRANE DB SYST REV, V11; Newberry Sydne J, 2016, Evid Rep Technol Assess (Full Rep), P1, DOI 10.23970/AHRQEPCERTA224; Nordgren TM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030197; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oken E, 2004, AM J EPIDEMIOL, V160, P774, DOI 10.1093/aje/kwh282; Olsen SF, 2007, EUR J CLIN NUTR, V61, P976, DOI 10.1038/sj.ejcn.1602609; Olsen SF, 2018, EBIOMEDICINE, V35, P325, DOI 10.1016/j.ebiom.2018.07.009; Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x; OLSEN SF, 1991, AM J OBSTET GYNECOL, V164, P1203, DOI 10.1016/0002-9378(91)90683-I; Patel FA, 2001, FRONT HORM RES, V27, P31; Saccone G, 2016, J MATERN-FETAL NEO M, V29, P2389, DOI 10.3109/14767058.2015.1086742; Sullivan TR, 2018, STAT METHODS MED RES, V27, P2610, DOI 10.1177/0962280216683570; Zhou SJ, 2019, AM J EPIDEMIOL, V188, P332, DOI 10.1093/aje/kwy225; Zhou SJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018360; Zhou SJ, 2012, AM J CLIN NUTR, V95, P1378, DOI 10.3945/ajcn.111.033217	28	43	44	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					1035	1045		10.1056/NEJMoa1816832	http://dx.doi.org/10.1056/NEJMoa1816832			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY2MW	31509674	Green Published, Bronze			2022-12-28	WOS:000486225900011
J	Willyard, C				Willyard, Cassandra			Too little, too late	NATURE			English	Editorial Material																		Abouk R, 2019, JAMA INTERN MED, V179, P805, DOI 10.1001/jamainternmed.2019.0272; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Cressman Alex M, 2017, CMAJ Open, V5, pE779, DOI 10.9778/cmajo.20170123; Goldman JE, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-018-0276-0; Green TC, 2018, JAMA PSYCHIAT, V75, P405, DOI 10.1001/jamapsychiatry.2017.4614; Karamouzian M, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0252-8; Puzantian T, 2018, JAMA-J AM MED ASSOC, V320, P1931, DOI 10.1001/jama.2018.12291	7	3	3	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					S17	S19		10.1038/d41586-019-02689-z	http://dx.doi.org/10.1038/d41586-019-02689-z			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511670				2022-12-28	WOS:000485415400010
J	Robinson, F				Robinson, Francesca			Caring for LGBT patients in the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												fran.robinson8@gmail.com						Government Equalities Office, 2018, LGBT ACT PLAN; Government Equalities Office, 2018, NAT LGBT SURV; House of Commons Women and Equalities Committee, 2019, OR EV HLTH SOC CAR L; Rimmer A, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4988; Stonewall, 2018, LGBT BRIT HLTH REP	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5374	10.1136/bmj.l5374	http://dx.doi.org/10.1136/bmj.l5374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506270				2022-12-28	WOS:000486648900005
J	Meertens, L; Hafirassou, ML; Couderc, T; Bonnet-Madin, L; Kril, V; Kummerer, BM; Labeau, A; Brugier, A; Simon-Loriere, E; Burlaud-Gaillard, J; Doyen, C; Pezzi, L; Goupil, T; Rafasse, S; Vidalain, PO; Bertrand-Legout, A; Gueneau, L; Juntas-Morales, R; Ben Yaou, R; Bonne, G; de Lamballerie, X; Benkirane, M; Roingeard, P; Delaugerre, C; Lecuit, M; Amara, A				Meertens, Laurent; Hafirassou, Mohamed Lamine; Couderc, Therese; Bonnet-Madin, Lucie; Kril, Vasiliya; Kummerer, Beate M.; Labeau, Athena; Brugier, Alexis; Simon-Loriere, Etienne; Burlaud-Gaillard, Julien; Doyen, Cecile; Pezzi, Laura; Goupil, Thibaud; Rafasse, Sophia; Vidalain, Pierre-Olivier; Bertrand-Legout, Anne; Gueneau, Lucie; Juntas-Morales, Raul; Ben Yaou, Rabah; Bonne, Gisele; de Lamballerie, Xavier; Benkirane, Monsef; Roingeard, Philippe; Delaugerre, Constance; Lecuit, Marc; Amara, Ali			FHL1 is a major host factor for chikungunya virus infection	NATURE			English	Article							SCALE CRISPR-CAS9 KNOCKOUT; MYOPATHY; GENES	Chikungunya virus (CHIKV) is a re-emerging alphavirus that is transmitted to humans by mosquito bites and causes musculoskeletal and joint pain(1,2). Despite intensive investigations, the human cellular factors that are critical for CHIKV infection remain unknown, hampering the understanding of viral pathogenesis and the development of anti-CHIKV therapies. Here we identified the four-and-a-half LIM domain protein 1 (FHL1)(3) as a host factor that is required for CHIKV permissiveness and pathogenesis in humans and mice. Ablation of FHL1 expression results in the inhibition of infection by several CHIKV strains and o'nyong-nyong virus, but not by other alphaviruses and flaviviruses. Conversely, expression of FHL1 promotes CHIKV infection in cells that do not normally express it. FHL1 interacts directly with the hypervariable domain of the nsP3 protein of CHIKV and is essential for the replication of viral RNA. FHL1 is highly expressed in CHIKV-target cells and is particularly abundant in muscles(3,4). Dermal fibroblasts and muscle cells derived from patients with Emery-Dreifuss muscular dystrophy that lack functional FHL1(5) are resistant to CHIKV infection. Furthermore, CHIKV infection is undetectable in Fhl1-knockout mice. Overall, this study shows that FHL1 is a key factor expressed by the host that enables CHIKV infection and identifies the interaction between nsP3 and FHL1 as a promising target for the development of anti-CHIKV therapies.	[Meertens, Laurent; Hafirassou, Mohamed Lamine; Bonnet-Madin, Lucie; Kril, Vasiliya; Labeau, Athena; Brugier, Alexis; Delaugerre, Constance; Amara, Ali] Univ Paris, Hop St Louis, INSERM U944, CNRS,UMR 7212,Genomes & Cell Biol Dis Unit,Inst R, Paris, France; [Couderc, Therese; Goupil, Thibaud; Rafasse, Sophia; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Inserm U1117, Paris, France; [Kummerer, Beate M.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany; [Simon-Loriere, Etienne] Inst Pasteur, G5 Evolutionary Genom RNA Viruses, Paris, France; [Burlaud-Gaillard, Julien; Roingeard, Philippe] Univ Tours, INSERM MAVIVH U1259, Tours, France; [Burlaud-Gaillard, Julien; Roingeard, Philippe] Univ Tours, IBiSA Microscopie Elect, Tours, France; [Burlaud-Gaillard, Julien; Roingeard, Philippe] CHRU Tours, Tours, France; [Doyen, Cecile; Benkirane, Monsef] Univ Montpellier, Inst Genet Humaine, Lab Virol Mol, CNRS, Montpellier, France; [Pezzi, Laura; de Lamballerie, Xavier] Aix Marseille Univ, Unite Virus Emergents, IRD190, Inserm 1207,EFS IRBA, Marseille, France; [Vidalain, Pierre-Olivier] Univ Paris 05, Equipe Chim & Biol Modelisat & Immunol Therapie, CNRS, UMR 8601, Paris, France; [Bertrand-Legout, Anne; Gueneau, Lucie; Ben Yaou, Rabah; Bonne, Gisele] Sorbonne Univ, Ctr Res Myol, INSERM, UMRS974, Paris, France; [Juntas-Morales, Raul] CHU Montpellier, Dept Neurol, Montpellier, France; [Delaugerre, Constance] Hop St Louis, APHP, Lab Virol, Paris, France; [Delaugerre, Constance] Hop St Louis, APHP, Dept Malad Infect, Paris, France; [Lecuit, Marc] Univ Paris, Necker Enfants Malades Univ Hosp, APHP, Dept Infect Dis & Trop Med,Inst Imagine, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Bonn; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Tours; Universite de Tours; CHU Tours; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Meertens, L; Amara, A (corresponding author), Univ Paris, Hop St Louis, INSERM U944, CNRS,UMR 7212,Genomes & Cell Biol Dis Unit,Inst R, Paris, France.	laurent.meertens@inserm.fr; ali.amara@inserm.fr	Lecuit, Marc/J-4073-2013; Bonne, Gisèle/G-3121-2013; Vidalain, Pierre-Olivier/F-9778-2019; Meertens, Laurent/E-8043-2017; Lecuit, Marc/M-4126-2019; Kümmerer, Beate/HGV-0882-2022; AMARA, Ali/ABX-9903-2022; Bertrand, Anne/AAR-6751-2020; BEN YAOU, Rabah/S-1443-2017	Lecuit, Marc/0000-0002-4491-1063; Bonne, Gisèle/0000-0002-2516-3258; Vidalain, Pierre-Olivier/0000-0003-3082-7407; Meertens, Laurent/0000-0003-2811-3675; Lecuit, Marc/0000-0002-4491-1063; AMARA, Ali/0000-0002-0283-1815; Pezzi, Laura/0000-0001-7921-9221; BEN YAOU, Rabah/0000-0002-0492-3414; Bertrand, Anne/0000-0001-7153-848X; Juntas Morales, Raul/0000-0003-2205-1741	French Government's Investissement d'Avenir program, Laboratoire d'Excellence `Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; 'Investissements d'Avenir' program [ANR-10-IHUB-0002, ANR-15-CE15-00029 ZIKAHOST]; 'Investissements d'Avenir' program (INCEPTION program) [ANR-16-CONV-0005]; Institut Pasteur; Inserm; European Research Council; EU Horizon 2020 research and innovation program [653316]; Laboratoire de Virologie, Universite de Corse-Inserm [EA7310]	French Government's Investissement d'Avenir program, Laboratoire d'Excellence `Integrative Biology of Emerging Infectious Diseases'(French National Research Agency (ANR)); 'Investissements d'Avenir' program(French National Research Agency (ANR)); 'Investissements d'Avenir' program (INCEPTION program)(French National Research Agency (ANR)); Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); EU Horizon 2020 research and innovation program; Laboratoire de Virologie, Universite de Corse-Inserm	This study received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence `Integrative Biology of Emerging Infectious Diseases' (ANR-10-LABX-62-IBEID), the 'Investissements d'Avenir' program (ANR-10-IHUB-0002, ANR-15-CE15-00029 ZIKAHOST and the INCEPTION program ANR-16-CONV-0005), Institut Pasteur, Inserm and European Research Council. Viruses were provided by the Europe and Virus Archive, which has received funding from the EU Horizon 2020 research and innovation program under grant agreement 653316. The authors thank the EA7310, Laboratoire de Virologie, Universite de Corse-Inserm for funding the doctoral position of L.P. We thank F. Rey, O. Schwartz, N. Manel, H. de The, Y. Gaudin, J. Hellert, M.-L. Chaix, S. Marot, S. Chawki, A. Canat, A. Zamborlini, A. Saib, F. Sigaux, S. Emiliani and F. Bachelerie for reading the manuscript and discussions; P. Thouvenot and D. Hardy for technical assistance; J. Chen and J. Bogomolovas for providing Fhl<SUP>1-/-</SUP> mice; M. Diamond and J. Fox, A. Merit and F. Tangy for providing the CHIKV 265 monoclonal antibody, the nsP3 antibodies and the alphavirus nsP1-4 constructs, respectively; and MGX-Montpellier facility for sequencing.	Bonne G, 1993, GENEREVIEWS; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Domenighetti AA, 2014, HUM MOL GENET, V23, P209, DOI 10.1093/hmg/ddt412; Glasker S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-235; Gotte B, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030105; Greene WK, 1999, GENE, V232, P203, DOI 10.1016/S0378-1119(99)00125-0; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Jose J, 2017, MBIO, V8, DOI [10.1128/mBio.02294-16, 10.1128/mbio.02294-16]; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320; Kim DY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005810; Krempler A, 2000, CYTOGENET CELL GENET, V90, P106, DOI 10.1159/000015643; Kummerer BM, 2012, J GEN VIROL, V93, P1991, DOI 10.1099/vir.0.043752-0; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Medina F., 2012, CURR PROTOC MICROBIO, V15; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Meshram CD, 2018, J VIROL, V92, DOI [10.1128/JVI.00838-18, 10.1128/jvi.00838-18]; Mutso M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050226; Ooi YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003835; Pellet J, 2010, NUCLEIC ACIDS RES, V38, pD371, DOI 10.1093/nar/gkp1000; Pen AE, 2015, EUR J MED GENET, V58, P222, DOI 10.1016/j.ejmg.2015.02.003; Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468; Roberts GC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15269-w; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Schessl J, 2011, SEMIN PEDIATR NEUROL, V18, P257, DOI 10.1016/j.spen.2011.10.007; Scholte FEM, 2015, J VIROL, V89, P4457, DOI 10.1128/JVI.03612-14; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shathasivam T, 2010, J CELL MOL MED, V14, P2702, DOI 10.1111/j.1582-4934.2010.01176.x; Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417; Tanaka A, 2017, J VIROL, V91, DOI [10.1128/JVI.00432-17, 10.1128/jvi.00432-17]; Zhang R, 2018, NATURE, V557, P570, DOI 10.1038/s41586-018-0121-3	35	34	34	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2019	574	7777					259	+		10.1038/s41586-019-1578-4	http://dx.doi.org/10.1038/s41586-019-1578-4			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD2DB	31554973				2022-12-28	WOS:000489784200050
J	Slomski, A				Slomski, Anita			Fecal Transplant Doesn't Improve Symptoms of IBS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1134	1134		10.1001/jama.2019.14756	http://dx.doi.org/10.1001/jama.2019.14756			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550030				2022-12-28	WOS:000488822800010
J	Aghajanian, H; Kimura, T; Rurik, JG; Hancock, AS; Leibowitz, MS; Li, L; Scholler, J; Monslow, J; Lo, A; Han, W; Wang, T; Bedi, K; Morley, MP; Saldana, RAL; Bolar, NA; McDaid, K; Assenmacher, CA; Smith, CL; Wirth, D; June, CH; Margulies, KB; Jain, R; Pure, E; Albelda, SM; Epstein, JA				Aghajanian, Haig; Kimura, Toru; Rurik, Joel G.; Hancock, Aidan S.; Leibowitz, Michael S.; Li, Li; Scholler, John; Monslow, James; Lo, Albert; Han, Wei; Wang, Tao; Bedi, Kenneth; Morley, Michael P.; Saldana, Ricardo A. Linares; Bolar, Nikhita A.; McDaid, Kendra; Assenmacher, Charles-Antoine; Smith, Cheryl L.; Wirth, Dagmar; June, Carl H.; Margulies, Kenneth B.; Jain, Rajan; Pure, Ellen; Albelda, Steven M.; Epstein, Jonathan A.			Targeting cardiac fibrosis with engineered T cells	NATURE			English	Article							FIBROBLAST ACTIVATION PROTEIN; MOLECULAR-CLONING; EXPRESSION; FAILURE; STROMA; ALPHA	Fibrosis is observed in nearly every form of myocardial disease(1). Upon injury, cardiac fibroblasts in the heart begin to remodel the myocardium by depositing excess extracellular matrix, resulting in increased stiffness and reduced compliance of the tissue. Excessive cardiac fibrosis is an important factor in the progression of various forms of cardiac disease and heart failure(2). However, clinical interventions and therapies that target fibrosis remain limited(3). Here we demonstrate the efficacy of redirected T cell immunotherapy to specifically target pathological cardiac fibrosis in mice. We find that cardiac fibroblasts that express a xenogeneic antigen can be effectively targeted and ablated by adoptive transfer of antigen-specific CD8(+) T cells. Through expression analysis of the gene signatures of cardiac fibroblasts obtained from healthy and diseased human hearts, we identify an endogenous target of cardiac fibroblasts-fibroblast activation protein. Adoptive transfer of T cells that express a chimeric antigen receptor against fibroblast activation protein results in a significant reduction in cardiac fibrosis and restoration of function after injury in mice. These results provide proof-of-principle for the development of immunotherapeutic drugs for the treatment of cardiac disease.	[Aghajanian, Haig; Rurik, Joel G.; Hancock, Aidan S.; Li, Li; Saldana, Ricardo A. Linares; Bolar, Nikhita A.; Smith, Cheryl L.; Jain, Rajan; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Aghajanian, Haig; Rurik, Joel G.; Hancock, Aidan S.; Li, Li; Wang, Tao; Bedi, Kenneth; Morley, Michael P.; Saldana, Ricardo A. Linares; Bolar, Nikhita A.; McDaid, Kendra; Smith, Cheryl L.; Margulies, Kenneth B.; Jain, Rajan; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Aghajanian, Haig; Rurik, Joel G.; Hancock, Aidan S.; Li, Li; Saldana, Ricardo A. Linares; Bolar, Nikhita A.; Smith, Cheryl L.; Jain, Rajan; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Kimura, Toru; Bedi, Kenneth; Morley, Michael P.; Margulies, Kenneth B.; Jain, Rajan; Albelda, Steven M.; Epstein, Jonathan A.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Leibowitz, Michael S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Leibowitz, Michael S.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Scholler, John; June, Carl H.] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Monslow, James; Lo, Albert; Pure, Ellen] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Han, Wei] Hosp Univ Penn, Echocardiog Lab, 3400 Spruce St, Philadelphia, PA 19104 USA; [Assenmacher, Charles-Antoine] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Wirth, Dagmar] Helmholtz Ctr Infect Res, Model Syst Infect & Immun, Braunschweig, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Helmholtz Association; Helmholtz-Center for Infection Research	Epstein, JA (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Epstein, JA (corresponding author), Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA.; Epstein, JA (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.; Epstein, JA (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	epsteinj@upenn.edu	Assenmacher, Charley/ABQ-6382-2022; Rurik, Joel/ABD-6427-2021	Smith, Cheryl/0000-0003-4323-6382; Linares, Ricardo/0000-0003-2657-825X; Epstein, Jonathan/0000-0001-8637-4465; Aghajanian, Haig/0000-0002-8317-0157; Morley, Michael/0000-0002-0958-7376; Kimura, Toru/0000-0003-4504-232X; Rurik, Joel/0000-0002-7156-4626	NIH [R35 HL140018, T32 HL007843-22, F31 HL147416]; Burroughs Wellcome Fund; Cotswold Foundation; W. W. Smith Endowed Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007843, R35HL140018, R01HL139783, F31HL147416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cotswold Foundation; W. W. Smith Endowed Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Molkentin for sharing the Postn<SUP>MCM</SUP> mice with us, A. Stout for help with imaging, D. Martinez for help with image analysis, M. Scherrer-Crosbie for guidance on the echocardiogram procedure and interpretation, F. Mourkioti for sharing the mdx/mTR<SUP>KO</SUP> mice with us, E. Radaelli for help with immunohistochemistry and the University of Pennsylvania Diabetes Research Center (DRC) for the use of the RIA Biomarker Core (P30-DK19525). This research was supported by NIH R35 HL140018, T32 HL007843-22, F31 HL147416, the Burroughs Wellcome Fund to R.J., the Cotswold Foundation and the W. W. Smith Endowed Chair to J.A.E.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Cebula M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068720; Chen CY, 2018, NAT MED, V24, P1225, DOI 10.1038/s41591-018-0046-2; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Dipla K, 1998, CIRCULATION, V97, P2316, DOI 10.1161/01.CIR.97.23.2316; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fan Zhaobo, 2016, Biomater Res, V20, P13, DOI 10.1186/s40824-016-0060-8; Fang L, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00186; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Ghobadi A, 2018, CURR RES TRANSL MED, V66, P43, DOI 10.1016/j.retram.2018.03.005; Govindaraju P, 2019, MATRIX BIOL, V75-76, P314, DOI 10.1016/j.matbio.2018.06.004; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ivey MJ, 2016, CIRC J, V80, P2269, DOI 10.1253/circj.CJ-16-1003; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kakarla S, 2013, MOL THER, V21, P1611, DOI 10.1038/mt.2013.110; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kaur H, 2016, CIRC RES, V118, P1906, DOI 10.1161/CIRCRESAHA.116.308643; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Lam CSP, 2018, EUR HEART J, V39, P2780, DOI 10.1093/eurheartj/ehy301; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Lo A, 2015, CANCER RES, V75, P2800, DOI 10.1158/0008-5472.CAN-14-3041; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; MULLARD A, 2017, NAT REV DRUG DISCOV, V16, P669; Newick K, 2016, CANCER IMMUNOL RES, V4, P541, DOI 10.1158/2326-6066.CIR-15-0263; Niedermeyer J, 1997, INT J CANCER, V71, P383, DOI 10.1002/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H; Ochel A, 2016, CELL MOL IMMUNOL, V13, P805, DOI 10.1038/cmi.2015.80; Ottaviano FG, 2011, J CARDIOVASC PHARM, V57, P513, DOI 10.1097/FJC.0b013e31821209ee; Petrausch U, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-615; RETTIG WJ, 1988, P NATL ACAD SCI USA, V85, P3110, DOI 10.1073/pnas.85.9.3110; Sandhu U, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq868; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Schmitt TM, 2009, HUM GENE THER, V20, P1240, DOI 10.1089/hum.2009.146; Schuberth PC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-187; Sun SJ, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2386187; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Tillmanns J, 2015, J MOL CELL CARDIOL, V87, P194, DOI 10.1016/j.yjmcc.2015.08.016; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027	45	232	239	18	158	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					430	+		10.1038/s41586-019-1546-z	http://dx.doi.org/10.1038/s41586-019-1546-z			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31511695	Green Accepted, Green Submitted			2022-12-28	WOS:000486647800053
J	Miniutti, G; Saxton, RD; Giustini, M; Alexander, KD; Fender, RP; Heywood, I; Monageng, I; Coriat, M; Tzioumis, AK; Read, AM; Knigge, C; Gandhi, P; Pretorius, ML; Agis-Gonzalez, B				Miniutti, G.; Saxton, R. D.; Giustini, M.; Alexander, K. D.; Fender, R. P.; Heywood, I.; Monageng, I.; Coriat, M.; Tzioumis, A. K.; Read, A. M.; Knigge, C.; Gandhi, P.; Pretorius, M. L.; Agis-Gonzalez, B.			Nine-hour X-ray quasi-periodic eruptions from a low-mass black hole galactic nucleus	NATURE			English	Article							RADIATION PRESSURE INSTABILITY; CHANGING-LOOK AGN; XMM-NEWTON VIEW; TIDAL DISRUPTION; ACCRETION DISCS; STAR-FORMATION; SOLAR MASSES; VARIABILITY; GALAXY; OSCILLATIONS	In the past two decades, high-amplitude electromagnetic outbursts have been detected from dormant galaxies and often attributed to the tidal disruption of a star by the central black hole(1,2). X-ray emission from the Seyfert 2 galaxy GSN 069 (2MASX J01190869-3411305) at a redshift of z = 0.018 was first detected in July 2010 and implies an X-ray brightening by a factor of more than 240 over ROSAT observations performed 16 years earlier(3,4). The emission has smoothly decayed over time since 2010, possibly indicating a long-lived tidal disruption event(5). The X-ray spectrum is ultra-soft and can be described by accretion disk emission with luminosity proportional to the fourth power of the disk temperature during long-term evolution. Here we report observations of quasi-periodic X-ray eruptions from the nucleus of GSN 069 over the course of 54 days, from December 2018 onwards. During these eruptions, the X-ray count rate increases by up to two orders of magnitude with an event duration of just over an hour and a recurrence time of about nine hours. These eruptions are associated with fast spectral transitions between a cold and a warm phase in the accretion flow around a low-mass black hole (of approximately 4 x 10(5) solar masses) with peak X-ray luminosity of about 5 x 10(42) erg per second. The warm phase has kT (where T is the temperature and k is the Boltzmann constant) of about 120 electronvolts, reminiscent of the typical soft-X-ray excess, an almost universal thermal-like feature in the X-ray spectra of luminous active nuclei(6-8). If the observed properties are not unique to GSN 069, and assuming standard scaling of timescales with black hole mass and accretion properties, typical active galactic nuclei with higher-mass black holes can be expected to exhibit high-amplitude optical to X-ray variability on timescales as short as months or years(9).	[Miniutti, G.; Giustini, M.] Ctr Astrobiol CSIC INTA, ESAC Campus, Madrid, Spain; [Saxton, R. D.] ESAC, Telespazio Vega UK ESA, Operat Dept, Madrid, Spain; [Alexander, K. D.] Northwestern Univ, CIERA, Evanston, IL USA; [Alexander, K. D.] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA; [Fender, R. P.; Heywood, I.] Univ Oxford, Dept Phys, Astrophys, Oxford, England; [Fender, R. P.] Univ Cape Town, Dept Astron, Rondebosch, South Africa; [Heywood, I.] Rhodes Univ, Dept Phys & Elect, Grahamstown, South Africa; [Heywood, I.] South African Radio Astron Observ, Cape Town, South Africa; [Monageng, I.; Pretorius, M. L.] South African Astron Observ, Cape Town, South Africa; [Coriat, M.] Univ Toulouse, IRAP, CNRS, CNES,UPS, Toulouse, France; [Tzioumis, A. K.] CSIRO, Australia Telescope Natl Facil, Epping, NSW, Australia; [Read, A. M.] Univ Leicester, Dept Phys & Astron, Leicester, Leics, England; [Knigge, C.; Gandhi, P.] Univ Southampton, Sch Phys & Astron, Southampton, Hants, England; [Agis-Gonzalez, B.] Univ Liege, Inst Astrophys & Geophys, Liege, Belgium	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); European Space Agency; Thales Group; Northwestern University; Northwestern University; University of Oxford; University of Cape Town; Rhodes University; National Research Foundation - South Africa; South African Astronomical Observatory; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Leicester; University of Southampton; University of Liege	Miniutti, G (corresponding author), Ctr Astrobiol CSIC INTA, ESAC Campus, Madrid, Spain.	gminiutti@cab.inta-csic.es	Miniutti, Giovanni/L-2721-2014; Giustini, Margherita/A-9704-2018; Giustini, Margherita/Z-1517-2019	Miniutti, Giovanni/0000-0003-0707-4531; Giustini, Margherita/0000-0002-1329-658X; Monageng, Itumeleng/0000-0002-4754-3526; Knigge, Christian/0000-0002-1116-2553; Agis-Gonzalez, Beatriz/0000-0001-7702-8931; Tzioumis, Anastasios/0000-0002-0988-7969	ESA Member States; Chandra X-ray Observatory; NASA/ESA Hubble Space Telescope, ATCA; Karl G. Jansky VLA; South African MeerKAT radio telescope; Australian Government; Spanish public funding [ESP2017-86582-C4-1-R, ESP2015-65597-C4-1-R]; Spanish State Research Agency (AEI) [ESP2017-87676-C5-1-R, MDM-2017-0737]; NASA through NASA Hubble Fellowship - Space Telescope Science Institute [HST-HF2-51403.001]; Oxford Hintze Centre for Astrophysical Surveys from Hintze Family Charitable Foundation; STFC; UGC-UKIERI Phase 3 Thematic Partnership; Fonds de la Recherche Scientifique-FNRS, Belgium [4.4501.19]; NASA [NAS5-26555]	ESA Member States(European Space Agency); Chandra X-ray Observatory; NASA/ESA Hubble Space Telescope, ATCA; Karl G. Jansky VLA; South African MeerKAT radio telescope; Australian Government(Australian GovernmentCGIAR); Spanish public funding; Spanish State Research Agency (AEI); NASA through NASA Hubble Fellowship - Space Telescope Science Institute; Oxford Hintze Centre for Astrophysical Surveys from Hintze Family Charitable Foundation; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UGC-UKIERI Phase 3 Thematic Partnership; Fonds de la Recherche Scientifique-FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); NASA(National Aeronautics & Space Administration (NASA))	The scientific results reported here are based on observations obtained with XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and NASA, the Chandra X-ray Observatory, the NASA/ESA Hubble Space Telescope, ATCA, the Karl G. Jansky VLA and the South African MeerKAT radio telescope. ATCA is part of the Australia Telescope National Facility which is funded by the Australian Government for operation as a National Facility managed by CSIRO. The NRAO operating the VLA is a facility of the US National Science Foundation operated under cooperative agreement by Associated Universities, Inc. The MeerKAT telescope is operated by SARAO, which is a facility of the National Research Foundation, an agency of the South African Department of Science and Innovation. We thank N. Schartel, B. Wilkes, J. Stevens, M. Claussen and F. Camilo for approving XMM-Newton, Chandra, ATCA, VLA and MeerKAT DDT observations, as well as the operation and scheduling teams of all involved observatories and facilities. We also thank the Neil Gehrels Swift Observatory for supporting a long-term monitoring campaign of GSN 069 over the years. G. M. thanks A. Laor for critically reading the article and suggesting the acronym QPE to describe the observed X-ray variability. G. M. and M. G. thank A. Janiuk, M. Grezdzielski and A. Rozanska for discussions on the physics of disk instabilities and soft excess. G. M. and M. G. acknowledge Spanish public funding through grants ESP2017-86582-C4-1-R and ESP2015-65597-C4-1-R, respectively. This research has been partially funded by the Spanish State Research Agency (AEI) project number ESP2017-87676-C5-1-R and MDM-2017-0737 Unidad de Excelencia "Maria de Maeztu"-Centro de Astrobiologia (INTA-CSIC). K.D.A. is a NASA Einstein Fellow and acknowledges support provided by NASA through NASA Hubble Fellowship grant HST-HF2-51403.001 awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS5-26555. I.H. acknowledges support of the Oxford Hintze Centre for Astrophysical Surveys which is funded through support from the Hintze Family Charitable Foundation. P.G. acknowledges support from STFC and a UGC-UKIERI Phase 3 Thematic Partnership. B.A.G. acknowledges support provided by the Fonds de la Recherche Scientifique-FNRS, Belgium, under grant number 4.4501.19.	Altamirano D, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L17; Auchettl K, 2017, ASTROPHYS J, V838, DOI 10.3847/1538-4357/aa633b; Belloni T, 1997, ASTROPHYS J, V488, pL109, DOI 10.1086/310944; Belloni T, 1997, ASTROPHYS J, V479, pL145, DOI 10.1086/310595; COHEN RD, 1986, ASTROPHYS J, V311, P135, DOI 10.1086/164758; Czerny B, 2003, ASTRON ASTROPHYS, V412, P317, DOI 10.1051/0004-6361:20031441; Denney KD, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/134; Dewangan GC, 2000, MON NOT R ASTRON SOC, V318, P309, DOI 10.1046/j.1365-8711.2000.03755.x; Dexter J, 2019, MON NOT R ASTRON SOC, V483, pL17, DOI 10.1093/mnrasl/sly213; Farrell SA, 2009, NATURE, V460, P73, DOI 10.1038/nature08083; Gierlinski M, 2004, MON NOT R ASTRON SOC, V349, pL7, DOI 10.1111/j.1365-2966.2004.07687.x; Gronkiewicz D., 2019, PREPRINT; Grzedzielski M, 2017, ASTRON ASTROPHYS, V603, DOI 10.1051/0004-6361/201629672; Ho LC, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/1/L16; Ingram A, 2009, MON NOT R ASTRON SOC, V397, pL101, DOI 10.1111/j.1745-3933.2009.00693.x; Janiuk A, 2000, ASTROPHYS J, V542, pL33, DOI 10.1086/312911; Janiuk A, 2004, ASTROPHYS J, V602, P595, DOI 10.1086/381159; Janiuk A, 2002, ASTROPHYS J, V576, P908, DOI 10.1086/341804; Janiuk A, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201425003; Janiuk A, 2011, MON NOT R ASTRON SOC, V414, P2186, DOI 10.1111/j.1365-2966.2011.18544.x; Jiang YF, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/106; Kalberla PMW, 2005, ASTRON ASTROPHYS, V440, P775, DOI 10.1051/0004-6361:20041864; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kenyon JS, 2018, MON NOT R ASTRON SOC, V478, P2399, DOI 10.1093/mnras/sty1221; Komossa S, 2015, J HIGH ENERGY ASTROP, V7, P148, DOI 10.1016/j.jheap.2015.04.006; LaMassa SM, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/144; LIGHTMAN AP, 1974, ASTROPHYS J, V187, pL1, DOI 10.1086/181377; Lin DC, 2017, MON NOT R ASTRON SOC, V468, P783, DOI 10.1093/mnras/stx489; Lin DC, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/1/L10; MacLeod CL, 2016, MON NOT R ASTRON SOC, V457, P389, DOI 10.1093/mnras/stv2997; MacLeod M, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/134; Mathur S, 2018, ASTROPHYS J, V866, DOI 10.3847/1538-4357/aadd91; Matt G, 2003, MON NOT R ASTRON SOC, V342, P422, DOI 10.1046/j.1365-8711.2003.06539.x; McElroy RE, 2016, ASTRON ASTROPHYS, V593, DOI 10.1051/0004-6361/201629102; McMullin JP, 2007, ASTR SOC P, V376, P127; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Merloni A, 2007, MON NOT R ASTRON SOC, V381, P589, DOI 10.1111/j.1365-2966.2007.12253.x; Merloni A, 2006, MON NOT R ASTRON SOC, V372, P728, DOI 10.1111/j.1365-2966.2006.10889.x; Miniutti G, 2013, MON NOT R ASTRON SOC, V433, P1764, DOI 10.1093/mnras/stt850; Miniutti G, 2009, MON NOT R ASTRON SOC, V394, P443, DOI 10.1111/j.1365-2966.2008.14334.x; MITSUDA K, 1984, PUBL ASTRON SOC JPN, V36, P741; Nayakshin S, 2000, ASTROPHYS J, V535, P798, DOI 10.1086/308860; Noda H, 2018, MON NOT R ASTRON SOC, V480, P3898, DOI 10.1093/mnras/sty2032; Offringa AR, 2014, MON NOT R ASTRON SOC, V444, P606, DOI 10.1093/mnras/stu1368; Petrucci PO, 2018, ASTRON ASTROPHYS, V611, DOI 10.1051/0004-6361/201731580; Phinney E. S., 1989, IAU S, V136, P543; Pickles AJ, 1998, PUBL ASTRON SOC PAC, V110, P863, DOI 10.1086/316197; Piconcelli E, 2005, ASTRON ASTROPHYS, V432, P15, DOI 10.1051/0004-6361:20041621; Raimundo SI, 2019, MON NOT R ASTRON SOC, V486, P123, DOI 10.1093/mnras/stz852; Ranalli P, 2003, ASTRON ASTROPHYS, V399, P39, DOI 10.1051/0004-6361:20021600; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; Reeves J, 2008, MON NOT R ASTRON SOC, V385, pL108, DOI 10.1111/j.1745-3933.2008.00443.x; Rivers E, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/63; Sadowski A, 2015, MON NOT R ASTRON SOC, V453, P3213, DOI 10.1093/mnras/stv1802; Sault RJ, 1995, ASTR SOC P, V77, P433; Saxton RD, 2008, ASTRON ASTROPHYS, V480, P611, DOI 10.1051/0004-6361:20079193; Saxton R. D., 2011, P SCI, V126; Shappee BJ, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/48; Shu XW, 2018, ASTROPHYS J LETT, V857, DOI 10.3847/2041-8213/aaba17; Shu XW, 2017, ASTROPHYS J, V837, DOI 10.3847/1538-4357/aa5eb3; Sun LM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/167; Tasse C., 2018, Astronomy & Astrophysics, V611, DOI 10.1051/0004-6361/201731474; Terashima Y, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/154; Valtonen MJ, 2008, NATURE, V452, P851, DOI 10.1038/nature06896; VANDERKLIS M, 1989, ANNU REV ASTRON ASTR, V27, P517, DOI 10.1146/annurev.astro.27.1.517; Vasudevan RV, 2009, MON NOT R ASTRON SOC, V392, P1124, DOI 10.1111/j.1365-2966.2008.14108.x; Williams P.K.G., 2017, ASCL1704001; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; Yuan W, 2010, ASTROPHYS J, V723, P508, DOI 10.1088/0004-637X/723/1/508	71	64	64	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					381	+		10.1038/s41586-019-1556-x	http://dx.doi.org/10.1038/s41586-019-1556-x			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31511696	Green Accepted, Green Submitted			2022-12-28	WOS:000486647800042
J	Zerhouni, E; Dye, NA; Mahmoud, A; Iyer, KV; Mateska, I; Ghosh, S; Nellas, I; Piscitello-Gomez, R; Zeidan, SA; Fuhrmann, J; Lewis, A; Krishna, A				Zerhouni, Elias; Dye, Natalie A.; Mahmoud, Ali; Iyer, K. Venkatesan; Mateska, Ivona; Ghosh, Suhrid; Nellas, Ioannis; Piscitello-Gomez, Romina; Zeidan, Salma Ahmed; Fuhrmann, Jana; Lewis, Allison; Krishna, Abhijeet			GAVI, the Vaccine Alliance	CELL			English	Editorial Material								This year's Lasker-Bloomberg Public Service Award goes to GAVI, the Vaccine Alliance, for providing sustained access to childhood vaccines around the globe, saving millions of lives, and highlighting the power of immunization to prevent disease.	[Zerhouni, Elias] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Dye, Natalie A.; Mahmoud, Ali; Iyer, K. Venkatesan; Mateska, Ivona; Ghosh, Suhrid; Nellas, Ioannis; Piscitello-Gomez, Romina; Zeidan, Salma Ahmed; Fuhrmann, Jana; Lewis, Allison; Krishna, Abhijeet] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Johns Hopkins University; Max Planck Society	Zerhouni, E (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.; Mateska, I; Piscitello-Gomez, R (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	eliaszerhouni1@gmail.com; mateska@mpi-cbg.de; piscitel@mpi-cbg.de							0	11	11	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					13	20		10.1016/j.cell.2019.08.026	http://dx.doi.org/10.1016/j.cell.2019.08.026			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31519310	Bronze			2022-12-28	WOS:000486618500004
J	Vogt, H; Green, S; Ekstrom, CT; Brodersen, J				Vogt, Henrik; Green, Sara; Ekstrom, Claus Thorn; Brodersen, John			How precision medicine and screening with big data could increase overdiagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH RESEARCH; WELLNESS; EVENTS		[Vogt, Henrik] Univ Oslo, Ctr Med Eth, Oslo, Norway; [Vogt, Henrik] Univ Oslo, Hybrid Technol Hub, Oslo, Norway; [Vogt, Henrik] Norwegian Univ Sci & Technol, Gen Practice Res Unit, Trondheim, Norway; [Green, Sara] Univ Copenhagen, Dept Sci Educ, Copenhagen, Denmark; [Green, Sara] Univ Copenhagen, Ctr Med Sci & Technol Studies, Copenhagen, Denmark; [Ekstrom, Claus Thorn] Univ Copenhagen, Dept Publ Hlth, Biostat, Copenhagen, Denmark; [Brodersen, John] Univ Copenhagen, Ctr Res & Educ Gen Practice, Copenhagen, Denmark; [Brodersen, John] Primary Hlth Care Res Unit, Copenhagen, Region Zealand, Denmark	University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Vogt, H (corresponding author), Univ Oslo, Ctr Med Eth, Oslo, Norway.; Vogt, H (corresponding author), Univ Oslo, Hybrid Technol Hub, Oslo, Norway.; Vogt, H (corresponding author), Norwegian Univ Sci & Technol, Gen Practice Res Unit, Trondheim, Norway.	henrik.vogt@medisin.uio.no		Ekstrom, Claus Thorn/0000-0003-1191-373X; Brodersen, John Brandt/0000-0001-9369-3376; Green, Sara/0000-0001-7011-7202				Alyass A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0108-y; Brodersen J, 2018, BMJ EVID-BASED MED, V23, P1, DOI 10.1136/ebmed-2017-110886; Diamandis EP, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0239-6; Few S., 2018, BIG DATA BIG DUPE LI, P96; FIRTH WJ, 1991, BRIT MED J, V303, P1565, DOI 10.1136/bmj.303.6817.1565; Fortmann-Roe S, 2012, UNDERSTANDING BIAS V; Hofmann B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3314; Johansson M, 2016, BMJ-BRIT MED J, V353, pi2230; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Koshy AN, 2018, INT J CARDIOL, V266, P124, DOI 10.1016/j.ijcard.2018.02.073; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; National Institutes of Health, 2018, NAT I HLTH COR PROT; Nebert DW, 2012, SCIENCE, V337, P910, DOI 10.1126/science.337.6097.910-a; Pathirana T, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3879; Perkins BA, 2018, P NATL ACAD SCI USA, V115, P3686, DOI 10.1073/pnas.1706096114; Price ND, 2017, NAT BIOTECHNOL, V35, P747, DOI 10.1038/nbt.3870; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rose SMSF, 2019, NAT MED, V25, P792, DOI 10.1038/s41591-019-0414-6; Sharon T, 2016, PERS MED, V13, P563, DOI 10.2217/pme-2016-0057; Shendure J, 2019, CELL, V177, P45, DOI 10.1016/j.cell.2019.02.003; Smith GD, 2011, INT J EPIDEMIOL, V40, P537, DOI 10.1093/ije/dyr117; Topol E., 2015, PATIENT WILL SEE YOU; Torkamani A, 2017, CELL, V170, P828, DOI 10.1016/j.cell.2017.08.007; Vogt H, 2018, NAT BIOTECHNOL, V36, P678, DOI 10.1038/nbt.4210; Vogt H, 2016, MED HEALTH CARE PHIL, V19, P307, DOI 10.1007/s11019-016-9683-8; Waldo AL, 2017, CIRCULATION, V136, P1795, DOI 10.1161/CIRCULATIONAHA.117.030705; Welch H, 2011, OVERDIAGNOSED MAKING; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; Wilson JMG, 1968, PRINCIPLES PRACTICE; Xu S, 2019, NATURE, V571, P319, DOI 10.1038/d41586-019-02143-0	30	15	16	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5270	10.1136/bmj.l5270	http://dx.doi.org/10.1136/bmj.l5270			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519649	Green Published			2022-12-28	WOS:000486649800002
J	Berger, ZD; Goldberg, DS				Berger, Zackary D.; Goldberg, Daniel S.			Caught in the Web - US Immigration and Compound Disadvantage	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Faced with gastroesophageal reflux disease, a behavioral health disorder, and difficulty navigating the U.S. health care system, a Honduran immigrant stops working and takes up a collection to return home. His compound disadvantage has profound ethical implications.	[Berger, Zackary D.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Berger, Zackary D.] Esperanza Ctr Hlth Clin, Baltimore, MD 21231 USA; [Goldberg, Daniel S.] Univ Colorado, Ctr Bioeth & Humanities, Anschutz Med Campus, Denver, CO USA	Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Berger, ZD (corresponding author), Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA.; Berger, ZD (corresponding author), Esperanza Ctr Hlth Clin, Baltimore, MD 21231 USA.		Berger, Zackary/AAW-5761-2020; Berger, Zackary/I-7032-2013	Berger, Zackary/0000-0002-5871-0342				Analysis of Energy Consumption and Behavior of Television in Resident Houses in Thailand, 2011, RAK SKUNPONGB P ENG, V8, P115; Baril N, 2019, UPSTREAM PUBLIC HLTH; Powers M, 2006, SOCIAL JUSTICE MORAL; Wolff J., 2007, DISADVANTAGE; Wolff J, 2009, PUBLIC HEALTH ETH-UK, V2, P214, DOI 10.1093/phe/php033	5	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					993	995		10.1056/NEJMp1902966	http://dx.doi.org/10.1056/NEJMp1902966			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY2MW	31509671				2022-12-28	WOS:000486225900005
J	Feinberg, J				Feinberg, Judith			Tackle the epidemic, not the opioids	NATURE			English	Editorial Material									[Feinberg, Judith] West Virginia Univ, Behav Med Psychiat & Infect Dis, Morgantown, WV 26506 USA	West Virginia University	Feinberg, J (corresponding author), West Virginia Univ, Behav Med Psychiat & Infect Dis, Morgantown, WV 26506 USA.	judith.feinberg@hsc.wvu.edu		feinberg, judith/0000-0003-4206-7214	NIGMS NIH HHS [U54 GM104942] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	7	7	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					165	165		10.1038/d41586-019-02671-9	http://dx.doi.org/10.1038/d41586-019-02671-9			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31501585	Bronze, Green Accepted			2022-12-28	WOS:000485415400021
J	Li, WQ; Zhang, JY; Ma, JL; Li, ZX; Zhang, L; Zhang, Y; Guo, Y; Zhou, T; Li, JY; Shen, L; Liu, WD; Han, ZX; Blot, WJ; Gail, MH; Pan, KF; You, WC				Li, Wen-Qing; Zhang, Jing-Yu; Ma, Jun-Ling; Li, Zhe-Xuan; Zhang, Lian; Zhang, Yang; Guo, Yang; Zhou, Tong; Li, Ji-You; Shen, Lin; Liu, Wei-Dong; Han, Zhong-Xiang; Blot, William J.; Gail, Mitchell H.; Pan, Kai-Feng; You, Wei-Cheng			Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HIGH-RISK; ENDOSCOPIC RESECTION; FACTORIAL TRIAL; ERADICATION; PREVENTION; LESIONS; REDUCE; CHINA; PROGRESSION; POPULATION	OBJECTIVE To assess the effects of Helicobacter pylori treatment, vitamin supplementation, and garlic supplementation in the prevention of gastric cancer. DESIGN Blinded randomized placebo controlled trial. SETTING Linqu County, Shandong province, China. PARTICIPANTS 3365 residents of a high risk region for gastric cancer. 2258 participants seropositive for antibodies to H pylori were randomly assigned to H pylori treatment, vitamin supplementation, garlic supplementation, or their placebos in a 2x2x2 factorial design, and 1107 H pylori seronegative participants were randomly assigned to vitamin supplementation, garlic supplementation, or their placebos in a 2x2 factorial design. INTERVENTIONS H pylori treatment with amoxicillin and omeprazole for two weeks; vitamin (C, E, and selenium) and garlic (extract and oil) supplementation for 7.3 years (1995-2003). MAIN OUTCOME MEASURES Primary outcomes were cumulative incidence of gastric cancer identified through scheduled gastroscopies and active clinical follow-up through 2017, and deaths due to gastric cancer ascertained from death certificates and hospital records. Secondary outcomes were associations with other cause specific deaths, including cancers or cardiovascular disease. RESULTS 151 incident cases of gastric cancer and 94 deaths from gastric cancer were identified during 1995-2017. A protective effect of H pylori treatment on gastric cancer incidence persisted 22 years post-intervention (odds ratio 0.48, 95% confidence interval 0.32 to 0.71). Incidence decreased significantly with vitamin supplementation but not with garlic supplementation (0.64, 0.46 to 0.91 and 0.81, 0.57 to 1.13, respectively). All three interventions showed significant reductions in gastric cancer mortality: fully adjusted hazard ratio for H pylori treatment was 0.62 (95% confidence interval 0.39 to 0.99), for vitamin supplementation was 0.48 (0.31 to 0.75), and for garlic supplementation was 0.66 (0.43 to 1.00). Effects of H pylori treatment on both gastric cancer incidence and mortality and of vitamin supplementation on gastric cancer mortality appeared early, but the effects of vitamin supplementation on gastric cancer incidence and of garlic supplementation only appeared later. No statistically significant associations were found between interventions and other cancers or cardiovascular disease. CONCLUSIONS H pylori treatment for two weeks and vitamin or garlic supplementation for seven years were associated with a statistically significant reduced risk of death due to gastric cancer for more than 22 years. H pylori treatment and vitamin supplementation were also associated with a statistically significantly reduced incidence of gastric cancer.	[Li, Wen-Qing; Zhang, Jing-Yu; Ma, Jun-Ling; Li, Zhe-Xuan; Zhang, Lian; Zhang, Yang; Guo, Yang; Zhou, Tong; Li, Ji-You; Shen, Lin; Pan, Kai-Feng; You, Wei-Cheng] Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China; [Liu, Wei-Dong; Han, Zhong-Xiang] Linqu Cty Publ Hlth Bur, Weifang, Shandong, Peoples R China; [Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Blot, William J.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Gail, Mitchell H.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Peking University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pan, KF (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Canc Epidemiol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China.	pankaifeng2002@yahoo.com	Li, Zhe-xuan/E-9182-2017	Li, Zhe-xuan/0000-0003-4023-6432; Li, Wen-Qing/0000-0002-8336-5552	Intramural Research Program of the National Institutes of Health, National Cancer Institute; National Cancer Institute [NO2-CP-71103, NO2-CP-21169]; National Basic Research Program of China (973 program) [2004CB518702, 2010CB529303]	Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Basic Research Program of China (973 program)(National Basic Research Program of China)	This study was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and in part by National Cancer Institute contracts NO2-CP-71103 and NO2-CP-21169. Additional support was from the National Basic Research Program of China (973 program: 2004CB518702 and 2010CB529303). The funding sources had no role in the study design; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication.	[Anonymous], IARC WORK GROUP REP; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Butt J, 2019, GASTROENTEROLOGY, V156, P175, DOI 10.1053/j.gastro.2018.09.054; Choi IJ, 2018, NEW ENGL J MED, V378, P1085, DOI 10.1056/NEJMoa1708423; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; CORREA P, 1992, CANCER RES, V52, P6735; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Freedberg DE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju148; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gail MH, 1998, CONTROL CLIN TRIALS, V19, P352, DOI 10.1016/S0197-2456(98)00016-6; Graham DY, 2015, GASTROENTEROLOGY, V148, P719, DOI 10.1053/j.gastro.2015.01.040; Herrero R, 2014, JAMA-J AM MED ASSOC, V312, P1197, DOI 10.1001/jama.2014.10498; Lee YC, 2016, GASTROENTEROLOGY, V150, P1113, DOI 10.1053/j.gastro.2016.01.028; Lee YC, 2013, GUT, V62, P676, DOI 10.1136/gutjnl-2012-302240; Leung WK, 2018, GASTROENTEROLOGY, V155, P67, DOI 10.1053/j.gastro.2018.03.028; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Li H, 2004, CHINESE MED J-PEKING, V117, P1155; Li WQ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju116; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; Nicastro HL, 2015, CANCER PREV RES, V8, P181, DOI 10.1158/1940-6207.CAPR-14-0172; Pan YM, 2016, ANTIOXID REDOX SIGN, V24, P839, DOI 10.1089/ars.2014.6128; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; Saito D, 2005, GASTROENTEROLOGY, V128, pA4; Suzuki H, 2018, NAT REV GASTRO HEPAT, V15, P458, DOI 10.1038/s41575-018-0023-8; Tanaka Shinji, 2004, Hiroshima Journal of Medical Sciences, V53, P39; Wang SM, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djy043; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Wong BCY, 2012, GUT, V61, P812, DOI 10.1136/gutjnl-2011-300154; Xie FJ, 2013, WORLD J GASTROENTERO, V19, P6098, DOI 10.3748/wjg.v19.i36.6098; You WC, 1999, INT J CANCER, V83, P615, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;615::AID-IJC8&gt;3.0.CO;2-L; You WC, 2000, J NATL CANCER I, V92, P1607, DOI 10.1093/jnci/92.19.1607; YOU WC, 1988, CANCER RES, V48, P3518; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Zhang L, 1996, CANCER EPIDEM BIOMAR, V5, P627; ZHANG L, 1994, INT J CANCER, V56, P650, DOI 10.1002/ijc.2910560508; Zhou LY, 2008, GASTROENTEROLOGY, V134, pA233; Zhou Y, 2011, GASTROENTEROLOGY, V141, P80, DOI 10.1053/j.gastro.2011.03.057	40	95	103	11	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2019	366								l5016	10.1136/bmj.l5016	http://dx.doi.org/10.1136/bmj.l5016			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MQ	31511230	Green Published, hybrid			2022-12-28	WOS:000486649100002
J	Rathinam, SR; Gonzales, JA; Thundikandy, R; Kanakath, A; Murugan, SB; Vedhanayaki, R; Lim, LL; Suhler, EB; Al-Dhibi, HA; Doan, T; Keenan, JD; Rao, MM; Ebert, CD; Nguyen, HH; Kim, E; Porco, TC; Acharya, NR				Rathinam, S. R.; Gonzales, John A.; Thundikandy, Radhika; Kanakath, Anuradha; Murugan, S. Bala; Vedhanayaki, R.; Lim, Lyndell L.; Suhler, Eric B.; Al-Dhibi, Hassan A.; Doan, Thuy; Keenan, Jeremy D.; Rao, Maya M.; Ebert, Caleb D.; Nguyen, Hieu H.; Kim, Eric; Porco, Travis C.; Acharya, Nisha R.			Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RHEUMATOID-ARTHRITIS; THERAPY; DRUGS; RECOMMENDATIONS; MANAGEMENT	ImportanceMethotrexate and mycophenolate mofetil are commonly used immunomodulatory therapies for achieving corticosteroid-sparing control of noninfectious uveitis, but there is uncertainty about which drug is more effective. ObjectiveTo compare the effect of methotrexate and mycophenolate for achieving corticosteroid-sparing control of noninfectious intermediate uveitis, posterior uveitis, and panuveitis. Design, Setting, and ParticipantsThe First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial screened 265 adults with noninfectious uveitis requiring corticosteroid-sparing immunosuppressive therapy from 9 referral eye centers in India, the United States, Australia, Saudi Arabia, and Mexico between August 22, 2013, and August 16, 2017. Follow-up ended on August 20, 2018. InterventionsPatients were randomized to receive oral methotrexate, 25 mg weekly (n=107), or oral mycophenolate mofetil, 3 g daily (n=109). Main Outcomes and MeasuresThe primary outcome was treatment success at 6 months, which was defined as having control of inflammation in both eyes, no more than 7.5 mg prednisone daily and less than or equal to 2 drops of prednisolone acetate 1%, and no treatment failure due to safety or intolerability. Patients underwent follow-up to 12 months while receiving the same treatment or switched to the other antimetabolite, depending on their 6-month outcome. ResultsAmong 216 patients who were randomized (median age, 38 years; 135 (62.5%) women), 194 (89.8%) completed follow-up through 6 months. Treatment success occurred in 64 (66.7%) patients in the methotrexate group vs 56 (57.1%) in the mycophenolate group (difference, 9.5% [95% CI, -5.3% to 21.8%]; odds ratio [OR], 1.50 [95% CI, 0.81 to 2.81]; P=.20). Among patients with posterior uveitis or panuveitis, treatment success was achieved in 58 (74.4%) in the methotrexate group vs 42 (55.3%) in the mycophenolate group (difference, 19.1% [95% CI, 3.6% to 30.6%]; OR, 2.35 [95% CI, 1.16 to 4.90]; P=.02); whereas among patients with intermediate uveitis treatment success occurred in 6 (33.3%) in the methotrexate group vs 14 (63.6%) in the mycophenolate group (difference, -30.3% [95% CI, -51.6% to 1.1%]; OR, 0.29 [95% CI, 0.08 to 1.05]; P=.07; P for interaction=.004). Elevated liver enzymes were the most common nonserious laboratory adverse event, occurring in 14 patients (13.0%) in the methotrexate group and 8 patients (7.4%) in the mycophenolate group. Conclusions and RelevanceAmong adults with noninfectious uveitis, the use of mycophenolate mofetil compared with methotrexate as first-line corticosteroid-sparing treatment did not result in superior control of inflammation. Further research is needed to determine if either drug is more effective based on the anatomical subtype of uveitis. Trial RegistrationClinicalTrials.gov Identifier: NCT01829295 This randomized trial compares the effects of oral methotrexate, 25 mg weekly vs oral mycophenolate mofetil, 3 g daily, on measures of inflammation in patients with noninfectious uveitis.	[Rathinam, S. R.; Thundikandy, Radhika; Vedhanayaki, R.] Aravind Eye Hosp & Postgrad Inst Ophthalmol, Uvea Serv, Madurai, Tamil Nadu, India; [Gonzales, John A.; Doan, Thuy; Keenan, Jeremy D.; Rao, Maya M.; Ebert, Caleb D.; Nguyen, Hieu H.; Kim, Eric; Porco, Travis C.; Acharya, Nisha R.] Univ Calif San Francisco, FI Proctor Fdn, 513 Parnassus Ave,S309, San Francisco, CA 94143 USA; [Gonzales, John A.; Doan, Thuy; Keenan, Jeremy D.; Porco, Travis C.; Acharya, Nisha R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Kanakath, Anuradha] Aravind Eye Hosp & Postgrad Inst Ophthalmol, Uvea Serv, Coimbatore, Tamil Nadu, India; [Murugan, S. Bala] Aravind Eye Hosp & Postgrad Inst Ophthalmol, Uvea Serv, Pondicherry, India; [Lim, Lyndell L.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Australia; [Suhler, Eric B.] Casey Eye Inst, Portland, OR USA; [Suhler, Eric B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Suhler, Eric B.] OHSU PSU Sch Publ Hlth, Portland, OR USA; [Suhler, Eric B.] VA Portland Hlth Care Syst, Portland, OR USA; [Al-Dhibi, Hassan A.] King Khalid Eye Specialist Hosp, Div Vitreoretinal Surg & Uveitis, Riyadh, Saudi Arabia; [Porco, Travis C.; Acharya, Nisha R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; King Khaled Eye Specialist Hospital; University of California System; University of California San Francisco	Acharya, NR (corresponding author), Univ Calif San Francisco, FI Proctor Fdn, 513 Parnassus Ave,S309, San Francisco, CA 94143 USA.	Nisha.Acharya@ucsf.edu	Keenan, Jeremy David/AAO-5882-2020	Keenan, Jeremy David/0000-0002-7118-1457; Lim, Lyndell/0000-0003-2491-685X; Bosco, Julian/0000-0001-5851-9751	NEI [U10 EY021125]; Research to Prevent Blindness Foundation from the NEI [EY06190]; That Man May See Foundation; NATIONAL EYE INSTITUTE [U10EY021125, P30EY002162] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Foundation from the NEI; That Man May See Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NEI cooperative agreement U10 EY021125 (to Dr Acharya, primary investigator). The University of California San Francisco pharmacy provided study drugs for all sites. The Department of Ophthalmology at UCSF is supported by an unrestricted grant from the Research to Prevent Blindness Foundation, a core grant (EY06190) from the NEI, and That Man May See Foundation.	[Anonymous], **DROPPED REF**; Baltatzis S, 2003, OPHTHALMOLOGY, V110, P1061, DOI 10.1016/S0161-6420(03)00092-7; Bom S, 2001, OCUL IMMUNOL INFLAMM, V9, P35, DOI 10.1076/ocii.9.1.35.3983; Daniel E, 2010, AM J OPHTHALMOL, V149, P423, DOI 10.1016/j.ajo.2009.09.026; Dev S, 1999, OPHTHALMOLOGY, V106, P111, DOI 10.1016/S0161-6420(99)90011-8; Dick AD, 2018, OPHTHALMOLOGY, V125, P757, DOI 10.1016/j.ophtha.2017.11.017; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; Fleiss JL., 2003, STAT METHODS RATES P; Foeldvari I, 2005, J RHEUMATOL, V32, P362; Food and Drug Administration, COLL RAC ETHN DAT CL; Galor A, 2008, OPHTHALMOLOGY, V115, P1826, DOI 10.1016/j.ophtha.2008.04.026; Gangaputra S, 2009, OPHTHALMOLOGY, V116, P2188, DOI 10.1016/j.ophtha.2009.04.020; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holz F G, 1992, Ger J Ophthalmol, V1, P142; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jabs DA, 2018, OPHTHALMOLOGY, V125, P193, DOI 10.1016/j.ophtha.2017.08.007; Jaffe GJ, 2016, NEW ENGL J MED, V375, P932, DOI 10.1056/NEJMoa1509852; Kempen JH, 2015, AM J OPHTHALMOL, V160, P1133, DOI 10.1016/j.ajo.2015.09.017; Kempen JH, 2008, AM J OPHTHALMOL, V146, P813, DOI 10.1016/j.ajo.2008.06.004; Rathinam SR, 2014, OPHTHALMOLOGY, V121, P1863, DOI 10.1016/j.ophtha.2014.04.023; Rosenbaum JT, 2018, ARTHRITIS RHEUMATOL, V70, P1533, DOI 10.1002/art.40568; Schiff MH, 2014, ANN RHEUM DIS, V73, P1549, DOI 10.1136/annrheumdis-2014-205228; SHAH SS, 1992, OPHTHALMOLOGY, V99, P1419; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Sobrin L, 2008, OPHTHALMOLOGY, V115, P1416, DOI 10.1016/j.ophtha.2007.12.011; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Teoh SC, 2008, AM J OPHTHALMOL, V146, P752, DOI 10.1016/j.ajo.2008.03.004; Thorne JE, 2005, OPHTHALMOLOGY, V112, P1472, DOI 10.1016/j.ophtha.2005.02.020	31	51	52	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					936	945		10.1001/jama.2019.12618	http://dx.doi.org/10.1001/jama.2019.12618			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY6YZ	31503307	Green Published, Bronze			2022-12-28	WOS:000486543500015
J	Newton, K; Wickliffe, KE; Dugger, DL; Maltzman, A; Roose-Girma, M; Dohse, M; Komuves, L; Webster, JD; Dixit, VM				Newton, Kim; Wickliffe, Katherine E.; Dugger, Debra L.; Maltzman, Allie; Roose-Girma, Merone; Dohse, Monika; Komuves, Laszlo; Webster, Joshua D.; Dixit, Vishva M.			Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis	NATURE			English	Article							CELL-DEATH; KINASE RIPK3; NECROSIS; DEFECTS; PATHWAY; MLKL	The aspartate-specific cysteine protease caspase-8 suppresses necroptotic cell death mediated by RIPK3 and MLKL. Indeed, mice that lack caspase-8 die in a RIPK3- and MLKL-dependent manner during embryogenesis(1-3). In humans, caspase-8 deficiency is associated with immunodeficiency(4) or very early onset inflammatory bowel disease(5). The substrates that are cleaved by caspase-8 to prevent necroptosis in vivo have not been defined. Here we show that knock-in mice that express catalytically inactive caspase-8(C362A) die as embryos owing to MLKL-dependent necroptosis, similar to caspase-8-deficient mice. Thus, caspase-8 must cleave itself, other proteins or both to inhibit necroptosis. Mice that express caspase-8(D212A/D218A/D225A/D387A), which cannot cleave itself, were viable, as were mice that express c-FLIP or CYLD proteins that had been mutated to prevent cleavage by caspase-8. By contrast, mice that express RIPK1(D325A), in which the caspase-8 cleavage site Asp325 had been mutated, died midgestation. Embryonic lethality was prevented by inactivation of RIPK1, loss of TNFR1, or loss of both MLKL and the caspase-8 adaptor FADD, but not by loss of MLKL alone. Thus, RIPK1(D325A) appears to trigger cell death mediated by TNF, the kinase activity of RIPK1 and FADD-caspase-8. Accordingly, dying endothelial cells that contain cleaved caspase-3 were abnormally abundant in yolk sacs of Ripk1(D325A/D325A) embryos. Heterozygous Ripk1(D325A/+) cells and mice were viable, but were also more susceptible to TNF-induced cell death than were wild-type cells or mice. Our data show that Asp325 of RIPK1 is essential for limiting aberrant cell death in response to TNF, consistent with the idea that cleavage of RIPK1 by caspase-8 is a mechanism for dismantling death-inducing complexes.	[Newton, Kim; Wickliffe, Katherine E.; Dugger, Debra L.; Maltzman, Allie; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Roose-Girma, Merone] Genentech Inc, Dept Mol Biol, San Francisco, CA USA; [Dohse, Monika; Komuves, Laszlo; Webster, Joshua D.] Genentech Inc, Dept Pathol, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Newton, K; Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	knewton@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Lehle AS, 2019, GASTROENTEROLOGY, V156, P275, DOI 10.1053/j.gastro.2018.09.041; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Webster JD, 2018, METHODS MOL BIOL, V1857, P153, DOI 10.1007/978-1-4939-8754-2_15; Zhang XH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1490-8	27	193	198	16	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2019	574	7778					428	+		10.1038/s41586-019-1548-x	http://dx.doi.org/10.1038/s41586-019-1548-x			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JE9DI	31511692				2022-12-28	WOS:000490988300070
J	Ham, YG; Kim, JH; Luo, JJ				Ham, Yoo-Geun; Kim, Jeong-Hwan; Luo, Jing-Jia			Deep learning for multi-year ENSO forecasts	NATURE			English	Article							EL-NINO; INDIAN-OCEAN; PREDICTION; FLAVORS	Variations in the El Nino/Southern Oscillation (ENSO) are associated with a wide array of regional climate extremes and ecosystem impacts(1). Robust, long-lead forecasts would therefore be valuable for managing policy responses. But despite decades of effort, forecasting ENSO events at lead times of more than one year remains problematic(2). Here we show that a statistical forecast model employing a deep-learning approach produces skilful ENSO forecasts for lead times of up to one and a half years. To circumvent the limited amount of observation data, we use transfer learning to train a convolutional neural network (CNN) first on historical simulations(3) and subsequently on reanalysis from 1871 to 1973. During the validation period from 1984 to 2017, the all-season correlation skill of the Nino3.4 index of the CNN model is much higher than those of current state-of-the-art dynamical forecast systems. The CNN model is also better at predicting the detailed zonal distribution of sea surface temperatures, overcoming a weakness of dynamical forecast models. A heat map analysis indicates that the CNN model predicts ENSO events using physically reasonable precursors. The CNN model is thus a powerful tool for both the prediction of ENSO events and for the analysis of their associated complex mechanisms.	[Ham, Yoo-Geun; Kim, Jeong-Hwan] Chonnam Natl Univ, Dept Oceanog, Gwangju, South Korea; [Luo, Jing-Jia] Nanjing Univ Informat Sci & Technol, Inst Climate & Applicat Res ICAR CICFEM KLME ILCE, Nanjing, Jiangsu, Peoples R China; [Luo, Jing-Jia] Chinese Acad Sci, Inst Earth Environm, SKLLQG, Xian, Shaanxi, Peoples R China	Chonnam National University; Nanjing University of Information Science & Technology; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Ham, YG (corresponding author), Chonnam Natl Univ, Dept Oceanog, Gwangju, South Korea.	ygham@jnu.ac.kr	Luo, Jing-Jia/T-9612-2019	Luo, Jing-Jia/0000-0003-2181-0638	Korea Meteorological Administration Research and Development Program [KMI2018-03214]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1A6A1A03012647]; 'The Startup Foundation for Introducing Talent' of NUIST	Korea Meteorological Administration Research and Development Program(Korea Meteorological Administration (KMA)); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); 'The Startup Foundation for Introducing Talent' of NUIST	This study is funded by the Korea Meteorological Administration Research and Development Program under grant KMI2018-03214. Y.-G.H. was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1A6A1A03012647). J.-J.L. is supported by 'The Startup Foundation for Introducing Talent' of NUIST. We are grateful to W. Merryfield for providing comments and to T. Doi for providing part of the SINTEX-F hindcast data used in the validation.	Anderson BT, 2007, J CLIMATE, V20, P1593, DOI 10.1175/JCLI4075.1; Barnston AG, 2012, B AM METEOROL SOC, V93, P631, DOI 10.1175/BAMS-D-11-00111.1; Behringer D.W., 2004, 8 S INTEGRATED OBSER; Bellenger H, 2014, CLIM DYNAM, V42, P1999, DOI 10.1007/s00382-013-1783-z; CANE MA, 1986, NATURE, V321, P827, DOI 10.1038/321827a0; Chen D, 2004, NATURE, V428, P733, DOI 10.1038/nature02439; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Gao C, 2017, CLIM DYNAM, V48, P597, DOI 10.1007/s00382-016-3097-4; Gebbie G, 2009, J CLIMATE, V22, P3894, DOI 10.1175/2009JCLI2516.1; Giese BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006695; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Ham YG, 2013, GEOPHYS RES LETT, V40, P4012, DOI 10.1002/grl.50729; Hu SN, 2016, P NATL ACAD SCI USA, V113, P2005, DOI 10.1073/pnas.1514182113; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Izumo T, 2010, NAT GEOSCI, V3, P168, DOI 10.1038/NGEO760; Johnson NC, 2013, J CLIMATE, V26, P4816, DOI 10.1175/JCLI-D-12-00649.1; Kalchbrenner N, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P655, DOI 10.3115/v1/p14-1062; Kirtman BP, 2014, B AM METEOROL SOC, V95, P585, DOI 10.1175/BAMS-D-12-00050.1; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kug JS, 2006, J CLIMATE, V19, P1784, DOI 10.1175/JCLI3660.1; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Luo JJ, 2008, J CLIMATE, V21, P84, DOI 10.1175/2007JCLI1412.1; Luo JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01479-9; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Oquab M, 2014, PROC CVPR IEEE, P1717, DOI 10.1109/CVPR.2014.222; Park JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33191-7; Pillai PA, 2017, CLIM DYNAM, V48, P3829, DOI 10.1007/s00382-016-3305-2; Reichstein M, 2019, NATURE, V566, P195, DOI 10.1038/s41586-019-0912-1; Tang YM, 2018, NATL SCI REV, V5, P826, DOI 10.1093/nsr/nwy105; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; WEBSTER PJ, 1992, Q J ROY METEOR SOC, V118, P877, DOI 10.1002/qj.49711850705; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Wu AM, 2006, NEURAL NETWORKS, V19, P145, DOI 10.1016/j.neunet.2006.01.004; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316; Yoo JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023513; Yosinski J, 2014, ADV NEURAL INF PROCE, V27, P3320, DOI DOI 10.1109/IJCNN.2016.7727519; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang ZY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44617-1; ZHOU B, 2016, PROC CVPR IEEE, P2921, DOI DOI 10.1109/CVPR.2016.319	39	287	309	77	379	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					568	+		10.1038/s41586-019-1559-7	http://dx.doi.org/10.1038/s41586-019-1559-7			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31534218				2022-12-28	WOS:000488247600055
J	Woodhead, J; Hergt, J; Giuliani, A; Maas, R; Phillips, D; Pearson, DG; Nowell, G				Woodhead, Jon; Hergt, Janet; Giuliani, Andrea; Maas, Roland; Phillips, David; Pearson, D. Graham; Nowell, Geoff			Kimberlites reveal 2.5-billion-year evolution of a deep, isolated mantle reservoir	NATURE			English	Article							ND ISOTOPIC COMPOSITION; LU-HF; CONSTRAINTS; SYSTEMATICS; ELEMENTS; EARTH; SUPERPLUME; PEROVSKITE; SEPARATION; MAGMATISM	The widely accepted paradigm of Earth's geochemical evolution states that the successive extraction of melts from the mantle over the past 4.5 billion years formed the continental crust, and produced at least one complementary melt-depleted reservoir that is now recognized as the upper-mantle source of mid-ocean-ridge basalts(1). However, geochemical modelling and the occurrence of high He-3/He-4 (that is, primordial) signatures in some volcanic rocks suggest that volumes of relatively undifferentiated mantle may reside in deeper, isolated regions(2). Some basalts from large igneous provinces may provide temporally restricted glimpses of the most primitive parts of the mantle(3,4), but key questions regarding the longevity of such sources on planetary timescales- and whether any survive today-remain unresolved. Kimberlites, small-volume volcanic rocks that are the source of most diamonds, offer rare insights into aspects of the composition of the Earth's deep mantle. The radiogenic isotope ratios of kimberlites of different ages enable us to map the evolution of this domain through time. Here we show that globally distributed kimberlites originate from a single homogeneous reservoir with an isotopic composition that is indicative of a uniform and pristine mantle source, which evolved in isolation over at least 2.5 billion years of Earth history-to our knowledge, the only such reservoir that has been identified to date. Around 200 million years ago, extensive volumes of the same source were perturbed, probably as a result of contamination by exogenic material. The distribution of affected kimberlites suggests that this event may be related to subduction along the margin of the Pangaea supercontinent. These results reveal a long-lived and globally extensive mantle reservoir that underwent subsequent disruption, possibly heralding a marked change to large-scale mantle-mixing regimes. These processes may explain why uncontaminated primordial mantle is so difficult to identify in recent mantle-derived melts.	[Woodhead, Jon; Hergt, Janet; Giuliani, Andrea; Maas, Roland; Phillips, David] Univ Melbourne, Sch Earth Sci, Melbourne, Vic, Australia; [Giuliani, Andrea] Macquarie Univ, Dept Earth & Planetary Sci, Sydney, NSW, Australia; [Pearson, D. Graham] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Nowell, Geoff] Univ Durham, Dept Earth Sci, Durham, England; [Giuliani, Andrea] Swiss Fed Inst Technol, Dept Earth Sci, Inst Geochem & Petrol, Zurich, Switzerland	University of Melbourne; Macquarie University; University of Alberta; Durham University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Woodhead, J (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic, Australia.	jdwood@unimelb.edu.au	Giuliani, Andrea/H-4825-2019; Pearson, Graham/AAN-5507-2020	Giuliani, Andrea/0000-0002-6823-2807; Woodhead, Jon/0000-0002-7614-0136; Nowell, Geoff/0000-0003-3229-128X; Hergt, Janet/0000-0003-3410-1670	Australian Research Council	Australian Research Council(Australian Research Council)	We thank the De Beers Group, S. Graham, B. Kjarsgaard and H. O'Brien for access to samples; M. Felgate and A Greig for technical assistance; D. Sandiford for advice on the use of GPlates; and S. Shirey for suggestions. R. Chesler and M. Felgate produced the Tanzania perovskite and Brazilian kimberlite data, respectively. J.W. and A.G. acknowledge funding from the Australian Research Council.	[Anonymous], 1982, THESIS; Bouvier A, 2016, NATURE, V537, P399, DOI 10.1038/nature19351; Bouvier A, 2008, EARTH PLANET SC LETT, V273, P48, DOI 10.1016/j.epsl.2008.06.010; Chauvel C., 2008, NAT GEOSCI; Chauvel C, 2014, EARTH PLANET SC LETT, V388, P48, DOI 10.1016/j.epsl.2013.11.045; Condie KC, 2004, PHYS EARTH PLANET IN, V146, P319, DOI 10.1016/j.pepi.2003.04.002; DEPAOLO DJ, 1976, GEOPHYS RES LETT, V3, P249, DOI 10.1029/GL003i005p00249; Dowall DP, 2003, PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES, P321, DOI 10.1039/9781847551689-00321; Eggins SM, 1997, CHEM GEOL, V134, P311, DOI 10.1016/S0009-2541(96)00100-3; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; Griffin WL, 2014, CONTRIB MINERAL PETR, V168, DOI 10.1007/s00410-014-1032-4; Harte B, 2012, GONDWANA RES, V21, P236, DOI 10.1016/j.gr.2011.07.001; Heaman LM, 2000, EARTH PLANET SC LETT, V178, P253, DOI 10.1016/S0012-821X(00)00079-0; Henning A., 2003, 8 INT KIMB C, V8, DOI [10.29173/ikc3024, DOI 10.29173/IKC3024]; Hofmann A.W., 2014, TREATISE GEOCHEMISTR, P67, DOI DOI 10.1016/B978-0-08-095975-7.00202-3; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Hulett SRW, 2016, NAT GEOSCI, V9, P904, DOI [10.1038/NGEO2831, 10.1038/ngeo2831]; Jackson MG, 2011, NATURE, V476, P316, DOI 10.1038/nature10326; Jackson MG, 2010, NATURE, V466, P853, DOI 10.1038/nature09287; Jweda J, 2016, GEOSTAND GEOANAL RES, V40, P101, DOI 10.1111/j.1751-908X.2015.00342.x; Kjarsgaard BA, 2009, LITHOS, V112, P236, DOI 10.1016/j.lithos.2009.06.001; Le Roex AP, 2003, J PETROL, V44, P2261, DOI 10.1093/petrology/egg077; LUGMAIR GW, 1978, EARTH PLANET SC LETT, V39, P349, DOI 10.1016/0012-821X(78)90021-3; Lyubetskaya T, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004223; Maruyama S, 2007, GONDWANA RES, V11, P7, DOI 10.1016/j.gr.2006.06.003; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Muller RD, 2016, ANNU REV EARTH PL SC, V44, P107, DOI 10.1146/annurev-earth-060115-012211; Munker C, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2001GC000183; Nestola F, 2018, NATURE, V555, P237, DOI 10.1038/nature25972; Nowell G, 2001, ROY SOC CH, P298, DOI 10.1039/9781847551696-00298; Nowell GM, 2004, J PETROL, V45, P1583, DOI 10.1093/petrology/egh024; Odin G.S., 1982, NUMERICAL DATING STR, P123, DOI DOI 10.1016/1359-0189(90)90126-I; Ottley CJ, 2003, PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES, P221, DOI 10.1039/9781847551689-00221; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; Pin C, 1997, ANAL CHIM ACTA, V339, P79, DOI 10.1016/S0003-2670(96)00499-0; Porter KA, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002656; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Salters VJM, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003617; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; SCOTESE C. R., 2016, PALEOMAP PALEOATLAS; Soderlund U, 2004, EARTH PLANET SC LETT, V219, P311, DOI 10.1016/S0012-821X(04)00012-3; Tachibana Y, 2006, GEOLOGY, V34, P273, DOI 10.1130/G22201.1; Tappe S, 2013, EARTH PLANET SC LETT, V371, P235, DOI 10.1016/j.epsl.2013.03.039; Timmerman S, 2019, SCIENCE, V365, P692, DOI 10.1126/science.aax5293; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; Trela J, 2017, NAT GEOSCI, V10, P451, DOI [10.1038/ngeo2954, 10.1038/NGEO2954]; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Vervoort JD, 1999, GEOCHIM COSMOCHIM AC, V63, P533, DOI 10.1016/S0016-7037(98)00274-9; Vervoort JD, 2011, GEOCHIM COSMOCHIM AC, V75, P5903, DOI 10.1016/j.gca.2011.07.046; Weis D, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000852; Woodhead J, 2017, GEOCHEM PERSPECT LET, V4, P1, DOI 10.7185/geochemlet.1727; Woodhead J, 2009, LITHOS, V112, P311, DOI 10.1016/j.lithos.2009.03.031	54	38	40	7	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					578	+		10.1038/s41586-019-1574-8	http://dx.doi.org/10.1038/s41586-019-1574-8			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31554979	Green Accepted			2022-12-28	WOS:000488247600057
J	Khine, A				Khine, Albert			A Teacher for All Seasons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a gastroenterologist describes the challenge of diagnosing a partner in his clinic with pancreatic cancer, which came a day short of the median time patients present and are diagnosed with the disease, and reflects on the positive example his colleague had on him, his career, and on the other physicians working at the clinic.	[Khine, Albert] Portland Clin LLP, Portland, OR USA		Khine, A (corresponding author), 800 SW 13th Ave, Portland, OR 97205 USA.	akhine@tpcllp.com		, Albert/0000-0001-6582-8229					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1145	1146		10.1001/jama.2019.14741	http://dx.doi.org/10.1001/jama.2019.14741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550035				2022-12-28	WOS:000488822800018
J	DeLoughery, T				DeLoughery, Thomas			Guideline: EULAR provided recommendations for thrombotic and obstetric antiphospholipid syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT		[DeLoughery, Thomas] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.		Tektonidou, Maria/AAF-1642-2019	Tektonidou, Maria/0000-0003-2238-0975; ANDREOLI, Laura/0000-0002-9107-3218				Garcia D, 2018, NEW ENGL J MED, V378, P2010, DOI 10.1056/NEJMra1705454; Jackson WG, 2017, BLOOD ADV, V1, P2320, DOI 10.1182/bloodadvances.2017008185; Keeling D, 2012, BRIT J HAEMATOL, V157, P47, DOI 10.1111/j.1365-2141.2012.09037.x; Pengo V, 2018, BLOOD, V132, P1365, DOI 10.1182/blood-2018-04-848333	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC26	JC26		10.7326/ACPJ201909170-026	http://dx.doi.org/10.7326/ACPJ201909170-026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525760				2022-12-28	WOS:000486101400002
J	Dyer, C				Dyer, Clare			MPs call for inquiry into troubled urology unit after whistleblower publishes book	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L1482; DYER C, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2352; WISE J, 2015, BMJ-BRIT MED J, V350, P36466, DOI DOI 10.1136/BMJ.H1221	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5602	10.1136/bmj.l5602	http://dx.doi.org/10.1136/bmj.l5602			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530625				2022-12-28	WOS:000487758600013
J	Koretz, RL				Koretz, Ronald L.			In US veterans, PPIs were linked to increased all-cause and some cause-specific mortality compared with H-2-blockers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In US veterans, are proton-pump inhibitors (PPIs) linked to increased risk for all-cause or cause-specific mortality compared with histamine H-2-receptor antagonists (H-2-blockers)? Methods Design: Cohort study using data from the Department of Veterans Affairs medical databases, with a median 10-year follow-up. Setting: US Department of Veterans Affairs. Patients: 214 467 patients (mean age 65 y, 96% men) who received a new prescription for PPIs (n = 157 625) or H-2-blockers (n = 56 842) between July 2002 and June 2004, had > 90 days of drug supply <= 180 days after the first prescription, and were alive 180 days after the first prescription. Exclusion criteria included prescription for acid-suppression drugs between October 1999 and June 2002; prescriptions for both PPIs and H(2)blockers <= 180 days after, and including, the first prescription; or missing data for date of birth, sex, race, or prescribing physician and facility. Risk factors: New prescriptions for PPIs or H-2-blockers. Outcomes: All-cause and cause-specific mortality identified using the National Death Index, with cause of death based on International Classification of Diseases, 10th revision, codes. Main results The main results for mortality are in the Table. Conclusion In US veterans, proton-pump inhibitors were linked to increased risk for all-cause and some cause-specific mortality at 10 years compared with histamine H2-receptor antagonists.	[Koretz, Ronald L.] Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Koretz, RL (corresponding author), Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA.							Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Moayyedi P, 2019, GASTROENTEROLOGY	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC35	JC35		10.7326/ACPJ201909170-035	http://dx.doi.org/10.7326/ACPJ201909170-035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525769				2022-12-28	WOS:000486101400011
J	Chan, J; Raju, SC; Topol, E				Chan, Justin; Raju, Sharat C.; Topol, Eric			Digital medicine Towards a tricorder for diagnosing paediatric conditions	LANCET			English	Editorial Material									[Chan, Justin] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA; [Raju, Sharat C.] Univ Washington, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA; [Topol, Eric] Scripps Res Translat Inst, La Jolla, CA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chan, J (corresponding author), Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA.	jucha@cs.washington.edu		Topol, Eric/0000-0002-1478-4729	US National Institutes of Health/National Center for Advancing Translational Sciences [UL1TR001114]	US National Institutes of Health/National Center for Advancing Translational Sciences	ET is supported by the US National Institutes of Health/National Center for Advancing Translational Sciences grant UL1TR001114	Chan J, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1102; de Greef L, 2014, UBICOMP'14: PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P331, DOI 10.1145/2632048.2632076; Liang HY, 2019, NAT MED, V25, P433, DOI 10.1038/s41591-018-0335-9; Mannino RG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07262-2; Porter P, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1046-6	5	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					907	907		10.1016/S0140-6736(19)32087-2	http://dx.doi.org/10.1016/S0140-6736(19)32087-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX7CE	31526726				2022-12-28	WOS:000485840600010
J	Davis, T				Davis, Tamara			An expanding controversy	SCIENCE			English	Editorial Material							CONSTANT		[Davis, Tamara] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Queensland	Davis, T (corresponding author), Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia.	tamarad@physics.uq.edu.au	Davis, Tamara/A-4280-2008	Davis, Tamara/0000-0002-4213-8783	Australian Research Council Laureate Fellowship [FL180100168]	Australian Research Council Laureate Fellowship(Australian Research Council)	T. D. is supported by an Australian Research Council Laureate Fellowship (FL180100168).	Abbott A, 2017, NATURE, V551, P425, DOI 10.1038/551425a; ADE PAR, 2016, ASTRON ASTROPHYS, V594, DOI DOI 10.1051/0004-6361/201525830; Alam S, 2017, MON NOT R ASTRON SOC, V470, P2822, DOI 10.1093/mnras/stx1421; Birrer S, 2019, MON NOT R ASTRON SOC, V484, P4726, DOI 10.1093/mnras/stz200; Freedman W. L., 2019, ARXIV190705922V1ASTR; Jee I, 2015, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2015/11/033; Jee I, 2019, SCIENCE, V365, P1134, DOI 10.1126/science.aat7371; Paraficz D, 2009, ASTRON ASTROPHYS, V507, pL49, DOI 10.1051/0004-6361/200913307; Riess AG, 2019, ASTROPHYS J, V876, DOI 10.3847/1538-4357/ab1422; Wojtak R, 2019, MON NOT R ASTRON SOC, V486, P5046, DOI 10.1093/mnras/stz1163	10	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1076	1077		10.1126/science.aay1331	http://dx.doi.org/10.1126/science.aay1331			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515370				2022-12-28	WOS:000485780800021
J	Christiansen, SC; Zuraw, BL				Christiansen, Sandra C.; Zuraw, Bruce L.			Treatment of Hypertension in Patients with Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HIGH BLOOD-PRESSURE; CONVERTING ENZYME-INHIBITORS; RENIN-ANGIOTENSIN SYSTEM; ASSOCIATION TASK-FORCE; REDUCED LUNG-FUNCTION; AIRWAY SMOOTH-MUSCLE; BODY-MASS INDEX; BRONCHIAL HYPERRESPONSIVENESS; MA/PCNA GUIDELINE; AMERICAN-COLLEGE	This article addresses the potential mechanistic links between hypertension and asthma as well as the influence of coexisting conditions. An approach to the treatment of hypertension in adult patients with asthma is outlined.	[Christiansen, Sandra C.; Zuraw, Bruce L.] Univ Calif San Diego, Dept Med, Div Rheumatol Alergy & Immunol, San Diego, CA 92103 USA; [Zuraw, Bruce L.] San Diego Vet Affairs Healthcare, Med Serv, San Diego, CA USA	University of California System; University of California San Diego	Christiansen, SC (corresponding author), 8899 Univ Ln,Suite 230,Mailcode 0976, San Diego, CA 92122 USA.	scchristiansen@ucsd.edu						Afsar B, 2018, HYPERTENSION, V72, P19, DOI 10.1161/HYPERTENSIONAHA.118.11128; [Anonymous], 2016, HLTH US 2015 SPEC FE; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Berlowitz DR, 2017, NEW ENGL J MED, V377, P733, DOI 10.1056/NEJMoa1611179; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Caldeira D, 2012, AM J CARDIOVASC DRUG, V12, P263, DOI 10.2165/11599990-000000000-00000; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; Chen SC, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0521-1; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Chiu KY, 2017, ANN ALLERG ASTHMA IM, V119, P518, DOI 10.1016/j.anai.2017.08.013; Christiansen SC, 2016, J ALLER CL IMM-PRACT, V4, P76, DOI 10.1016/j.jaip.2015.07.009; Chrysant GS, 1999, PROG CARDIOVASC DIS, V42, P23, DOI 10.1016/S0033-0620(99)70007-1; Coffman TM, 2011, NAT MED, V17, P1402, DOI 10.1038/nm.2541; DeMarco VG, 2014, NAT REV ENDOCRINOL, V10, P364, DOI 10.1038/nrendo.2014.44; Dogra S, 2007, J ASTHMA, V44, P849, DOI 10.1080/02770900701752391; Droyvold WB, 2005, INT J OBESITY, V29, P650, DOI 10.1038/sj.ijo.0802944; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Ferguson S, 2014, LUNG, V192, P675, DOI 10.1007/s00408-014-9600-y; Flack JM, 2010, HYPERTENSION, V56, P780, DOI 10.1161/HYPERTENSIONAHA.110.152892; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; FRAUNFELDER FT, 1984, NEW ENGL J MED, V311, P1441; Gauthier M, 2015, AM J RESP CRIT CARE, V192, P660, DOI 10.1164/rccm.201504-0763PP; Gibas-Dorna M, 2015, J PHYSIOL PHARMACOL, V66, P367; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Harman J, 2013, J CLIN HYPERTENS, V15, P367, DOI 10.1111/jch.12088; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; Khaltaev N, 2007, GLOBAL SURVEILLANCE; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lee DL, 2004, HYPERTENSION, V44, P259, DOI 10.1161/01.HYP.0000139913.56461.fb; Leineweber K, 2009, BRIT J PHARMACOL, V158, P61, DOI 10.1111/j.1476-5381.2009.00187.x; LIPWORTH BJ, 1989, AM J MED, V86, P653, DOI 10.1016/0002-9343(89)90438-5; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; LUNDE H, 1994, BRIT MED J, V308, P18, DOI 10.1136/bmj.308.6920.18; Ma J, 2016, EUR RESPIR J, V47, P122, DOI 10.1183/13993003.00591-2015; Manka LA, 2018, ANN ALLERG ASTHMA IM, V121, P406, DOI 10.1016/j.anai.2018.07.033; MILLAR EA, 1994, THORAX, V49, P492, DOI 10.1136/thx.49.5.492; Modena BD, 2014, AM J RESP CRIT CARE, V190, P1363, DOI 10.1164/rccm.201406-1099OC; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Morales DR, 2014, CHEST, V145, P779, DOI 10.1378/chest.13-1235; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mukae S, 2002, J HUM HYPERTENS, V16, P857, DOI 10.1038/sj.jhh.1001486; Myou S, 2000, AM J RESP CRIT CARE, V162, P40, DOI 10.1164/ajrccm.162.1.9907127; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; Omboni S, 2011, THER CLIN RISK MANAG, V7, P459, DOI 10.2147/TCRM.S25976; PATAKAS D, 1987, J ALLERGY CLIN IMMUN, V79, P959, DOI 10.1016/0091-6749(87)90247-8; PATAKAS D, 1983, J ALLERGY CLIN IMMUN, V72, P269, DOI 10.1016/0091-6749(83)90031-3; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Peters U, 2018, J ALLERGY CLIN IMMUN, V141, P1169, DOI 10.1016/j.jaci.2018.02.004; Qi H, 2018, AM J HYPERTENS, V31, P835, DOI 10.1093/ajh/hpy027; Quinto KB, 2011, J ALLERGY CLIN IMMUN, V128, P964, DOI 10.1016/j.jaci.2011.06.031; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Rosenberg SL, 2014, J ALLERGY CLIN IMMUN, V134, P1009, DOI 10.1016/j.jaci.2014.07.005; Rucker AJ, 2018, ANNU REV PHYSIOL, V80, P283, DOI 10.1146/annurev-physiol-021317-121134; Ryan S, 2009, THORAX, V64, P631, DOI 10.1136/thx.2008.105577; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Rzucidlo EM, 2009, VASCULAR, V17, pS15, DOI 10.2310/6670.2008.00089; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Salpeter SR, 2002, ANN INTERN MED, V137, P715, DOI 10.7326/0003-4819-137-9-200211050-00035; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Sholter DE, 2000, CAN J CARDIOL, V16, P505; Simcock DE, 2008, AM J RESP CRIT CARE, V178, P460, DOI 10.1164/rccm.200707-1046OC; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Spruill TM, 2010, CURR HYPERTENS REP, V12, P10, DOI 10.1007/s11906-009-0084-8; Tanaka H, 2001, CIRCULATION, V104, P281, DOI 10.1161/01.CIR.104.3.281; Taniguchi M, 1990, Nihon Kyobu Shikkan Gakkai Zasshi, V28, P156; Toennesen LL, 2018, J ALLER CL IMM-PRACT, V6, P803, DOI 10.1016/j.jaip.2017.09.028; Vukadinovic D, 2019, CLIN PHARMACOL THER, V105, P652, DOI 10.1002/cpt.1018; Wang YH, 2011, CURR ALLERGY ASTHM R, V11, P388, DOI 10.1007/s11882-011-0210-y; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wenzel U, 2016, J AM SOC NEPHROL, V27, P677, DOI 10.1681/ASN.2015050562; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Whelton PK, 2018, CIRCULATION, V138, pE484, DOI 10.1161/CIR.0000000000000596; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; WOO KS, 1995, BRIT J CLIN PHARMACO, V40, P141	88	27	29	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					1046	1057		10.1056/NEJMra1800345	http://dx.doi.org/10.1056/NEJMra1800345			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY2MW	31509675				2022-12-28	WOS:000486225900012
J	Majer, O; Liu, B; Kreuk, LSM; Krogan, N; Barton, GM				Majer, Olivia; Liu, Bo; Kreuk, Lieselotte S. M.; Krogan, Nevan; Barton, Gregory M.			UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity	NATURE			English	Article							TOLL-LIKE RECEPTORS; NUCLEIC-ACID; RECOGNITION; RESPONSES; ROLES; DNA	At least two members of the Toll-like receptor (TLR) family, TLR7 and TLR9, can recognize self-RNA and self-DNA, respectively. Despite the structural and functional similarities between these receptors, their contributions to autoimmune diseases such as systemic lupus erythematosus can differ. For example, TLR7 and TLR9 have opposing effects in mouse models of systemic lupus erythematosus-disease is exacerbated in TLR9-deficient mice but attenuated in TLR7-deficient mice(1). However, the mechanisms of negative regulation that differentiate between TLR7 and TLR9 are unknown. Here we report a function for the TLR trafficking chaperone UNC93B1 that specifically limits signalling of TLR7, but not TLR9, and prevents TLR7-dependent autoimmunity in mice. Mutations in UNC93B1 that lead to enhanced TLR7 signalling also disrupt binding of UNC93B1 to syntenin-1, which has been implicated in the biogenesis of exosomes(2). Both UNC93B1 and TLR7 can be detected in exosomes, suggesting that recruitment of syntenin-1 by UNC93B1 facilitates the sorting of TLR7 into intralumenal vesicles of multivesicular bodies, which terminates signalling. Binding of syntenin-1 requires phosphorylation of UNC93B1 and provides a mechanism for dynamic regulation of TLR7 activation and signalling. Thus, UNC93B1 not only enables the proper trafficking of nucleic acid-sensing TLRs, but also sets the activation threshold of potentially self-reactive TLR7.	[Majer, Olivia; Liu, Bo; Kreuk, Lieselotte S. M.; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA; [Krogan, Nevan] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Liu, B; Barton, GM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	liub@berkeley.edu; barton@berkeley.edu	Liu, Bo/AAU-9183-2020		National Institutes of Health (NIH) [AI072429, AI105184, AI063302]; Lupus Research Institute; Erwin Schrodinger [J 3415-B22]; CRI Irvington postdoctoral fellowship; UC Berkeley Tang Distinguished Scholars Program; NIH [1S10OD018136-01, S10RR025622]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072429, R01AI105184, P01AI063302, U19AI135990] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Erwin Schrodinger; CRI Irvington postdoctoral fellowship; UC Berkeley Tang Distinguished Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Vance and members of the Barton and Vance laboratories for discussions and critical reading of the manuscript, A.Yiu-fai Lee and the Gene Targeting Facilty of the Cancer Research Center at UC Berkeley for generating the Unc93b1PKP/PKP knock-in mice, L. Kohlstaedt and the Vincent J. Coates Proteomics/Mass Spectrometry Laboratory at UC Berkeley for identification of UNC93B1-interacting proteins, H. Nolla and A. Valeros for assistance with cell sorting at the Flow Cytometry Facility of the Cancer Research Laboratory at UC Berkeley, and S. Ruzin and D. Schichnes for assistance with microscopy on the Zeiss Elyra PS.1 at the Biological Imaging Center at UC Berkeley. This work was supported by the National Institutes of Health (NIH; AI072429, AI105184 and AI063302 to G.M.B.) and by the Lupus Research Institute (Distinguished Innovator Award to G.M.B.). O.M. was supported by an Erwin Schrodinger (J 3415-B22) and CRI Irvington postdoctoral fellowship. B.L. was supported by the UC Berkeley Tang Distinguished Scholars Program. Research reported in this publication was supported in part by the NIH S10 program under award number 1S10OD018136-01 and by the NIH S10 Instrumentation Grant S10RR025622.	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen F, 2008, CELL SIGNAL, V20, P666, DOI 10.1016/j.cellsig.2007.12.002; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Grassel L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32337; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Kagan J. C., 2014, COLD SPRING HARB PER, V7; Kegelman TP, 2015, EXPERT OPIN THER TAR, V19, P97, DOI 10.1517/14728222.2014.959495; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latty SL, 2018, ELIFE, V7, DOI 10.7554/eLife.31377; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Majer O, 2019, NATURE, V575, P371, DOI 10.1038/s41586-019-1611-7; Majer O, 2017, CURR OPIN IMMUNOL, V44, P26, DOI 10.1016/j.coi.2016.10.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tamura K, 2015, IMMUNOBIOLOGY, V220, P597, DOI 10.1016/j.imbio.2014.12.003; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30	32	48	54	3	63	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 14	2019	575	7782					366	+		10.1038/s41586-019-1612-6	http://dx.doi.org/10.1038/s41586-019-1612-6			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JN5KW	31546246	Green Accepted, Green Submitted			2022-12-28	WOS:000496938200060
J	Majer, O; Liu, B; Woo, BJ; Kreuk, LSM; Van Dis, E; Barton, GM				Majer, Olivia; Liu, Bo; Woo, Brian J.; Kreuk, Lieselotte S. M.; Van Dis, Erik; Barton, Gregory M.			Release from UNC93B1 reinforces the compartmentalized activation of select TLRs	NATURE			English	Article							TOLL-LIKE RECEPTORS; NUCLEIC-ACID; MURINE MODEL; RECOGNITION; DNA; AUTOIMMUNITY; RESPONSES	Nucleic acid-sensing Toll-like receptors (TLRs) are subject to complex regulation to facilitate the recognition of microbial DNA and RNA while limiting the recognition of an organism's own nucleic acids(1). Failure to properly regulate these TLRs can lead to autoimmune and autoinflammatory diseases(2-6). Intracellular localization of these receptors is thought to be crucial for the discrimination between self and non-self(7), but the molecular mechanisms that reinforce compartmentalized activation of intracellular TLRs remain poorly understood. Here we describe a mechanism that prevents the activation of TLR9 from locations other than endosomes. This control is achieved through the regulated release of the receptor from its trafficking chaperone UNC93B1, which occurs only within endosomes and is required for ligand binding and signal transduction. Preventing release of TLR9 from UNC93B1, either by mutations in UNC93B1 that increase affinity for TLR9 or through an artificial tether that impairs release, results in defective signalling. Whereas TLR9 and TLR3 are released from UNC93B1, TLR7 does not dissociate from UNC93B1 in endosomes and is regulated by distinct mechanisms. This work defines a checkpoint that reinforces the compartmentalized activation of TLR9, and provides a mechanism by which activation of individual endosomal TLRs may be distinctly regulated.	[Majer, Olivia; Liu, Bo; Woo, Brian J.; Kreuk, Lieselotte S. M.; Van Dis, Erik; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Barton, GM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	barton@berkeley.edu	Liu, Bo/AAU-9183-2020	Van Dis, Erik S/0000-0003-4773-379X	National Institutes of Health (NIH) [AI072429, AI105184, AI063302]; Lupus Research Institute; Erwin Schrodinger [J 3415-B22]; CRI Irvington postdoctoral fellowship; UC Berkeley Tang Distinguished Scholars Program; UC Berkeley; National Institutes of Health [1S10OD018136-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI135990, P01AI063302, R01AI072429, R01AI105184] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Erwin Schrodinger; CRI Irvington postdoctoral fellowship; UC Berkeley Tang Distinguished Scholars Program; UC Berkeley; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Barton and Vance laboratory for discussions and critical reading of the manuscript. We thank B. Li and S. Brohawn for supplying the DDM/CHS detergent and for technical advice, A. Yiu-fai Lee and the Gene Targeting Facility of the Cancer Research Laboratory at UC Berkeley for generating the Unc93b1<SUP>S282A/-</SUP> knock-in mice, H. Nolla and A. Valeros for assistance with cell sorting at the Flow Cytometry Facility of the Cancer Research Laboratory at UC Berkeley, S. Ruzin and D. Schichnes for assistance with microscopy on the Zeiss Elyra PS.1 at the Biological Imaging Center at UC Berkeley. This work was supported by the National Institutes of Health (NIH; AI072429, AI105184 and AI063302 to G.M.B.) and by the Lupus Research Institute (Distinguished Innovator Award to G.M.B.). O.M. was supported by an Erwin Schrodinger (J 3415-B22) and CRI Irvington postdoctoral fellowship. B.L. was supported by the UC Berkeley Tang Distinguished Scholars Program. B.J.W. was supported by a summer undergraduate research fellowship from UC Berkeley. Research reported in this publication was supported in part by the National Institutes of Health S10 program under award number 1S10OD018136-01.	Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Chan MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6853; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Majer O, 2019, NATURE, V575, P366, DOI 10.1038/s41586-019-1612-6; Majer O, 2017, CURR OPIN IMMUNOL, V44, P26, DOI 10.1016/j.coi.2016.10.003; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Roberts AW, 2017, IMMUNITY, V47, P913, DOI 10.1016/j.immuni.2017.10.006; Shibata T, 2016, INT IMMUNOL, V28, P211, DOI 10.1093/intimm/dxv062; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011	24	38	39	2	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 14	2019	575	7782					371	+		10.1038/s41586-019-1611-7	http://dx.doi.org/10.1038/s41586-019-1611-7			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JN5KW	31546247	Green Submitted, Green Accepted			2022-12-28	WOS:000496938200061
J	Cohen, D; Melamed, S; Millman, A; Shulman, G; Oppenheimer-Shaanan, Y; Kacen, A; Doron, S; Amitai, G; Sorek, R				Cohen, Daniel; Melamed, Sarah; Millman, Adi; Shulman, Gabriela; Oppenheimer-Shaanan, Yaara; Kacen, Assaf; Doron, Shany; Amitai, Gil; Sorek, Rotem			Cyclic GMP-AMP signalling protects bacteria against viral infection	NATURE			English	Article							PREDICTION; MECHANISM; ORIGIN	The cyclic GMP-AMP synthase (cGAS)-STING pathway is a central component of the cell-autonomous innate immune system in animals(1,2). The cGAS protein is a sensor of cytosolic viral DNA and, upon sensing DNA, it produces a cyclic GMP-AMP (cGAMP) signalling molecule that binds to the STING protein and activates the immune response(3-5). The production of cGAMP has also been detected in bacteria(6), and has been shown, in Vibrio cholerae, to activate a phospholipase that degrades the inner bacterial membrane(7). However, the biological role of cGAMP signalling in bacteria remains unknown. Here we show that cGAMP signalling is part of an antiphage defence system that is common in bacteria. This system is composed of a four-gene operon that encodes the bacterial cGAS and the associated phospholipase, as well as two enzymes with the eukaryotic-like domains E1, E2 and JAB. We show that this operon confers resistance against a wide variety of phages. Phage infection triggers the production of cGAMP, which-in turn-activates the phospholipase, leading to a loss of membrane integrity and to cell death before completion of phage reproduction. Diverged versions of this system appear in more than 10% of prokaryotic genomes, and we show that variants with effectors other than phospholipase also protect against phage infection. Our results suggest that the eukaryotic cGAS-STING antiviral pathway has ancient evolutionary roots that stem from microbial defences against phages.	[Cohen, Daniel; Melamed, Sarah; Millman, Adi; Shulman, Gabriela; Oppenheimer-Shaanan, Yaara; Doron, Shany; Amitai, Gil; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel; [Kacen, Assaf] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Amitai, G; Sorek, R (corresponding author), Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel.	gil.amitai@weizmann.ac.il; rotem.sorek@weizmann.ac.il	Oppenheimer-Shaanan, Yaara/AGM-2041-2022	Millman, Adi/0000-0002-6844-7613; Melamed, Sarah/0000-0002-0604-3605	Israel Science Foundation [1360/16]; European Research Council [ERC-CoG 681203]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Knell Family Center for Microbiology; Ariane de Rothschild Women Doctoral Program	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Knell Family Center for Microbiology; Ariane de Rothschild Women Doctoral Program	We thank A. Leavitt and S. Sharir for assistance in DNA extraction, library preparation and sequencing, A. Bernheim for assistance in data visualization, and members of the Sorek laboratory for fruitful discussions. This study was supported in part by the Israel Science Foundation (personal grant 1360/16), the European Research Council (grant ERC-CoG 681203), the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine, and the Knell Family Center for Microbiology. A.M. was supported by a fellowship from the Ariane de Rothschild Women Doctoral Program.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Burroughs AM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1267; Chen IMA, 2019, NUCLEIC ACIDS RES, V47, pD666, DOI 10.1093/nar/gky901; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Kato K, 2015, STRUCTURE, V23, P843, DOI 10.1016/j.str.2015.01.023; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Lam V, 2012, J BIOMOL SCREEN, V17, P245, DOI 10.1177/1087057111422944; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004; Margulis L, 1996, P NATL ACAD SCI USA, V93, P1071, DOI 10.1073/pnas.93.3.1071; MOLINEUX IJ, 1991, NEW BIOL, V3, P230; Ofir G, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0051-0; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Severin GB, 2018, P NATL ACAD SCI USA, V115, pE6048, DOI 10.1073/pnas.1801233115; SNYDER L, 1995, MOL MICROBIOL, V15, P415, DOI 10.1111/j.1365-2958.1995.tb02255.x; Steinegger M, 2017, NAT BIOTECHNOL, V35, P1026, DOI 10.1038/nbt.3988; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; WALKER JT, 1980, J VIROL, V35, P519, DOI 10.1128/JVI.35.2.519-530.1980; Whiteley AT, 2019, NATURE, V567, P194, DOI 10.1038/s41586-019-0953-5; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	35	168	182	9	113	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 31	2019	574	7780					691	+		10.1038/s41586-019-1605-5	http://dx.doi.org/10.1038/s41586-019-1605-5			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JI9UH	31533127				2022-12-28	WOS:000493807800046
J	Lynch, HF; Joffe, S				Lynch, Holly Fernandez; Joffe, Steven			Pay-to-Participate Trials and Vulnerabilities in Research Ethics Oversight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses ethical considerations surrounding randomized clinical trials (RCTs) funded by patients who pay to enroll in them, and gaps in IRB oversight that could allow the trials to be approved despite possible patient exploitation and questionable scientific quality and social value.	[Lynch, Holly Fernandez; Joffe, Steven] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lynch, Holly Fernandez; Joffe, Steven] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lynch, HF (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall, Philadelphia, PA 19104 USA.	lynchhf@pennmedicine.upenn.edu						[Anonymous], 2017, FED REGISTER, V82, P7149; Emanuel EJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5204; Robbins R., 2019, STAT NEWS; Shaw D, 2017, MED HEALTH CARE PHIL, V20, P219, DOI 10.1007/s11019-016-9741-2; Wagner DE, 2018, LANCET RESP MED, V6, P579, DOI 10.1016/S2213-2600(18)30242-X; Wenner DM, 2015, CELL STEM CELL, V17, P135, DOI 10.1016/j.stem.2015.07.016; Zarin DA, 2019, JAMA-J AM MED ASSOC, V322, P813, DOI 10.1001/jama.2019.9892	7	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2019	322	16					1553	1554		10.1001/jama.2019.14703	http://dx.doi.org/10.1001/jama.2019.14703			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0VU	31545335				2022-12-28	WOS:000498673500011
J	Selak, V; Jackson, R; Poppe, K; Wu, B; Harwood, M; Grey, C; Pylypchuk, R; Mehta, S; Choi, YH; Kerr, A; Wells, S				Selak, Vanessa; Jackson, Rod; Poppe, Katrina; Wu, Billy; Harwood, Matire; Grey, Corina; Pylypchuk, Romana; Mehta, Suneela; Choi, Yeun-Hyang; Kerr, Andrew; Wells, Sue			Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention A Benefit-Harm Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							INDIVIDUALIZED PREDICTION; COLORECTAL-CANCER; TASK-FORCE; DISEASE; RISK; ASSOCIATION; VALIDATION; DERIVATION; EVENTS	Background: Whether the benefits of aspirin for the primary prevention of cardiovascular disease (CVD) outweigh its bleeding harms in some patients is unclear. Objective: To identify persons without CVD for whom aspirin would probably result in a net benefit. Design: Individualized benefit-harm analysis based on sex-specific risk scores and estimates of the proportional effect of aspirin on CVD and major bleeding from a 2019 meta-analysis. Setting: New Zealand primary care. Participants: 245 028 persons (43.6% women) aged 30 to 79 years without established CVD who had their CVD risk assessed between 2012 and 2016. Measurements: The net effect of aspirin was calculated for each participant by subtracting the number of CVD events likely to be prevented (CVD risk score x proportional effect of aspirin on CVD risk) from the number of major bleeds likely to be caused (major bleed risk score x proportional effect of aspirin on major bleeding risk) over 5 years. Results: 2.5% of women and 12.1% of men were likely to have a net benefit from aspirin treatment for 5 years if 1 CVD event was assumed to be equivalent in severity to 1 major bleed, increasing to 21.4% of women and 40.7% of men if 1 CVD event was assumed to be equivalent to 2 major bleeds. Net benefit subgroups had higher baseline CVD risk, higher levels of most established CVD risk factors, and lower levels of bleeding-specific risk factors than net harm subgroups. Limitations: Risk scores and effect estimates were uncertain. Effects of aspirin on cancer outcomes were not considered. Applicability to non-New Zealand populations was not assessed. Conclusion: For some persons without CVD, aspirin is likely to result in net benefit.	[Selak, Vanessa; Jackson, Rod; Poppe, Katrina; Wu, Billy; Grey, Corina; Pylypchuk, Romana; Mehta, Suneela; Choi, Yeun-Hyang; Kerr, Andrew; Wells, Sue] Univ Auckland, Sect Epidemiol & Biostat, Private Bag 92019, Auckland 1142, New Zealand; [Harwood, Matire] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Private Bag 92019, Auckland 1142, New Zealand; [Kerr, Andrew] Middlemore Hosp, Auckland, New Zealand	University of Auckland; University of Auckland	Selak, V (corresponding author), Univ Auckland, Sect Epidemiol & Biostat, Private Bag 92019, Auckland 1142, New Zealand.	v.selak@auckland.ac.nz		Pylypchuk, Romana/0000-0002-8507-0467	Health Research Council of New Zealand (HRC) [15/165]; HRC for progra; Heart Foundation of New Zealand Hynds Senior Fellowship; National Heart Foundation of New Zealand Research Fellowship	Health Research Council of New Zealand (HRC)(Health Research Council of New Zealand); HRC for progra; Heart Foundation of New Zealand Hynds Senior Fellowship; National Heart Foundation of New Zealand Research Fellowship	This research was funded by a project grant (15/165) from the Health Research Council of New Zealand (HRC). Drs. Jackson, Poppe, Harwood, Grey, Mehta, Kerr, and Wells and Mr. Wu are receiving funding from the HRC for program, project, and clinical research training grants for CVD research. Dr. Poppe is the recipient of a Heart Foundation of New Zealand Hynds Senior Fellowship, and Dr. Grey is the recipient of a National Heart Foundation of New Zealand Research Fellowship.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Bowman L, 2018, NEW ENGL J MED, V379, P1529, DOI 10.1056/NEJMoa1804988; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Coon SA, 2017, J AM PHARM ASSOC, V57, P585, DOI 10.1016/j.japh.2017.07.003; Dehmer SP, 2016, ANN INTERN MED, V164, P777, DOI 10.7326/M15-2129; Dorresteijn JAN, 2011, EUR HEART J, V32, P2962, DOI 10.1093/eurheartj/ehr423; Dugani S, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0717-y; Gaziano JM, 2018, LANCET, V392, P1036, DOI 10.1016/S0140-6736(18)31924-X; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hennekens CH, 2012, NAT REV CARDIOL, V9, P262, DOI 10.1038/nrcardio.2012.26; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; McNeil JJ, 2018, NEW ENGL J MED, V379, P1509, DOI 10.1056/NEJMoa1805819; Mora S, 2016, JAMA-J AM MED ASSOC, V316, P709, DOI 10.1001/jama.2016.8362; Perk J, 2012, EUR J PREV CARDIOL, V19, P585, DOI 10.1177/2047487312450228; Puhan MA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0493-2; Pylypchuk R, 2018, LANCET, V391, P1897, DOI [10.1016/s0140-6736(18)30664-0, 10.1016/S0140-6736(18)30664-0]; Selak V, 2019, ANN INTERN MED, V170, P357, DOI 10.7326/M18-2808; Selak V, 2018, JAMA-J AM MED ASSOC, V319, P2507, DOI 10.1001/jama.2018.8194; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; van der Leeuw J, 2014, EUR HEART J, V35, P837, DOI 10.1093/eurheartj/ehu004; Wells S, 2017, INT J EPIDEMIOL, V46, P22, DOI 10.1093/ije/dyv312; Zheng SL, 2019, JAMA-J AM MED ASSOC, V321, P277, DOI 10.1001/jama.2018.20578	24	12	12	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2019	171	8					529	+		10.7326/M19-1132	http://dx.doi.org/10.7326/M19-1132			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD4JV	31525775				2022-12-28	WOS:000489944700012
J	Godinho-Silva, C; Domingues, RG; Rendas, M; Raposo, B; Ribeiro, H; da Silva, JA; Vieira, A; Costa, RM; Barbosa-Morais, NL; Carvalho, T; Veiga-Fernandes, H				Godinho-Silva, Cristina; Domingues, Rita G.; Rendas, Miguel; Raposo, Bruno; Ribeiro, Helder; da Silva, Joaquim Alves; Vieira, Ana; Costa, Rui M.; Barbosa-Morais, Nuno L.; Carvalho, Tania; Veiga-Fernandes, Henrique			Light-entrained and brain-tuned circadian circuits regulate ILC3s and gut homeostasis	NATURE			English	Article							INNATE LYMPHOID-CELLS; RECEPTOR RET; MICE LACKING; EXPRESSION; RHYTHMICITY; MICROBIOTA; PROGRAMS; TYROSINE; IMMUNE	Group 3 innate lymphoid cells (ILC3s) are major regulators of inflammation, infection, microbiota composition and metabolism(1). ILC3s and neuronal cells have been shown to interact at discrete mucosal locations to steer mucosal defence(2,3). Nevertheless, it is unclear whether neuroimmune circuits operate at an organismal level, integrating extrinsic environmental signals to orchestrate ILC3 responses. Here we show that light-entrained and brain-tuned circadian circuits regulate enteric ILC3s, intestinal homeostasis, gut defence and host lipid metabolism in mice. We found that enteric ILC3s display circadian expression of clock genes and ILC3-related transcription factors. ILC3-autonomous ablation of the circadian regulator Arntl led to disrupted gut ILC3 homeostasis, impaired epithelial reactivity, a deregulated microbiome, increased susceptibility to bowel infection and disrupted lipid metabolism. Loss of ILC3-intrinsic Arntl shaped the gut 'postcode receptors' of ILC3s. Strikingly, light-dark cycles, feeding rhythms and microbial cues differentially regulated ILC3 clocks, with light signals being the major entraining cues of ILC3s. Accordingly, surgically or genetically induced deregulation of brain rhythmicity led to disrupted circadian ILC3 oscillations, a deregulated microbiome and altered lipid metabolism. Our work reveals a circadian circuitry that translates environmental light cues into enteric ILC3s, shaping intestinal health, metabolism and organismal homeostasis.	[Godinho-Silva, Cristina; Domingues, Rita G.; Rendas, Miguel; Raposo, Bruno; Ribeiro, Helder; da Silva, Joaquim Alves; Vieira, Ana; Costa, Rui M.; Veiga-Fernandes, Henrique] Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal; [da Silva, Joaquim Alves] Champalimaud Ctr Unknown, Champalimaud Clin Ctr, Lisbon, Portugal; [Costa, Rui M.] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY USA; [Barbosa-Morais, Nuno L.; Carvalho, Tania] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal	Fundacao Champalimaud; Fundacao Champalimaud; Columbia University; Universidade de Lisboa	Veiga-Fernandes, H (corresponding author), Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal.	henrique.veigafernandes@research.fchampalimaud.org	da Silva, Joaquim Alves/AAY-1702-2020; Barbosa-Morais, Nuno L/I-2743-2013; Carvalho, Tânia/GNM-6203-2022; Carvalho, Tania/J-3656-2013	da Silva, Joaquim Alves/0000-0002-3967-3603; Barbosa-Morais, Nuno L/0000-0002-1215-0538; Costa, Rui M./0000-0003-0495-8374; Godinho-Silva, Cristina/0000-0002-0300-8839; Rendas, Miguel Alves/0000-0003-0755-9782; Carvalho, Tania/0000-0002-5283-5013; Ribeiro, Helder/0000-0002-7090-9274	Fundacao para a Ciencia e Tecnologia (FCT), Portugal; FCT, Portugal; European Molecular Biology Organisation (EMBO); ERC [647274]; EU; The Paul G. Allen Frontiers Group, US	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); ERC(European Research Council (ERC)European Commission); EU(European Commission); The Paul G. Allen Frontiers Group, US	We thank the Vivarium, Flow Cytometry, Histology, Molecular Biology and Hardware platforms at the Champalimaud Centre for the Unknown; the Congento infrastructure for genetic model organisms; R. Pirzgalka, R. Klein Wolterink, S. Correia, I. Godinho, F. Cardoso, B. Garcia Cassani and K. Fischer for technical help and discussions; C. French for helping in behaviour analysis; N. Shemesh, T. Serradas Duarte and D. Nunes for MRI imaging; A. Silva for technical help with hardware; F. Rijo-Ferreira and L. Petreanu for discussions; and P. Faisca for pathology scoring. C.G.-S., R.G.D. and M.R. were supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal. N.L.B.-M. is supported by FCT, Portugal, and the European Molecular Biology Organisation (EMBO). H.V.-F. is supported by the ERC (647274), the EU, The Paul G. Allen Frontiers Group, US, and the FCT, Portugal.	Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Cheng HYM, 2009, HUM MOL GENET, V18, P3110, DOI 10.1093/hmg/ddp252; Chomez P, 2000, DEVELOPMENT, V127, P1489; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Godinho-Silva C, 2019, ANNU REV IMMUNOL, V37, P19, DOI 10.1146/annurev-immunol-042718-041812; Henslee EA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02161-4; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hoshi M, 2012, DEVELOPMENT, V139, P2405, DOI 10.1242/dev.078667; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Husse J, 2014, FASEB J, V28, P4950, DOI 10.1096/fj.14-256594; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Izumo M, 2014, ELIFE, V3, DOI 10.7554/eLife.04617; Koronowski KB, 2019, CELL, V177, P1448, DOI 10.1016/j.cell.2019.04.025; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Masri S, 2018, NAT MED, V24, P1795, DOI 10.1038/s41591-018-0271-8; Mittelstadt PR, 2012, J CLIN INVEST, V122, P2384, DOI 10.1172/JCI63067; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scheiermann C, 2018, NAT REV IMMUNOL, V18, P423, DOI 10.1038/s41577-018-0008-4; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seamons A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079182; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Tapial J, 2017, GENOME RES, V27, P1759, DOI 10.1101/gr.220962.117; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Veiga-Fernandes H, 2018, SCIENCE, V359, P1465, DOI 10.1126/science.aap9598; Veiga-Fernandes H, 2017, NAT IMMUNOL, V18, P116, DOI 10.1038/ni.3634; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Welz PS, 2019, CELL, V177, P1436, DOI 10.1016/j.cell.2019.05.009; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06	51	89	92	6	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 10	2019	574	7777					254	+		10.1038/s41586-019-1579-3	http://dx.doi.org/10.1038/s41586-019-1579-3			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD2DB	31534216	Green Accepted, Green Submitted			2022-12-28	WOS:000489784200049
J	Beck, RW; Bergenstal, RM; Laffel, LM; Pickup, JC				Beck, Roy W.; Bergenstal, Richard M.; Laffel, Lori M.; Pickup, John C.			Advances in technology for management of type 1 diabetes	LANCET			English	Review							INSULIN-PUMP THERAPY; QUALITY-OF-LIFE; G5 CGM SYSTEM; GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; ARTIFICIAL PANCREAS; INTENSIVE TREATMENT; PRACTICAL APPROACH; RANDOMIZED-TRIAL; DELIVERY-SYSTEM	Technological advances have had a major effect on the management of type 1 diabetes. In addition to blood glucose meters, devices used by people with type 1 diabetes include insulin pumps, continuous glucose monitors, and, most recently, systems that combine both a pump and a monitor for algorithm-driven automation of insulin delivery. In the next 5 years, as many advances are expected in technology for the management of diabetes as there have been in the past 5 years, with improvements in continuous glucose monitoring and more available choices of systems that automate insulin delivery. Expansion of the use of technology will be needed beyond endocrinology practices to primary-care settings and broader populations of patients. Tools to support decision making will also need to be developed to help patients and health-care providers to use the output of these devices to optimise diabetes management.	[Beck, Roy W.] Jaeb Ctr Hlth Res, Tampa, FL 33618 USA; [Bergenstal, Richard M.] Pk Nicollet & Hlth Partners, Int Diabet Ctr, Minneapolis, MN USA; [Laffel, Lori M.] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA; [Pickup, John C.] Kings Coll London, Guys Hosp, Fac Life Sci & Med, London, England	JAEB Center For Health Research; International Diabetes Center; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Beck, RW (corresponding author), Jaeb Ctr Hlth Res, Tampa, FL 33618 USA.	rbeck@jaeb.org						Abraham MB, 2018, DIABETES CARE, V41, P303, DOI 10.2337/dc17-1604; Aleppo G, 2017, J ENDOCR SOC, V1, P1445, DOI 10.1210/js.2017-00388; Aleppo G, 2017, DIABETES CARE, V40, P538, DOI 10.2337/dc16-2482; American Diabetes Association, 2019, Diabetes Care, V42, pS71, DOI 10.2337/dc19-S007; Association of British Clinical Diabetologists Diabetes Technology Network, 2018, BEST PRACT GUID CONT; Bally L, 2018, NEW ENGL J MED, V379, P547, DOI 10.1056/NEJMoa1805233; Battelino T, 2012, DIABETOLOGIA, V55, P3155, DOI 10.1007/s00125-012-2708-9; Battelino T, 2019, DIABETES CARE, V42, P1593, DOI 10.2337/dci19-0028; Battelino T, 2017, DIABETES CARE, V40, P764, DOI 10.2337/dc16-2584; Battelino T, 2011, DIABETES CARE, V34, P795, DOI 10.2337/dc10-1989; Beato-Vibora P, 2015, DIABETIC MED, V32, P1453, DOI 10.1111/dme.12869; Beck RW, 2017, JAMA-J AM MED ASSOC, V317, P371, DOI 10.1001/jama.2016.19975; Beck RW, 2009, DIABETES CARE, V32, P1378, DOI 10.2337/dc09-0108; Benhamou PY, 2019, LANCET DIGIT HEALTH, V1, pE17, DOI 10.1016/S2589-7500(19)30003-2; Bergenstal RM, 2018, DIABETES CARE, V41, P2275, DOI 10.2337/dc18-1581; Bergenstal RM, 2016, JAMA-J AM MED ASSOC, V316, P1407, DOI 10.1001/jama.2016.11708; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Bergenstal RM, 2013, DIABETES TECHNOL THE, V15, P198, DOI 10.1089/dia.2013.0051; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Bolinder J, 2016, LANCET, V388, P2254, DOI 10.1016/S0140-6736(16)31535-5; Bosi E, 2019, LANCET DIABETES ENDO, V7, P462, DOI 10.1016/S2213-8587(19)30150-0; Brown SA, N ENGL J MED; Brown S, 2018, DIABETES CARE, V41, P2634, DOI 10.2337/dc18-1249; Cengiz E, 2013, PEDIATR DIABETES, V14, P447, DOI 10.1111/pedi.12030; Cescon Marzia, 2016, J Diabetes Sci Technol, V10, P1268; Danne T, 2017, DIABETES CARE, V40, P1631, DOI 10.2337/dc17-1600; DiMeglio LA, 2018, PEDIATR DIABETES, V19, P105, DOI 10.1111/pedi.12737; Ekhlaspour Laya, 2017, J Diabetes Sci Technol, V11, P558, DOI 10.1177/1932296816672237; Facchinetti A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122093; Feig DS, 2017, LANCET, V390, P2347, DOI 10.1016/S0140-6736(17)32400-5; Fonseca V, 2017, ENDOCR PRACT, V23, P629, DOI 10.4158/1934-2403-23.5.629; Fonseca VA, 2016, ENDOCR PRACT, V22, P1008, DOI 10.4158/EP161392.CS; Food and Drug Administration, 2018, SUMM SAF EFF DAT EV; Food and Drug Administration, 2018, EV AUT CLASS 3 DES D; Food and Drug Administration, SUMM SAF EFF DAT MIN; Forlenza GP, 2019, DIABETES TECHNOL THE, V21, P11, DOI 10.1089/dia.2018.0264; Forlenza GP, 2018, DIABETES CARE, V41, P2155, DOI 10.2337/dc18-0771; Foster NC, 2019, DIABETES TECHNOL THE, V21, P66, DOI 10.1089/dia.2018.0384; Garg SK, 2017, DIABETES TECHNOL THE, V19, P155, DOI 10.1089/dia.2016.0421; Guenego A, 2016, DIABETES TECHNOL THE, V18, P820, DOI 10.1089/dia.2016.0265; Hauzenberger JR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18790-0; Heinemann L, 2018, LANCET, V391, P1367, DOI 10.1016/S0140-6736(18)30297-6; Heinemann L, 2016, DIABETES TECHNOL THE, V18, P327, DOI 10.1089/dia.2016.0013; Heinemann L, 2015, DIABETES CARE, V38, P716, DOI 10.2337/dc15-0168; Heller S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1285; Hultstrom Michael, 2014, J Diabetes Sci Technol, V8, P453, DOI 10.1177/1932296814530060; International Organization for Standardization, 2018, 151972013 ISO; Jaeb Center for Health Research, GLUC MAN IND; Karges B, 2017, JAMA-J AM MED ASSOC, V318, P1358, DOI 10.1001/jama.2017.13994; Klonoff DC, 2018, DIABETES CARE, V41, P1681, DOI 10.2337/dc17-1960; Kowalski A, 2015, DIABETES CARE, V38, P1036, DOI 10.2337/dc15-0364; Kowalski AJ, 2009, DIABETES TECHNOL THE, V11, pS113, DOI 10.1089/dia.2008.0031; Laffel LM, 2017, J ENDOCR SOC, V1, P1461, DOI 10.1210/js.2017-00389; Lee JM, 2017, DIABETES TECHNOL THE, V19, P209, DOI 10.1089/dia.2016.0312; Leelarathna L, 2017, DIABETIC MED, V34, P1372, DOI 10.1111/dme.13412; Lewis Dana, 2016, J Diabetes Sci Technol, V10, P1411; Lind M, 2017, JAMA-J AM MED ASSOC, V317, P379, DOI 10.1001/jama.2016.19976; Little SA, 2018, DIABETES CARE, V41, P1600, DOI 10.2337/dc17-2682; Ly TT, 2013, JAMA-J AM MED ASSOC, V310, P1240, DOI 10.1001/jama.2013.277818; Martin CT, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1177-7; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Mueller-Godeffroy E, 2009, DIABETIC MED, V26, P493, DOI 10.1111/j.1464-5491.2009.02707.x; National Institute for Health and Care Excellence, 2008, CONT SUBC INS INF TR; NHS Digital, 2018, NAT DIAB AUD INS PUM; Nixon R, 2014, DIABETIC MED, V31, P1174, DOI 10.1111/dme.12486; O'Connell MA, 2009, DIABETOLOGIA, V52, P1250, DOI 10.1007/s00125-009-1365-0; Patel PJ, 2014, DIABETES TECHNOL THE, V16, P15, DOI 10.1089/dia.2013.0119; Petruzelkova L, 2018, DIABETES TECHNOL THE, V20, P744, DOI 10.1089/dia.2018.0214; Pickup JC, 2008, DIABETIC MED, V25, P765, DOI 10.1111/j.1464-5491.2008.02486.x; Pickup JC, 2019, DIABETIC MED, V36, P269, DOI 10.1111/dme.13793; Pickup JC, 2014, DIABETES TECHNOL THE, V16, P145, DOI 10.1089/dia.2013.0192; Pickup JC, 2012, NEW ENGL J MED, V366, P1616, DOI 10.1056/NEJMct1113948; Pihoker C, 2018, PEDIATR DIABETES, V19, P84, DOI 10.1111/pedi.12757; Polonsky WH, 2017, DIABETES CARE, V40, P736, DOI 10.2337/dc17-0133; Quiros C, 2016, DIABETIC MED, V33, P1422, DOI 10.1111/dme.13094; Riddlesworth TD, 2018, DIABETES TECHNOL THE, V20, P314, DOI 10.1089/dia.2017.0455; Rodbard D, 2017, DIABETES TECHNOL THE, V19, pS25, DOI 10.1089/dia.2017.0035; Roze S, 2015, DIABETIC MED, V32, P1415, DOI 10.1111/dme.12792; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Shah VN, 2018, DIABETES TECHNOL THE, V20, P428, DOI 10.1089/dia.2018.0143; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sherr JL, 2016, DIABETES CARE, V39, P1127, DOI 10.2337/dc16-0089; Sherr JL, 2016, DIABETOLOGIA, V59, P87, DOI 10.1007/s00125-015-3790-6; Steineck I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3234; Stewart ZA, 2018, DIABETES CARE, V41, P1391, DOI 10.2337/dc17-2534; Stewart ZA, 2016, NEW ENGL J MED, V375, P644, DOI 10.1056/NEJMoa1602494; Szypowska A, 2016, PEDIATR DIABETES, V17, P38, DOI 10.1111/pedi.12416; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Tauschmann M, 2019, DIABETES CARE, V42, P594, DOI 10.2337/dc18-1881; Tauschmann M, 2018, LANCET, V392, P1321, DOI 10.1016/S0140-6736(18)31947-0; The National Institute for Health and Care Excellence, DIAB TYP 1 TYP 2 CHI; Umpierrez GE, 2018, DIABETES CARE, V41, P1579, DOI 10.2337/dci18-0002; US Food and Drug Administration, 2018, SUMM SAF EFF DAT FRE; van Beers CAJ, 2016, LANCET DIABETES ENDO, V4, P893, DOI 10.1016/S2213-8587(16)30193-0; Wallia Amisha, 2017, J Diabetes Sci Technol, V11, P1036, DOI 10.1177/1932296817706151; Weinstock RS, 2013, J CLIN ENDOCR METAB, V98, P3411, DOI 10.1210/jc.2013-1589; Weisman A, 2017, LANCET DIABETES ENDO, V5, P501, DOI 10.1016/S2213-8587(17)30167-5	97	80	84	2	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1265	1273		10.1016/S0140-6736(19)31142-0	http://dx.doi.org/10.1016/S0140-6736(19)31142-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8XK	31533908				2022-12-28	WOS:000488862500032
J	Berkley, S				Berkley, Seth			The Power of Vaccines and How Gavi Has Helped Make the World Healthier 2019 Lasker-Bloomberg Public Service Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this Viewpoint, the CEO of Lasker-Bloomberg Public Service Award winner Gavi, the Vaccine Alliance, describes its work improving access to affordable childhood vaccines in low-income countries.	[Berkley, Seth] Gavi, Vaccine Alliance, Geneva, Switzerland		Berkley, S (corresponding author), Gavi, Vaccine Alliance, Global Hlth Campus,Chemin Pommier 40, CH-1218 Grand Saconnex, Switzerland.	sberkley@gavi.org						ImmunizationEconomics.org, DEC VACC EC RET INV; Steulet C, 2018, PROGR REGIONAL MEASL; UN Interagency Group for Child Mortality Estimation, LEV TRENDS CHILD MOR; United Nations, WORLD URB PROSP 2018; WHO, EB VIR DIS DEM REP C; World Healt Organization, 2016, SIT REP EB VIR DIS; World Health Organization, IMM VACC BIOL	7	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1251	1252		10.1001/jama.2019.13190	http://dx.doi.org/10.1001/jama.2019.13190			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31503276	Bronze			2022-12-28	WOS:000489331900009
J	Ji, C; Li, B; Liu, WJ; Smith, JS; Majumdar, A; Luo, W; Ahuja, R; Shu, JF; Wang, JY; Sinogeikin, S; Meng, Y; Prakapenka, VB; Greenberg, E; Xu, RQ; Huang, XR; Yang, WE; Shen, GY; Mao, WL; Mao, HK				Ji, Cheng; Li, Bing; Liu, Wenjun; Smith, Jesse S.; Majumdar, Arnab; Luo, Wei; Ahuja, Rajeev; Shu, Jinfu; Wang, Junyue; Sinogeikin, Stanislav; Meng, Yue; Prakapenka, Vitali B.; Greenberg, Eran; Xu, Ruqing; Huang, Xianrong; Yang, Wenge; Shen, Guoyin; Mao, Wendy L.; Mao, Ho-Kwang			Ultrahigh-pressure isostructural electronic transitions in hydrogen	NATURE			English	Article							X-RAY-DIFFRACTION; EQUATION-OF-STATE; PHASE-TRANSITION; QUANTUM	High-pressure transitions are thought to modify hydrogen molecules to a molecular metallic solid and finally to an atomic metal(1), which is predicted to have exotic physical properties and the topology of a two-component (electron and proton) superconducting superfluid condensate(2,3). Therefore, understanding such transitions remains an important objective in condensed matter physics(4,5). However, measurements of the crystal structure of solid hydrogen, which provides crucial information about the metallization of hydrogen under compression, are lacking for most high-pressure phases, owing to the considerable technical challenges involved in X-ray and neutron diffraction measurements under extreme conditions. Here we present a single-crystal X-ray diffraction study of solid hydrogen at pressures of up to 254 gigapascals that reveals the crystallographic nature of the transitions from phase I to phases III and IV. Under compression, hydrogen molecules remain in the hexagonal close-packed (hcp) crystal lattice structure, accompanied by a monotonic increase in anisotropy. In addition, the pressure-dependent decrease of the unit cell volume exhibits a slope change when entering phase IV, suggesting a second-order isostructural phase transition. Our results indicate that the precursor to the exotic two-component atomic hydrogen may consist of electronic transitions caused by a highly distorted hcp Brillouin zone and molecular-symmetry breaking.	[Ji, Cheng; Li, Bing; Shu, Jinfu; Wang, Junyue; Yang, Wenge; Mao, Ho-Kwang] Ctr High Pressure Sci & Technol Adv Res, Beijing, Peoples R China; [Ji, Cheng; Smith, Jesse S.; Sinogeikin, Stanislav; Meng, Yue; Shen, Guoyin] Carnegie Inst Sci, Geophys Lab, High Pressure Collaborat Access Team, Argonne, IL USA; [Li, Bing] Florida Int Univ, Ctr Study Matter Extreme Condit, Miami, FL 33199 USA; [Li, Bing] Florida Int Univ, Dept Mech & Mat Engn, Miami, FL 33199 USA; [Liu, Wenjun; Xu, Ruqing; Huang, Xianrong] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Majumdar, Arnab; Luo, Wei; Ahuja, Rajeev] Uppsala Univ, Dept Phys & Astron, Condensed Matter Theory Mat Theory Div, Uppsala, Sweden; [Prakapenka, Vitali B.; Greenberg, Eran] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; [Mao, Wendy L.] Stanford Univ, Dept Geol Sci, Stanford, CA 94305 USA; [Mao, Wendy L.] Stanford Inst Mat & Energy Sci, SLAC Natl Accelerator Lab, Menlo Pk, CA USA; [Smith, Jesse S.; Meng, Yue; Shen, Guoyin] Argonne Natl Lab, Xray Sci Div, HPCAT, Lemont, IL USA; [Sinogeikin, Stanislav] DAC Tools LLC, Naperville, IL USA	Carnegie Institution for Science; State University System of Florida; Florida International University; State University System of Florida; Florida International University; United States Department of Energy (DOE); Argonne National Laboratory; Uppsala University; University of Chicago; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Mao, HK (corresponding author), Ctr High Pressure Sci & Technol Adv Res, Beijing, Peoples R China.	maohk@hpstar.ac.cn	liu, wen/HGE-3071-2022; Majumdar, Arnab/P-4360-2019; Greenberg, Eran/P-8012-2018	Majumdar, Arnab/0000-0001-8136-3863; Greenberg, Eran/0000-0002-1630-0628; Ji, Cheng/0000-0002-5423-2873; Luo, Wei/0000-0001-9787-6751	National Natural Science Foundation of China (NSFC) [U1530402, 11811530001]; US Department of Energy (DOE), Office of Basic Energy Science, Division of Materials Sciences and Engineering [DE-FG02-99ER45775]; Office of Experimental Sciences of the DOE National Nuclear Security Administration [DE-NA0001974]; National Science Foundation (NSF) [MRI EAR/IF1531583]; NSF-Earth Sciences [EAR-1128799]; DOE-Geosciences [DE-FG02-94ER14466]; DOE Office of Science [DE-AC02-06CH11357]; Carl Tryggers Stiftelse for Vetenskaplig Forskning (CTS); Swedish Research Council (VR)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); US Department of Energy (DOE), Office of Basic Energy Science, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Office of Experimental Sciences of the DOE National Nuclear Security Administration; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF-Earth Sciences(National Science Foundation (NSF)); DOE-Geosciences(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE)); Carl Tryggers Stiftelse for Vetenskaplig Forskning (CTS); Swedish Research Council (VR)(Swedish Research Council)	We thank R. Ferry and M. Somayazulu for help with the gas loading systems; Y. Wang for the use of the MCC of Geo Soil Enviro Consortium for Advanced Radiation Sources (GSECARS); and E. Gregoryanz, A. Goncharov, D. Kim, D. Popov, Y. Ma, H. Liu and J. Tse for discussions. We acknowledge financial support from the National Natural Science Foundation of China (NSFC) under grant numbers U1530402 and 11811530001. This research was also supported by the US Department of Energy (DOE), Office of Basic Energy Science, Division of Materials Sciences and Engineering under award DE-FG02-99ER45775. Portions of this work were performed at the 34 IDE, 16 IDB (HPCAT), 13 IDD (GSECARS) and 1-BM beamlines of APS, ANL in USA, as well as the BL15U1 beamline of SSRF in China. HPCAT operations are supported by the Office of Experimental Sciences of the DOE National Nuclear Security Administration under award DE-NA0001974. V.B.P. is grateful to the National Science Foundation (NSF) for award MRI EAR/IF1531583. GSECARS is supported by NSF-Earth Sciences (grant number EAR-1128799) and DOE-Geosciences (grant number DE-FG02-94ER14466). This research used resources of the APS, a US DOE Office of Science User Facility operated for the DOE Office of Science by ANL under contract number DE-AC02-06CH11357. A. M., R. A. and W. Luo acknowledge support from Carl Tryggers Stiftelse for Vetenskaplig Forskning (CTS) and the Swedish Research Council (VR). SNIC and HPC2N are also acknowledged for providing computing time.	Akahama Y, 2017, J PHYS CONF SER, V950, DOI 10.1088/1742-6596/950/4/042060; Akahama Y, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012195; Akahama Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.060101; ANDERSON OL, 1989, J APPL PHYS, V65, P1534, DOI 10.1063/1.342969; Babaev E, 2004, NATURE, V431, P666, DOI 10.1038/nature02910; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bonev SA, 2004, NATURE, V431, P669, DOI 10.1038/nature02968; Dalladay-Simpson P, 2016, NATURE, V529, P63, DOI 10.1038/nature16164; Eremets MI, 2011, NAT MATER, V10, P927, DOI [10.1038/NMAT3175, 10.1038/nmat3175]; Feng QG, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa5f8e; Glazyrin K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.117206; Goncharov AF, 2001, P NATL ACAD SCI USA, V98, P14234, DOI 10.1073/pnas.201528198; Goncharov AF, 1996, PHYS REV B, V54, P15590, DOI 10.1103/PhysRevB.54.R15590; Gonzalez-Platas J, 2016, J APPL CRYSTALLOGR, V49, P1377, DOI 10.1107/S1600576716008050; HAZEN RM, 1987, PHYS REV B, V36, P3944, DOI 10.1103/PhysRevB.36.3944; HEMLEY RJ, 1988, PHYS REV LETT, V61, P857, DOI 10.1103/PhysRevLett.61.857; Howie RT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.214104; Howie RT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.125501; Hrubiak R, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5057518; Hrubiak R, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4926889; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kvashnin YO, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.134422; Liu HY, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4745186; Liu XD, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.065301; LORENZANA HE, 1990, PHYS REV LETT, V64, P1939, DOI 10.1103/PhysRevLett.64.1939; Loubeyre P, 1996, NATURE, V383, P702, DOI 10.1038/383702a0; Magdau IB, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.094107; MAO HK, 1988, SCIENCE, V239, P1131, DOI 10.1126/science.239.4844.1131; MAO HK, 1994, REV MOD PHYS, V66, P671, DOI 10.1103/RevModPhys.66.671; Mao HK, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.015007; Mazin II, 1997, PHYS REV LETT, V78, P1066, DOI 10.1103/PhysRevLett.78.1066; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Monserrat B, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.255701; Monserrat B, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.134101; Mostofi AA, 2014, COMPUT PHYS COMMUN, V185, P2309, DOI 10.1016/j.cpc.2014.05.003; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pickard CJ, 2007, NAT PHYS, V3, P473, DOI 10.1038/nphys625; Pickard CJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.214114; Prescher C, 2017, P NATL ACAD SCI USA, V114, P10041, DOI 10.1073/pnas.1708882114; Prescher C, 2015, HIGH PRESSURE RES, V35, P223, DOI 10.1080/08957959.2015.1059835; Speziale S, 2001, J GEOPHYS RES-SOL EA, V106, P515, DOI 10.1029/2000JB900318; Sun WW, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.115130; Turnbull R, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.195702; Wang L, 2010, P NATL ACAD SCI USA, V107, P6140, DOI 10.1073/pnas.1001141107; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499	48	58	62	15	126	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					558	+		10.1038/s41586-019-1565-9	http://dx.doi.org/10.1038/s41586-019-1565-9			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31554980	Green Submitted			2022-12-28	WOS:000488247600053
J	Rosenstock, J; Kahn, SE; Johansen, OE; Zinman, B; Espeland, MA; Woerle, HJ; Pfarr, E; Keller, A; Mattheus, M; Baanstra, D; Meinicke, T; George, JT; von Eynatten, M; McGuire, DK; Marx, N				Rosenstock, Julio; Kahn, Steven E.; Johansen, Odd Erik; Zinman, Bernard; Espeland, Mark A.; Woerle, Hans J.; Pfarr, Egon; Keller, Annett; Mattheus, Michaela; Baanstra, David; Meinicke, Thomas; George, Jyothis T.; von Eynatten, Maximilian; McGuire, Darren K.; Marx, Nikolaus		CAROLINA Investigators	Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; SULFONYLUREA; METFORMIN	Key PointsQuestionWhat is the effect of linagliptin compared with glimepiride on major cardiovascular events in patients with relatively early type 2 diabetes and elevated cardiovascular risk? FindingsIn this randomized noninferiority clinical trial that included 6033 participants followed up for a median of 6.3 years, the use of linagliptin compared with glimepiride added to usual care resulted in rates of the composite outcome (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) of 11.8% vs 12.0%. The upper limit of the 95.47% CI of the hazard ratio was 1.14, which met the noninferiority criterion of a hazard ratio of less than 1.3. MeaningCompared with glimepiride, the use of linagliptin demonstrated noninferiority with regard to the risk of major cardiovascular events over a median of 6.3 years in patients with relatively early type 2 diabetes and elevated cardiovascular risk. ImportanceType 2 diabetes is associated with increased cardiovascular risk. In placebo-controlled cardiovascular safety trials, the dipeptidyl peptidase-4 inhibitor linagliptin demonstrated noninferiority, but it has not been tested against an active comparator. ObjectiveThis trial assessed cardiovascular outcomes of linagliptin vs glimepiride (sulfonylurea) in patients with relatively early type 2 diabetes and risk factors for or established atherosclerotic cardiovascular disease. Design, Setting, and ParticipantsRandomized, double-blind, active-controlled, noninferiority trial, with participant screening from November 2010 to December 2012, conducted at 607 hospital and primary care sites in 43 countries involving 6042 participants. Adults with type 2 diabetes, glycated hemoglobin of 6.5% to 8.5%, and elevated cardiovascular risk were eligible for inclusion. Elevated cardiovascular risk was defined as documented atherosclerotic cardiovascular disease, multiple cardiovascular risk factors, aged at least 70 years, and evidence of microvascular complications. Follow-up ended in August 2018. InterventionsPatients were randomized to receive 5 mg of linagliptin once daily (n=3023) or 1 to 4 mg of glimepiride once daily (n=3010) in addition to usual care. Investigators were encouraged to intensify glycemic treatment, primarily by adding or adjusting metformin, alpha-glucosidase inhibitors, thiazolidinediones, or insulin, according to clinical need. Main Outcomes and MeasuresThe primary outcome was time to first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke with the aim to establish noninferiority of linagliptin vs glimepiride, defined by the upper limit of the 2-sided 95.47% CI for the hazard ratio (HR) of linagliptin relative to glimepiride of less than 1.3. ResultsOf 6042 participants randomized, 6033 (mean age, 64.0 years; 2414 [39.9%] women; mean glycated hemoglobin, 7.2%; median duration of diabetes, 6.3 years; 42% with macrovascular disease; 59% had undergone metformin monotherapy) were treated and analyzed. The median duration of follow-up was 6.3 years. The primary outcome occurred in 356 of 3023 participants (11.8%) in the linagliptin group and 362 of 3010 (12.0%) in the glimepiride group (HR, 0.98 [95.47% CI, 0.84-1.14]; P<.001 for noninferiority), meeting the noninferiority criterion but not superiority (P=.76). Adverse events occurred in 2822 participants (93.4%) in the linagliptin group and 2856 (94.9%) in the glimepiride group, with 15 participants (0.5%) in the linagliptin group vs 16 (0.5%) in the glimepiride group with adjudicated-confirmed acute pancreatitis. At least 1 episode of hypoglycemic adverse events occurred in 320 (10.6%) participants in the linagliptin group and 1132 (37.7%) in the glimepiride group (HR, 0.23 [95% CI, 0.21-0.26]). Conclusions and RelevanceAmong adults with relatively early type 2 diabetes and elevated cardiovascular risk, the use of linagliptin compared with glimepiride over a median 6.3 years resulted in a noninferior risk of a composite cardiovascular outcome. Trial RegistrationClinicalTrials.gov Identifier: NCT01243424 This randomized noninferiority clinical trial examines the effect of treatment with the dipeptidyl peptidase-4 inhibitor linagliptin vs the commonly used sulfonylurea glimepiride on cardiovascular safety in patients with type 2 diabetes and cardiovascular risk factors or established atherosclerotic cardiovascular disease.	[Rosenstock, Julio] Dallas Diabet Res Ctr Med City, Dallas, TX USA; [Rosenstock, Julio; McGuire, Darren K.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA; [Johansen, Odd Erik] Boehringer Ingelheim Norway KS, Asker, Norway; [Zinman, Bernard] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Zinman, Bernard] Univ Toronto, Div Endocrinol, Toronto, ON, Canada; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC USA; [Woerle, Hans J.] Ulm Univ, Ulm, Germany; [Pfarr, Egon; Keller, Annett; Mattheus, Michaela; George, Jyothis T.; von Eynatten, Maximilian] Boehringer Ingelheim Int GmbH & Co KG, Ingelheim, Germany; [Baanstra, David] Boehringer Ingelheim GmbH & Co KG, Alkmaar, Netherlands; [Meinicke, Thomas] Boehringer Ingelheim Int GmbH & Co KG, Biberach, Germany; [Marx, Nikolaus] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med 1, Pauwelsstr 30, D-52074 Aachen, Germany	Diabetes & Endocrine Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Boehringer Ingelheim; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Wake Forest University; Ulm University; Boehringer Ingelheim; Boehringer Ingelheim; RWTH Aachen University; RWTH Aachen University Hospital	Marx, N (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med 1, Pauwelsstr 30, D-52074 Aachen, Germany.	nmarx@ukaachen.de	Woerle, Hans/ABE-1013-2021; McGuire, Darren K./AAL-4172-2021; Cruz, Vítor Tedim/AAM-3014-2020	Cruz, Vítor Tedim/0000-0002-5333-4771	Boehringer Ingelheim; Eli Lilly and Company	Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly and Company(Eli Lilly)	This study was sponsored by Boehringer Ingelheim and Eli Lilly and Company.	Bain S, 2017, DIABETES OBES METAB, V19, P329, DOI 10.1111/dom.12821; Boehringer Ingelheim Pharmaceuticals, TRAD LIN TABL PRESCR; Budnitz D.S., 2012, NEW ENGL J MED, V365, P2002, DOI DOI 10.1056/NEJMsa1103053; Center for Drug Evaluation and Research, APPL NUMB 204042ORIG, V20; Das SR, 2018, J AM COLL CARDIOL, V72, P3200, DOI 10.1016/j.jacc.2018.09.020; Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI 10.2337/dci18-0033; Foroutan N, 2016, CLIN INVEST MED, V39, pE48; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Heaton PC, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0084-z; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Loganadan NK, 2016, PHARMACOGENOMICS J, V16, P209, DOI 10.1038/tpj.2015.95; Marx N, 2017, DIABETES CARE, V40, P1144, DOI 10.2337/dc17-0068; Marx N, 2015, DIABETES VASC DIS RE, V12, P164, DOI 10.1177/1479164115570301; McGuire DK, 2019, DIABETES OBES METAB, V21, P1073, DOI 10.1111/dom.13645; MEINERT CL, 1970, DIABETES, V19, P789; Montvida O, 2018, DIABETES CARE, V41, P69, DOI 10.2337/dc17-1414; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V321, P69, DOI 10.1001/jama.2018.18269; Schramm TK, 2011, EUR HEART J, V32, P1900, DOI 10.1093/eurheartj/ehr077; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; US Department of Health and Human Services, 2018, DIAB MELL EV CARD RI; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; World Health Organization, GUID 2 3 LIN MED TYP; Zimdahl H, 2014, DIABETOLOGIA, V57, P1869, DOI 10.1007/s00125-014-3276-y	24	307	316	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1155	1166		10.1001/jama.2019.13772	http://dx.doi.org/10.1001/jama.2019.13772			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31536101	Bronze, Green Published			2022-12-28	WOS:000488822800022
J	Wise, J				Wise, Jacqui			European drug agency approves cannabis-based medicine for severe forms of epilepsy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DIJK S, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L5280	1	3	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5708	10.1136/bmj.l5708	http://dx.doi.org/10.1136/bmj.l5708			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551241				2022-12-28	WOS:000488488300016
J	[Anonymous]				[Anonymous]			Estradiol/Progesterone (Bijuva) for Menopausal Vasomotor Symptoms (Reprinted from Medical Letter on Drugs and Therapeutics, vol 61, pg 99-101, 2019)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint								This Medical Letter review summarizes prescribing information for Bijuva, a fixed-dose combination of bioidentical estradiol and progesterone, for oral treatment of moderate to severe vasomotor symptoms due to menopause in women with an intact uterus.										American College of Obstetricians and Gynecologists, 2012, OBSTET GYNECOL, V120, P411, DOI DOI 10.1097/AOG.0B013E318268049E; [Anonymous], 2016, MED LETT DRUGS THER, V58, P142; Cobin RH, 2017, ENDOCR PRACT, V23, P869, DOI 10.4158/EP171828.PS; Gaudard AM, 2016, COCHRANE DB SYST REV, V8; Lobo RA, 2018, OBSTET GYNECOL, V132, P161, DOI 10.1097/AOG.0000000000002645; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Santoro N, 2016, J CLIN ENDOCR METAB, V101, P1318, DOI 10.1210/jc.2016-1271; Shifren JL, 2019, JAMA-J AM MED ASSOC, V321, P2458, DOI 10.1001/jama.2019.5346; Stanczyk FZ, 2019, MENOPAUSE, V26, P966, DOI 10.1097/GME.0000000000001356; US Food and Drug Administration, FDA SUMMARY REVIEW; VINOGRADOVA Y, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.K4810; 2019, MED LETT DRUGS THER, V61, P99	12	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1206	1207		10.1001/jama.2019.10692	http://dx.doi.org/10.1001/jama.2019.10692			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550026				2022-12-28	WOS:000488822800027
J	Munoz, D; Uzoije, P; Reynolds, C; Miller, R; Walkley, D; Pappalardo, S; Tousey, P; Munro, H; Gonzales, H; Song, W; White, C; Blot, WJ; Wang, TJ				Munoz, Daniel; Uzoije, Prince; Reynolds, Cassandra; Miller, Roslynn; Walkley, David; Pappalardo, Susan; Tousey, Phyllis; Munro, Heather; Gonzales, Holly; Song, Wenliang; White, Charles; Blot, William J.; Wang, Thomas J.			Polypill for Cardiovascular Disease Prevention in an Underserved Population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSOCIATION TASK-FORCE; BLOOD-PRESSURE; AMERICAN-COLLEGE; RANDOMIZED-TRIAL; UNITED-STATES; RISK-FACTORS; HYPERTENSION; HEART; PREVALENCE; CARE	Participants in an underserved minority population in the United States were randomly assigned to receive a polypill that included low doses of atorvastatin, amlodipine, losartan, and hydrochlorothiazide or to receive usual care. At 12 months, systolic blood pressure and LDL cholesterol levels were significantly lower in the polypill group. Background Persons with low socioeconomic status and nonwhite persons in the United States have high rates of cardiovascular disease. The use of combination pills (also called "polypills") containing low doses of medications with proven benefits for the prevention of cardiovascular disease may be beneficial in such persons. However, few data are available regarding the use of polypill therapy in underserved communities in the United States, in which adherence to guideline-based care is generally low. Methods We conducted a randomized, controlled trial involving adults without cardiovascular disease. Participants were assigned to the polypill group or the usual-care group at a federally qualified community health center in Alabama. Components of the polypill were atorvastatin (at a dose of 10 mg), amlodipine (2.5 mg), losartan (25 mg), and hydrochlorothiazide (12.5 mg). The two primary outcomes were the changes from baseline in systolic blood pressure and low-density lipoprotein (LDL) cholesterol level at 12 months. Results The trial enrolled 303 adults, of whom 96% were black. Three quarters of the participants had an annual income below $15,000. The mean estimated 10-year cardiovascular risk was 12.7%, the baseline blood pressure was 140/83 mm Hg, and the baseline LDL cholesterol level was 113 mg per deciliter. The monthly cost of the polypill was $26. At 12 months, adherence to the polypill regimen, as assessed on the basis of pill counts, was 86%. The mean systolic blood pressure decreased by 9 mm Hg in the polypill group, as compared with 2 mm Hg in the usual-care group (difference, -7 mm Hg; 95% confidence interval [CI], -12 to -2; P=0.003). The mean LDL cholesterol level decreased by 15 mg per deciliter in the polypill group, as compared with 4 mg per deciliter in the usual-care group (difference, -11 mg per deciliter; 95% CI, -18 to -5; P<0.001). Conclusions A polypill-based strategy led to greater reductions in systolic blood pressure and LDL cholesterol level than were observed with usual care in a socioeconomically vulnerable minority population. (Funded by the American Heart Association Strategically Focused Prevention Research Network and the National Institutes of Health; ClinicalTrials.gov number, .)	[Munoz, Daniel; Reynolds, Cassandra; Wang, Thomas J.] Vanderbilt Univ, Med Ctr, Vanderbilt Translat & Clin Cardiovasc Res Ctr, Nashville, TN USA; [Munoz, Daniel; Reynolds, Cassandra; Gonzales, Holly; Song, Wenliang; Wang, Thomas J.] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN USA; [Walkley, David; Pappalardo, Susan; Tousey, Phyllis; Munro, Heather; Blot, William J.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Walkley, David; Pappalardo, Susan; Tousey, Phyllis; Munro, Heather; Blot, William J.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Clin & Translat Res, Nashville, TN USA; [Uzoije, Prince; Miller, Roslynn; White, Charles] Franklin Primary Hlth Ctr, Mobile, AL USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wang, TJ (corresponding author), Vanderbilt Univ, Vanderbilt Translat & Clin Cardiovasc Res Ctr, Div Cardiovasc Med, Med Ctr, 2220 Pierce Ave,PRB 383, Nashville, TN 37232 USA.	thomas.j.wang@vumc.org; thomas.j.wang@vumc.org		Wang, Thomas/0000-0003-4063-6508; Song, Wenliang/0000-0002-1866-0635	American Heart Association Strategically Focused Prevention Research Network; National Institutes of Health; NATIONAL CANCER INSTITUTE [U01CA202979] Funding Source: NIH RePORTER	American Heart Association Strategically Focused Prevention Research Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the American Heart Association Strategically Focused Prevention Research Network and the National Institutes of Health; ClinicalTrials.gov number, NCT02278471.	Agodoa L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5680; Ahluwalia JS, 1997, J GEN INTERN MED, V12, P7, DOI 10.1046/j.1525-1497.1997.12107.x; American College of Cardiology, 2016, ASCVD RISK EST PLUS; [Anonymous], 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI DOI 10.1001/jama.2016.15450; Chow CK, 2017, LANCET, V389, P1035, DOI 10.1016/S0140-6736(17)30260-X; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hill MN, 1999, AM J HYPERTENS, V12, P951, DOI 10.1016/S0895-7061(99)00121-1; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260; Kotchen JM, 1998, AM J PUBLIC HEALTH, V88, P1696, DOI 10.2105/AJPH.88.11.1696; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Mensah GA, 2018, CIRC RES, V122, P213, DOI 10.1161/CIRCRESAHA.117.312243; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Patel A, 2015, EUR J PREV CARDIOL, V22, P920, DOI 10.1177/2047487314530382; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Psaty BM, 2018, JAMA-J AM MED ASSOC, V320, P751, DOI 10.1001/jama.2018.8377; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Roth GA, 2017, JAMA-J AM MED ASSOC, V317, P1976, DOI 10.1001/jama.2017.4150; Sampson UKA, 2014, CIRC-CARDIOVASC QUAL, V7, P33, DOI 10.1161/CIRCOUTCOMES.113.000155; Selak V, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3318; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Sundstrom J, 2015, ANN INTERN MED, V162, P184, DOI 10.7326/M14-0773; Taylor HA, 2009, AM J MED, V122, P454, DOI 10.1016/j.amjmed.2008.09.049; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Webster R, 2018, JAMA-J AM MED ASSOC, V320, P566, DOI 10.1001/jama.2018.10359; Whelton PK, 2018, CIRCULATION, V138, pE484, DOI 10.1161/CIR.0000000000000596; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177; Zanchetti A, 2015, CIRC RES, V116, P1058, DOI 10.1161/CIRCRESAHA.116.303641	39	77	79	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1114	1123		10.1056/NEJMoa1815359	http://dx.doi.org/10.1056/NEJMoa1815359			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ4PY	31532959	Green Accepted, Bronze			2022-12-28	WOS:000487066900006
J	Cohen, D				Cohen, Deborah			NHS England explores funding options for cystic fibrosis drug	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, BBC NEWSNIGHT   0913; Christie B, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5556	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5600	10.1136/bmj.l5600	http://dx.doi.org/10.1136/bmj.l5600			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530544				2022-12-28	WOS:000487758600012
J	El Kawkgi, OM; Montori, VM				El Kawkgi, Omar M.; Montori, Victor M.			In high-risk type 1 diabetes, insulin pumps with suspend-before-low technology reduced hypoglycemic events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In adults with type 1 diabetes who are prone to hypoglycemia, do continuous subcutaneous insulin infusion (CSII) pumps with vs without continuous glucose monitoring (CGM) and suspendbefore- low technology reduce hypoglycemic events? Methods Design: Randomized controlled trial (Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes [SMILE]). ClinicalTrials. gov NCT02733991. Allocation: Unclear allocation concealment.* Blinding: Unblinded.* Follow-up period: 24 weeks. Setting: 16 centers in Canada, France, Italy, The Netherlands, and UK. Patients: 153 patients 24 to 75 years of age (mean age 48 y, 50% men, mean diabetes duration 29 y) who had type 1 diabetes mellitus for >= 10 years; hemoglobin (Hb) A(1c) level 5.8% to 10.0% (40 to 86 mmol/mol) in the past 15 days; high risk for hypoglycemia (documented severe hypoglycemia event or Clarke or Gold score >= 4 in the past 12 mo); use of CSII pumps for >= 6 months, without CGM or flash glucose monitoring in the past 3 months; and a successful 2-week run-in phase. Exclusion criteria included gastroparesis; hypopituitarism; untreated Addison disease, thyroid disorder, or growth hormone deficiency; renal failure in the past 3 months; or use of pramlintide, sodium-glucose cotransporter 2 inhibitors, or glucagon-like peptide-1 receptor agonists at screening. Intervention: CSII pump (Medtronic MiniMed 640G) usingCGM with suspend-before-low technology (n = 76) or CSII pump with blood glucose self-monitoring and without use ofCGMexcept during 3 twoweek blindedCGMassessment periods (n = 77). Outcomes: Primary outcome was sensor hypoglycemic events (glucose levels >= 55 mg/dL [<= 3.1 mmol/L] for > 20 consecutive min with >= 30 min between distinct events). Other outcomes included time in target glucose range, change in HbA(1c) level, and severe hypoglycemia. Patient follow-up: 96% completed the trial; 100% were included in the intention-to-treat analysis. Main results The main results are in the Table. Conclusion In high-risk type 1 diabetes, insulin pumps with continuous glucose monitoring and suspend-before-low technology reduced hypoglycemic events compared with pumps without either feature.	[El Kawkgi, Omar M.; Montori, Victor M.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	El Kawkgi, OM (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							Little SA, 2014, DIABETES CARE, V37, P2114, DOI 10.2337/dc14-0030; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC30	JC30		10.7326/ACPJ201909170-030	http://dx.doi.org/10.7326/ACPJ201909170-030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525764				2022-12-28	WOS:000486101400006
J	Haskell, H				Haskell, Helen			Unleash the power of patients to make care safer around the world: an essay by Helen Haskell	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS		[Haskell, Helen] Consumers Adv Patient Safety, Chicago, IL 60611 USA		Haskell, H (corresponding author), Consumers Adv Patient Safety, Chicago, IL 60611 USA.	haskell.helen@gmail.com						Daniels JP, 2012, CAN MED ASSOC J, V184, P29, DOI 10.1503/cmaj.110393; Giardina TD, 2018, HEALTH AFFAIR, V37, P1821, DOI 10.1377/hlthaff.2018.0698; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; Metwally N., 2019, COMMUNICATION; National Patient Safety Foundation, 2016, RCA2 IMPR ROOT CAUS; Panagioti M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4185; Saudi Arabia Ministry of Health, 2019, JEDD DECL PAT SAF; Slawomirski L, 2017, OECD HLTH WORKING PA; Turle S, 2017, BMJ OPINION; Vazquez Curiel E., 2019, RESUMEN 15 ANOS SECU; Weissman JS, 2008, ANN INTERN MED, V149, P100, DOI 10.7326/0003-4819-149-2-200807150-00006; World Health Assembly, 2019, GLOB ACT PAT SAF 72; World Health Organization, WHO FRAM INT PEOPL C; World Health Organization, PAT SAF PAT PAT SAF; World Health Organization, PATIENT SAFETY; World Health Organization, 2019, GLOB ACT PAT SAF REP	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5565	10.1136/bmj.l5565	http://dx.doi.org/10.1136/bmj.l5565			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530550	Bronze			2022-12-28	WOS:000487758600007
J	Anderegg, L; Cheuk, LW; Bao, YC; Burchesky, S; Ketterle, W; Ni, KK; Doyle, JM				Anderegg, Loic; Cheuk, Lawrence W.; Bao, Yicheng; Burchesky, Sean; Ketterle, Wolfgang; Ni, Kang-Kuen; Doyle, John M.			An optical tweezer array of ultracold molecules	SCIENCE			English	Article								Ultracold molecules have important applications that range from quantum simulation and computation to precision measurements probing physics beyond the Standard Model. Optical tweezer arrays of laser-cooled molecules, which allow control of individual particles, offer a platform for realizing this full potential. In this work, we report on creating an optical tweezer array of laser-cooled calcium monofluoride molecules. This platform has also allowed us to observe ground-state collisions of laser-cooled molecules both in the presence and absence of near-resonant light.	[Anderegg, Loic; Cheuk, Lawrence W.; Bao, Yicheng; Burchesky, Sean; Ni, Kang-Kuen; Doyle, John M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Anderegg, Loic; Cheuk, Lawrence W.; Bao, Yicheng; Burchesky, Sean; Ketterle, Wolfgang; Ni, Kang-Kuen; Doyle, John M.] Harvard MIT Ctr Ultracold Atoms, Cambridge, MA 02138 USA; [Ketterle, Wolfgang] MIT, Dept Phys, Cambridge, MA 02139 USA; [Ni, Kang-Kuen] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University	Anderegg, L (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Anderegg, L (corresponding author), Harvard MIT Ctr Ultracold Atoms, Cambridge, MA 02138 USA.	anderegg@g.harvard.edu		Burchesky, Sean/0000-0002-6740-3977; Anderegg, Loic/0000-0002-4282-3369; Cheuk, Lawrence/0000-0002-8329-8812; Bao, Yicheng/0000-0002-0955-8567	NSF; Max PlanckHarvard Research Center for Quantum Optics	NSF(National Science Foundation (NSF)); Max PlanckHarvard Research Center for Quantum Optics	This work was supported by the NSF. L.W.C. acknowledges supports from the Max PlanckHarvard Research Center for Quantum Optics.	Anderegg L, 2018, NAT PHYS, V14, P890, DOI 10.1038/s41567-018-0191-z; Anderegg L, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.103201; Balakrishnan N, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4964096; Barredo D, 2016, SCIENCE, V354, P1021, DOI 10.1126/science.aah3778; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Blackmore JA, 2019, QUANTUM SCI TECHNOL, V4, DOI 10.1088/2058-9565/aaee35; Buchler HP, 2007, NAT PHYS, V3, P726, DOI 10.1038/nphys678; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Cheuk LW, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.083201; Collopy AL, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.213201; De Marco L, 2019, SCIENCE, V363, P853, DOI 10.1126/science.aau7230; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; Fuhrmanek A, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062708; Karra M, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4942928; Kozyryev I, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.133002; Kozyryev I, 2016, CHEMPHYSCHEM, V17, P3641, DOI 10.1002/cphc.201601051; Krems RV, 2008, PHYS CHEM CHEM PHYS, V10, P4079, DOI 10.1039/b802322k; Lim J, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.123201; Liu LR, 2018, SCIENCE, V360, P900, DOI 10.1126/science.aar7797; McCarron DJ, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.013202; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Ni KK, 2018, CHEM SCI, V9, P6830, DOI 10.1039/c8sc02355g; Norrgard EB, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.063004; Schlosser N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.023005; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Tarbutt MR, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.053401; Truppe S, 2017, NAT PHYS, V13, P1173, DOI 10.1038/NPHYS4241; Williams HJ, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.163201; Ye J., 2006, AIP C P; Yelin SF, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.050301	32	134	134	10	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1156	+		10.1126/science.aax1265	http://dx.doi.org/10.1126/science.aax1265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515390	Green Submitted			2022-12-28	WOS:000485780800044
J	Jee, I; Suyu, SH; Komatsu, E; Fassnacht, CD; Hilbert, S; Koopmans, LVE				Jee, Inh; Suyu, Sherry H.; Komatsu, Eiichiro; Fassnacht, Christopher D.; Hilbert, Stefan; Koopmans, Leon V. E.			A measurement of the Hubble constant from angular diameter distances to two gravitational lenses	SCIENCE			English	Article							ELLIPTIC GALAXIES; DARK-MATTER; H-0; MODEL; PRECISION; SUPERNOVAE; VELOCITY; LAMBDA; LIGHT; MASS	The local expansion rate of the Universe is parametrized by the Hubble constant, H-0, the ratio between recession velocity and distance. Different techniques lead to inconsistent estimates of H-0. Observations of Type la supernovae (SNe) can be used to measure H-0, but this requires an external calibrator to convert relative distances to absolute ones. We use the angular diameter distance to strong gravitational lenses as a suitable calibrator, which is only weakly sensitive to cosmological assumptions. We determine the angular diameter distances to two gravitational lenses, 810(-13)(0)(+160) and 1230(-150)(+1)(80) g megaparsec, at redshifts z = 0.295 and 0.6304. Using these absolute distances to calibrate 740 previously measured relative distances to SNe, we measure the Hubble constant to be H-0 = 82.4(-8.3)(+8.4) kilometers per second per megaparsec.	[Jee, Inh; Suyu, Sherry H.; Komatsu, Eiichiro] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Suyu, Sherry H.] Acad Sinica, Inst Astron & Astrophys, 11F Astron Math Bldg,1,Sect 4,Roosevelt Rd, Taipei 10617, Taiwan; [Suyu, Sherry H.] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Komatsu, Eiichiro] Univ Tokyo, Todai Inst Adv Study, World Premier Int Res Ctr Initiat, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan; [Fassnacht, Christopher D.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Hilbert, Stefan] Exzellenzcluster Universe, D-85748 Garching, Germany; [Hilbert, Stefan] Ludwig Maximilians Univ Munchen, Univ Sternwarte, D-81679 Munich, Germany; [Koopmans, Leon V. E.] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands	Max Planck Society; Academia Sinica - Taiwan; Technical University of Munich; University of Tokyo; University of California System; University of California Davis; University of Munich; University of Groningen	Jee, I; Suyu, SH (corresponding author), Max Planck Inst Astrophys, D-85741 Garching, Germany.; Suyu, SH (corresponding author), Acad Sinica, Inst Astron & Astrophys, 11F Astron Math Bldg,1,Sect 4,Roosevelt Rd, Taipei 10617, Taiwan.; Suyu, SH (corresponding author), Tech Univ Munich, Dept Phys, D-85748 Garching, Germany.	jee1213@mpa-garching.mpg.de; suyu@mpa-garching.mpg.de		Fassnacht, Christopher/0000-0002-4030-5461; Komatsu, Eiichiro/0000-0002-0136-2404	Max Planck Society through the Max Planck Research Group; National Science Foundation [AST-1312329]; DFG cluster of excellence 'Origin and Structure of the Universe'; NWO-VICI career grant [639.043.308]	Max Planck Society through the Max Planck Research Group; National Science Foundation(National Science Foundation (NSF)); DFG cluster of excellence 'Origin and Structure of the Universe'(German Research Foundation (DFG)); NWO-VICI career grant	S.H.S. thanks the Max Planck Society for support through the Max Planck Research Group. C.D.F. acknowledges support from the National Science Foundation grant AST-1312329. S.H. acknowledges support by the DFG cluster of excellence 'Origin and Structure of the Universe' (www.universe-cluster.de). L.V.E.K. is supported in part through an NWO-VICI career grant (project no. 639.043.308).	Abbott BP, 2017, NATURE, V551, P85, DOI 10.1038/nature24471; Abbott TMC, 2018, MON NOT R ASTRON SOC, V480, P3879, DOI 10.1093/mnras/sty1939; Ade PAR, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201525830; Aghanim N., 2018, ARXIV180706209; Appell P., 1925, MEM SCI MATH ACAD SC; Aubourg E, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.123516; Audren B, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/08/039; Audren B, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/02/001; Barnabe M, 2012, MON NOT R ASTRON SOC, V423, P1073, DOI 10.1111/j.1365-2966.2012.20934.x; Betoule M, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201423413; Cappellari M, 2008, MON NOT R ASTRON SOC, V390, P71, DOI 10.1111/j.1365-2966.2008.13754.x; Churazov E, 2010, MON NOT R ASTRON SOC, V404, P1165, DOI 10.1111/j.1365-2966.2010.16377.x; Colavecchia FD, 2001, COMPUT PHYS COMMUN, V138, P29, DOI 10.1016/S0010-4655(01)00186-2; Collett TE, 2018, SCIENCE, V360, P1342, DOI 10.1126/science.aao2469; Cuesta AJ, 2015, MON NOT R ASTRON SOC, V448, P3463, DOI 10.1093/mnras/stv261; FALCO EE, 1985, ASTROPHYS J, V289, pL1, DOI 10.1086/184422; Fassnacht CD, 2002, ASTROPHYS J, V581, P823, DOI 10.1086/344368; Fassnacht CD, 1996, ASTROPHYS J, V460, pL103, DOI 10.1086/309984; Freedman WL, 2017, NAT ASTRON, V1, DOI 10.1038/s41550-017-0121; Freedman WL, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/24; Hilbert S, 2009, ASTRON ASTROPHYS, V499, P31, DOI 10.1051/0004-6361/200811054; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; JAFFE W, 1983, MON NOT R ASTRON SOC, V202, P995, DOI 10.1093/mnras/202.4.995; Jee I, 2015, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2015/11/033; Koopmans LVE, 2003, ASTROPHYS J, V599, P70, DOI 10.1086/379226; Lemos P, 2019, MON NOT R ASTRON SOC, V483, P4803, DOI 10.1093/mnras/sty3082; Mamon GA, 2005, MON NOT R ASTRON SOC, V363, P705, DOI 10.1111/j.1365-2966.2005.09400.x; MERRITT D, 1985, ASTRON J, V90, P1027, DOI 10.1086/113810; Munoz JB, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.103537; MYERS ST, 1995, ASTROPHYS J, V447, pL5, DOI 10.1086/309556; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Osipkov L. P., 1979, Pis'ma v Astronomicheskie Zhurnal, V25, P77; Paraficz D, 2009, ASTRON ASTROPHYS, V507, pL49, DOI 10.1051/0004-6361/200913307; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Planck Collaboration et al, 2018, ARXIV180706205ASTROP; da Silva GP, 2018, BRAZ J PHYS, V48, P521, DOI 10.1007/s13538-018-0581-9; REFSDAL S, 1964, MON NOT R ASTRON SOC, V128, P307, DOI 10.1093/mnras/128.4.307; Riess AG, 2018, ASTROPHYS J, V855, DOI 10.3847/1538-4357/aaadb7; Riess AG, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/1/56; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Rusu CE, 2017, MON NOT R ASTRON SOC, V467, P4220, DOI 10.1093/mnras/stx285; Schneider P, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201321882; SCHUTZ BF, 1986, NATURE, V323, P310, DOI 10.1038/323310a0; Sersic J. L., 1963, B ASOC ARGENTINA AST, V6, P41; Sluse D, 2007, ASTRON ASTROPHYS, V468, P885, DOI 10.1051/0004-6361:20066821; Sluse D, 2017, MON NOT R ASTRON SOC, V470, P4838, DOI 10.1093/mnras/stx1484; Sluse D, 2003, ASTRON ASTROPHYS, V406, pL43, DOI 10.1051/0004-6361:20030904; Suyu SH, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L35; Suyu SH, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/70; Suyu SH, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/10; Suyu SH, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201015481; Suyu SH, 2010, ASTROPHYS J, V711, P201, DOI 10.1088/0004-637X/711/1/201; Suyu SH, 2009, ASTROPHYS J, V691, P277, DOI 10.1088/0004-637X/691/1/277; Tewes M, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201220352; van de Ven G, 2010, ASTROPHYS J, V719, P1481, DOI 10.1088/0004-637X/719/2/1481; Wertz O, 2018, ASTRON ASTROPHYS, V617, DOI 10.1051/0004-6361/201732240; Wong KC, 2017, MON NOT R ASTRON SOC, V465, P4895, DOI 10.1093/mnras/stw3077; Yildirim A., 2019, ARXIV190407237ASTROP	64	30	31	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1134	+		10.1126/science.aat7371	http://dx.doi.org/10.1126/science.aat7371			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515387	Green Submitted, Green Published			2022-12-28	WOS:000485780800040
J	Shepherd, A				Shepherd, Alison			Cosmetic surgery meets reality TV: passing judgment on The Surjury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ashepherd@bmj.com							0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2019	366								l5478	10.1136/bmj.l5478	http://dx.doi.org/10.1136/bmj.l5478			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MV	31515256				2022-12-28	WOS:000486649600004
J	Bachert, C; Han, JK; Desrosiers, M; Hellings, PW; Amin, N; Lee, SE; Mullol, J; Greos, LS; Bosso, JV; Laidlaw, TM; Cervin, AU; Maspero, JF; Hopkins, C; Olze, H; Canonica, GW; Paggiaro, P; Cho, SH; Fokkens, WJ; Fujieda, S; Zhang, M; Lu, X; Fan, CP; Draikiwicz, S; Kamat, SA; Khan, A; Pirozzi, G; Patel, N; Graham, NMH; Ruddy, M; Staudinger, H; Weinreich, D; Stahl, N; Yancopoulos, GD; Mannent, LP				Bachert, Claus; Han, Joseph K.; Desrosiers, Martin; Hellings, Peter W.; Amin, Nikhil; Lee, Stella E.; Mullol, Joaquim; Greos, Leon S.; Bosso, John V.; Laidlaw, Tanya M.; Cervin, Anders U.; Maspero, Jorge F.; Hopkins, Claire; Olze, Heidi; Canonica, G. Walter; Paggiaro, Pierluigi; Cho, Seong H.; Fokkens, Wytske J.; Fujieda, Shigeharu; Zhang, Mei; Lu, Xin; Fan, Chunpeng; Draikiwicz, Steven; Kamat, Siddhesh A.; Khan, Asif; Pirozzi, Gianluca; Patel, Naimish; Graham, Neil M. H.; Ruddy, Marcella; Staudinger, Heribert; Weinreich, David; Stahl, Neil; Yancopoulos, George D.; Mannent, Leda P.			Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials	LANCET			English	Article							PERSISTENT ASTHMA; PREVALENCE; HUMANIZATION; INFLAMMATION; DISEASE; IMPACT; SMELL; PLUS	Background Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of life, often requiring recurring systemic corticosteroid use and repeated sinus surgery. Dupilumab is a fully human monoclonal antibody that inhibits signalling of interleukin (IL)-4 and IL-13, key drivers of type 2 inflammation, and has been approved for use in atopic dermatitis and asthma. In these two studies, we aimed to assess efficacy and safety of dupilumab in patients with CRSwNP despite previous treatment with systemic corticosteroids, surgery, or both. Methods LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52 were two multinational, multicentre, randomised, double- blind, placebo- controlled, parallel-group studies assessing dupilumab added to standard of care in adults with severe CRSwNP. SINUS-24 was done in 67 centres in 13 countries, and SINUS-52 was done in 117 centres in 14 countries. Eligible patients were 18 years or older with bilateral CRSwNP and symptoms despite intranasal corticosteroid use, receiving systemic corticosteroids in the preceding 2 years, or having had sinonasal surgery. Patients in SINUS-24 were randomly assigned (1:1) to subcutaneous dupilumab 300 mg or placebo every 2 weeks for 24 weeks. Patients in SINUS-52 were randomly assigned (1:1:1) to dupilumab 300 mg every 2 weeks for 52 weeks, dupilumab every 2 weeks for 24 weeks and then every 4 weeks for the remaining 28 weeks, or placebo every 2 weeks for 52 weeks. All patients were randomly assigned centrally with a permuted block randomisation schedule. Randomisation was stratified by asthma or non-steroidal anti-inflammatory drug-exacerbated respiratory disease status at screening, previous surgery at screening, and country. Patients with or without comorbid asthma were included. Coprimary endpoints were changes from baseline to week 24 in nasal polyp score (NPS), nasal congestion or obstruction, and sinus Lund-Mackay CT scores (a coprimary endpoint in Japan), done in an intention-to-treat population. Safety was assessed in a pooled population of both dupilumab groups in SINUS-52 up to week 24 and the dupilumab group in SINUS-24 and the placebo groups in both studies until week 24. The trials are complete and registered at ClinicalTrials.gov, NCT02912468 and NCT02898454. Findings Between Dec 5, 2016, and Aug 3, 2017, 276 patients were enrolled in SINUS-24, with 143 in the dupilumab group and 133 in the placebo group receiving at least one study drug dose. Between Nov 28, 2016, and Aug 28, 2017, 448 patients were enrolled in SINUS-52, with 150 receiving at least one dose of dupilumab every 2 weeks, 145 receiving at least one dose of dupilumab every 2 weeks for 24 weeks and every 4 weeks until week 52, and 153 receiving at least one dose of placebo. Dupilumab significantly improved the coprimary endpoints in both studies. At 24 weeks, least squares mean difference in NPS of dupilumab treatment versus placebo was -2.06 (95% CI -2.43 to -1.69; p<0.0001) in SINUS-24 and -1. 80 (-2.10 to -1.51; p<0.0001) in SINUS-52; difference in nasal congestion or obstruction score was -0.89 (-1.07 to -0.71; p<0.0001) in SINUS-24 and -0.87 (-1.03 to -0.71; p<0.0001) in SINUS-52; and difference in Lund-Mackay CT scores was -7.44 (-8.35 to -6.53; p<0.0001) in SINUS-24 and -5.13 (-5.80 to - 4.46; p<0.0001) in SINUS-52. The most common adverse events (nasopharyngitis, worsening of nasal polyps and asthma, headache, epistaxis, and injection-site erythema) were more frequent with placebo. Interpretation In adult patients with severe CRSwNP, dupilumab reduced polyp size, sinus opacification, and severity of symptoms and was well tolerated. These results support the benefits of adding dupilumab to daily standard of care for patients with severe CRSwNP who otherwise have few therapeutic options. Funding Sanofi and Regeneron Pharmaceuticals. Copyright (c) 2019 Elsevier Ltd. All rights reserved.	[Bachert, Claus] Univ Ghent, Fac Med, Upper Airways Res Lab, Ghent, Belgium; [Bachert, Claus] Karolinska Inst, CLINTEC, Stockholm, Sweden; [Han, Joseph K.] Eastern Virginia Med Sch, Div Allergy, Norfolk, VA 23501 USA; [Desrosiers, Martin] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Hellings, Peter W.] Univ Hosp Leuven, Dept Otorhinolaryngol Head & Neck Surg, Expt Immunol Lab, Leuven, Belgium; [Amin, Nikhil; Kamat, Siddhesh A.; Graham, Neil M. H.; Ruddy, Marcella; Weinreich, David; Stahl, Neil; Yancopoulos, George D.] Regeneron Pharmaceut, Tarrytown, NY USA; [Lee, Stella E.] Univ Pittsburgh, Med Ctr, Div Sinonasal Disorders & Allergy, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA; [Mullol, Joaquim] Univ Barcelona, Hosp Clin, IDIBAPS, CIBERES, Barcelona, Spain; [Greos, Leon S.] Colorado Allergy & Asthma Ctr, Centennial, CO USA; [Bosso, John V.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Div Rhinol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Laidlaw, Tanya M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Cervin, Anders U.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Cervin, Anders U.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Maspero, Jorge F.] Fdn CIDEA, Allergy & Resp Res Unit, Buenos Aires, DF, Argentina; [Hopkins, Claire] Guys & St Thomas Hosp, Dept Ear Nose & Throat, London, England; [Olze, Heidi] Charite Univ Med Berlin, Dept Otorhinolaryngol Head & Neck Surg, Berlin, Germany; [Canonica, G. Walter] Humanitas Univ, Clin & Res Ctr, IRCCS, Personalized Med Asthma & Allergy, Milan, Italy; [Paggiaro, Pierluigi] Univ Pisa, Dept Surg Med Mol Biol & Crit Care, Pisa, Italy; [Cho, Seong H.] Univ S Florida, Div Allergy Immunol, Tampa, FL USA; [Fokkens, Wytske J.] Acad Med Ctr, Amsterdam, Netherlands; [Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Fukui, Japan; [Zhang, Mei; Lu, Xin; Fan, Chunpeng; Draikiwicz, Steven; Pirozzi, Gianluca; Staudinger, Heribert] Sanofi, Bridgewater, NJ USA; [Khan, Asif; Mannent, Leda P.] Sanofi, Chilly Mazarin, France; [Patel, Naimish] Sanofi, Cambridge, MA USA	Ghent University; Karolinska Institutet; Eastern Virginia Medical School; Universite de Montreal; KU Leuven; University Hospital Leuven; Regeneron; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; University of Queensland; Royal Brisbane & Women's Hospital; Guy's & St Thomas' NHS Foundation Trust; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humanitas University; University of Pisa; State University System of Florida; University of South Florida; University of Amsterdam; Academic Medical Center Amsterdam; University of Fukui; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Bachert, C (corresponding author), Univ Ghent, Upper Airways Res Lab, B-9000 Ghent, Belgium.	claus.bachert@ugent.be	Fokkens, Wytske WJ/ABF-2185-2020; canonica, giorgio walter/ABF-2037-2020; Bachert, Claus/J-8825-2012; Lee, Stella/AAI-6029-2021; Khan, Asif H/GRJ-1775-2022; Philpott, Carl/H-4509-2019	canonica, giorgio walter/0000-0001-8467-2557; Khan, Asif H/0000-0001-9158-0116; Philpott, Carl/0000-0002-1125-3236; Olze, Heidi/0000-0001-9987-6392; Weinreich, David/0000-0003-0971-1530	Sanofi; Regeneron Pharmaceuticals	Sanofi; Regeneron Pharmaceuticals(Regeneron)	Sanofi and Regeneron Pharmaceuticals.	Alobid I, 2008, ALLERGY, V63, P1267, DOI 10.1111/j.1398-9995.2008.01828.x; Alobid I, 2014, LARYNGOSCOPE, V124, P50, DOI 10.1002/lary.24330; Alobid I, 2011, RHINOLOGY, V49, P519, DOI 10.4193/Rhino10.295; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bachert C, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-25; Bhattacharyya N, 2019, LARYNGOSCOPE, V129, P1969, DOI 10.1002/lary.27852; Blauvelt A, 2017, LANCET, V389, P2287, DOI 10.1016/S0140-6736(17)31191-1; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Chung JH, 2015, ANN OTO RHINOL LARYN, V124, P663, DOI 10.1177/0003489415576181; DeConde AS, 2017, LARYNGOSCOPE, V127, P550, DOI 10.1002/lary.26391; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gandhi NA, 2017, EXPERT REV CLIN IMMU, V13, P425, DOI 10.1080/1744666X.2017.1298443; Hakansson K, 2014, AM J RHINOL ALLERGY, V28, P383, DOI 10.2500/ajra.2014.28.4076; Han JK, 2013, LARYNGOSCOPE, V123, pS15, DOI 10.1002/lary.23979; Hedman J, 1999, INT J EPIDEMIOL, V28, P717, DOI 10.1093/ije/28.4.717; Hopkins C, 2009, CLIN OTOLARYNGOL, V34, P447, DOI 10.1111/j.1749-4486.2009.01995.x; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Kohli P, 2017, LARYNGOSCOPE, V127, P309, DOI 10.1002/lary.26316; Laidlaw TM, 2016, NEW ENGL J MED, V374, P484, DOI 10.1056/NEJMcibr1514013; Macdonald LE, 2014, P NATL ACAD SCI USA, V111, P5147, DOI 10.1073/pnas.1323896111; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Rabe KF, 2018, NEW ENGL J MED, V378, P2475, DOI 10.1056/NEJMoa1804093; Robinson D, 2017, CLIN EXP ALLERGY, V47, P161, DOI 10.1111/cea.12880; SETTIPANE GA, 1977, J ALLERGY CLIN IMMUN, V59, P17, DOI 10.1016/0091-6749(77)90171-3; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Stevens WW, 2017, J ALLER CL IMM-PRACT, V5, P1061, DOI 10.1016/j.jaip.2016.12.027; Thaci D, 2016, LANCET, V387, P40, DOI 10.1016/S0140-6736(15)00388-8; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5	30	461	478	8	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2019	394	10209					1638	1650		10.1016/S0140-6736(19)31881-1	http://dx.doi.org/10.1016/S0140-6736(19)31881-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI8SM	31543428				2022-12-28	WOS:000493733600032
J	Kostis, JB				Kostis, John B.			Individualize Treatment With Aspirin for Primary Prevention	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EVENTS; RISK		[Kostis, John B.] Rutgers Robert Wood Johnson Med Sch, Cardiovasc Inst, 125 Paterson St,CAB-4180A, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kostis, JB (corresponding author), Rutgers Robert Wood Johnson Med Sch, Cardiovasc Inst, 125 Paterson St,CAB-4180A, New Brunswick, NJ 08901 USA.	kostis@rwjms.rutgers.edu						Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]; Lacaze P, 2017, INTERN MED J, V47, P461, DOI 10.1111/imj.13384; Mahmoud AN, 2019, EUR HEART J, V40, P607, DOI 10.1093/eurheartj/ehy813; Montinari MR, 2019, VASC PHARMACOL, V113, P1, DOI 10.1016/j.vph.2018.10.008; Pylypchuk R, 2018, LANCET, V391, P1897, DOI [10.1016/s0140-6736(18)30664-0, 10.1016/S0140-6736(18)30664-0]; Selak V, 2019, ANN INTERN MED, V171, P529, DOI 10.7326/M19-1132; Sundstrom J, 2017, CIRCULATION, V136, P1183, DOI 10.1161/CIRCULATIONAHA.117.028321; U.S. Food and Drug Administration, 2014, USE OF ASPIRIN FOR P; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Wells S, 2017, INT J EPIDEMIOL, V46, P22, DOI 10.1093/ije/dyv312	10	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2019	171	8					583	584		10.7326/M19-2475	http://dx.doi.org/10.7326/M19-2475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD4JV	31525772				2022-12-28	WOS:000489944700020
J	O'Brien, MJ; Sacks, DB				O'Brien, Matthew J.; Sacks, David B.			Point-of-Care Hemoglobin A(1c)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLUCOSE		[O'Brien, Matthew J.] Northwestern Univ, Feinberg Sch Med, Div Gen Internal Med & Geriatr, Chicago, IL 60611 USA; [O'Brien, Matthew J.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [O'Brien, Matthew J.] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA	O'Brien, MJ (corresponding author), Northwestern Univ, Feinberg Sch Med, 750 N Lake Shore Dr,Sixth Floor, Chicago, IL 60611 USA.	matthew.obrien1@northwestern.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK112066] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK112066] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; Hirst JA, 2017, CLIN CHEM LAB MED, V55, P167, DOI 10.1515/cclm-2016-0303; Lenters-Westra E, 2014, CLIN CHEM, V60, P1062, DOI 10.1373/clinchem.2014.224311; Little RR, 2019, CLIN CHEM, V65, P839, DOI 10.1373/clinchem.2018.296962; Nathan David M, 2019, J Diabetes Sci Technol, V13, P1149, DOI 10.1177/1932296819836101; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Whitley Heather P, 2015, Diabetes Spectr, V28, P201, DOI 10.2337/diaspect.28.3.201; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	9	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2019	322	14					1404	1405		10.1001/jama.2019.14063	http://dx.doi.org/10.1001/jama.2019.14063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JE1GT	31513231	Green Accepted			2022-12-28	WOS:000490441900022
J	Voelker, R				Voelker, Rebecca			Medical News & Perspectives Finding the Right Words to Stop Cancer Screening in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2019	322	14					1339	1340		10.1001/jama.2019.14732	http://dx.doi.org/10.1001/jama.2019.14732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JE1GT	31532447				2022-12-28	WOS:000490441900002
J	Gibson, BA; Doolittle, LK; Schneider, MWG; Jensen, LE; Gamarra, N; Henry, L; Gerlich, DW; Redding, S; Rosen, MK				Gibson, Bryan A.; Doolittle, Lynda K.; Schneider, Maximillian W. G.; Jensen, Liv E.; Gamarra, Nathan; Henry, Lisa; Gerlich, Daniel W.; Redding, Sy; Rosen, Michael K.			Organization of Chromatin by Intrinsic and Regulated Phase Separation	CELL			English	Article							NUCLEOSOME CORE PARTICLE; HISTONE ACETYLATION; LINKER HISTONES; DNA; YEAST; PROTEINS; DYNAMICS; VISUALIZATION; DETERMINANTS; MECHANISMS	Eukaryotic chromatin is highly condensed but dynamically accessible to regulation and organized into subdomains. We demonstrate that recor chromatin undergoes histone tail-driven liquid-liquid phase separation (LLPS) in physiologic salt and when microinjected into cell nuclei, producing dense and dynamic droplets. Linker histone H1 and internucleo-some linker lengths shared across eukaryotes promote phase separation of chromatin, tune droplet properties, and coordinate to form condensates of consistent density in manners that parallel chromatin behavior in cells. Histone acetylation by p300 antagonizes chromatin phase separation, dissolving droplets in vitro and decreasing droplet formation in nuclei. In the presence of multi-bromodomain proteins, such as BRD4, highly acetylated chromatin forms a new phase-separated state with droplets of distinct physical properties, which can be immiscible with unmodified chromatin droplets, mimicking nuclear chromatin subdomains. Our data suggest a framework, based on intrinsic phase separation of the chromatin polymer, for understanding the organization and regulation of eukaryotic genomes.	[Gibson, Bryan A.; Doolittle, Lynda K.; Henry, Lisa; Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Gibson, Bryan A.; Doolittle, Lynda K.; Henry, Lisa; Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Schneider, Maximillian W. G.; Gerlich, Daniel W.] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Jensen, Liv E.; Gamarra, Nathan; Redding, Sy] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Jensen, Liv E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of California System; University of California San Francisco; University of California System; University of California Berkeley	Rosen, MK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu	Gamarra, Nathan/AAR-5024-2020; Gerlich, Daniel Wolfram W/A-6991-2016	Gamarra, Nathan/0000-0002-2430-8662; Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Schneider, Maximilian/0000-0001-7485-0460; Redding, Sy/0000-0003-3463-7985; Jensen, Liv/0000-0003-1492-1743	Howard Hughes Medical Institute; Paul G. Allen Frontiers Distinguished Investigator Award; NIH [F32GM129925]; Welch Foundation [I-1544]; European Research Council [281198]; Austrian Science Fund [SFB F34-06, DK W1238]; Wiener Wissenschafts-, Forschungsund Technologiefonds [LS14-009, LS17-003]; Boehringer Ingelheim Fonds PhD fellowship; UCSF Program for Breakthrough Biomedical Research (PBBR) by the Sandler Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM129925] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Paul G. Allen Frontiers Distinguished Investigator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Wiener Wissenschafts-, Forschungsund Technologiefonds; Boehringer Ingelheim Fonds PhD fellowship(Boehringer Ingelheim); UCSF Program for Breakthrough Biomedical Research (PBBR) by the Sandler Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Geeta Narlikar for advice and sharing unpublished results. Research was supported by the Howard Hughes Medical Institute, a Paul G. Allen Frontiers Distinguished Investigator Award (to M.K.R.), and grants from the NIH (F32GM129925 to B.A.G.), the Welch Foundation (I-1544 to M.K.R.), the European Research Council (281198 to D.W.G.), the Austrian Science Fund (SFB F34-06 and DK W1238 to D.W.G), the Wiener Wissenschafts-, Forschungsund Technologiefonds (LS14-009 and LS17-003 to D.W.G), a Boehringer Ingelheim Fonds PhD fellowship (to M.W.G.S.), and funding from the UCSF Program for Breakthrough Biomedical Research (PBBR) provided by the Sandler Foundation (to S.R.).	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Amendola M, 2015, EMBO REP, V16, P610, DOI 10.15252/embr.201439789; Balleza E, 2018, NAT METHODS, V15, P47, DOI [10.1038/NMETH.4509, 10.1038/nmeth.4509]; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bass MV, 2019, J BIOL CHEM, V294, P4233, DOI 10.1074/jbc.RA118.006412; Bednar J, 2017, MOL CELL, V66, P384, DOI 10.1016/j.molcel.2017.04.012; Bintu B, 2018, SCIENCE, V362, P419, DOI 10.1126/science.aau1783; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chen C, 2016, MOL BIOL CELL, V27, P3357, DOI 10.1091/mbc.E16-07-0506; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Cho WK, 2016, ELIFE, V5, DOI 10.7554/eLife.13617; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Colby R.H., 2003, POLYM PHYS; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Di Pierro M, 2016, P NATL ACAD SCI USA, V113, P12168, DOI 10.1073/pnas.1613607113; DUBOCHET J, 1986, EMBO J, V5, P519, DOI 10.1002/j.1460-2075.1986.tb04241.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Falk M, 2019, NATURE, V570, P395, DOI 10.1038/s41586-019-1275-3; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Fujisawa T, 2017, NAT REV MOL CELL BIO, V18, P246, DOI 10.1038/nrm.2016.143; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hergeth SP, 2015, EMBO REP, V16, P1439, DOI 10.15252/embr.201540749; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104029; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kundu S, 2017, MOL CELL, V65, P432, DOI 10.1016/j.molcel.2017.01.009; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; LOHR D, 1979, P NATL ACAD SCI USA, V76, P6326, DOI 10.1073/pnas.76.12.6326; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Maeshima K, 2016, CURR OPIN GENET DEV, V37, P36, DOI 10.1016/j.gde.2015.11.006; Maeshima K, 2016, EMBO J, V35, P1115, DOI 10.15252/embj.201592660; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Mirny LA, 2019, CURR OPIN CELL BIOL, V58, P142, DOI 10.1016/j.ceb.2019.05.001; Nikitina T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700957; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nozaki T, 2017, MOL CELL, V67, P282, DOI 10.1016/j.molcel.2017.06.018; Olins DE, 2003, NAT REV MOL CELL BIO, V4, P809, DOI 10.1038/nrm1225; Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plys AJ, 2019, GENE DEV, V33, P799, DOI 10.1101/gad.326488.119; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2009, R LANG ENV STAT COMP; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Turner AL, 2018, P NATL ACAD SCI USA, V115, P11964, DOI 10.1073/pnas.1805943115; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Voong LN, 2016, CELL, V167, P1555, DOI 10.1016/j.cell.2016.10.049; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; WIDOM J, 1986, J MOL BIOL, V190, P411, DOI 10.1016/0022-2836(86)90012-4; Williamson DJ, 2014, NAT PROTOC, V9, P253, DOI 10.1038/nprot.2014.003; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730	89	382	385	21	171	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2019	179	2					470	+		10.1016/j.cell.2019.08.037	http://dx.doi.org/10.1016/j.cell.2019.08.037			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JB7WL	31543265	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000488775900016
J	Hoegh-Guldberg, O; Northrop, E; Lubchenco, J				Hoegh-Guldberg, Ove; Northrop, Eliza; Lubchenco, Jane			The ocean is key to achieving climate and societal goals	SCIENCE			English	Editorial Material									[Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia; [Northrop, Eliza] World Resources Inst, Washington, DC 20006 USA; [Lubchenco, Jane] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA	University of Queensland; Oregon State University	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia.	oveh@uq.edu.au; enorthrop@wri.org; lubchenco@oregonstate.edu	Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713				[Anonymous], 2019, IPCC SPECIAL REPORT; Furre AK, 2017, ENRGY PROCED, V114, P3916, DOI 10.1016/j.egypro.2017.03.1523; Gaines SD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1378; Herr D., 2016, OPPORTUNITIES NATL D; Levin K., 2018, LONG TERM LOW GREENH; Lovelock CE, 2017, FRONT ECOL ENVIRON, V15, P257, DOI 10.1002/fee.1491; Lubchenco J, 2019, SCIENCE, V364, P911, DOI 10.1126/science.aay2241; Machado L, 2016, J APPL PHYCOL, V28, P1443, DOI 10.1007/s10811-015-0639-9; Masson-Delmotte V, 2018, GLOBAL WARMING OF 15; Portner H.-O., 2019, IPCC SPECIAL REPORT, DOI 10.1017/9781009157964.001; Roberts CM, 2017, P NATL ACAD SCI USA, V114, P6167, DOI 10.1073/pnas.1701262114; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; World Bank, 2017, SUNK BILL REV PROGR, P35; *WORLD RES I, 2018, CLIM WATCH	15	38	38	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2019	365	6460					1372	+		10.1126/science.aaz4390	http://dx.doi.org/10.1126/science.aaz4390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB8QM	31554733				2022-12-28	WOS:000488838600020
J	Kandel, YP; Qiao, HF; Fallahi, S; Gardner, GC; Manfra, MJ; Nichol, JM				Kandel, Yadav P.; Qiao, Haifeng; Fallahi, Saeed; Gardner, Geoffrey C.; Manfra, Michael J.; Nichol, John M.			Coherent spin-state transfer via Heisenberg exchange	NATURE			English	Article							QUANTUM COMPUTATION; DOTS	Quantum information science has the potential to revolutionize modern technology by providing resource-efficient approaches to computing(1), communication(2) and sensing(3). Although the physical qubits in a realistic quantum device will inevitably suffer errors, quantum error correction creates a path to fault-tolerant quantum information processing(4). Quantum error correction, however, requires that individual qubits can interact with many other qubits in the processor. Engineering such high connectivity can pose a challenge for platforms such as electron spin qubits(5), which naturally favour linear arrays. Here we present an experimental demonstration of the transmission of electron spin states via the Heisenberg exchange interaction in an array of spin qubits. Heisenberg exchange coupling-a direct manifestation of the Pauli exclusion principle, which prevents any two electrons with the same spin state from occupying the same orbital-tends to swap the spin states of neighbouring electrons. By precisely controlling the wavefunction overlap between electrons in a semiconductor quadruple quantum dot array, we generate a series of coherent SWAP operations to transfer both single-spin and entangled states back and forth in the array without moving any electrons. Because the process is scalable to large numbers of qubits, state transfer through Heisenberg exchange will be useful for multi-qubit gates and error correction in spin-based quantum computers.	[Kandel, Yadav P.; Qiao, Haifeng; Nichol, John M.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Fallahi, Saeed; Manfra, Michael J.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA; [Fallahi, Saeed; Gardner, Geoffrey C.; Manfra, Michael J.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Gardner, Geoffrey C.; Manfra, Michael J.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; [Manfra, Michael J.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA	University of Rochester; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nichol, JM (corresponding author), Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA.	jnich10@ur.rochester.edu	Qiao, Haifeng/HHC-4519-2022; Nichol, John/B-4565-2014	Kandel, Yadav Prasad/0000-0002-9673-4556; Nichol, John/0000-0003-2864-2243; Qiao, Haifeng/0000-0003-3198-800X	Defense Advanced Research Projects Agency [D18AC00025]; Army Research Office [W911NF-16-1-0260, W911NF-19-1-0167]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office	This work was sponsored the Defense Advanced Research Projects Agency under grant number D18AC00025 and the Army Research Office under grant numbers W911NF-16-1-0260 and W911NF-19-1-0167. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Office or the US Government. The US Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein.	Angus SJ, 2007, NANO LETT, V7, P2051, DOI 10.1021/nl070949k; Baart TA, 2016, NAT NANOTECHNOL, V11, P330, DOI [10.1038/NNANO.2015.291, 10.1038/nnano.2015.291]; Baart TA, 2017, NAT NANOTECHNOL, V12, P26, DOI [10.1038/NNANO.2016.188, 10.1038/nnano.2016.188]; Barthel C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.160503; Bertrand B, 2016, NAT NANOTECHNOL, V11, P672, DOI [10.1038/nnano.2016.82, 10.1038/NNANO.2016.82]; Bluhm H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.216803; Chan KW, 2018, PHYS REV APPL, V10, DOI 10.1103/PhysRevApplied.10.044017; Degen CL, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.035002; Ekert A, 1996, REV MOD PHYS, V68, P733, DOI 10.1103/RevModPhys.68.733; Flentje H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00534-3; Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; Fowler AG, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042314; Friesen M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230503; Fujita T, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0024-4; Gottesman D, 2000, J MOD OPTIC, V47, P333, DOI 10.1080/095003400148240; Greentree AD, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.041305; Huang W, 2019, NATURE, V569, P532, DOI 10.1038/s41586-019-1197-0; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Landig AJ, 2018, NATURE, V560, P179, DOI 10.1038/s41586-018-0365-y; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Malinowski FK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09194-x; Martins F, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.116801; Mi X, 2018, NATURE, V555, P599, DOI 10.1038/nature25769; Mortemousque P. A., 2018, PREPRINT; Muhonen JT, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/15/154205; Mukhopadhyay U, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5025928; Nakajima T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04544-7; Nichol JM, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-016-0003-1; Nichol JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8682; Orona LA, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.125404; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Samkharadze N, 2018, SCIENCE, V359, P1123, DOI 10.1126/science.aar4054; Shilton JM, 1996, J PHYS-CONDENS MAT, V8, pL531, DOI 10.1088/0953-8984/8/38/001; Shulman MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6156; Sigillito A. J., 2019, PREPRINT; Studenikin SA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4749281; Taylor JM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035315; Volk C, 2019, NPJ QUANTUM INFORM, V5, DOI 10.1038/s41534-019-0146-y; Wang X, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2003; Yoneda J, 2018, NAT NANOTECHNOL, V13, P102, DOI 10.1038/s41565-017-0014-x; Zajac DM, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.054013	48	50	50	4	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					553	+		10.1038/s41586-019-1566-8	http://dx.doi.org/10.1038/s41586-019-1566-8			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31554982	Green Submitted			2022-12-28	WOS:000488247600052
J	Dyer, C				Dyer, Clare			Ophthalmologist who misled patients about treatment benefits is struck off	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2019	366								l5648	10.1136/bmj.l5648	http://dx.doi.org/10.1136/bmj.l5648			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WD	31537535				2022-12-28	WOS:000487759400008
J	Huycke, TR; Miller, BM; Gill, HK; Nerurkar, NL; Sprinzak, D; Mahadevan, L; Tabin, CJ				Huycke, Tyler R.; Miller, Bess M.; Gill, Hasreet K.; Nerurkar, Nandan L.; Sprinzak, David; Mahadevan, L.; Tabin, Clifford J.			Genetic and Mechanical Regulation of Intestinal Smooth Muscle Development	CELL			English	Article							ENTERIC NERVOUS-SYSTEM; SONIC-HEDGEHOG; INTERSTITIAL-CELLS; SIGNALING PATHWAY; NEURAL-TUBE; DIFFERENTIATION; MORPHOGENESIS; GROWTH; NOGGIN; ROLES	The gastrointestinal tract is enveloped by concentric and orthogonally aligned layers of smooth muscle; however, an understanding of the mechanisms by which these muscles become patterned and aligned in the embryo has been lacking. We find that Hedgehog acts through Bmp to delineate the position of the circumferentially oriented inner muscle layer, whereas localized Bmp inhibition is critical for allowing formation of the later-forming, longitudinally oriented outer layer. Because the layers form at different developmental stages, the muscle cells are exposed to unique mechanical stimuli that direct their alignments. Differential growth within the early gut tube generates residual strains that orient the first layer circumferentially, and when formed, the spontaneous contractions of this layer align the second layer longitudinally. Our data link morphogen-based patterning to mechanically controlled smooth muscle cell alignment and provide a mechanistic context for potentially understanding smooth muscle organization in a wide variety of tubular organs.	[Huycke, Tyler R.; Gill, Hasreet K.; Tabin, Clifford J.] Harvard Med Sch, Blavatnik Inst, Dept Genet, Boston, MA 02115 USA; [Miller, Bess M.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Nerurkar, Nandan L.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Sprinzak, David] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, Tel Aviv, Israel; [Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Columbia University; Tel Aviv University; Harvard University; Harvard University; Harvard University; Harvard University	Tabin, CJ (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Huycke, Tyler/0000-0001-8328-5061; Miller, Bess/0000-0002-9868-5436	NIH [F31DK111059, R01HD087234]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD087234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK111059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Joe Patrice for providing excellent care for animals used in this study. We are additionally thankful to the members of the Tabin and Cepko labs, Maxwell Heiman, Olivier Pourquie, and David Breault, for thoughtful discussions of the work. We additionally thank the Microscopy Resources on the North Quad (MicRoN) core at Harvard Medical School. This work was funded by NIH F31DK111059 (to T.R.H.) and R01HD087234 (to C.J.T.).	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Aghajanian P, 2016, DEV BIOL, V420, P43, DOI 10.1016/j.ydbio.2016.10.011; Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Antebi YE, 2017, CELL, V170, P1184, DOI 10.1016/j.cell.2017.08.015; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Aw WY, 2016, CURR BIOL, V26, P2090, DOI 10.1016/j.cub.2016.06.030; Barbara PD, 2005, DEV DYNAM, V234, P312, DOI 10.1002/dvdy.20554; Barlow AJ, 2008, DEVELOPMENT, V135, P1681, DOI 10.1242/dev.017418; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bono N, 2016, BIOTECHNOL BIOENG, V113, P2254, DOI 10.1002/bit.25979; Brunet T, 2016, ELIFE, V5, DOI 10.7554/eLife.19607; BUCK RC, 1982, IN VITRO CELL DEV B, V18, P783, DOI 10.1007/BF02796502; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Chanet S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15014; Chanet S, 2014, PROG MOL BIOL TRANSL, V126, P317, DOI 10.1016/B978-0-12-394624-9.00013-0; Cheng W, 2008, J UROLOGY, V180, P1543, DOI 10.1016/j.juro.2008.06.003; Chevalier NR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172511; Chevalier NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20927; Chevalier NR, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0322; CLARK RB, 1958, J EXP BIOL, V35, P731; Coletta R, 2018, J TISSUE ENG REGEN M, V12, P252, DOI 10.1002/term.2409; Cotton JL, 2017, DEV CELL, V43, P35, DOI 10.1016/j.devcel.2017.08.019; COULOMBRE AJ, 1958, J EMBRYOL EXP MORPH, V6, P403; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Faust U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028963; Felsenthal N, 2017, DEVELOPMENT, V144, P4271, DOI 10.1242/dev.151266; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; FUNG YC, 1991, ANN BIOMED ENG, V19, P237, DOI 10.1007/BF02584301; Gabella G, 2002, RES PRO CEL, V38, P1; Gazzerro E, 2007, J BIOL CHEM, V282, P31549, DOI 10.1074/jbc.M701317200; Georgas KM, 2015, DEVELOPMENT, V142, P1893, DOI 10.1242/dev.117903; Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003; Greif DM, 2012, DEV CELL, V23, P482, DOI 10.1016/j.devcel.2012.07.009; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; HOUSTON B, 1994, J MOL ENDOCRINOL, V13, P289, DOI 10.1677/jme.0.0130289; Huang H, 2013, J BIOL CHEM, V288, P17589, DOI 10.1074/jbc.M113.467498; Kan A, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-4; KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605; Kanda K, 1992, ASAIO J, V38, pM382, DOI 10.1097/00002480-199207000-00060; KEDINGER M, 1990, DIFFERENTIATION, V43, P87, DOI 10.1111/j.1432-0436.1990.tb00434.x; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kishimoto K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05189-2; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lecoin L, 1996, DEVELOPMENT, V122, P725; Lewis AE, 2013, DEV BIOL, V379, P229, DOI 10.1016/j.ydbio.2013.04.026; Li A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07661-5; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Liu BC, 2010, INT J DEV BIOL, V54, P175, DOI 10.1387/ijdb.082610bl; Livne A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4938; Livshits A, 2017, CELL REP, V18, P1410, DOI 10.1016/j.celrep.2017.01.036; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; Mamo TM, 2017, HUM MOL GENET, V26, P3553, DOI 10.1093/hmg/ddx242; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MCHUGH KM, 1995, DEV DYNAM, V204, P278, DOI 10.1002/aja.1002040306; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy N, 2016, DEVELOPMENT, V143, P264, DOI 10.1242/dev.128132; Nam E, 2016, MACROMOL BIOSCI, V16, P995, DOI 10.1002/mabi.201600068; Nandadasa S, 2015, CELL REP, V11, P1519, DOI 10.1016/j.celrep.2015.05.005; Nerurkar NL, 2017, P NATL ACAD SCI USA, V114, P2277, DOI 10.1073/pnas.1700307114; Notarnicola C, 2012, GASTROENTEROLOGY, V143, P687, DOI 10.1053/j.gastro.2012.05.047; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rens EG, 2017, BIOPHYS J, V112, P755, DOI 10.1016/j.bpj.2016.12.012; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Roberts RR, 2010, J PHYSIOL-LONDON, V588, P1153, DOI 10.1113/jphysiol.2009.185421; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Safran SA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.060901; Sagnol S, 2014, NUCLEIC ACIDS RES, V42, P10173, DOI 10.1093/nar/gku692; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz T, 2003, NEUROGASTROENT MOTIL, V15, P129, DOI 10.1046/j.1365-2982.2003.00401.x; Scimone ML, 2017, NATURE, V551, P623, DOI 10.1038/nature24660; Seiler C, 2010, DEV DYNAM, V239, P2806, DOI 10.1002/dvdy.22420; Shyer AE, 2015, CELL, V161, P569, DOI 10.1016/j.cell.2015.03.041; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Smith DM, 2000, DEVELOPMENT, V127, P3671; Southwell BR, 2006, ANAT REC PART A, V288A, P909, DOI 10.1002/ar.a.20349; Stafford DA, 2011, DEVELOPMENT, V138, P1005, DOI 10.1242/dev.051938; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Streit A, 1998, DEVELOPMENT, V125, P507; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tamiello C, 2016, CELL MOL BIOENG, V9, P12, DOI 10.1007/s12195-015-0422-7; Tasian G, 2010, DIFFERENTIATION, V80, P106, DOI 10.1016/j.diff.2010.05.004; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; VANDENBURGH HH, 1989, IN VITRO CELL DEV B, V25, P607; Viana R, 2007, DEVELOPMENT, V134, P3763, DOI 10.1242/dev.011270; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wallace AS, 2005, CELL TISSUE RES, V319, P367, DOI 10.1007/s00441-004-1023-2; Walton KD, 2016, DEVELOPMENT, V143, P427, DOI 10.1242/dev.130112; Walton KD, 2012, P NATL ACAD SCI USA, V109, P15817, DOI 10.1073/pnas.1205669109; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Weidenhamer NK, 2013, TISSUE ENG PART C-ME, V19, P386, DOI [10.1089/ten.TEC.2012.0423, 10.1089/ten.tec.2012.0423]; Weitkunat M, 2017, DEVELOPMENT, V144, P1261, DOI 10.1242/dev.140723; Yin WG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05043-5; Yu J, 2002, DEVELOPMENT, V129, P5301; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025	116	49	50	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					90	+		10.1016/j.cell.2019.08.041	http://dx.doi.org/10.1016/j.cell.2019.08.041			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539501	Green Accepted, Bronze			2022-12-28	WOS:000486618500016
J	Luteijn, RD; Zaver, SA; Gowen, BG; Wyman, SK; Garelis, NE; Onia, L; McWhirter, SM; Katibah, GE; Corn, JE; Woodward, JJ; Raulet, DH				Luteijn, Rutger D.; Zaver, Shivam A.; Gowen, Benjamin G.; Wyman, Stacia K.; Garelis, Nick E.; Onia, Liberty; McWhirter, Sarah M.; Katibah, George E.; Corn, Jacob E.; Woodward, Joshua J.; Raulet, David H.			SLC19A1 transports immunoreactive cyclic dinucleotides	NATURE			English	Article							REDUCED FOLATE CARRIER; C-DI-AMP; INTERFERON REGULATORY FACTOR-3; NF-KAPPA-B; MEMBRANE-TRANSPORT; DIRECT ACTIVATION; L1210 LEUKEMIA; STING PATHWAY; DNA SENSOR; METHOTREXATE	The accumulation of DNA in the cytosol serves as a key immunostimulatory signal associated with infections, cancer and genomic damage(1,2). Cytosolic DNA triggers immune responses by activating the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway(3). The binding of DNA to cGAS activates its enzymatic activity, leading to the synthesis of a second messenger, cyclic guanosine monophosphate-adenosine monophosphate (2'3'-cGAMP)(4-7). This cyclic dinucleotide (CDN) activates STING(8), which in turn activates the transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B), promoting the transcription of genes encoding type I interferons and other cytokines and mediators that stimulate a broader immune response. Exogenous 2'3'-cGAMP produced by malignant cells(9) and other CDNs, including those produced by bacteria(10-12) and synthetic CDNs used in cancer immunotherapy(13,14), must traverse the cell membrane to activate STING in target cells. How these charged CDNs pass through the lipid bilayer is unknown. Here we used a genome-wide CRISPR-interference screen to identify the reduced folate carrier SLC19A1, a folate-organic phosphate antiporter, as the major transporter of CDNs. Depleting SLC19A1 in human cells inhibits CDN uptake and functional responses, and overexpressing SLC19A1 increases both uptake and functional responses. In human cell lines and primary cells ex vivo, CDN uptake is inhibited by folates as well as two medications approved for treatment of inflammatory diseases, sulfasalazine and the antifolate methotrexate. The identification of SLC19A1 as the major transporter of CDNs into cells has implications for the immunotherapeutic treatment of cancer(13), host responsiveness to CDN-producing pathogenic microorganisms(11) and-potentially-for some inflammatory diseases.	[Luteijn, Rutger D.; Gowen, Benjamin G.; Garelis, Nick E.; Onia, Liberty; Corn, Jacob E.; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Luteijn, Rutger D.; Garelis, Nick E.; Onia, Liberty; Raulet, David H.] Univ Calif Berkeley, Canc Res Lab, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Zaver, Shivam A.; Woodward, Joshua J.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Gowen, Benjamin G.; Wyman, Stacia K.; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [McWhirter, Sarah M.; Katibah, George E.] Aduro Biotech, Berkeley, CA USA; [Corn, Jacob E.] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Raulet, DH (corresponding author), Univ Calif Berkeley, Canc Res Lab, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA.	raulet@berkeley.edu		Luteijn, Rutger/0000-0002-6183-4573; Zaver, Shivam/0000-0001-5254-0963	Cancer Research Institute; NIH S10 Instrumentation [S10 OD018174, S10RR029668, S10RR027303]; Pew Scholars Program in the Biomedical Sciences; Lupus Research Alliance [1R21AI137758-01]; University of Washington/Fred Hutchinson Cancer Research Center Viral Pathogenesis Training Program [AI083203]; University of Washington Medical Scientist Training Program [GM007266]; Seattle ARCS foundation; National Institute of Health New Innovator Awards [DP2 HL141006]; Li Ka Shing Foundation; Heritage Medical Research Institute; NIH [R01-AI113041, R01-CA093678]; IGI-AstraZeneca Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA093678] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL141006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083203, R01AI113041, R21AI137758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	Cancer Research Institute; NIH S10 Instrumentation; Pew Scholars Program in the Biomedical Sciences; Lupus Research Alliance; University of Washington/Fred Hutchinson Cancer Research Center Viral Pathogenesis Training Program; University of Washington Medical Scientist Training Program; Seattle ARCS foundation; National Institute of Health New Innovator Awards; Li Ka Shing Foundation; Heritage Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IGI-AstraZeneca Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Zhang and E. Seidel for laboratory and technical assistance, H. Nolla and A. Valeros for assistance with cell sorting, the UC Berkeley High Throughput Screening Facility for preparation of gRNA lentivirus, A. P. McFarland for assistance in the isolation of primary cells from mice, S. L. McDevitt for assistance with deep sequencing, J. An and K. Elkon for assistance in the collection and isolation of primary peripheral blood leukocytes from healthy, human volunteers, and Raulet laboratory members, R. Vance, M. DuPage, M. van Gent, J. Thorner and A. van Elsas for helpful discussions. R.D.L. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. D.H.R. is supported by NIH grants R01-AI113041 and R01-CA093678. B.G.G. is supported by the IGI-AstraZeneca Postdoctoral Fellowship, J.J.W. is supported by the Pew Scholars Program in the Biomedical Sciences, the Lupus Research Alliance and NIH grant 1R21AI137758-01. S.A.Z. is supported by grants from the University of Washington/Fred Hutchinson Cancer Research Center Viral Pathogenesis Training Program (AI083203), the University of Washington Medical Scientist Training Program (GM007266) and the Seattle ARCS foundation. J.E.C. is supported by the National Institute of Health New Innovator Awards (DP2 HL141006), the Li Ka Shing Foundation and the Heritage Medical Research Institute. This work employed the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants S10 OD018174, S10RR029668 and S10RR027303.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Corrales L, 2016, J CLIN INVEST, V126, P2404, DOI 10.1172/JCI86892; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; GOLDMAN ID, 1971, BIOCHIM BIOPHYS ACTA, V233, P624, DOI 10.1016/0005-2736(71)90162-3; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400; Hamblett KJ, 2015, CANCER RES, V75, P5329, DOI 10.1158/0008-5472.CAN-15-1610; HENDERSON GB, 1981, BIOCHEM BIOPH RES CO, V99, P163, DOI 10.1016/0006-291X(81)91727-7; HENDERSON GB, 1984, J BIOL CHEM, V259, P4558; HENDERSON GB, 1980, ARCH BIOCHEM BIOPHYS, V202, P144, DOI 10.1016/0003-9861(80)90416-6; HENDERSON GB, 1983, ARCH BIOCHEM BIOPHYS, V221, P438, DOI 10.1016/0003-9861(83)90162-5; Horlbeck M. A., 2016, ELIFE, V5, P1; Hou ZJ, 2014, CURR TOP MEMBR, V73, P175, DOI 10.1016/B978-0-12-800223-0.00004-9; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jansen G, 2004, ARTHRITIS RHEUM-US, V50, P2130, DOI 10.1002/art.20375; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kato K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06922-7; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Lin RT, 1999, MOL CELL BIOL, V19, P959; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; McFarland AP, 2017, IMMUNITY, V46, P433, DOI 10.1016/j.immuni.2017.02.014; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Plosker GL, 2005, DRUGS, V65, P1825, DOI 10.2165/00003495-200565130-00008; Rajitha P, 2017, CURR PHARM DESIGN, V23, P3550, DOI 10.2174/1381612823666170601105439; Sadlish H, 2002, J BIOL CHEM, V277, P42105, DOI 10.1074/jbc.M206459200; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; van de Weijer ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4832; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; Visentin M, 2012, MOL PHARMACOL, V82, P209, DOI 10.1124/mol.112.078642; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; YANG CH, 1984, J MEMBRANE BIOL, V79, P285, DOI 10.1007/BF01871067; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001; Zhao RB, 2001, J BIOL CHEM, V276, P1114, DOI 10.1074/jbc.M007919200; Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133	46	132	136	3	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					434	+		10.1038/s41586-019-1553-0	http://dx.doi.org/10.1038/s41586-019-1553-0			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31511694	Green Accepted, Green Submitted			2022-12-28	WOS:000486647800054
J	MacFerrin, M; Machguth, H; van As, D; Charalampidis, C; Stevens, CM; Heilig, A; Vandecrux, B; Langen, PL; Mottram, R; Fettweis, X; van den Broeke, MR; Pfeffer, WT; Moussavi, MS; Abdalati, W				MacFerrin, M.; Machguth, H.; van As, D.; Charalampidis, C.; Stevens, C. M.; Heilig, A.; Vandecrux, B.; Langen, P. L.; Mottram, R.; Fettweis, X.; van den Broeke, M. R.; Pfeffer, W. T.; Moussavi, M. S.; Abdalati, W.			Rapid expansion of Greenland's low-permeability ice slabs	NATURE			English	Article							LOWER ACCUMULATION AREA; MELTWATER STORAGE; SHEET; FIRN; VARIABILITY; PERCOLATION; RETENTION; RUNOFF; MODEL; WATER	In recent decades, meltwater runoff has accelerated to become the dominant mechanism for mass loss in the Greenland ice sheet(1-3). In Greenland's high-elevation interior, porous snow and firn accumulate; these can absorb surface meltwater and inhibit runoff(4), but this buffering effect is limited if enough water refreezes near the surface to restrict percolation(5,6). However, the influence of refreezing on runoff from Greenland remains largely unquantified. Here we use firn cores, radar observations and regional climate models to show that recent increases in meltwater have resulted in the formation of metres-thick, low-permeability 'ice slabs' that have expanded the Greenland ice sheet's total runoff area by 26 +/- 3 per cent since 2001. Although runoff from the top of ice slabs has added less than one millimetre to global sea-level rise so far, this contribution will grow substantially as ice slabs expand inland in a warming climate. Runoff over ice slabs is set to contribute 7 to 33 millimetres and 17 to 74 millimetres to global sea-level rise by 2100 under moderate-and high-emissions scenarios, respectively-approximately double the estimated runoff from Greenland's high-elevation interior, as predicted by surface mass balance models without ice slabs. Ice slabs will have an important role in enhancing surface meltwater feedback processes, fundamentally altering the ice sheet's present and future hydrology.	[MacFerrin, M.; Moussavi, M. S.; Abdalati, W.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Machguth, H.] Univ Fribourg, Dept Geosci, Fribourg, Switzerland; [Machguth, H.] Univ Zurich, Dept Geog, Zurich, Switzerland; [van As, D.; Vandecrux, B.] Geol Survey Denmark & Greenland, Copenhagen, Denmark; [Charalampidis, C.] Bavarian Acad Sci & Humanities, Munich, Germany; [Stevens, C. M.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Heilig, A.] WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland; [Heilig, A.] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Munich, Germany; [Heilig, A.] Alfred Wegener Inst Helmholtz, Ctr Polar & Marine, Bremerhaven, Germany; [Heilig, A.] Tech Univ Denmark, Dept Civil Engn, Lyngby, Denmark; [Vandecrux, B.] Danish Meteorol Inst, Copenhagen, Denmark; [Langen, P. L.; Mottram, R.] Univ Liege, Dept Geog, Liege, Belgium; [Fettweis, X.] Univ Utrecht, Inst Marine & Atmospher Res, Utrecht, Netherlands; [van den Broeke, M. R.] Univ Colorado, Dept Civil Engn, Boulder, CO 80309 USA; [Pfeffer, W. T.; Moussavi, M. S.] Univ Colorado, Natl Snow & Ice Data Ctr, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; University of Fribourg; University of Zurich; Geological Survey Of Denmark & Greenland; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Munich; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Technical University of Denmark; Danish Meteorological Institute DMI; University of Liege; Utrecht University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	MacFerrin, M (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	michael.macferrin@colorado.edu	Van den Broeke, Michiel R./F-7867-2011; Charalampidis, Charalampos/O-2939-2015; Langen, Peter L/AAR-1120-2021; Vandecrux, Baptiste/ABD-6079-2020; MacFerrin, Michael/A-5794-2018	Van den Broeke, Michiel R./0000-0003-4662-7565; Charalampidis, Charalampos/0000-0003-0853-697X; Langen, Peter L/0000-0003-2185-012X; Vandecrux, Baptiste/0000-0002-4169-8973; Machguth, Horst/0000-0001-5924-0998; MacFerrin, Michael/0000-0001-8157-7159; Fettweis, Xavier/0000-0002-4140-3813	National Aeronautics and Space Administration (NASA) [NNX10AR76G, NNX15AC62G]; Retain project - Danish Council for Independent Research [4002-00234]; European Research Council under the European Union [610055]	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Retain project - Danish Council for Independent Research; European Research Council under the European Union(European Research Council (ERC))	We acknowledge National Aeronautics and Space Administration (NASA) awards NNX10AR76G and NNX15AC62G for funding most of the work, including field campaigns. This work was also supported by the Retain project, funded by the Danish Council for Independent Research (grant number 4002-00234). Research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 610055 as part of the ice2ice project. We thank the field team members for their contributions to field data collection in 2012-2017.	Benson C.S., 1962, 70 SIPRE US ARM SNOW; Bentsen M, 2013, GEOSCI MODEL DEV, V6, P687, DOI 10.5194/gmd-6-687-2013; Bevis M, 2019, P NATL ACAD SCI USA, V116, P1934, DOI 10.1073/pnas.1806562116; BRAITHWAITE RJ, 1994, J GLACIOL, V40, P477, DOI 10.3189/S002214300001234X; Brown J, 2011, ANN GLACIOL, V52, P35, DOI 10.3189/172756411799096286; Charalampidis C, 2015, CRYOSPHERE, V9, P2163, DOI 10.5194/tc-9-2163-2015; Christensen OB, 2007, HIRHAM REGIONAL CLIM; Chylek P., 2011, ATMOS CHEM PHYS DISC, V11, P22893, DOI 10.5194/acpd-11-22893-2011; Collins W.J., 2008, 74 HCTN MET OFF HADL, DOI DOI 10.1088/1748-9326/8/2/024024; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Doyle SH, 2015, NAT GEOSCI, V8, P647, DOI [10.1038/ngeo2482, 10.1038/NGEO2482]; Doyle SH, 2014, GEOPHYS RES LETT, V41, P899, DOI 10.1002/2013GL058933; Fettweis X, 2017, CRYOSPHERE, V11, P1015, DOI 10.5194/tc-11-1015-2017; Fitzpatrick AAW, 2014, CRYOSPHERE, V8, P107, DOI 10.5194/tc-8-107-2014; Forster RR, 2014, NAT GEOSCI, V7, P95, DOI [10.1038/ngeo2043, 10.1038/NGEO2043]; Hanna E, 2018, CRYOSPHERE, V12, P3287, DOI 10.5194/tc-12-3287-2018; Harper J, 2012, NATURE, V491, P240, DOI 10.1038/nature11566; Hazeleger W, 2010, B AM METEOROL SOC, V91, P1357, DOI 10.1175/2010BAMS2877.1; Heilig A, 2018, CRYOSPHERE, V12, P1851, DOI 10.5194/tc-12-1851-2018; Howat IM, 2014, CRYOSPHERE, V8, P1509, DOI 10.5194/tc-8-1509-2014; Humphrey NF, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002083; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Koenig LS, 2015, CRYOSPHERE, V9, P1333, DOI 10.5194/tc-9-1333-2015; Langen PL, 2017, FRONT EARTH SC-SWITZ, V4, DOI 10.3389/feart.2016.00110; Leuschen C., 2014, ICEBRIDGE ACCUMULATI; MacGregor JA, 2016, J GEOPHYS RES-EARTH, V121, P1328, DOI 10.1002/2015JF003803; Machguth H, 2016, NAT CLIM CHANGE, V6, P390, DOI [10.1038/nclimate2899, 10.1038/NCLIMATE2899]; Miege C, 2016, J GEOPHYS RES-EARTH, V121, P2381, DOI 10.1002/2016JF003869; Mikkelsen AB, 2016, CRYOSPHERE, V10, P1147, DOI 10.5194/tc-10-1147-2016; Montgomery L, 2018, EARTH SYST SCI DATA, V10, P1959, DOI 10.5194/essd-10-1959-2018; Mottram R, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11121407; Munneke PK, 2014, GEOPHYS RES LETT, V41, P476, DOI 10.1002/2013GL058389; Nghiem SV, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053611; PFEFFER WT, 1991, J GEOPHYS RES-OCEANS, V96, P22117, DOI 10.1029/91JC02502; Phillips T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044397; Poinar K, 2015, GEOPHYS RES LETT, V42, P1800, DOI 10.1002/2015GL063192; Porter C., 2018, **DATA OBJECT**, DOI 10.7910/DVN/OHHUKH; Rennermalm AK, 2013, CRYOSPHERE, V7, P1433, DOI 10.5194/tc-7-1433-2013; Sommers AN, 2017, FRONT EARTH SC-SWITZ, V5, DOI 10.3389/feart.2017.00020; Tedesco M, 2013, CRYOSPHERE, V7, P615, DOI 10.5194/tc-7-615-2013; Trusel LD, 2018, NATURE, V564, P104, DOI 10.1038/s41586-018-0752-4; van As D, 2018, ARCT ANTARCT ALP RES, V50, DOI 10.1080/15230430.2018.1433799; van As D, 2017, CRYOSPHERE, V11, P1371, DOI 10.5194/tc-11-1371-2017; van den Broeke MR, 2016, CRYOSPHERE, V10, P1933, DOI 10.5194/tc-10-1933-2016; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1	46	53	54	3	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					403	+		10.1038/s41586-019-1550-3	http://dx.doi.org/10.1038/s41586-019-1550-3			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31534244	Green Submitted			2022-12-28	WOS:000486647800047
J	Ng, NBH; Yeo, WS				Ng, Nicholas Beng-Hui; Yeo, Wee-Song			An extensive perioral rash	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ng, Nicholas Beng-Hui; Yeo, Wee-Song] Khoo Teck Puat Natl Univ, Dept Paediat, Childrens Med Inst, Singapore, Singapore		Ng, NBH (corresponding author), Khoo Teck Puat Natl Univ, Dept Paediat, Childrens Med Inst, Singapore, Singapore.	nicholas_bh_ng@nuhs.edu.sg	Ng, Nicholas Beng Hui/AAN-8509-2021	Ng, Nicholas Beng Hui/0000-0002-7948-8891				Amir J, 1999, PEDIATR DERMATOL, V16, P259, DOI 10.1046/j.1525-1470.1999.00072.x; Kimberlin DW, 2005, PEDIATR CLIN N AM, V52, P837, DOI 10.1016/j.pcl.2005.02.006; Kolokotronis A, 2006, CLIN MICROBIOL INFEC, V12, P202, DOI 10.1111/j.1469-0691.2005.01336.x; Long S, PRINCIPLES PRACTICE	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2019	366								l5014	10.1136/bmj.l5014	http://dx.doi.org/10.1136/bmj.l5014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WD	31537536				2022-12-28	WOS:000487759400001
J	Bereczky, T				Bereczky, Tamas			U=U is a blessing: but only for patients with access to HIV treatment: an essay by Tamas Bereczky	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bereczky, Tamas] European Patients Acad Therapeut Innovat, Berlin, Germany		Bereczky, T (corresponding author), European Patients Acad Therapeut Innovat, Berlin, Germany.	tamas@eupati.eu	Bereczky, Tamás/AGX-0476-2022					Adams N, 2019, 25 ANN C BRIT HIV AS; Androulaki I., 2017, CNN GREECE       MAR; Cairns G., 2019, UNDETECTABLE VIRAL L; Calabrese SK, 2019, LANCET HIV, V6, pE211, DOI 10.1016/S2352-3018(19)30030-X; Centers for Disease Control and Prevention, 2019, EFF PREV STRAT RED R; Gokengin D, 2018, INT J INFECT DIS, V70, P121, DOI 10.1016/j.ijid.2018.03.007; Harm Reduction International, 2018, GLOB OV NUMB; Human Rights Watch, 2019, RUSS NEW WAV ANTILGB; International Treatment Preparedness Coalition Eastern Europe and Central Asia, 2019, AN PROC ARV DRUGS RU; Jouquet G, 2016, EC EVALUATION VIRAL; Rettman A., 2018, EU OBSERVER; Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0; Santora M., 2019, NY TIMES; Takacs J, 2013, SEX RES SOC POLICY, V10, P24, DOI 10.1007/s13178-012-0102-5; Takacs J., 2018, J INT WOMENS STUDIES, V20, P68; Vourli G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207355	16	4	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5554	10.1136/bmj.l5554	http://dx.doi.org/10.1136/bmj.l5554			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530547				2022-12-28	WOS:000487758600006
J	Kuehn, B				Kuehn, Bridget			Multidrug-Resistant Malaria Expands its Reach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1035	1035		10.1001/jama.2019.13075	http://dx.doi.org/10.1001/jama.2019.13075			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31529013				2022-12-28	WOS:000488821100004
J	Sancar, F				Sancar, Feyza			First Generics of Pregabalin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1036	1036		10.1001/jama.2019.14151	http://dx.doi.org/10.1001/jama.2019.14151			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31528993				2022-12-28	WOS:000488821100007
J	Mahase, E				Mahase, Elisabeth			Caring for migrant populations in general practice: five minutes with... Jessica Carter	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l5577	10.1136/bmj.l5577	http://dx.doi.org/10.1136/bmj.l5577			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VP	31527171				2022-12-28	WOS:000487758000010
J	Hagedorn, F; Gavazov, K; Alexander, JM				Hagedorn, Frank; Gavazov, Konstantin; Alexander, Jake M.			Above- and belowground linkages shape responses of mountain vegetation to climate change	SCIENCE			English	Review							SOIL CARBON LOSS; ELEVATION GRADIENT; COMMUNITY COMPOSITION; MICROBIAL DIVERSITY; PLANT-COMMUNITIES; GRASSLAND SOILS; CO2 ENRICHMENT; TREE-LINE; FOREST; SHIFTS	Upward shifts of mountain vegetation lag behind rates of climate warming, partly related to interconnected changes belowground. Here, we unravel above- and belowground linkages by drawing insights from short-term experimental manipulations and elevation gradient studies. Soils will likely gain carbon in early successional ecosystems, while losing carbon as forest expands upward, and the slow, high-elevation soil development will constrain warming-induced vegetation shifts. Current approaches fail to predict the pace of these changes and how much they will be modified by interactions among plants and soil biota. Integrating mountain soils and their biota into monitoring programs, combined with innovative comparative and experimental approaches, will be crucial to overcome the paucity of belowground data and to better understand mountain ecosystem dynamics and their feedbacks to climate.	[Hagedorn, Frank; Gavazov, Konstantin] Swiss Fed Inst Forest Snow & Landscape Res WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland; [Alexander, Jake M.] Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hagedorn, F (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland.	frank.hagedorn@wsl.ch	Gavazov, Konstantin/E-9628-2013; Alexander, Jake/P-2580-2014	Gavazov, Konstantin/0000-0003-4479-7202; Alexander, Jake/0000-0003-2226-7913; Hagedorn, Frank/0000-0001-5218-7776	Swiss National Science Foundation [171171, PZ00P2_174047, 31003A_176044]; European Union's Horizon 2020 research and innovation program [678841]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union's Horizon 2020 research and innovation program	F.H. received funding from the Swiss National Science Foundation (grant no. 171171); K.G. was supported by funding from the Swiss National Science Foundation (grant no. PZ00P2_174047); and J.M.A. received funding from the European Union's Horizon 2020 research and innovation program (grant no. 678841) and from the Swiss National Science Foundation (grant no. 31003A_176044).	Adamczyk B, 2019, NEW PHYTOL, V223, P16, DOI 10.1111/nph.15729; Adamczyk M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01080; Alexander JM, 2018, GLOBAL CHANGE BIOL, V24, P563, DOI 10.1111/gcb.13976; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Anadon-Rosell A, 2018, SCI TOTAL ENVIRON, V642, P1172, DOI 10.1016/j.scitotenv.2018.06.117; Bahram M, 2018, NATURE, V560, P233, DOI 10.1038/s41586-018-0386-6; Baldos AP, 2015, ECOLOGY, V96, P749, DOI 10.1890/14-0295.1; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Bassin S, 2013, ECOSYSTEMS, V16, P1105, DOI 10.1007/s10021-013-9670-3; Bonpland A., 1801, ESSAI GEOGRAPHIE PLA, V1805, DOI [10.3931/e-rara-24316, DOI 10.3931/E-RARA-24316]; Bradford MA, 2016, NAT CLIM CHANGE, V6, P751, DOI [10.1038/nclimate3071, 10.1038/NCLIMATE3071]; Brown CD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1779; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Budge K, 2011, BIOGEOSCIENCES, V8, P1911, DOI 10.5194/bg-8-1911-2011; Cardinaux A, 2018, J ECOL, V106, P1853, DOI 10.1111/1365-2745.13029; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Clemmensen KE, 2006, NEW PHYTOL, V171, P391, DOI 10.1111/j.1469-8137.2006.01778.x; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Dawes MA, 2017, J ECOL, V105, P1723, DOI 10.1111/1365-2745.12780; Dawes MA, 2017, GLOBAL CHANGE BIOL, V23, P421, DOI 10.1111/gcb.13365; Dawes MA, 2015, GLOBAL CHANGE BIOL, V21, P2005, DOI 10.1111/gcb.12819; de Mesquita CPB, 2018, FUNGAL ECOL, V36, P63, DOI 10.1016/j.funeco.2018.07.009; Devi SB, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7470-8; Djukic I, 2010, SOIL BIOL BIOCHEM, V42, P155, DOI 10.1016/j.soilbio.2009.10.006; Doetterl S, 2015, NAT GEOSCI, V8, P780, DOI [10.1038/NGEO2516, 10.1038/ngeo2516]; Dolezal J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24881; Donhauser J, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy099; Elmendorf SC, 2015, P NATL ACAD SCI USA, V112, P448, DOI 10.1073/pnas.1410088112; Fajardo A, 2017, J ECOL, V105, P517, DOI 10.1111/1365-2745.12697; Ferrari A, 2016, OECOLOGIA, V181, P25, DOI 10.1007/s00442-015-3427-y; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Fisher JB, 2013, OECOLOGIA, V172, P889, DOI 10.1007/s00442-012-2522-6; Gavazov K, 2016, OECOLOGIA, V180, P257, DOI 10.1007/s00442-015-3458-4; Gosheva S, 2017, ECOSYSTEMS, V20, P1512, DOI 10.1007/s10021-017-0129-9; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Harte J, 2015, GLOBAL CHANGE BIOL, V21, P2349, DOI 10.1111/gcb.12831; Heer C, 2002, BASIC APPL ECOL, V3, P39, DOI 10.1078/1439-1791-00075; Hendershot JN, 2017, ECOLOGY, V98, P1757, DOI 10.1002/ecy.1829; Henne PD, 2011, J BIOGEOGR, V38, P933, DOI 10.1111/j.1365-2699.2010.02460.x; HilleRisLambers J, 2013, ANN NY ACAD SCI, V1297, P112, DOI 10.1111/nyas.12182; Hobbie SE, 2015, TRENDS ECOL EVOL, V30, P357, DOI 10.1016/j.tree.2015.03.015; Kaarlejarvi E, 2013, FUNCT ECOL, V27, P1244, DOI 10.1111/1365-2435.12113; Kammer A, 2009, GLOBAL CHANGE BIOL, V15, P1570, DOI 10.1111/j.1365-2486.2009.01856.x; Kivlin SN, 2017, DIVERS DISTRIB, V23, P1067, DOI 10.1111/ddi.12595; Klanderud K, 2008, J VEG SCI, V19, P363, DOI 10.3170/2008-8-18376; Knowles JF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09149-2; Kolb E, 2018, APPL SOIL ECOL, V123, P622, DOI 10.1016/j.apsoil.2017.09.040; Korner C., 2003, ALPINE PLANT LIFE, P344, DOI [10.1007/978-3-642-18970-8, DOI 10.1007/978-3-642-18970-8]; Korner C, 2016, ALPINE BOT, V126, P153, DOI 10.1007/s00035-016-0170-x; Kramer MG, 2016, ECOLOGY, V97, P2384, DOI 10.1002/ecy.1467; Kueppers LM, 2017, GLOBAL CHANGE BIOL, V23, P2383, DOI 10.1111/gcb.13561; Kulonen A, 2018, DIVERS DISTRIB, V24, P252, DOI 10.1111/ddi.12673; Leifeld J, 2009, GLOBAL CHANGE BIOL, V15, P668, DOI 10.1111/j.1365-2486.2008.01782.x; Liang EY, 2016, P NATL ACAD SCI USA, V113, P4380, DOI 10.1073/pnas.1520582113; Lim H, 2019, NAT CLIM CHANGE, V9, P49, DOI 10.1038/s41558-018-0373-9; Liu FT, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aae43b; Lyu LX, 2019, DENDROCHRONOLOGIA, V53, P40, DOI 10.1016/j.dendro.2018.11.006; Majdi H, 2004, GLOBAL CHANGE BIOL, V10, P182, DOI 10.1111/j.1365-2486.2004.00733.x; Mayor JR, 2017, NATURE, V542, P91, DOI 10.1038/nature21027; Melillo JM, 2017, SCIENCE, V358, P101, DOI 10.1126/science.aan2874; Melillo JM, 2011, P NATL ACAD SCI USA, V108, P9508, DOI 10.1073/pnas.1018189108; Mohl P, 2019, J ECOL, V107, P768, DOI 10.1111/1365-2745.13073; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Moret P, 2019, P NATL ACAD SCI USA, V116, P12889, DOI 10.1073/pnas.1904585116; Moser G, 2011, GLOBAL CHANGE BIOL, V17, P2211, DOI 10.1111/j.1365-2486.2010.02367.x; Moyes AB, 2013, BIOGEOCHEMISTRY, V113, P683, DOI 10.1007/s10533-012-9797-x; Myers-Smith IH, 2018, J ECOL, V106, P547, DOI 10.1111/1365-2745.12817; Nottingham AT, 2015, BIOSCIENCE, V65, P906, DOI 10.1093/biosci/biv109; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Parker TC, 2015, GLOBAL CHANGE BIOL, V21, P2070, DOI 10.1111/gcb.12793; Paulsen J, 2014, ALPINE BOT, V124, P1, DOI 10.1007/s00035-014-0124-0; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; Pepin N., 2003, ALPINE PLANT LIFE, DOI [10.1007/978-3-642-18970-8, DOI 10.1007/978-3-642-18970-8]; Poeplau C, 2011, GLOBAL CHANGE BIOL, V17, P2415, DOI 10.1111/j.1365-2486.2011.02408.x; Porazinska DL, 2018, ECOLOGY, V99, P1942, DOI 10.1002/ecy.2420; Rumpf SB, 2018, P NATL ACAD SCI USA, V115, P1848, DOI 10.1073/pnas.1713936115; Schindlbacher A, 2015, GLOBAL CHANGE BIOL, V21, P4265, DOI 10.1111/gcb.12996; Shen CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01184; Smittenberg RH, 2012, GLOBAL CHANGE BIOL, V18, P1941, DOI 10.1111/j.1365-2486.2012.02654.x; Solly EF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05460-6; Solly EF, 2017, NEW PHYTOL, V215, P766, DOI 10.1111/nph.14603; Solly EF, 2017, OECOLOGIA, V183, P571, DOI 10.1007/s00442-016-3785-0; Speed JDM, 2015, BIOGEOSCIENCES, V12, P1615, DOI 10.5194/bg-12-1615-2015; Steinbauer MJ, 2018, NATURE, V556, P231, DOI 10.1038/s41586-018-0005-6; Streit K, 2014, GLOBAL CHANGE BIOL, V20, P1327, DOI 10.1111/gcb.12396; SVEINBJORNSSON B, 1992, FUNCT ECOL, V6, P213, DOI 10.2307/2389757; Thebault A, 2014, OIKOS, V123, P729, DOI 10.1111/j.1600-0706.2013.00860.x; Vaisanen M, 2014, NAT CLIM CHANGE, V4, P384, DOI [10.1038/nclimate2147, 10.1038/NCLIMATE2147]; van der Putten WH, 2016, FUNCT ECOL, V30, P1109, DOI 10.1111/1365-2435.12657; van Gestel N, 2018, NATURE, V554, pE4, DOI 10.1038/nature25745; Wackett AA, 2018, BIOL INVASIONS, V20, P1377, DOI 10.1007/s10530-017-1642-7; Walker TWN, 2018, NAT CLIM CHANGE, V8, P885, DOI 10.1038/s41558-018-0259-x; Wang LX, 2017, EUR J FOREST RES, V136, P881, DOI 10.1007/s10342-017-1076-x; Weedon JT, 2012, GLOBAL CHANGE BIOL, V18, P138, DOI 10.1111/j.1365-2486.2011.02548.x; Wu ZT, 2012, NAT CLIM CHANGE, V2, P458, DOI 10.1038/NCLIMATE1486; Yang Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00423; Zak DR, 2019, NEW PHYTOL, V223, P33, DOI 10.1111/nph.15679; Zhang SH, 2012, BIOL FERT SOILS, V48, P393, DOI 10.1007/s00374-011-0634-5; Zimmermann M, 2012, BIOGEOCHEMISTRY, V107, P423, DOI 10.1007/s10533-010-9562-y	100	69	74	39	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1119	+		10.1126/science.aax4737	http://dx.doi.org/10.1126/science.aax4737			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515385	Green Accepted			2022-12-28	WOS:000485780800038
J	Heywood, I; Camilo, F; Cotton, WD; Yusef-Zadeh, F; Abbott, TD; Adam, RM; Aldera, MA; Bauermeister, EF; Booth, RS; Botha, AG; Botha, DH; Brederode, LRS; Brits, ZB; Buchner, SJ; Burger, JP; Chalmers, JM; Cheetham, T; de Villiers, D; Dikgale-Mahlakoana, MA; du Toit, LJ; Esterhuyse, SWP; Fanaroff, BL; Foley, AR; Fourie, DJ; Gamatham, RRG; Goedhart, S; Gounden, S; Hlakola, MJ; Hoek, CJ; Hokwana, A; Horn, DM; Horrell, JMG; Hugo, B; Isaacson, AR; Jonas, JL; Jordaan, JDBL; Joubert, AF; Jozsa, GIG; Julie, RPM; Kapp, FB; Kenyon, JS; Kotze, PPA; Kriel, H; Kusel, TW; Lehmensiek, R; Liebenberg, D; Loots, A; Lord, RT; Lunsky, BM; Macfarlane, PS; Magnus, LG; Magozore, CM; Mahgoub, O; Main, JPL; Malan, JA; Malgas, RD; Manley, JR; Maree, MDJ; Merry, B; Millenaar, R; Mnyandu, N; Moeng, IPT; Monama, TE; Mphego, MC; New, WS; Ngcebetsha, B; Oozeer, N; Otto, AJ; Passmoor, SS; Patel, AA; Peens-Hough, A; Perkins, SJ; Ratcliffe, SM; Renil, R; Rust, A; Salie, S; Schwardt, LC; Serylak, M; Siebrits, R; Sirothia, SK; Smirnov, OM; Sofeya, L; Swart, PS; Tasse, C; Taylor, DT; Theron, IP; Thorat, K; Tiplady, AJ; Tshongweni, S; van Balla, TJ; van der Byl, A; van der Merwe, C; van Dyk, CL; Van Rooyen, R; Van Tonder, V; Van Wyk, R; Wallace, BH; Welz, MG; Williams, LP				Heywood, I.; Camilo, F.; Cotton, W. D.; Yusef-Zadeh, F.; Abbott, T. D.; Adam, R. M.; Aldera, M. A.; Bauermeister, E. F.; Booth, R. S.; Botha, A. G.; Botha, D. H.; Brederode, L. R. S.; Brits, Z. B.; Buchner, S. J.; Burger, J. P.; Chalmers, J. M.; Cheetham, T.; de Villiers, D.; Dikgale-Mahlakoana, M. A.; du Toit, L. J.; Esterhuyse, S. W. P.; Fanaroff, B. L.; Foley, A. R.; Fourie, D. J.; Gamatham, R. R. G.; Goedhart, S.; Gounden, S.; Hlakola, M. J.; Hoek, C. J.; Hokwana, A.; Horn, D. M.; Horrell, J. M. G.; Hugo, B.; Isaacson, A. R.; Jonas, J. L.; Jordaan, J. D. B. L.; Joubert, A. F.; Jozsa, G. I. G.; Julie, R. P. M.; Kapp, F. B.; Kenyon, J. S.; Kotze, P. P. A.; Kriel, H.; Kusel, T. W.; Lehmensiek, R.; Liebenberg, D.; Loots, A.; Lord, R. T.; Lunsky, B. M.; Macfarlane, P. S.; Magnus, L. G.; Magozore, C. M.; Mahgoub, O.; Main, J. P. L.; Malan, J. A.; Malgas, R. D.; Manley, J. R.; Maree, M. D. J.; Merry, B.; Millenaar, R.; Mnyandu, N.; Moeng, I. P. T.; Monama, T. E.; Mphego, M. C.; New, W. S.; Ngcebetsha, B.; Oozeer, N.; Otto, A. J.; Passmoor, S. S.; Patel, A. A.; Peens-Hough, A.; Perkins, S. J.; Ratcliffe, S. M.; Renil, R.; Rust, A.; Salie, S.; Schwardt, L. C.; Serylak, M.; Siebrits, R.; Sirothia, S. K.; Smirnov, O. M.; Sofeya, L.; Swart, P. S.; Tasse, C.; Taylor, D. T.; Theron, I. P.; Thorat, K.; Tiplady, A. J.; Tshongweni, S.; van Balla, T. J.; van der Byl, A.; van der Merwe, C.; van Dyk, C. L.; Van Rooyen, R.; Van Tonder, V.; Van Wyk, R.; Wallace, B. H.; Welz, M. G.; Williams, L. P.			Inflation of 430-parsec bipolar radio bubbles in the Galactic Centre by an energetic event	NATURE			English	Article							COSMIC-RAY; GAMMA-RAY; FILAMENTS; FIELD	The Galactic Centre contains a supermassive black hole with a mass of four million Suns(1) within an environment that differs markedly from that of the Galactic disk. Although the black hole is essentially quiescent in the broader context of active galactic nuclei, X-ray observations have provided evidence for energetic outbursts from its surroundings(2). Also, although the levels of star formation in the Galactic Centre have been approximately constant over the past few hundred million years, there is evidence of increased short-duration bursts(3), strongly influenced by the interaction of the black hole with the enhanced gas density present within the ring-like central molecular zone(4) at Galactic longitude vertical bar l vertical bar < 0.7 degrees and latitude vertical bar b vertical bar < 0.2 degrees. The inner 200-parsec region is characterized by large amounts of warm molecular gas(5), a high cosmic-ray ionization rate(6), unusual gas chemistry, enhanced synchrotron emission(7,8), and a multitude of radio-emitting magnetized filaments(9), the origin of which has not been established. Here we report radio imaging that reveals a bipolar bubble structure, with an overall span of 1 degree by 3 degrees (140 parsecs x 430 parsecs), extending above and below the Galactic plane and apparently associated with the Galactic Centre. The structure is edge-brightened and bounded, with symmetry implying creation by an energetic event in the Galactic Centre. We estimate the age of the bubbles to be a few million years, with a total energy of 7 x 10(52) ergs. We postulate that the progenitor event was a major contributor to the increased cosmic-ray density in the Galactic Centre, and is in turn the principal source of the relativistic particles required to power the synchrotron emission of the radio filaments within and in the vicinity of the bubble cavities.	[Heywood, I.] Univ Oxford, Dept Phys, Oxford, England; [Heywood, I.; Hugo, B.; Jonas, J. L.; Jozsa, G. I. G.; Kenyon, J. S.; Ngcebetsha, B.; Sirothia, S. K.; Smirnov, O. M.; Tasse, C.; Theron, I. P.; Thorat, K.] Rhodes Univ, Dept Phys & Elect, Grahamstown, South Africa; [Heywood, I.; Camilo, F.; Cotton, W. D.; Abbott, T. D.; Adam, R. M.; Bauermeister, E. F.; Botha, A. G.; Brederode, L. R. S.; Brits, Z. B.; Buchner, S. J.; Burger, J. P.; Chalmers, J. M.; Cheetham, T.; Dikgale-Mahlakoana, M. A.; Esterhuyse, S. W. P.; Fanaroff, B. L.; Foley, A. R.; Fourie, D. J.; Gamatham, R. R. G.; Goedhart, S.; Gounden, S.; Hlakola, M. J.; Hoek, C. J.; Hokwana, A.; Horn, D. M.; Hugo, B.; Isaacson, A. R.; Jonas, J. L.; Jordaan, J. D. B. L.; Joubert, A. F.; Jozsa, G. I. G.; Julie, R. P. M.; Kapp, F. B.; Kotze, P. P. A.; Kriel, H.; Kusel, T. W.; Liebenberg, D.; Loots, A.; Lord, R. T.; Lunsky, B. M.; Macfarlane, P. S.; Magnus, L. G.; Magozore, C. M.; Mahgoub, O.; Main, J. P. L.; Malan, J. A.; Malgas, R. D.; Manley, J. R.; Maree, M. D. J.; Merry, B.; Millenaar, R.; Mnyandu, N.; Moeng, I. P. T.; Monama, T. E.; Mphego, M. C.; New, W. S.; Ngcebetsha, B.; Oozeer, N.; Otto, A. J.; Passmoor, S. S.; Patel, A. A.; Peens-Hough, A.; Perkins, S. J.; Ratcliffe, S. M.; Renil, R.; Rust, A.; Salie, S.; Schwardt, L. C.; Serylak, M.; Siebrits, R.; Sirothia, S. K.; Smirnov, O. M.; Sofeya, L.; Swart, P. S.; Taylor, D. T.; Thorat, K.; Tiplady, A. J.; Tshongweni, S.; van Balla, T. J.; van der Byl, A.; van der Merwe, C.; Van Rooyen, R.; Van Tonder, V.; Van Wyk, R.; Wallace, B. H.; Welz, M. G.; Williams, L. P.] South African Radio Astron Observ, Cape Town, South Africa; [Cotton, W. D.] Natl Radio Astron Observ, Charlottesville, VA USA; [Yusef-Zadeh, F.] Northwestern Univ, CIERA, Evanston, IL USA; [Yusef-Zadeh, F.] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA; [Aldera, M. A.] Tellumat Pty Ltd, Retreat, South Africa; [Booth, R. S.] Chalmers Univ Technol, Gothenburg, Sweden; [Botha, D. H.; du Toit, L. J.; Jordaan, J. D. B. L.; Lehmensiek, R.; Theron, I. P.] EMSS Antennas Pty Ltd, Stellenbosch, South Africa; [de Villiers, D.] Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, South Africa; [Horrell, J. M. G.] Univ Cape Town, IDIA, Rondebosch, South Africa; [Lehmensiek, R.] Cape Peninsula Univ Technol, Dept Elect Engn, Bellville, South Africa; [Loots, A.] Presidential Infrastruct Coordinating Commiss, Pretoria, South Africa; [Oozeer, N.] African Inst Math Sci, Muizenberg, South Africa; [Serylak, M.] Univ Western Cape, Dept Phys & Astron, Bellville, South Africa; [Tasse, C.] PSL Res Univ, CNRS, GEPI, Meudon, France; [van Dyk, C. L.] Peralex Elect Pty Ltd, Bergvliet, South Africa; [Brederode, L. R. S.] Jodrell Bank, SKA Org, Macclesfield, Cheshire, England	University of Oxford; Rhodes University; National Radio Astronomy Observatory (NRAO); Northwestern University; Northwestern University; Chalmers University of Technology; Stellenbosch University; University of Cape Town; Cape Peninsula University of Technology; University of the Western Cape; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; University of Manchester; Jodrell Bank Centre for Astrophysics	Heywood, I (corresponding author), Univ Oxford, Dept Phys, Oxford, England.; Heywood, I (corresponding author), Rhodes Univ, Dept Phys & Elect, Grahamstown, South Africa.; Heywood, I; Camilo, F (corresponding author), South African Radio Astron Observ, Cape Town, South Africa.	ian.heywood@physics.ox.ac.uk; fernando@ska.ac.za	Smirnov, Oleg/AEO-9012-2022; Oozeer, Nadeem/GNM-5857-2022; Burger, Johan/AAW-9549-2020; Smirnov, Alexey/AAB-2521-2020	Oozeer, Nadeem/0000-0002-0155-6321; Smirnov, Alexey/0000-0001-5361-8232; Bauermeister, Etienne/0000-0002-2535-6818; Lehmensiek, Robert/0000-0001-9388-3081; Abbott, Thomas/0000-0002-5143-5894; Van Rooyen, Ruby/0000-0001-8940-4228; De Villiers, Dirk/0000-0003-1273-5365; Buchner, Sarah/0000-0002-1691-0215; Jonas, Justin/0000-0002-3528-4280; Thorat, Kshitij/0000-0002-4760-080X; Schwardt, Ludwig/0000-0003-1234-1921	US National Science Foundation [ACI-1440620, AST-0807400]; National Aeronautics and Space Administration's Earth Science Technology Office [NCC5-626]; Oxford Hintze Centre for Astrophysical Surveys - Hintze Family Charitable Foundation	US National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration's Earth Science Technology Office; Oxford Hintze Centre for Astrophysical Surveys - Hintze Family Charitable Foundation	The MeerKAT telescope is operated by the South African Radio Astronomy Observatory, which is a facility of the National Research Foundation, an agency of the Department of Science and Innovation. We acknowledge use of the Inter-University Institute for Data Intensive Astronomy (IDIA) data intensive research cloud for data processing. IDIA is a South African university partnership involving the University of Cape Town, the University of Pretoria and the University of the Western Cape. This research made use of Montage, which is funded by the US National Science Foundation under grant number ACI-1440620, and was previously funded by the National Aeronautics and Space Administration's Earth Science Technology Office, Computation Technologies Project, under cooperative agreement number NCC5-626 between NASA and the California Institute of Technology. I.H. acknowledges support from the Oxford Hintze Centre for Astrophysical Surveys, which is funded through generous support from the Hintze Family Charitable Foundation. F.Y.-Z. is partially supported by grant AST-0807400 from the US National Science Foundation.	Blasi P, 2011, ASTROPART PART SPACE, V6, P493; Camilo F, 2018, ASTROPHYS J, V856, DOI 10.3847/1538-4357/aab35a; Carretti E, 2013, NATURE, V493, P66, DOI 10.1038/nature11734; Condon J. J, 2016, ESSENTIAL RADIO ASTR, V183; Crocker RM, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/2/107; Crocker RM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.101102; Everett JE, 2010, ASTROPHYS J, V711, P13, DOI 10.1088/0004-637X/711/1/13; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Gillessen S, 2017, ASTROPHYS J, V837, DOI 10.3847/1538-4357/aa5c41; GRAY AD, 1995, ASTROPHYS J, V448, P164, DOI 10.1086/175949; HUTTEMEISTER S, 1993, ASTRON ASTROPHYS, V280, P255; Indriolo N, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/40; Kenyon JS, 2018, MON NOT R ASTRON SOC, V478, P2399, DOI 10.1093/mnras/sty1221; LaRosa TN, 2005, ASTROPHYS J, V626, pL23, DOI 10.1086/431647; LaRosa TN, 2004, ASTROPHYS J, V607, P302, DOI 10.1086/383233; Law CJ, 2010, ASTROPHYS J, V708, P474, DOI 10.1088/0004-637X/708/1/474; Law CJ, 2009, ASTROPHYS J, V695, P1070, DOI 10.1088/0004-637X/695/2/1070; Le Petit F, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201526658; Linden T, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/95; Morris M, 1996, IAU SYMP, P247; Nakashima S, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/20; Offringa AR, 2017, MON NOT R ASTRON SOC, V471, P301, DOI 10.1093/mnras/stx1547; Offringa AR, 2014, MON NOT R ASTRON SOC, V444, P606, DOI 10.1093/mnras/stu1368; Oka T, 2005, ASTROPHYS J, V632, P882, DOI 10.1086/432679; Parker QA, 2006, MON NOT R ASTRON SOC, V373, P79, DOI 10.1111/j.1365-2966.2006.10950.x; Ponti G, 2019, NATURE, V567, P347, DOI 10.1038/s41586-019-1009-6; Ponti G, 2010, ASTROPHYS J, V714, P732, DOI 10.1088/0004-637X/714/1/732; Siodmiak N, 2001, ASTRON ASTROPHYS, V373, P1032, DOI 10.1051/0004-6361:20010664; SOFUE Y, 1984, NATURE, V310, P568, DOI 10.1038/310568a0; Sormani MC, 2018, MON NOT R ASTRON SOC, V475, P2383, DOI 10.1093/mnras/stx3258; Su M, 2010, ASTROPHYS J, V724, P1044, DOI 10.1088/0004-637X/724/2/1044; Wardle M, 2014, ASTROPHYS J LETT, V787, DOI 10.1088/2041-8205/787/1/L14; Webber WR, 1998, ASTROPHYS J, V506, P329, DOI 10.1086/306222; Yang HYK, 2013, MON NOT R ASTRON SOC, V436, P2734, DOI 10.1093/mnras/stt1772; Yusef-Zadeh F, 2004, ASTROPHYS J SUPPL S, V155, P421, DOI 10.1086/425257; Yusef-Zadeh F, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/33; YUSEFZADEH F, 1984, NATURE, V310, P557, DOI 10.1038/310557a0	38	65	65	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					235	+		10.1038/s41586-019-1532-5	http://dx.doi.org/10.1038/s41586-019-1532-5			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31511683	Green Submitted			2022-12-28	WOS:000485415400049
J	Pannu, AK; Manikandan, G				Pannu, Ashok K.; Manikandan, Gopal			Disseminated Varicella Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 29-year-old man with aplastic anemia presented with fever, cough, and a rash with numerous papules, vesicles, pustules, and crusted vesicles. A diagnosis of disseminated varicella infection was made.	[Pannu, Ashok K.; Manikandan, Gopal] Post Grad Inst Med Educ & Res, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Pannu, AK (corresponding author), Post Grad Inst Med Educ & Res, Chandigarh, India.	gawaribacchi@gmail.com		Pannu, Ashok/0000-0002-4476-3478					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					E21	E21		10.1056/NEJMicm1814626	http://dx.doi.org/10.1056/NEJMicm1814626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY2MW	31509677				2022-12-28	WOS:000486225900001
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Trust and truth telling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Bloom D, 2019, MIRROR; Godlee Fiona, 2011, BMJ, V342, pc7452, DOI 10.1136/bmj.c7452; Iacobucci G, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5379; Ipsos MORI, 2018, IPS MORI VER IND 201; Valdivia-Garcia M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46238-0	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5477	10.1136/bmj.l5477	http://dx.doi.org/10.1136/bmj.l5477			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506277	Bronze			2022-12-28	WOS:000486648900011
J	Wilensky, G				Wilensky, Gail			Federal Government Increases Focus on Price Transparency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Wilensky, Gail] Project HOPE, Bethesda, MD 20814 USA		Wilensky, G (corresponding author), Project HOPE, Bethesda, MD 20814 USA.	gwilensky@projecthope.org							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					916	917		10.1001/jama.2019.12912	http://dx.doi.org/10.1001/jama.2019.12912			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY6YZ	31503298	Bronze			2022-12-28	WOS:000486543500003
J	Vantyghem, MC; de Koning, EJP; Pattou, F; Rickels, MR				Vantyghem, Marie-Christine; de Koning, Eelco J. P.; Pattou, Francois; Rickels, Michael R.			Advances in beta-cell replacement therapy for the treatment of type 1 diabetes	LANCET			English	Review							CLINICAL ISLET TRANSPLANTATION; PANCREAS-KIDNEY TRANSPLANTATION; PROCEDURE-RELATED COMPLICATIONS; FREE IMMUNOSUPPRESSIVE REGIMEN; PRIMARY GRAFT FUNCTION; 5-YEAR FOLLOW-UP; INSULIN INDEPENDENCE; METABOLIC-CONTROL; GLYCEMIC CONTROL; CULTURED ISLETS	The main goal of treatment for type 1 diabetes is to control glycaemia with insulin therapy to reduce disease complications. For some patients, technological approaches to insulin delivery are inadequate, and allogeneic islet transplantation is a safe alternative for those patients who have had severe hypoglycaemia complicated by impaired hypoglycaemia awareness or glycaemic lability, or who already receive immunosuppressive drugs for a kidney transplant. Since 2000, intrahepatic islet transplantation has proven efficacious in alleviating the burden of labile diabetes and preventing complications related to diabetes, whether or not a previous kidney transplant is present. Age, body-mass index, renal status, and cardiopulmonary status affect the choice between pancreas or islet transplantation. Access to transplantation is limited by the number of deceased donors and the necessity of immunosuppression. Future approaches might include alternative sources of islets (eg, xenogeneic tissue or human stem cells), extrahepatic sites of implantation (eg, omental, subcutaneous, or intra-muscular), and induction of immune tolerance or encapsulation of islets.	[Vantyghem, Marie-Christine; Pattou, Francois] Univ Lille, European Genom Inst Diabet, Lille, France; [Vantyghem, Marie-Christine] CHU Lille, Dept Endocrinol Diabetol & Metab, F-59037 Lille, France; [Pattou, Francois] CHU Lille, Dept Gen & Endocrine Surg Ctr, Lille, France; [Vantyghem, Marie-Christine; Pattou, Francois] INSERM, Translat Res Diabet, Lille, France; [de Koning, Eelco J. P.] Leiden Univ, Med Ctr, Dept Med, Leiden, Netherlands; [de Koning, Eelco J. P.] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [de Koning, Eelco J. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Rickels, Michael R.] Hosp Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Rickels, Michael R.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Vantyghem, MC (corresponding author), CHU Lille, Dept Endocrinol Diabetol & Metab, F-59037 Lille, France.	mc-vantyghem@chru-lille.fr	Pattou, Francois/O-6151-2017; Rickels, Michael/D-1380-2009; de Koning, Eelco JP/H-6030-2011	Pattou, Francois/0000-0001-8388-3766; Rickels, Michael/0000-0002-9253-838X; de Koning, Eelco JP/0000-0002-1232-7022	Public Health Services Research Grant [R01 DK091331]; French Ministry of Health, Programme Hospitalier de Recherch Clinique; European Community (Fond Europeen de Developpement Regional); Conseil Regional du Nord-Pas-de-Calais; Programme d'investissements d'avenir Labex European Genomic Institute for Diabetes [ANR-10-LABX-46]; Societe Francaise d'Endocrinologie; Association de Recherche pour le Diabete; Santelys; Agence de la Biomedecine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091331] Funding Source: NIH RePORTER	Public Health Services Research Grant; French Ministry of Health, Programme Hospitalier de Recherch Clinique; European Community (Fond Europeen de Developpement Regional); Conseil Regional du Nord-Pas-de-Calais(Region Hauts-de-FranceRegion Ile-de-France); Programme d'investissements d'avenir Labex European Genomic Institute for Diabetes(French National Research Agency (ANR)); Societe Francaise d'Endocrinologie; Association de Recherche pour le Diabete; Santelys; Agence de la Biomedecine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	No financial support was provided specifically for the writing of this manuscript. MRR is supported in part by Public Health Services Research Grant R01 DK091331. M-CV and FP are, or have been, supported by the French Ministry of Health, Programme Hospitalier de Recherch Clinique, the European Community (Fond Europeen de Developpement Regional), Conseil Regional du Nord-Pas-de-Calais, Programme d'investissements d'avenir Labex European Genomic Institute for Diabetes ANR-10-LABX-46, the Societe Francaise d'Endocrinologie, the Association de Recherche pour le Diabete, Santelys, and the Agence de la Biomedecine.	Baidal DA, 2017, NEW ENGL J MED, V376, P1887, DOI 10.1056/NEJMc1613959; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bellin MD, 2008, AM J TRANSPLANT, V8, P2463, DOI 10.1111/j.1600-6143.2008.02404.x; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Benomar K, 2018, AM J TRANSPLANT, V18, P945, DOI 10.1111/ajt.14514; Brooks AM, 2013, AM J TRANSPLANT, V13, P3236, DOI 10.1111/ajt.12469; Caiazzo R, 2008, TRANSPLANTATION, V86, P360, DOI 10.1097/TP.0b013e31817ef846; Caiazzo R, 2015, TRANSPLANTATION, V99, P979, DOI 10.1097/TP.0000000000000458; Chen CC, 2018, J CLIN INVEST, V128, P219, DOI 10.1172/JCI93542; Choudhary P, 2015, DIABETES CARE, V38, P1016, DOI 10.2337/dc15-0090; Collaborative Islet Transplant Registry, 2017, 10 ANN COLL ISL TRAN; Cure P, 2008, TRANSPLANTATION, V85, P801, DOI 10.1097/TP.0b013e318166a27b; Deng SP, 2009, TRANSPLANTATION, V88, P820, DOI 10.1097/TP.0b013e3181b4bdbb; Denner J, 2017, NEW ENGL J MED, V377, P1891, DOI 10.1056/NEJMcibr1710853; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Fensom B, 2016, DIABETES RES CLIN PR, V122, P101, DOI 10.1016/j.diabres.2016.10.011; Fiorina P, 2003, DIABETES CARE, V26, P1129, DOI 10.2337/diacare.26.4.1129; Foster ED, 2018, DIABETES CARE, V41, P1001, DOI 10.2337/dc17-1779; Foster NC, 2019, DIABETES TECHNOL THE, V21, P66, DOI 10.1089/dia.2018.0384; Frank A, 2004, ANN SURG, V240, P631, DOI 10.1097/01.sla.0000140754.26575.2a; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x; Gerber PA, 2008, DIABETOLOGIA, V51, P110, DOI 10.1007/s00125-007-0860-4; Gerber PA, 2015, TRANSPLANTATION, V99, P2174, DOI 10.1097/TP.0000000000000720; Gruessner AC, 2016, CURR OPIN ORGAN TRAN, V21, P377, DOI 10.1097/MOT.0000000000000331; Hafiz MM, 2005, TRANSPLANTATION, V80, P1718, DOI 10.1097/01.tp.0000187881.97068.77; Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Hering BJ, 2004, AM J TRANSPLANT, V4, P390, DOI 10.1046/j.1600-6143.2003.00351.x; Holmes-Walker DJ, 2017, TRANSPLANTATION, V101, P1268, DOI 10.1097/TP.0000000000001381; Huurman VAL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002435; Kessler L, 2009, AM J TRANSPLANT, V9, P1961, DOI 10.1111/j.1600-6143.2009.02711.x; Korutla L, 2019, AM J TRANSPLANT, V19, P1852, DOI 10.1111/ajt.15322; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar AF, 2008, DIABETES CARE, V31, P1639, DOI 10.2337/dc07-2453; Lablanche S, 2018, LANCET DIABETES ENDO, V6, P527, DOI 10.1016/S2213-8587(18)30078-0; Lablanche S, 2015, DIABETES CARE, V38, P1714, DOI 10.2337/dc15-0094; Lee MH, 2018, TRANSPLANT DIRECT, V4, DOI 10.1097/TXD.0000000000000841; Lehmann R, 2015, DIABETES CARE, V38, P752, DOI 10.2337/dc14-1686; Ludwig B, 2017, P NATL ACAD SCI USA, V114, P11745, DOI 10.1073/pnas.1708420114; Madrigal JM, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13059; Maffi P, 2014, TRANSPLANTATION, V98, P1301, DOI 10.1097/TP.0000000000000396; Maffi Paola, 2011, Rev Diabet Stud, V8, P44, DOI 10.1900/RDS.2011.8.44; Matsumoto S, 2006, TRANSPLANTATION, V82, P1629, DOI 10.1097/01.tp.0000250547.52725.ff; Matsumoto S, 2011, CELL TRANSPLANT, V20, P1641, DOI 10.3727/096368910X564058; McCoy RG, 2012, DIABETES CARE, V35, P1897, DOI 10.2337/dc11-2054; Millman JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11463; Monti P, 2015, CURR DIABETES REV, V11, P135, DOI 10.2174/1573399811666150317125820; Moreau F, 2012, TRANSPLANTATION, V93, pE10, DOI 10.1097/TP.0b013e31823f7fb2; Naziruddin B, 2012, CELL TRANSPLANT, V21, P901, DOI 10.3727/096368911X612468; Nijhoff MF, 2016, AM J TRANSPLANT, V16, P246, DOI 10.1111/ajt.13425; O'Connell PJ, 2013, AM J TRANSPLANT, V13, P1850, DOI 10.1111/ajt.12250; Odorico J, 2018, TRANSPLANTATION, V102, P1223, DOI 10.1097/TP.0000000000002217; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Papas KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134428; Pattou F, 2010, NEW ENGL J MED, V363, P1289, DOI 10.1056/NEJMc1004547; Peixoto E, 2016, DIABETES CARE, V39, pE209, DOI 10.2337/dc16-1093; Pepper AR, 2019, DIABETES, V68, P953, DOI 10.2337/db18-0788; Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211; Perdigoto AL, 2019, DIABETOLOGIA, V62, P655, DOI 10.1007/s00125-018-4786-9; Posselt AM, 2010, TRANSPLANTATION, V90, P1595, DOI 10.1097/TP.0b013e3181fe1377; Pullen LC, 2018, AM J TRANSPLANT, V18, P1581, DOI 10.1111/ajt.14954; Qi M, 2014, ACTA DIABETOL, V51, P833, DOI 10.1007/s00592-014-0627-6; Rafael E, 2008, AM J TRANSPLANT, V8, P458, DOI 10.1111/j.1600-6143.2007.02060.x; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Rickels MR, 2019, AM J TRANSPLANT, V19, P298, DOI 10.1111/ajt.14972; Rickels MR, 2018, TRANSPLANTATION, V102, P1479, DOI 10.1097/TP.0000000000002158; Rickels MR, 2016, J CLIN ENDOCR METAB, V101, P4421, DOI 10.1210/jc.2016-1649; Rickels MR, 2015, DIABETES, V64, P1713, DOI 10.2337/db14-1620; Rickels MR, 2013, DIABETES, V62, P2890, DOI 10.2337/db12-1802; Ricordi C, 2016, DIABETES, V65, P3418, DOI 10.2337/db16-0234; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; SCHARP DW, 1990, DIABETES, V39, P515, DOI 10.2337/diabetes.39.4.515; Senior PA, 2007, AM J TRANSPLANT, V7, P91, DOI 10.1111/j.1600-6143.2006.01573.x; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6; Sui L, 2018, DIABETES, V67, P26, DOI 10.2337/db17-0120; Takita M, 2012, CLIN TRANSPLANT, V26, pE471, DOI 10.1111/ctr.12011; Tan JM, 2008, DIABETES, V57, P2666, DOI 10.2337/db08-0358; Thompson DM, 2011, TRANSPLANTATION, V91, P373, DOI 10.1097/TP.0b013e31820437f3; Turgeon NA, 2010, AM J TRANSPLANT, V10, P2082, DOI 10.1111/j.1600-6143.2010.03212.x; TZAKIS AG, 1990, LANCET, V336, P402, DOI 10.1016/0140-6736(90)91946-8; Vantyghem MC, 2014, DIABETES CARE, V37, pE141, DOI 10.2337/dc14-0320; Vantyghem MC, 2012, J CLIN ENDOCR METAB, V97, pE2078, DOI 10.1210/jc.2012-2115; Vantyghem MC, 2009, DIABETES CARE, V32, P1473, DOI 10.2337/dc08-1685; Vantyghem MC, 2009, TRANSPLANTATION, V87, P66, DOI 10.1097/TP.0b013e31818bbdab; Vantyghem MC, DIABETES CARE; Villiger P, 2005, AM J TRANSPLANT, V5, P2992, DOI 10.1111/j.1600-6143.2005.01108.x; Wojtusciszyn A, 2019, DIABETES METAB, V45, P224, DOI 10.1016/j.diabet.2018.07.006	92	80	83	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1274	1285		10.1016/S0140-6736(19)31334-0	http://dx.doi.org/10.1016/S0140-6736(19)31334-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8XK	31533905	Green Accepted, Green Published			2022-12-28	WOS:000488862500033
J	Lazopulo, S; Lazopulo, A; Baker, JD; Syed, S				Lazopulo, Stanislav; Lazopulo, Andrey; Baker, James D.; Syed, Sheyum			Daytime colour preference in Drosophila depends on the circadian clock and TRP channels	NATURE			English	Article							MELANOGASTER; BEHAVIOR; VISION; RHODOPSIN; SLEEP; SYNCHRONIZATION; DISCRIMINATION; IDENTIFICATION; EXPRESSION; NEURONS	Light discrimination according to colour can confer survival advantages by guiding animals towards food and shelter and away from potentially harmful situations(1,2). Such colour-dependent behaviour can be learned or innate. Data on innate colour preference in mammals remain controversial(3) and there are limited data for simpler organisms(4-7). Here we show that, when given a choice among blue, green and dim light, fruit flies exhibit an unexpectedly complex pattern of colour preference that changes according to the time of day. Flies show a strong preference for green in the early morning and late afternoon, a reduced green preference at midday and a robust avoidance of blue throughout the day. Genetic manipulations reveal that the peaks in green preference require rhodopsin-based visual photoreceptors and are controlled by the circadian clock. The midday reduction in green preference in favour of dim light depends on the transient receptor potential (TRP) channels dTRPA1 and Pyrexia, and is also timed by the clock. By contrast, avoidance of blue light is primarily mediated by multidendritic neurons, requires rhodopsin 7 and the TRP channel Painless, and is independent of the clock. Our findings show that several TRP channels are involved in colour-driven behaviour in Drosophila, and reveal distinct pathways of innate colour preference that coordinate the behavioural dynamics of flies in ambient light.	[Lazopulo, Stanislav; Lazopulo, Andrey; Syed, Sheyum] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA; [Baker, James D.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami; University of Miami	Syed, S (corresponding author), Univ Miami, Dept Phys, Coral Gables, FL 33124 USA.	s.syed@miami.edu	Lazopulo, Stanislav/AAA-5669-2020	Syed, Sheyum/0000-0002-4642-6678	National Science Foundation [IOS-1656603]	National Science Foundation(National Science Foundation (NSF))	We thank C. Desplan, J. Giebultowicz, F. Hamada, C. Helfrich-Forster, L. and Y.-N. Jan, W. Joiner, M. Kim, M. Klein, C. Montell, R. Stanewsky, D. Top, Y. Xiang, M. Young, the Kyoto Stock Centre, and the Bloomington Drosophila Stock Centre for fly stocks; J. Dallman, M. Dallman, B. de Bivort, M. Klein and J. Truman for comments on the manuscript; M. Klein and W. Li for discussions; and J. A. Lopez and M. Collazo for technical support. This work was supported in part by the National Science Foundation under grant IOS-1656603 to S.S.	Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Bernardo-Garcia FJ, 2017, FLY, V11, P112, DOI 10.1080/19336934.2016.1244591; DESALOMON CH, 1983, J COMP PHYSIOL, V150, P31, DOI 10.1007/BF00605285; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Doring F, 2002, J BIOL CHEM, V277, P25554, DOI 10.1074/jbc.M202385200; FISCHBACH KF, 1979, J COMP PHYSIOL, V130, P161, DOI 10.1007/BF00611050; Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gorczyca DA, 2014, CELL REP, V9, P1446, DOI 10.1016/j.celrep.2014.10.034; Green EW, 2015, P NATL ACAD SCI USA, V112, P8702, DOI 10.1073/pnas.1506093112; Guo F, 2014, ELIFE, V3, DOI 10.7554/eLife.02780; Hall H, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0443-y; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Hori M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07383; Im SH, 2012, DEV DYNAM, V241, P16, DOI 10.1002/dvdy.22737; Kistenpfennig C, 2017, J BIOL RHYTHM, V32, P406, DOI 10.1177/0748730417721826; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lamaze A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40304; Lazopulo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140481; MCMANUS IC, 1981, PERCEPTION, V10, P651, DOI 10.1068/p100651; Ni JD, 2017, NATURE, V545, P340, DOI 10.1038/nature22325; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; Otsuna H, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00008; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Roessingh S, 2015, J BIOL RHYTHM, V30, P492, DOI 10.1177/0748730415605633; Sakai K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07461-9; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlichting M, 2016, J NEUROSCI, V36, P9084, DOI 10.1523/JNEUROSCI.0992-16.2016; Schloss KB, 2017, COGNITIVE SCI, V41, P1589, DOI 10.1111/cogs.12429; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; SCHUMPERLI RA, 1973, J COMP PHYSIOL, V86, P77, DOI 10.1007/BF00694480; Seidner G, 2015, CURR BIOL, V25, P2928, DOI 10.1016/j.cub.2015.10.006; Senthilan PR, 2016, PEERJ, V4, DOI 10.7717/peerj.2427; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Shimono K, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-37; Sokabe T, 2016, CELL REP, V17, P336, DOI 10.1016/j.celrep.2016.09.028; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Szular J, 2012, J BIOL RHYTHM, V27, P25, DOI 10.1177/0748730411431673; Tang X, 2013, J NEUROSCI, V33, P894, DOI 10.1523/JNEUROSCI.1894-12.2013; Wolfgang W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0959; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; Yoshii T, 2012, PROG BRAIN RES, V199, P59, DOI 10.1016/B978-0-444-59427-3.00027-7; Zanini D, 2018, NEURON, V98, P67, DOI 10.1016/j.neuron.2018.02.028	49	23	25	13	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					108	+		10.1038/s41586-019-1571-y	http://dx.doi.org/10.1038/s41586-019-1571-y			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31534223	Green Submitted			2022-12-28	WOS:000488832500040
J	Conn, CA				Conn, C. Ann			Unsteady Thoughts - Telling the Truth of Psychosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Psychosis is a primitive agony that arises from the deepest part of the brain, unregulated by considered thought - raw, visceral, and turbulent. But much of its territory remains uncharted. How is a physician-mother to help her suffering sons?	[Conn, C. Ann] Adv Pain Inst, Covington, LA 70433 USA		Conn, CA (corresponding author), Adv Pain Inst, Covington, LA 70433 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1198	1199		10.1056/NEJMp1905350	http://dx.doi.org/10.1056/NEJMp1905350			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC5OT	31553832				2022-12-28	WOS:000489333500004
J	Iacobucci, G; Mahase, E				Iacobucci, Gareth; Mahase, Elisabeth			Motions from Brighton: Labour Party conference roundup	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2019	366								l5697	10.1136/bmj.l5697	http://dx.doi.org/10.1136/bmj.l5697			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WY	31554609				2022-12-28	WOS:000488488700008
J	Walrath, D; Lawlor, B				Walrath, Dana; Lawlor, Brian			Dementia: towards a new republic of hope	LANCET			English	Editorial Material									[Walrath, Dana; Lawlor, Brian] Trinity Coll Dublin, Global Brain Hlth Inst, Dublin 2, Ireland; [Lawlor, Brian] St James Hosp, Mercers Inst Successful Ageing, Memory Clin, Dublin 8, Ireland	Trinity College Dublin; Trinity College Dublin	Walrath, D (corresponding author), Trinity Coll Dublin, Global Brain Hlth Inst, Dublin 2, Ireland.	dana.walrath@gbhi.org						Epstein Steven., 1996, IMPURE SCI; Farmer P., 2003, PATHOLOGIES POWER HL; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; SCHEPER-HUGHES N, 1987, Medical Anthropology Quarterly, V1, P6, DOI 10.1525/maq.1987.1.1.02a00020; Sontag S., 2009, ILLNESS METAPHOR AID; Walrath, 2016, ALICEHEIMERS ALZHEIM	6	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					1002	1003		10.1016/S0140-6736(19)32099-9	http://dx.doi.org/10.1016/S0140-6736(19)32099-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31544739				2022-12-28	WOS:000487038700015
J	Burlingame, Q; Huang, XH; Liu, X; Jeong, C; Coburn, C; Forrest, SR				Burlingame, Quinn; Huang, Xiaheng; Liu, Xiao; Jeong, Changyeong; Coburn, Caleb; Forrest, Stephen R.			Intrinsically stable organic solar cells under high-intensity illumination	NATURE			English	Article							LONG-TERM STABILITY; PHOTOVOLTAICS; RECOMBINATION; LIFETIME	Organic photovoltaic cells are now approaching commercially viable efficiencies, particularly for applications that make use of their unique potential for flexibility and semitransparency(1-3). However, their reliability remains a major concern, as even the most stable devices reported so far degrade within only a few years(4-8). This has led to the belief that short operational lifetimes are an intrinsic disadvantage of devices that are fabricated using weakly bonded organic materials-an idea that persists despite the rapid growth and acceptance of organic light-emitting devices, which can achieve lifetimes of several million hours(9). Here we study an extremely stable class of thermally evaporated single-junction organic photovoltaic cells. We accelerated the ageing process by exposing the packaged cells to white-light illumination intensities of up to 37 Suns. The cells maintained more than 87 per cent of their starting efficiency after exposure for more than 68 days. The degradation rate increases superlinearly with intensity, leading to an extrapolated intrinsic lifetime, T-80, of more than 4.9 x 10(7) hours, where T-80 is the time taken for the power conversion efficiency to decrease to 80 per cent of its initial value. This is equivalent to 27,000 years outdoors. Additionally, we subjected a second group of organic photovoltaic cells to 20 Suns of ultraviolet illumination (centred at 365 nanometres) for 848 hours, a dose that would take 1.7 x 10(4) hours (9.3 years) to accumulate outdoors. No efficiency loss was observed over the duration of the test. Overall, we find that organic solar cells packaged in an inert atmosphere can be extremely stable, which is promising for their future use as a practical energy-generation technology.	[Burlingame, Quinn; Huang, Xiaheng; Liu, Xiao; Jeong, Changyeong; Forrest, Stephen R.] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Coburn, Caleb; Forrest, Stephen R.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Forrest, Stephen R.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Forrest, SR (corresponding author), Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA.; Forrest, SR (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.; Forrest, SR (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.	stevefor@umich.edu	Liu, Xiao/B-9299-2018	Liu, Xiao/0000-0002-5397-6694; Huang, Xiaheng/0000-0002-0960-1211; Burlingame, Quinn/0000-0002-4511-2271	United States Department of Energy SunShot Program [DE-EE0006708, DE-EE0005310]; Department of the Navy, Office of Naval Research [N00014-17-1-2211]	United States Department of Energy SunShot Program(United States Department of Energy (DOE)); Department of the Navy, Office of Naval Research(Office of Naval Research)	This work was supported by the United States Department of Energy SunShot Program under awards DE-EE0006708 and DE-EE0005310 and the Department of the Navy, Office of Naval Research under award N00014-17-1-2211.	Baran D, 2017, NAT MATER, V16, P363, DOI [10.1038/NMAT4797, 10.1038/nmat4797]; Bartesaghi D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8083; Burlingame Q, 2017, ORG ELECTRON, V41, P274, DOI 10.1016/j.orgel.2016.11.015; Burlingame Q, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201601094; Burlingame Q, 2015, ENERG ENVIRON SCI, V8, P1005, DOI 10.1039/c4ee03444a; Burrows PE, 2000, APPL PHYS LETT, V76, P2493, DOI 10.1063/1.126386; Chang SY, 2018, JOULE, V2, P1039, DOI 10.1016/j.joule.2018.04.005; Che XZ, 2018, NAT ENERGY, V3, P422, DOI 10.1038/s41560-018-0134-z; Dibb GFA, 2013, J PHYS CHEM LETT, V4, P803, DOI 10.1021/jz400140p; Franke R, 2008, SOL ENERG MAT SOL C, V92, P732, DOI 10.1016/j.solmat.2007.12.001; Fry C., 2005, APPL PHYS LETT, V87, P1; Garner LE, 2018, J MATER CHEM A, V6, P4623, DOI 10.1039/c7ta10995d; Gasparini N, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201700770; Giebink NC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2884530; Habte A, 2017, NRELTP5D0067722; Haillant O, 2011, SOL ENERG MAT SOL C, V95, P1889, DOI 10.1016/j.solmat.2011.02.013; Hermenau M, 2012, SOL ENERG MAT SOL C, V97, P102, DOI 10.1016/j.solmat.2011.09.026; Jeong C, 2019, ORG ELECTRON, V64, P15, DOI 10.1016/j.orgel.2018.10.001; Jiang X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00137-y; Lakhwani G, 2014, ANNU REV PHYS CHEM, V65, P557, DOI 10.1146/annurev-physchem-040513-103615; Li YX, 2017, J AM CHEM SOC, V139, P17114, DOI 10.1021/jacs.7b11278; Liu X, 2016, ACS NANO, V10, P7619, DOI 10.1021/acsnano.6b02865; Pearson AJ, 2016, ORG ELECTRON, V30, P225, DOI 10.1016/j.orgel.2015.12.024; Peters CH, 2011, ADV ENERGY MATER, V1, P491, DOI 10.1002/aenm.201100138; Rau U, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085303; Sapkota SB, 2014, SOL ENERG MAT SOL C, V130, P144, DOI 10.1016/j.solmat.2014.07.004; Scholz S, 2015, CHEM REV, V115, P8449, DOI 10.1021/cr400704v; Vandewal K, 2009, NAT MATER, V8, P904, DOI [10.1038/NMAT2548, 10.1038/nmat2548]; Wang NN, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754690; WILSON PF, 1991, IEEE T ELECTROMAGN C, V33, P10, DOI 10.1109/15.68245; Zhang H., 2014, ADV ENERGY MATER, V5, P1; Zhang YF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6008	32	115	114	11	160	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					394	+		10.1038/s41586-019-1544-1	http://dx.doi.org/10.1038/s41586-019-1544-1			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31501570	Green Submitted			2022-12-28	WOS:000486647800045
J	Gilding, P				Gilding, Paul			Why I welcome a climate emergency	NATURE			English	Editorial Material									[Gilding, Paul] Univ Cambridge, Inst Sustainabil Leadership, Cambridge, England	University of Cambridge	Gilding, P (corresponding author), Univ Cambridge, Inst Sustainabil Leadership, Cambridge, England.	paulgilding@me.com						Randers J, 2010, J GLOB RESPONSIB, V1, P170, DOI 10.1108/20412561011039762	1	4	4	0	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					311	311		10.1038/d41586-019-02735-w	http://dx.doi.org/10.1038/d41586-019-02735-w			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31530929				2022-12-28	WOS:000486647800013
J	Mahase, E				Mahase, Elisabeth			Half of trials supporting new cancer drug approval in Europe had high risk of bias	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mintzes B, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5399; Naci H, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5221	2	0	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2019	366								l5619	10.1136/bmj.l5619	http://dx.doi.org/10.1136/bmj.l5619			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WD	31537545				2022-12-28	WOS:000487759400006
J	Farid, H				Farid, Huma			Who Heals the Healer?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EMPATHY	In this narrative medicine essay, an obstetrician-gynecologist struggles with the overwhelming strains of her profession, family obligations, and struggling marriage that together buried her sense of empathy until a grateful patient hugs her, an expression that reaches what she feared had been long extinguished.	[Farid, Huma] Harvard Med Sch, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Kirstein 3, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Farid, H (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Kirstein 3, Boston, MA 02215 USA.	hfarid@bidmc.harvard.edu						Han JL, 2018, J SURG EDUC, V75, P88, DOI 10.1016/j.jsurg.2017.06.035; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; Ochsner KN, 2008, SOC COGN AFFECT NEUR, V3, P144, DOI 10.1093/scan/nsn006	3	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1045	1046		10.1001/jama.2019.14043	http://dx.doi.org/10.1001/jama.2019.14043			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31529011				2022-12-28	WOS:000488821100014
J	Graham, J				Graham, Jeremy			After stroke due to ICH while on anti-thrombotics, starting vs avoiding anti-platelets did not differ for symptomatic ICH	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In patients who had stroke due to intracerebral hemorrhage (ICH) while receiving antithrombotic therapy, what is the relative efficacy of starting vs avoiding antiplatelet therapy for recurrent symptomatic ICH? Methods Design: Randomized controlled trial (RCT) (REstart or STop Antithrombotics Randomised Trial [RESTART]). ISRCTN 71907627. Allocation: Concealed.* Blinding: Blinded* (outcome assessors and outcome adjudicators). Follow-up period: Median 2 years. Setting: 104 hospitals in the UK. Patients: 537 adults >= 18 years of age (mean age 76 y, 67% men) who survived >= 24 hours after spontaneous, confirmed ICH that occurred while they were receiving antithrombotic therapy and stopped antithrombotic therapy after the ICH, and for whom it was uncertain whether antiplatelet therapy should be started or avoided. Exclusion criteria included ICH due to head injury or hemorrhagic transformation of an ischemic stroke. Intervention: Starting (n = 268) or avoiding (n = 269) anti-platelet therapy (oral aspirin, dipyridamole, and/or clopidogrel) within 24 hours of randomization (doses were at the discretion of the responsible physician). Outcomes: Proven (radiographically or pathologically) recurrent symptomatic ICH. Secondary outcomes included all major hemorrhagic events, major occlusive vascular events (ischemic stroke; myocardial infarction; mesenteric ischemia; peripheral arterial occlusion; deep venous thrombosis; pulmonary embolism; and carotid, coronary, or peripheral arterial revascularization procedures), and major hemorrhagic or occlusive vascular events. The trial did not enroll the 720 patients needed for 90% power to detect an increase in the primary outcome from 4.5% to 9.0% (alpha = 0.05), even though the recruitment period was increased from 1 year to 2 years. Patient follow-up: 99%. Main results The results are in the Table. Conclusion In patients who had stroke due to intracerebral hemorrhage while receiving antithrombotic therapy, starting vs avoiding antiplatelet therapy did not differ for recurrent symptomatic intracerebral hemorrhage.	[Graham, Jeremy] Washington State Univ, Elson S Floyd Coll Med, Spokane, WA 99202 USA	Washington State University	Graham, J (corresponding author), Washington State Univ, Elson S Floyd Coll Med, Spokane, WA 99202 USA.			Al-Shahi Salman, Rustam/0000-0002-2108-9222				Casaubon LK, 2015, INT J STROKE, V10, P924, DOI 10.1111/ijs.12551; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Salman RAS, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2542-6	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC32	JC32		10.7326/ACPJ201909170-032	http://dx.doi.org/10.7326/ACPJ201909170-032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525766				2022-12-28	WOS:000486101400008
J	Aman, A; Gashumba, D; Magaziner, I; Nordstrom, A				Aman, Amir; Gashumba, Diane; Magaziner, Ira; Nordstrom, Anders			Financing universal health coverage: four steps to go from aspiration to action	LANCET			English	Editorial Material									[Aman, Amir] Ethiopia Fed Minist Hlth, Addis Ababa, Ethiopia; [Gashumba, Diane] Rwanda Minist Hlth, Kigali, Rwanda; [Magaziner, Ira] Clinton Hlth Access Initiat, Boston, MA USA; [Nordstrom, Anders] Govt Sweden, Minist Foreign Affairs, S-10333 Stockholm, Sweden		Nordstrom, A (corresponding author), Govt Sweden, Minist Foreign Affairs, S-10333 Stockholm, Sweden.	anders.nordstrom@gov.se			Swedish Government by the Clinton Health Access Initiative for health	Swedish Government by the Clinton Health Access Initiative for health	The Swedish Government is a funder of work by the Clinton Health Access Initiative for health financing in Ethiopia and Rwanda among other countries. We declare no other competing interests.	Admasu K, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010305; [Anonymous], 2015, GOING UNIVERSAL 24 D; Dieleman J, 2017, LANCET, V389, P1981, DOI 10.1016/S0140-6736(17)30874-7; Dieleman JL, 2018, LANCET, V391, P1799, DOI 10.1016/S0140-6736(18)30698-6; Dieleman JL, 2018, LANCET, V391, P1783, DOI 10.1016/S0140-6736(18)30697-4; Federal democratic republic of Ethiopia Ministry of Health, 2015, HLTH SECT TRANSF PLA; Jani IV, 2018, AIDS, V32, P1453, DOI [10.1097/QAD.0000000000001846, 10.1097/qad.0000000000001846]; Kozel TR, 2017, J CLIN MICROBIOL, V55, P2313, DOI 10.1128/JCM.00476-17; Organization for Economic Cooperation and Development, 2016, UN HLTH COV HLTH OUT; Republic of Rwanda Ministry of Health, 2019, HLTH FIN STRAT PLAN; Stevens WS, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0040-2016; UN General Assembly, 2019, POL DECL HIGH LEV M; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE192, DOI 10.1016/S2214-109X(17)30429-1; 2010, WORLD HLTH REP HLTH, P1	14	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					902	903		10.1016/S0140-6736(19)32095-1	http://dx.doi.org/10.1016/S0140-6736(19)32095-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX7CE	31526723				2022-12-28	WOS:000485840600007
J	Lange, C; Dheda, K; Chesov, D; Mandalakas, AM; Udwadia, Z; Horsburgh, CR				Lange, Christoph; Dheda, Keertan; Chesov, Dumitru; Mandalakas, Anna Maria; Udwadia, Zarir; Horsburgh, C. Robert, Jr.			Management of drug-resistant tuberculosis	LANCET			English	Article							CARE XPERT MTB/RIF; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; BEDAQUILINE; MULTICENTER; THERAPY; NEVIRAPINE; INFECTION; DELAMANID; CHILDREN	Drug-resistant tuberculosis is a major public health concern in many countries. Over the past decade, the number of patients infected with Mycobacterium tuberculosis resistant to the most effective drugs against tuberculosis (ie, rifampicin and isoniazid), which is called multidrug-resistant tuberculosis, has continued to increase. Globally, 4.6% of patients with tuberculosis have multidrug-resistant tuberculosis, but in some areas, like Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, this proportion exceeds 25%. Treatment for patients with multidrug-resistant tuberculosis is prolonged (ie, 9-24 months) and patients with multidrug-resistant tuberculosis have less favourable outcomes than those treated for drug-susceptible tuberculosis. Individualised multidrug-resistant tuberculosis treatment with novel (eg, bedaquiline) and repurposed (eg, linezolid, clofazimine, or meropenem) drugs and guided by genotypic and phenotypic drug susceptibility testing can improve treatment outcomes. Some clinical trials are evaluating 6-month regimens to simplify management and improve outcomes of patients with multidrug-resistant tuberculosis. Here we review optimal diagnostic and treatment strategies for patients with drug-resistant tuberculosis and their contacts.	[Lange, Christoph; Chesov, Dumitru] Res Ctr Borstel, Clin Infect Dis, D-23845 Borstel, Germany; [Lange, Christoph] Univ Lubeck, Resp Med & Int Hlth, Lubeck, Germany; [Lange, Christoph] German Ctr Infect Res, Clin TB Unit, Borstel, Germany; [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden; [Dheda, Keertan] Univ Cape Town, Dept Med, Div Pulmonol, Ctr Lung Infect & Immun,Lung Inst, Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Ctr Study Antimicrobial Resistance, Cape Town, South Africa; [Dheda, Keertan] South African Med Res Council, Cape Town, South Africa; [Dheda, Keertan] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London, England; [Chesov, Dumitru] Nicoale Testemitanu State Univ Med & Pharm, Dept Pneumol & Alergoll, Kishinev, Moldova; [Mandalakas, Anna Maria] Texas Childrens Hosp, Global TB Programme, Houston, TX 77030 USA; [Mandalakas, Anna Maria] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Udwadia, Zarir] Hinduja Hosp & Res Ctr, Veer Savarkar Marg, Mumbai, Maharashtra, India; [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	Forschungszentrum Borstel; University of Lubeck; German Center for Infection Research; Karolinska Institutet; University of Cape Town; University of Cape Town; South African Medical Research Council; University of London; London School of Hygiene & Tropical Medicine; Baylor College of Medicine; Baylor College of Medicine; Boston University; Boston University; Boston University; Boston University	Lange, C (corresponding author), Res Ctr Borstel, Clin Infect Dis, D-23845 Borstel, Germany.	clange@fz-borstel.de	Chesov, Dumitru/AAR-5114-2020	Chesov, Dumitru/0000-0001-6203-5020	South African Medical Research Council [RFA-EMU-02-2017]; Providence and Boston Center for AIDS Research; Boston University; Rutgers Tuberculosis Research Unit; US India Vaccine Action Program Initiative on Tuberculosis; European and Developing Countries Clinical Trials Partnership [TMA-2015SF-1043, TMA-1051-TESAII]; German Center for Infection Research	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Providence and Boston Center for AIDS Research; Boston University; Rutgers Tuberculosis Research Unit; US India Vaccine Action Program Initiative on Tuberculosis; European and Developing Countries Clinical Trials Partnership; German Center for Infection Research	CL reports personal fees from Chiesi, Gilead, Janssen, Lucane, Novartis, Oxoid, Berlin Chemie, and Thermofisher outside the submitted work, and is supported by the German Center for Infection Research. KD is supported by the South African Medical Research Council (RFA-EMU-02-2017) and the The European and Developing Countries Clinical Trials Partnership (TMA-2015SF-1043 and TMA-1051-TESAII). AMM reports personal fees from Janssen Pharmaceuticals outside of the submitted work. CRH Jr is supported by the Providence and Boston Center for AIDS Research, the Boston University and Rutgers Tuberculosis Research Unit, and the US India Vaccine Action Program Initiative on Tuberculosis. All other authors declare no competing interests.	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; ALLAN WGL, 1977, AM REV RESPIR DIS, V115, P727; Allix-Beguec C, 2018, NEW ENGL J MED, V379, P1403, DOI 10.1056/NEJMoa1800474; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Bloemberg GV, 2015, NEW ENGL J MED, V373, P1986, DOI 10.1056/NEJMc1505196; Brown AC, 2015, J CLIN MICROBIOL, V53, P2230, DOI 10.1128/JCM.00486-15; Conradie F, 2018, INT J TUBERC LUNG D, V22, pS69; Dheda K, 2018, AM J RESP CRIT CARE, V198, P1208, DOI [10.1164/rccm.201711-2333OC, 10.1164/rccm.201711-2333oc]; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/s2213-2600(17)30079-6, 10.1016/S2213-2600(17)30079-6]; Dominguez J, 2016, INT J TUBERC LUNG D, V20, P24, DOI 10.5588/ijtld.15.0221; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Esmail A, 2018, J THORAC DIS, V10, P3102, DOI 10.21037/jtd.2018.05.11; Fox GJ, 2017, CLIN MICROBIOL INFEC, V23, P147, DOI 10.1016/j.cmi.2016.08.024; Fox GJ, 2016, CLIN INFECT DIS, V62, P887, DOI 10.1093/cid/ciw002; Fregonese F, 2018, LANCET RESP MED, V6, P265, DOI 10.1016/S2213-2600(18)30078-X; Furin J, 2018, LANCET CHILD ADOLESC, V2, P237, DOI 10.1016/S2352-4642(18)30068-3; Garcia-Prats A J, 2018, Int J Tuberc Lung Dis, V22, P15, DOI 10.5588/ijtld.17.0355; Garcia-Prats AJ, 2018, CLIN INFECT DIS, V67, P1777, DOI 10.1093/cid/ciy416; Gegia M, 2017, LANCET INFECT DIS, V17, P223, DOI 10.1016/S1473-3099(16)30407-8; Gunther G, 2016, NEW ENGL J MED, V375, P1103, DOI 10.1056/NEJMc1603274; Gupta A, 2020, CLIN INFECT DIS, V70, P425, DOI 10.1093/cid/ciz235; Gupta A, 2016, CLIN INFECT DIS, V62, P761, DOI 10.1093/cid/civ991; Harris RC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1585-0; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Heyckendorf J, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02122-2017; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Ismail N, 2018, DATA BRIEF, V20, P1975, DOI 10.1016/j.dib.2018.09.057; Jenkins H E, 2018, Int J Tuberc Lung Dis, V22, P3, DOI 10.5588/ijtld.17.0357; Jolliffe DA, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02003-2018; Kendall EA, 2019, INT J TUBERC LUNG D, V23, P535, DOI 10.5588/ijtld.18.0217; Kurbatova EV, 2015, LANCET RESP MED, V3, P201, DOI 10.1016/S2213-2600(15)00036-3; Lange C, 2018, J INTERN MED, V284, P163, DOI 10.1111/joim.12780; Lange C, 2018, LANCET RESP MED, V6, P893, DOI 10.1016/S2213-2600(18)30428-4; Lange C, 2018, LANCET RESP MED, V6, P246, DOI 10.1016/S2213-2600(18)30104-8; Lange C, 2016, AM J RESP CRIT CARE, V194, P1029, DOI 10.1164/rccm.201606-1097LE; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Malik AA, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02569-18; Mallikaarjun S, 2016, ANTIMICROB AGENTS CH, V60, P5976, DOI 10.1128/AAC.00509-16; Marks SM, 2017, CLIN INFECT DIS, V64, P1670, DOI 10.1093/cid/cix208; Metcalfe JZ, 2017, AM J RESP CRIT CARE, V196, P1191, DOI 10.1164/rccm.201703-0556OC; Miotto P, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01354-2017; Ndjeka N, 2015, INT J TUBERC LUNG D, V19, P979, DOI 10.5588/ijtld.14.0944; Nunn AJ, 2019, NEW ENGL J MED, V380, P1201, DOI 10.1056/NEJMoa1811867; Olayanju O, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00544-2018; Pai M, 2014, LANCET GLOB HEALTH, V2, pE189, DOI 10.1016/S2214-109X(14)70198-6; Pandie M, 2016, J ANTIMICROB CHEMOTH, V71, P1037, DOI 10.1093/jac/dkv447; Pooran A, 2019, LANCET GLOB HEALTH, V7, pE798, DOI 10.1016/S2214-109X(19)30164-0; Pribis JP, 2019, MOL CELL, V74, P785, DOI 10.1016/j.molcel.2019.02.037; Ragheb MN, 2019, MOL CELL, V73, P157, DOI 10.1016/j.molcel.2018.10.015; Rao M, 2019, INT J INFECT DIS, V80, pS62, DOI 10.1016/j.ijid.2019.01.039; Reid MJA, 2019, LANCET, V393, P1331, DOI 10.1016/S0140-6736(19)30024-8; Reimann M, 2019, INT J TUBERC LUNG D, V23, P93, DOI 10.5588/ijtld.18.0354; Rohilla M, 2016, CASE REP OBSTET GYNE, V2016; Schaaf HS, 2019, INDIAN J PEDIATR, V86, P717, DOI 10.1007/s12098-018-02846-8; Schnippel K, 2016, SAMJ S AFR MED J, V106, P30, DOI [10.7196/SAMJ.2016.v106i4.10205, 10.7196/samj.2016v106i4.10205]; Schnippel K, 2018, LANCET RESP MED, V6, P699, DOI 10.1016/S2213-2600(18)30235-2; Seddon JA, 2013, J INFECTION, V66, P320, DOI 10.1016/j.jinf.2012.09.002; Shah NS, 2014, CLIN INFECT DIS, V58, P381, DOI 10.1093/cid/cit643; Shangase ZP, 2017, ANN GLOB HEALTH, V83, P501, DOI 10.1016/j.aogh.2017.05.007; Sharma A, 2017, LANCET INFECT DIS, V17, P707, DOI 10.1016/S1473-3099(17)30247-5; Sharma SK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26990-5; Singla Neeta, 2009, Indian J Tuberc, V56, P206; Skrahin Aliaksandr, 2016, J Clin Tuberc Other Mycobact Dis, V4, P21; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Subbaraman R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001018; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; Svensson EM, 2014, ANTIMICROB AGENTS CH, V58, P6406, DOI 10.1128/AAC.03246-14; Theron G, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01696-17, 10.1128/jcm.01696-17]; Theron G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010705.pub3; Theron G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010705.pub2; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Thompson EG, 2017, TUBERCULOSIS, V107, P48, DOI 10.1016/j.tube.2017.08.004; Tiberi S, 2018, LANCET INFECT DIS, V18, pE183, DOI 10.1016/S1473-3099(18)30110-5; Tomasicchio M, 2016, SCI REP-UK, V6, DOI 10.1038/srep17850; University of Liverpool, 2019, HIV DRUG INT; US Department of Health and Human Services, 2019, AIDS INF DRUGS; Vashakidze SA, 2019, INT J INFECT DIS, V82, P66, DOI 10.1016/j.ijid.2019.02.039; Visca D, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02184-2018; von Groote-Bidlingmaier F, 2019, LANCET RESP MED, V7, P249, DOI [10.1016/S2213-2600(18)30426-0, 10.1016/s2213-2600(18)30426-0]; Wang MG, 2018, INFECT DRUG RESIST, V11, P873, DOI 10.2147/IDR.S164596; Weld ED, 2017, LANCET RESP MED, V5, P245, DOI 10.1016/S2213-2600(17)30078-4; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2010, ANT THER HIV INF AD; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; WHO, 2015, END TB STRATEGY; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2018, TECHN REP CRIT CONC; World Health Organization, 2018, US NEXT GEN SEQ TECH; World Health Organization, 2018, LAT TUB INF UPD CONS; Xie YL, 2017, NEW ENGL J MED, V377, P1043, DOI 10.1056/NEJMoa1614915; Zumla Alimuddin, 2016, Int J Mycobacteriol, V5 Suppl 1, pS21, DOI 10.1016/j.ijmyco.2016.09.044	92	108	120	10	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					953	966		10.1016/S0140-6736(19)31882-3	http://dx.doi.org/10.1016/S0140-6736(19)31882-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX7CE	31526739				2022-12-28	WOS:000485840600027
J	Malakof, D; Sugden, A				Malakof, David; Sugden, Andrew			HIGH LIVING	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1092	1093		10.1126/science.aaz3670	http://dx.doi.org/10.1126/science.aaz3670			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515379				2022-12-28	WOS:000485780800032
J	Deweerdt, S				Deweerdt, Sarah			The natural history of an epidemic	NATURE			English	Editorial Material							PAIN											Cerda M, 2015, J PEDIATR-US, V167, P605, DOI 10.1016/j.jpeds.2015.04.071; PORTENOY RK, 1986, PAIN, V25, P171, DOI 10.1016/0304-3959(86)90091-6; PORTER J, 1980, NEW ENGL J MED, V302, P123; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005	4	54	54	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					S10	S12		10.1038/d41586-019-02686-2	http://dx.doi.org/10.1038/d41586-019-02686-2			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511672				2022-12-28	WOS:000485415400007
J	Gelman, A; Greenland, S				Gelman, Andrew; Greenland, Sander			Are confidence intervals better termed "uncertainty intervals"?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gelman, Andrew] Columbia Univ, New York, NY 10027 USA; [Greenland, Sander] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Greenland, Sander] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gelman, A (corresponding author), Columbia Univ, New York, NY 10027 USA.	gelman@stat.columbia.edu; lesdomes@ucla.edu			US Office of Naval Research	US Office of Naval Research(Office of Naval Research)	AG thanks the US Office of Naval Research for partial support of this work.	Amrhein V, 2019, AM STAT, V73, P262, DOI 10.1080/00031305.2018.1543137; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Bowley AL, 1934, J R STAT SOC, V97, P607; Garmendia CA, 2019, JAMA INTERN MED, V179, P582, DOI 10.1001/jamainternmed.2018.7661; Gelman A, 2016, AM STAT, V70, P10; Gelman A, 2014, BAYESIAN DATA ANALYS; Gelman A, 2017, J AM STAT ASSOC, V112, P899, DOI 10.1080/01621459.2017.1311263; Greenland S, 2017, AM J EPIDEMIOL, V186, P639, DOI 10.1093/aje/kwx259; Lash TL, 2014, INT J EPIDEMIOL, V43, P1969, DOI 10.1093/ije/dyu149; McShane BB, 2019, AM STAT, V73, P235, DOI 10.1080/00031305.2018.1527253; Shirani-Mehr H, 2018, J AM STAT ASSOC, V113, P607, DOI 10.1080/01621459.2018.1448823; Vasishth S, 2018, J MEM LANG, V103, P151, DOI 10.1016/j.jml.2018.07.004; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; Welton NJ, 2009, J R STAT SOC A STAT, V172, P119, DOI 10.1111/j.1467-985X.2008.00548.x	14	31	32	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5381	10.1136/bmj.l5381	http://dx.doi.org/10.1136/bmj.l5381			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506269				2022-12-28	WOS:000486648900006
J	Kuehn, B				Kuehn, Bridget			Norovirus Outbreak	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					919	919		10.1001/jama.2019.12274	http://dx.doi.org/10.1001/jama.2019.12274			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY6YZ	31503314				2022-12-28	WOS:000486543500006
J	Lipoff, JB				Lipoff, Jules B.			Don't Fear the Reaper	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a dermatologist recalls his moments with his grandmother a fierce educator and administrator in the New York City Schools who taught him about life and death with advice and by example and whom he helped guide through her transition at 96 years-proud to be her medical advocate, sad to let her go.	[Lipoff, Jules B.] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lipoff, JB (corresponding author), Univ Penn, Dept Dermatol, 3737 Market St,Penn Med Univ City,Ste 1100, Philadelphia, PA 19104 USA.	jules.lipoff@pennmedicine.upenn.edu							0	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					929	930		10.1001/jama.2019.12602	http://dx.doi.org/10.1001/jama.2019.12602			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY6YZ	31503312				2022-12-28	WOS:000486543500012
J	Wise, J				Wise, Jacqui			GPs should provide tailored support to people bereaved by suicide, says NICE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2019, SUIC PREV QUAL STAND; Support after Suicide Partnership, HELP IS HAND SUPP SO; World Health Organization, 2019, SUIC WORLD GLOB HLTH	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5498	10.1136/bmj.l5498	http://dx.doi.org/10.1136/bmj.l5498			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506258				2022-12-28	WOS:000486648900014
J	Mosenzon, O; Leibowitz, G				Mosenzon, Ofri; Leibowitz, Gil			VERIFY the role of initial combination therapy in patients with type 2 diabetes	LANCET			English	Editorial Material									[Mosenzon, Ofri; Leibowitz, Gil] Hebrew Univ Jerusalem, Diabet Unit, Dept Endocrinol & Metab, Hadassah Med Ctr,Fac Med, IL-91905 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Mosenzon, O (corresponding author), Hebrew Univ Jerusalem, Diabet Unit, Dept Endocrinol & Metab, Hadassah Med Ctr,Fac Med, IL-91905 Jerusalem, Israel.	ofrim@hadassah.org.il						Abdul-Ghani MA, 2015, DIABETES OBES METAB, V17, P268, DOI 10.1111/dom.12417; [Anonymous], 1995, Diabetes, V44, P1249; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Francesco Grant Peter Cosentino, 2019, EUR HEART J, V41, P255, DOI [10.1093/eurheartj/ehz486, DOI 10.1093/EURHEARTJ/EHZ486]; Garber AJ, 2019, ENDOCR PRACT, V25, P69, DOI 10.4158/CS-2018-0535; Kristensen SL, 2019, LANCET DIABETES ENDO, V7, P776, DOI 10.1016/S2213-8587(19)30249-9; Laiteerapong N, 2019, DIABETES CARE, V42, P416, DOI 10.2337/dc17-1144; Leibowitz G, 2015, DIABETES OBES METAB, V17, P487, DOI 10.1111/dom.12445; Matthews DR, 2019, LANCET, V394, P1519, DOI 10.1016/S0140-6736(19)32131-2; Phung OJ, 2014, DIABETES OBES METAB, V16, P410, DOI [10.1111/dom.12233, 10.1111/dom.12235]; Raz I, 2013, DIABETES CARE, V36, pS190, DOI 10.2337/dcS13-2014; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X	12	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2019	394	10208					1483	1485		10.1016/S0140-6736(19)32165-8	http://dx.doi.org/10.1016/S0140-6736(19)32165-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JI3WL	31542294				2022-12-28	WOS:000493399500005
J	Vanezis, AP				Vanezis, Andrew Peter			The broken promise of remote ischaemic conditioning	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ANGIOPLASTY		[Vanezis, Andrew Peter] Royal Alexandra Hosp, CK Hui Heart Ctr, Edmonton, AB T5H 3V9, Canada	Royal Alexandra Hospital	Vanezis, AP (corresponding author), Royal Alexandra Hosp, CK Hui Heart Ctr, Edmonton, AB T5H 3V9, Canada.	andrew.vanezis@nhs.net	Vanezis, Andrew/AAX-2515-2020	Vanezis, Andrew/0000-0002-8569-7075				Andreka G, 2007, HEART, V93, P749, DOI 10.1136/hrt.2006.114504; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Davidson SM, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0704-z; Eitel I, 2015, EUR HEART J, V36, P3049, DOI 10.1093/eurheartj/ehv463; Gaspar A, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0672-3; Hassell MECJ, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000569; Hausenloy DJ, 2019, LANCET, V394, P1415, DOI 10.1016/S0140-6736(19)32039-2; Johnsen J, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0529-6; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; Munk K, 2010, CIRC-CARDIOVASC IMAG, V3, P656, DOI 10.1161/CIRCIMAGING.110.957340; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Traverse JH, 2019, CIRC RES, V124, P769, DOI 10.1161/CIRCRESAHA.118.314060	12	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2019	394	10207					1389	1390		10.1016/S0140-6736(19)32047-1	http://dx.doi.org/10.1016/S0140-6736(19)32047-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JE5IX	31500850	hybrid			2022-12-28	WOS:000490727200005
J	Bashford-Rogers, RJM; Bergamaschi, L; McKinney, EF; Pombal, DC; Mescia, F; Lee, JC; Thomas, DC; Flint, SM; Kellam, P; Jayne, DRW; Lyons, PA; Smith, KGC				Bashford-Rogers, R. J. M.; Bergamaschi, L.; McKinney, E. F.; Pombal, D. C.; Mescia, F.; Lee, J. C.; Thomas, D. C.; Flint, S. M.; Kellam, P.; Jayne, D. R. W.; Lyons, P. A.; Smith, K. G. C.			Analysis of the B cell receptor repertoire in six immune-mediated diseases	NATURE			English	Article							NUCLEOTIDE-SEQUENCE; PERIPHERAL-BLOOD; IMMUNOGLOBULIN; GRANULOMATOSIS; CLASSIFICATION; DIVERSITY; MECHANISM; CRITERIA; ORIGIN	B cells are important in the pathogenesis of many, and perhaps all, immune-mediated diseases. Each B cell expresses a single B cell receptor (BCR)(1), and the diverse range of BCRs expressed by the total B cell population of an individual is termed the 'BCR repertoire: Our understanding of the BCR repertoire in the context of immune-mediated diseases is incomplete, and defining this could provide new insights into pathogenesis and therapy. Here, we compared the BCR repertoire in systemic lupus erythematosus, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, Crohn's disease, Behcet's disease, eosinophilic granulomatosis with polyangiitis, and immunoglobulin A (IgA) vasculitis by analysing BCR clonality, use of immunoglobulin heavy-chain variable region (IGHV) genes and-in particular-isotype use. An increase in clonality in systemic lupus erythematosus and Crohn's disease that was dominated by the IgA isotype, together with skewed use of the IGHV genes in these and other diseases, suggested a microbial contribution to pathogenesis. Different immun o suppressive treatments had specific and distinct effects on the repertoire; B cells that persisted after treatment with rituximab were predominately isotype-switched and clonally expanded, whereas the inverse was true for B cells that persisted after treatment with mycophenolate mofetil. Our comparative analysis of the BCR repertoire in immunemediated disease reveals a complex B cell architecture, providing a platform for understanding pathological mechanisms and designing treatment strategies.	[Bashford-Rogers, R. J. M.; Bergamaschi, L.; McKinney, E. F.; Pombal, D. C.; Mescia, F.; Lee, J. C.; Thomas, D. C.; Flint, S. M.; Jayne, D. R. W.; Lyons, P. A.; Smith, K. G. C.] Univ Cambridge, Dept Med, Cambridge, England; [Bashford-Rogers, R. J. M.] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England; [Bergamaschi, L.; McKinney, E. F.; Pombal, D. C.; Mescia, F.; Lee, J. C.; Lyons, P. A.; Smith, K. G. C.] Univ Cambridge, Jeffrey Cheah Biomed Ctr, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge, England; [Kellam, P.] Imperial Coll, Div Infect Dis, Dept Med, London, England; [Flint, S. M.] GlaxoSmithKline, Immunoinflammat Therapy Area Unit, Stevenage, Herts, England	University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; Imperial College London; GlaxoSmithKline	Bashford-Rogers, RJM; Smith, KGC (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.; Bashford-Rogers, RJM (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Oxford, England.; Smith, KGC (corresponding author), Univ Cambridge, Jeffrey Cheah Biomed Ctr, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge, England.	rbr1@well.ox.ac.uk; kgcs2@cam.ac.uk	Mescia, Federica/ABE-1176-2020; Lee, James/ABD-5920-2020; Bergamaschi, Laura/ABE-1175-2020	Mescia, Federica/0000-0002-2759-4027; Lee, James/0000-0001-5711-9385; Bashford-Rogers, Rachael/0000-0002-6838-0711; Thomas, David/0000-0002-9738-2329; Jayne, David/0000-0002-1712-0637; Smith, Kenneth/0000-0003-3829-4326	Wellcome Trust [WT106068AIA, 083650/Z/07/Z]; EU [733100]; UK Medical Research Council [MR/L019027]; UK National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre; MRC [MR/L019027/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grants WT106068AIA and 083650/Z/07/Z), the EU H2020 project SYSCID (grant 733100), the UK Medical Research Council (program grant MR/L019027) and the UK National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre. We thank the patients who participated in this study; V. Morrison; A. Reynolds; all NIHR Cambridge BioResource staff and volunteers; the Cambridge NIHR BRC Cell Phenotyping Hub (particularly A. Petrunkina Harrison, N. S. Yarkoni, E. Perez, S. McCallum and C. Bowman); F. Alberici, N. Noor and other members of the Addenbrooke's Vasculitis and Gastroenterology services; N. E. Urquijo for discussions about network subsampling, and P. Naydenova; and G. Manferrari. We are grateful to J. A. Todd and D. M. Tarlinton for reading the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anolik JH, 2007, ARTHRITIS RHEUM, V56, P3044, DOI 10.1002/art.22810; Bashford-Rogers RJM, 2016, LEUKEMIA, V30, P2312, DOI 10.1038/leu.2016.142; Bashford-Rogers RJM, 2013, GENOME RES, V23, P1874, DOI 10.1101/gr.154815.113; Bende RJ, 2016, HAEMATOLOGICA, V101, DOI 10.3324/haematol.2015.139626; Croote D, 2018, SCIENCE, V362, P1306, DOI 10.1126/science.aau2599; Davydov AN, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02309; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Ellis JA, 2005, J HUM GENET, V50, P534, DOI 10.1007/s10038-005-0289-x; Espeli M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09434-0; Fanger, 2000, INSTANT NOTES IMMUNO; Galeone Massimiliano, 2012, Patholog Res Int, V2012, P595380, DOI 10.1155/2012/595380; Giltiay NV, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3918; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Horns F, 2016, ELIFE, V5, DOI [10.7554/eLife.16578, 10.7554/eLife.23066]; JAYNE DRW, 1995, QJM-MON J ASSOC PHYS, V88, P127; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Karnell JL, 2011, J IMMUNOL, V187, P3603, DOI 10.4049/jimmunol.1003319; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P633, DOI 10.1101/pdb.ip85; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Macallan DC, 2005, BLOOD, V105, P3633, DOI 10.1182/blood-2004-09-3740; MANGER BJ, 1985, SCAND J IMMUNOL, V21, P369, DOI 10.1111/j.1365-3083.1985.tb01443.x; Marioni RE, 2017, J ALZHEIMERS DIS, V57, P275, DOI 10.3233/JAD-161070; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Mei HE, 2010, BLOOD, V116, P5181, DOI 10.1182/blood-2010-01-266536; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; NOSSAL GJV, 1958, NATURE, V181, P1419, DOI 10.1038/1821383a0; PASCUAL V, 1991, J IMMUNOL, V146, P4385; Petrova VN, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01784; Saunders SP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00715; Schickel JN, 2017, J EXP MED, V214, P1991, DOI 10.1084/jem.20160201; Seifert M, 2016, LEUKEMIA, V30, P2283, DOI 10.1038/leu.2016.226; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stavnezer J, 2014, J IMMUNOL, V193, P5370, DOI 10.4049/jimmunol.1401849; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Villalta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071458; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Wechsler ME, 2017, NEW ENGL J MED, V376, P1921, DOI 10.1056/NEJMoa1702079; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00	48	83	84	4	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					122	+		10.1038/s41586-019-1595-3	http://dx.doi.org/10.1038/s41586-019-1595-3			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31554970	Green Accepted, Green Submitted			2022-12-28	WOS:000488832500043
J	Mahase, E				Mahase, Elisabeth			Research evaluating AI for diagnosing disease is weak, finds review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HAWKES N, 2019, BMJ-BRIT MED J, V366, P75511, DOI DOI 10.1136/BMJ.L5011; Liu X, 2019, LANCET DIGITAL HLTH	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2019	366								l5714	10.1136/bmj.l5714	http://dx.doi.org/10.1136/bmj.l5714			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WY	31551297				2022-12-28	WOS:000488488700009
J	Cohen, D				Cohen, Deborah			Avastin: drug regulator clears way for use for wet AMD	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cohen D., 2018, BBC NEWS; COHEN D, 2015, BMJ-BRIT MED J, V350, DOI [DOI 10.1136/bmj.h1654, DOI 10.1136/BMJ.H1654]; Cohen D, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k4035	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5701	10.1136/bmj.l5701	http://dx.doi.org/10.1136/bmj.l5701			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551338				2022-12-28	WOS:000488488300013
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: The importance of coffee	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Hall LH, 2019, BRIT J GEN PRACT, V69, pE507, DOI 10.3399/bjgp19X702713; Montgomery A, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4774	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5519	10.1136/bmj.l5519	http://dx.doi.org/10.1136/bmj.l5519			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551231	Bronze			2022-12-28	WOS:000488488300003
J	Majesty, H; Mswati, IK				Majesty, His; Mswati, Ingwenyama King, III			An Africa free of malaria	LANCET			English	Editorial Material									[Majesty, His; Mswati, Ingwenyama King, III] Lozitha Palace, Kwaluseni M201, MERSEYSI		Mswati, IK (corresponding author), Lozitha Palace, Kwaluseni M201, MERSEYSI.	nlushaba@kingsoffice.sz						African Leaders Malaria Alliance, 2019, KING MSW 3 LAUNCH EN; African Union, 2016, CAT FRAM END AIDS TB; African Union Department of Social Affairs, 2016, AFR HLTH STRAT 2016; New Partnership for Africa's Development. African Union Commission, 2015, AG 2063 AFR WE WANT; WHO, 1957, EXP COMM MAL; WHO, 1955, 8 WORLD HLTH ASS; WHO, 1955, REP DIR GEN 1954; WHO, 2008, GLOB MAL CONTR EL RE; WHO UNICEF, 2015, ACH MAL MDG TARG REV; World Health Organization, 2018, WORLD MAL REP 2018	10	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					988	989		10.1016/S0140-6736(19)31952-X	http://dx.doi.org/10.1016/S0140-6736(19)31952-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31511195				2022-12-28	WOS:000487038700008
J	Mahase, E				Mahase, Elisabeth			Penalty system for free prescription claims must be "more humane," say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, P62957, DOI DOI 10.1136/BMJ.L651; MAHASE E, 2019, BMJ-BRIT MED J, V365, P62957, DOI DOI 10.1136/BMJ.L2200	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2019	366								l5660	10.1136/bmj.l5660	http://dx.doi.org/10.1136/bmj.l5660			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WG	31540893				2022-12-28	WOS:000487759700006
J	Puddu, F; Herzog, M; Selivanova, A; Wang, SY; Zhu, J; Klein-Lavi, S; Gordon, M; Meirman, R; Millan-Zambrano, G; Ayestaran, I; Salguero, I; Sharan, R; Li, R; Kupiec, M; Jackson, SP				Puddu, Fabio; Herzog, Mareike; Selivanova, Alexandra; Wang, Siyue; Zhu, Jin; Klein-Lavi, Shir; Gordon, Molly; Meirman, Roi; Millan-Zambrano, Gonzalo; Ayestaran, Inigo; Salguero, Israel; Sharan, Roded; Li, Rong; Kupiec, Martin; Jackson, Stephen P.			Genome architecture and stability in the Saccharomyces cerevisiae knockout collection	NATURE			English	Article							YEAST GENES; DNA; ANEUPLOIDY; PATHWAY; IDENTIFICATION; REPLICATION; POLYMERASE; SEQUENCES; MUTATION; MUTANTS	Despite major progress in defining the functional roles of genes, a complete understanding of their influences is far from being realized, even in relatively simple organisms. A major milestone in this direction arose via the completion of the yeast Saccharomyces cerevisiae gene-knockout collection (YKOC), which has enabled high-throughput reverse genetics, phenotypic screenings and analyses of synthetic-genetic interactions(1-3). Ensuing experimental work has also highlighted some inconsistencies and mistakes in the YKOC, or genome instability events that rebalance the effects of specific knockouts(4-6), but a complete overview of these is lacking. The identification and analysis of genes that are required for maintaining genomic stability have traditionally relied on reporter assays and on the study of deletions of individual genes, but whole-genome-sequencing technologies now enable-in principle-the direct observation of genome instability globally and at scale. To exploit this opportunity, we sequenced the whole genomes of nearly all of the 4,732 strains comprising the homozygous diploid YKOC. Here, by extracting information on copy-number variation of tandem and interspersed repetitive DNA elements, we describe-for almost every single non-essential gene-the genomic alterations that are induced by its loss. Analysis of this dataset reveals genes that affect the maintenance of various genomic elements, highlights cross-talks between nuclear and mitochondrial genome stability, and shows how strains have genetically adapted to life in the absence of individual non-essential genes.	[Puddu, Fabio; Herzog, Mareike; Selivanova, Alexandra; Wang, Siyue; Millan-Zambrano, Gonzalo; Ayestaran, Inigo; Salguero, Israel; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust CRUK Gurdon Inst, Cambridge, England; [Puddu, Fabio; Herzog, Mareike; Selivanova, Alexandra; Wang, Siyue; Ayestaran, Inigo; Salguero, Israel; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge, England; [Puddu, Fabio; Herzog, Mareike] Wellcome Sanger Inst, Hinxton, England; [Zhu, Jin; Gordon, Molly; Li, Rong] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD USA; [Klein-Lavi, Shir; Meirman, Roi; Kupiec, Martin] Tel Aviv Univ, Sch Mol Cell Biol & Biotechnol, Tel Aviv, Israel; [Millan-Zambrano, Gonzalo] Univ Cambridge, Dept Pathol, Cambridge, England; [Sharan, Roded] Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Johns Hopkins University; Tel Aviv University; University of Cambridge; Tel Aviv University	Puddu, F; Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust CRUK Gurdon Inst, Cambridge, England.; Puddu, F; Jackson, SP (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.; Puddu, F (corresponding author), Wellcome Sanger Inst, Hinxton, England.	f.puddu@gurdon.cam.ac.uk; s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Millan-Zambrano, Gonzalo/AAA-5562-2020; Puddu, Fabio/A-5359-2011	Jackson, Stephen Philip/0000-0001-9317-7937; Millan-Zambrano, Gonzalo/0000-0002-4530-6359; Puddu, Fabio/0000-0002-2033-5209; Ayestaran, Inigo/0000-0003-0335-195X; Herzog, Mareike/0000-0001-9747-2327	Wellcome [101126/Z/13/Z, 206388/Z/17/Z, 098051, WT203144]; Cancer Research UK [C6/A18796, C6946/A24843]; National Institutes of Health [R35 GM118172]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R35GM118172] Funding Source: NIH RePORTER	Wellcome; Cancer Research UK(Cancer Research UK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Warringer for providing the YKOC and discussing results; E. Alonso-Perez for help with YKOC management; the Cancer Genome Project and DNA sequencing pipelines at the Wellcome Sanger Institute for help with sample submission, tracking, library preparation and sequencing; C. Bradshaw for help with HPC cluster and nanopore sequencing; R. Wellinger for providing mutant strains; V. Mustonen, I. Vazquez-Garcia, M. Stratton, D. Adams, S. Nik-Zainal and members of the laboratory of S.P.J. for advice. This research was supported by: Wellcome Strategic Award 101126/Z/13/Z (COMSIG); Wellcome Investigator Award 206388/Z/17/Z; Wellcome PhD Fellowship 098051 to M.H.; Cancer Research UK Programme Grant C6/A18796; Cancer Research UK C6946/A24843 and Wellcome WT203144 Institute Core Funding; and the National Institutes of Health R35 GM118172 to R.L.	Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Ben-Shitrit T, 2012, NAT METHODS, V9, P373, DOI [10.1038/NMETH.1890, 10.1038/nmeth.1890]; Carlsson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052094; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Daniel JA, 2006, GENETICS, V172, P53, DOI 10.1534/genetics.105.046441; Endo K, 2007, GENES GENET SYST, V82, P35, DOI 10.1266/ggs.82.35; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Hendry JA, 2015, G3-GENES GENOM GENET, V5, P997, DOI 10.1534/g3.115.016576; Herzog M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24400-4; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ide S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003410; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lehner KR, 2007, GENETICS, V177, P1951, DOI 10.1534/genetics.107.079368; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; LIEFSHITZ B, 1995, GENETICS, V140, P1199; Mansisidor A, 2018, MOL CELL, V72, P583, DOI 10.1016/j.molcel.2018.08.036; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; MURRAY AW, 1986, CELL, V45, P529, DOI 10.1016/0092-8674(86)90284-9; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Pereira C, 2018, BBA-BIOENERGETICS, V1859, P591, DOI 10.1016/j.bbabio.2018.04.011; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Rog O, 2005, CURR GENET, V47, P18, DOI 10.1007/s00294-004-0548-y; Rubinstein L, 2014, NUCLEIC ACIDS RES, V42, P6314, DOI 10.1093/nar/gku267; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Saka K, 2016, NUCLEIC ACIDS RES, V44, P4211, DOI 10.1093/nar/gkw110; Seibt KM, 2018, BIOINFORMATICS, V34, P3575, DOI 10.1093/bioinformatics/bty395; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Leeuwen J, 2016, SCIENCE, V354, DOI 10.1126/science.aag0839; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vernon M, 2008, GENETICS, V179, P237, DOI 10.1534/genetics.107.086603; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Yona AH, 2012, P NATL ACAD SCI USA, V109, P21010, DOI 10.1073/pnas.1211150109; Zhu J, 2015, G3-GENES GENOM GENET, V5, P1043, DOI 10.1534/g3.115.017913; Zou XQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04052-8	48	26	27	4	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					416	+		10.1038/s41586-019-1549-9	http://dx.doi.org/10.1038/s41586-019-1549-9			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31511699	Green Submitted, Green Accepted			2022-12-28	WOS:000486647800050
J	Warren, OU; Blackwood, B				Warren, Otis U.; Blackwood, Benjamin			Acquired Methemoglobinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 25-year-old woman presented with weakness, fatigue, shortness of breath, and skin discoloration. Her oxygen saturation of 88% did not improve with the use of supplemental oxygen. A diagnosis of methemoglobinemia was made.	[Warren, Otis U.; Blackwood, Benjamin] Miriam Hosp, Providence, RI 02906 USA	Lifespan Health Rhode Island; Miriam Hospital	Warren, OU (corresponding author), Miriam Hosp, Providence, RI 02906 USA.	otis.warren@brownphysicians.org							0	7	8	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1158	1158		10.1056/NEJMicm1816026	http://dx.doi.org/10.1056/NEJMicm1816026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4PY	31532963				2022-12-28	WOS:000487066900010
J	Witze, A				Witze, Alexandra			Dramatic sea-ice melt caps tough Arctic summer	NATURE			English	News Item																			0	5	5	1	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					320	321		10.1038/d41586-019-02653-x	http://dx.doi.org/10.1038/d41586-019-02653-x			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31530916	Bronze			2022-12-28	WOS:000486647800017
J	Loupy, A; Aubert, O; Orandi, BJ; Naesens, M; Bouatou, Y; Raynaud, M; Divard, G; Jackson, AM; Viglietti, D; Giral, M; Kamar, N; Thaunat, O; Morelon, E; Delahousse, M; Kuypers, D; Hertig, A; Rondeau, E; Bailly, E; Eskandary, F; Bohmig, G; Gupta, G; Glotz, D; Legendre, C; Montgomery, RA; Stegall, MD; Empana, JP; Jouven, X; Segev, DL; Lefaucheur, C				Loupy, Alexandre; Aubert, Olivier; Orandi, Babak J.; Naesens, Maarten; Bouatou, Yassine; Raynaud, Marc; Divard, Gillian; Jackson, Annette M.; Viglietti, Denis; Giral, Magali; Kamar, Nassim; Thaunat, Olivier; Morelon, Emmanuel; Delahousse, Michel; Kuypers, Dirk; Hertig, Alexandre; Rondeau, Eric; Bailly, Elodie; Eskandary, Farsad; Bohmig, Georg; Gupta, Gaurav; Glotz, Denis; Legendre, Christophe; Montgomery, Robert A.; Stegall, Mark D.; Empana, Jean-Philippe; Jouven, Xavier; Segev, Dorry L.; Lefaucheur, Carmen			Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIBODY-MEDIATED REJECTION; TERM GRAFT-SURVIVAL; RANDOMIZED-TRIAL; END-POINTS; FAILURE; OUTCOMES; BIOPSY; MODELS	OBJECTIVE To develop and validate an integrative system to predict long term kidney allograft failure. DESIGN International cohort study. SETTING Three cohorts including kidney transplant recipients from 10 academic medical centres from Europe and the United States. PARTICIPANTS Derivation cohort: 4000 consecutive kidney recipients prospectively recruited in four French centres between 2005 and 2014. Validation cohorts: 2129 kidney recipients from three centres in Europe and 1428 from three centres in North America, recruited between 2002 and 2014. Additional validation in three randomised controlled trials (NCT01079143, EudraCT 2007-003213-13, and NCT01873157). MAIN OUTCOME MEASURE Allograft failure (return to dialysis or pre-emptive retransplantation). 32 candidate prognostic factors for kidney allograft survival were assessed. RESULTS Among the 7557 kidney transplant recipients included, 1067 (14.1%) allografts failed after a median post-transplant follow-up time of 7.12 (interquartile range 3.51-8.77) years. In the derivation cohort, eight functional, histological, and immunological prognostic factors were independently associated with allograft failure and were then combined into a risk prediction score (iBox). This score showed accurate calibration and discrimination (C index 0.81, 95% confidence interval 0.79 to 0.83). The performance of the iBox was also confirmed in the validation cohorts from Europe (C index 0.81, 0.78 to 0.84) and the US (0.80, 0.76 to 0.84). The iBox system showed accuracy when assessed at different times of evaluation post-transplant, was validated in different clinical scenarios including type of immunosuppressive regimen used and response to rejection therapy, and outperformed previous risk prediction scores as well as a risk score based solely on functional parameters including estimated glomerular filtration rate and proteinuria. Finally, the accuracy of the iBox risk score in predicting long term allograft loss was confirmed in the three randomised controlled trials. CONCLUSION An integrative, accurate, and readily implementable risk prediction score for kidney allograft failure has been developed, which shows generalisability across centres worldwide and common clinical scenarios. The iBox risk prediction score may help to guide monitoring of patients and further improve the design and development of a valid and early surrogate endpoint for clinical trials.	[Loupy, Alexandre; Aubert, Olivier; Bouatou, Yassine; Raynaud, Marc; Divard, Gillian; Viglietti, Denis; Glotz, Denis; Legendre, Christophe; Jouven, Xavier; Lefaucheur, Carmen] Univ Paris, INSERM, Paris Translat Res Ctr Organ Transplantat, Paris, France; [Loupy, Alexandre; Aubert, Olivier] Hop Necker Enfants Malad, AP HP, Kidney Transplant Dept, Paris, France; [Orandi, Babak J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Naesens, Maarten; Kuypers, Dirk] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Jackson, Annette M.] Duke Univ, Dept Surg, Sch Med, Durham, NC USA; [Viglietti, Denis; Lefaucheur, Carmen] St Louis Hosp, AP HP, Kidney Transplant Dept, Paris, France; [Giral, Magali] Ctr Hosp Univ Nantes, Dept Nephrol, Nantes, France; [Kamar, Nassim] Univ Paul Sabatier, Dept Nephrol & Organ Transplantat, INSERM, CHU Rangueil Purpan, Toulouse, France; [Thaunat, Olivier; Morelon, Emmanuel] Hosp Civils Lyon, Dept Transplantat Nephrol & Clin Immunol, Lyon, France; [Delahousse, Michel] Foch Hosp, Dept Transplantat Nephrol & Clin Immunol, Suresnes, France; [Hertig, Alexandre; Rondeau, Eric; Bailly, Elodie] Tenon Hosp, AP HP, Kidney Transplant Dept, Paris, France; [Eskandary, Farsad; Bohmig, Georg] Gen Hosp Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria; [Gupta, Gaurav] Virginia Commonwealth Univ Sch Med, Dept Internal Med, Div Nephrol, Richmond, VA USA; [Montgomery, Robert A.] NYU, Langone Transplant Inst, New York, NY USA; [Stegall, Mark D.] Mayo Clin, William J Liebig Ctr Transplantat & Clin Regenera, Rochester, MN USA; [Empana, Jean-Philippe] Pompidou Hosp, AP HP, Cardiol & Heart Transplant Dept, Paris, France; [Segev, Dorry L.] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; KU Leuven; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Lyon; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; New York University; Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University	Loupy, A (corresponding author), Univ Paris, INSERM, Paris Translat Res Ctr Organ Transplantat, Paris, France.; Loupy, A (corresponding author), Hop Necker Enfants Malad, AP HP, Kidney Transplant Dept, Paris, France.	alexandre.loupy@inserm.fr	lefaucheur, carmen/AAS-7494-2020; Empana, Jean-Philippe/AAF-6923-2021; Aubert, Olivier/K-8526-2019; Loupy, Alexandre/K-8512-2019; Stegall, Mark/AAX-6496-2020; Bailly, Elodie/AAF-7022-2020; Gupta, Gaurav/AAX-4935-2020; Divard, Gillian/AAE-7226-2019; Kamar, Nassim/L-6462-2014	Empana, Jean-Philippe/0000-0002-1469-7772; Stegall, Mark/0000-0002-1392-0792; Bailly, Elodie/0000-0001-6740-3961; Divard, Gillian/0000-0002-3450-0033; Thaunat, Olivier/0000-0002-3648-8963; Loupy, Alexandre/0000-0003-3388-7747; Kamar, Nassim/0000-0003-1930-8964	INSERM-Action thematique incitative sur programme Avenir (ATIP-Avenir); Fondation Bettencourt Schueller; Research Foundation, Flanders (FWO) [IWT.150199]; Flanders Innovation and Entrepreneurship of the Flemish government [IWT.130758]; Clinical Research Foundation of the University Hospitals Leuven; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR003097] Funding Source: NIH RePORTER	INSERM-Action thematique incitative sur programme Avenir (ATIP-Avenir); Fondation Bettencourt Schueller; Research Foundation, Flanders (FWO)(FWO); Flanders Innovation and Entrepreneurship of the Flemish government; Clinical Research Foundation of the University Hospitals Leuven; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	INSERM-Action thematique incitative sur programme Avenir (ATIP-Avenir) provided financial support; OA received a grant from the Fondation Bettencourt Schueller; MN received grants from the Research Foundation, Flanders (FWO; IWT.150199), the Flanders Innovation and Entrepreneurship of the Flemish government (IWT.130758), and the Clinical Research Foundation of the University Hospitals Leuven.	Coemans M, 2018, KIDNEY INT, V94, P964, DOI 10.1016/j.kint.2018.05.018; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eskandary F, 2018, J AM SOC NEPHROL, V29, P591, DOI 10.1681/ASN.2017070818; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Gonzales MM, 2016, J AM SOC NEPHROL, V27, P3165, DOI 10.1681/ASN.2015070811; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; He X, 2009, TRANSPLANTATION, V87, P384, DOI 10.1097/TP.0b013e31819004a1; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hosmer D. W., 2000, APPL LOGISTIC REGRES, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Kaplan B, 2003, AM J TRANSPLANT, V3, P1560, DOI 10.1046/j.1600-6135.2003.00275.x; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mills KT, 2015, KIDNEY INT, V88, P950, DOI 10.1038/ki.2015.230; Moore J, 2011, AM J KIDNEY DIS, V57, P744, DOI 10.1053/j.ajkd.2010.12.017; Naesens M, 2016, J AM SOC NEPHROL, V27, P281, DOI 10.1681/ASN.2015010062; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Perl J, 2014, CLIN J AM SOC NEPHRO, V9, P1153, DOI 10.2215/CJN.04670514; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Premaud A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180236; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Rostaing L, 2015, AM J TRANSPLANT, V15, P1303, DOI 10.1111/ajt.13132; Sautenet B, 2016, TRANSPLANTATION, V100, P391, DOI 10.1097/TP.0000000000000958; Schold JD, 2010, AM J TRANSPLANT, V10, P1163, DOI 10.1111/j.1600-6143.2010.03104.x; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Shabir S, 2014, AM J KIDNEY DIS, V63, P643, DOI 10.1053/j.ajkd.2013.10.059; Stegall MD, 2016, AM J TRANSPLANT, V16, P1094, DOI 10.1111/ajt.13582; Uno H, 2013, STAT MED, V32, P2430, DOI 10.1002/sim.5647; Vincenti F, 2016, NEW ENGL J MED, V374, P333, DOI 10.1056/NEJMoa1506027; Yilmaz S, 2003, J AM SOC NEPHROL, V14, P773, DOI 10.1097/01.ASN.0000054496.68498.13	32	124	127	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l4923	10.1136/bmj.l4923	http://dx.doi.org/10.1136/bmj.l4923			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530561	Green Published, hybrid			2022-12-28	WOS:000487758600001
J	Watson, R				Watson, Rory			Brexit: European health experts emphasise dangers to patient safety of no deal	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		O'Dowd A., 2019, BMJ-BRIT MED J, V366, DOI [10.1136/bmj.l552931515260, DOI 10.1136/BMJ.L552931515260]	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l5583	10.1136/bmj.l5583	http://dx.doi.org/10.1136/bmj.l5583			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VP	31527044				2022-12-28	WOS:000487758000012
J	Kotochigova, S				Kotochigova, Svetlana			Making perfectly controlled arrays of molecules at rest	SCIENCE			English	Editorial Material									[Kotochigova, Svetlana] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kotochigova, S (corresponding author), Temple Univ, Dept Phys, Philadelphia, PA 19122 USA.	skotoch@temple.edu			NSF [PHY-1908637]; AFOSR [FA9550-14-1-0321]	NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Supported by NSF grant PHY-1908637 and AFOSR grant FA9550-14-1-0321.	Anderegg L, 2019, SCIENCE, V365, P1156, DOI 10.1126/science.aax1265; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; Jones KM, 2006, REV MOD PHYS, V78, P483, DOI 10.1103/RevModPhys.78.483; Kendrick BK, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5014989; Kozyryev I, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.173201; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Truppe S, 2017, NAT PHYS, V13, P1173, DOI 10.1038/NPHYS4241	8	0	0	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1079	1079		10.1126/science.aay3989	http://dx.doi.org/10.1126/science.aay3989			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515372				2022-12-28	WOS:000485780800023
J	Mayor, S				Mayor, Susan			UK maternity services: audit finds wide variation in birth complications	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Maternity and Perinatal Audit, 2019, CLIN REP 2019; WISE J, 2019, BMJ-BRIT MED J, V366, P9602, DOI DOI 10.1136/BMJ.L4678	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5568	10.1136/bmj.l5568	http://dx.doi.org/10.1136/bmj.l5568			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519765				2022-12-28	WOS:000486649800016
J	Reinhold, AS; Sanguinetti-Scheck, JI; Hartmann, K; Brecht, M				Reinhold, Annika Stefanie; Sanguinetti-Scheck, Juan Ignacio; Hartmann, Konstantin; Brecht, Michael			Behavioral and neural correlates of hide-and-seek in rats	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; PLAY-BEHAVIOR	Evolutionary, cognitive, and neural underpinnings of mammalian play are not yet fully elucidated. We played hide-and-seek, an elaborate role-play game, with rats. We did not offer food rewards but engaged in playful interactions after finding or being found. Rats quickly learned the game and learned to alternate between hiding versus seeking roles. They guided seeking by vision and memories of past hiding locations and emitted game event-specific vocalizations. When hiding, rats vocalized infrequently and they preferred opaque over transparent hiding enclosures, a preference not observed during seeking. Neuronal recordings revealed intense prefrontal cortex activity that varied with game events and trial types ("hide" versus "seek") and might instruct role play. The elaborate cognitive capacities for hide-and-seek in rats suggest that this game might be evolutionarily old.	[Reinhold, Annika Stefanie; Sanguinetti-Scheck, Juan Ignacio; Hartmann, Konstantin; Brecht, Michael] Humboldt Univ, Bernstein Ctr Computat Neurosci Berlin, Philippstr 13,Haus 6, D-10115 Berlin, Germany; [Brecht, Michael] Humboldt Univ, NeuroCure Cluster Excellence, Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Brecht, M (corresponding author), Humboldt Univ, Bernstein Ctr Computat Neurosci Berlin, Philippstr 13,Haus 6, D-10115 Berlin, Germany.; Brecht, M (corresponding author), Humboldt Univ, NeuroCure Cluster Excellence, Berlin, Germany.	michael.brecht@bccn-berlin.de		Reinhold, Annika/0000-0002-7841-2270; Brecht, Michael/0000-0002-5387-0953; Sanguinetti-Scheck, Juan Ignacio/0000-0002-2511-208X; Hartmann, Konstantin/0000-0001-9714-8607	Bernstein Center for Computational Neuroscience Berlin; Humboldt-Universitat zu Berlin; BrainPlay-ERC-Synergy grant; Leibniz prize; German Academic Scholarship Foundation	Bernstein Center for Computational Neuroscience Berlin; Humboldt-Universitat zu Berlin; BrainPlay-ERC-Synergy grant; Leibniz prize(German Research Foundation (DFG)); German Academic Scholarship Foundation	This study was supported by the Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universitat zu Berlin, a BrainPlay-ERC-Synergy grant, and a Leibniz prize to M. B. K. H. is funded by a stipend from the German Academic Scholarship Foundation.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Burke CJ, 2017, BEHAV PROCESS, V144, P72, DOI 10.1016/j.beproc.2017.09.014; Dayan P, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.001.2007; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Heyes CM, 1998, BEHAV BRAIN SCI, V21, P101, DOI 10.1017/S0140525X98000703; Himmler SM, 2016, BEHAVIOUR, V153, P1103, DOI 10.1163/1568539X-00003307; HOMMEL G, 1989, BIOMETRIKA, V76, P624, DOI 10.1093/biomet/76.3.624; Huizinga J., 1998, HOMOLUDENS STUDY PLA; Ishiyama S, 2016, SCIENCE, V354, P757, DOI 10.1126/science.aah5114; Karlsson MP, 2012, SCIENCE, V338, P135, DOI 10.1126/science.1226518; Kobak D, 2016, ELIFE, V5, DOI 10.7554/eLife.10989; Lee E, 2016, J NEUROSCI, V36, P6926, DOI 10.1523/JNEUROSCI.0307-16.2016; LILLARD AS, 1993, CHILD DEV, V64, P348, DOI 10.2307/1131255; Lopes G, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00007; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pellis SM, 2007, CURR DIR PSYCHOL SCI, V16, P95, DOI 10.1111/j.1467-8721.2007.00483.x; Pellis SM, 1997, NEUROSCI BIOBEHAV R, V21, P105, DOI 10.1016/0149-7634(95)00060-7; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; Schneider M, 2005, NEUROPSYCHOPHARMACOL, V30, P944, DOI 10.1038/sj.npp.1300634; Seyfarth RM, 2013, P NATL ACAD SCI USA, V110, P10349, DOI 10.1073/pnas.1301223110; Siviy SM, 2016, BEHAVIOUR, V153, P819, DOI 10.1163/1568539X-00003349; Trafton J. G., 2006, 1st Annual Conference on Human-Robot Interaction, P242; Vanderschuren LJMJ, 1997, NEUROSCI BIOBEHAV R, V21, P309, DOI 10.1016/S0149-7634(96)00020-6; Wiese E, 2018, COGN AFFECT BEHAV NE, V18, P837, DOI 10.3758/s13415-018-0608-2	27	29	29	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1180	+		10.1126/science.aax4705	http://dx.doi.org/10.1126/science.aax4705			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515395				2022-12-28	WOS:000485780800050
J	Alvarez, SA; Gibbs, SJ; Bown, PR; Kim, H; Sheward, RM; Ridgwell, A				Alvarez, Sarah A.; Gibbs, Samantha J.; Bown, Paul R.; Kim, Hojung; Sheward, Rosie M.; Ridgwell, Andy			Diversity decoupled from ecosystem function and resilience during mass extinction recovery	NATURE			English	Article							EARLY EOCENE; LATE PALEOCENE; ASTRONOMICAL CALIBRATION; CALCAREOUS NANNOPLANKTON; SOUTH ATLANTIC; BIODIVERSITY LOSS; STABLE-ISOTOPE; CARBON; OCEAN; PRODUCTIVITY	The Chicxulub bolide impact 66 million years ago drove the near-instantaneous collapse of ocean ecosystems. The devastating loss of diversity at the base of ocean food webs probably triggered cascading extinctions across all trophic levels(1-3) and caused severe disruption of the biogeochemical functions of the ocean, and especially disrupted the cycling of carbon between the surface and deep sea(4,5). The absence of sufficiently detailed biotic data that span the post-extinction interval has limited our understanding of how ecosystem resilience and biochemical function was restored; estimates(6-8) of ecosystem 'recovery' vary from less than 100 years to 10 million years. Here, using a 13-million-year-long nannoplankton time series, we show that post-extinction communities exhibited 1.8 million years of exceptional volatility before a more stable equilibrium-state community emerged that displayed hallmarks of resilience. The transition to this new equilibrium-state community with a broader spectrum of cell sizes coincides with indicators of carbon-cycle restoration and a fully functioning biological pump(9). These findings suggest a fundamental link between ecosystem recovery and biogeochemical cycling over timescales that are longer than those suggested by proxies of export production(7,8), but far shorter than the return of taxonomic richness(6). The fact that species richness remained low as both community stability and biological pump efficiency re-emerged suggests that ecological functions rather than the number of species are more important to community resilience and biochemical functions.	[Alvarez, Sarah A.] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Alvarez, Sarah A.; Bown, Paul R.; Kim, Hojung] UCL, Dept Earth Sci, London, England; [Gibbs, Samantha J.] Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Sheward, Rosie M.] Goethe Univ Frankfurt, Inst Geosci, Frankfurt, Germany; [Ridgwell, Andy] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Alvarez, Sarah A.] Univ Gibraltar, Europa Point Campus, Gibraltar, Gibraltar	University of Bristol; University of London; University College London; NERC National Oceanography Centre; University of Southampton; Goethe University Frankfurt; University of California System; University of California Riverside	Alvarez, SA (corresponding author), Univ Bristol, Sch Geog Sci, Bristol, Avon, England.; Alvarez, SA (corresponding author), UCL, Dept Earth Sci, London, England.; Gibbs, SJ (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton, Hants, England.; Alvarez, SA (corresponding author), Univ Gibraltar, Europa Point Campus, Gibraltar, Gibraltar.	sarah.alvarez@unigib.edu.gi; sxg@noc.soton.ac.uk	Ridgwell, Andy/AAD-9487-2021; Bown, Paul/C-5235-2011	Ridgwell, Andy/0000-0003-2333-0128; Bown, Paul/0000-0001-6777-4463; Sheward, Rosie/0000-0001-6857-2038	Royal Society; University of Southampton; Natural Environment Research Council (NERC) studentship [1272561]; European Union [ERC-2013-CoG-617303]; Heising-Simons Foundation; NERC [NE/H017291/1] Funding Source: UKRI	Royal Society(Royal Society of London); University of Southampton; Natural Environment Research Council (NERC) studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Union(European Commission); Heising-Simons Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research used samples provided by the International Ocean Discovery Program. We thank the Royal Society for funding S.J.G. through a URF. R.M.S. was funded jointly through a Vice Chancellor's studentship from the University of Southampton and a Natural Environment Research Council (NERC) studentship (award reference 1272561) and H.K. was supported in part by a UCL Dean's prize. We thank the European Union for post-doctoral research funding for S.A.A. (grant ERC-2013-CoG-617303). A.R. was supported in part by an award from the Heising-Simons Foundation as well as by grant ERC-2013-CoG-617303. We thank T. Ezard for contributions to the interpretation of the datasets and P. Wilson for his independent editing of the manuscript.	Agnini C, 2007, MAR MICROPALEONTOL, V64, P215, DOI 10.1016/j.marmicro.2007.05.003; Alegret L, 2007, MAR MICROPALEONTOL, V64, P1, DOI 10.1016/j.marmicro.2006.12.003; Alegret L, 2012, P NATL ACAD SCI USA, V109, P728, DOI 10.1073/pnas.1110601109; Arenillas I, 2008, TERRA NOVA, V20, P38, DOI 10.1111/j.1365-3121.2007.00784.x; Aubry MP, 2011, MICROPALEONTOLOGY, V57, P269; Barnosky AD, 2017, SCIENCE, V355, DOI 10.1126/science.aah4787; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bernaola G, 2007, GEOL SOC AM BULL, V119, P785, DOI 10.1130/B26132.1; Birch HS, 2016, GEOLOGY, V44, P287, DOI 10.1130/G37581.1; Birch HS, 2012, PALEOBIOLOGY, V38, P374, DOI 10.1666/11027.1; Bornemann A, 2009, J GEOL SOC LONDON, V166, P1135, DOI 10.1144/0016-76492008-104; Bown P, 2005, GEOLOGY, V33, P653, DOI 10.1130/G21566.1; Bown PR, 2008, GEOL SOC AM BULL, V120, P3, DOI 10.1130/B26261.1; Bown P.R., 1998, P16; Bown Paul R., 2016, Journal of Nannoplankton Research, V36, P1; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Bralower T. J., 2002, P OCEAN DRILLING PRO, V198, P1, DOI DOI 10.2973/ODP.PROC.IR.198.2002; Buesseler KO, 2009, LIMNOL OCEANOGR, V54, P1210, DOI 10.4319/lo.2009.54.4.1210; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cleland E.E., 2011, NATURE ED KNOWL, V3, P14; Coccioni R, 2010, EARTH PLANET SC LETT, V297, P298, DOI 10.1016/j.epsl.2010.06.031; Coxall HK, 2006, GEOLOGY, V34, P297, DOI 10.1130/G21702.1; Cramer BS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000909; D'Hondt S, 2005, ANNU REV ECOL EVOL S, V36, P295, DOI 10.1146/annurev.ecolsys.35.021103.105715; Dinares-Turell J, 2014, EARTH PLANET SC LETT, V405, P119, DOI 10.1016/j.epsl.2014.08.027; Esmeray-Senlet S, 2015, PALEOCEANOGRAPHY, V30, P718, DOI 10.1002/2014PA002724; Fischer G, 2009, BIOGEOSCIENCES, V6, P85, DOI 10.5194/bg-6-85-2009; Fuqua LM, 2008, PALAIOS, V23, P185, DOI 10.2110/palo.2007.p07-004r; Gallala N, 2009, MAR MICROPALEONTOL, V72, P196, DOI 10.1016/j.marmicro.2009.05.001; GERSTEL J, 1987, GEOLOGY, V15, P665, DOI 10.1130/0091-7613(1987)15<665:DFSPFR>2.0.CO;2; Gibbs SJ, 2012, BIOGEOSCIENCES, V9, P4679, DOI 10.5194/bg-9-4679-2012; Gibbs SJ, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0075; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1, DOI 10.1016/B978-0-444-59425-9.00001-9; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Henehan MJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0510; Hodgson D, 2015, TRENDS ECOL EVOL, V30, P503, DOI 10.1016/j.tree.2015.06.010; Hull P, 2015, CURR BIOL, V25, pR941, DOI 10.1016/j.cub.2015.08.053; Jehle S, 2015, GEOPH RES ABSTR, V17; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Kroon D., 2007, P ODP SCI RESULTS, V208, P1, DOI DOI 10.2973/ODP.PROC.SR.208.201.2007; Littler K, 2014, EARTH PLANET SC LETT, V401, P18, DOI 10.1016/j.epsl.2014.05.054; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; MacLeod KG, 2018, SCIENCE, V360, P1467, DOI 10.1126/science.aap8525; Mai H, 1997, MICROPALEONTOLOGY, V43, P281, DOI 10.2307/1485829; Mai Hartmut, 1998, Journal of Nannoplankton Research, V20, P21; Monechi S, 2013, MAR MICROPALEONTOL, V98, P28, DOI 10.1016/j.marmicro.2012.11.002; Monechi S, 2012, MICROPALEONTOLOGY, V58, P351; Nicolo MJ, 2007, GEOLOGY, V35, P699, DOI 10.1130/G23648A.1; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Perch-Nielsen K., 1985, P427; Pospichal James J., 1996, Geological Society of America Special Paper, V307, P335; Quillevere F, 2002, PALAEOGEOGR PALAEOCL, V184, P371, DOI 10.1016/S0031-0182(02)00275-4; Quillevere F, 2008, EARTH PLANET SC LETT, V265, P600, DOI 10.1016/j.epsl.2007.10.040; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Saez AG, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P251; Schmidt A, 2016, NAT GEOSCI, V9, P77, DOI [10.1038/NGEO2588, 10.1038/ngeo2588]; Schmitz B, 1998, NEWSL STRATIGR, V36, P35; Schmitz B, 1997, PALAEOGEOGR PALAEOCL, V133, P49, DOI 10.1016/S0031-0182(97)00024-2; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Sepulveda J, 2009, SCIENCE, V326, P129, DOI 10.1126/science.1176233; Sprain CJ, 2019, SCIENCE, V363, P866, DOI 10.1126/science.aav1446; Stap L, 2010, GEOLOGY, V38, P607, DOI 10.1130/G30777.1; van Heck S.E., 1987, Abhandlungen der Geologischen Bundesanstalt (Vienna), V39, P285; VAROL O, 1989, BR MICROPAL, P267; Vellekoop J, 2014, P NATL ACAD SCI USA, V111, P7537, DOI 10.1073/pnas.1319253111; WESTERHOLD T, 2006, P OC DRILL PROGR SCI, V0198; Westerhold T, 2018, PALEOCEANOGR PALEOCL, V33, P626, DOI 10.1029/2017PA003306; Westerhold T, 2015, CLIM PAST, V11, P1181, DOI 10.5194/cp-11-1181-2015; Westerhold T, 2008, PALAEOGEOGR PALAEOCL, V257, P377, DOI 10.1016/j.palaeo.2007.09.016; Westerhold T, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002092; Young J. R, NANNOTAX 3; Young JR, 2014, CRYPTOGAMIE ALGOL, V35, P353, DOI 10.7872/crya.v35.iss4.2014.353; Young JR, 2005, MICROPALEONTOLOGY, V51, P267, DOI 10.2113/gsmicropal.51.4.267; Zachos JC, 2010, EARTH PLANET SC LETT, V299, P242, DOI 10.1016/j.epsl.2010.09.004; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zeebe RE, 2017, PALEOCEANOGRAPHY, V32, P440, DOI 10.1002/2016PA003054	77	33	33	6	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2019	574	7777					242	+		10.1038/s41586-019-1590-8	http://dx.doi.org/10.1038/s41586-019-1590-8			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD2DB	31554971	Green Submitted, Green Accepted			2022-12-28	WOS:000489784200046
J	Liao, YC; Fernandopulle, MS; Wang, GZ; Choi, H; Hao, L; Drerup, CM; Patel, R; Qamar, S; Nixon-Abell, J; Shen, Y; Meadows, W; Vendruscolo, M; Knowles, TPJ; Nelson, M; Czekalska, MA; Musteikyte, G; Gachechiladze, MA; Stephens, CA; Pasolli, HA; Forrest, LR; St George-Hyslop, P; Lippincott-Schwartz, J; Ward, ME				Liao, Ya-Cheng; Fernandopulle, Michael S.; Wang, Guozhen; Choi, Heejun; Hao, Ling; Drerup, Catherine M.; Patel, Rajan; Qamar, Seema; Nixon-Abell, Jonathon; Shen, Yi; Meadows, William; Vendruscolo, Michele; Knowles, Tuomas P. J.; Nelson, Matthew; Czekalska, Magdalena A.; Musteikyte, Greta; Gachechiladze, Mariam A.; Stephens, Christina A.; Pasolli, H. Amalia; Forrest, Lucy R.; St George-Hyslop, Peter; Lippincott-Schwartz, Jennifer; Ward, Michael E.			RNA Granules Hitchhike on Lysosomes for Long-Distance Transport, Using Annexin A11 as a Molecular Tether	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIN MESSENGER-RNA; AXONAL-TRANSPORT; GROWTH CONES; LOCAL TRANSLATION; PROTEIN-SYNTHESIS; REPEAT EXPANSION; STRESS GRANULES; LIQUID-PHASE; LOCALIZATION	Long-distance RNA transport enables local protein synthesis at metabolically-active sites distant from the nucleus. This process ensures an appropriate spatial organization of proteins, vital to polarized cells such as neurons. Here, we present a mechanism for RNA transport in which RNA granules "hitchhike" on moving lysosomes. In vitro biophysical modeling, live-cell microscopy, and unbiased proximity labeling proteomics reveal that annexin A11 (ANXA11), an RNA granule-associated phosphoinositide-binding protein, acts as a molecular tether between RNA granules and lysosomes. ANXA11 possesses an N-terminal low complexity domain, facilitating its phase separation into membraneless RNA granules, and a C-terminal membrane binding domain, enabling interactions with lysosomes. RNA granule transport requires ANXA11, and amyotrophic lateral sclerosis (ALS)-associated mutations in ANXA11 impair RNA granule transport by disrupting their interactions with lysosomes.Thus, ANXA11 mediates neuronal RNA transport by tethering RNA granules to actively-transported lysomes, performing a critical cellular function that is disrupted in ALS.	[Liao, Ya-Cheng; Choi, Heejun; Pasolli, H. Amalia; Lippincott-Schwartz, Jennifer] HHMI Janelia Res Campus, Ashburn, VA 20147 USA; [Fernandopulle, Michael S.; Hao, Ling; Patel, Rajan; Nelson, Matthew; Gachechiladze, Mariam A.; Stephens, Christina A.; Forrest, Lucy R.; Ward, Michael E.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Wang, Guozhen; Qamar, Seema; Nixon-Abell, Jonathon; Meadows, William; St George-Hyslop, Peter] Univ Cambridge, Dept Clin Neurosci, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Drerup, Catherine M.] NICHD, NIH, Bethesda, MD USA; [Shen, Yi; Vendruscolo, Michele; Knowles, Tuomas P. J.; Czekalska, Magdalena A.; Musteikyte, Greta] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Knowles, Tuomas P. J.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England; [St George-Hyslop, Peter] Univ Toronto, Dept Med, Div Neurol, Toronto, ON M5S 3H2, Canada; [St George-Hyslop, Peter] Univ Hlth Network, Toronto, ON M5S 3H2, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Cambridge; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Cambridge; University of Cambridge; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lippincott-Schwartz, J (corresponding author), HHMI Janelia Res Campus, Ashburn, VA 20147 USA.	lippincottschwartzj@janelia.hhmi.org	Knowles, Tuomas/C-6663-2009; Ward, Michael Emmerson/ABG-5892-2021; Nixon-Abell, Jonathon/AAN-3897-2021; Shen, Yi/N-9285-2017	Knowles, Tuomas/0000-0002-7879-0140; Ward, Michael Emmerson/0000-0002-5296-8051; Czekalska, Magdalena/0000-0002-4494-4463; Sneideriene, Greta/0000-0002-4585-5091; Choi, Heejun/0000-0002-1337-3813; hao, ling/0000-0002-0106-5266; Pasolli, Hilda Amalia/0000-0003-3899-3530; Nelson, Matthew/0000-0001-7819-0922; Gachechiladze, Mariam/0000-0003-0004-425X; Nixon-Abell, Jonathon/0000-0003-4169-0012; Shen, Yi/0000-0002-0456-3850	NINDS, NIH; Canadian Institutes of Health Research; Wellcome Trust; ALS Society of Canada/Brain Canada; HHMI Janelia Research Campus; NATIONAL INSTITUTE ON AGING [F30AG060722] Funding Source: NIH RePORTER	NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); ALS Society of Canada/Brain Canada; HHMI Janelia Research Campus; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the J.L.-S. lab for critical feedback and suggestions, and Maia Parsadanian for technical assistance in cell culture. We would like to thank Derek Narendra for his assistance with LAMP1-APEX2 EM imaging experiments; Tamas Balla for his guidance regarding liposome preparation; Virginia Crocker and the NINDS EM Facility for technical assistance; Kory Johnson for help with bioinformatics; Young J. Yoon and Robert H. Singer for actin-MS2/MCP plasmids/advice; Jeff Kowalak, Yan Li, and the NINDS proteomics core facilities for technical assistance; and Kurt Fischbeck for constructive feedback on our manuscript. This work was supported, in part, by the Intramural Research Program, NINDS, NIH (M.E.W., C.D.), by Canadian Institutes of Health Research (P.St.G.-H.), Wellcome Trust (P.St.G.-H., M.E.V., T.P.K.), ALS Society of Canada/Brain Canada (P.St.G.-H), and HHMI Janelia Research Campus (J.L.S.).	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Baird Fiona J, 2013, J Genet Syndr Gene Ther, V4, P203; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bakthavachalu B, 2018, NEURON, V98, P754, DOI 10.1016/j.neuron.2018.04.032; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bassell GJ, 1998, J NEUROSCI, V18, P251; Baumann S, 2012, J CELL SCI, V125, P2740, DOI 10.1242/jcs.101212; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cheng XT, 2018, J CELL BIOL, V217, P3127, DOI 10.1083/jcb.201711083; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Cioni JM, 2019, CELL, V176, P56, DOI 10.1016/j.cell.2018.11.030; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Dix CI, 2013, J CELL BIOL, V202, P479, DOI 10.1083/jcb.201211052; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Drerup CM, 2016, METHOD CELL BIOL, V131, P311, DOI 10.1016/bs.mcb.2015.06.007; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Farias GG, 2017, P NATL ACAD SCI USA, V114, pE2955, DOI 10.1073/pnas.1616363114; Fernandopulle Michael S, 2018, Curr Protoc Cell Biol, V79, pe51, DOI 10.1002/cpcb.51; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Gagnon JA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001551; Gang HZ, 2018, ANAL CHEM, V90, P3284, DOI 10.1021/acs.analchem.7b04820; Gaspar I, 2017, EMBO J, V36, P319, DOI 10.15252/embj.201696038; Gershoni-Emek N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00311; Glock C, 2017, CURR OPIN NEUROBIOL, V45, P169, DOI 10.1016/j.conb.2017.05.005; Gopal PP, 2017, P NATL ACAD SCI USA, V114, pE2466, DOI 10.1073/pnas.1614462114; Guerreiro R, 2015, CELL, V160, P798, DOI 10.1016/j.cell.2015.01.052; Guimaraes SC, 2015, J CELL BIOL, V211, P945, DOI 10.1083/jcb.201505086; Higuchi Y, 2014, J CELL BIOL, V204, P343, DOI 10.1083/jcb.201307164; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hung V, 2016, NAT PROTOC, V11, P456, DOI 10.1038/nprot.2016.018; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Ikonomov OC, 2009, BIOCHEM BIOPH RES CO, V382, P566, DOI 10.1016/j.bbrc.2009.03.063; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Khong A, 2018, J CELL BIOL, V217, P4124, DOI 10.1083/jcb.201806183; Khong A, 2017, MOL CELL, V68, P808, DOI 10.1016/j.molcel.2017.10.015; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knowles RB, 1996, J NEUROSCI, V16, P7812; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Langdon EM, 2018, SCIENCE, V360, P922, DOI 10.1126/science.aar7432; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Mandal A, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00144; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Milovanovic D, 2018, SCIENCE, V361, P604, DOI 10.1126/science.aat5671; Mittag T, 2018, J MOL BIOL, V430, P4636, DOI 10.1016/j.jmb.2018.08.005; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nadezhdina ES, 2010, BBA-MOL CELL RES, V1803, P361, DOI 10.1016/j.bbamcr.2009.12.004; Nakayama K, 2017, ELIFE, V6, DOI 10.7554/eLife.29677; Nicolas A, 2018, NEURON, V97, P1268, DOI 10.1016/j.neuron.2018.02.027; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Pohlmann T, 2015, ELIFE, V4, DOI 10.7554/eLife.06041; Pottier C, 2015, ACTA NEUROPATHOL, V130, P77, DOI 10.1007/s00401-015-1436-x; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sahoo PK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05647-x; Salogiannis J, 2017, TRENDS CELL BIOL, V27, P141, DOI 10.1016/j.tcb.2016.09.005; Salogiannis J, 2016, J CELL BIOL, V212, P289, DOI 10.1083/jcb.201512020; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Smith BN, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9157; Tsai PC, 2018, NEUROBIOL AGING, V72, DOI 10.1016/j.neurobiolaging.2018.07.002; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Van Treeck B, 2018, CELL, V174, P791, DOI 10.1016/j.cell.2018.07.023; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Ward ME, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5642; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wheeler JR, 2017, METHODS, V126, P12, DOI 10.1016/j.ymeth.2017.04.020; Wong HHW, 2017, NEURON, V95, P852, DOI 10.1016/j.neuron.2017.07.016; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoon YJ, 2016, P NATL ACAD SCI USA, V113, pE6877, DOI 10.1073/pnas.1614267113; Zhang K, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000237; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang P., 2018, BIORXIV; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	91	171	172	3	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					147	+		10.1016/j.cell.2019.08.050	http://dx.doi.org/10.1016/j.cell.2019.08.050			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539493	Green Accepted, hybrid, Green Published, Green Submitted			2022-12-28	WOS:000486618500020
J	Moberly, T				Moberly, Tom			Cancer survivor swims channel four times non-stop	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5604	10.1136/bmj.l5604	http://dx.doi.org/10.1136/bmj.l5604			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530536				2022-12-28	WOS:000487758600014
J	Nager, CW; Visco, AG; Richter, HE; Rardin, CR; Rogers, RG; Harvie, HS; Zyczynski, HM; Paraiso, MFR; Mazloomdoost, D; Grey, S; Sridhar, A; Wallace, D; Lukacz, ES; Albo, ME; Alperin, M; Kirby, AC; Ferrante, K; Wasenda, E; Columbo, J; Ruppert, E; Herrala, K; Johnson, S; Menefee, SA; Tan-Kim, J; Diwadkar, GB; Dyer, KY; Mackinnon, LM; Zazueta-Damian, G; Weidner, A; Amundsen, C; Siddiqui, N; Kawasaki, A; McLean, S; Raynor, M; Longoria, N; Hayes, A; Gilliam, R; Harris, A; Varner, RE; Holley, RL; Wilson, T; Ballard, A; Ellington, D; Johnson, R; Long, A; Pair, L; Willis, V; Howell, A; Saxon, N; Carter, K; Willingham, R; Hyde, J; Patel, S; Sung, VW; Myers, DL; Carberry, C; Hampton, BS; Wohlrab, K; Korbly, N; Meers, AS; Douglas, S; Viscione, EA; Komesu, Y; Dunivan, G; Jeppson, P; Cichowski, S; Middendorf, J; Box, K; Arya, L; Andy, U; Smith, A; Flick, L; Kingslee, M; Carney, T; Thompson, D; Bonidie, M; Lowder, J; Moalli, P; Shepherd, J; Sutkin, G; Gruss, J; Mislanovich, K; Amodei, K; Pung, L; Graham, A; Krishnan, G; Dastoli, K; Edington, M; Barber, M; Unger, C; Walters, M; Jelovsek, E; Ridgeway, B; Gantz, M; Thomas, S; Shaffer, A; Grant, T; Koeller-Anna, K; Carper, B; Honeycutt, E; Whitworth, R; Davis, T; Burson, K; Glass, K; Pickett, J; Connellly, A; Dickersin, K; Tulikangas, P; Rickey, L; McClish, D; Shade, D; Tuteja, A; Kong, L; Yount, S; Jiang, LH; Lavender, M; O'Dell, K; Ryan, K				Nager, Charles W.; Visco, Anthony G.; Richter, Holly E.; Rardin, Charles R.; Rogers, Rebecca G.; Harvie, Heidi S.; Zyczynski, Halina M.; Paraiso, Marie Fidela R.; Mazloomdoost, Donna; Grey, Scott; Sridhar, Amaanti; Wallace, Dennis; Lukacz, Emily S.; Albo, Michael E.; Alperin, Marianna; Kirby, Anna C.; Ferrante, Kimberly; Wasenda, Erika; Columbo, Joann; Ruppert, Erika; Herrala, Kyle; Johnson, Sherella; Menefee, Shawn A.; Tan-Kim, Jasmine; Diwadkar, Gouri B.; Dyer, Keisha Y.; Mackinnon, Linda M.; Zazueta-Damian, Gisselle; Weidner, Alison; Amundsen, Cindy; Siddiqui, Nazema; Kawasaki, Amie; McLean, Shantae; Raynor, Mary; Longoria, Nicole; Hayes, Akira; Gilliam, Robin; Harris, Acacia; Varner, R. Edward; Holley, Robert L.; Wilson, Tracey; Ballard, Alicia; Ellington, David; Johnson, Ryanne; Long, Alyssa; Pair, Lisa; Willis, Velria; Howell, Alice; Saxon, Nancy; Carter, Kathy; Willingham, Robin; Hyde, Jill; Patel, Sunita; Sung, Vivian W.; Myers, Deborah L.; Carberry, Cassandra; Hampton, B. Star; Wohlrab, Kyle; Korbly, Nicole; Meers, Ann S.; Douglas, Samantha; Viscione, Elizabeth-Ann; Komesu, Yuko; Dunivan, Gena; Jeppson, Peter; Cichowski, Sara; Middendorf, Julia; Box, Karen; Arya, Lily; Andy, Uduak; Smith, Ariana; Flick, Lorraine; Kingslee, Michelle; Carney, Teresa; Thompson, Donna; Bonidie, Michael; Lowder, Jerry; Moalli, Pamela; Shepherd, Jonathan; Sutkin, Gary; Gruss, Judy; Mislanovich, Karen; Amodei, Kate; Pung, Ly; Graham, Annette; Krishnan, Geetha; Dastoli, Kathleen; Edington, Maryori; Barber, Matthew; Unger, Cecile; Walters, Mark; Jelovsek, Eric; Ridgeway, Beri; Gantz, Marie; Thomas, Sonia; Shaffer, Amanda; Grant, Tracey; Koeller-Anna, Kelly; Carper, Ben; Honeycutt, Emily; Whitworth, Ryan; Davis, Tracey; Burson, Katrina; Glass, Kendra; Pickett, James; Connellly, AnnaMarie; Dickersin, Kay; Tulikangas, Paul; Rickey, Leslie; McClish, Donna; Shade, David; Tuteja, Ashok; Kong, Lan; Yount, Susan; Jiang, Luohua; Lavender, Missy; O'Dell, Kate; Ryan, Kate		NICHD Pelvic Floor Disorders	Effect of Vaginal Mesh Hysteropexy vs Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PELVIC ORGAN PROLAPSE; SACROSPINOUS HYSTEROPEXY; URINARY-INCONTINENCE; BODY-IMAGE; VALIDATION; ESTIMATOR; DESCENT; SCALE; RISK	Key PointsQuestionIs there a difference in treatment failure for vaginal mesh hysteropexy vs vaginal hysterectomy with uterosacral ligament suspension in women with uterovaginal prolapse? FindingsIn this randomized clinical trial that included 175 postmenopausal women with symptomatic uterovaginal prolapse undergoing surgical intervention, vaginal mesh hysteropexy compared with vaginal hysterectomy with uterosacral ligament suspension resulted in a hazard ratio for a composite measure of treatment failure of 0.62 after 3 years. This was not statistically significant, but the CI was wide and the P value was .06. MeaningAlthough vaginal mesh hysteropexy did not result in a statistically significantly better outcome compared with vaginal hysterectomy with uterosacral ligament suspension, the wide CI for the treatment effect precludes a definitive conclusion, and further research is needed to assess whether vaginal mesh hysteropexy is more effective than vaginal hysterectomy with uterosacral ligament suspension. ImportanceVaginal hysterectomy with suture apical suspension is commonly performed for uterovaginal prolapse. Transvaginal mesh hysteropexy is an alternative option. ObjectiveTo compare the efficacy and adverse events of vaginal hysterectomy with suture apical suspension and transvaginal mesh hysteropexy. Design, Setting, ParticipantsAt 9 clinical sites in the US Pelvic Floor Disorders Network, 183 postmenopausal women with symptomatic uterovaginal prolapse were enrolled in a randomized superiority clinical trial between April 2013 and February 2015. The study was designed for primary analysis when the last randomized participant reached 3 years of follow-up in February 2018. InterventionsNinety-three women were randomized to undergo vaginal mesh hysteropexy and 90 were randomized to undergo vaginal hysterectomy with uterosacral ligament suspension. Main Outcomes and MeasuresThe primary treatment failure composite outcome (re-treatment of prolapse, prolapse beyond the hymen, or prolapse symptoms) was evaluated with survival models. Secondary outcomes included operative outcomes and adverse events, and were evaluated with longitudinal models or contingency tables as appropriate. ResultsA total of 183 participants (mean age, 66 years) were randomized, 175 were included in the trial, and 169 (97%) completed the 3-year follow-up. The primary outcome was not significantly different among women who underwent hysteropexy vs hysterectomy through 48 months (adjusted hazard ratio, 0.62 [95% CI, 0.38-1.02]; P=.06; 36-month adjusted failure incidence, 26% vs 38%). Mean (SD) operative time was lower in the hysteropexy group vs the hysterectomy group (111.5 [39.7] min vs 156.7 [43.9] min; difference, -45.2 [95% CI, -57.7 to -32.7]; P=<.001). Adverse events in the hysteropexy vs hysterectomy groups included mesh exposure (8% vs 0%), ureteral kinking managed intraoperatively (0% vs 7%), granulation tissue after 12 weeks (1% vs 11%), and suture exposure after 12 weeks (3% vs 21%). Conclusions and RelevanceAmong women with symptomatic uterovaginal prolapse undergoing vaginal surgery, vaginal mesh hysteropexy compared with vaginal hysterectomy with uterosacral ligament suspension did not result in a significantly lower rate of the composite prolapse outcome after 3 years. However, imprecision in study results precludes a definitive conclusion, and further research is needed to assess whether vaginal mesh hysteropexy is more effective than vaginal hysterectomy with uterosacral ligament suspension. Trial RegistrationClinicalTrials.gov Identifier: NCT01802281 This randomized clinical trial compares effectiveness and adverse events of transvaginal mesh-augmented hysteropexy vs vaginal hysterectomy with suture apical uterosacral ligament suspension in postmenopausal women with symptomatic uterovaginal prolapse.	[Nager, Charles W.] UC San Diego Hlth, Obstet Gynecol & Reprod Sci, San Diego, CA USA; [Visco, Anthony G.] Duke Univ, Med Ctr, Durham, NC USA; [Richter, Holly E.] Univ Alabama Birmingham, Dept OB GYN, Birmingham, AL USA; [Rardin, Charles R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Rogers, Rebecca G.] Univ New Mexico, Albuquerque, NM 87131 USA; [Rogers, Rebecca G.] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA; [Harvie, Heidi S.] Univ Penn, Flourtown, PA USA; [Zyczynski, Halina M.] Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Paraiso, Marie Fidela R.] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Mazloomdoost, Donna] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Grey, Scott; Sridhar, Amaanti; Wallace, Dennis] Res Triangle Int, Res Triangle Pk, NC USA; [Lukacz, Emily S.; Albo, Michael E.; Alperin, Marianna; Kirby, Anna C.; Ferrante, Kimberly; Wasenda, Erika; Columbo, Joann; Ruppert, Erika; Herrala, Kyle; Johnson, Sherella] NICHD Pelv Floor Disorders Network, Bethesda, MD USA; [Lukacz, Emily S.; Albo, Michael E.; Alperin, Marianna; Kirby, Anna C.; Ferrante, Kimberly; Wasenda, Erika; Columbo, Joann; Ruppert, Erika; Herrala, Kyle; Johnson, Sherella] UC San Diego Hlth, San Diego, CA USA; [Menefee, Shawn A.; Tan-Kim, Jasmine; Diwadkar, Gouri B.; Dyer, Keisha Y.; Mackinnon, Linda M.; Zazueta-Damian, Gisselle] Kaiser Permanente San Diego, San Diego, CA USA; [Weidner, Alison; Amundsen, Cindy; Siddiqui, Nazema; Kawasaki, Amie; McLean, Shantae; Raynor, Mary; Longoria, Nicole; Hayes, Akira; Gilliam, Robin; Harris, Acacia] Duke Univ, Med Ctr, Durham, NC USA; [Varner, R. Edward; Holley, Robert L.; Wilson, Tracey; Ballard, Alicia; Ellington, David; Johnson, Ryanne; Long, Alyssa; Pair, Lisa; Willis, Velria; Howell, Alice; Saxon, Nancy; Carter, Kathy; Willingham, Robin; Hyde, Jill; Patel, Sunita] Univ Alabama Birmingham, Dept OB GYN, Birmingham, AL USA; [Sung, Vivian W.; Myers, Deborah L.; Carberry, Cassandra; Hampton, B. Star; Wohlrab, Kyle; Korbly, Nicole; Meers, Ann S.; Douglas, Samantha; Viscione, Elizabeth-Ann] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Komesu, Yuko; Dunivan, Gena; Jeppson, Peter; Cichowski, Sara; Middendorf, Julia; Box, Karen] Univ New Mexico, Albuquerque, NM 87131 USA; [Arya, Lily; Andy, Uduak; Smith, Ariana; Flick, Lorraine; Kingslee, Michelle; Carney, Teresa; Thompson, Donna] Univ Penn, Philadelphia, PA 19104 USA; [Bonidie, Michael; Lowder, Jerry; Moalli, Pamela; Shepherd, Jonathan; Sutkin, Gary; Gruss, Judy; Mislanovich, Karen; Amodei, Kate] Univ Pittsburgh, Dept OB GYN & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA USA; [Pung, Ly; Graham, Annette; Krishnan, Geetha; Dastoli, Kathleen; Edington, Maryori; Barber, Matthew; Unger, Cecile; Walters, Mark; Jelovsek, Eric; Ridgeway, Beri] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Gantz, Marie; Thomas, Sonia; Shaffer, Amanda; Grant, Tracey; Koeller-Anna, Kelly; Carper, Ben; Honeycutt, Emily; Whitworth, Ryan; Davis, Tracey; Burson, Katrina; Glass, Kendra; Pickett, James] RTI Int, Res Triangle Pk, NC USA; [Connellly, AnnaMarie] Univ N Carolina, Chapel Hill, NC 27515 USA; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Data & Safety Monitoring Board, Baltimore, MD USA; [Tulikangas, Paul] Univ Connecticut, Hartford Hosp, Storrs, CT USA; [Rickey, Leslie] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA; [McClish, Donna] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Shade, David] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Tuteja, Ashok] Univ Utah, Salt Lake City, UT 84112 USA; [Kong, Lan] Penn State Univ, Coll Med, University Pk, PA 16802 USA; [Yount, Susan] Frontier Nursing Univ, Lexington, KY USA; [Jiang, Luohua] Texas A&M Hlth Sci Univ, Bryan, TX USA; [Lavender, Missy] Womens Hlth Fdn, Chicago, IL USA; [O'Dell, Kate] UMass Mem Med Ctr, Worcester, MA USA; [Ryan, Kate] Natl Womens Hlth Network, Washington, DC USA	Duke University; University of Alabama System; University of Alabama Birmingham; Brown University; University of New Mexico; University of Texas System; University of Texas Austin; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Kaiser Permanente; Duke University; University of Alabama System; University of Alabama Birmingham; Brown University; University of New Mexico; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Cleveland Clinic Foundation; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Hartford Hospital; University of Connecticut; Yale University; Virginia Commonwealth University; Johns Hopkins University; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Worcester	Nager, CW (corresponding author), UC San Diego Hlth, Dept Obstet Gynecol & Reprod Sci, 9300 Campus Point Dr, La Jolla, CA 92037 USA.	cnager@ucsd.edu	Wallace, Dennis/AAR-7005-2021; Cichowski, Sara/AAD-9400-2020; Grey, Scott/AAK-9922-2021	Sridhar, Amaanti/0000-0001-7216-7713; Richter, Holly E/0000-0001-7741-5771; Harvie, Heidi/0000-0002-6675-9808	Eunice Kennedy Shriver National Institute of Child Health and Development [U10 HD054214, U10 HD041267, U10 HD041261, U10 HD069013, U10 HD069025, U10 HD069010, U10 HD069006, U10 HD054215, U01 HD069031]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health Office of Research on Women's Health; Boston Scientific Corporation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD069010] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); Boston Scientific Corporation(Boston Scientific); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was conducted by the Eunice Kennedy Shriver National Institute of Child Health and Development-sponsored Pelvic Floor Disorders Network (grant numbers U10 HD054214, U10 HD041267, U10 HD041261, U10 HD069013, U10 HD069025, U10 HD069010, U10 HD069006, U10 HD054215, and U01 HD069031). The project was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health. Boston Scientific Corporation provided partial study support through an unrestricted grant.	Barber MD, 2014, JAMA-J AM MED ASSOC, V311, P1023, DOI 10.1001/jama.2014.1719; Barber MD, 2012, FEMALE PELVIC MED RE, V18, P198, DOI 10.1097/SPV.0b013e31825d65aa; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Bradley CS, 2008, OBSTET GYNECOL, V111, P1148, DOI 10.1097/AOG.0b013e31816a3b96; Broglio K, 2018, JAMA-J AM MED ASSOC, V319, P2223, DOI 10.1001/jama.2018.6360; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; Detollenaere RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3717; Dietz V, 2010, INT UROGYNECOL J, V21, P209, DOI 10.1007/s00192-009-1014-7; Dietz V, 2009, INT UROGYNECOL J, V20, P349, DOI 10.1007/s00192-008-0779-4; Glazener CMA, 2017, LANCET, V389, P381, DOI 10.1016/S0140-6736(16)31596-3; Gutman RE, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.08.035; Hopwood P, 2001, EUR J CANCER, V37, P189, DOI 10.1016/S0959-8049(00)00353-1; Jelovsek JE, 2006, AM J OBSTET GYNECOL, V194, P1455, DOI 10.1016/j.ajog.2006.01.060; Jha S, 2018, INT UROGYNECOL J, V29, P795, DOI 10.1007/s00192-017-3476-3; Jirschele K, 2015, INT UROGYNECOL J, V26, P743, DOI 10.1007/s00192-014-2564-x; Kapoor S, 2017, INT UROGYNECOL J, V28, P1285, DOI 10.1007/s00192-017-3291-x; Korbly NB, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.003; Madsen AM, 2017, FEMALE PELVIC MED RE, V23, P365, DOI 10.1097/SPV.0000000000000426; Maher C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012376; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; McCarthy M, 2005, J AM COLL SURGEONS, V201, P171, DOI 10.1016/j.jamcollsurg.2005.03.035; Meriwether KV, 2018, AM J OBSTET GYNECOL, V219, P129, DOI 10.1016/j.ajog.2018.01.018; Nager CW, 2016, FEMALE PELVIC MED RE, V22, P182, DOI 10.1097/SPV.0000000000000270; Rockwood TH, 2013, INT UROGYNECOL J, V24, P1105, DOI 10.1007/s00192-012-2037-z; Rogers RG, 2013, INT UROGYNECOL J, V24, P1091, DOI 10.1007/s00192-012-2020-8; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; SATO T, 1989, BIOMETRICS, V45, P1323; Sun JG, 1996, STAT MED, V15, P1387, DOI 10.1002/(SICI)1097-0258(19960715)15:13&lt;1387::AID-SIM268&gt;3.0.CO;2-R; US Food and Drug Administration, UROGYNECOLOGIC SURGI; US Food and Drug Administration, FDAS ACTIVITIES UROG; Vu MK, 2012, INT UROGYNECOL J, V23, P1753, DOI 10.1007/s00192-012-1780-5; Wellner JA, 1997, J AM STAT ASSOC, V92, P945, DOI 10.2307/2965558; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286; Yalcin I, 2003, AM J OBSTET GYNECOL, V189, P98, DOI 10.1067/mob.2003.379	35	43	45	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1054	1065		10.1001/jama.2019.12812	http://dx.doi.org/10.1001/jama.2019.12812			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31529008	Green Published, Bronze			2022-12-28	WOS:000488821100018
J	Vearey, J; Orcutt, M; Gostin, L; Braham, CA; Duigan, P				Vearey, Jo; Orcutt, Miriam; Gostin, Larry; Braham, Christy Adeola; Duigan, Patrick			Building alliances for the global governance of migration and health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POLITICS		[Vearey, Jo] Univ Witwatersrand, African Ctr Migrat & Soc, Johannesburg, Gauteng, South Africa; [Vearey, Jo] Univ Edinburgh, Ctr African Studies, Edinburgh, Midlothian, Scotland; [Orcutt, Miriam] UCL, Inst Global Hlth, London, England; [Gostin, Larry] Georgetown Univ, Ctr Aphasia Res & Rehabil, Washington, DC USA; [Gostin, Larry] WHO, Collaborating Ctr Natl & Global Hlth Law, Washington, DC USA; [Braham, Christy Adeola] African Platform Migrat & Inclus Hlth, London, England; [Braham, Christy Adeola] Univ Sheffield, Sheffield, S Yorkshire, England; [Duigan, Patrick] Int Org Migrat, Reg Off Asia & Pacific, Bangkok, Thailand	University of Witwatersrand; University of Edinburgh; University of London; University College London; Georgetown University; World Health Organization; University of Sheffield; International Organization for Migration	Vearey, J (corresponding author), Univ Witwatersrand, African Ctr Migrat & Soc, Johannesburg, Gauteng, South Africa.; Vearey, J (corresponding author), Univ Edinburgh, Ctr African Studies, Edinburgh, Midlothian, Scotland.	jovearey@gmail.com		Vearey, Jo/0000-0002-6636-1322	ESRC [1891875] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Abubakar I, 2018, LANCET, V392, P2606, DOI 10.1016/S0140-6736(18)32114-7; Allen W, 2018, GEOPOLITICS, V23, P217, DOI 10.1080/14650045.2017.1327740; Amnesty International, 2018, BETWEEN THE DEVIL AN; [Anonymous], 2016, LANCET INFECT DIS, V16, P867, DOI 10.1016/S1473-3099(16)30218-3; Bennett B, 2018, GLOB PUBLIC HEALTH, V13, P519, DOI 10.1080/17441692.2017.1296172; de Vries LA, 2018, J ETHN MIGR STUD, DOI [10.1080/136918, DOI 10.1080/136918]; Greenaway C, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay060; Griswold KS, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0082-y; Hanefeld J, 2017, LANCET, V389, P2358, DOI 10.1016/S0140-6736(17)31588-X; Horner J, 2013, NEW POLIT SCI, V35, P463, DOI 10.1080/07393148.2013.813699; Internal Displacement Monitoring Centre, 2017, GLOBAL REPORT ON INT; International Organization for Migration, 2017, REPORT OF THE 2ND GL; International Organization for Migration, 2013, WORLD MIGRATION REPO; International Organization for Migration, MISSING MIGRANTS PRO; Khan MS, 2016, LANCET INFECT DIS, V16, pE173, DOI 10.1016/S1473-3099(16)30134-7; Kickbusch I, 2016, INT J HEALTH POLICY, V5, P349, DOI 10.15171/ijhpm.2016.27; Krasnik A, 2018, EUR J PUBLIC HEALTH, V28, P1, DOI 10.1093/eurpub/cky046; McInnes C, 2006, REV INT STUD, V32, P5, DOI 10.1017/S0260210506006905; Pugh S., 2018, GLOBAL HEALTH AND SE; Sweileh WM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5689-x; Trummer U, 2018, EUR J PUBLIC HEALTH, V28, DOI [10.1093/eurpub/cky048.061, DOI 10.1093/EURPUB/CKY048.061]; United Nations, 2017, WORKING PAPER NO ESA; Vearey J, WORLD MIGRATION REPO; WICKRAMAGE K, 2017, MIGRATION HEALTH RES, V1, DOI DOI 10.3390/IJERPH14101248; Wickramage K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5932-5; Williams K, 2018, INT MIGR, V56, P74, DOI 10.1111/imig.12439; World Health Organization, 2014, HEALTH IN ALL POLICI	27	9	9	4	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l4143	10.1136/bmj.l4143	http://dx.doi.org/10.1136/bmj.l4143			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JA3VP	31527042	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000487758000001
J	Cowper, A				Cowper, Andy			Yellowhammer outlines how things fall apart in a no deal Brexit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cowper, Andy] Hlth Policy Insight, London, England		Cowper, A (corresponding author), Hlth Policy Insight, London, England.	andycowper@hotmail.com						Hawkes N, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4603; HM Government, 2019, OP YELL HMG REAS WOR; McKee M., 2019, BMJ OPINION; PoliticsHome, 2019, POLITICSHOME     SEP; Urwin R, 2019, TIMES	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5569	10.1136/bmj.l5569	http://dx.doi.org/10.1136/bmj.l5569			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519650				2022-12-28	WOS:000486649800017
J	Rahbek, C; Borregaard, MK; Antonelli, A; Colwell, RK; Holt, BG; Nogues-Bravo, D; Rasmussen, CMO; Richardson, K; Rosing, MT; Whittaker, RJ; Fjeldsa, J				Rahbek, Carsten; Borregaard, Michael K.; Antonelli, Alexandre; Colwell, Robert K.; Holt, Ben G.; Nogues-Bravo, David; Rasmussen, Christian M. O.; Richardson, Katherine; Rosing, Minik T.; Whittaker, Robert J.; Fjeldsa, Jon			Building mountain biodiversity: Geological and evolutionary processes	SCIENCE			English	Review							ANDEAN UPLIFT; PATTERNS; RICHNESS; BIRDS	Mountain regions are unusually biodiverse, with rich aggregations of small-ranged species that form centers of endemism. Mountains play an array of roles for Earth's biodiversity and affect neighboring lowlands through biotic interchange, changes in regional climate, and nutrient runoff. The high biodiversity of certain mountains reflects the interplay of multiple evolutionary mechanisms: enhanced speciation rates with distinct opportunities for coexistence and persistence of lineages, shaped by long-term climatic changes interacting with topographically dynamic landscapes. High diversity in most tropical mountains is tightly linked to bedrock geology-notably, areas comprising mafic and ultramafic lithologies, rock types rich in magnesium and poor in phosphate that present special requirements for plant physiology. Mountain biodiversity bears the signature of deep-time evolutionary and ecological processes, a history well worth preserving.	[Rahbek, Carsten; Borregaard, Michael K.; Colwell, Robert K.; Holt, Ben G.; Nogues-Bravo, David; Rasmussen, Christian M. O.; Richardson, Katherine; Whittaker, Robert J.; Fjeldsa, Jon] Univ Copenhagen, GLOBE Inst, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Rahbek, Carsten] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Rahbek, Carsten] Univ Southern Denmark, Danish Inst Adv Study, Campusvej 55, DK-5230 Odense M, Denmark; [Antonelli, Alexandre] Royal Bot Gardens, Richmond TW9 3AE, Surrey, England; [Antonelli, Alexandre] Gothenburg Global Biodivers Ctr, SE-41319 Gothenburg, Sweden; [Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Colwell, Robert K.; Fjeldsa, Jon] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Rasmussen, Christian M. O.] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Rosing, Minik T.] Univ Copenhagen, GLOBE Inst, Sect GeoBiol, Copenhagen, Denmark; [Whittaker, Robert J.] Univ Oxford, Sch Geog & Environm, South Parks Rd, Oxford OX1 3QY, England	University of Copenhagen; Imperial College London; University of Southern Denmark; Royal Botanic Gardens, Kew; University of Gothenburg; University of Connecticut; University of Colorado System; University of Colorado Boulder; University of Copenhagen; University of Copenhagen; University of Oxford	Rahbek, C (corresponding author), Univ Copenhagen, GLOBE Inst, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.; Rahbek, C (corresponding author), Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England.; Rahbek, C (corresponding author), Univ Southern Denmark, Danish Inst Adv Study, Campusvej 55, DK-5230 Odense M, Denmark.	crahbek@snm.ku.dk	Richardson, Katherine/D-7592-2014; Rahbek, Carsten/GVQ-0752-2022; Antonelli, Alexandre/ABE-6321-2020; Antonelli, Alexandre/A-5353-2011; Whittaker, Robert/H-1548-2015; Borregaard, Michael/B-8442-2008; Rasmussen, Christian M. O./E-1537-2012	Richardson, Katherine/0000-0003-3785-2787; Rahbek, Carsten/0000-0003-4585-0300; Antonelli, Alexandre/0000-0003-1842-9297; Antonelli, Alexandre/0000-0003-1842-9297; Nogues-Bravo, David/0000-0002-4060-0153; Holt, Ben G./0000-0003-0831-9684; Whittaker, Robert/0000-0001-7775-3383; Borregaard, Michael/0000-0002-8146-8435; Rasmussen, Christian M. O./0000-0003-2982-9931	Danish National Research Foundation [DNRF96]; Villum Foundation [25925]; Individual Fellowship from Marie Sklodowska-Curie actions [IDEA707968]; Swedish Foundation for Strategic Research; Swedish Research Council; Knut and Alice Wallenberg Foundation; VILLUM Foundation's Young Investigator Programme [VKR023452]; Geocenter Denmark [2015-5, 3-2017]; Novo Nordisk Foundation [NNF16SH0020278]	Danish National Research Foundation(Danmarks Grundforskningsfond); Villum Foundation(Villum Fonden); Individual Fellowship from Marie Sklodowska-Curie actions; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); VILLUM Foundation's Young Investigator Programme(Villum Fonden); Geocenter Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	C.R., M.K.B., R.K.C., B.G.H., D.N.-B., K.R., R.J.W., and J.F. thank the Danish National Research Foundation for its support of the Center for Macroecology, Evolution and Climate (CMEC) (DNRF96). C.R. was funded by a Villum Investigator grant (25925) from The Villum Foundation; M.K.B. was supported by an Individual Fellowship from Marie Sklodowska-Curie actions (IDEA707968); A.A. was supported by the Swedish Foundation for Strategic Research, the Swedish Research Council, and the Knut and Alice Wallenberg Foundation; C.M.O.R. received funding from the VILLUM Foundation's Young Investigator Programme (VKR023452) and Geocenter Denmark (2015-5 and 3-2017); and M.T.R. was supported by Novo Nordisk Foundation (NNF16SH0020278).	Anacker BL, 2011, EVOLUTION, V65, P365, DOI 10.1111/j.1558-5646.2010.01114.x; Antonelli A, 2018, PEERJ, V6, DOI 10.7717/peerj.5644; Antonelli A, 2018, NAT GEOSCI, V11, P718, DOI 10.1038/s41561-018-0236-z; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Badgley C, 2017, TRENDS ECOL EVOL, V32, P211, DOI 10.1016/j.tree.2016.12.010; Batjes N., 2011, GLOBAL DISTRIBUTION; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Connolly SR, 2017, TRENDS ECOL EVOL, V32, P835, DOI 10.1016/j.tree.2017.08.011; Craw D, 2016, NAT GEOSCI, V9, P140, DOI 10.1038/NGEO2618; Eronen JT, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0136; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Fine PVA, 2005, EVOLUTION, V59, P1464; FJELDSA J, 1994, BIODIVERS CONSERV, V3, P207, DOI 10.1007/BF00055939; Fjeldsa J, 2012, ANNU REV ECOL EVOL S, V43, P249, DOI 10.1146/annurev-ecolsys-102710-145113; Flenley JR, 2011, J BIOGEOGR, V38, P809, DOI 10.1111/j.1365-2699.2011.02480.x; GRAVES GR, 1985, AUK, V102, P556, DOI 10.1093/auk/102.3.556; Hazzi NA, 2018, P NATL ACAD SCI USA, V115, P7985, DOI 10.1073/pnas.1803908115; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hoorn C, 2018, MOUNTAINS CLIMATE BI; Humboldt Alexander von, 1868, COSMOS SKETCH PHYS D; Hutter CR, 2017, AM NAT, V190, P828, DOI 10.1086/694319; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Luebert F, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00027; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Madrinan Santiago, 2013, Frontiers in Genetics, V4, P192, DOI 10.3389/fgene.2013.00192; Naka LN, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8575; Nevado B, 2018, NEW PHYTOL, V219, P779, DOI 10.1111/nph.15243; Oliveros CH, 2019, P NATL ACAD SCI USA, V116, P7916, DOI 10.1073/pnas.1813206116; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 2019, SCIENCE, V365, P1108, DOI 10.1126/science.aax0149; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TF, 2018, SCIENCE, V361, DOI 10.1126/science.aar5452; REID EM, 1935, P ROY SOC LOND B BIO, V118, P197; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; Sedano RE, 2010, J BIOGEOGR, V37, P325, DOI 10.1111/j.1365-2699.2009.02200.x; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Valencia BG, 2016, NEW PHYTOL, V212, P510, DOI 10.1111/nph.14042; Viles H, 2016, GEOMORPHOLOGY, V270, P121, DOI 10.1016/j.geomorph.2016.07.011; Wallace A. R., 1880; Zaffosa A, 2017, P NATL ACAD SCI USA, V114, P5653, DOI 10.1073/pnas.1702297114	42	199	205	52	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1114	+		10.1126/science.aax0151	http://dx.doi.org/10.1126/science.aax0151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515384	Green Accepted, Green Submitted			2022-12-28	WOS:000485780800037
J	Gravitz, L				Gravitz, Lauren			A slippery target	NATURE			English	Editorial Material																		Badiani A, 2018, NEUROPSYCHOPHARMACOL, DOI [10.1038/s41386-018-0265-8, DOI 10.1038/S41386-018-0265-8]; Caprioli D, 2009, BIOL PSYCHIAT, V65, P893, DOI 10.1016/j.biopsych.2008.12.009; Kang M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42658; Lee K, 2018, NEUROPSYCHOPHARMACOL, V43, P2606, DOI 10.1038/s41386-018-0211-9; Lichenstein S, 2019, BIOL PSYCHIAT, V85, pS112, DOI 10.1016/j.biopsych.2019.03.281; Yip SW, 2019, AM J PSYCHIAT, V176, P156, DOI 10.1176/appi.ajp.2018.17101147; Zilverstand A, 2018, NEURON, V98, P886, DOI 10.1016/j.neuron.2018.03.048	7	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					S20	S21		10.1038/d41586-019-02690-6	http://dx.doi.org/10.1038/d41586-019-02690-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511669				2022-12-28	WOS:000485415400011
J	Hanefeld, J; Reeves, A; Brown, C; Ostlin, P				Hanefeld, Johanna; Reeves, Aaron; Brown, Chris; Ostlin, Piroska			Achieving health equity: democracy matters	LANCET			English	Editorial Material									[Hanefeld, Johanna] London Sch Hyg & Trop Med, London WC1H 9SH, England; [Reeves, Aaron] Univ Oxford, Dept Social Policy & Intervent, Oxford, England; [Brown, Chris] WHO, Off Investment Hlth & Dev, Venice, Italy; [Ostlin, Piroska] WHO, Reg Off Europe, Copenhagen, Denmark	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; World Health Organization; World Health Organization	Hanefeld, J (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	johanna.hanefeld@lshtm.ac.uk		Reeves, Aaron/0000-0001-9114-965X	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Avendano M, 2014, SOCIAL EPIDEMIOL, V1, P182, DOI [10.1093/med/9780195377903.001.0001, DOI 10.1093/MED/9780195377903.001.0001]; Barr B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3310; Bollyky TJ, 2019, LANCET, V393, P1628, DOI 10.1016/S0140-6736(19)30235-1; Clair A, 2019, J EUR SOC POLICY, V29, P13, DOI 10.1177/0958928718768334; Drutman L, 2015, BUSINESS AM IS LOBBY; Freudenberg N, 2008, J PUBLIC HEALTH POL, V29, P86, DOI 10.1057/palgrave.jphp.3200158; Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0; Lundberg O, 2008, LANCET, V372, P1633, DOI 10.1016/S0140-6736(08)61686-4; Mackenbach JP, 2018, P NATL ACAD SCI USA, V115, P6440, DOI 10.1073/pnas.1800028115; Marmot M., 2005, LANCET; Reeves A, 2019, SOC SCI MED, V234, DOI 10.1016/j.socscimed.2019.112371; Reeves A, 2017, HEALTH ECON, V26, P639, DOI 10.1002/hec.3336; Shaw M., 2014, ANNU REV PUBL HEALTH, V25, P397; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; WHO Europe, 2019, HIGH LEV C HLTH EQ L; WHO Regional Office for Europe, 2019, HLTH PROSP LIV ALL E	16	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2019	394	10209					1600	1601		10.1016/S0140-6736(19)32128-2	http://dx.doi.org/10.1016/S0140-6736(19)32128-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JI8SM	31519433				2022-12-28	WOS:000493733600009
J	Cheng, MP; Stenstrom, R; Paquette, K; Stabler, SN; Akhter, M; Davidson, AC; Gavric, M; Lawandi, A; Jinah, R; Saeed, Z; Demir, K; Huang, K; Mahpour, A; Shamatutu, C; Caya, C; Troquet, JM; Clark, G; Yansouni, CP; Sweet, D; Cheng, MP; Stenstrom, R; Paquette, K; Stabler, SN; Akhter, M; Davidson, A; Gavric, M; Lawandi, A; Jinah, R; Saeed, Z; Demir, K; Huang, K; Mahpour, A; Shamatutu, C; Caya, C; Troquet, JM; Clark, G; Yansouni, C; Sweet, D; Ryan, E; Kadatz, MJ; Sekhon, M; Sangsari, S; Osati, F				Cheng, Matthew P.; Stenstrom, Robert; Paquette, Katryn; Stabler, Sarah N.; Akhter, Murtaza; Davidson, Adam C.; Gavric, Marko; Lawandi, Alexander; Jinah, Rehman; Saeed, Zahid; Demir, Koray; Huang, Kelly; Mahpour, Amirali; Shamatutu, Chris; Caya, Chelsea; Troquet, Jean-Marc; Clark, Greg; Yansouni, Cedric P.; Sweet, David; Cheng, Matthew P.; Stenstrom, Robert; Paquette, Katryn; Stabler, Sarah N.; Akhter, Murtaza; Davidson, Adam; Gavric, Marko; Lawandi, Alexander; Jinah, Rehman; Saeed, Zahid; Demir, Koray; Huang, Kelly; Mahpour, Amirali; Shamatutu, Chris; Caya, Chelsea; Troquet, Jean-Marc; Clark, Greg; Yansouni, Cedric; Sweet, David; Ryan, Emily; Kadatz, Matthew J.; Sekhon, Myphinder; Sangsari, Sassan; Osati, Farzaneh		FABLED Investigators	Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis A Diagnostic Study	ANNALS OF INTERNAL MEDICINE			English	Article							GOAL-DIRECTED RESUSCITATION; SEPTIC SHOCK; ANTIBIOTIC-THERAPY; ORGAN FAILURE; MORTALITY; LACTATE; DEFINITIONS; GUIDELINES; SURVIVAL; IMPACT	Background: Administering antimicrobial agents before obtaining blood cultures could potentially decrease time to treatment and improve outcomes, but it is unclear how this strategy affects diagnostic sensitivity. Objective: To determine the sensitivity of blood cultures obtained shortly after initiation of antimicrobial therapy in patients with severe manifestations of sepsis. Design: Patient-level, single-group, diagnostic study. (Clinical Trials.gov: NCT01867905) Setting: 7 emergency departments in North America. Participants: Adults with severe manifestations of sepsis, including systolic blood pressure less than 90 mm Hg or a serum lactate level of 4 mmol/L or more. Intervention: Blood cultures were obtained before and within 120 minutes after initiation of antimicrobial treatment. Measurements: Sensitivity of blood cultures obtained after initiation of antimicrobial therapy. Results: Of 3164 participants screened, 325 were included in the study (mean age, 65.6 years; 62.8% men) and had repeated blood cultures drawn after initiation of antimicrobial therapy (median time, 70 minutes [interquartile range, 50 to 110 minutes]). Preantimicrobial blood cultures were positive for 1 or more microbial pathogens in 102 of 325 (31.4%) patients. Post-antimicrobial blood cultures were positive for 1 or more microbial pathogens in 63 of 325 (19.4%) patients. The absolute difference in the proportion of positive blood cultures between pre- and postantimicrobial testing was 12.0% (95% CI, 5.4% to 18.6%; P < 0.001). Sensitivity of postantimicrobial culture was 52.9% (CI, 42.8% to 62.9%). When the results of other microbiological cultures were included, microbial pathogens were found in 69 of 102 (67.6% [CI, 57.7% to 76.6%]) patients. Limitation: Only a proportion of screened patients were recruited. Conclusion: Among patients with severe manifestations of sepsis, initiation of empirical antimicrobial therapy significantly reduces the sensitivity of blood cultures drawn shortly after treatment initiation.	[Cheng, Matthew P.] Harvard Med Sch, Brigham & Womens Hosp, 75 Francis St,PBB-A4, Boston, MA 02115 USA; [Stenstrom, Robert; Osati, Farzaneh] Univ British Columbia, St Pauls Hosp, Vancouver, BC, Canada; [Stenstrom, Robert; Osati, Farzaneh] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Paquette, Katryn] McGill Univ, Montreal Childrens Hosp, Montreal, PQ, Canada; [Stabler, Sarah N.] Univ British Columbia, Surrey Mem Hosp, Surrey, BC, Canada; [Akhter, Murtaza; Davidson, Adam] Univ Arizona, Coll Med, Phoenix, AZ USA; [Davidson, Adam C.; Gavric, Marko; Jinah, Rehman; Huang, Kelly; Shamatutu, Chris; Sweet, David; Kadatz, Matthew J.; Sekhon, Myphinder] Univ British Columbia, 317-2194 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Davidson, Adam C.] Lions Gate Hosp, Vancouver, BC, Canada; [Lawandi, Alexander; Demir, Koray; Caya, Chelsea; Yansouni, Cedric P.] McGill Univ, Hlth Ctr, 1001 Blvd Decarie,Glen Site Block E, Montreal, PQ H4A 3J1, Canada; [Troquet, Jean-Marc] McGill Univ, Hlth Ctr, 1001 Blvd Decarie,CS1-6143, Montreal, PQ H4A 3J1, Canada; [Clark, Greg] McGill Univ, Hlth Ctr, 1001 Blvd Decarie,CS1-6224, Montreal, PQ H4A 3J1, Canada; [Saeed, Zahid] Banner Univ, Med Ctr, 1111 East McDowell Rd, Phoenix, AZ 85006 USA; [Mahpour, Amirali] London Hlth Sci Ctr, 1151 Richmond St, London, ON N6A 4V2, Canada; [Jinah, Rehman; Sweet, David; Kadatz, Matthew J.; Sekhon, Myphinder] Vancouver Gen Hosp, 899 West 12th Ave,Intens Care Unit JPN2,Room 2438, Vancouver, BC V5Z 1M9, Canada; [Stenstrom, Robert] St Pauls Hosp, 1081 Burrard St, Vancouver, BC V1S 1Y1, Canada; [Paquette, Katryn] Montreal Childrens Hosp, 1001 Blvd Decarie,B05-2043, Montreal, PQ H4A 3J1, Canada; [Stabler, Sarah N.] Surrey Mem Hosp, 13750 96th Ave, Surrey, BC V3V 1Z2, Canada; [Akhter, Murtaza] Maricopa Integrated Hlth Syst, 2601 East Roosevelt St, Phoenix, AZ 85008 USA; [Davidson, Adam C.] Lions Gate Hosp, 231 East 15th St, N Vancouver, BC, Canada; [Gavric, Marko] 1908 Scotia St, Vancouver, BC V5T 0E8, Canada; [Huang, Kelly] Vancouver Gen Hosp, 899 West 12th Ave, Vancouver, BC V5Z 1M9, Canada; [Ryan, Emily] Dalhousie Univ, Halifax, NS, Canada; [Sangsari, Sassan] Univ Cologne, Cologne, Germany; [Sangsari, Sassan] Univ Cologne, Ctr Heart, Cologne, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McGill University; University of British Columbia; University of Arizona; University of British Columbia; McGill University; McGill University; McGill University; London Health Sciences Centre; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; McGill University; Maricopa County General Hospital; University of British Columbia; Dalhousie University; University of Cologne; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf	Cheng, MP (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 75 Francis St,PBB-A4, Boston, MA 02115 USA.	mcheng@bwh.harvard.edu	Lawandi, Alexander/AAA-8505-2022; Cheng, Matthew P./AAO-7051-2020	Lawandi, Alexander/0000-0001-7948-3161; Clark, Gregory/0000-0002-6752-9676; /0000-0002-4765-3469	Vancouver Coastal Health, St. Paul's Hospital Foundation Emergency Department Support Fund; Fonds de recherche Sante-Quebec; Maricopa Medical Foundation	Vancouver Coastal Health, St. Paul's Hospital Foundation Emergency Department Support Fund; Fonds de recherche Sante-Quebec; Maricopa Medical Foundation	Vancouver Coastal Health, St. Paul's Hospital Foundation Emergency Department Support Fund, the Fonds de recherche Sante-Quebec, and the Maricopa Medical Foundation.	Alam N, 2018, LANCET RESP MED, V6, P40, DOI 10.1016/S2213-2600(17)30469-1; Baron EJ, 2005, CUMITECH 1C BLOOD CU; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; Clinical and Laboratory Standards Institute, 2019, M100ED292019 CLSI; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Gordon AC, 2016, NEW ENGL J MED, V375, P1638, DOI 10.1056/NEJMoa1609409; Grace CJ, 2001, CLIN INFECT DIS, V32, P1651, DOI 10.1086/320527; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee CC, 2012, AM J EMERG MED, V30, P1447, DOI 10.1016/j.ajem.2011.11.010; Levy MM, 2018, AM J RESP CRIT CARE, V198, P1406, DOI [10.1164/rccm.201712-2545OC, 10.1164/rccm.201712-2545oc]; Liu VX, 2017, AM J RESP CRIT CARE, V196, P856, DOI 10.1164/rccm.201609-1848OC; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Morelli A, 2013, JAMA-J AM MED ASSOC, V310, P1683, DOI 10.1001/jama.2013.278477; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rowan KM, 2017, NEW ENGL J MED, V376, P2223, DOI 10.1056/NEJMoa1701380; Scheer CS, 2019, CLIN MICROBIOL INFEC, V25, P326, DOI 10.1016/j.cmi.2018.05.016; Schermer CR, 2002, J TRAUMA, V52, P463, DOI 10.1097/00005373-200203000-00008; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	33	65	67	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2019	171	8					547	+		10.7326/M19-1696	http://dx.doi.org/10.7326/M19-1696			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD4JV	31525774				2022-12-28	WOS:000489944700014
J	Agusti, A; Hogg, JC				Agusti, Alvar; Hogg, James C.			Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SMALL-AIRWAY OBSTRUCTION; LUNG-FUNCTION; NATURAL-HISTORY; DNA METHYLATION; GLOBAL STRATEGY; EMPHYSEMA; SMOKERS; INFLAMMATION; COPD; HYPERTENSION	A pair of review articles examines our current understanding of the biology, diagnosis, and treatment of chronic obstructive pulmonary disease. This article focuses on the pathogenesis of COPD.	[Agusti, Alvar] Inst Invest Agusti Pi i Sunyer, Resp Inst, Hosp Clin, Barcelona, Spain; [Agusti, Alvar] Univ Barcelona, Barcelona, Spain; [Agusti, Alvar] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain; [Hogg, James C.] Univ British Columbia, St Pauls Hosp, Ctr Heart & Lung Innovat, Vancouver, BC, Canada	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Agusti, A (corresponding author), Hosp Clin Barcelona, Resp Inst, Villarroel 170, Barcelona 08036, Spain.	aagusti@clinic.cat						Agusti A., 2017, ERJ OPEN RES, V3, P117, DOI DOI 10.1183/23120541.00117-2017; Agusti A, 2019, LANCET RESP MED, V7, P358, DOI 10.1016/S2213-2600(18)30529-0; Agusti A, 2018, LANCET RESP MED, V6, P324, DOI 10.1016/S2213-2600(18)30060-2; Agusti A, 2017, LANCET RESP MED, V5, P935, DOI 10.1016/S2213-2600(17)30434-4; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Boucher RC, 2019, NEW ENGL J MED, V380, P1941, DOI 10.1056/NEJMra1813799; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Bui DS, 2018, LANCET RESP MED, V6, P535, DOI 10.1016/S2213-2600(18)30100-0; Celli BR, 2019, NEW ENGL J MED, V381, P1257, DOI 10.1056/NEJMra1900500; Celli BR, 2018, ERJ OPEN RES, V4; Center for Disease Control and Prevention,, 2010, TOB SMOK CAUS DIS BI; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Coxson HO, 2004, AM J RESP CRIT CARE, V170, P748, DOI 10.1164/rccm.200405-651OC; de-Torres JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151856; Du Y, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0639-1; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Faner R, 2016, AM J RESP CRIT CARE, V193, P1242, DOI 10.1164/rccm.201507-1311OC; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Ghosh M, 2018, AM J RESP CRIT CARE, V197, P885, DOI 10.1164/rccm.201704-0667OC; Golpe R, 2017, INT J CHRONIC OBSTR, V12, P2639, DOI 10.2147/COPD.S141068; Gulia KK, 2005, PROCEEDINGS OF THE 2ND INTERIM CONGRESS OF THE WORLD FEDERATION OF SLEEP RESEARCH AND SLEEP MEDICINE SOCIETIES, P7; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Houssaini A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.93203; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kheradmand F, 2012, EXPERT REV CLIN IMMU, V8, P285, DOI [10.1586/ECI.12.7, 10.1586/eci.12.7]; Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Koo HK, 2018, LANCET RESP MED, V6, P591, DOI 10.1016/S2213-2600(18)30196-6; Kovacs G, 2018, AM J RESP CRIT CARE, V198, P1000, DOI 10.1164/rccm.201801-0095PP; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; MEAD J, 1970, NEW ENGL J MED, V282, P1318, DOI 10.1056/NEJM197006042822311; Meiners S, 2015, EUR RESPIR J, V45, P807, DOI 10.1183/09031936.00186914; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Morrow JD, 2018, AM J RESP CRIT CARE, V197, P1275, DOI 10.1164/rccm.201707-1434OC; Morrow JD, 2016, EPIGENETICS-US, V11, P730, DOI 10.1080/15592294.2016.1226451; Noguera A, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-101; Olloquequi J, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0718-y; Palange P, 2006, EUR RESPIR J, V27, P529, DOI 10.1183/09031936.06.00120604; Peinado VI, 1999, AM J RESP CRIT CARE, V159, P1605, DOI 10.1164/ajrccm.159.5.9807059; Prakash YS, 2017, CHEST, V152, P618, DOI 10.1016/j.chest.2017.03.020; Qiu WL, 2015, EPIGENETICS-US, V10, P1064, DOI 10.1080/15592294.2015.1106672; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Ryter Stefan W, 2010, Expert Rev Respir Med, V4, P573, DOI 10.1586/ers.10.61; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Selman M, 2019, AM J RESP CRIT CARE, V199, P279, DOI 10.1164/rccm.201806-1166PP; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Sharafkhaneh Amir, 2008, Proc Am Thorac Soc, V5, P475, DOI 10.1513/pats.200708-126ET; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Staudt MR, 2014, AM J RESP CRIT CARE, V190, P955, DOI 10.1164/rccm.201406-1167LE; Tanabe N, 2018, EUR RESPIR J, V51, P51; Taraseviciene-Stewart L, 2005, AM J RESP CRIT CARE, V171, P734, DOI 10.1164/rccm.200409-1275OC; Taraseviciene-Stewart Laima, 2006, Proc Am Thorac Soc, V3, P687, DOI 10.1513/pats.200605-105SF; Tuder RM, 2003, AM J RESP CELL MOL, V28, P551, DOI 10.1165/rcmb.F269; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Wain LV, 2017, NAT GENET, V49, P416, DOI 10.1038/ng.3787; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971	73	182	187	40	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1248	1256		10.1056/NEJMra1900475	http://dx.doi.org/10.1056/NEJMra1900475			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OT	31553836				2022-12-28	WOS:000489333500009
J	Orben, A				Orben, Amy			A journal club to fix science	NATURE			English	Editorial Material									[Orben, Amy] Univ Cambridge, Cambridge, England	University of Cambridge	Orben, A (corresponding author), Univ Cambridge, Cambridge, England.	aco35@cam.ac.uk		Orben, Amy/0000-0002-2937-4183	MRC [MC_UU_00005/9] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Chambers CD, 2013, CORTEX, V49, P609, DOI 10.1016/j.cortex.2012.12.016; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; TENNANT JP, 2016, RES, V5, P632	4	13	13	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					465	465		10.1038/d41586-019-02842-8	http://dx.doi.org/10.1038/d41586-019-02842-8			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31551562	Bronze			2022-12-28	WOS:000488247600022
J	Epling, JW; Borsky, AE; Gerteis, J				Epling, John W.; Borsky, Amanda E.; Gerteis, Jessie			Improvements to the US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint summarizes results of dissemination and implementation research conducted by the US Preventive Services Task Force (USPSTF) to reevaluate the presentation of USPSTF Recommendation Statements and explains changes made to the statements and accompanying materials to increase clarity and enhance implementation of recommendations.	[Epling, John W.] Virginia Tech, Carilion Sch Med, Roanoke, VA USA; [Borsky, Amanda E.] Agcy Healthcare Res & Qual, Rockville, MD USA; [Gerteis, Jessie] Abt Associates Inc, Cambridge, MA USA	Virginia Polytechnic Institute & State University; Agency for Healthcare Research & Quality; ABT Associates	Epling, JW (corresponding author), Virginia Tech, Carilion Sch Med, Dept Family & Community Med, One Riverside Cir,Ste 102, Roanoke, VA 24016 USA.	jwepling@carilionclinic.org	Epling, John W/J-1097-2019	Epling, John W/0000-0001-9445-8669; Borsky, Amanda/0000-0002-0038-2219	AHRQ [HHSA-290-2016-00006-C]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF. The literature review and interviews were supported by AHRQ through contract HHSA-290-2016-00006-C.	Graham R, 2011, CLIN PRACTICE GUIDEL; Kurth AE, 2018, AM J PREV MED, V54, pS81, DOI 10.1016/j.amepre.2017.07.004; US Preventive Services Task Force, 2019, SCREEN AS BACT AD US; Woo M, 2018, UNDERSTANDING EVIDEN	4	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1143	1144		10.1001/jama.2019.11311	http://dx.doi.org/10.1001/jama.2019.11311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550039				2022-12-28	WOS:000488822800017
J	Shan, ZL; Rehm, CD; Rogers, G; Ruan, MY; Wang, DD; Hu, FB; Mozaffarian, D; Zhang, FF; Bhupathiraju, SN				Shan, Zhilei; Rehm, Colin D.; Rogers, Gail; Ruan, Mengyuan; Wang, Dong D.; Hu, Frank B.; Mozaffarian, Dariush; Zhang, Fang Fang; Bhupathiraju, Shilpa N.			Trends in Dietary Carbohydrate, Protein, and Fat Intake and Diet Quality Among US Adults, 1999-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; ENERGY; ASSOCIATIONS	Key PointsQuestionWhat were the trends in carbohydrate, fat, and protein intake among US adults from 1999 to 2016? FindingsIn this nationally representative serial cross-sectional study that included 43996 adults, there were decreases in low-quality carbohydrates (primarily added sugar) and increases in high-quality carbohydrates (primarily whole grains), plant protein (primarily whole grains and nuts), and polyunsaturated fat. However, 42% of energy intake was still derived from low-quality carbohydrates and the intake of saturated fat remained above 10% of energy. MeaningThe macronutrient composition of diet among US adults has improved, but continued high intake of low-quality carbohydrates and saturated fat remain. ImportanceChanges in the economy, nutrition policies, and food processing methods can affect dietary macronutrient intake and diet quality. It is essential to evaluate trends in dietary intake, food sources, and diet quality to inform policy makers. ObjectiveTo investigate trends in dietary macronutrient intake, food sources, and diet quality among US adults. Design, Setting, and ParticipantsSerial cross-sectional analysis of the US nationally representative 24-hour dietary recall data from 9 National Health and Nutrition Examination Survey cycles (1999-2016) among adults aged 20 years or older. ExposureSurvey cycle. Main Outcomes and MeasuresDietary intake of macronutrients and their subtypes, food sources, and the Healthy Eating Index 2015 (range, 0-100; higher scores indicate better diet quality; a minimal clinically important difference has not been defined). ResultsThere were 43996 respondents (weighted mean age, 46.9 years; 51.9% women). From 1999 to 2016, the estimated energy from total carbohydrates declined from 52.5% to 50.5% (difference, -2.02%; 95% CI, -2.41% to -1.63%), whereas that of total protein and total fat increased from 15.5% to 16.4% (difference, 0.82%; 95% CI, 0.67%-0.97%) and from 32.0% to 33.2% (difference, 1.20%; 95% CI, 0.84%-1.55%), respectively (all P<.001 for trend). Estimated energy from low-quality carbohydrates decreased by 3.25% (95% CI, 2.74%-3.75%; P<.001 for trend) from 45.1% to 41.8%. Increases were observed in estimated energy from high-quality carbohydrates (by 1.23% [95% CI, 0.84%-1.61%] from 7.42% to 8.65%), plant protein (by 0.38% [95% CI, 0.28%-0.49%] from 5.38% to 5.76%), saturated fatty acids (by 0.36% [95% CI, 0.20%-0.51%] from 11.5% to 11.9%), and polyunsaturated fatty acids (by 0.65% [95% CI, 0.56%-0.74%] from 7.58% to 8.23%) (all P<.001 for trend). The estimated overall Healthy Eating Index 2015 increased from 55.7 to 57.7 (difference, 2.01; 95% CI, 0.86-3.16; P<.001 for trend). Trends in high- and low-quality carbohydrates primarily reflected higher estimated energy from whole grains (0.65%) and reduced estimated energy from added sugars (-2.00%), respectively. Trends in plant protein were predominantly due to higher estimated intake of whole grains (0.12%) and nuts (0.09%). Conclusions and RelevanceFrom 1999 to 2016, US adults experienced a significant decrease in percentage of energy intake from low-quality carbohydrates and significant increases in percentage of energy intake from high-quality carbohydrates, plant protein, and polyunsaturated fat. Despite improvements in macronutrient composition and diet quality, continued high intake of low-quality carbohydrates and saturated fat remained. This national survey study uses NHANES data to characterize trends in dietary macronutrient intake, food sources, and diet quality among US adults from 1999 to 2016.	[Shan, Zhilei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan, Hubei, Peoples R China; [Shan, Zhilei; Rogers, Gail; Ruan, Mengyuan; Mozaffarian, Dariush; Zhang, Fang Fang] Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA; [Shan, Zhilei; Wang, Dong D.; Hu, Frank B.; Bhupathiraju, Shilpa N.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA; [Rehm, Colin D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Rogers, Gail; Zhang, Fang Fang] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ruan, Mengyuan] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bhupathiraju, Shilpa N.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Bhupathiraju, Shilpa N.] Harvard Med Sch, Boston, MA 02115 USA	Huazhong University of Science & Technology; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Tufts University; United States Department of Agriculture (USDA); Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shan, ZL; Zhang, FF (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.; Shan, ZL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	zshan@hsph.harvard.edu; fang_fang.zhang@tufts.edu	Shan, Zhilei/S-5189-2019; Wang, Dong D./AAU-2951-2021; Mozaffarian, Dariush/ABC-2822-2020; Zhang, Fang/HHN-2153-2022	Wang, Dong D./0000-0002-0897-3048; Shan, Zhilei/0000-0002-6723-3381	National Institutes of Health [K01 DK107804, R01 MD011501]; National Natural Science Foundation of China [81703214]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK107804] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD011501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is supported by National Institutes of Health grant R01 MD011501 to Drs Shan, Rehm, and Zhang; National Institutes of Health grant K01 DK107804 to Dr Bhupathiraju; and the Young Scientists Fund of the National Natural Science Foundation of China grant 81703214 to Dr Shan.	Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Berryman CE, 2018, AM J CLIN NUTR, V108, P405, DOI 10.1093/ajcn/nqy088; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, INF DIET VAR NAT HLT; Centers for Disease Control and Prevention, KEY CONC NHANES SAMP; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Cohen E, 2015, NUTRITION, V31, P727, DOI 10.1016/j.nut.2015.02.007; Farvid MS, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3437; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; La Berge AF, 2008, J HIST MED ALL SCI, V63, P139, DOI 10.1093/jhmas/jrn001; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Ludwig DS, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2340; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Pan A, 2018, CELL METAB, V27, P489, DOI 10.1016/j.cmet.2018.02.017; Pasiakos SM, 2015, NUTRIENTS, V7, P7058, DOI 10.3390/nu7085322; Reedy J, 2018, J ACAD NUTR DIET, V118, P1622, DOI 10.1016/j.jand.2018.05.019; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Song MY, 2016, JAMA INTERN MED, V176, P1453, DOI 10.1001/jamainternmed.2016.4182; Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001	29	175	177	9	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1178	1187		10.1001/jama.2019.13771	http://dx.doi.org/10.1001/jama.2019.13771			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550032	Green Published, Bronze			2022-12-28	WOS:000488822800024
J	Woskie, L; Fallah, M				Woskie, Liana; Fallah, Mosoka			Overcoming distrust to deliver universal health coverage: lessons from Ebola	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRUST; SYSTEM; DETERMINANTS; PERCEPTIONS; PROVIDERS; SERVICES; QUALITY; LIBERIA		[Woskie, Liana] Harvard Global Hlth Inst, Cambridge, MA USA; [Woskie, Liana] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England; [Fallah, Mosoka] Natl Publ Hlth Inst Liberia, Monrovia, Liberia; [Fallah, Mosoka] Harvard Med Sch, Boston, MA 02115 USA	University of London; London School Economics & Political Science; Harvard University; Harvard Medical School	Fallah, M (corresponding author), Natl Publ Hlth Inst Liberia, Monrovia, Liberia.; Fallah, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mfallah1969@gmail.com		Woskie, Liana/0000-0002-7451-6849				Abiola SE, 2011, HEALTH AFFAIR, V30, P1478, DOI 10.1377/hlthaff.2010.1055; Ambesh Paurush, 2016, Indian Heart J, V68, P749, DOI 10.1016/j.ihj.2016.07.023; [Anonymous], 2019, Nature, V567, P433, DOI 10.1038/d41586-019-00892-6; Beaumont P., 2019, GUARDIAN; Berwick DM, 2018, LANCET, V392, P194, DOI 10.1016/S0140-6736(18)31430-2; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Bowser D, 2010, EXPLORING EVIDENCE D; Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Dhillon RS, 2015, NEW ENGL J MED, V373, P787, DOI 10.1056/NEJMp1508413; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; Duckett J, 2016, HEALTH POLICY PLANN, V31, P1001, DOI 10.1093/heapol/czw024; Fallah M, 2016, ANN INTERN MED, V164, P367, DOI 10.7326/M15-1464; Government of Liberia. Ministry of Health and Social Welfare, 2008, COMM HLTH SURV HLTH; Hogan DR, 2018, LANCET GLOB HEALTH, V6, pE152, DOI 10.1016/S2214-109X(17)30472-2; Jiao ML, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006719; Kruk ME, 2011, MED CARE, V49, P585, DOI 10.1097/MLR.0b013e31820f0dd4; LaVeist TA, 2009, HEALTH SERV RES, V44, P2093, DOI 10.1111/j.1475-6773.2009.01017.x; Mascarenhas OAJ, 2006, CLIN INTERV AGING, V1, P175, DOI 10.2147/ciia.2006.1.2.175; Morse B, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000007; Mostashari F, 1998, J ACQ IMMUN DEF SYND, V18, P341, DOI 10.1097/00042560-199808010-00005; National Academy of Medicine, 2018, CROSSING THE GLOBAL; O'Malley AS, 2004, PREV MED, V38, P777, DOI 10.1016/j.ypmed.2004.01.018; Ozawa S, 2013, SOC SCI MED, V91, P10, DOI 10.1016/j.socscimed.2013.05.005; Ozawa S, 2011, HEALTH POLICY PLANN, V26, pi20, DOI 10.1093/heapol/czr045; Petit D, 2013, SOC SCI MED, V78, P42, DOI 10.1016/j.socscimed.2012.11.026; Rose A, 2004, J GEN INTERN MED, V19, P57, DOI 10.1111/j.1525-1497.2004.21146.x; Shea JA, 2008, J GEN INTERN MED, V23, P727, DOI 10.1007/s11606-008-0575-3; Shi JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131461; Svoronos T, 2015, HEALTH POLICY PLANN, V30, P823, DOI 10.1093/heapol/czu065; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Unicef, 2019, DRC EB SIT REP; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Williamson LD, 2018, PATIENT EDUC COUNS, V101, P1786, DOI 10.1016/j.pec.2018.05.007; Wu D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006431; Zhao DH, 2016, CHINESE MED J-PEKING, V129, P814, DOI 10.4103/0366-6999.178971	36	14	14	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5482	10.1136/bmj.l5482	http://dx.doi.org/10.1136/bmj.l5482			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB3WS	31548212	Green Published, hybrid			2022-12-28	WOS:000488488000005
J	Bhuyan, A				Bhuyan, Anoo			Foundation backed by Philip Morris funds schoolchildren's global science contest	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												anoo.email@gmail.com						Bhuyan A., 2019, WIRE            0206; Bhuyan A., 2017, TOP U REJECT BIG TOB; Foundation for a Smoke Free World, FREQ ASK QUEST; Hansen JP, 2018, COMMUNICATION BY GAZE INTERACTION (COGAIN 2018), DOI 10.1145/3206343.3206344; Kalra A., 2019, RPT INDIA ASKS ITS S; WHO Framework Convention on Tobacco Control, 2017, SECR STAT LAUNCH FDN; World Health Organization, 2019, WHO REP GLOB TOB EP	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2019	366								l5366	10.1136/bmj.l5366	http://dx.doi.org/10.1136/bmj.l5366			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WD	31537544				2022-12-28	WOS:000487759400002
J	Ganz, T				Ganz, Tomas			Anemia of Inflammation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COLONY-FORMING-UNITS; ERYTHROPOIETIN PRODUCTION; IRON-DEFICIENCY; STAINABLE IRON; MOUSE MODEL; HEPCIDIN; INHIBITION; DISEASE; MOMELOTINIB; METABOLISM	Anemia of inflammation is a common normocytic, normochromic anemia associated with systemic inflammation that increases the level of hepcidin and results in defective iron reuse from body stores. Reducing inflammation can help correct the defect.	[Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ganz, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 43-229 CHS,Box 951690,10833 LeConte Ave, Los Angeles, CA 90095 USA.	tganz@mednet.ucla.edu	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Ganz, Tomas/0000-0002-2830-5469				Asshoff M, 2017, BLOOD, V129, P1823, DOI 10.1182/blood-2016-09-740092; Auerbach M, 2017, HEMODIAL INT, V21, pS83, DOI 10.1111/hdi.12560; Barrett TD, 2015, BRIT J PHARMACOL, V172, P4078, DOI 10.1111/bph.13188; Barron BA, 2001, ANN HEMATOL, V80, P166, DOI 10.1007/s002770000261; Belotti A, 2015, LEUKEMIA RES, V39, P88, DOI 10.1016/j.leukres.2014.11.003; Boutou AK, 2015, CLIN SCI, V128, P283, DOI 10.1042/CS20140344; Boyce M, 2016, BRIT J PHARMACOL, V173, P1580, DOI 10.1111/bph.13433; Bullock GC, 2010, BLOOD, V116, P97, DOI 10.1182/blood-2009-10-251496; CARTWRIGHT G. E., 1966, SEMINARS HEMATOL, V3, P351; CAVILL I, 1982, BRIT J HAEMATOL, V50, P583, DOI 10.1111/j.1365-2141.1982.tb01958.x; Cazzola M, 1996, BLOOD, V87, P4824, DOI 10.1182/blood.V87.11.4824.bloodjournal87114824; Chen N, 2017, NEPHROL DIAL TRANSPL, V32, P1373, DOI 10.1093/ndt/gfx011; Cody JD, 2016, COCHRANE DB SYST REV, V1; Corwin HL, 2000, CRIT CARE MED, V28, P3098, DOI 10.1097/00003246-200008000-00079; Dulmovits BM, 2017, CURR OPIN HEMATOL, V24, P159, DOI 10.1097/MOH.0000000000000328; Dzierzak E, 2013, COLD SPRING HARB PER, V3; Fischer R, 2007, PEDIATR PULM, V42, P1193, DOI 10.1002/ppul.20717; Fishbane S, 2019, AM J KIDNEY DIS, V73, P297, DOI 10.1053/j.ajkd.2018.11.006; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gil-Santana L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37860-5; Girelli D, 2019, HAEMATOLOGICA, V104, P417, DOI 10.3324/haematol.2018.208066; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hanudel MR, 2016, AM J PHYSIOL-RENAL, V311, pF1369, DOI 10.1152/ajprenal.00281.2016; Hedenus M, 2009, MED ONCOL, V26, P105, DOI 10.1007/s12032-008-9072-0; Hohlbaum AM, 2018, BRIT J PHARMACOL, V175, P1054, DOI 10.1111/bph.14143; Khalil S, 2018, J EXP MED, V215, P661, DOI 10.1084/jem.20170396; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Kimachi M, 2015, NEPHRON, V131, P123, DOI 10.1159/000438870; Kovac S, 2016, HAEMATOLOGICA, V101, DOI 10.3324/haematol.2015.140772; KRAUSE JR, 1979, AM J CLIN PATHOL, V72, P68; Li Hongyan, 2009, Journal of Pharmacological and Toxicological Methods, V59, P171, DOI 10.1016/j.vascn.2009.02.004; Libregts SF, 2011, BLOOD, V118, P2578, DOI 10.1182/blood-2010-10-315218; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P39, DOI 10.1093/ndt/17.suppl_11.39; Marti-Carvajal AJ, 2013, COCHRANE DB SYST REV, V2; MEANS RT, 1992, J CELL PHYSIOL, V150, P59, DOI 10.1002/jcp.1041500109; MEANS RT, 1991, BLOOD, V78, P2564; Mesa RA, 2017, J CLIN ONCOL, V35, P3844, DOI 10.1200/JCO.2017.73.4418; MILLER CB, 1990, NEW ENGL J MED, V322, P1689, DOI 10.1056/NEJM199006143222401; Mitlyng BL, 2006, AM J HEMATOL, V81, P432, DOI 10.1002/ajh.20644; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Opasich C, 2005, EUR HEART J, V26, P2232, DOI 10.1093/eurheartj/ehi388; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orsini M, 2019, CELL DEATH DIFFER, V26, P1796, DOI 10.1038/s41418-018-0245-x; Peterson P., 2017, BLOOD, V130, P937; Petzer V, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040135; Poli M, 2014, BIOCHEM PHARMACOL, V92, P467, DOI 10.1016/j.bcp.2014.09.007; Roth MP, 2019, VITAM HORM, V110, P101, DOI 10.1016/bs.vh.2019.01.005; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Scharte M, 2003, CRIT CARE MED, V31, pS651, DOI 10.1097/01.CCM.0000098036.90796.ED; Shaw JG, 2011, ANEMIA, V2011, DOI 10.1155/2011/260380; Sheetz M, 2019, BRIT J CLIN PHARMACO, V85, P935, DOI 10.1111/bcp.13877; Song SNJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4323; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; Stauder R, 2018, BLOOD, V131, P505, DOI 10.1182/blood-2017-07-746446; Stefanova D, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00253-18; Stefanova D, 2017, BLOOD, V130, P245, DOI 10.1182/blood-2017-03-772715; Stoffel NU, 2019, HAEMATOLOGICA, V104, P1143, DOI 10.3324/haematol.2018.208645; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Thomas J, 2010, HEART LUNG, V39, P217, DOI 10.1016/j.hrtlng.2009.07.002; Thomason RW, 2007, AM J CLIN PATHOL, V128, P590, DOI 10.1309/WEDK7D1P7YPT8G0F; Truman-Rosentsvit M, 2018, BLOOD, V131, P342, DOI 10.1182/blood-2017-02-768580; Tussing-Humphreys LM, 2010, OBESITY, V18, P1449, DOI 10.1038/oby.2009.319; Vadhan-Raj S, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0427-x; Wang CY, 2019, BLOOD, V133, P18, DOI 10.1182/blood-2018-06-815894; WEBER J, 1988, ANN RHEUM DIS, V47, P404, DOI 10.1136/ard.47.5.404; WEISS LM, 1995, ARTHRITIS RHEUM, V38, P434; Wouters HJCM, 2019, HAEMATOLOGICA, V104, P468, DOI 10.3324/haematol.2018.195552; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538	71	180	189	6	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1148	1157		10.1056/NEJMra1804281	http://dx.doi.org/10.1056/NEJMra1804281			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ4PY	31532961				2022-12-28	WOS:000487066900009
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on... cancer bells	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Johnston N., 2019, HOSP REMOVES END TRE; Taylor J., 2019, BMJ BLOGS	2	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2019	366								l5644	10.1136/bmj.l5644	http://dx.doi.org/10.1136/bmj.l5644			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WD	31537533				2022-12-28	WOS:000487759400007
J	Kuehn, B				Kuehn, Bridget			African Women's Preferences for HIV Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1035	1035		10.1001/jama.2019.13825	http://dx.doi.org/10.1001/jama.2019.13825			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31529014				2022-12-28	WOS:000488821100005
J	Torjesen, I				Torjesen, Ingrid			Cancer screening: only a third of women in England take up all offers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rebolj M, 2020, J MED SCREEN, V27, P9, DOI 10.1177/0969141319871977	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5588	10.1136/bmj.l5588	http://dx.doi.org/10.1136/bmj.l5588			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530548				2022-12-28	WOS:000487758600010
J	Sugimura, K; Sasaki, O; Shinoda, M; Kawasaki, S; Shinkai, M				Sugimura, Kazunori; Sasaki, Osamu; Shinoda, Masahiro; Kawasaki, Sho; Shinkai, Masaharu			Catamenial pneumothorax: a cause of monthly breathlessness	LANCET			English	Editorial Material									[Sugimura, Kazunori; Sasaki, Osamu; Shinoda, Masahiro; Kawasaki, Sho; Shinkai, Masaharu] Tokyo Shinagawa Hosp, Dept Internal Med, Shinagawa Ku, Tokyo 1408522, Japan		Sasaki, O (corresponding author), Tokyo Shinagawa Hosp, Dept Internal Med, Shinagawa Ku, Tokyo 1408522, Japan.	osamu1620@aol.com		Sugimura, Kazunori/0000-0003-3391-4733					0	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					952	952		10.1016/S0140-6736(19)32094-X	http://dx.doi.org/10.1016/S0140-6736(19)32094-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX7CE	31526738				2022-12-28	WOS:000485840600026
J	Appenzeller, T				Appenzeller, Tim			FIRE ON THE MOUNTAIN	SCIENCE			English	Editorial Material																			0	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1094	1097		10.1126/science.365.6458.1094	http://dx.doi.org/10.1126/science.365.6458.1094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515380				2022-12-28	WOS:000485780800033
J	Brody, H				Brody, Herb			OPIOIDS	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					S1	S1		10.1038/d41586-019-02681-7	http://dx.doi.org/10.1038/d41586-019-02681-7			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511676				2022-12-28	WOS:000485415400074
J	Seiferle, B; von der Wense, L; Bilous, PV; Amersdorffer, I; Lemell, C; Libisch, F; Stellmer, S; Schumm, T; Dullmann, CE; Palffy, A; Thirolf, PG				Seiferle, Benedict; von der Wense, Lars; Bilous, Pavlo V.; Amersdorffer, Ines; Lemell, Christoph; Libisch, Florian; Stellmer, Simon; Schumm, Thorsten; Duellmann, Christoph E.; Palffy, Adriana; Thirolf, Peter G.			Energy of the Th-229 nuclear clock transition	NATURE			English	Article							LASER SPECTROSCOPY; IONIZATION; SEPARATION; LIFETIME; SYSTEM; STATE; IONS	Owing to its low excitation energy and long radiative lifetime, the first excited isomeric state of thorium-229, Th-229m, can be optically controlled by a laser(1,2) and is an ideal candidate for the creation of a nuclear optical clock(3), which is expected to complement and outperform current electronic-shell-based atomic clocks(4). A nuclear clock will have various applications-such as in relativistic geodesy(5), dark matter research(6) and the observation of potential temporal variations of fundamental constants(7)-but its development has so far been impeded by the imprecise knowledge of the energy of Th-229m. Here we report a direct measurement of the transition energy of this isomeric state to the ground state with an uncertainty of 0.17 electronvolts (one standard deviation) using spectroscopy of the internal conversion electrons emitted in flight during the decay of neutral Th-229m atoms. The energy of the transition between the ground state and the first excited state corresponds to a wavelength of 149.7 +/- 3.1 nanometres, which is accessible by laser spectroscopy through high-harmonic generation. Our method combines nuclear and atomic physics measurements to advance precision metrology, and our findings are expected to facilitate the application of high-resolution laser spectroscopy on nuclei and to enable the development of a nuclear optical clock of unprecedented accuracy.	[Seiferle, Benedict; von der Wense, Lars; Amersdorffer, Ines; Thirolf, Peter G.] Ludwig Maximilians Univ Munchen, Garching, Germany; [Bilous, Pavlo V.; Palffy, Adriana] Max Planck Inst Kernphys, Heidelberg, Germany; [Lemell, Christoph; Libisch, Florian] TU Wien, Inst Theoret Phys, Vienna, Austria; [Stellmer, Simon] Univ Bonn, Bonn, Germany; [Schumm, Thorsten] TU Wien, Atominst, Vienna, Austria; [Duellmann, Christoph E.] GSI Helmholtzzentrum Schwerionenforsch, Darmstadt, Germany; [Duellmann, Christoph E.] Helmholtz Inst Mainz, Mainz, Germany; [Duellmann, Christoph E.] Johannes Gutenberg Univ Mainz, Mainz, Germany	University of Munich; Max Planck Society; Technische Universitat Wien; University of Bonn; Technische Universitat Wien; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Johannes Gutenberg University of Mainz	Seiferle, B (corresponding author), Ludwig Maximilians Univ Munchen, Garching, Germany.	benedict.seiferle@physik.uni-muenchen.de	Lemell, Christoph/B-5147-2009; Schumm, Thorsten/B-8565-2008; Düllmann, Christoph E/L-3401-2017; Libisch, Florian/AAV-3718-2021; Palffy, Adriana/C-7330-2014	Lemell, Christoph/0000-0003-2560-4495; Schumm, Thorsten/0000-0002-1066-202X; Düllmann, Christoph E/0000-0002-1194-0423; Libisch, Florian/0000-0001-5641-9458; Palffy, Adriana/0000-0002-1543-8211	DFG [Th956/3-2]; LMU Chair of Medical Physics via the Maier-Leibnitz Laboratory Garching; European Union's Horizon 2020 research and innovation programme [664732]	DFG(German Research Foundation (DFG)); LMU Chair of Medical Physics via the Maier-Leibnitz Laboratory Garching; European Union's Horizon 2020 research and innovation programme	We acknowledge discussions with D. Habs, J. Weitenberg, M. Laatiaoui, A. Ulrich, W. Plass and colleagues, J. Crespo, C. Weber, F. Zacherl and K. Beeks and we thank K. Eberhardt, C. Mokry, J. Runke and N. Trautmann for producing the 233U and 234U sources. This work was supported by DFG (Th956/3-2), by the LMU Chair of Medical Physics via the Maier-Leibnitz Laboratory Garching and by the European Union's Horizon 2020 research and innovation programme under grant agreement number 664732 (nuClock).	Amersdorffer I., 2018, THESIS; Arnau A, 1997, SURF SCI REP, V27, P117; Beck BR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.142501; Beck B. R., 2009, LLNLPROC415170; Behrens R. G, 1989, GMELIN HDB INORGANIC; Bilous PV, 2018, PHYS REV C, V97, DOI 10.1103/PhysRevC.97.044320; Bilous PV, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.032503; Blaise J, 2014, DATABASE SELECTED CO; Borisyuk PV, 2018, LASER PHYS LETT, V15, DOI 10.1088/1612-202X/aaacf8; BURGDORFER J, 1991, PHYS REV A, V44, P5674, DOI 10.1103/PhysRevA.44.5674; Burke DG, 2008, NUCL PHYS A, V809, P129, DOI 10.1016/j.nuclphysa.2008.06.009; Campbell CJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120802; Campbell CJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.223001; Derevianko A, 2014, NAT PHYS, V10, P933, DOI 10.1038/NPHYS3137; Eberhardt K, 2018, AIP CONF PROC, V1962, DOI 10.1063/1.5035526; Eland J. H. D., 1984, PHOTOELECTRON SPECTR; Flambaum VV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.092502; Fritzsche S, 2012, COMPUT PHYS COMMUN, V183, P1525, DOI 10.1016/j.cpc.2012.02.016; GARDNER JL, 1976, J ELECTRON SPECTROSC, V8, P469, DOI 10.1016/0368-2048(76)80033-3; Gruber E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13948; Haettner E, 2018, NUCL INSTRUM METH A, V880, P138, DOI 10.1016/j.nima.2017.10.003; HARADA K, 1994, J MOL SPECTROSC, V163, P436, DOI 10.1006/jmsp.1994.1038; HELMER RG, 1994, PHYS REV C, V49, P1845, DOI 10.1103/PhysRevC.49.1845; Jeet J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.253001; Jonsson P, 2013, COMPUT PHYS COMMUN, V184, P2197, DOI 10.1016/j.cpc.2013.02.016; Karpeshin FF, 2018, NUCL PHYS A, V969, P173, DOI 10.1016/j.nuclphysa.2017.10.003; Karpeshin FF, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.054313; Kazakov GA, 2014, NUCL INSTRUM METH A, V735, P229, DOI 10.1016/j.nima.2013.09.012; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; KROGER LA, 1976, NUCL PHYS A, V259, P29, DOI 10.1016/0375-9474(76)90494-2; Lias S. G, 2005, NIST CHEM WEBBOOK NI; Masuda T, 2019, NATURE, V573, P238, DOI 10.1038/s41586-019-1542-3; Mehlstaubler TE, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aab409; Minkov N, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.212501; Palffy A, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012715; Peik E, 2003, EUROPHYS LETT, V61, P181, DOI 10.1209/epl/i2003-00210-x; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Raeder S, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/16/165005; REICH CW, 1990, PHYS REV LETT, V64, P271, DOI 10.1103/PhysRevLett.64.271; Rellergert WG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.200802; Roy SK, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3598517; Seiferle B, 2018, PRECISE DETERMINATIO; Seiferle B, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.042501; Stellmer S, 2018, PHYS REV C, V98, DOI 10.1103/PhysRevC.98.014317; Stellmer S, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.062506; Thielking J, 2018, NATURE, V556, P321, DOI 10.1038/s41586-018-0011-8; Tkalya EV, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.054324; van der Wense L., 2018, DIRECT DETECTION TH; von der Wense L, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.132503; von der Wense L, 2016, NATURE, V533, P47, DOI 10.1038/nature17669; Von der Wense L, 2015, EUR PHYS J A, V51, DOI 10.1140/epja/i2015-15029-8; Yamaguchi A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/5/053053; Yamakita Y, 2000, REV SCI INSTRUM, V71, P3042, DOI 10.1063/1.1305819	54	94	95	2	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					243	+		10.1038/s41586-019-1533-4	http://dx.doi.org/10.1038/s41586-019-1533-4			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31511684	Green Submitted			2022-12-28	WOS:000485415400051
J	[Anonymous]				[Anonymous]			Correspondence Cancer Said to Be Caused by a Single Injury (Reprinted from JAMA, vol 126, pg 125, 1944)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1944, JAMA-J AM MED ASSOC, V126, P125	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					985	985		10.1001/jama.2018.15506	http://dx.doi.org/10.1001/jama.2018.15506			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY6YZ	31503299				2022-12-28	WOS:000486543500020
J	Weinberg, DS; Schoen, RE				Weinberg, David S.; Schoen, Robert E.			Preneoplastic Colorectal Polyps: "I Found Them and Removed Them-Now What?"	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COLONOSCOPY; CANCER; ADENOMA		[Weinberg, David S.] Fox Chase Canc Ctr, Dept Med, 333 Cottman Ave, Philadelphia, PA 19111 USA; [Schoen, Robert E.] Univ Pittsburgh, PUH, 200 Lothrop St,Mezzanine Level,C Wing, Pittsburgh, PA 15213 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weinberg, DS (corresponding author), Fox Chase Canc Ctr, Dept Med, 333 Cottman Ave, Philadelphia, PA 19111 USA.	david.weinberg@fccc.edu						Atkin W, 2017, LANCET ONCOL, V18, P823, DOI 10.1016/S1470-2045(17)30187-0; Click B, 2018, JAMA-J AM MED ASSOC, V319, P2021, DOI 10.1001/jama.2018.5809; Cross AJ, 2019, GUT, V68, P1642, DOI 10.1136/gutjnl-2018-317297; Dube C, 2017, AM J GASTROENTEROL, V112, P1790, DOI 10.1038/ajg.2017.360; Jeon J, 2018, GASTROENTEROLOGY, V154, P2152, DOI 10.1053/j.gastro.2018.02.021; Joseph DA, 2016, CANCER-AM CANCER SOC, V122, P2479, DOI 10.1002/cncr.30070; Ladabaum U, 2019, GASTROENTEROLOGY, V157, P137, DOI 10.1053/j.gastro.2019.03.023; Meester RGS, 2019, ANN INTERN MED, V171, P612, DOI 10.7326/M18-3633; Rex DK, 2018, GASTROINTEST ENDOSC, V88, P335, DOI 10.1016/j.gie.2018.02.043; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457	10	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2019	171	9					667	+		10.7326/M19-2795	http://dx.doi.org/10.7326/M19-2795			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JK6WN	31546250				2022-12-28	WOS:000494983000012
J	Pustogow, A; Luo, YK; Chronister, A; Su, YS; Sokolov, DA; Jerzembeck, F; Mackenzie, AP; Hicks, CW; Kikugawa, N; Raghu, S; Bauer, ED; Brown, SE				Pustogow, A.; Luo, Yongkang; Chronister, A.; Su, Y. -S.; Sokolov, D. A.; Jerzembeck, F.; Mackenzie, A. P.; Hicks, C. W.; Kikugawa, N.; Raghu, S.; Bauer, E. D.; Brown, S. E.			Constraints on the superconducting order parameter in Sr2RuO4 from oxygen-17 nuclear magnetic resonance	NATURE			English	Article							LAYERED PEROVSKITE; SYMMETRY-BREAKING	Phases of matter are usually identified through spontaneous symmetry breaking, especially regarding unconventional superconductivity and the interactions from which it originates. In that context, the superconducting state of the quasi-two-dimensional and strongly correlated perovskite Sr2RuO4 is considered to be the only solid-state analogue to the superfluid He-3-A phase(1,2), with an odd-parity order parameter that is unidirectional in spin space for all electron momenta and breaks time-reversal symmetry. This characterization was recently called into question by a search for an expected 'split' transition in a Sr2RuO4 crystal under in-plane uniaxial pressure, which failed to find any such evidence; instead, a dramatic rise and a peak in a single-transition temperature were observed(3,4). Here we use nuclear magnetic resonance (NMR) spectroscopy of oxygen-17, which is directly sensitive to the order parameter via hyperfine coupling to the electronic spin degrees of freedom, to probe the nature of superconductivity in Sr2RuO4 and its evolution under strain. A reduction of the Knight shift is observed for all strain values and at temperatures below the critical temperature, consistent with a drop in spin polarization in the superconducting state. In unstrained samples, our results contradict a body of previous NMR work reporting no change in the Knight shift' and the most prevalent theoretical interpretation of the order parameter as a chiral p-wave state. Sr2RuO4 is an extremely clean layered perovskite and its superconductivity emerges from a strongly correlated Fermi liquid, and our work imposes tight constraints on the order parameter symmetry of this archetypal system.	[Pustogow, A.; Luo, Yongkang; Chronister, A.; Su, Y. -S.; Brown, S. E.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90032 USA; [Luo, Yongkang] Huazhong Univ Sci & Technol, Wuhan Natl High Magnet Field Ctr, Wuhan, Hubei, Peoples R China; [Luo, Yongkang] Huazhong Univ Sci & Technol, Sch Phys, Wuhan, Hubei, Peoples R China; [Sokolov, D. A.; Jerzembeck, F.; Mackenzie, A. P.; Hicks, C. W.] Max Planck Inst Chem Phys Solids, Dresden, Germany; [Mackenzie, A. P.] Univ St Andrews, Sch Phys & Astron, St Andrews, Fife, Scotland; [Kikugawa, N.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Raghu, S.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Bauer, E. D.] Los Alamos Natl Lab, Los Alamos, NM USA	University of California System; University of California Los Angeles; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Max Planck Society; University of St Andrews; National Institute for Materials Science; Stanford University; United States Department of Energy (DOE); Los Alamos National Laboratory	Pustogow, A; Luo, YK; Brown, SE (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90032 USA.; Luo, YK (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl High Magnet Field Ctr, Wuhan, Hubei, Peoples R China.; Luo, YK (corresponding author), Huazhong Univ Sci & Technol, Sch Phys, Wuhan, Hubei, Peoples R China.	pustogow@physics.ucla.edu; mpzslyk@gmail.com; brown@physics.ucla.edu	Mackenzie, Andrew P/K-6742-2015; Hicks, Clifford W/N-9719-2015; Pustogow, Andrej/AAK-8945-2020; Sokolov, Dmitry/P-6635-2019; Sokolov, D A/G-7755-2011	Mackenzie, Andrew P/0000-0001-8000-4949; Pustogow, Andrej/0000-0001-9428-5083; Sokolov, Dmitry/0000-0003-3282-7144; Sokolov, D A/0000-0003-3282-7144; Jerzembeck, Fabian/0000-0003-0003-8140	Alexander von Humboldt Foundation; 1000 Youth Talents Plan of China; JSPS KAKENHI [JP18K04715]; JST-Mirai Program in Japan [JPMJMI18A3]; US Department of Energy, Office of Basic Energy Sciences [DEAC02-76SF00515]; National Science Foundation [DMR-1709304]; Laboratory Directed Research and Development (LDRD) programme of Los Alamos National Laboratory [20170204ER]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); 1000 Youth Talents Plan of China; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST-Mirai Program in Japan; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Laboratory Directed Research and Development (LDRD) programme of Los Alamos National Laboratory	We thank M. Ikeda and S. Kivelson for conversations. We particularly appreciate discussions with K. Ishida and Y. Maeno about the implications of our findings, and K. Ishida for reproducing our results. A.P. acknowledges support by the Alexander von Humboldt Foundation through a Feodor Lynen Fellowship. Y.L. acknowledges support by the 1000 Youth Talents Plan of China. N.K. acknowledges support from JSPS KAKENHI (number JP18K04715) and JST-Mirai Program (number JPMJMI18A3) in Japan. S.R. is supported in part by the US Department of Energy, Office of Basic Energy Sciences, contract DEAC02-76SF00515. This work was supported in part by the National Science Foundation (DMR-1709304) and by the Laboratory Directed Research and Development (LDRD) programme of Los Alamos National Laboratory under project number 20170204ER.	Bjornsson PG, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.012504; Hassinger E, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011032; Hicks CW, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4881611; Hicks CW, 2014, SCIENCE, V344, P283, DOI 10.1126/science.1248292; Hicks CW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214501; Hoult D. I., 2007, EMAGRES; Ishida K, 1998, NATURE, V396, P658, DOI 10.1038/25315; Kittaka S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174514; Kittaka S, 2018, J PHYS SOC JPN, V87, DOI 10.7566/JPSJ.87.093703; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; Li Y.-N., 2019, PREPRINT; Luke GM, 1998, NATURE, V394, P558, DOI 10.1038/29038; Luo YK, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021044; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; Mackenzie AP, 1996, PHYS REV LETT, V76, P3786, DOI 10.1103/PhysRevLett.76.3786; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Matano K, 2016, NAT PHYS, V12, P852, DOI [10.1038/nphys3781, 10.1038/NPHYS3781]; OGUCHI T, 1995, PHYS REV B, V51, P1385, DOI 10.1103/PhysRevB.51.1385; RICE TM, 1995, J PHYS-CONDENS MAT, V7, pL643, DOI 10.1088/0953-8984/7/47/002; Steppke A, 2017, SCIENCE, V355, DOI 10.1126/science.aaf9398; Sunko V, 2019, NPJ QUANTUM MATER, V4, DOI 10.1038/s41535-019-0185-9; Veenstra CN, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.127002; Vollhardt D., 1990, SUPERFLUID PHASES HE, V3; VOLOVIK GE, 1993, JETP LETT+, V58, P469; Watson CA, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.094521; Xia J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167002; Yonezawa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.077003	27	188	190	12	179	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					72	+		10.1038/s41586-019-1596-2	http://dx.doi.org/10.1038/s41586-019-1596-2			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31548658	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000488832500032
J	Hodson, R				Hodson, Richard			DIGITAL HEALTH	NATURE			English	Editorial Material																			0	1	1	3	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					S97	S97		10.1038/d41586-019-02869-x	http://dx.doi.org/10.1038/d41586-019-02869-x			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554989	Bronze			2022-12-28	WOS:000488247600011
J	Morris, JP; Yashinskie, JJ; Koche, R; Chandwani, R; Tian, S; Chen, CC; Baslan, T; Marinkovic, ZS; Sanchez-Rivera, FJ; Leach, SD; Carmona-Fontaine, C; Thompson, CB; Finley, LWS; Lowe, SW				Morris, John P.; Yashinskie, Jossie J.; Koche, Richard; Chandwani, Rohit; Tian, Sha; Chen, Chi-Chao; Baslan, Timour; Marinkovic, Zoran S.; Sanchez-Rivera, Francisco J.; Leach, Steven D.; Carmona-Fontaine, Carlos; Thompson, Craig B.; Finley, Lydia W. S.; Lowe, Scott W.			alpha-Ketoglutarate links p53 to cell fate during tumour suppression	NATURE			English	Article							PANCREATIC-CANCER; SOMATIC INACTIVATION; RESTORATION; EXPRESSION; GROWTH; KRAS; GENE; IDENTIFICATION; METABOLISM; ACTIVATION	The tumour suppressor TP53 is mutated in the majority of human cancers, and in over 70% of pancreatic ductal adenocarcinoma (PDAC)(1,2). Wild-type p53 accumulates in response to cellular stress, and regulates gene expression to alter cell fate and prevent tumour development(2). Wild-type p53 is also known to modulate cellular metabolic pathways(3), although p53-dependent metabolic alterations that constrain cancer progression remain poorly understood. Here we find that p53 remodels cancer-cell metabolism to enforce changes in chromatin and gene expression that favour a premalignant cell fate. Restoring p53 function in cancer cells derived from KRAS-mutant mouse models of PDAC leads to the accumulation of alpha-ketoglutarate (alpha KG, also known as 2-oxoglutarate), a metabolite that also serves as an obligate substrate for a subset of chromatin-modifying enzymes. p53 induces transcriptional programs that are characteristic of premalignant differentiation, and this effect can be partially recapitulated by the addition of cell-permeable alpha KG. Increased levels of the alpha KG-dependent chromatin modification 5-hydroxymethylcytosine (5hmC) accompany the tumour-cell differentiation that is triggered by p53, whereas decreased 5hmC characterizes the transition from premalignant to de-differentiated malignant lesions that is associated with mutations in Trp53. Enforcing the accumulation of alpha KG in p53-deficient PDAC cells through the inhibition of oxoglutarate dehydrogenase-an enzyme of the tricarboxylic acid cycle-specifically results in increased 5hmC, tumour-cell differentiation and decreased tumour-cell fitness. Conversely, increasing the intracellular levels of succinate (a competitive inhibitor of alpha KG-dependent dioxygenases) blunts p53-driven tumour suppression. These data suggest that alpha KG is an effector of p53-mediated tumour suppression, and that the accumulation of alpha KG in p53-deficient tumours can drive tumour-cell differentiation and antagonize malignant progression.	[Morris, John P.; Tian, Sha; Chen, Chi-Chao; Baslan, Timour; Sanchez-Rivera, Francisco J.; Thompson, Craig B.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Yashinskie, Jossie J.; Finley, Lydia W. S.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA; [Yashinskie, Jossie J.; Koche, Richard; Thompson, Craig B.; Finley, Lydia W. S.] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA; [Yashinskie, Jossie J.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Chandwani, Rohit] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Chandwani, Rohit; Leach, Steven D.] Mem Sloan Kettering Canc Ctr, Rubinstein Ctr Pancreat Canc Res, 1275 York Ave, New York, NY 10021 USA; [Chandwani, Rohit] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Chandwani, Rohit] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Marinkovic, Zoran S.; Carmona-Fontaine, Carlos] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Lowe, Scott W.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Leach, Steven D.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Hanover, NH USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; New York University; Howard Hughes Medical Institute; Dartmouth College; Norris Cotton Cancer Center	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.; Finley, LWS (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.; Finley, LWS (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA.; Lowe, SW (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	finleyl@mskcc.org; lowes@mskcc.org	Sánchez-Rivera, Francisco J./AAV-6985-2020	Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Marinkovic, Zoran/0000-0002-7720-2802; Koche, Richard/0000-0002-6820-5083; Chandwani, Rohit/0000-0003-4781-6069	American Cancer Society Postdoctoral Fellowship [126337-PF-14-066-01-TBE]; T32 training grant from the NICHD [T32HD060600]; MSKCC Translational Research Oncology Training Fellowship [NIH T32-CA160001]; NIH [NIH R00CA191021]; American Association for Cancer Research/Pancreatic Cancer Action Network Pathway to Leadership Award; William C. and Joyce C. O'Neil Charitable Trust; Memorial Sloan Kettering Single Cell Sequencing Initiative; Damon Runyon Cancer Research Foundation [DFS-23-17]; Lustgarten Research Investigator Award; National Cancer Institute; Emerson Collective; Starr Cancer Consortium [I11-039, I12-0051]; Concern Foundation; Anna Fuller Fund; Memorial Sloan Kettering Cancer Center Support Grant [P30 CA008748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060600] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA013106, P01CA087497, R01CA204228, R00CA191021, P30CA008748, T32CA160001] Funding Source: NIH RePORTER	American Cancer Society Postdoctoral Fellowship(American Cancer Society); T32 training grant from the NICHD; MSKCC Translational Research Oncology Training Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research/Pancreatic Cancer Action Network Pathway to Leadership Award; William C. and Joyce C. O'Neil Charitable Trust; Memorial Sloan Kettering Single Cell Sequencing Initiative; Damon Runyon Cancer Research Foundation; Lustgarten Research Investigator Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Emerson Collective; Starr Cancer Consortium; Concern Foundation; Anna Fuller Fund; Memorial Sloan Kettering Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Lowe and Finley laboratory. Pancreatic intraepithelial neoplasia and PDAC tissue microarrays were generated by G. Askan and O. Basturk, and were generously provided as a resource from the David M. Rubenstein Center for Pancreatic Cancer Research. J.P.M. IV was supported by an American Cancer Society Postdoctoral Fellowship (126337-PF-14-066-01-TBE). J. J. Y. is supported by a T32 training grant from the NICHD (T32HD060600). F. J. S.-R. is an HHMI Hanna Gray Fellow and was partially supported by an MSKCC Translational Research Oncology Training Fellowship (NIH T32-CA160001). S.D.L. is supported by NIH grant (NIH R01CA204228). R.C. is supported by an American Association for Cancer Research/Pancreatic Cancer Action Network Pathway to Leadership Award. T. B. is supported by the William C. and Joyce C. O'Neil Charitable Trust and Memorial Sloan Kettering Single Cell Sequencing Initiative. C. C.-F is supported by NIH grant (NIH R00CA191021). L.W.S.F. is a Dale F. Frey-William Raveis Charitable Fund Scientist supported by the Damon Runyon Cancer Research Foundation (DFS-23-17) and a Searle Scholar. S. W. L. is an investigator in the Howard Hughes Medical Institute. This work was additionally supported by a Lustgarten Research Investigator Award (S. W. L.), a Program Program Project grant from the National Cancer Institute (S. W. L.), research grants from the Emerson Collective (S. W. L.), the Starr Cancer Consortium (I11-039 and I12-0051 L. W. S. F.), the Concern Foundation (L. W. S. F.), the Anna Fuller Fund (L. W. S. F.) and the Memorial Sloan Kettering Cancer Center Support Grant P30 CA008748.	Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Cimmino L, 2017, CURR OPIN GENET DEV, V42, P1, DOI 10.1016/j.gde.2016.11.003; Davie K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004994; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hosoda W, 2017, J PATHOL, V242, P16, DOI 10.1002/path.4884; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marino S, 2000, GENE DEV, V14, P994; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Morris JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090353; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ongusaha PP, 2003, ONCOGENE, V22, P3749, DOI 10.1038/sj.onc.1206439; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Raffel S, 2017, NATURE, V551, P384, DOI 10.1038/nature24294; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ruscetti M, 2018, SCIENCE, V362, P1416, DOI 10.1126/science.aas9090; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schvartzman JM, 2018, J CELL BIOL, V217, P2247, DOI 10.1083/jcb.201803061; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zafra MP, 2018, NAT BIOTECHNOL, V36, P888, DOI 10.1038/nbt.4194	61	110	112	3	62	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					595	+		10.1038/s41586-019-1577-5	http://dx.doi.org/10.1038/s41586-019-1577-5			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31534224	Green Accepted			2022-12-28	WOS:000488247600061
J	Oliver, D				Oliver, David			David Oliver: Vocation takes doctors only so far	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Davidoliver372@googlemail.com						[Anonymous], 2016, BBC NEWS; [Anonymous], 2019, PULSE; Green Ben, 2017, BMC Res Notes, V10, P777, DOI 10.1186/s13104-017-3114-7; Health Education England, REAL LIF STOR WHY I; Lee D., 2019, HLTH SERV J; Legraien L., 2019, PULSE; Naqvi J., 2017, WASHINGTON POST; Online Etymology Dictionary, VOC; Taylor R., 2019, TIMES	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2019	366								l5610	10.1136/bmj.l5610	http://dx.doi.org/10.1136/bmj.l5610			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WY	31554618	Bronze			2022-12-28	WOS:000488488700005
J	Iacobucci, G				Iacobucci, Gareth			Labour pledges free personal care for over 65s most in need	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5689	10.1136/bmj.l5689	http://dx.doi.org/10.1136/bmj.l5689			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WS	31548282				2022-12-28	WOS:000488488000019
J	Cooper, M				Cooper, Max			A Lymphocyte Journey	CELL			English	Editorial Material								Immunology is one of the most rapidly evolving and interdisciplinary fields in the biological sciences. We keep learning about new immune cell types; their curious origins; and the seemingly fundamental roles they play in cancer, metabolism, the central nervous system, and beyond. It may seem surprising, but just a few decades ago, scientists knew little about what kinds of cells defined our immune defenses and their developmental origins. The 2019 Albert Lasker Basic Medical Research Award recognizes the contributions of Max D. Cooper and Jacques Miller for their discovery of B and T lymphocytes and for paving the path toward modern immunology. Cell's Sri Narasimhan had a conversation with Max Cooper about the early days in the field, his journey, and the road ahead. Excerpts from this conversation are presented below, and the full conversation is available with the article online.	[Cooper, Max] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University	Cooper, M (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.								0	0	0	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					37	39		10.1016/j.cell.2019.08.030	http://dx.doi.org/10.1016/j.cell.2019.08.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31519308	Bronze			2022-12-28	WOS:000486618500008
J	Morrison, TH; Hughes, TP; Adger, WN; Brown, K; Barnett, J; Lemos, MC; Huitema, D; Huchery, C; Chaigneau, T; Turner, R; Hettiarachchi, M				Morrison, Tiffany H.; Hughes, Terry P.; Adger, W. Neil; Brown, Katrina; Barnett, Jon; Lemos, Maria Carmen; Huitema, Dave; Huchery, Cindy; Chaigneau, Tomas; Turner, Rachel; Hettiarachchi, Missaka			Save reefs to rescue all ecosystems	NATURE			English	Editorial Material									[Morrison, Tiffany H.] Australian Res Council, Ctr Excellence Coral Reef Studies, Environm Governance, Townsville, Qld, Australia; [Hughes, Terry P.] Australian Res Council, Ctr Excellence Coral Reef Studies, Biol, Townsville, Qld, Australia; [Adger, W. Neil] Univ Exeter, Human Geog, Exeter, Devon, England; [Brown, Katrina] Univ Exeter, Social Sci, Exeter, Devon, England; [Barnett, Jon] Univ Melbourne, Global Environm Change, Melbourne, Vic, Australia; [Lemos, Maria Carmen] Univ Michigan, Environm & Sustainabil, Ann Arbor, MI 48109 USA	University of Exeter; University of Exeter; University of Melbourne; University of Michigan System; University of Michigan	Morrison, TH (corresponding author), Australian Res Council, Ctr Excellence Coral Reef Studies, Environm Governance, Townsville, Qld, Australia.	tiffany.morrison@jcu.edu.au	Barnett, Jon/AAQ-9002-2021; Morrison, Tiffany/D-4460-2012; Chaigneau, Tomas/AAM-2491-2020; Hughes, Terry/L-4721-2013	Barnett, Jon/0000-0002-0862-0808; Morrison, Tiffany/0000-0001-5433-037X; Chaigneau, Tomas/0000-0002-0874-216X; Hughes, Terry/0000-0002-5257-5063; Lemos, Maria Carmen/0000-0001-6686-730X				Bayraktarov E, 2019, RESTOR ECOL, V27, P981, DOI 10.1111/rec.12977; Beck MW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04568-z; Bellwood DR, 2019, BIOL CONSERV, V236, P604, DOI 10.1016/j.biocon.2019.05.056; Cunsolo A, 2018, NAT CLIM CHANGE, V8, P275, DOI 10.1038/s41558-018-0092-2; Eakin CM, 2019, CORAL REEFS, V38, P539, DOI 10.1007/s00338-019-01844-2; Granit J., 2017, CONCEPTUAL FRAMEWORK; Heron S.F., 2018, IMPACTS CLIMATE CHAN; Hughes TP, 2019, NAT CLIM CHANGE, V9, P40, DOI 10.1038/s41558-018-0351-2; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Intergovernmental Panel on Climate Change, 2018, SPEC REP GLOB WARM 1; Morrison TH, 2015, J ENVIRON PLANN MAN, V58, P1601, DOI 10.1080/09640568.2014.940514; National Academies of Sciences E and Medicine, 2019, RES REV INT INCR PER; Nyberg D., 2019, ACAD MANAG P, DOI [10.5465/AMBPP.2019.90, DOI 10.5465/AMBPP.2019.90]; Piggott-McKellar AE, 2017, J SUSTAIN TOUR, V25, P397, DOI 10.1080/09669582.2016.1213849; Rawe T., 2019, TRANSFORMING FOOD SY; Republic of Fiji, 2018, COP23 TAL DIAL SUBM; Savage A, 2020, CLIM DEV, V12, P120, DOI 10.1080/17565529.2019.1605284; Turner M, PHIL T R SOC B; Wear SL, 2019, BIOSCIENCE, V69, P360, DOI 10.1093/biosci/biz025; World Health Organization, 2018, PROGR PREV CONTR NON	20	33	35	8	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					333	336		10.1038/d41586-019-02737-8	http://dx.doi.org/10.1038/d41586-019-02737-8			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534250	Green Accepted			2022-12-28	WOS:000486647800020
J	Willyard, C				Willyard, Cassandra			Flu on the farm	NATURE			English	Editorial Material																		Anderson BD, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0086-1; Ip HS, 2015, EMERG INFECT DIS, V21, P886, DOI 10.3201/eid2105.142020; Li Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208884; Shi JZ, 2018, CELL HOST MICROBE, V24, P558, DOI 10.1016/j.chom.2018.08.006; Wu J, 2019, EMERG INFECT DIS, V25, P116, DOI [10.3201/eid2501181259, 10.3201/eid2501.181259]	5	2	2	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					S62	S63		10.1038/d41586-019-02757-4	http://dx.doi.org/10.1038/d41586-019-02757-4			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534253				2022-12-28	WOS:000486647800010
J	Wolf, Y; Bartok, O; Patkar, S; Bar Eli, G; Cohen, S; Litchfield, K; Levy, R; Jimenez-Sanchez, A; Trabish, S; Lee, JS; Karathia, H; Barnea, E; Day, CP; Cinnamon, E; Stein, I; Solomon, A; Bitton, L; Perez-Guijarro, E; Dubovik, T; Shen-Orr, SS; Miller, ML; Merlino, G; Levin, Y; Pikarsky, E; Eisenbach, L; Admon, A; Swanton, C; Ruppin, E; Samuels, Y				Wolf, Yochai; Bartok, Osnat; Patkar, Sushant; Bar Eli, Gitit; Cohen, Sapir; Litchfield, Kevin; Levy, Ronen; Jimenez-Sanchez, Alejandro; Trabish, Sophie; Lee, Joo Sang; Karathia, Hiren; Barnea, Eilon; Day, Chi-Ping; Cinnamon, Einat; Stein, Ilan; Solomon, Adam; Bitton, Lital; Perez-Guijarro, Eva; Dubovik, Tania; Shen-Orr, Shai S.; Miller, Martin L.; Merlino, Glenn; Levin, Yishai; Pikarsky, Eli; Eisenbach, Lea; Admon, Arie; Swanton, Charles; Ruppin, Eytan; Samuels, Yardena			UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma	CELL			English	Article							CD4(+) T-CELLS; CANCER-IMMUNOTHERAPY; MUTATIONAL PROCESSES; CTLA-4 BLOCKADE; READ ALIGNMENT; PD-1 BLOCKADE; NEO-ANTIGENS; IDENTIFICATION; GENERATION; NEOANTIGENS	Although clonal neo-antigen burden is associated with improved response to immune therapy, the functional basis for this remains unclear. Here we study this question in a novel controlled mouse melanoma model that enables us to explore the effects of intra-tumor heterogeneity (ITH) on tumor aggressiveness and immunity independent of tumor mutational burden. Induction of UVB-derived mutations yields highly aggressive tumors with decreased anti-tumor activity. However, single-cell-derived tumors with reduced ITH are swiftly rejected. Their rejection is accompanied by increased T cell reactivity and a less suppressive microenvironment. Using phylogenetic analyses and mixing experiments of single-cell clones, we dissect two characteristics of ITH: the number of clones forming the tumor and their clonal diversity. Our analysis of melanoma patient tumor data recapitulates our results in terms of overall survival and response to immune checkpoint therapy. These findings highlight the importance of clonal mutations in robust immune surveillance and the need to quantify patient ITH to determine the response to checkpoint blockade.	[Wolf, Yochai; Bartok, Osnat; Bar Eli, Gitit; Cohen, Sapir; Levy, Ronen; Trabish, Sophie; Bitton, Lital; Samuels, Yardena] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Patkar, Sushant; Lee, Joo Sang; Karathia, Hiren; Ruppin, Eytan] NCI, Canc Data Sci Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Litchfield, Kevin; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London NW1 1AT, England; [Jimenez-Sanchez, Alejandro; Miller, Martin L.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England; [Barnea, Eilon; Admon, Arie] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Day, Chi-Ping; Perez-Guijarro, Eva; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Cinnamon, Einat; Stein, Ilan; Pikarsky, Eli] Hebrew Univ Jerusalem, Lautenberg Ctr Immunol & Canc Res, IMRIC, Hadassah Med Sch, Jerusalem, Israel; [Solomon, Adam; Eisenbach, Lea] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Dubovik, Tania; Shen-Orr, Shai S.] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Levin, Yishai] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Rehovot, Israel; [Litchfield, Kevin; Swanton, Charles] UCL, Canc Res UK Lung Canc Ctr Excellence London, Inst Canc, London WC1E 6DD, England; [Swanton, Charles] Univ Coll London Hosp, Dept Med Oncol, London NW1 2BU, England	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Francis Crick Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Technion Israel Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Weizmann Institute of Science; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Samuels, Y (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Ruppin, E (corresponding author), NCI, Canc Data Sci Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	eyruppin@gmail.com; yardena.samuels@weizmann.ac.il	pikarsky, eli/GXV-7099-2022; Karathia, Hiren/AAD-2361-2021	Karathia, Hiren/0000-0003-3607-6552; Shen-Orr, Shai/0000-0002-6991-7736; solomon, adam/0000-0003-1263-0707; Litchfield, Kevin/0000-0002-3725-0914; Wolf, Yochai/0000-0003-0270-2025; Miller, Martin L/0000-0003-3161-8690	Israel Science Foundation [696/17]; European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program [770854]; ERC [CoG-770854]; Rising Tide Foundation; Knell family; Hamburger family; Fienberg School Dean of Faculty fellowship; Cancer Research UK Cambridge Institute; Mexican National Council of Science and Technology (CONACyT); Francis Crick Institute - Cancer Research UK [FC001169, FC001202]; UK Medical Research Council [FC001169, FC001202, MR/P014712/1]; Wellcome Trust [FC001169, FC001202]; Cancer Research UK core grant [C14303/A17197]; Intramural Research Program, NCI, NIH; NIH intramural funds; MRC [MR/P014712/1] Funding Source: UKRI	Israel Science Foundation(Israel Science Foundation); European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); Rising Tide Foundation; Knell family; Hamburger family; Fienberg School Dean of Faculty fellowship; Cancer Research UK Cambridge Institute; Mexican National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK core grant; Intramural Research Program, NCI, NIH; NIH intramural funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank S. Motola and M. Gershovis (Israel National Center for Personalized Medicine) for their help with the WES and the INCPM proteomic unit for their assistance with the proteomic analysis, Prof. Jung (Immunology Department, Weizmann Institute of Science) for the CD80/86<SUP>-/-</SUP> mice, Dr. Harmelin (veterinary resources, Weizmann Institute of Science) for help with pathologic assessment of histology, Dr. Bassani-Sternberg (University of Lausanne) for assistance with peptidomics analysis, Dr. McGranahan (University College London) and R. Rosenthal (Francis Crick Institute) for assistance with clonality analysis, and Dr. A. Snir-Wolf for fruitful discussions. Y.S. is supported by Israel Science Foundation grant 696/17, the European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program (grant agreement 770854), the ERC (CoG-770854), The Rising Tide Foundation, the Knell family, and the Hamburger family. Y.W. is supported by a Fienberg School Dean of Faculty fellowship. A.J.-S. is supported by the Cancer Research UK Cambridge Institute and the Mexican National Council of Science and Technology (CONACyT). C.S. is Royal Society Napier Research Professor. This work was supported by the Francis Crick Institute that receives its core funding from Cancer Research UK (FC001169, FC001202), the UK Medical Research Council (FC001169, FC001202), and the Wellcome Trust (FC001169, FC001202). M.L.M. is supported by a Cancer Research UK core grant (C14303/A17197). K.L. is funded by a Skills Development Fellowship from the UK Medical Research Council (MR/P014712/1). G.M., C.P.D., and E.P.G. were funded by the Intramural Research Program, NCI, NIH.E.R. is supported by NIH intramural funds.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Bar-On L, 2011, EUR J IMMUNOL, V41, P291, DOI 10.1002/eji.201041169; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Bassani-Sternberg M, 2010, P NATL ACAD SCI USA, V107, P18769, DOI 10.1073/pnas.1008501107; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borst J, 2018, NAT REV IMMUNOL, V18, P635, DOI 10.1038/s41577-018-0044-0; Brown JM, 2017, CLIN CANCER RES, V23, P3241, DOI 10.1158/1078-0432.CCR-16-3122; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Budden T, 2016, ONCOTARGET, V7, P60940, DOI 10.18632/oncotarget.10902; Chan TA, 2019, ANN ONCOL, V30, P44, DOI 10.1093/annonc/mdy495; Chen HX, 2014, J INVEST DERMATOL, V134, P2080, DOI 10.1038/jid.2014.161; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Chowell D, 2015, P NATL ACAD SCI USA, V112, pE1754, DOI 10.1073/pnas.1500973112; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dang HX, 2017, ANN ONCOL, V28, P3076, DOI 10.1093/annonc/mdx517; De Fabo EC, 2004, CANCER RES, V64, P6372, DOI 10.1158/0008-5472.CAN-04-1454; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gejman RS, 2018, ELIFE, V7, DOI 10.7554/eLife.41090; Germano G, 2017, NATURE, V552, P116, DOI 10.1038/nature24673; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Gubin MM, 2018, CELL, V175, P1014, DOI 10.1016/j.cell.2018.09.030; Gubin MM, 2015, J CLIN INVEST, V125, P3413, DOI 10.1172/JCI80008; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Hellmann MD, 2018, CANCER CELL, V33, P843, DOI 10.1016/j.ccell.2018.03.018; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Janiszewska M, 2019, NAT CELL BIOL, V21, P879, DOI 10.1038/s41556-019-0346-x; Kalaora S, 2018, CANCER DISCOV, V8, P1366, DOI 10.1158/2159-8290.CD-17-1418; Kalaora S, 2016, ONCOTARGET, V7, P5110, DOI 10.18632/oncotarget.6960; Kather JN, 2018, ELIFE, V7, DOI 10.7554/eLife.36967; Konig L, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5320-2; Krepler C, 2017, CELL REP, V21, P1953, DOI 10.1016/j.celrep.2017.10.021; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lesur A, 2015, PROTEOMICS, V15, P880, DOI 10.1002/pmic.201400450; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Lladser A, 2010, CANCER IMMUNOL IMMUN, V59, P81, DOI 10.1007/s00262-009-0725-4; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McDonald KA, 2019, ANN SURG ONCOL, V26, P2191, DOI 10.1245/s10434-019-07338-3; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miao D, 2018, NAT GENET, V50, P1271, DOI 10.1038/s41588-018-0200-2; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Milner E, 2013, MOL CELL PROTEOMICS, V12, P1853, DOI 10.1074/mcp.M112.026013; Milo I, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1435; Morris LGT, 2016, ONCOTARGET, V7, P10051, DOI 10.18632/oncotarget.7067; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; PORGADOR A, 1991, INT J CANCER, P54; Pulido AD, 2018, CANCER CELL, V33, P60, DOI 10.1016/j.ccell.2017.11.019; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reuben A, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0013-8; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rollman E, 2007, J IMMUNOL, V179, P4571, DOI 10.4049/jimmunol.179.7.4571; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sahin U, 2018, SCIENCE, V359, P1355, DOI 10.1126/science.aar7112; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shi TJ, 2016, PROTEOMICS, V16, P2160, DOI 10.1002/pmic.201500449; Shi WW, 2018, CELL REP, V25, P1446, DOI 10.1016/j.celrep.2018.10.046; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2016, P NATL ACAD SCI USA, V113, pE7759, DOI 10.1073/pnas.1609376113; Spranger S, 2016, TRENDS IMMUNOL, V37, P349, DOI 10.1016/j.it.2016.04.008; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Therneau TM, 2000, MODELING SURVIVAL DA; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vargas FA, 2017, IMMUNITY, V46, P577, DOI 10.1016/j.immuni.2017.03.013; Veatch JR, 2018, J CLIN INVEST, V128, P1563, DOI 10.1172/JCI98689; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Wang J, 2017, PIGM CELL MELANOMA R, V30, P428, DOI 10.1111/pcmr.12591; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Wolf Y, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2018-000475; Wolf Y, 2018, EUR J IMMUNOL, V48, P1308, DOI 10.1002/eji.201847540; Zanetti M, 2015, J IMMUNOL, V194, P2049, DOI 10.4049/jimmunol.1402669	104	163	168	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					219	+		10.1016/j.cell.2019.08.032	http://dx.doi.org/10.1016/j.cell.2019.08.032			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31522890	hybrid, Green Published			2022-12-28	WOS:000486618500025
J	Ghali, N; Sobey, G; Burrows, N				Ghali, Neeti; Sobey, Glenda; Burrows, Nigel			Ehlers-Danlos syndromes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLASSIFICATION; HYPERMOBILITY; NOSOLOGY		[Ghali, Neeti] London North West Univ Healthcare NHS Trust, North West Thames Reg Genet Serv & Natl EDS Serv, Harrow HA1 3UJ, Middx, England; [Sobey, Glenda] Sheffield Childrens NHS Fdn Trust, Natl EDS Serv, Sheffield, S Yorkshire, England; Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England	Sheffield Children's NHS Foundation Trust; University of Cambridge	Ghali, N (corresponding author), London North West Univ Healthcare NHS Trust, North West Thames Reg Genet Serv & Natl EDS Serv, Harrow HA1 3UJ, Middx, England.; Sobey, G (corresponding author), Sheffield Childrens NHS Fdn Trust, Natl EDS Serv, Sheffield, S Yorkshire, England.	neeti.ghali@nhs.net; Glenda.sobey@nhs.net	Ghali, Neeti/L-5665-2019	Ghali, Neeti/0000-0003-2847-1376				Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BEIGHTON P, 1969, Journal of Bone and Joint Surgery British Volume, V51-B, P444; Blackburn PR, 2018, AM J HUM GENET, V102, P696, DOI 10.1016/j.ajhg.2018.02.018; Bowen JM, 2017, AM J MED GENET C, V175, P27, DOI 10.1002/ajmg.c.31548; Brady AF, 2017, AM J MED GENET C, V175, P70, DOI 10.1002/ajmg.c.31550; Byers PH, 2017, AM J MED GENET C, V175, P40, DOI 10.1002/ajmg.c.31553; Castori M, 2017, AM J MED GENET C, V175, P148, DOI 10.1002/ajmg.c.31539; Colombi M, 2018, EUR J MED GENET, V61, P17, DOI 10.1016/j.ejmg.2017.10.005; Giunta C, 2018, GENET MED, V20, P42, DOI 10.1038/gim.2017.70; Hakim A, 2003, BEST PRACT RES CL RH, V17, P989, DOI 10.1016/j.berh.2003.08.001; Kapferer-Seebacher I, 2016, AM J HUM GENET, V99, P1005, DOI 10.1016/j.ajhg.2016.08.019; Malfait F, 2018, MATRIX BIOL, V71-72, P380, DOI 10.1016/j.matbio.2018.04.013; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Steinmann Beat, 1993, P351; Tinkle B, 2017, AM J MED GENET C, V175, P48, DOI 10.1002/ajmg.c.31538	17	30	30	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2019	366								l4966	10.1136/bmj.l4966	http://dx.doi.org/10.1136/bmj.l4966			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VZ	31533917				2022-12-28	WOS:000487759000001
J	Chambers, C				Chambers, Chris			What's next for Registered Reports?	NATURE			English	Editorial Material									[Chambers, Chris] Cardiff Univ, Cognit Neurosci, Cardiff, S Glam, Wales	Cardiff University	Chambers, C (corresponding author), Cardiff Univ, Cognit Neurosci, Cardiff, S Glam, Wales.	chambersc1@cardiff.ac.uk						Allen C, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000246; [Anonymous], 2015, LANCET, V386, P2456; [Anonymous], 2019, NATURE HUM BEHAV, V3, P763; Hummer L. T, 2017, PREPRINT OSF PREPRIN, DOI [10.31219/osf.io/5y8w7, DOI 10.31219/OSF.IO/5Y8W7]; Munafo MR, 2017, NICOTINE TOB RES, V19, P773, DOI 10.1093/ntr/ntx081; Nosek BA., 2013, SOC PSYCHOL-GERMANY, V44, P59, DOI [10.1027/1864-9335/a000143, DOI 10.1027/1864-9335/A000143]; Ouares KA, 2019, EUR J NEUROSCI, V49, P6, DOI 10.1111/ejn.14251; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P552, DOI 10.1177/1745691614543974	8	80	81	1	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					187	189		10.1038/d41586-019-02674-6	http://dx.doi.org/10.1038/d41586-019-02674-6			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31506624	Bronze, Green Accepted			2022-12-28	WOS:000485415400029
J	Thomas, JD				Thomas, Jane D.			Breaching the Professional-Personal Boundary - An Unrecognized Risk for Burnout	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The boundary between physicians' personal and professional lives is breached when we're called on to care for people we know personally. Burnout may be exacerbated by such requests, which are likely to increase sharply in the coming decades, as the population ages.	[Thomas, Jane D.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Thomas, JD (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							Guzman JA, 2011, CLEV CLIN J MED, V78, P90, DOI 10.3949/ccjm.78a.10113; Lupu D, 2018, J PAIN SYMPTOM MANAG, V55, P1221, DOI 10.1016/j.jpainsymman.2018.01.011; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Ortman JM, 2015, PROJECTIONS SIZE COM	4	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					998	999		10.1056/NEJMp1904812	http://dx.doi.org/10.1056/NEJMp1904812			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY2MW	31509673				2022-12-28	WOS:000486225900007
J	Kuehn, B				Kuehn, Bridget			Declining US Fertility	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					919	919		10.1001/jama.2019.13200	http://dx.doi.org/10.1001/jama.2019.13200			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY6YZ	31503315				2022-12-28	WOS:000486543500007
J	Mahase, E				Mahase, Elisabeth			Health checks: no convincing evidence in favour exists, argue academic GPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Heneghan C, 2020, BMJ EVID-BASED MED, V25, P115, DOI 10.1136/bmjebm-2019-111227; Krogsboll LT, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009009.pub3; MAHASE E, 2019, BMJ-BRIT MED J, V366, P20331, DOI DOI 10.1136/BMJ.L5201	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5504	10.1136/bmj.l5504	http://dx.doi.org/10.1136/bmj.l5504			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506267				2022-12-28	WOS:000486648900016
J	Mahase, E				Mahase, Elisabeth			Tackle prescription drug dependency with improved clinician training, says review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Davies J, 2019, ADDICT BEHAV, V97, P111, DOI 10.1016/j.addbeh.2018.08.027; National Survivor User Network, 2017, DRAFT NICE GUID REC; NICE, 2009, DEPR AD REC MAN; Public Health England, 2019, DEP WITHDR ASS SOM P	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5497	10.1136/bmj.l5497	http://dx.doi.org/10.1136/bmj.l5497			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506253				2022-12-28	WOS:000486648900013
J	Dyer, C				Dyer, Clare			Former GP partner who took images of patients in states of undress is struck off	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K3227	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5488	10.1136/bmj.l5488	http://dx.doi.org/10.1136/bmj.l5488			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501085				2022-12-28	WOS:000486648500011
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on... NHS passports	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5474	10.1136/bmj.l5474	http://dx.doi.org/10.1136/bmj.l5474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501169				2022-12-28	WOS:000486648500007
J	Chinthrajah, RS; Purington, N; Andorf, S; Long, A; O'Laughlin, KL; Lyu, SC; Manohar, M; Boyd, SD; Tibshirani, R; Maecker, H; Plaut, M; Mukai, K; Tsai, M; Desai, M; Galli, SJ; Nadeau, KC				Chinthrajah, R. Sharon; Purington, Natasha; Andorf, Sandra; Long, Andrew; O'Laughlin, Katherine L.; Lyu, Shu Chen; Manohar, Monali; Boyd, Scott D.; Tibshirani, Robert; Maecker, Holden; Plaut, Marshall; Mukai, Kaori; Tsai, Mindy; Desai, Manisha; Galli, Stephen J.; Nadeau, Kari C.			Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study	LANCET			English	Article							FOOD ALLERGY; EOSINOPHILIC ESOPHAGITIS; CHILDREN; UNRESPONSIVENESS; ACTIVATION; BASOPHIL; IGE	Background Dietary avoidance is recommended for peanut allergies. We evaluated the sustained effects of peanut allergy oral immunotherapy (OIT) in a randomised long-term study in adults and children. Methods In this randomised, double-blind, placebo-controlled, phase 2 study, we enrolled participants at the Sean N Parker Center for Allergy and Asthma Research at Stanford University (Stanford, CA, USA) with peanut allergy aged 7-55 years with a positive result from a double-blind, placebo-controlled, food challenge (DBPCFC; <= 500 mg of peanut protein), a positive skin-prick test (SPT) result (>= 5 mm wheal diameter above the negative control), and peanut-specific immunoglobulin (Ig)E concentration of more than 4 kU/L. Participants were randomly assigned (2.4:1.4:1) in a two-by-two block design via a computerised system to be built up and maintained on 4000 mg peanut protein through to week 104 then discontinued on peanut (peanut-0 group), to be built up and maintained on 4000 mg peanut protein through to week 104 then to ingest 300 mg peanut protein daily (peanut-300 group) for 52 weeks, or to receive oat flour (placebo group). DBPCFCs to 4000 mg peanut protein were done at baseline and weeks 104, 117, 130, 143, and 156. The pharmacist assigned treatment on the basis of a randomised computer list. Peanut or placebo (oat) flour was administered orally and participants and the study team were masked throughout by use of oat flour that was similar in look and feel to the peanut flour and nose clips, as tolerated, to mask taste. The statistician was also masked. The primary endpoint was the proportion of participants who passed DBPCFCs to a cumulative dose of 4000 mg at both 104 and 117 weeks. The primary efficacy analysis was done in the intention-to-treat population. Safety was assessed in the intention-to-treat population. This trial is registered at ClinicalTrials.gov, NCT02103270. Findings Between April 15, 2014, and March 2, 2016, of 152 individuals assessed, we enrolled 120 participants, who were randomly assigned to the peanut-0 (n=60), peanut-300 (n=35), and placebo groups (n=25). 21 (35%) of peanut-0 group participants and one (4%) placebo group participant passed the 4000 mg challenge at both 104 and 117 weeks (odds ratio [OR] 12.7, 95% CI 1.8-554.8; p=0.0024). Over the entire study, the most common adverse events were mild gastrointestinal symptoms, which were seen in 90 of 120 patients (50/60 in the peanut-0 group, 29/35 in the peanut-300 group, and 11/25 in the placebo group) and skin disorders, which were seen in 50/120 patients (26/60 in the peanut-0 group, 15/35 in the peanut-300 group, and 9/25 in the placebo group). Adverse events decreased over time in all groups. Two participants in the peanut groups had serious adverse events during the 3-year study. In the peanut-0 group, in which eight (13%) of 60 participants passed DBPCFCs at week 156, higher baseline peanut-specific IgG4 to IgE ratio and lower Ara h 2 IgE and basophil activation responses were associated with sustained unresponsiveness. No treatment-related deaths occurred. Interpretation Our study suggests that peanut OIT could desensitise individuals with peanut allergy to 4000 mg peanut protein but discontinuation, or even reduction to 300 mg daily, could increase the likelihood of regaining clinical reactivity to peanut. Since baseline blood tests correlated with week 117 treatment outcomes, this study might aid in optimal patient selection for this therapy. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Chinthrajah, R. Sharon; Purington, Natasha; Andorf, Sandra; Long, Andrew; O'Laughlin, Katherine L.; Lyu, Shu Chen; Manohar, Monali; Boyd, Scott D.; Maecker, Holden; Mukai, Kaori; Tsai, Mindy; Galli, Stephen J.; Nadeau, Kari C.] Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Chinthrajah, R. Sharon; Purington, Natasha; Andorf, Sandra; Long, Andrew; O'Laughlin, Katherine L.; Lyu, Shu Chen; Manohar, Monali; Nadeau, Kari C.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Boyd, Scott D.; Mukai, Kaori; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Tibshirani, Robert] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Tibshirani, Robert] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Maecker, Holden; Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Purington, Natasha; Desai, Manisha] Stanford Univ, Quantitat Sci Unit, Stanford, CA 94305 USA; [Plaut, Marshall] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nadeau, KC (corresponding author), Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA.	knadeau@stanford.edu	Long, Andrew/AAF-2527-2020	Tsai, Mindy/0000-0002-8421-4721; Andorf, Sandra/0000-0002-3093-2568	National Institute of Allergy and Infectious Diseases (NIAID) [AADCRC U19AI104209]; Sean N Parker Center for Allergy and Asthma Research at Stanford University; Myra Reinhard Family Foundation, Food Allergy Research & Education Center of Excellence, End Allergies Together, TripAdvisor Charitable Foundation; Crown Family Philanthropies; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104209] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sean N Parker Center for Allergy and Asthma Research at Stanford University; Myra Reinhard Family Foundation, Food Allergy Research & Education Center of Excellence, End Allergies Together, TripAdvisor Charitable Foundation; Crown Family Philanthropies; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) grant AADCRC U19AI104209 (SJG, KCN, SDB, and RSC), the Sean N Parker Center for Allergy and Asthma Research at Stanford University, the Myra Reinhard Family Foundation, Food Allergy Research & Education Center of Excellence, End Allergies Together, TripAdvisor Charitable Foundation, and Crown Family Philanthropies (endowment for SDB). The study drug was manufactured through the Stanford good manufacturing practice (GMP) facility as per good clinical practice and GMP guidelines. All quality assurance and quality control was done as per US Food and Drug Administration GMP guidelines. We thank Dana Tupa, Sayantani Sindher, Vanitha Sampath, the nurses, dieticians, study coordinators, other staff, and, especially, the participants and their families, who were involved in the study.; National Institute of Allergy and Infectious Diseases.	Anagnostou K, 2014, LANCET, V383, P1297, DOI 10.1016/S0140-6736(13)62301-6; Andorf S, 2019, ECLINICALMEDICINE, V7, P27, DOI 10.1016/j.eclinm.2018.12.006; Andorf S, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0224-7; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Bird JA, 2018, J ALLER CL IMM-PRACT, V6, P476, DOI 10.1016/j.jaip.2017.09.016; Bluemchen K, 2019, ALLERGY, V74, P220, DOI 10.1111/all.13644; Blumchen K, 2019, J ALLER CL IMM-PRACT, V7, P479, DOI 10.1016/j.jaip.2018.10.048; BOCK SA, 1988, J ALLERGY CLIN IMMUN, V82, P986; Cherkaoui S, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0055-x; Chinthrajah RS, 2018, ANN ALLERG ASTHMA IM, V121, P69, DOI 10.1016/j.anai.2018.04.020; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Feuille E, 2016, ANN NUTR METAB, V68, P19, DOI 10.1159/000445391; Food Allergy Research & Education, 2018, FOOD ALL AN EM CAR P; Frischmeyer-Guerrerio PA, 2017, J ALLERGY CLIN IMMUN, V140, P1043, DOI 10.1016/j.jaci.2017.03.028; Gorelik M, 2015, J ALLERGY CLIN IMMUN, V135, P1283, DOI 10.1016/j.jaci.2014.11.010; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Jhamnani Rekha D, 2016, Curr Treat Options Allergy, V3, P282, DOI 10.1007/s40521-016-0091-3; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1117, DOI 10.1016/j.jaci.2015.12.1316; Kulis M, 2019, CLIN EXP ALLERGY, V49, P180, DOI 10.1111/cea.13256; Lucendo AJ, 2014, ANN ALLERG ASTHMA IM, V113, P624, DOI 10.1016/j.anai.2014.08.004; Mukai K, 2017, J ALLERGY CLIN IMMUN, V139, P889, DOI 10.1016/j.jaci.2016.04.060; Nachshon L, 2018, PEDIAT ALLERG IMM-UK, V29, P519, DOI 10.1111/pai.12914; Nurmatov U, 2017, ALLERGY, V72, P1133, DOI 10.1111/all.13124; Petroni D, 2018, ANN ALLERG ASTHMA IM, V120, P237, DOI 10.1016/j.anai.2017.11.016; Purington N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02057; Reier-Nilsen T, 2019, ALLERGY, V74, P337, DOI 10.1111/all.13604; Roberts G, 2019, LANCET, V393, P2180, DOI 10.1016/S0140-6736(19)30767-6; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P1249, DOI 10.1016/j.jaci.2015.01.012; Sindher S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02689; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; US Department of Health and Human Services, COMM TERM CROT ADV E; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Virkud YV, 2017, J ALLERGY CLIN IMMUN, V139, P882, DOI 10.1016/j.jaci.2016.07.030; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P1103, DOI 10.1016/j.jaci.2015.10.005; Wright BL, 2016, ALLERGY, V71, P1552, DOI 10.1111/all.12895; Wright BL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02624	38	121	122	9	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2019	394	10207					1437	1449		10.1016/S0140-6736(19)31793-3	http://dx.doi.org/10.1016/S0140-6736(19)31793-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JE5IX	31522849	Green Accepted			2022-12-28	WOS:000490727200028
J	Fulchand, S				Fulchand, Shivali			Children with cancer are missing out on precision medicine, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Fulchand, Shivali/AET-0921-2022	Fulchand, Shivali/0000-0003-2918-3931				Cancer Research UK, CHILDR CANC STAT; George SL, 2019, EUR J CANCER, DOI [10.1016/j.ejca.2019.07.027.31543384, DOI 10.1016/J.EJCA.2019.07.027.31543384]	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5696	10.1136/bmj.l5696	http://dx.doi.org/10.1136/bmj.l5696			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551245				2022-12-28	WOS:000488488300012
J	Salas, RN; Jha, AK				Salas, Renee N.; Jha, Ashish K.			Climate change threatens the achievement of effective universal healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMBIENT-TEMPERATURES; HEAT EXPOSURE; INJURIES; RISK		[Salas, Renee N.; Jha, Ashish K.] Harvard Global Hlth Inst, 42 Church St, Cambridge, MA 02138 USA		Jha, AK (corresponding author), Harvard Global Hlth Inst, 42 Church St, Cambridge, MA 02138 USA.	ajha@hsph.harvard.edu						[Anonymous], 2015, CLIM HLTH COUNTR PRO; Bai L, 2018, HEART, V104, P673, DOI 10.1136/heartjnl-2017-311821; Berry HL, 2010, INT J PUBLIC HEALTH, V55, P123, DOI 10.1007/s00038-009-0112-0; Blauw LL, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000317; Bloom G, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2107; Bowles DC, 2015, J ROY SOC MED, V108, P390, DOI 10.1177/0141076815603234; Bunker A, 2016, EBIOMEDICINE, V6, P258, DOI 10.1016/j.ebiom.2016.02.034; Das J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1716; Guilbert JJ, 2006, EDUC HEALTH, V19, P385, DOI 10.1080/13576280600937911; Gupta V, 2015, LANCET GLOB HEALTH, V3, pE306, DOI 10.1016/S2214-109X(15)00007-8; Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873; Hallegatte S., 2016, CLIMATE CHANGE DEV S; Hickel J, 2019, SUSTAIN DEV, V27, P873, DOI 10.1002/sd.1947; IPCC, 2018, GLOB WARM 1 5C SUMM; Keellings D, 2019, GEOPHYS RES LETT, V46, P2964, DOI 10.1029/2019GL082077; Kishore N, 2018, NEW ENGL J MED, V379, P162, DOI [10.1056/NEJMsa1803972, 10.1056/nejmsa1803972]; Laurent JGC, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002605; Milazzo A, 2017, FOODBORNE PATHOG DIS, V14, P125, DOI 10.1089/fpd.2016.2201; Pichler PP, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab19e1; Salas RN, 2018, LANCET COUNTDOWN HLT; Sampath N, 2017, NATL GEOGR; Sorensen C, 2019, NEW ENGL J MED, V381, P693, DOI 10.1056/NEJMp1907859; Stapleton S, 2017, CLIMATE CHANGE MIGRA; University of Notre Dame, ND GAIN NOTR DAM GLO; US EPA, GLOB GREENH GAS EM D; Varghese BM, 2019, ENVIRON RES, V170, P101, DOI 10.1016/j.envres.2018.12.024; Varghese BM, 2018, SAFETY SCI, V110, P380, DOI 10.1016/j.ssci.2018.04.027; Watts N, 2018, LANCET, V392, P2479, DOI 10.1016/S0140-6736(18)32594-7; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Wei JN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003572; Wei JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109476; Wei JN, 2014, ENVIRON RES, V134, P301, DOI 10.1016/j.envres.2014.08.006; WHO, 2018, COP24 SPEC REP HLTH; Wondmagegn BY, 2019, SCI TOTAL ENVIRON, V657, P608, DOI 10.1016/j.scitotenv.2018.11.479; World Health Organization, 2019, WORLD HLTH STAT MON; World Health Organization (WHO), UN HLTH COV IND ESS; World Health Organization World Bank, 2017, TRACK UN HLTH COV 20	37	23	23	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5302	10.1136/bmj.l5302	http://dx.doi.org/10.1136/bmj.l5302			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WS	31548271	hybrid, Green Published			2022-12-28	WOS:000488488000004
J	Horwitz, LI; Kuznetsova, M; Jones, SA				Horwitz, Leora I.; Kuznetsova, Masha; Jones, Simon A.			Creating a Learning Health System through Rapid-Cycle, Randomized Testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY IMPROVEMENT; CARE	Randomized tests of quality-improvement interventions were embedded within an existing health care system. Quality and efficiency were improved by abandoning ineffective interventions and continuing successful quality-improvement strategies.	[Horwitz, Leora I.; Kuznetsova, Masha; Jones, Simon A.] NYU Langone Hlth, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10016 USA; [Horwitz, Leora I.; Jones, Simon A.] NYU, Sch Med, Dept Med, Div Healthcare Delivery Sci, New York, NY 10003 USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Med, Div Gen Internal Med & Clin Innovat, New York, NY 10003 USA	NYU Langone Medical Center; New York University; New York University	Horwitz, LI (corresponding author), NYU Langone Hlth, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10016 USA.; Horwitz, LI (corresponding author), NYU, Sch Med, Dept Med, Div Healthcare Delivery Sci, New York, NY 10003 USA.; Horwitz, LI (corresponding author), NYU, Sch Med, Dept Med, Div Gen Internal Med & Clin Innovat, New York, NY 10003 USA.		Horwitz, Leora/ABD-1292-2020	Kuznetsova, Masha/0000-0001-6710-526X; Jones, Simon/0000-0002-8267-5647				Baily MA, 2008, NEW ENGL J MED, V358, P768, DOI 10.1056/NEJMp0800372; Baily MA, 2006, HASTINGS CENT REP, V36, pS1, DOI 10.1353/hcr.2006.0054; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Brenner AT, 2018, CANCER-AM CANCER SOC, V124, P3346, DOI 10.1002/cncr.31566; Bulik M, 2016, NY TIMES; Etchells E, 2016, BMJ QUAL SAF, V25, P202, DOI 10.1136/bmjqs-2015-005094; Finkelstein JA, 2015, CLIN TRIALS, V12, P457, DOI 10.1177/1740774515597682; Hanington J, 2012, ABCS A B TESTING; Lind J, 1753, TREATISE SCURVY 3 PA; Pallmann P, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1017-7; Smith M.D., 2012, BETTER CARE LOWER CO	11	101	101	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1175	1179		10.1056/NEJMsb1900856	http://dx.doi.org/10.1056/NEJMsb1900856			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4PY	31532967				2022-12-28	WOS:000487066900016
J	Schmidt, C				Schmidt, Charles			The social forecast	NATURE			English	Editorial Material																			0	5	5	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					S58	S59		10.1038/d41586-019-02755-6	http://dx.doi.org/10.1038/d41586-019-02755-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534256				2022-12-28	WOS:000486647800008
J	Maki, DG				Maki, Dennis G.			The T2Bacteria Panel had 90% sensitivity for detecting targeted organisms, 43% for any bloodstream infection organism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In hospitalized patients with suspected bloodstream infection (BSI), does the T2Bacteria Panel accurately detect BSI? Methods Design: Comparison of the T2Bacteria Panel and blood cultures. Setting: 11 acute care hospitals in the USA. Patients: 1427 hospitalized patients >= 18 years of age (median age 56 y, 57% men) who had suspected BSI or sepsis and a diagnostic blood culture ordered. Exclusion criteria included previous testing with the T2Bacteria Panel; receipt of an investigational, novel drug in the past 30 days; or comorbidity limiting participation. Description of test: Whole blood was collected for the T2Bacteria Panel and tested locally in a T2Dx instrument. The result for each of 5 targeted ESKAPE bacteria species (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli), which comprise about 50% of all BSIs, was reported as positive or negative. Results of the T2Bacteria Panel were not provided to health care teams. Diagnostic standard: 2 companion whole blood culture samples, 1 aerobic and 1 anaerobic, were taken from the same anatomical sites as the blood for the T2Bacteria Panel. Culture followed local practices, and samples were incubated for >= 5 days if needed. Outcomes: Operating characteristics of the T2Bacteria Panel for detecting T2Bacteria-targeted organisms and for detecting any BSI organism. Main results 2.7% of patients had T2Bacteria-targeted organisms (39/1427), and 5.9% had any BSI organism (82/1427) detected through whole blood culture. Operating characteristics of the T2Bacteria Panel are in the Table. The T2Bacteria Panel missed 10% (4/39) of T2Bacteria-targeted organisms and 57% (47/82) of all BSI organisms. Conclusion In hospitalized patients with suspected bloodstream infections, the T2Bacteria Panel had 90% sensitivity for detecting T2Bacteria-targeted organisms and 43% sensitivity for detecting any bloodstream infection organism.	[Maki, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							Clancy CJ, 2018, J ANTIMICROB CHEMOTH, V73, P2, DOI 10.1093/jac/dky050; Ehren K, 2019, CLIN INFECT DIS; Peker N, 2018, CLIN MICROBIOL INFEC, V24, P944, DOI 10.1016/j.cmi.2018.05.007; Pliakos EE, 2018, CLIN MICROBIOL REV, V31, DOI [10.1128/CMR.00095-17, 10.1128/cmr.00095-17]; Timbrook TT, 2017, CLIN INFECT DIS, V64, P15, DOI 10.1093/cid/ciw649	5	5	5	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC34	JC34		10.7326/ACPJ201909170-034	http://dx.doi.org/10.7326/ACPJ201909170-034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525768				2022-12-28	WOS:000486101400010
J	Rahbek, C; Borregaard, MK; Colwell, RK; Dalsgaard, B; Holt, BG; Morueta-Holme, N; Nogues-Bravo, D; Whittaker, RJ; Fjeldsa, J				Rahbek, Carsten; Borregaard, Michael K.; Colwell, Robert K.; Dalsgaard, Bo; Holt, Ben G.; Morueta-Holme, Naia; Nogues-Bravo, David; Whittaker, Robert J.; Fjeldsa, Jon			Humboldt's enigma: What causes global patterns of mountain biodiversity?	SCIENCE			English	Review							SPECIES RICHNESS; ELEVATIONAL GRADIENT; CONTINENTAL-SCALE; GEOGRAPHIC RANGE; CLIMATE; ENERGY; DIVERSIFICATION; DETERMINANTS; DIVERSITY	Mountains contribute disproportionately to the terrestrial biodiversity of Earth, especially in the tropics, where they host hotspots of extraordinary and puzzling richness. With about 25% of all land area, mountain regions are home to more than 85% of the world's species of amphibians, birds, and mammals, many entirely restricted to mountains. Biodiversity varies markedly among these regions. Together with the extreme species richness of some tropical mountains, this variation has proven challenging to explain under traditional climatic hypotheses. However, the complex climatic characteristics of rugged mountain regions differ fundamentally from those of lowland regions, likely playing a key role in generating and maintaining diversity. With ongoing global changes in climate and land use, the role of mountains as refugia for biodiversity may well come under threat.	[Rahbek, Carsten; Borregaard, Michael K.; Colwell, Robert K.; Dalsgaard, Bo; Holt, Ben G.; Morueta-Holme, Naia; Nogues-Bravo, David; Whittaker, Robert J.; Fjeldsa, Jon] Univ Copenhagen, CMEC, GLOBE Inst, DK-1350 Copenhagen K, Denmark; [Rahbek, Carsten] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Rahbek, Carsten] Univ Southern Denmark, Danish Inst Adv Study, DK-5230 Odense M, Denmark; [Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Colwell, Robert K.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Whittaker, Robert J.] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Fjeldsa, Jon] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	University of Copenhagen; Imperial College London; University of Southern Denmark; University of Connecticut; University of Colorado System; University of Colorado Boulder; University of Oxford; University of Copenhagen	Rahbek, C (corresponding author), Univ Copenhagen, CMEC, GLOBE Inst, DK-1350 Copenhagen K, Denmark.; Rahbek, C (corresponding author), Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England.; Rahbek, C (corresponding author), Univ Southern Denmark, Danish Inst Adv Study, DK-5230 Odense M, Denmark.	crahbek@snm.ku.dk	Morueta-Holme, Naia/J-4952-2013; Rahbek, Carsten/GVQ-0752-2022; Whittaker, Robert/H-1548-2015; Borregaard, Michael/B-8442-2008; Fjeldsa, Jon/A-9699-2013	Morueta-Holme, Naia/0000-0002-0776-4092; Rahbek, Carsten/0000-0003-4585-0300; Holt, Ben G./0000-0003-0831-9684; Whittaker, Robert/0000-0001-7775-3383; Dalsgaard, Bo/0000-0003-2867-2805; Borregaard, Michael/0000-0002-8146-8435; Nogues-Bravo, David/0000-0002-4060-0153; Fjeldsa, Jon/0000-0003-0790-3600	Danish National Research Foundation [DNRF96]; Villum Foundation [25925]; Individual Fellowships under the Marie Sklodowska-Curie grant [707968, 746334]	Danish National Research Foundation(Danmarks Grundforskningsfond); Villum Foundation(Villum Fonden); Individual Fellowships under the Marie Sklodowska-Curie grant	We thank the Danish National Research Foundation for its support of the Center for Macroecology, Evolution and Climate (DNRF96). Also supported by Villum Investigator grant no. 25925 from the Villum Foundation (C.R.) and by Individual Fellowships under the Marie Sklodowska-Curie grant agreement (no. 707968, M.K.B.; no. 746334, N.M.-H.).	Antonelli A, 2018, NAT GEOSCI, V11, P718, DOI 10.1038/s41561-018-0236-z; Balslev H, 1998, MAN BIOSPH, V21, P585; Barthlott W, 2005, NOVA ACT LC, V92, P61; Beck J, 2017, GLOBAL ECOL BIOGEOGR, V26, P412, DOI 10.1111/geb.12548; Chan WP, 2016, SCIENCE, V351, P1437, DOI 10.1126/science.aab4119; Connolly SR, 2017, TRENDS ECOL EVOL, V32, P835, DOI 10.1016/j.tree.2017.08.011; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fjeldsa J, 2012, ANNU REV ECOL EVOL S, V43, P249, DOI 10.1146/annurev-ecolsys-102710-145113; Fordham DA, 2019, CURR BIOL, V29, pR356, DOI 10.1016/j.cub.2019.04.001; GRAVES GR, 1988, AUK, V105, P47, DOI 10.1093/auk/105.1.47; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Hoorn C, 2018, MOUNTAINS CLIMATE BI; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 2004, AMBIO, P11; Korner C, 2017, ALPINE BOT, V127, P1, DOI 10.1007/s00035-016-0182-6; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; McFadden IR, 2019, ECOL LETT, V22, P1126, DOI 10.1111/ele.13269; Moret P, 2019, P NATL ACAD SCI USA, V116, P12889, DOI 10.1073/pnas.1904585116; Morueta-Holme N, 2015, P NATL ACAD SCI USA, V112, P12741, DOI 10.1073/pnas.1509938112; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Payne NL, 2017, ECOL LETT, V20, P70, DOI 10.1111/ele.12707; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Rahbek C., 2019, MOUNTAIN REGIONS WOR; Rahbek C, 2019, SCIENCE, V365, P1114, DOI 10.1126/science.aax0151; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TF, 2018, SCIENCE, V361, DOI 10.1126/science.aar5452; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Steinbauer MJ, 2018, NATURE, V556, P231, DOI 10.1038/s41586-018-0005-6; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; von Humboldt Alexander, 2009, ESSAY GEOGRAPHY PLAN; Woutersen A, 2018, PEERJ, V6, DOI 10.7717/peerj.5055; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	46	273	280	57	294	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1108	1113		10.1126/science.aax0149	http://dx.doi.org/10.1126/science.aax0149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515383	Green Accepted, Green Submitted			2022-12-28	WOS:000485780800036
J	Nowogrodzki, A; Hurd, Y				Nowogrodzki, Anna; Hurd, Yasmin			A better treatment for opioid addiction	NATURE			English	Editorial Material																		Hurd YL, 2015, NEUROTHERAPEUTICS, V12, P807, DOI 10.1007/s13311-015-0373-7	1	0	0	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					S7	S7		10.1038/d41586-019-02684-4	http://dx.doi.org/10.1038/d41586-019-02684-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511678				2022-12-28	WOS:000485415400005
J	Meester, RGS; Lansdorp-Vogelaar, I; Winawer, SJ; Zauber, AG; Knudsen, AB; Ladabaum, U				Meester, Reinier G. S.; Lansdorp-Vogelaar, Iris; Winawer, Sidney J.; Zauber, Ann G.; Knudsen, Amy B.; Ladabaum, Uri			High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							LARGE-INTESTINE; LARGE-BOWEL; COLONOSCOPY SURVEILLANCE; RISK-STRATIFICATION; CANCER MORTALITY; TASK-FORCE; POLYPS; COLON; US; POLYPECTOMY	Background: Surveillance of patients with colorectal adenomas has limited long-term evidence to support current practice. Objective: To compare the lifetime benefits and costs of high-versus low-intensity surveillance. Design: Microsimulation model. Data Sources: U.S. cancer registry, cost data, and published literature. Target Population: U.S. patients aged 50, 60, or 70 years with low-risk adenomas (LRAs) (1 to 2 small adenomas) or high-risk adenomas (HRAs) (3 to 10 small adenomas or >= 1 large adenoma) removed after screening with colonoscopy or fecal immunochemical testing (FIT). Time Horizon: Lifetime. Perspective: Societal. Intervention: No further screening or surveillance, routine screening after 10 years, low-intensity surveillance (10 years after LRA removal and 5 years after HRA removal), and high-intensity surveillance (5 years after LRA removal and 3 years after HRA removal). Outcome Measures: Colorectal cancer (CRC) incidence and incremental cost-effectiveness. Results of Base-Case Analysis: Without surveillance or screening, lifetime CRC incidence for patients aged 50 years was 10.9% after LRA removal and 17.2% after HRA removal at screening colonoscopy. Subsequent colonoscopic screening, low-intensity surveillance, or high-intensity surveillance decreased incidence by 39%, 46% to 48%, and 55% to 56%, respectively. Incidence of CRC and surveillance benefits were higher for adenomas detected at FIT screening and lower for older patients. High-intensity surveillance cost less than $30 000 per quality-adjusted life-year (QALY) gained compared with low-intensity surveillance. Results of Sensitivity Analysis: High-intensity surveillance cost less than $100 000 per QALY gained in most alternative scenarios for adenoma recurrence, CRC incidence, longevity, quality of life, screening ages, surveillance ages, test performance, disutilities, and cost. Limitation: Few surveillance outcome data exist. Conclusion: The model suggests that high-intensity surveillance as recommended in the United States provides modest but clinically relevant benefits over low-intensity surveillance at acceptable cost.	[Meester, Reinier G. S.; Lansdorp-Vogelaar, Iris] Erasmus MC Univ Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Winawer, Sidney J.] Mem Sloan Kettering Canc Ctr, 25 Sutton Pl S, New York, NY 10022 USA; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave, New York, NY 10017 USA; [Knudsen, Amy B.] Massachusetts Gen Hosp, Inst Technol Assessment, 101 Merrimac St,Suite 1010, Boston, MA 02114 USA; [Ladabaum, Uri] Stanford Med, 430 Broadway, Redwood City, CA 94063 USA	Erasmus University Rotterdam; Erasmus MC; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital	Meester, RGS (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	r.meester@erasmusmc.nl			National Cancer Institute of the National Institutes of Health [U01 CA 199335, P30 CA 008748]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research reported in this article was supported by the National Cancer Institute of the National Institutes of Health under awards U01 CA 199335 (Drs. Meester, Lansdorp-Vogelaar, Zauber, and Knudsen) and P30 CA 008748 (Drs. Winawer and Zauber).	American Joint Committee on Cancer AJCC, 1997, AJCC CANC STAGING MA; Anderson JC, 2018, GASTROENTEROLOGY, V154, P117, DOI 10.1053/j.gastro.2017.09.011; Arias Elizabeth, 2012, Natl Vital Stat Rep, V61, P1; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Atkin WS, 2012, ENDOSCOPY, V44, pSE151, DOI 10.1055/s-0032-1309821; Atkin W, 2017, LANCET ONCOL, V18, P823, DOI 10.1016/S1470-2045(17)30187-0; Austin GL, 2013, AM J GASTROENTEROL, V108, P296, DOI 10.1038/ajg.2012.195; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Brenner H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2467; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; Chung SJ, 2011, GUT, V60, P1537, DOI 10.1136/gut.2010.232876; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Click B, 2018, JAMA-J AM MED ASSOC, V319, P2021, DOI 10.1001/jama.2018.5809; Coleman HG, 2015, CANCER EPIDEM BIOMAR, V24, P1373, DOI 10.1158/1055-9965.EPI-15-0085; Dube C, 2017, AM J GASTROENTEROL, V112, P1790, DOI 10.1038/ajg.2017.360; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Greuter MJE, 2017, ANN INTERN MED, V167, P544, DOI 10.7326/M16-2891; Gupta S, 2017, GUT, V66, P446, DOI 10.1136/gutjnl-2015-310196; Hanmer J, 2007, MED CARE, V45, P1171, DOI 10.1097/MLR.0b013e3181354828; Holme O, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009259.pub2; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Jover R, 2016, ENDOSCOPY, V48, P571, DOI 10.1055/s-0042-104116; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Ladabaum U, 2016, GASTROENTEROLOGY, V150, P791, DOI 10.1053/j.gastro.2016.01.033; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Loberg M, 2014, NEW ENGL J MED, V371, P799, DOI 10.1056/NEJMoa1315870; Martinez ME, 2012, ANN INTERN MED, V157, P856, DOI 10.7326/0003-4819-157-12-201212180-00005; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Meester RGS, 2018, CANCER-AM CANCER SOC, V124, P2974, DOI 10.1002/cncr.31542; Meester RGS, 2015, JAMA-J AM MED ASSOC, V313, P2349, DOI [10.1001/jama.2015.6251, 10.1001/ja]; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Peterse EFP, 2018, CANCER-AM CANCER SOC, V124, P2964, DOI 10.1002/cncr.31543; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Rex DK, 2017, GASTROINTEST ENDOSC, V86, P18, DOI 10.1016/j.gie.2017.04.003; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Saini SD, 2010, GASTROENTEROLOGY, V138, P2292, DOI 10.1053/j.gastro.2010.03.004; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Schroy PC, 2013, ANN INTERN MED, V159, P13, DOI 10.7326/0003-4819-159-1-201307020-00004; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Surveillance Epidemiology and End Results Program, 2013, SEER STAT DAT INC BA; Turner KO, 2018, AM J GASTROENTEROL, V113, P303, DOI 10.1038/ajg.2017.439; van Hees F, 2014, ANN INTERN MED, V160, P750, DOI 10.7326/M13-2263; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Wang L, 2018, GASTROENTEROLOGY, V154, P540, DOI 10.1053/j.gastro.2017.10.006; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhao SB, 2019, GASTROENTEROLOGY, V156, P1661, DOI 10.1053/j.gastro.2019.01.260	65	9	9	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2019	171	9					612	+		10.7326/M18-3633	http://dx.doi.org/10.7326/M18-3633			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JK6WN	31546257	Green Accepted			2022-12-28	WOS:000494983000005
J	Micic, D; Rao, VL; Rubin, DT				Micic, Dejan; Rao, Vijaya L.; Rubin, David T.			Clinical Approach to Lactose Intolerance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MILK	This JAMA Insights Clinical Update summarizes the causes, clinical manifestations, diagnosis, and treatment of patients with lactose intolerance.	[Micic, Dejan; Rao, Vijaya L.; Rubin, David T.] Univ Chicago Med, Sect Gastroenterol Hepatol & Nutr, Dept Internal Med, 5841 S Maryland Ave,Ste MC 4076, Chicago, IL 60637 USA		Micic, D (corresponding author), Univ Chicago Med, Sect Gastroenterol Hepatol & Nutr, Dept Internal Med, 5841 S Maryland Ave,Ste MC 4076, Chicago, IL 60637 USA.	dmicic@medicine.bsd.uchicago.edu						BAYLESS TM, 1966, J AMER MED ASSOC, V197, P968, DOI 10.1001/jama.197.12.968; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Gasbarrini A, 2009, ALIMENT PHARM THER, V29, P1, DOI 10.1111/j.1365-2036.2009.03951.x; HUANG SS, 1968, SCIENCE, V160, P83, DOI 10.1126/science.160.3823.83-a; Labrie V, 2016, NAT STRUCT MOL BIOL, V23, P566, DOI 10.1038/nsmb.3227; Rezaie A, 2017, AM J GASTROENTEROL, V112, P775, DOI 10.1038/ajg.2017.46; Storhaug CL, 2017, LANCET GASTROENTEROL, V2, P738, DOI 10.1016/S2468-1253(17)30154-1; SUAREZ FL, 1995, NEW ENGL J MED, V333, P1, DOI 10.1056/NEJM199507063330101; Suchy Frederick J, 2010, NIH Consens State Sci Statements, V27, P1	10	5	6	6	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2019	322	16					1600	1601		10.1001/jama.2019.14740	http://dx.doi.org/10.1001/jama.2019.14740			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0VU	31556907				2022-12-28	WOS:000498673500019
J	Kickbusch, I; Agrawal, A; Jack, A; Lee, N; Horton, R				Kickbusch, Ilona; Agrawal, Anurag; Jack, Andrew; Lee, Naomi; Horton, Richard			Governing health futures 2030: growing up in a digital world-a joint The Lancet and Financial Times Commission	LANCET			English	Editorial Material									[Kickbusch, Ilona] Grad Inst Int & Dev Studies, Global Hlth Ctr, CH-1211 Geneva, Switzerland; [Agrawal, Anurag] CSIR Inst Genom & Integrat Biol, New Delhi, India; [Jack, Andrew] Financial Times, London, England; [Lee, Naomi; Horton, Richard] The Lancet, London, England	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Kickbusch, I (corresponding author), Grad Inst Int & Dev Studies, Global Hlth Ctr, CH-1211 Geneva, Switzerland.	ilona.kickbusch@graduateinstitute.ch	Agrawal, Anurag/GZL-5821-2022	Jack, Andrew/0000-0001-9679-2898; Agrawal, Anurag/0000-0002-0340-5252				[Anonymous], 2019, LANCET DIGIT HEALTH, V1, pE1; National Academies of Sciences Engineering and Medicine, 2019, AUTH INT SEC DIG WOR	2	15	15	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1309	1309		10.1016/S0140-6736(19)32181-6	http://dx.doi.org/10.1016/S0140-6736(19)32181-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9RJ	31548090				2022-12-28	WOS:000489613700010
J	Aria, C; Caron, JB				Aria, Cedric; Caron, Jean-Bernard			A middle Cambrian arthropod with chelicerae and proto-book gills	NATURE			English	Article							FUNCTIONAL-MORPHOLOGY; ORDOVICIAN; EVOLUTION	The chelicerates are a ubiquitous and speciose group of animals that has a considerable ecological effect on modern terrestrial ecosystems-notably as predators of insects and also, for instance, as decomposers(1). The fossil record shows that chelicerates diversified early in the marine ecosystems of the Palaeozoic era, by at least the Ordovician period(2). However, the timing of chelicerate origins and the type of body plan that characterized the earliest members of this group have remained controversial. Although megacheirans(3-5) have previously been interpreted as chelicerate-like, and habeliidans(6) (including Sanctacaris(7,8)) have been suggested to belong to their immediate stem lineage, evidence for the specialized feeding appendages (chelicerae) that are diagnostic of the chelicerates has been lacking. Here we use exceptionally well-preserved and abundant fossil material from the middle Cambrian Burgess Shale (Marble Canyon, British Columbia, Canada) to show that Mollisonia plenovenatrix sp. nov. possessed robust but short chelicerae that were placed very anteriorly, between the eyes. This suggests that chelicerae evolved a specialized feeding function early on, possibly as a modification of short antennules. The head also encompasses a pair of large compound eyes, followed by three pairs of long, uniramous walking legs and three pairs of stout, gnathobasic masticatory appendages; this configuration links habeliidans with euchelicerates ('true' chelicerates, excluding the sea spiders). The trunk ends in a four-segmented pygidium and bears eleven pairs of identical limbs, each of which is composed of three broad lamellate exopod flaps, and endopods are either reduced or absent. These overlapping exopod flaps resemble euchelicerate book gills, although they lack the diagnostic operculum(9). In addition, the eyes of M. plenovenatrix were innervated by three optic neuropils, which strengthens the view that a complex malacostracan-like visual system(10,11) might have been plesiomorphic for all crown euarthropods. These fossils thus show that chelicerates arose alongside mandibulates(12) as benthic micropredators, at the heart of the Cambrian explosion.	[Aria, Cedric] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Aria, Cedric] Chinese Acad Sci, Ctr Excellence Life & Palaeoenvironm, Nanjing, Jiangsu, Peoples R China; [Caron, Jean-Bernard] Royal Ontario Museum, Palaeobiol Sect, Dept Nat Hist, Toronto, ON, Canada; [Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Caron, Jean-Bernard] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada	Chinese Academy of Sciences; Chinese Academy of Sciences; Royal Ontario Museum; University of Toronto; University of Toronto	Aria, C (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China.; Aria, C (corresponding author), Chinese Acad Sci, Ctr Excellence Life & Palaeoenvironm, Nanjing, Jiangsu, Peoples R China.; Caron, JB (corresponding author), Royal Ontario Museum, Palaeobiol Sect, Dept Nat Hist, Toronto, ON, Canada.; Caron, JB (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.; Caron, JB (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON, Canada.	cedric.aria@protonmail.com; jcaron@rom.on.ca	Aria, Cédric/J-4449-2019	Aria, Cédric/0000-0002-0567-1730	Royal Ontario Museum; Polk Milstein family; National Geographic Society [9475-14]; Swedish Research Council; National Science Foundation [NSF-EAR-1554897]; Pomona College; NSERC Discovery Grant [341944]; Dorothy Strelsin Foundation (Royal Ontario Museum); President's International Fellowship Initiative Grant [2018PC0043]; China Postdoctoral Science Foundation [2018M630616]; Royal Ontario Museum Burgess Shale project [84]	Royal Ontario Museum; Polk Milstein family; National Geographic Society(National Geographic Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Science Foundation(National Science Foundation (NSF)); Pomona College; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dorothy Strelsin Foundation (Royal Ontario Museum); President's International Fellowship Initiative Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Royal Ontario Museum Burgess Shale project	Fossils for this study were collected by Royal Ontario Museum field parties under several Parks Canada Research and Collections permits to J.-B.C. (YNP2012-12054, KOONIP 2014-16317 and YNP-2016-21639). We thank T. Keith from Parks Canada for facilitating fieldwork activities. Major funding support for fieldwork comes from the Royal Ontario Museum (research and collection grants, and natural history fieldwork grants), the Polk Milstein family, the National Geographic Society (no. 9475-14 to J.-B.C.), the Swedish Research Council (to M. Streng), the National Science Foundation (NSF-EAR-1554897) and Pomona College (to R. R. Gaines). Research was also supported by J.-B. C.'s NSERC Discovery Grant (no. 341944) and the Dorothy Strelsin Foundation (Royal Ontario Museum), and C.A.'s President's International Fellowship Initiative Grant (no. 2018PC0043) and China Postdoctoral Science Foundation Grant (no. 2018M630616). We thank S. Scharf for editorial suggestions and J. Liang for the illustrations of M. plenovenatrix. This is Royal Ontario Museum Burgess Shale project number 84.	Aria C, 2019, GEOL MAG, V156, P1463, DOI 10.1017/S0016756819000475; Aria C, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1088-7; Aria C, 2017, NATURE, V545, P89, DOI 10.1038/nature22080; Aria C, 2015, PALAEONTOLOGY, V58, P629, DOI 10.1111/pala.12161; BRIGGS DEG, 1988, PALAEONTOLOGY, V31, P779; Briggs DEG, 2008, J PALEONTOL, V82, P238, DOI 10.1666/06-086.1; Briggs DEG, 2012, P NATL ACAD SCI USA, V109, P15702, DOI 10.1073/pnas.1205875109; Caron JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4210; Dunlop JA, 2004, T ROY SOC EDIN-EARTH, V94, P207; Dunlop JA, 2017, ARTHROPOD STRUCT DEV, V46, P395, DOI 10.1016/j.asd.2016.05.002; Edgecombe GD, 2017, CURR BIOL, V27, pR807, DOI 10.1016/j.cub.2017.07.016; Farley RD, 2010, ARTHROPOD STRUCT DEV, V39, P369, DOI 10.1016/j.asd.2010.04.001; Gaines RR, 2008, GEOLOGY, V36, P755, DOI 10.1130/G24961A.1; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; Legg DA, 2014, NATURWISSENSCHAFTEN, V101, P1065, DOI 10.1007/s00114-014-1245-4; Lehmann T, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0293-6; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Liu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5440; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Paterson JR, 2019, P NATL ACAD SCI USA, V116, P4394, DOI 10.1073/pnas.1819366116; Raymond P. E., 1931, Bulletin of the Museum of Comparative Zoology, V55, P165; Robison R.A., 1991, P77; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schwager E.E., 2015, EVOLUTIONARY DEV BIO, V3, P99; Simonetta A.M, 1975, Palaeontographia Italica, V69, P1; Stein M, 2013, ZOOL ANZ, V253, P164, DOI 10.1016/j.jcz.2013.05.001; Strausfeld NJ, 2016, ARTHROPOD STRUCT DEV, V45, P152, DOI 10.1016/j.asd.2015.07.005; Sutton MD, 2002, P ROY SOC B-BIOL SCI, V269, P1195, DOI 10.1098/rspb.2002.1986; van der Meijden A, 2012, J EXP BIOL, V215, P3411, DOI 10.1242/jeb.072926; Van Roy P, 2010, NATURE, V465, P215, DOI 10.1038/nature09038; Vannier J, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172206; Walcott Charles D., 1912, Smithsonian Institution Miscellaneous Collection, V57; Yang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27709; Zeng H, 2017, GEOL MAG, V154, P1306, DOI 10.1017/S0016756817000279; Zhang XL, 2002, J PALEONTOL, V76, P1106, DOI 10.1666/0022-3360(2002)076<1106:TBSAMM>2.0.CO;2	35	26	26	2	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					586	+		10.1038/s41586-019-1525-4	http://dx.doi.org/10.1038/s41586-019-1525-4			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31511691				2022-12-28	WOS:000488247600059
J	Tang, CG; Syafiqah, MN; Koh, QM; Zhao, C; Zaini, J; Seah, QJ; Cass, MJ; Humphries, MJ; Grizzi, I; Burroughes, JH; Png, RQ; Chua, LL; Ho, PKH				Tang, Cindy G.; Syafiqah, Mazlan Nur; Koh, Qi-Mian; Zhao, Chao; Zaini, Jamal; Seah, Qiu-Jing; Cass, Michael J.; Humphries, Martin J.; Grizzi, Ilaria; Burroughes, Jeremy H.; Png, Rui-Qi; Chua, Lay-Lay; Ho, Peter K. H.			Multivalent anions as universal latent electron donors	NATURE			English	Article							HOLE-INJECTION; CONJUGATED POLYELECTROLYTES; MADELUNG CONSTANTS; POLYMER; FULLERENES; ULTRAHIGH; REDUCTION; PHASE	Electrodes with low work functions are required to efficiently inject electrons into semiconductor devices. However, when the work function drops below about 4 electronvolts, the electrode suffers oxidation in air, which prevents its fabrication in ambient conditions. Here we show that multivalent anions such as oxalate, carbonate and sulfite can act as powerful latent electron donors when dispersed as small ion clusters in a matrix, while retaining their ability to be processed in solution in ambient conditions. The anions in these clusters can even n-dope the semiconductor core of p-conjugated polyelectrolytes that have low electron affinities, through a ground-state doping mechanism that is further amplified by a hole-sensitized or photosensitized mechanism in the device. A theoretical analysis of donor levels of these anions reveals that they are favourably upshifted from ionic lattices by a decrease in the Coulomb stabilization of small ion clusters, and by irreversibility effects. We attain an ultralow effective work function of 2.4 electronvolts with the polyfluorene core. We realize high-performance, solution-processed, white-light-emitting diodes and organic solar cells using polymer electron injection layers with these universal anion donors, demonstrating a general approach to chemically designed and ambient-processed Ohmic electron contacts for semiconductor devices.	[Tang, Cindy G.; Zhao, Chao; Png, Rui-Qi; Chua, Lay-Lay; Ho, Peter K. H.] Natl Univ Singapore, Dept Phys, Singapore, Singapore; [Syafiqah, Mazlan Nur; Koh, Qi-Mian; Zaini, Jamal; Seah, Qiu-Jing; Chua, Lay-Lay] Natl Univ Singapore, Dept Chem, Singapore, Singapore; [Cass, Michael J.; Humphries, Martin J.; Grizzi, Ilaria; Burroughes, Jeremy H.] Cambridge Display Technol Ltd, Godmanchester, England	National University of Singapore; National University of Singapore	Png, RQ; Chua, LL (corresponding author), Natl Univ Singapore, Dept Phys, Singapore, Singapore.; Chua, LL (corresponding author), Natl Univ Singapore, Dept Chem, Singapore, Singapore.	ruiqi@nus.edu.sg; chmcll@nus.edu.sg	Humphries, Martin/HGD-1281-2022	, Zaini/0000-0002-3676-6994	Sumitomo Chemical; National Research Foundation, Prime Minister's Office, Singapore, under its Competitive Research Programme (CRP) [NRF-CRP 11-2012-03: R-144-000-339-281, R-143-000-608-281]	Sumitomo Chemical; National Research Foundation, Prime Minister's Office, Singapore, under its Competitive Research Programme (CRP)(National Research Foundation, Singapore)	We thank D.W.Y. Teo, Y. Wang, M.C.Y. Ang and A.Y.H. Ang for contributions to the experimental work, and Sumitomo Chemical for support. This research is partially funded by the National Research Foundation, Prime Minister's Office, Singapore, under its Competitive Research Programme (CRP award no. NRF-CRP 11-2012-03: R-144-000-339-281, R-143-000-608-281).	Abbaszadeh D, 2016, NAT MATER, V15, P628, DOI [10.1038/nmat4626, 10.1038/NMAT4626]; Baker AD, 2009, J PHYS CHEM C, V113, P14793, DOI 10.1021/jp905015u; Belaineh D, 2015, ADV FUNCT MATER, V25, P5504, DOI 10.1002/adfm.201500784; Bradley C, 2016, J MATER CHEM A, V4, P8777, DOI 10.1039/c6ta01479h; Broggi J, 2014, ANGEW CHEM INT EDIT, V53, P384, DOI 10.1002/anie.201209060; CAMPBELL IH, 1995, APPL PHYS LETT, V67, P3171, DOI 10.1063/1.115152; Chen ZM, 2017, J MATER CHEM A, V5, P19447, DOI 10.1039/c7ta05246d; Chia PJ, 2007, ADV MATER, V19, P4202, DOI 10.1002/adma.200700086; Chia PJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096602; Chua LL, 2005, NATURE, V434, P194, DOI 10.1038/nature03376; Dadashi-Silab S, 2016, CHEM REV, V116, P10212, DOI 10.1021/acs.chemrev.5b00586; Glasser L, 2012, INORG CHEM, V51, P2420, DOI 10.1021/ic2023852; Guha S, 2012, J AM CHEM SOC, V134, P13679, DOI 10.1021/ja303173n; Guo S, 2012, ADV MATER, V24, P699, DOI 10.1002/adma.201103238; Hasegawa T., 2004, SID S, V35, P154; Hoven C, 2007, J AM CHEM SOC, V129, P10976, DOI 10.1021/ja072612q; Hu ZC, 2017, SOL RRL, V1, DOI 10.1002/solr.201700055; Hwang J, 2009, MAT SCI ENG R, V64, P1, DOI 10.1016/j.mser.2008.12.001; Kotadiya NB, 2018, NAT MATER, V17, P329, DOI 10.1038/s41563-018-0022-8; Lee BH, 2014, ADV FUNCT MATER, V24, P1100, DOI 10.1002/adfm.201301810; Li CZ, 2013, ADV MATER, V25, P4425, DOI 10.1002/adma.201300580; Lin X, 2017, NAT MATER, V16, P1209, DOI [10.1038/nmat5027, 10.1038/NMAT5027]; Lin YZ, 2015, ADV MATER, V27, P1170, DOI 10.1002/adma.201404317; Lussem B, 2013, PHYS STATUS SOLIDI A, V210, P9, DOI 10.1002/pssa.201228310; Matsunaga Y, 2014, CHEM-EUR J, V20, P7309, DOI 10.1002/chem.201304849; Nicolai HT, 2012, NAT MATER, V11, P882, DOI [10.1038/NMAT3384, 10.1038/nmat3384]; Nicolai HT, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3391668; Nonoguchi Y, 2016, ADV FUNCT MATER, V26, P3021, DOI 10.1002/adfm.201600179; Olthof S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176601; Onwubiko A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02852-6; Png RQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11948; Poplavskyy D, 2003, APPL PHYS LETT, V83, P707, DOI 10.1063/1.1596722; Reilly TH, 2012, ADV ENERGY MATER, V2, P455, DOI 10.1002/aenm.201100446; Russ B, 2016, CHEM SCI, V7, P1914, DOI 10.1039/c5sc04217h; Seah WL, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201606291; Tan JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05200-w; Tang CC, 2016, NATURE, V539, P536, DOI 10.1038/nature20133; Trefz D, 2015, J PHYS CHEM C, V119, P22760, DOI 10.1021/acs.jpcc.5b05756; van Woudenbergh T, 2004, ADV FUNCT MATER, V14, P677, DOI 10.1002/adfm.200305178; Vaynzof Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3564903; Wang XB, 2003, J CHEM PHYS, V119, P3631, DOI 10.1063/1.1590641; Wang ZF, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201700232; Weber CD, 2014, J MATER CHEM A, V2, P303, DOI [10.1039/c3ta14132, 10.1039/c3ta14132b]; Wei P, 2010, J AM CHEM SOC, V132, P8852, DOI 10.1021/ja103173m; Wu ZH, 2016, J AM CHEM SOC, V138, P2004, DOI 10.1021/jacs.5b12664; Yamamoto T, 2014, ORG ELECTRON, V15, P1077, DOI 10.1016/j.orgel.2014.02.019; Zaikowski L, 2012, J AM CHEM SOC, V134, P10852, DOI 10.1021/ja301494n; Zamadar M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3818; Zhou M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4728121; Zhou M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.036601	50	35	35	14	130	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					519	+		10.1038/s41586-019-1575-7	http://dx.doi.org/10.1038/s41586-019-1575-7			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31554981				2022-12-28	WOS:000488247600047
J	Owens, DK; Davidson, KW; Krist, AH; Barry, MJ; Cabana, M; Caughey, AB; Doubeni, CA; Epling, JW; Kubik, M; Landefeld, CS; Mangione, CM; Pbert, L; Silverstein, M; Simon, MA; Tseng, CW; Wong, JB				Owens, Douglas K.; Davidson, Karina W.; Krist, Alex H.; Barry, Michael J.; Cabana, Michael; Caughey, Aaron B.; Doubeni, Chyke A.; Epling, John W., Jr.; Kubik, Martha; Landefeld, C. Seth; Mangione, Carol M.; Pbert, Lori; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							URINARY-TRACT-INFECTIONS; ANTIMICROBIAL TREATMENT; PREGNANCY; PYELONEPHRITIS; WOMEN	ImportanceAmong the general adult population, women (across all ages) have the highest prevalence of asymptomatic bacteriuria, although rates increase with age among both men and women. Asymptomatic bacteriuria is present in an estimated 1% to 6% of premenopausal women and an estimated 2% to 10% of pregnant women and is associated with pyelonephritis, one of the most common nonobstetric reasons for hospitalization in pregnant women. Among pregnant persons, pyelonephritis is associated with perinatal complications including septicemia, respiratory distress, low birth weight, and spontaneous preterm birth. ObjectiveTo update its 2008 recommendation, the USPSTF commissioned a review of the evidence on potential benefits and harms of screening for and treatment of asymptomatic bacteriuria in adults, including pregnant persons. PopulationThis recommendation applies to community-dwelling adults 18 years and older and pregnant persons of any age without signs and symptoms of a urinary tract infection. Evidence AssessmentBased on a review of the evidence, the USPSTF concludes with moderate certainty that screening for and treatment of asymptomatic bacteriuria in pregnant persons has moderate net benefit in reducing perinatal complications. There is adequate evidence that pyelonephritis in pregnancy is associated with negative maternal outcomes and that treatment of screen-detected asymptomatic bacteriuria can reduce the incidence of pyelonephritis in pregnant persons. The USPSTF found adequate evidence of harms associated with treatment of asymptomatic bacteriuria (including adverse effects of antibiotic treatment and changes in the microbiome) to be at least small in magnitude. The USPSTF concludes with moderate certainty that screening for and treatment of asymptomatic bacteriuria in nonpregnant adults has no net benefit. The known harms associated with treatment include adverse effects of antibiotic use and changes to the microbiome. Based on these known harms, the USPSTF determined the overall harms to be at least small in this group. RecommendationsThe USPSTF recommends screening pregnant persons for asymptomatic bacteriuria using urine culture. (B recommendation) The USPSTF recommends against screening for asymptomatic bacteriuria in nonpregnant adults. (D recommendation) This 2019 Recommendation Statement from the US Preventive Services Task Force recommends screening pregnant persons for asymptomatic bacteriuria using urine culture (B recommendation) and recommends against screening for asymptomatic bacteriuria in nonpregnant adults (D recommendation).	[Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, 616 Serra St,Encina Hall,Room C336, Stanford, CA 94305 USA; [Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, New York, NY USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Cabana, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, NY USA; [Epling, John W., Jr.] Virginia Tech, Carilion Sch Med, Roanoke, VA USA; [Kubik, Martha] Temple Univ, Philadelphia, PA 19122 USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Pbert, Lori] Univ Massachusetts, Sch Med, Worcester, MA USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Northwell Health; Virginia Commonwealth University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Oregon Health & Science University; Mayo Clinic; Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Owens, DK (corresponding author), Stanford Univ, 616 Serra St,Encina Hall,Room C336, Stanford, CA 94305 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Epling, John W/J-1097-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Wong, John/0000-0003-4203-9010				ABRUTYN E, 1994, ANN INTERN MED, V120, P827, DOI 10.7326/0003-4819-120-10-199405150-00003; American Academy of Pediatrics, 2012, GUID PREN CAR; American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V111, P785, DOI 10.1097/AOG.0b013e318169f6ef; [Anonymous], SUMM REC CLIN PREV S; [Anonymous], 2018, PROC MAN; ASSCHER AW, 1969, J INFECT DIS, V120, P17, DOI 10.1093/infdis/120.1.17; BOSCIA JA, 1987, JAMA-J AM MED ASSOC, V257, P1067, DOI 10.1001/jama.257.8.1067; BRUMFITT W, 1975, KIDNEY INT, V8, pS113; Calonge N, 2008, ANN INTERN MED, V149, P43, DOI 10.7326/0003-4819-149-1-200807010-00009; Canadian Task Force on Preventive Health Care (CTFPHC), 2018, AS BACT PREGN; Dull RB, 2014, PHARMACOTHERAPY, V34, P941, DOI 10.1002/phar.1437; ELDER HA, 1971, AM J OBSTET GYNECOL, V111, P441, DOI 10.1016/0002-9378(71)90793-9; Farkash E, 2012, EUR J OBSTET GYN R B, V162, P24, DOI 10.1016/j.ejogrb.2012.01.024; Ferroni M, 2015, UROL CLIN N AM, V42, P537, DOI 10.1016/j.ucl.2015.07.003; FOLEY ME, 1987, BRIT MED J, V295, P270, DOI 10.1136/bmj.295.6592.270; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; FURNESS ET, 1975, NEW ZEAL MED J, V81, P417; Giamarellou H, 1998, CLIN DRUG INVEST, V15, P187, DOI 10.2165/00044011-199815030-00003; Glaser AP, 2015, UROL CLIN N AM, V42, P547, DOI 10.1016/j.ucl.2015.05.004; GOLD EM, 1966, OBSTET GYNECOL, V27, P206; GRATACOS E, 1994, J INFECT DIS, V169, P1390, DOI 10.1093/infdis/169.6.1390; Harding GKM, 2002, NEW ENGL J MED, V347, P1576, DOI 10.1056/NEJMoa021042; Henderson J, 2019, SCREENING ASYMPTOMAT; Henderson JT, 2019, JAMA-J AM MED ASSOC, V322, P1195, DOI 10.1001/jama.2019.10060; Hill JB, 2005, OBSTET GYNECOL, V105, P18, DOI 10.1097/01.AOG.0000149154.96285.a0; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; Juthani-Mehta M, 2007, CLIN GERIATR MED, V23, P585, DOI 10.1016/j.cger.2007.03.001; Kazemier BM, 2015, LANCET INFECT DIS, V15, P1324, DOI 10.1016/S1473-3099(15)00070-5; KINCAIDSMITH P, 1965, LANCET, V1, P395; LITTLE PJ, 1966, LANCET, V2, P925; Macejko AM, 2007, UROL CLIN N AM, V34, P35, DOI 10.1016/j.ucl.2006.10.010; National Institute for Health and Care Excellence (NICE), 2018, UR TRACT INF LOW ANT; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Nicolle LE, 2019, CLIN INFECT DIS, V68, P1611, DOI [10.1093/cid/ciz021, 10.1093/cid/ciy1121]; PATHAK UN, 1969, J INFECT DIS, V120, P91, DOI 10.1093/infdis/120.1.91; SAVAGE WE, 1967, MEDICINE, V46, P385, DOI 10.1097/00005792-196709000-00002; Schnarr J, 2008, EUR J CLIN INVEST, V38, P50, DOI 10.1111/j.1365-2362.2008.02009.x; Smaill FM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub3; Uncu Y, 2002, Clin Exp Obstet Gynecol, V29, P281; US Preventive Services Task Force, 2004, SCREEN AS BACT REC S; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Verani J, 2010, PREVENTION PREINATAL; WILLIAMS GL, 1969, BRIT MED J, V3, P212, DOI 10.1136/bmj.3.5664.212; Wing DA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.006; WREN BG, 1969, MED J AUSTRALIA, V2, P596, DOI 10.5694/j.1326-5377.1969.tb107290.x	45	37	38	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1188	1194		10.1001/jama.2019.13069	http://dx.doi.org/10.1001/jama.2019.13069			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550038	Bronze			2022-12-28	WOS:000488822800025
J	Lagarde, M; Huicho, L; Papanicolas, I				Lagarde, Mylene; Huicho, Luis; Papanicolas, Irene			Motivating provision of high quality care: it is not all about the money	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PAY-FOR-PERFORMANCE; HEALTH-CARE; FINANCIAL INCENTIVES; SELECTION METHODS; FIELD EXPERIMENT; MORTALITY; COUNTRIES; IMPACT; INFORMATION; PROVIDERS		[Lagarde, Mylene; Papanicolas, Irene] London Sch Econ, Dept Hlth Policy, London, England; [Huicho, Luis] Univ Peruana Cayetano Heredia, Ctr Invest Salud Materna & Infantil, Lima, Peru; [Huicho, Luis] Univ Peruana Cayetano Heredia, Ctr Invest Desarrollo Integral & Sostenible, Lima, Peru; [Papanicolas, Irene] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	University of London; London School Economics & Political Science; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Harvard University; Harvard T.H. Chan School of Public Health	Papanicolas, I (corresponding author), London Sch Econ, Dept Hlth Policy, London, England.; Papanicolas, I (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	i.n.papanicolas@lse.ac.uk	Lagarde, Mylene/GVS-9289-2022; Huicho, Luis/AAD-7353-2019	Huicho, Luis/0000-0002-5272-5885				Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; ARROW KJ, 1963, AM ECON REV, V53, P941; Ashraf N, 2017, AM ECON REV, V107, P70, DOI 10.1257/aer.p20171097; Austin JM, 2015, HEALTH AFFAIR, V34, P423, DOI 10.1377/hlthaff.2014.0201; Banerjee AV, 2008, J EUR ECON ASSOC, V6, P487, DOI 10.1162/JEEA.2008.6.2-3.487; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Berwick DM, 2003, MED CARE, V41, pI30; Besley T, 2005, AM ECON REV, V95, P616, DOI 10.1257/0002828054201413; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Blumenthal DM, 2018, JAMA CARDIOL, V3, P629, DOI 10.1001/jamacardio.2018.1095; Borghi J, 2015, HEALTH AFFAIR, V34, P406, DOI 10.1377/hlthaff.2014.0608; Braithwaite J, 2017, COMPLEXITY SCI HEALT; Brock JM, 2016, J HUM RESOUR, V51, P133, DOI 10.3368/jhr.51.1.133; Callen M, 2016, 22340 NBER; Campanella P, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1543-y; Currie J, 2014, J DEV ECON, V110, P39, DOI 10.1016/j.jdeveco.2014.05.006; Dal Bo E, 2013, Q J ECON, V128, P1169, DOI 10.1093/qje/qjt008; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Das J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1716; Das J, 2016, AM ECON REV, V106, P3765, DOI 10.1257/aer.20151138; Deci E. L., 1985, INTRINSIC MOTIVATION, DOI [10.1007/978-1-4899-2271-7, DOI 10.1007/978-1-4899-2271-7]; Delfgaauw J, 2007, DEDICATED DOCTORS PU; Deserranno E, 2019, AM ECON J-APPL ECON, V11, P277, DOI 10.1257/app.20170670; Devarajan S, 2002, MAKING SERVICES WORK; Dhaliwal I, 2017, J DEV ECON, V124, P1, DOI 10.1016/j.jdeveco.2016.08.008; Donato K, 2017, AM ECON REV, V107, P506, DOI 10.1257/aer.p20171105; Dranove D, 2003, J POLIT ECON, V111, P555, DOI 10.1086/374180; Eijkenaar F, 2012, MED CARE RES REV, V69, P251, DOI 10.1177/1077558711432891; Emanuel EJ, 2016, ANN INTERN MED, V164, P114, DOI 10.7326/M15-1330; Frey B., 1997, NOT JUST MONEY EC TH; Gertler P, 2013, 19046 NBER; Grant AM, 2011, PSYCHOL SCI, V22, P1494, DOI 10.1177/0956797611419172; Grobler L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005314.pub2; Herzberg F, 2003, HARVARD BUS REV, V81, P87; Hickam D H, 2003, Evid Rep Technol Assess (Summ), P1; Joynt KE, 2016, ANN INTERN MED, V165, P153, DOI 10.7326/M15-1462; Kolstad JT, 2013, AM ECON REV, V103, P2875, DOI 10.1257/aer.103.7.2875; Kruk ME, 2016, LANCET GLOB HEALTH, V4, pE594, DOI 10.1016/S2214-109X(16)30131-0; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Lagarde M, 2014, J ECON BEHAV ORGAN, V107, P136, DOI 10.1016/j.jebo.2014.09.004; Lagarde M, 2012, SOC SCI MED, V75, P801, DOI 10.1016/j.socscimed.2012.05.005; Larsson S, 2012, HEALTH AFFAIR, V31, P220, DOI 10.1377/hlthaff.2011.0762; Lee S, 2018, INTRINSIC INCENTIVES; Leonard KL, 2010, J DEV ECON, V93, P226, DOI 10.1016/j.jdeveco.2009.11.001; Lewis T, 2012, B WORLD HEALTH ORGAN, V90, P332, DOI 10.2471/BLT.11.099820; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Liu T, 2013, J ECON BEHAV ORGAN, V85, P79, DOI 10.1016/j.jebo.2012.11.002; Maslow A.H., 1987, MOTIVATION PERSONALI; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mendelson A, 2017, ANN INTERN MED, V166, P341, DOI 10.7326/M16-1881; Mohanan M, 2015, JAMA PEDIATR, V169, P349, DOI 10.1001/jamapediatrics.2014.3445; National Academies of Sciences, 2018, MED CROSS GLOB QUAL; Papanicolas I, 2015, J HEALTH ECON, V44, P25, DOI 10.1016/j.jhealeco.2015.08.001; Patterson F, 2017, ADV HEALTH SCI EDUC, V22, P229, DOI 10.1007/s10459-017-9752-7; Patterson F, 2016, ADV HEALTH SCI EDUC, V21, P859, DOI 10.1007/s10459-014-9579-4; Patterson F, 2016, MED EDUC, V50, P36, DOI 10.1111/medu.12817; Roy AD, 1951, OXFORD ECON PAP, V3, P135, DOI 10.1093/oxfordjournals.oep.a041827; Ryan AM, 2012, HEALTH AFFAIR, V31, P585, DOI 10.1377/hlthaff.2011.0719; Schouten LMT, 2008, BMJ-BRIT MED J, V336, P1491, DOI 10.1136/bmj.39570.749884.BE; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Sherry TB, 2017, AM J HEALTH ECON, V3, P192, DOI 10.1162/ajhe_a_00072; SIDDIQUI DEF, 2018, DEV DISCUSSION PAPER, V65; Vallance AE, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1581; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; White A, 2016, CIN-COMPUT INFORM NU, V34, P206, DOI [10.1097/CIN.0000000000000231, 10.1097/01.NCN.0000484013.73650.48]; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; World Bank, 2003, WORLD DEVELOPMENT RE	69	8	8	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5210	10.1136/bmj.l5210	http://dx.doi.org/10.1136/bmj.l5210			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB3WS	31548200	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000488488000002
J	Bender, E				Bender, Eric			Breaking out of the egg	NATURE			English	Editorial Material																		Dunkle LM, 2017, NEW ENGL J MED, V376, P2427, DOI [10.1056/NEJMoa1608862, 10.1056/nejmoa1608862]	1	1	1	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					S60	S61		10.1038/d41586-019-02756-5	http://dx.doi.org/10.1038/d41586-019-02756-5			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534255				2022-12-28	WOS:000486647800009
J	Tollefson, J				Tollefson, Jeff			CAN THE WORLD SLOW GLOBAL WARMING?	NATURE			English	News Item																			0	24	24	7	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					324	324		10.1038/d41586-019-02711-4	http://dx.doi.org/10.1038/d41586-019-02711-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31534259	Bronze			2022-12-28	WOS:000486647800018
J	[Anonymous]				[Anonymous]			US Preventive Services Task Force. Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement (vol 322, pg 349, 2019)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Correction																		Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P349, DOI 10.1001/jama.2019.9365; 2019, JAMA-J AM MED ASSOC, V322, P349, DOI DOI 10.1001/JAMA.2019.9365	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1108	1108		10.1001/jama.2019.12797	http://dx.doi.org/10.1001/jama.2019.12797			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31528989	Green Published, Bronze			2022-12-28	WOS:000488821100036
J	Carsch, KM; DiMucci, IM; Iovan, DA; Li, A; Zheng, SL; Titus, CJ; Lee, SJ; Irwin, KD; Nordlund, D; Lancaster, KM; Betley, TA				Carsch, Kurtis M.; DiMucci, Ida M.; Iovan, Diana A.; Li, Alex; Zheng, Shao-Liang; Titus, Charles J.; Lee, Sang Jun; Irwin, Kent D.; Nordlund, Dennis; Lancaster, Kyle M.; Betley, Theodore A.			Synthesis of a copper-supported triplet nitrene complex pertinent to copper-catalyzed amination	SCIENCE			English	Article							ENANTIOSELECTIVE TOTAL-SYNTHESIS; DENSITY-FUNCTIONAL CALCULATIONS; TRANSITION-METAL-COMPLEXES; H BOND AMINATION; IMIDO COMPLEXES; AZIRIDINATION; REACTIVITY; LIGAND; APPROXIMATION; ENERGY	Terminal copper-nitrenoid complexes have inspired interest in their fundamental bonding structures as well as their putative intermediacy in catalytic nitrene-transfer reactions. Here, we report that aryl azides react with a copper(I) dinitrogen complex bearing a sterically encumbered dipyrrin ligand to produce terminal copper nitrene complexes with near-linear, short copper-nitrenoid bonds [1.745(2) to 1.759(2) angstroms]. X-ray absorption spectroscopy and quantum chemistry calculations reveal a predominantly triplet nitrene adduct bound to copper(I), as opposed to copper(II) or copper(III) assignments, indicating the absence of a copper-nitrogen multiple-bond character. Employing electron-deficient aryl azides renders the copper nitrene species competent for alkane amination and alkene aziridination, lending further credence to the intermediacy of this species in proposed nitrene-transfer mechanisms.	[Carsch, Kurtis M.; Iovan, Diana A.; Li, Alex; Zheng, Shao-Liang; Nordlund, Dennis; Betley, Theodore A.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [DiMucci, Ida M.; Lancaster, Kyle M.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA; [Titus, Charles J.; Irwin, Kent D.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Lee, Sang Jun] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Irwin, Kent D.] SLAC Natl Accelerator Lab, Menlo Pk, CA USA	Harvard University; Cornell University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Betley, TA (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Lancaster, KM (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA.	kml236@cornell.edu; betley@chemistry.harvard.edu	Lee, Sang-Jun/A-3892-2015; Nordlund, Dennis/A-8902-2008; Titus, Charles/L-7736-2019	Lee, Sang-Jun/0000-0002-8199-3993; Nordlund, Dennis/0000-0001-9524-6908; Titus, Charles/0000-0001-6312-8552; Irwin, Kent/0000-0002-2998-9743; Li, Alex/0000-0001-9912-1643	NIH [GM-115815]; Dreyfus Foundation; Harvard University; Fannie and John Hertz Foundation; National Science Foundation; NSF [CHE-1454455]; Alfred P. Sloan Foundation; U.S. Department of Energy Office of Science and Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy's Office of Biological and Environmental Research; U.S. Department of Energy Office of Basic Energy Sciences [100487]; NIH/HIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115815, P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dreyfus Foundation; Harvard University; Fannie and John Hertz Foundation; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); U.S. Department of Energy Office of Science and Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH/HIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.A.B. acknowledges a grant from the NIH (GM-115815), the Dreyfus Foundation (Teacher-Scholar Award), and Harvard University. K.M.C. acknowledges the Fannie and John Hertz Foundation and the National Science Foundation for financial support of this research. K.M.L. acknowledges NSF (CHE-1454455) and the Alfred P. Sloan Foundation for financial support. XAS data were obtained at SSRL, which is supported by the U.S. Department of Energy Office of Science and Office of Basic Energy Sciences (contract no. DE-AC02-76SF00515). The SSRL Structural Molecular Biology Program is supported by the Department of Energy's Office of Biological and Environmental Research and NIH/HIGMS (including P41GM103393). The work at SSRL was also supported by the U.S. Department of Energy Office of Basic Energy Sciences (proposal no. 100487).	Aguila MJB, 2013, J AM CHEM SOC, V135, P9399, DOI 10.1021/ja400879m; Ajvazi N, 2016, TETRAHEDRON LETT, V57, P2430, DOI 10.1016/j.tetlet.2016.04.083; [Anonymous], 2013, PRIMARY EXPLOSIVES; Badiei YM, 2006, J AM CHEM SOC, V128, P15056, DOI 10.1021/ja065299l; Badiei YM, 2008, ANGEW CHEM INT EDIT, V47, P9961, DOI 10.1002/anie.200804304; Bakhoda A. (Gus), 2019, ANGEW CHEM, V131, P3459; Bakhoda A, 2017, ANGEW CHEM INT EDIT, V56, P6426, DOI 10.1002/anie.201611275; Barral K, 2007, ORG LETT, V9, P1809, DOI 10.1021/ol070527h; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bencivenni G, 2010, ORG BIOMOL CHEM, V8, P5097, DOI 10.1039/c0ob00084a; Berry JF, 2009, COMMENT INORG CHEM, V30, P28, DOI 10.1080/02603590902768875; Chan KH, 2014, ANGEW CHEM INT EDIT, V53, P2982, DOI 10.1002/anie.201309888; Chemler SR, 2013, SCIENCE, V341, P624, DOI 10.1126/science.1237175; CORDELL GA, 1975, J ORG CHEM, V40, P3161, DOI 10.1021/jo00910a001; Corona T, 2016, ANGEW CHEM INT EDIT, V55, P14005, DOI 10.1002/anie.201607238; Cundari TR, 2008, INORG CHEM, V47, P10067, DOI 10.1021/ic801337f; Diaz-Requejo MM, 2003, J AM CHEM SOC, V125, P12078, DOI 10.1021/ja037072l; Dielmann F, 2014, J AM CHEM SOC, V136, P3800, DOI 10.1021/ja5007355; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; EVANS DA, 1993, J AM CHEM SOC, V115, P5328, DOI 10.1021/ja00065a068; EVANS DA, 1991, J ORG CHEM, V56, P6744, DOI 10.1021/jo00024a008; Fantauzzi S, 2007, EUR J ORG CHEM, V2007, P6053, DOI 10.1002/ejoc.200700678; Fowler JW, 2016, J LOW TEMP PHYS, V184, P374, DOI 10.1007/s10909-015-1380-0; GEORGE SJ, 1993, J AM CHEM SOC, V115, P2968, DOI 10.1021/ja00060a052; Gephart RT, 2012, ORGANOMETALLICS, V31, P7728, DOI 10.1021/om300840z; Goetz MK, 2018, J AM CHEM SOC, V140, P13176, DOI 10.1021/jacs.8b07399; Gross E. K. U., 1990, ADV QUANTUM CHEM, V21, P255, DOI DOI 10.1016/S0065-3276(08)60600-0; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Hamilton CW, 2004, CHEM COMMUN, P1628, DOI 10.1039/b404515g; Hoffmann R, 2016, CHEM REV, V116, P8173, DOI 10.1021/acs.chemrev.6b00251; Holland PL, 2010, DALTON T, V39, P5415, DOI 10.1039/c001397h; Hu MY, 2008, ORG LETT, V10, P5529, DOI 10.1021/ol802286g; Hutson GE, 2013, J AM CHEM SOC, V135, P4988, DOI 10.1021/ja401908m; Iovan DA, 2017, CHEM COMMUN, V53, P10306, DOI 10.1039/c7cc05014c; Iovan DA, 2016, J AM CHEM SOC, V138, P1983, DOI 10.1021/jacs.5b12582; Itadani A, 2007, J PHYS CHEM C, V111, P16701, DOI 10.1021/jp076944t; Jin LM, 2014, CHEM SCI, V5, P2422, DOI 10.1039/c4sc00697f; Jin LM, 2013, ANGEW CHEM INT EDIT, V52, P5309, DOI 10.1002/anie.201209599; Jorgensen CK., 1966, COORDIN CHEM REV, V1, P164, DOI [10.1016/S0010-8545(00)80170-8, DOI 10.1016/S0010-8545(00)80170-8]; King ER, 2012, J AM CHEM SOC, V134, P17858, DOI 10.1021/ja307699u; King ER, 2011, J AM CHEM SOC, V133, P4917, DOI 10.1021/ja110066j; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Kogut E, 2005, J AM CHEM SOC, V127, P11248, DOI 10.1021/ja0533186; Krause L, 2015, J APPL CRYSTALLOGR, V48, P3, DOI 10.1107/S1600576714022985; Kundu S, 2012, J AM CHEM SOC, V134, P14710, DOI 10.1021/ja306674h; Kung YC, 2009, J POLYM SCI POL CHEM, V47, P1740, DOI 10.1002/pola.23264; KWART H, 1967, J AM CHEM SOC, V89, P1951, DOI 10.1021/ja00984a035; Laitar DS, 2003, INORG CHEM, V42, P7354, DOI 10.1021/ic035056j; Laskowski CA, 2011, J AM CHEM SOC, V133, P771, DOI 10.1021/ja1101213; LI Z, 1995, J AM CHEM SOC, V117, P5889, DOI 10.1021/ja00126a044; LI Z, 1993, J AM CHEM SOC, V115, P5326, DOI 10.1021/ja00065a067; Liao Y, 2017, ACS CATAL, V7, P7529, DOI 10.1021/acscatal.7b02558; LOWDIN PO, 1955, PHYS REV, V97, P1474, DOI 10.1103/PhysRev.97.1474; Lukens JT, 2019, CHEM SCI, V10, P5044, DOI 10.1039/c8sc03350a; Lv YH, 2013, CHEM COMMUN, V49, P6439, DOI 10.1039/c3cc43129k; Mankad NP, 2009, J AM CHEM SOC, V131, P3878, DOI 10.1021/ja809834k; Matsuo T, 2015, B CHEM SOC JPN, V88, P1201, DOI 10.1246/bcsj.20150130; Matsuo T, 2011, B CHEM SOC JPN, V84, P1178, DOI 10.1246/bcsj.20110090; MEYER EM, 1989, ORGANOMETALLICS, V8, P1067, DOI 10.1021/om00106a031; Mindiola DJ, 2006, ACCOUNTS CHEM RES, V39, P813, DOI 10.1021/ar0500113; Morhac M, 2008, APPL SPECTROSC, V62, P91, DOI 10.1366/000370208783412762; Murray LJ, 2014, J AM CHEM SOC, V136, P13502, DOI 10.1021/ja506445d; Murray R. B., 2019, TRANSITION METAL DIN, P403; Neese F, 2003, J CHEM PHYS, V119, P9428, DOI 10.1063/1.1615956; Neese F, 2002, INORG CHIM ACTA, V337, P181, DOI 10.1016/S0020-1693(02)01031-9; Neese F, 2006, J AM CHEM SOC, V128, P10213, DOI 10.1021/ja061798a; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Neese F, 2009, CHEM PHYS, V356, P98, DOI 10.1016/j.chemphys.2008.10.036; Nugent W. A., 1988, METAL LIGAND MULTIPL; Ojeda-Amador AI, 2016, INORG CHEM, V55, P5719, DOI 10.1021/acs.inorgchem.6b00839; Overman LE, 1998, J AM CHEM SOC, V120, P4039, DOI 10.1021/ja974361z; Park SH, 2005, B KOREAN CHEM SOC, V26, P1190; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Politanskaya L, 2018, J FLUORINE CHEM, V214, P48, DOI 10.1016/j.jfluchem.2018.06.011; Ramadhar TR, 2015, ACTA CRYSTALLOGR A, V71, P46, DOI 10.1107/S2053273314019573; Ramlall P, 1999, J CHEM SOC PERK T 2, P225, DOI 10.1039/a807567k; Rieth RD, 2004, ORG LETT, V6, P3981, DOI 10.1021/ol048367m; Rueping M, 2012, ORG LETT, V14, P768, DOI 10.1021/ol203310h; SCRIVEN EFV, 1988, CHEM REV, V88, P297, DOI 10.1021/cr00084a001; Sebest F, 2018, CHEMCATCHEM, V10, P2041, DOI 10.1002/cctc.201701992; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; SMITH PAS, 1962, J AM CHEM SOC, V84, P480, DOI 10.1021/ja00862a032; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suarez AIO, 2013, ANGEW CHEM INT EDIT, V52, P12510, DOI 10.1002/anie.201301487; Takaoka A, 2012, J AM CHEM SOC, V134, P6695, DOI 10.1021/ja211603f; TIAN XR, 1995, J AM CHEM SOC, V117, P3643, DOI 10.1021/ja00117a046; Titus CJ, 2017, J CHEM PHYS, V147, DOI 10.1063/1.5000755; Tomson NC, 2015, CHEM SCI, V6, P2474, DOI 10.1039/c4sc03294b; Trost BM, 2006, J AM CHEM SOC, V128, P6054, DOI 10.1021/ja061105q; van Lenthe E, 1998, J CHEM PHYS, V108, P4783, DOI 10.1063/1.475889; van Wullen C, 1998, J CHEM PHYS, V109, P392, DOI 10.1063/1.476576; Vanicek S, 2019, ORGANOMETALLICS, V38, P1361, DOI 10.1021/acs.organomet.8b00681; Walroth RC, 2017, J AM CHEM SOC, V139, P13507, DOI 10.1021/jacs.7b07186; Walroth RC, 2016, J AM CHEM SOC, V138, P1922, DOI 10.1021/jacs.5b10819; Walroth RC, 2015, CHEM COMMUN, V51, P9864, DOI 10.1039/c5cc01827g; Webb SM, 2005, PHYS SCRIPTA, VT115, P1011; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; White RD, 2004, ORG LETT, V6, P1123, DOI 10.1021/ol049918b; Wilding MJT, 2017, J AM CHEM SOC, V139, P14757, DOI 10.1021/jacs.7b08714; Wilding MJT, 2017, J AM CHEM SOC, V139, P12043, DOI 10.1021/jacs.7b06682; Yamamoto K, 2016, ORG LETT, V18, P2644, DOI 10.1021/acs.orglett.6b00975; Yao XN, 2017, J AM CHEM SOC, V139, P373, DOI 10.1021/jacs.6b11043; Zalatan DN, 2010, TOP CURR CHEM, V292, P347, DOI 10.1007/128_2009_19; Zanato C, 2015, SYNTHESIS-STUTTGART, V47, P817, DOI 10.1055/s-0034-1379887; Zhang L, 2014, J AM CHEM SOC, V136, P15525, DOI 10.1021/ja509731z; Zhang SY, 2016, ANGEW CHEM INT EDIT, V55, P9927, DOI 10.1002/anie.201603970	110	82	82	8	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1138	+		10.1126/science.aax4423	http://dx.doi.org/10.1126/science.aax4423			151	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515388	Green Accepted			2022-12-28	WOS:000485780800041
J	Welford, P; O'Brien, A				Welford, Paul; O'Brien, Aileen			Improving student mental wellbeing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Welford, Paul] Severn Deanery, Bristol, Avon, England; [O'Brien, Aileen] St Georges Univ London, London, England	St Georges University London	Welford, P (corresponding author), Severn Deanery, Bristol, Avon, England.	paul.welford@gmail.com	Welford, Paul/AAY-8913-2020	Welford, Paul/0000-0001-9147-783X				APPLEBY J, 2016, BMJ-BRIT MED J, V354, P9602, DOI DOI 10.1136/BMJ.I3951; Brown P, 2016, INVISIBLE PROBLEM IM; General Medical Council, 2015, SUPP MED STUD MENT H; General Medical Council, 2018, TRAIN ENV 2018 KEY F; McCann C.M., 2013, INT J WELLBEING, V3, P1, DOI [10.5502/ijw.v3i1.4, DOI 10.5502/IJW.V3I1.4]; Nunez-Mulder L, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3969; Peters D, 2018, BMJ OPINION	7	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l2421	10.1136/bmj.l2421	http://dx.doi.org/10.1136/bmj.l2421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY8MX	31519646				2022-12-28	WOS:000486649800001
J	Gregoriou, S; Petra, AI; Kontochristopoulos, G				Gregoriou, Stamatis; Petra, Anastasia I.; Kontochristopoulos, George			A mass on the shin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PSORIASIS; RISK		[Gregoriou, Stamatis; Petra, Anastasia I.; Kontochristopoulos, George] Univ Athens, Med Sch, Andreas Syggros Hosp, Dept Dermatol & Venereol, Athens, Greece	National & Kapodistrian University of Athens	Gregoriou, S (corresponding author), Univ Athens, Med Sch, Andreas Syggros Hosp, Dept Dermatol & Venereol, Athens, Greece.	stamgreg@yahoo.gr	Gregoriou, Stamatis/H-6587-2019	Gregoriou, Stamatis/0000-0002-7585-1032				Fuxench ZCC, 2016, JAMA DERMATOL, V152, P282, DOI 10.1001/jamadermatol.2015.4847; Nast A, 2017, J EUR ACAD DERMATOL, V31, P1951, DOI 10.1111/jdv.14454; Nast A, 2015, J EUR ACAD DERMATOL, V29, pE1, DOI 10.1111/jdv.13353; Paul CF, 2003, J INVEST DERMATOL, V120, P211, DOI 10.1046/j.1523-1747.2003.12040.x	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2019	366								l4822	10.1136/bmj.l4822	http://dx.doi.org/10.1136/bmj.l4822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MV	31515222				2022-12-28	WOS:000486649600001
J	Rieder, TN				Rieder, Travis N.			The painful truth about pain	NATURE			English	Editorial Material									[Rieder, Travis N.] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Rieder, TN (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	trieder@jhu.edu							0	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					S16	S16		10.1038/d41586-019-02688-0	http://dx.doi.org/10.1038/d41586-019-02688-0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511671				2022-12-28	WOS:000485415400009
J	Adhikari, R				Adhikari, Rojita			US "global gag rule" on abortion is limiting family planning choices for women in Nepal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rojitaadhikari@gmail.com						Center for Research on Environment Health and Population Activities, 2017, AB UN PREGN NEP 2017; International Women's Health Coalition, 2019, CRIS CAR YEAR 2 TRUM; KMIETOWICZ Z, 2019, BMJ-BRIT MED J, V365, P71561, DOI DOI 10.1136/BMJ.L4118; Puri M, 2019, EARLY IMPACTS EXPAND	4	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5354	10.1136/bmj.l5354	http://dx.doi.org/10.1136/bmj.l5354			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506255				2022-12-28	WOS:000486648900004
J	Christie, B				Christie, Bryan			GMC pledges to improve doctors' training at Scotland's largest hospital	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Education for Scotland, 2019, SCOTL DEAN QUAL MAN	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5505	10.1136/bmj.l5505	http://dx.doi.org/10.1136/bmj.l5505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506257				2022-12-28	WOS:000486648900017
J	Mallucci, CL; Jenkinson, MD; Conroy, EJ; Hartley, JC; Brown, M; Dalton, J; Kearns, T; Moitt, T; Griffiths, MJ; Culeddu, G; Solomon, T; Hughes, D; Gamble, C				Mallucci, Conor L.; Jenkinson, Michael D.; Conroy, Elizabeth J.; Hartley, John C.; Brown, Michaela; Dalton, Joanne; Kearns, Tom; Moitt, Tracy; Griffiths, Michael J.; Culeddu, Giovanna; Solomon, Tom; Hughes, Dyfrig; Gamble, Carrol		BASICS Study Collaborators	Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation	LANCET			English	Article							EXTERNAL VENTRICULAR DRAINS; IMPREGNATED CATHETERS; COMPETING RISKS; INFECTIONS; HYDROCEPHALUS; HAZARDS; MODEL; META	Background Insertion of a ventriculoperitoneal shunt for hydrocephalus is one of the commonest neurosurgical procedures worldwide. Infection of the implanted shunt affects up to 15% of these patients, resulting in prolonged hospital treatment, multiple surgeries, and reduced cognition and quality of life. Our aim was to determine the clinical and cost-effectiveness of antibiotic (rifampicin and clindamycin) or silver shunts compared with standard shunts at reducing infection. Methods In this parallel, multicentre, single-blind, randomised controlled trial, we included patients with hydrocephalus of any aetiology undergoing insertion of their first ventriculoperitoneal shunt irrespective of age at 21 regional adult and paediatric neurosurgery centres in the UK and Ireland. Patients were randomly assigned (1:1:1 in random permuted blocks of three or six) to receive standard shunts (standard shunt group), antibiotic-impregnated (0.15% clindamycin and 0.054% rifampicin; antibiotic shunt group), or silver-impregnated shunts (silver shunt group) through a randomisation sequence generated by an independent statistician. All patients and investigators who recorded and analysed the data were masked for group assignment, which was only disclosed to the neurosurgical staff at the time of operation. Participants receiving a shunt without evidence of infection at the time of insertion were followed up for at least 6 months and a maximum of 2 years. The primary outcome was time to shunt failure due the infection and was analysed with Fine and Gray survival regression models for competing risk by intention to treat. This trial is registered with ISRCTN 49474281. Findings Between June 26, 2013, and Oct 9, 2017, we assessed 3505 patients, of whom 1605 aged up to 91 years were randomly assigned to receive either a standard shunt (n=536), an antibiotic-impregnated shunt (n=538), or a silver shunt (n=531). 1594 had a shunt inserted without evidence of infection at the time of insertion (533 in the standard shunt group, 535 in the antibiotic shunt group, and 526 in the silver shunt group) and were followed up for a median of 22 months (IQR 10-24; 53 withdrew from follow-up). 32 (6%) of 533 evaluable patients in the standard shunt group had a shunt revision for infection, compared with 12 (2%) of 535 evaluable patients in the antibiotic shunt group (cause-specific hazard ratio [csHR] 0.38, 97.5% CI 0.18-0.80, p=0.0038) and 31 (6%) of 526 patients in the silver shunt group (0.99, 0.56-1.74, p=0.96). 135 (25%) patients in the standard shunt group, 127 (23%) in the antibiotic shunt group, and 134 (36%) in the silver shunt group had adverse events, which were not life-threatening and were mostly related to valve or catheter function. Interpretation The BASICS trial provides evidence to support the adoption of antibiotic shunts in UK patients who are having their first ventriculoperitoneal shunt insertion. This practice will benefit patients of all ages by reducing the risk and harm of shunt infection.	[Mallucci, Conor L.] Alder Hey Childrens Hosp, Dept Paediat Neurosurg, Liverpool L12 2AP, Merseyside, England; [Griffiths, Michael J.] Alder Hey Childrens Hosp, Dept Paediat Neurol, Liverpool, Merseyside, England; [Jenkinson, Michael D.] Walton Ctr Natl Hlth Serv Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England; [Solomon, Tom] Walton Ctr Natl Hlth Serv Fdn Trust, Dept Neurol, Liverpool, Merseyside, England; [Jenkinson, Michael D.] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Conroy, Elizabeth J.; Brown, Michaela; Dalton, Joanne; Kearns, Tom; Moitt, Tracy; Gamble, Carrol] Univ Liverpool, Clin Trials Res Ctr, Liverpool, Merseyside, England; [Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Hartley, John C.] Great Ormond St Childrens Hosp, Dept Microbiol, London, England; [Culeddu, Giovanna; Hughes, Dyfrig] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Walton Centre; Walton Centre; University of Liverpool; University of Liverpool; University of Liverpool; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Bangor University	Mallucci, CL (corresponding author), Alder Hey Childrens Hosp, Dept Paediat Neurosurg, Liverpool L12 2AP, Merseyside, England.	cmallucci@me.com	Edwards, Richard/AAD-9508-2022; Gamble, Carrol/AAE-9895-2019; Hughes, Dyfrig/H-5252-2012	Edwards, Richard/0000-0001-8415-2180; Gamble, Carrol/0000-0002-3021-1955; Mallucci, Conor/0000-0002-5509-0547; Kolias, Angelos/0000-0003-3992-0587; Zaben, Malik/0000-0002-7446-4532; Goodden, John/0000-0003-1115-6310; Shastin, Dmitri/0000-0003-3937-3675; Bulters, Diederik/0000-0001-9884-9050; CRAVEN, CLAUDIA/0000-0002-6199-0090; Conroy, Elizabeth/0000-0003-4858-727X; Culeddu, Giovanna/0000-0001-5032-4255; Hughes, Dyfrig/0000-0001-8247-7459; Solomon, Tom/0000-0001-7266-6547; Aquilina, Kristian/0000-0001-7015-5196; Thorne, Lewis/0000-0002-7692-0378; Merola, Joseph/0000-0001-6514-4353	UK National Institute for Health Research Health Technology Assessment programme; MRC [G116/194, MC_PC_15096] Funding Source: UKRI	UK National Institute for Health Research Health Technology Assessment programme(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK National Institute for Health Research Health Technology Assessment programme.	Attenello FJ, 2010, NEUROSURGERY, V66, P284, DOI 10.1227/01.NEU.0000363405.12584.4D; Austin PC, 2017, STAT MED, V36, P4391, DOI 10.1002/sim.7501; Curtis L., 2017, UNIT COSTS HLTH SOCI; Department of Health and Social Care UK, NHS REF COSTS 2015 2; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Drake JM, 1998, NEUROSURGERY, V43, P294, DOI 10.1097/00006123-199808000-00068; Edwards NC, 2015, J NEUROSURG, V122, P139, DOI 10.3171/2014.9.JNS131277; Farber SH, 2010, WORLD NEUROSURG, V74, P528, DOI 10.1016/j.wneu.2010.07.014; Fernandez-Mendez R, 2019, J NEUROL NEUROSUR PS, V90, P747, DOI 10.1136/jnnp-2018-319927; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Govender ST, 2003, J NEUROSURG, V99, P831, DOI 10.3171/jns.2003.99.5.0831; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Isaacs AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204926; Jamjoom AAB, 2018, J NEUROL NEUROSUR PS, V89, P120, DOI 10.1136/jnnp-2017-316415; Jenkinson MD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-4; Joint Formulary Committee, 2017, BRIT NATL FORMULARY; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Klimo P, 2011, J NEUROSURG-PEDIATR, V8, P600, DOI 10.3171/2011.8.PEDS11346; Kulkarni AV, 2004, J NEUROSURG, V101, P134, DOI 10.3171/ped.2004.101.2.0134; Latouche A, 2013, J CLIN EPIDEMIOL, V66, P648, DOI 10.1016/j.jclinepi.2012.09.017; NHS England, NHS NAT TAR PAYM SYS; Parker SL, 2015, WORLD NEUROSURG, V83, P382, DOI 10.1016/j.wneu.2014.06.010; Pintilie M, 2002, STAT MED, V21, P3317, DOI 10.1002/sim.1271; Richards HK, 2009, J NEUROSURG-PEDIATR, V4, P389, DOI 10.3171/2009.4.PEDS09210; Root BK, 2016, WORLD NEUROSURG, V86, P306, DOI [10.1016/j.wneu.2015.09.032, 10.1016/J.WNEU.2015.09.032]; Schreffler RT, 2002, PEDIATR INFECT DIS J, V21, P632, DOI 10.1097/00006454-200207000-00006; Thomas R, 2012, BRIT J NEUROSURG, V26, P175, DOI 10.3109/02688697.2011.603856; Vinchon M, 2006, CHILD NERV SYST, V22, P692, DOI 10.1007/s00381-005-0037-8	29	63	63	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2019	394	10208					1530	1539		10.1016/S0140-6736(19)31603-4	http://dx.doi.org/10.1016/S0140-6736(19)31603-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI3WL	31522843	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000493399500024
J	Abbasi, J				Abbasi, Jennifer			First Biomarker-Based Screening Tool for PTSD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News article discusses a biomarker panel being developed to screen for war zone-related posttraumatic stress disorder.											0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2019	322	15					1437	1437		10.1001/jama.2019.15339	http://dx.doi.org/10.1001/jama.2019.15339			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI4ST	31553409				2022-12-28	WOS:000493458400002
J	Nordling, L				Nordling, Linda			Mind the gap	NATURE			English	Editorial Material																		Black E, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-018-0446-6; Blasimme A., 2019, PREPRINT, DOI [10.2139/ssrn.3368756, DOI 10.2139/SSRN.3368756]; Lee P, 2019, AM J EMERG MED, V37, P1770, DOI 10.1016/j.ajem.2019.06.014; Montgomery K, 2018, J INFORM POLICY, V8, P34, DOI 10.5325/jinfopoli.8.2018.0034; Obermeyer Z, 2019, FAT*'19: PROCEEDINGS OF THE 2019 CONFERENCE ON FAIRNESS, ACCOUNTABILITY, AND TRANSPARENCY, P89, DOI 10.1145/3287560.3287593; Smallman M, 2019, NATURE, V567, P7, DOI 10.1038/d41586-019-00737-2	6	25	25	1	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					S103	S105		10.1038/d41586-019-02872-2	http://dx.doi.org/10.1038/d41586-019-02872-2			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554993	Bronze			2022-12-28	WOS:000488247600014
J	Savage, N				Savage, Neil			Tech support	NATURE			English	Editorial Material																		Martinez M., 2017, PREPRINT; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Titano JJ, 2018, NAT MED, V24, P1337, DOI 10.1038/s41591-018-0147-y; Wei JW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40041-7	4	4	4	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					S98	S99		10.1038/d41586-019-02870-4	http://dx.doi.org/10.1038/d41586-019-02870-4			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554994	Bronze			2022-12-28	WOS:000488247600012
J	Zhang, Y; Zhang, XF; Ba, ZQ; Liang, ZY; Dring, EW; Hu, HL; Lou, JM; Kyritsis, N; Zurita, J; Shamim, MS; Aiden, AP; Aiden, EL; Alt, FW				Zhang, Yu; Zhang, Xuefei; Ba, Zhaoqing; Liang, Zhuoyi; Dring, Edward W.; Hu, Hongli; Lou, Jiangman; Kyritsis, Nia; Zurita, Jeffrey; Shamim, Muhammad S.; Aiden, Aviva Presser; Aiden, Erez Lieberman; Alt, Frederick W.			The fundamental role of chromatin loop extrusion in physiological V(D)J recombination	NATURE			English	Article							GENE SEGMENTS; GENOME; REVEALS; IGH; IDENTIFICATION; REARRANGEMENT; DOMAINS; ORIENTATION; INITIATION; PRINCIPLES	The RAG endonuclease initiates Igh V(D)J assembly in B cell progenitors by joining D segments to J(H) segments, before joining upstream V-H segments to DJ(H) intermediates(1). In mouse progenitor B cells, the CTCF-binding element (CBE)-anchored chromatin loop domain(2) at the 3' end of Igh contains an internal subdomain that spans the 5' CBE anchor (IGCR1)(3), the D-H segments, and a RAG-bound recombination centre (RC)(4). The RC comprises the J(H)-proximal D segment (DQ52), four J(H) segments, and the intronic enhancer (iE mu)(5). Robust RAG-mediated cleavage is restricted to paired V(D) J segments flanked by complementary recombination signal sequences (12RSS and 23RSS)(6). D segments are flanked downstream and upstream by 12RSSs that mediate deletional joining with convergently oriented J(H)-23RSSs and V-H-23RSSs, respectively(6). Despite 12/23 compatibility, inversional D-to-J(H) joining via upstream D-12RSSs is rare(7,8). Plasmid-based assays have attributed the lack of inversional D-to-J(H) joining to sequence-based preference for downstream D-12RSSs(9), as opposed to putative linear scanning mechanisms(10,11). As RAG linearly scans convergent CBE-anchored chromatin loops(4,12-14), potentially formed by cohesin-mediated loop extrusion(15-18), we revisited its scanning role. Here we show that the chromosomal orientation of J(H)-23RSS programs RC-bound RAG to linearly scan upstream chromatin in the 3' Igh subdomain for convergently oriented D-12RSSs and, thereby, to mediate deletional joining of all D segments except RC-based DQ52, which joins by a diffusion-related mechanism. In a DQ52-based RC, formed in the absence of JH segments, RAG bound by the downstream DQ52-RSS scans the downstream constant region exon-containing 3' Igh subdomain, in which scanning can be impeded by targeted binding of nuclease-dead Cas9, by transcription through repetitive Igh switch sequences, and by the 3' Igh CBE-based loop anchor. Each scanning impediment focally increases RAG activity on potential substrate sequences within the impeded region. High-resolution mapping of chromatin interactions in the RC reveals that such focal RAG targeting is associated with corresponding impediments to the loop extrusion process that drives chromatin past RC-bound RAG.	[Zhang, Yu; Zhang, Xuefei; Ba, Zhaoqing; Liang, Zhuoyi; Dring, Edward W.; Hu, Hongli; Lou, Jiangman; Kyritsis, Nia; Zurita, Jeffrey; Alt, Frederick W.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Zhang, Yu; Zhang, Xuefei; Ba, Zhaoqing; Liang, Zhuoyi; Dring, Edward W.; Hu, Hongli; Lou, Jiangman; Kyritsis, Nia; Zurita, Jeffrey; Alt, Frederick W.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Zhang, Yu; Zhang, Xuefei; Ba, Zhaoqing; Liang, Zhuoyi; Dring, Edward W.; Hu, Hongli; Lou, Jiangman; Kyritsis, Nia; Zurita, Jeffrey; Alt, Frederick W.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhang, Yu] Western Michigan Univ, Homer Stryker MD Sch Med, Dept Biomed Sci, Ctr Immunobiol, Kalamazoo, MI 49008 USA; [Shamim, Muhammad S.; Aiden, Aviva Presser; Aiden, Erez Lieberman] Baylor Coll Med, Dept Mol & Human Genet, Ctr Genome Architecture, Houston, TX 77030 USA; [Shamim, Muhammad S.; Aiden, Aviva Presser] Rice Univ, Dept Bioengn, Houston, TX USA; [Shamim, Muhammad S.; Aiden, Erez Lieberman] Rice Univ, Dept Comp Sci, Houston, TX USA; [Shamim, Muhammad S.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Aiden, Aviva Presser] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Aiden, Erez Lieberman] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Aiden, Erez Lieberman] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Aiden, Erez Lieberman] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Western Michigan University; Baylor College of Medicine; Rice University; Rice University; Baylor College of Medicine; Baylor College of Medicine; Rice University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; ShanghaiTech University	Alt, FW (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Alt, FW (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Alt, FW (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Aiden, Erez Lieberman/A-2908-2010	Shamim, Muhammad/0000-0002-2600-5147; Hu, Hongli/0000-0003-1932-5027; Liang, Zhuoyi/0000-0003-1622-524X; Ba, Zhaoqing/0000-0002-8431-5469; Zhang, Yu/0000-0002-1126-770X	NIH [R01 AI020047]; Thrasher Research Fund Early Career Award; NSF Physics Frontiers Center Award [PHY1427654]; Welch Foundation [Q-1866]; USDA Agriculture and Food Research Initiative Grant [2017-05741]; NIH 4D Nucleome Grant [U01HL130010]; NIH Encyclopedia of DNA Elements Mapping Center Award [UM1HG009375]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL130010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG009375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund Early Career Award; NSF Physics Frontiers Center Award; Welch Foundation(The Welch Foundation); USDA Agriculture and Food Research Initiative Grant; NIH 4D Nucleome Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Encyclopedia of DNA Elements Mapping Center Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. P. Sleckman for the v-Abl transformed, RAG2-deficient mouse pro-B cell line and Rag2-expressing shuttle plasmid, and Alt laboratory members for stimulating discussions. This work was supported by NIH R01 AI020047 (to F.W.A). F.W.A. is an investigator of the Howard Hughes Medical Institute. Y.Z. is a special fellow of the Leukemia and Lymphoma Society. Z. B. was a Cancer Research Institute Irvington fellow. A. P. A was supported by a Thrasher Research Fund Early Career Award. E.L.A. was supported by an NSF Physics Frontiers Center Award (PHY1427654), the Welch Foundation (Q-1866), a USDA Agriculture and Food Research Initiative Grant (2017-05741), an NIH 4D Nucleome Grant (U01HL130010), and an NIH Encyclopedia of DNA Elements Mapping Center Award (UM1HG009375).	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; Benner C, 2015, P NATL ACAD SCI USA, V112, P12776, DOI 10.1073/pnas.1512995112; Bevington S, 2013, EMBO J, V32, P1381, DOI 10.1038/emboj.2013.42; Bolland DJ, 2007, MOL CELL BIOL, V27, P5523, DOI 10.1128/MCB.02407-06; Bolland DJ, 2016, CELL REP, V15, P2475, DOI 10.1016/j.celrep.2016.05.020; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Choi NM, 2013, J IMMUNOL, V191, P2393, DOI 10.4049/jimmunol.1301279; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cowell LG, 2003, J EXP MED, V197, P207, DOI 10.1084/jem.20020250; Cowell LG, 2002, GENOME BIOL, V3; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gapud EJ, 2011, J IMMUNOL, V187, P1826, DOI 10.4049/jimmunol.1101388; GAUSS GH, 1992, GENE DEV, V6, P1553, DOI 10.1101/gad.6.8.1553; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hu JZ, 2016, NAT PROTOC, V11, P853, DOI 10.1038/nprot.2016.043; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Jain S, 2018, CELL, V174, P102, DOI 10.1016/j.cell.2018.04.035; Kim MS, 2015, NATURE, V518, P507, DOI 10.1038/nature14174; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin SG, 2018, ADV IMMUNOL, V139, P93, DOI 10.1016/bs.ai.2018.07.001; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Marinov GK, 2017, METHODS MOL BIOL, V1543, P3, DOI 10.1007/978-1-4939-6716-2_1; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Merelli I, 2010, NUCLEIC ACIDS RES, V38, pW262, DOI 10.1093/nar/gkq391; Predeus AV, 2014, J IMMUNOL, V192, P1064, DOI 10.4049/jimmunol.1302800; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; SOLLBACH AE, 1995, MOL CELL BIOL, V15, P671; Teng G, 2015, ADV IMMUNOL, V128, P1, DOI 10.1016/bs.ai.2015.07.002; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; WOOD C, 1983, P NATL ACAD SCI-BIOL, V80, P3030, DOI 10.1073/pnas.80.10.3030; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Zhao LJ, 2016, J EXP MED, V213, P1921, DOI 10.1084/jem.20160670	44	65	66	1	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					600	+		10.1038/s41586-019-1547-y	http://dx.doi.org/10.1038/s41586-019-1547-y			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31511698	Green Accepted, Green Submitted			2022-12-28	WOS:000488247600062
J	Rubin, R				Rubin, Rita			"Smoldering" Brain Lesions Might Signal Severe Multiple Sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1133	1133		10.1001/jama.2019.14344	http://dx.doi.org/10.1001/jama.2019.14344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550013				2022-12-28	WOS:000488822800004
J	Fernandes, A; Connors, JM; Carrier, M				Fernandes, Amanda; Connors, Jean M.; Carrier, Marc			Anticoagulation for Subsegmental Pulmonary Embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECURRENT VENOUS THROMBOEMBOLISM; DIRECT ORAL ANTICOAGULANTS; RISK; RULE; PROBABILITY; MULTICENTER; MANAGEMENT; DIAGNOSIS	This interactive feature about a patient with a single subsegmental pulmonary embolus offers a case vignette accompanied by essays that either support or discourage the use of anticoagulation therapy for this type of embolism.	[Fernandes, Amanda] Brown Univ, Dept Endocrinol, Warren Alpert Med Sch, Providence, RI 02912 USA; [Connors, Jean M.] Brigham & Womens Hosp, Dept Hematol, 75 Francis St, Boston, MA 02115 USA; [Carrier, Marc] Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada	Brown University; Harvard University; Brigham & Women's Hospital; University of Ottawa; Ottawa Hospital Research Institute	Fernandes, A (corresponding author), Brown Univ, Dept Endocrinol, Warren Alpert Med Sch, Providence, RI 02912 USA.			Carrier, Marc/0000-0001-8296-2972				Bariteau A, 2018, ACAD EMERG MED, V25, P828, DOI 10.1111/acem.13399; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; den Exter PL, 2013, BLOOD, V122, P1144, DOI 10.1182/blood-2013-04-497545; Ghanima W, 2007, ACTA RADIOL, V48, P165, DOI 10.1080/02841850601100859; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Louzada ML, 2012, CIRCULATION, V126, P448, DOI 10.1161/CIRCULATIONAHA.111.051920; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Salaun PY, 2011, CHEST, V139, P1294, DOI 10.1378/chest.10-1209; Singer AJ, 2019, AM J EMERG MED, V37, P33, DOI 10.1016/j.ajem.2018.04.040; Stein PD, 1997, CHEST, V111, P1246, DOI 10.1378/chest.111.5.1246; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van der Hulle T, 2016, J THROMB HAEMOST, V14, P105, DOI 10.1111/jth.13172; van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1; van Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04571232, 10.1182/blood-2014-04-571232]; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Wu C, 2015, THROMB RES, V135, P243, DOI 10.1016/j.thromres.2014.10.033	17	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1171	1174		10.1056/NEJMclde1907665	http://dx.doi.org/10.1056/NEJMclde1907665			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4PY	31532966				2022-12-28	WOS:000487066900015
J	Goldstein, JL				Goldstein, Joseph L.			Seurat's Dots: A Shot Heard 'Round the Art World-Fired by an Artist, Inspired by a Scientist	CELL			English	Editorial Material								The iconic phrase "a shot heard 'round the world'' signifies an exceptional event. Seurat's masterpiece La Grande Jatte, painted with many thousand dots of color, came as a shot to the art world-a shot fired by the imagination of the artist and inspired by the color theories of a scientist.	[Goldstein, Joseph L.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu						Burleigh R., 2004, SEURAT GRANDE JATTE; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carmichael E B, 1973, Ala J Med Sci, V10, P223; Emerson R. W., 1996, CONCORD HYMN OTHER P; Foa M., 2015, G SEURAT ART VISION; Goldstein R., 2010, NY TIMES; Herbert R. L., 2004, SEURAT MAKING GRANDE; Lemay P., 1948, J CHEM EDUC, V25, P62, DOI DOI 10.1021/ED025P62; Loske A., 2019, COLOR VISUAL HIST NE; Rich Frank., NEW YORK TIMES, pC21; Richardson Jr R. D., 2015, EMERSON MIND FIRE; Roque G., 2011, CHEVRUELS COLOUR THE; Saatchi C., 2017, TELEGRAPH	13	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					46	50		10.1016/j.cell.2019.07.051	http://dx.doi.org/10.1016/j.cell.2019.07.051			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31519312	Bronze			2022-12-28	WOS:000486618500010
J	Roll-Mecak, A				Roll-Mecak, Antonina			A Microtubule-Myelination Connection	CELL			English	Editorial Material								Microtubules are critical for the extension of oligodendrocyte processes and myelin deposition, yet our knowledge of their microtubule biogenesis is limited. In this issue of Cell, Fu et al. (2019) identify an oligodendrocyte-enriched microtubule regulator that promotes microtubule growth from Golgi outposts and controls myelin sheath elongation, linking microtubule cytoarchitecture and myelination in the CNS.	[Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Roll-Mecak, Antonina] NHLBI, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), NINDS, Cell Biol & Biophys Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Roll-Mecak, A (corresponding author), NHLBI, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	antonina@mail.nih.gov			National Institute of Neurological Disorders and Stroke (NINDS); National, Heart, Lung and Blood Institute (NHLBI)	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National, Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A.R.M. is supported by the intramural programs of the National Institute of Neurological Disorders and Stroke (NINDS) and the National, Heart, Lung and Blood Institute (NHLBI).	Auer F, 2018, CURR BIOL, V28, P549, DOI 10.1016/j.cub.2018.01.017; DEVRIES H, 1993, J NEUROSCI RES, V36, P336, DOI 10.1002/jnr.490360311; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Fu Y, 2019, PROTEINS, V87, P979, DOI 10.1002/prot.25760; Kaller MS, 2017, CURR OPIN NEUROBIOL, V47, P86, DOI 10.1016/j.conb.2017.09.014; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zuchero JB, 2015, DEV CELL, V34, P152, DOI 10.1016/j.devcel.2015.06.011	8	3	3	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					54	56		10.1016/j.cell.2019.08.046	http://dx.doi.org/10.1016/j.cell.2019.08.046			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31522889	Bronze			2022-12-28	WOS:000486618500012
J	Lipscombe, LL				Lipscombe, Lorraine L.			In patients >= 50 years with type 2 diabetes and CV disease or risk factors, dulaglutide reduced CV outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR OUTCOMES	Question In patients >= 50 years of age with type 2 diabetes and previous cardiovascular (CV) disease or risk factors, does dulaglutide reduce risk for CV events? Methods Design: Randomized placebo-controlled trial (Researching Cardiovascular Events with a Weekly Incretin in Diabetes [REWIND] trial). ClinicalTrials. gov NCT01394952. Allocation: Concealed.* Blinding: Blinded* (patients, {clinicians, data collectors, and outcome adjudicators}dagger). Follow-up period: Median 5.4 years. Setting: 371 clinical centers in 24 countries. Patients: 9901 adults >= 50 years of age (mean age 66 y, 54% men) who had type 2 diabetes mellitus, hemoglobin (Hb) A(1c) <= 9.5% on stable doses of <= 2 oral glucose-lowering drugs (with or without basal insulin therapy), and body mass index >= 23 kg/m(2), and completed a 3-week run-in period with 100% adherence to weekly placebo injections. Patients >= 50 years also hadto have vascular disease. Patients >= 55 years had to have myocardial ischemia; coronary, carotid, or lower-extremity artery stenosis > 50%; left ventricular hypertrophy; estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2); or albuminuria. Patients >= 60 years had to have >= 2 of tobacco use, dyslipidemia, hypertension, or abdominal obesity. Exclusion criteria included eGFR < 15 mL/min/1.73 m2, plans for revascularization, a coronary or cerebrovascular event in the past 2 months, severe hypoglycemia in the past year, cancer in the past 5 years, or life expectancy < 1 year. Intervention: Subcutaneous dulaglutide, 1.5 mg once per week (n = 4949), or placebo (n = 4952), via preloaded syringes. Outcomes: A composite of nonfatal myocardial infarction (MI), nonfatal stroke, or death from CV or unknown causes. Secondary outcomes included components of the primary composite outcome, fatal MI, fatal stroke, non-CV death, all-cause death, hospitalization for heart failure or urgent visit, hospitalization for unstable angina, microvascular eye outcomes (photocoagulation, antivascular endothelial growth factor therapy, or vitrectomy), microvascular renal outcomes (new macroalbuminuria, sustained decline in eGFR >= 30% from baseline, or long-term renal replacement therapy), study drug discontinuation, and adverse events. Patient follow-up: 97% (intention-to-treat analysis). Main results The significant efficacy results are in the Table; groups did not differ for other outcomes. Conclusion In patients >= 50 years of age with type 2 diabetes and previous cardiovascular (CV) disease or risk factors, dulaglutide reduced risk for CV outcomes compared with placebo.	[Lipscombe, Lorraine L.] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada.			Lipscombe, Lorraine/0000-0001-7412-7993				Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Reaven PD, 2019, NEW ENGL J MED, V380, P2215, DOI 10.1056/NEJMoa1806802; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V321, P1466, DOI 10.1001/jama.2019.2942; Sposito AC, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0800-2; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	6	0	0	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC27	JC29		10.7326/ACPJ201909170-027	http://dx.doi.org/10.7326/ACPJ201909170-027			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525761				2022-12-28	WOS:000486101400003
J	Biamonte, JD; Dorozhkin, P; Zacharov, I				Biamonte, Jacob D.; Dorozhkin, Pavel; Zacharov, Igor			Keep quantum computing global and open	NATURE			English	Editorial Material									[Biamonte, Jacob D.] Skolkovo Inst Sci & Technol, Moscow, Russia; [Dorozhkin, Pavel] Skolkovo Inst Sci & Technol, Ind Programmes Dept, Moscow, Russia; [Zacharov, Igor] Skolkovo Inst Sci & Technol, Deep Quantum Lab, Moscow, Russia	Skolkovo Institute of Science & Technology; Skolkovo Institute of Science & Technology; Skolkovo Institute of Science & Technology	Biamonte, JD (corresponding author), Skolkovo Inst Sci & Technol, Moscow, Russia.	j.biamonte@skoltech.ru	Zacharov, Igor/GLN-6099-2022; Biamonte, Jacob Daniel/U-8622-2019; Solodushenkova, Anastasia/H-1732-2019	Zacharov, Igor/0000-0002-3256-6514; Biamonte, Jacob Daniel/0000-0002-0590-3327; 				Biamonte J, 2017, NATURE, V549, P195, DOI 10.1038/nature23474; Giles M., 2019, MIT TECHNOL REV; Kandala A, 2017, NATURE, V549, P242, DOI 10.1038/nature23879; Leddy C., 2019, MIT NEWS; Mervis J, 2019, SCIENCE, DOI [10.1126/science.aaw9541, DOI 10.1126/SCIENCE.AAW9541]; Metz C., 2018, NY TIMES; National Academies of Sciences Engineering and Medicine, 2019, QUANT COMP PROGR PRO; Preskill J, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-08-06-79	8	4	4	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					190	191		10.1038/d41586-019-02675-5	http://dx.doi.org/10.1038/d41586-019-02675-5			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511667				2022-12-28	WOS:000485415400030
J	Nam, HH; Ison, MG				Nam, Hannah H.; Ison, Michael G.			Respiratory syncytial virus infection in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CELL TRANSPLANT RECIPIENTS; HEMATOPOIETIC STEM-CELL; FACTORS DETERMINING PROGRESSION; COMMUNITY-ACQUIRED PNEUMONIA; REVERSE TRANSCRIPTION-PCR; RSV FUSION INHIBITOR; VIRAL-INFECTIONS; AEROSOLIZED RIBAVIRIN; HUMAN METAPNEUMOVIRUS; INFLUENZA-VIRUS	Human respiratory syncytial virus (RSV) belongs to the recently defined Pneumoviridae family, Orthopneumovirus genus. It is a negative sense, single stranded RNA virus that results in epidemics of respiratory infections that typically peak in the winter in temperate climates and during the rainy season in tropical climates. Generally, one of the two genotypes (A and B) predominates in a single season, alternating annually, although regional variation occurs. RSV is a cause of disease and death in children, older people, and immunocompromised patients, and its clinical effect on adults admitted to hospital is clarified with expanded use of multiplex molecular assays. Among adults, RSV produces a wide range of clinical symptoms including upper respiratory tract infections, severe lower respiratory tract infections, and exacerbations of underlying disease. Here we discuss the latest evidence on the burden of RSV related disease in adults, especially in those with immunocompromise or other comorbidities. We review current therapeutic and prevention options, as well as those in development.	[Nam, Hannah H.; Ison, Michael G.] Northwestern Univ, Feinberg Sch Med, Div Infect Dis & Organ Transplantat, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ison, MG (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Infect Dis & Organ Transplantat, Chicago, IL 60611 USA.	mgison@northwestern.edu	Nam, Hannah/ABX-8674-2022		 [T32 AI095207]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095207] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HHN is supported through T32 AI095207.	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; AGAH R, 1987, AM J DIS CHILD, V141, P695, DOI 10.1001/archpedi.1987.04460060111049; Al-Toum R, 2006, J TROP PEDIATRICS, V52, P282, DOI 10.1093/tropej/fml002; Amirthalingam G, 2014, LANCET, V384, P1521, DOI 10.1016/S0140-6736(14)60686-3; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Ariza-Heredia EJ, 2012, TRANSPL INFECT DIS, V14, P64, DOI 10.1111/j.1399-3062.2011.00673.x; Battles MB, 2016, NAT CHEM BIOL, V12, P87, DOI [10.1038/nchembio.1982, 10.1038/NCHEMBIO.1982]; Beaird OE, 2016, TRANSPL INFECT DIS, V18, P210, DOI 10.1111/tid.12510; Beckhaus AA, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0225; Beigel JH, 2019, ANTIVIR RES, V167, P45, DOI 10.1016/j.antiviral.2019.04.006; Belperio John A, 2009, Proc Am Thorac Soc, V6, P108, DOI 10.1513/pats.200807-073GO; Binder W, 2017, AM J EMERG MED, V35, P1162, DOI 10.1016/j.ajem.2017.06.022; Blaschke AJ, 2017, OPEN FORUM INFECT DI, V4, pS354, DOI [10.1093/ofid/ofx163.857, DOI 10.1093/OFID/OFX163.857]; Boeckh M, 2007, CLIN INFECT DIS, V44, P245, DOI 10.1086/509930; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Branche AR, 2015, DRUG AGING, V32, P261, DOI 10.1007/s40266-015-0258-9; Branche AR, 2014, J CLIN MICROBIOL, V52, P3590, DOI 10.1128/JCM.01523-14; Brandenburg AH, 1997, J MED VIROL, V52, P97, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;97::AID-JMV16&gt;3.0.CO;2-Y; Broadbent L, 2015, INFLUENZA OTHER RESP, V9, P169, DOI 10.1111/irv.12313; Burrows FS, 2015, J HEART LUNG TRANSPL, V34, P958, DOI 10.1016/j.healun.2015.01.009; Capella C, 2017, J INFECT DIS, V216, P1398, DOI 10.1093/infdis/jix489; Casiano-Colon AE, 2003, J CLIN VIROL, V28, P169, DOI 10.1016/S1386-6532(03)00002-7; Centers for Disease Control and Prevention, 2018, FDA CLEARED RT PCR A; Challa S, 2015, ANTIMICROB AGENTS CH, V59, P1080, DOI 10.1128/AAC.04119-14; CHANOCK R, 1957, AM J HYG, V66, P291, DOI 10.1093/oxfordjournals.aje.a119902; Chartrand C, 2015, J CLIN MICROBIOL, V53, P3738, DOI 10.1128/JCM.01816-15; Chatzis O, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3002-3; Chavez-Bueno S, 2007, PEDIATR INFECT DIS J, V26, P1089, DOI 10.1097/INF.0b013e3181343b7e; Chemaly RF, 2016, TRANSPL INFECT DIS, V18, P634, DOI 10.1111/tid.12551; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; Chemaly RF, 2014, CLIN INFECT DIS, V59, pS344, DOI 10.1093/cid/ciu623; Chemaly RF, 2012, J INFECT DIS, V206, P1367, DOI 10.1093/infdis/jis516; Cho CH, 2014, DIAGN MICR INFEC DIS, V79, P14, DOI 10.1016/j.diagmicrobio.2014.01.016; Choi EH, 2013, CURR TOP MICROBIOL, V372, P121, DOI 10.1007/978-3-642-38919-1_6; Choudhuri JA, 2006, PEDIATRICS, V117, P349, DOI 10.1542/peds.2004-2795; Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316; Cohen R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214517; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Colosia AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182321; Cortez K, 2002, J INFECT DIS, V186, P834, DOI 10.1086/342412; Cullen LM, 2017, HUM VACC IMMUNOTHER, V13, P2814, DOI 10.1080/21645515.2017.1329069; Damasio GAC, 2015, J MED VIROL, V87, P1456, DOI 10.1002/jmv.24210; de Fontbrune FS, 2007, CLIN INFECT DIS, V45, P1019, DOI 10.1086/521912; DeVicenzo T, 2018, AM J RESP CRIT CARE, V197, pA7715; DeVincenzo JP, 2015, NEW ENGL J MED, V373, P2048, DOI 10.1056/NEJMoa1413275; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Domachowske JB, 2018, PEDIATR INFECT DIS J, V37, P886, DOI [10.1097/inf.0000000000001916, 10.1097/INF.0000000000001916]; Espinosa Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030654; Falsey AR, 2006, J MED VIROL, V78, P1493, DOI 10.1002/jmv.20724; Falsey AR, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12657; Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839; Falsey AR, 2006, J CLIN VIROL, V35, P46, DOI 10.1016/j.jcv.2005.04.004; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; Falsey AR, 2002, J CLIN MICROBIOL, V40, P817, DOI 10.1128/JCM.40.3.817-820.2002; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Fedechkin SO, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3534; FISHAUT M, 1980, J PEDIATR-US, V96, P179, DOI 10.1016/S0022-3476(80)80799-2; Foolad F, 2019, CLIN INFECT DIS, V68, P1641, DOI 10.1093/cid/ciy760; French CE, 2016, INFLUENZA OTHER RESP, V10, P268, DOI 10.1111/irv.12379; Fuentes S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005554; Gadsby NJ, 2010, J CLIN MICROBIOL, V48, P2213, DOI 10.1128/JCM.02446-09; Gan SW, 2008, PROTEIN SCI, V17, P813, DOI 10.1110/ps.073366208; Garcia-Maurino C, 2019, J INFECT DIS, V219, P1207, DOI 10.1093/infdis/jiy655; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Gharabaghi F, 2011, CLIN MICROBIOL INFEC, V17, P1900, DOI 10.1111/j.1469-0691.2011.03529.x; Ghosh S, 2000, BONE MARROW TRANSPL, V25, P751, DOI 10.1038/sj.bmt.1702228; Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879; Glanville AR, 2005, J HEART LUNG TRANSPL, V24, P2114, DOI 10.1016/j.healun.2005.06.027; Gottlieb J, 2018, J HEART LUNG TRANSPL, V37, pS155, DOI 10.1016/j.healun.2018.01.375; Grad YH, 2014, J VIROL, V88, P7286, DOI 10.1128/JVI.00038-14; Graham BS, 2017, CURR OPIN VIROL, V23, P107, DOI 10.1016/j.coviro.2017.03.012; Graham BS, 2015, CURR OPIN IMMUNOL, V35, P30, DOI 10.1016/j.coi.2015.04.005; Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16; GROOTHUIS JR, 1995, PEDIATRICS, V95, P463; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; Hall CB, 2000, CLIN INFECT DIS, V31, P590, DOI 10.1086/313960; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; HALL CB, 1983, JAMA-J AM MED ASSOC, V249, P2666, DOI 10.1001/jama.249.19.2666; HALL CB, 1981, AM J DIS CHILD, V135, P512, DOI 10.1001/archpedi.1981.02130300012006; HALL CB, 1981, J PEDIATR-US, V99, P100, DOI 10.1016/S0022-3476(81)80969-9; Hanfelt-Goade D, 2018, AMERICAN THORACIC SO; Healy CM, 2012, CLIN OBSTET GYNECOL, V55, P474, DOI 10.1097/GRF.0b013e31824f3acb; HEGELE RG, 1995, AM J RESP CRIT CARE, V151, P1659; Hirsch HH, 2013, CLIN INFECT DIS, V56, P258, DOI 10.1093/cid/cis844; Ivey KS, 2018, J AM COLL CARDIOL, V71, P1574, DOI 10.1016/j.jacc.2018.02.013; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Johnson TR, 2014, MOL THER, V22, P196, DOI 10.1038/mt.2013.142; Karnik SC, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4271; Kassis C, 2010, BIOL BLOOD MARROW TR, V16, P1265, DOI 10.1016/j.bbmt.2010.03.011; Khanna N, 2008, CLIN INFECT DIS, V46, P402, DOI 10.1086/525263; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim YJ, 2014, J INFECT DIS, V209, P1195, DOI 10.1093/infdis/jit832; Kim YI, 2017, INFLUENZA OTHER RESP, V11, P525, DOI 10.1111/irv.12503; Knudson CJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004757; Krzyzaniak MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003309; Landry ML, 2014, J CLIN MICROBIOL, V52, P3057, DOI 10.1128/JCM.00738-14; LECLAIR JM, 1987, NEW ENGL J MED, V317, P329, DOI 10.1056/NEJM198708063170601; Lee N, 2013, CLIN INFECT DIS, V57, P1069, DOI 10.1093/cid/cit471; Lewinsohn DM, 1996, ANTIMICROB AGENTS CH, V40, P2555, DOI 10.1128/AAC.40.11.2555; Li L, 2012, J HEART LUNG TRANSPL, V31, P839, DOI 10.1016/j.healun.2012.04.002; Liang B, 2016, J VIROL, V90, P10022, DOI 10.1128/JVI.01196-16; Liao RS, 2009, J CLIN MICROBIOL, V47, P527, DOI 10.1128/JCM.01213-08; Lieberman D, 2010, CHEST, V138, P811, DOI 10.1378/chest.09-2717; Liu V, 2010, TRANSPL INFECT DIS, V12, P38, DOI 10.1111/j.1399-3062.2009.00453.x; Ljungman P, 2014, J INFECT DIS, V209, P1151, DOI 10.1093/infdis/jit833; Lopez-Medrano F, 2007, TRANSPLANTATION, V84, P851, DOI 10.1097/01.tp.0000282788.70383.8b; Loubet P, 2017, CLIN MICROBIOL INFEC, V23, P253, DOI 10.1016/j.cmi.2016.11.014; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Manuel O, 2019, CLIN TRANSPLANT, V33, DOI 10.1111/ctr.13511; Marcelin JR, 2014, TRANSPL INFECT DIS, V16, P242, DOI 10.1111/tid.12194; Martinello RA, 2002, J INFECT DIS, V186, P839, DOI 10.1086/342414; MartinonTorres F, 2018, IDWEEK 2018 OCT 3 7, DOI [10.1093/ofid/ofy210.1614, DOI 10.1093/OFID/OFY210.1614]; McCarthy AJ, 1999, BONE MARROW TRANSPL, V24, P1315, DOI 10.1038/sj.bmt.1702078; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mehta J, 2013, COPD, V10, P293, DOI 10.3109/15412555.2012.744741; Milstone AP, 2006, EUR RESPIR J, V28, P131, DOI 10.1183/09031936.06.00105505; Mora AL, 2018, MABS-AUSTIN, V10, P778, DOI 10.1080/19420862.2018.1470727; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; MURPHY BR, 1986, J CLIN MICROBIOL, V23, P1009, DOI 10.1128/JCM.23.6.1009-1014.1986; MURPHY D, 1981, J PEDIATR-US, V99, P746, DOI 10.1016/S0022-3476(81)80401-5; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nichols WG, 2001, BIOL BLOOD MARROW TR, V7, p11S, DOI 10.1053/bbmt.2001.v7.pm11777098; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pangesti KNA, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1968; Pelaez A, 2009, J HEART LUNG TRANSPL, V28, P67, DOI 10.1016/j.healun.2008.10.008; Piedimonte G, 2014, PEDIATR REV, V35, P519, DOI 10.1542/pir.35-12-519; Popow-Kraupp Therese, 2011, Open Microbiol J, V5, P128, DOI 10.2174/1874285801105010128; Popowitch EB, 2015, J CLIN MICROBIOL, V53, P2720, DOI 10.1128/JCM.00972-15; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Raghunandan R, 2014, VACCINE, V32, P6485, DOI 10.1016/j.vaccine.2014.09.030; Randolph AG, 1996, ARCH PEDIAT ADOL MED, V150, P942, DOI 10.1001/archpedi.1996.02170340056011; Rima B, 2017, J GEN VIROL, V98, P2912, DOI 10.1099/jgv.0.000959; Roberts JN, 2016, VACCINE, V34, P4843, DOI 10.1016/j.vaccine.2016.07.057; Salez N, 2015, DIAGN MICR INFEC DIS, V81, P256, DOI 10.1016/j.diagmicrobio.2015.01.008; Schiffer JT, 2009, HAEMATOL-HEMATOL J, V94, P1101, DOI 10.3324/haematol.2008.003186; Schmidt MR, 2014, J VIROL, V88, P10165, DOI 10.1128/JVI.01250-14; Schwartz RH, 2015, PEDIATR EMERG CARE, V31, P830, DOI 10.1097/PEC.0000000000000371; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; Seo S, 2013, BIOL BLOOD MARROW TR, V19, P589, DOI 10.1016/j.bbmt.2012.12.019; Shadman KA, 2011, EXPERT OPIN BIOL TH, V11, P1455, DOI 10.1517/14712598.2011.608062; Shah DP, 2014, BLOOD, V123, P3263, DOI 10.1182/blood-2013-12-541359; Shah DP, 2013, J ANTIMICROB CHEMOTH, V68, P1872, DOI 10.1093/jac/dkt111; Shah JN, 2011, BLOOD, V117, P2755, DOI 10.1182/blood-2010-08-263400; Shi T, 2020, J INFECT DIS, V222, pS577, DOI 10.1093/infdis/jiz059; Siegel JD, 2007, GUIDELINE ISOLATION; Simoes EAF, 1998, J PEDIATR-US, V133, P492, DOI 10.1016/S0022-3476(98)70056-3; Simoes EAF, 2015, J INFECT DIS, V211, pS1, DOI 10.1093/infdis/jiu828; Simon A., 2012, EUR RESPIR J, V40, P1476; Sokol KA, 2016, TRANSPL INFECT DIS, V18, P965, DOI 10.1111/tid.12608; Stevens M, 2018, J INFECT DIS, V218, P748, DOI 10.1093/infdis/jiy227; Sundaram ME, 2014, CLIN INFECT DIS, V58, P342, DOI 10.1093/cid/cit767; Sung AD, 2016, CLIN INFECT DIS, V63, P999, DOI 10.1093/cid/ciw451; TABER LH, 1983, PEDIATRICS, V72, P613; Talbot HK, 2010, CLIN INFECT DIS, V50, P747, DOI 10.1086/650486; Taleb SA, 2018, EUR J CLIN MICROBIOL, V37, P1817, DOI 10.1007/s10096-018-3289-4; Taylor G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5757; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Timbrook T, 2015, INFECT DIS THER, V4, P297, DOI 10.1007/s40121-015-0087-5; Trang TP, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12844; Tripp RA, 2018, J VIROL, V92, DOI 10.1128/JVI.01302-17; Van Heeke G, 2017, PHARMACOL THERAPEUT, V169, P47, DOI 10.1016/j.pharmthera.2016.06.012; Vekemans J, 2019, VACCINE, V37, P7394, DOI 10.1016/j.vaccine.2017.09.092; Volling C, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0665-2; Waghmare A, 2013, CLIN INFECT DIS, V57, P1731, DOI 10.1093/cid/cit639; WALD TG, 1995, J AM GERIATR SOC, V43, P170, DOI 10.1111/j.1532-5415.1995.tb06384.x; Walsh E.E., 2015, MANDELL DOUGLAS BENN, P1948; Walsh EE, 2007, J INFECT DIS, V195, P1046, DOI 10.1086/511986; Wasserman RL, 2017, EXPERT REV CLIN IMMU, V13, P1107, DOI 10.1080/1744666X.2017.1389647; Weigt SS, 2011, SEMIN RESP CRIT CARE, V32, P471, DOI 10.1055/s-0031-1283286; Weinberg A, 2010, TRANSPL INFECT DIS, V12, P330, DOI 10.1111/j.1399-3062.2010.00509.x; WELLIVER RC, 1994, J INFECT DIS, V170, P425, DOI 10.1093/infdis/170.2.425; Welliver TP, 2008, PEDIATR INFECT DIS J, V27, pS92, DOI 10.1097/INF.0b013e318168b706; Widjojoatmodjo MN, 2015, VACCINE, V33, P5406, DOI 10.1016/j.vaccine.2015.08.056; Widmer K, 2014, INFLUENZA OTHER RESP, V8, P347, DOI 10.1111/irv.12234; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705; Zaia J, 2009, BONE MARROW TRANSPL, V44, P471, DOI 10.1038/bmt.2009.258; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	186	70	75	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5021	10.1136/bmj.l5021	http://dx.doi.org/10.1136/bmj.l5021			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506273				2022-12-28	WOS:000486648900002
J	Webster, K; Fishburn, S; Maresh, M; Findlay, SC; Chappell, LC; Barclay, P; Beswick, S; Chong, A; Clark, M; Harding, C; Mainie, P; Parisaei, M; Smith, L; Tighe, M; Trivedi, A; Wu, P				Webster, Katie; Fishburn, Sarah; Maresh, Mike; Findlay, Sarah C.; Chappell, Lucy C.; Barclay, Philip; Beswick, Sarah; Chong, Alena; Clark, Maria; Harding, Christine; Mainie, Pramod; Parisaei, Maryam; Smith, Lisa; Tighe, Mark; Trivedi, Ashifa; Wu, Pensee		Guideline Comm	Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Webster, Katie; Fishburn, Sarah; Maresh, Mike] Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London, England; [Chappell, Lucy C.] Kings Coll London, London, England	University of London; King's College London	Chappell, LC (corresponding author), Kings Coll London, London, England.	lucy.chappell@kcl.ac.uk	Wu, Pensée/ABD-2931-2020; Chappell, Lucy/U-4778-2018	Wu, Pensée/0000-0003-0011-5636; Chappell, Lucy/0000-0001-6219-3379	National Institute for Health and Care Excellence	National Institute for Health and Care Excellence	The National Guideline Alliance was commissioned and funded by the National Institute for Health and Care Excellence to develop this guideline and write this BMJ summary.	National Institute for Health and Care Excellence, HYP AD DIAGN MAN; National Institute for Health and Care Excellence, 2018, STOP SMOK INT SERV; National Institute for Health and Care Excellence, OB PREV; National Institute for Health and Care Excellence, PRET LAB BIRTH; National Institute for Health and Care Excellence, 2019, HYP PREGN DIAGN MAN; National Institute for Health and Care Excellence, 2016, PLGF BAS TEST HELP D; National Institute for Health and Care Excellence, 2010, CARD DIS PREV; National Institute for Health and Care Excellence, ANT CAR UNC PREGN	8	101	111	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5119	10.1136/bmj.l5119	http://dx.doi.org/10.1136/bmj.l5119			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501137				2022-12-28	WOS:000486648500001
J	Stevens, WW				Stevens, Whitney W.			A new treatment for chronic rhinosinusitis with nasal polyps	LANCET			English	Editorial Material							MEPOLIZUMAB		[Stevens, Whitney W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Stevens, WW (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	whitney-stevens@northwestern.edu			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	I have previously served on an advisory board discussing biomarkers in airway diseases sponsored by GlaxoSmithKline.	Akinlade B, 2019, BRIT J DERMATOL, V181, P459, DOI 10.1111/bjd.17869; Bachert C, 2019, LANCET, V394, P1638, DOI 10.1016/S0140-6736(19)31881-1; Bachert C, 2017, J ALLERGY CLIN IMMUN, V140, P1024, DOI 10.1016/j.jaci.2017.05.044; Bhattacharyya N, 2019, LARYNGOSCOPE, V129, P1969, DOI 10.1002/lary.27852; Gevaert P, 2013, J ALLERGY CLIN IMMUN, V131, P110, DOI 10.1016/j.jaci.2012.07.047; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Laidlaw TM, 2019, LARYNGOSCOPE, V129, pE61, DOI 10.1002/lary.27564; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Stevens WW, 2019, J ALLER CL IMM-PRACT, V7, P2812, DOI 10.1016/j.jaip.2019.05.009; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Zhang Y, 2019, ALLERGY, V74, P131, DOI 10.1111/all.13489	12	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2019	394	10209					1595	1597		10.1016/S0140-6736(19)32133-6	http://dx.doi.org/10.1016/S0140-6736(19)32133-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JI8SM	31543427				2022-12-28	WOS:000493733600007
J	Heiser, S; Conway, PH; Rajkumar, R				Heiser, Scott; Conway, Patrick H.; Rajkumar, Rahul			Primary Care Selection: A Building Block for Value-Based Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In the context of "attribution gaps" that leave payers uncertain which physicians are to be credited with patient care quality and outcome measures in accountable care organization (ACO) payment models, this Viewpoint discusses the importance of patient selection of primary care providers to patient-centered value-based care, and changes CMS will need to implement to integrate the measure.	[Heiser, Scott; Conway, Patrick H.; Rajkumar, Rahul] Blue Cross Blue Shield North Carolina, 4713 Univ Dr,Bldg 700, Durham, NC 27701 USA		Heiser, S (corresponding author), Blue Cross Blue Shield North Carolina, 4713 Univ Dr,Bldg 700, Durham, NC 27701 USA.	scott.heiser@bcbsnc.com						Centers for Medicare & Medicaid Services, 2019, CMS9115P; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; McWilliams JM, 2018, NEW ENGL J MED, V379, P1139, DOI 10.1056/NEJMsa1803388; McWilliams JM, 2016, JAMA-J AM MED ASSOC, V316, P1711, DOI 10.1001/jama.2016.12049; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; Medicare Payment Advisory Commission, 2018, MEDPAC COMM CMSS PRO	6	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2019	322	16					1551	1552		10.1001/jama.2019.14190	http://dx.doi.org/10.1001/jama.2019.14190			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0VU	31513233				2022-12-28	WOS:000498673500010
J	Cooper, MD; Miller, JFAP				Cooper, Max Dale; Miller, Jacques F. A. P.			Discovery of 2 Distinctive Lineages of Lymphocytes, T Cells and B Cells, as the Basis of the Adaptive Immune System and Immunologic Function 2019 Albert Lasker Basic Medical Research Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THYMUS		[Cooper, Max Dale] Emory Univ, Sch Med, 1462 Clifton Rd,DSB 403C, Atlanta, GA 30322 USA; [Miller, Jacques F. A. P.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia	Emory University; Walter & Eliza Hall Institute	Cooper, MD (corresponding author), Emory Univ, Sch Med, 1462 Clifton Rd,DSB 403C, Atlanta, GA 30322 USA.							COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; COOPER MD, 1966, SCIENCE, V151, P471, DOI 10.1126/science.151.3709.471; Hirano M, 2013, NATURE, V501, P435, DOI 10.1038/nature12467; MILLER JF, 1961, LANCET, V2, P748; MILLER JFA, 1962, NATURE, V195, P1318, DOI 10.1038/1951318a0; MILLER JFAP, 1962, PROC R SOC SER B-BIO, V156, P415, DOI 10.1098/rspb.1962.0048; MITCHELL GF, 1968, J EXP MED, V128, P821, DOI 10.1084/jem.128.4.821	8	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1247	1248		10.1001/jama.2019.13815	http://dx.doi.org/10.1001/jama.2019.13815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31503279	Bronze			2022-12-28	WOS:000489331900007
J	Di Marco, M; Ferrier, S; Harwood, TD; Hoskins, AJ; Watson, JEM				Di Marco, Moreno; Ferrier, Simon; Harwood, Tom D.; Hoskins, Andrew J.; Watson, James E. M.			Wilderness areas halve the extinction risk of terrestrial biodiversity	NATURE			English	Article							LAND-USE; DIVERSITY; RESPONSES	Reducing the rate of global biodiversity loss is a major challenge facing humanity(1), as the consequences of biological annihilation would be irreversible for humankind(2-4). Although the ongoing degradation of ecosystems(5,6) and the extinction of species that comprise them(7,8) are now well-documented, little is known about the role that remaining wilderness areas have in mitigating the global biodiversity crisis. Here we model the persistence probability of biodiversity, combining habitat condition with spatial variation in species composition, to show that retaining these remaining wilderness areas is essential for the international conservation agenda. Wilderness areas act as a buffer against species loss, as the extinction risk for species within wilderness communities is-on average-less than half that of species in non-wilderness communities. Although all wilderness areas have an intrinsic conservation value(9,10), we identify the areas on every continent that make the highest relative contribution to the persistence of biodiversity. Alarmingly, these areas-in which habitat loss would have a more-marked effect on biodiversity-are poorly protected. Given globally high rates of wilderness loss(10), these areas urgently require targeted protection to ensure the long-term persistence of biodiversity, alongside efforts to protect and restore more-degraded environments.	[Di Marco, Moreno] CSIRO Land & Water, Dutton Pk EcoSci Precinct, Brisbane, Qld, Australia; [Di Marco, Moreno] Sapienza Univ Rome, Dept Biol & Biotechnol, Rome, Italy; [Ferrier, Simon; Harwood, Tom D.] CSIRO Land & Water, Black Mt Labs, Canberra, ACT, Australia; [Hoskins, Andrew J.] James Cook Univ, CSIRO Hlth & Biosecur, Townsville, Qld, Australia; [Watson, James E. M.] Univ Queensland, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Watson, James E. M.] Wildlife Conservat Soc, Global Conservat Program, New York, NY USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Sapienza University Rome; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; University of Queensland; Wildlife Conservation Society	Di Marco, M (corresponding author), CSIRO Land & Water, Dutton Pk EcoSci Precinct, Brisbane, Qld, Australia.; Di Marco, M (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol, Rome, Italy.	moreno.dimarco@gmail.com	Hoskins, Andrew/T-2694-2019; Harwood, Tom D/C-7271-2009; Watson, James Edward Maxwell/D-8779-2013; Ferrier, Simon/C-1490-2009; Di Marco, Moreno/J-4285-2012	Hoskins, Andrew/0000-0001-8907-6682; Harwood, Tom D/0000-0002-3855-5306; Watson, James Edward Maxwell/0000-0003-4942-1984; Ferrier, Simon/0000-0001-7884-2388; Di Marco, Moreno/0000-0002-8902-4193	University of Queensland [2017113325]; European Union's Horizon 2020 research and innovation programme (Marie Sklodowska-Curie grant) [793212]; CSIRO [2017113325]	University of Queensland(University of Queensland); European Union's Horizon 2020 research and innovation programme (Marie Sklodowska-Curie grant); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was funded by Research Agreement no. 2017113325 between CSIRO and the University of Queensland. M.D.M. acknowledges support from the European Union's Horizon 2020 research and innovation programme (Marie Sklodowska-Curie grant agreement no. 793212).	Allan JR, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.187; Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Amatulli G, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.40; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Butchart SHM, 2015, CONSERV LETT, V8, P329, DOI 10.1111/conl.12158; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CBD, 2010, C PART CONV BIOL DIV; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Chapman A, 2009, NUMBERS LIVING SPECI, P1; Chaudhary A, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082764; Clark JA, 2002, SCIENCE, V297, P191; COHEN J, 1988, NEW YORK TIMES BK R, P26; Di Marco M, 2019, GLOBAL CHANGE BIOL, V25, P2763, DOI 10.1111/gcb.14663; Di Marco M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07049-5; Di Marco M, 2017, GLOB ECOL CONSERV, V10, P32, DOI 10.1016/j.gecco.2017.01.008; DiMiceli C. M., 2017, ANN GLOBAL AUTOMATED; Drielsma M, 2007, ECOL MODEL, V202, P324, DOI 10.1016/j.ecolmodel.2006.10.016; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Ferrier S., 2012, CSIRO CLIMATE ADAPTI, V13; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Gorenflo LJ, 2012, P NATL ACAD SCI USA, V109, P8032, DOI 10.1073/pnas.1117511109; GRASS Development Team, 2017, GEOGRAPHIC RESOURCES; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill SLL, 2018, WORLDWIDE IMPACTS PR, DOI [10.1101/311787, DOI 10.1101/311787]; Hoskins A. J., 2019, SUPPORTING GLOBAL BI, DOI [10.1101/309377v3, DOI 10.1101/309377V3]; Hoskins AJ, 2016, ECOL EVOL, V6, P3040, DOI 10.1002/ece3.2104; Hudson LN, 2017, ECOL EVOL, V7, P145, DOI 10.1002/ece3.2579; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; IUCN & UNEP-WCMC, 2018, WORLD DAT PROT AR WD; Johnson CN, 2017, SCIENCE, V356, P270, DOI 10.1126/science.aam9317; Kim H, 2018, GEOSCI MODEL DEV, V11, P4537, DOI 10.5194/gmd-11-4537-2018; Leclere D, 2018, PATHWAYS BENDING CUR; Mappin B, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12646; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Newbold T, 2016, SCIENCE, V353, P288, DOI 10.1126/science.aaf2201; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pesaresi M., 2015, GHS BUILT UP GRID DE; Pimm SL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2616; Potapov P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600821; QGIS Development Team, 2019, QGIS GEOGR INF SYST; R Development Core Team, 2009, R LANG ENV STAT COMP; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Venter O, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.67; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Ware C, 2018, DIVERS DISTRIB, V24, P1333, DOI 10.1111/ddi.12766; Watson JEM, 2018, NATURE, V563, P27, DOI 10.1038/d41586-018-07183-6; Watson JEM, 2016, CONSERV LETT, V9, P413, DOI 10.1111/conl.12295; Watson JEM, 2016, CURR BIOL, V26, P2929, DOI 10.1016/j.cub.2016.08.049	50	84	86	23	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					582	+		10.1038/s41586-019-1567-7	http://dx.doi.org/10.1038/s41586-019-1567-7			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31534225				2022-12-28	WOS:000488247600058
J	Mathew, R				Mathew, Rammya			Rammya Mathew: Improving referrals isn't about rationing care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rammya.mathew@nhs.net						Taylor D., 2019, GUARDIAN	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5592	10.1136/bmj.l5592	http://dx.doi.org/10.1136/bmj.l5592			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551234	Bronze			2022-12-28	WOS:000488488300006
J	Ghebreyesus, TA				Ghebreyesus, Tedros Adhanom			The malaria eradication challenge	LANCET			English	Editorial Material									[Ghebreyesus, Tedros Adhanom] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Ghebreyesus, TA (corresponding author), WHO, CH-1211 Geneva, Switzerland.	DGOffice@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		African Union, 2019, AFR LEAD GATH LAUNCH; Feachem RGA, 2019, LANCET, V394, P1056, DOI 10.1016/S0140-6736(19)31139-0; Rabinovich RN, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002456; RBM Partnership to End Malaria-Vector Control Working Group, 2022, FOC M AN STEPH DEC 2; UN, 2015, 2030 AG SUST DEV; WHO, 2016, WORLD MAL REP 2016; WHO, 2019, GLOB MAL PROGR COUNT; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2019, STRAT ADV GROUP MAL; WHO, 2019, MAL VACC PIL LAUCH M; World Health Organization, 2018, WORLD MAL REP 2018; World Health Organization, 2017, ER MAL REP SECR	12	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					990	991		10.1016/S0140-6736(19)31951-8	http://dx.doi.org/10.1016/S0140-6736(19)31951-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31511197				2022-12-28	WOS:000487038700009
J	Cohen, D; Barnes, H				Cohen, Deborah; Barnes, Hannah			Gender dysphoria in children: puberty blockers study draws further criticism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUPPRESSION		[Cohen, Deborah; Barnes, Hannah] BBC Newsnight, London, England		Cohen, D (corresponding author), BBC Newsnight, London, England.	deborah.cohen02@bbc.co.uk						American Psychiatric Association, WHAT IS GEND DYSPH; [Anonymous], 2019, BMJ EBM SPOTLIGH FEB; Cohen D, 2019, BBC NEWS; de Vries ALC, 2011, J SEX MED, V8, P2276, DOI 10.1111/j.1743-6109.2010.01943.x; Doyle-Price J., 2019, BODY IMAGE MENTAL HL; Entwistle K., 2018, MEDIUM; Gender Identity Development Service, 2019, EPATH END UPD; Gilligan A., 2019, TIMES; Joseph T, 2019, J PEDIATR ENDOCR MET, V32, P1077, DOI 10.1515/jpem-2019-0046; Manning S, 2014, MAIL SUNDAY      MAY; Moore M, 2019, INVENTING TRANSGENDE; Phillips H., 2017, I WISH I KNEW THIS S; Royal College of General Practitioners, 2019, ROL GP CAR GEND QUES; Tavistock and Portman NHS Foundation Trust, 2019, GIDS REV ACT PLAN; Vlot MC, 2017, BONE, V95, P11, DOI 10.1016/j.bone.2016.11.008	15	6	6	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2019	366								l5647	10.1136/bmj.l5647	http://dx.doi.org/10.1136/bmj.l5647			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WG	31540909				2022-12-28	WOS:000487759700004
J	Dedden, D; Schumacher, S; Kelley, CF; Zacharias, M; Biertumpfel, C; Fassler, R; Mizuno, N				Dedden, Dirk; Schumacher, Stephanie; Kelley, Charlotte F.; Zacharias, Martin; Biertuempfel, Christian; Faessler, Reinhard; Mizuno, Naoko			The Architecture of Talin1 Reveals an Autoinhibition Mechanism	CELL			English	Article							INTEGRIN ACTIVATION; FERM DOMAIN; NANOSCALE ARCHITECTURE; VINCULIN ACTIVATION; STRUCTURAL BASIS; BINDING DOMAIN; CRYO-EM; ADHESION; HEAD; SITES	Focal adhesions (FAs) are protein machineries essential for cell adhesion, migration, and differentiation. Talin is an integrin-activating and tension-sensing FA component directly connecting integrins in the plasma membrane with the actomyosin cytoskeleton. To understand how talin function is regulated, we determined a cryoelectron microscopy (cryo-EM) structure of full-length talin1 revealing a two-way mode of autoinhibition. The actin-binding rod domains fold into a 15-nm globular arrangement that is interlocked by the integrin-binding FERM head. In turn d domains R9 and R12 shield access of the FERM domain to integrin and the phospholipid PIP2 at the membrane. This mechanism likely ensures synchronous inhibition of integrin, membrane, and cytoskeleton binding. We also demonstrate that compacted talin1 reversibly unfolds to an similar to 60-nm string-like conformation, revealing interaction sites for vinculin and actin. Our data explain how fast switching between active and inactive conformations of talin could regulate FA turnover, a process critical for cell adhesion and signaling.	[Dedden, Dirk; Schumacher, Stephanie; Kelley, Charlotte F.; Biertuempfel, Christian; Mizuno, Naoko] Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany; [Zacharias, Martin] Tech Univ Munich, Phys Dept T38, James Franck Str 1, D-85748 Garching, Germany; [Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18, D-82152 Martinsried, Germany	Max Planck Society; Technical University of Munich; Max Planck Society	Mizuno, N (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	mizuno@biochem.mpg.de	Mizuno, Naoko/AAY-1926-2021	Mizuno, Naoko/0000-0002-1594-2821; Schumacher, Stephanie/0000-0002-4113-1723	Max Planck Society, Germany; Boehringer Ingelheim Foundation Plus 3 Program, Germany; European Research Council (ERC-CoG), European Union [724209]; EMBO Young Investigator award; EMBO long-term fellowship [EMBO ALTF 450-2017]; Alexander von Humboldt (Germany)	Max Planck Society, Germany(Max Planck Society); Boehringer Ingelheim Foundation Plus 3 Program, Germany(Boehringer Ingelheim); European Research Council (ERC-CoG), European Union; EMBO Young Investigator award(European Molecular Biology Organization (EMBO)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Alexander von Humboldt (Germany)(Alexander von Humboldt Foundation)	We thank Carsten Grashoff and Giovanni Cardone for assistance at various stages of the project, Elena Conti, Wolfgang Baumeister, and the biochemistry-and cryo-EM core facilities for resources and infrastructure (Max Planck Institute of Biochemistry). N.M. acknowledges the Max Planck Society, Germany, Boehringer Ingelheim Foundation Plus 3 Program, Germany, and the European Research Council (ERC-CoG, 724209), European Union, for funding. N.M. is a recipient of the EMBO Young Investigator award. C.F.K. is supported by an EMBO long-term fellowship (EMBO ALTF 450-2017) and an Alexander von Humboldt (Germany) research fellowship for postdoctoral researchers.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Austen K, 2015, NAT CELL BIOL, V17, P1597, DOI 10.1038/ncb3268; Bachir AI, 2014, CURR BIOL, V24, P1845, DOI 10.1016/j.cub.2014.07.011; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Case LB, 2015, NAT CELL BIOL, V17, P880, DOI 10.1038/ncb3180; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chinthalapudi K, 2018, P NATL ACAD SCI USA, V115, P10339, DOI 10.1073/pnas.1806275115; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Desiniotis A, 2011, INT REV CEL MOL BIO, V289, P117, DOI 10.1016/B978-0-12-386039-2.00004-3; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Ellis SJ, 2013, CURR BIOL, V23, P1825, DOI 10.1016/j.cub.2013.07.054; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang KP, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2076-9; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; GOLDMANN WH, 1994, J STRUCT BIOL, V112, P3, DOI 10.1006/jsbi.1994.1002; Goult BT, 2018, J CELL BIOL, V217, P3776, DOI 10.1083/jcb.201808061; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Haining AWM, 2016, FASEB J, V30, P2073, DOI 10.1096/fj.201500080R; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hemmings L, 1996, J CELL SCI, V109, P2715; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kumar A, 2016, J CELL BIOL, V213, P371, DOI 10.1083/jcb.201510012; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MOLONY L, 1987, J BIOL CHEM, V262, P7790; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Orlowski A, 2015, J PHYS CHEM B, V119, P12381, DOI 10.1021/acs.jpcb.5b06457; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plak K, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-015-0078-0; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Sun ZQ, 2019, NAT CELL BIOL, V21, P25, DOI 10.1038/s41556-018-0234-9; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Winkler J, 1997, EUR J BIOCHEM, V243, P430, DOI 10.1111/j.1432-1033.1997.0430a.x; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Yao MX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04610; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zeiler M, 2014, MOL CELL PROTEOMICS, V13, P3435, DOI 10.1074/mcp.M114.038513; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01822-8; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	72	54	56	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					120	+		10.1016/j.cell.2019.08.034	http://dx.doi.org/10.1016/j.cell.2019.08.034			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539492	Green Published, hybrid			2022-12-28	WOS:000486618500018
J	Hawkes, N				Hawkes, Nigel			Sixty seconds on... prostate testing	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Xu L, 2019, J UROL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2019	366								l5608	10.1136/bmj.l5608	http://dx.doi.org/10.1136/bmj.l5608			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WD	31537551				2022-12-28	WOS:000487759400005
J	Iacobucci, G				Iacobucci, Gareth			Vaping among US teens has doubled since 2017	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Miech RA, 2019, MONITORING FUTURE NA, V1; Miech R, 2019, NEW ENGL J MED, V380, P192, DOI 10.1056/NEJMc1814130	2	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2019	366								l5653	10.1136/bmj.l5653	http://dx.doi.org/10.1136/bmj.l5653			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WD	31537611				2022-12-28	WOS:000487759400010
J	Sawyers, CL				Sawyers, Charles L.			Herceptin: A First Assault on Oncogenes that Launched a Revolution	CELL			English	Editorial Material							GROWTH-FACTOR-RECEPTOR; PLUS ADJUVANT CHEMOTHERAPY; MONOCLONAL-ANTIBODY; BREAST-CANCER; TRASTUZUMAB; GENE; AMPLIFICATION; EXPRESSION; SURVIVAL	This year's Lasker Clinical Research Award honors H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich for their invention of Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and for its development as a life-saving therapy for women with breast cancer.	[Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Human Oncol & Pathogenesis Program, New York, NY 10021 USA.	sawyersc@mskcc.org						Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Doi T, 2017, LANCET ONCOL, V18, P1512, DOI 10.1016/S1470-2045(17)30604-6; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124	18	12	14	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					8	12		10.1016/j.cell.2019.08.027	http://dx.doi.org/10.1016/j.cell.2019.08.027			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31519311	Bronze			2022-12-28	WOS:000486618500003
J	Xiang, JB; Shang, M; Kawamata, Y; Lundberg, H; Reisberg, SH; Chen, M; Mykhailiuk, P; Beutner, G; Collins, MR; Davies, A; Del Bel, M; Gallego, GM; Spangler, JE; Starr, J; Yang, SL; Blackmond, DG; Baran, PS				Xiang, Jinbao; Shang, Ming; Kawamata, Yu; Lundberg, Helena; Reisberg, Solomon H.; Chen, Miao; Mykhailiuk, Pavel; Beutner, Gregory; Collins, Michael R.; Davies, Alyn; Del Bel, Matthew; Gallego, Gary M.; Spangler, Jillian E.; Starr, Jeremy; Yang, Shouliang; Blackmond, Donna G.; Baran, Phil S.			Hindered dialkyl ether synthesis with electrogenerated carbocations	NATURE			English	Article							ELECTROCHEMICAL SYNTHESIS; ANODIC OXIDATION; ACID; ELECTROLYSIS; ALCOHOLS; CARBON	Hindered ethers are of high value for various applications; however, they remain an underexplored area of chemical space because they are difficult to synthesize via conventional reactions(1,2). Such motifs are highly coveted in medicinal chemistry, because extensive substitution about the ether bond prevents unwanted metabolic processes that can lead to rapid degradation in vivo. Here we report a simple route towards the synthesis of hindered ethers, in which electrochemical oxidation is used to liberate high-energy carbocations from simple carboxylic acids. These reactive carbocation intermediates, which are generated with low electrochemical potentials, capture an alcohol donor under non-acidic conditions; this enables the formation of a range of ethers (more than 80 have been prepared here) that would otherwise be difficult to access. The carbocations can also be intercepted by simple nucleophiles, leading to the formation of hindered alcohols and even alkyl fluorides. This method was evaluated for its ability to circumvent the synthetic bottlenecks encountered in the preparation of 12 chemical scaffolds, leading to higher yields of the required products, in addition to substantial reductions in the number of steps and the amount of labour required to prepare them. The use of molecular probes and the results of kinetic studies support the proposed mechanism and the role of additives under the conditions examined. The reaction manifold that we report here demonstrates the power of electrochemistry to access highly reactive intermediates under mild conditions and, in turn, the substantial improvements in efficiency that can be achieved with these otherwise-inaccessible intermediates.	[Xiang, Jinbao; Shang, Ming; Kawamata, Yu; Lundberg, Helena; Reisberg, Solomon H.; Chen, Miao; Mykhailiuk, Pavel; Blackmond, Donna G.; Baran, Phil S.] Scripps Res, Dept Chem, La Jolla, CA 92037 USA; [Xiang, Jinbao] Jilin Univ, Sch Pharmaceut Sci, Ctr Combinatorial Chem & Drug Discovery, Jilin, Jilin, Peoples R China; [Lundberg, Helena] KTH Royal Inst Technol, Dept Chem, Stockholm, Sweden; [Mykhailiuk, Pavel] Enamine Ltd, Kiev, Ukraine; [Mykhailiuk, Pavel] Taras Shevchenko Natl Univ Kyiv, Chem Dept, Kiev, Ukraine; [Beutner, Gregory] Bristol Myers Squibb, Chem & Synthet Dev, New Brunswick, NJ USA; [Collins, Michael R.; Del Bel, Matthew; Gallego, Gary M.; Spangler, Jillian E.; Yang, Shouliang] Pfizer Inc, Dept Chem, La Jolla Labs, San Diego, CA USA; [Davies, Alyn; Starr, Jeremy] Pfizer Med Sci, Groton, CT USA	Scripps Research Institute; Jilin University; Royal Institute of Technology; Enamine Ltd; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Bristol-Myers Squibb; Pfizer; Pfizer	Baran, PS (corresponding author), Scripps Res, Dept Chem, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Mykhailiuk, Pavel/K-8262-2012; Lundberg, Helena/U-1095-2018	Mykhailiuk, Pavel/0000-0003-1821-9011; Lundberg, Helena/0000-0002-4704-1892	Pfizer, Inc.; National Science Foundation (CCI Phase 1 grant) [1740656]; National Institutes of Health [GM-118176]; China Scholarship Council; Jilin University; Zhejiang Yuanhong Medicine Technology Co. Ltd; Hewitt Foundation; Swedish Research Council; Fulbright Fellowship; NSF Graduate Research Fellowship Program [2017237151]; Donald and Delia Baxter Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118176] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); National Science Foundation (CCI Phase 1 grant); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Jilin University(Jilin University); Zhejiang Yuanhong Medicine Technology Co. Ltd; Hewitt Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Fulbright Fellowship; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Donald and Delia Baxter Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by Pfizer, Inc., the National Science Foundation (CCI Phase 1 grant 1740656), and the National Institutes of Health (grant number GM-118176). China Scholarship Council and Jilin University supported a fellowship to J.X., Zhejiang Yuanhong Medicine Technology Co. Ltd supported a fellowship to M.S., The Hewitt Foundation supported a fellowship to Y.K., The Swedish Research Council supported a fellowship to H.L., Fulbright Fellowship supported a fellowship to P.M., and S.H.R. acknowledges an NSF Graduate Research Fellowship Program (no. 2017237151) and a Donald and Delia Baxter Fellowship. We thank D.-H. Huang and L. Pasternack for assistance with NMR spectroscopy; J. Chen for measuring the high-resolution mass spectroscopy data, and A. Rheingold, C. E. Moore and M. A. Galella for X-ray crystallographic analysis.	Abraham S, 2011, International patent, Patent No. [WO2011088045A1, 2011088045]; BEYERMAN HC, 1965, RECL TRAV CHIM PAY-B, V84, P203; BUNYAN PJ, 1962, J CHEM SOC, P1360, DOI 10.1039/jr9620001360; Coleman J. P, J CHEM SOC PERKIN T, V2, P1064; COREY EJ, 1960, J AM CHEM SOC, V82, P2645, DOI 10.1021/ja01495a066; EBERSON L, 1964, ACTA CHEM SCAND, V18, P1567, DOI 10.3891/acta.chem.scand.18-1567; Fischer J., 2006, ANALOGUE BASED DRUG, P206; Hofer H, 1902, LIEBIGS ANN CHEM, V323, P284; Huang XY, 2015, ANGEW CHEM INT EDIT, V54, P5241, DOI 10.1002/anie.201500399; IWASAKI T, 1979, B CHEM SOC JPN, V52, P826, DOI 10.1246/bcsj.52.826; IWASAKI T, 1977, J ORG CHEM, V42, P2419, DOI 10.1021/jo00434a015; KOEHL WJ, 1964, J AM CHEM SOC, V86, P4686, DOI 10.1021/ja01075a032; Kolbe H., 1847, J PRAKT CHEM, V41, P137, DOI DOI 10.1002/PRAC.18470410118; Kurti L, 2005, STRATEGIC APPL NAMED, P484; Luo XY, 2018, CHEM COMMUN, V54, P9969, DOI 10.1039/c8cc05843a; Mao RZ, 2018, ANGEW CHEM INT EDIT, V57, P13624, DOI 10.1002/anie.201808024; ROSS SD, 1969, J ORG CHEM, V34, P2923, DOI 10.1021/jo01262a027; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Sch?fer H.-J., 1990, TOP CURR CHEM, V152, P91, DOI DOI 10.1007/BFB0034365; Shtelman AV, 2011, J ORG CHEM, V76, P4710, DOI 10.1021/jo200254z; Smith M. B., 2007, MARCHS ADV ORGANIC C, P1037; Swamy KCK, 2009, CHEM REV, V109, P2551, DOI 10.1021/cr800278z; Tajima T, 2007, J AM CHEM SOC, V129, P6680, DOI 10.1021/ja070283w; TORII S, 1979, J ORG CHEM, V44, P2303, DOI 10.1021/jo01327a065; Williamson A. I., 1851, LIEBIGS ANN CHEM, V77, P37, DOI [10.1002/jlac.18510770104, DOI 10.1002/JLAC.18510770104]; Yan M, 2017, CHEM REV, V117, P13230, DOI 10.1021/acs.chemrev.7b00397	26	163	163	13	175	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					398	+		10.1038/s41586-019-1539-y	http://dx.doi.org/10.1038/s41586-019-1539-y			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31501569	Green Accepted			2022-12-28	WOS:000486647800046
J	Mahase, E				Mahase, Elisabeth			NHS opens eight walk-in FGM clinics across England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Digital, 2019, FEM GEN MUT APR JUN; NHS England, 2019, NHS RAMPS SUPP SURV	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2019	366								l5552	10.1136/bmj.l5552	http://dx.doi.org/10.1136/bmj.l5552			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MV	31515255				2022-12-28	WOS:000486649600011
J	Hawkes, N				Hawkes, Nigel			Pensions crisis: government sets out plans to give doctors more flexibility	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2019, NHS PENS SCHEM INCR; MAHASE E, 2019, BMJ-BRIT MED J, V366, P50357, DOI DOI 10.1136/BMJ.L5053	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2019	366								l5513	10.1136/bmj.l5513	http://dx.doi.org/10.1136/bmj.l5513			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MQ	31511235				2022-12-28	WOS:000486649100007
J	Agarwal, R; Rossignol, P; Romero, A; Garza, D; Mayo, MR; Warren, S; Ma, J; White, WB; Williams, B				Agarwal, Rajiv; Rossignol, Patrick; Romero, Alain; Garza, Dahlia; Mayo, Martha R.; Warren, Suzette; Ma, Jia; White, William B.; Williams, Bryan			Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							SERUM POTASSIUM; HYPERKALEMIA	Background Spironolactone is effective at reducing blood pressure in patients with uncontrolled resistant hypertension. However, the use of spironolactone in patients with chronic kidney disease can be restricted by hyperkalaemia. We evaluated use of the potassium binder patiromer to allow more persistent use of spironolactone in patients with chronic kidney disease and resistant hypertension. Methods In this phase 2 multicentre, randomised, double-blind, placebo-controlled study, we enrolled participants aged 18 years and older with chronic kidney disease (estimated glomerular filtration rate 25 to <= 45 mL/min per 1.73 m(2)) and uncontrolled resistant hypertension from 62 outpatient centres in ten countries (Bulgaria, Croatia, Georgia, Hungary, Ukraine, France, Germany, South Africa, the UK, and the USA). Patients meeting all eligibility criteria at the final screening visit were stratified by local serum potassium measurement (4.3 to <4.7 mmol/L vs 4.7 to 5.1 mmol/L) and history of diabetes. Participants were randomly assigned (1:1) with an interactive web response system to receive either placebo or patiromer (8.4 g once daily), in addition to open-label spironolactone (starting at 25 mg once daily) and their baseline blood pressure medications. Participants, the study team that administered treatments and measured blood pressure, and the investigators were masked to assigned treatment groups. Dose titrations were permitted after 1 week (patiromer) and 3 weeks (spironolactone). The primary endpoint was the between-group difference at week 12 in the proportion of patients on spironolactone. Efficacy endpoints and safety were assessed in all randomised patients (intention to treat). The study was registered with Clinicaltrials.gov, NCT03071263. Findings Between Feb 13, 2017, and Aug 20, 2018, we screened 574 patients. 295 (51%) of 574 patients met all inclusion criteria and were randomly assigned to spironolactone in addition to double-blind treatment with either placebo (n=148) or patiromer (n=147). At week 12, 98 (66%) of 148 patients in the placebo group and 126 (86%) of 147 patients in the patiromer group remained on spironolactone (between-group difference 19.5%, 95% CI 10.0-29.0; p<0.0001). Adverse events were mostly mild or moderate in severity and occurred in 79 (53%) of 148 patients in the placebo group and 82 (56%) of 147 patients in the patiromer group. Interpretation In patients with resistant hypertension and chronic kidney disease, patiromer enabled more patients to continue treatment with spironolactone with less hyperkalaemia. Persistent spironolactone enablement in this population of patients has clinical relevance for the treatment of resistant hypertension.	[Agarwal, Rajiv] Indiana Univ, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Agarwal, Rajiv] Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA; [Rossignol, Patrick] Univ Lorraine, Inserm 1433 CIC P, CHRU Nancy, Inserm U1116, Nancy, France; [Rossignol, Patrick] French Clin Res Infrastruct Network INI CRCT, Nancy, France; [Romero, Alain] Relypsa, Med Affairs, Redwood City, CA USA; [Garza, Dahlia; Mayo, Martha R.; Warren, Suzette] Relypsa, Clin Dev, Redwood City, CA USA; [Ma, Jia] Relypsa, Biometr, Redwood City, CA USA; [White, William B.] Univ Connecticut, Sch Med, Calhoun Cardiol Ctr, Farmington, CT USA; [Williams, Bryan] UCL, Inst Cardiovasc Sci, London, England; [Williams, Bryan] UCL Hosp Biomed Res Ctr, Natl Inst Hlth Res UCL, London, England	Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Connecticut; University of London; University College London; University of London; University College London	Agarwal, R (corresponding author), Indiana Univ, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA.; Agarwal, R (corresponding author), Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.	ragarwal@iu.edu	Agarwal, Rajiv/H-3454-2019	Agarwal, Rajiv/0000-0001-8355-7100; Williams, Bryan/0000-0002-8094-1841	Relypsa, a Vifor Pharma Group Company	Relypsa, a Vifor Pharma Group Company	Relypsa, a Vifor Pharma Group Company.	Agarwal R, 2018, AM J NEPHROL, V48, P172, DOI 10.1159/000492622; Agarwal R, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004536; Agarwal R, 2016, J AM SOC NEPHROL, V27, P924, DOI 10.1681/ASN.2015030243; Bakris GL, 2015, JAMA-J AM MED ASSOC, V314, P151, DOI 10.1001/jama.2015.7446; Bolignano D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007004.pub3; Dahal K, 2015, AM J HYPERTENS, V28, P1376, DOI 10.1093/ajh/hpv031; De Nicola L, 2013, J AM COLL CARDIOL, V61, P2461, DOI 10.1016/j.jacc.2012.12.061; Epstein M, 2015, LANCET DIABETES ENDO, V3, P993, DOI 10.1016/S2213-8587(15)00289-2; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Muntner P, 2019, HYPERTENSION, V73, pE35, DOI 10.1161/HYP.0000000000000087; Noubiap JJ, 2019, HEART, V105, P98, DOI 10.1136/heartjnl-2018-313599; Pergola PE, 2017, AM J NEPHROL, V46, P323, DOI 10.1159/000481270; Pitt B, 2011, EUR HEART J, V32, P820, DOI 10.1093/eurheartj/ehq502; Rossignol P, 2015, LANCET, V386, P1588, DOI 10.1016/S0140-6736(15)00418-3; US Food and Drug Administration, 2018, VELT PAT PRESCR INF; Weir MR, 2015, NEW ENGL J MED, V372, P211, DOI 10.1056/NEJMoa1410853; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Williams B, 2018, LANCET DIABETES ENDO, V6, P464, DOI 10.1016/S2213-8587(18)30071-8; Williams B, 2015, LANCET, V386, P2059, DOI 10.1016/S0140-6736(15)00257-3	20	149	155	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2019	394	10208					1540	1550		10.1016/S0140-6736(19)32135-X	http://dx.doi.org/10.1016/S0140-6736(19)32135-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI3WL	31533906	Green Submitted			2022-12-28	WOS:000493399500025
J	Stahl, A; Lepore, D; Fielder, A; Fleck, B; Reynolds, JD; Chiang, MF; Li, J; Liew, M; Maier, R; Zhu, Q; Marlow, N				Stahl, Andreas; Lepore, Domenico; Fielder, Alistair; Fleck, Brian; Reynolds, James D.; Chiang, Michael F.; Li, Jun; Liew, Melissa; Maier, Rainer; Zhu, Qi; Marlow, Neil			Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL BEVACIZUMAB; TYPE-1 RETINOPATHY; INJECTION; EFFICACY; PHARMACOKINETICS; OUTCOMES	Background Despite increasing worldwide use of anti-vascular endothelial growth factor agents for treatment of retinopathy of prematurity (ROP), there are few data on their ocular efficacy, the appropriate drug and dose, the need for retreatment, and the possibility of long-term systemic effects. We evaluated the efficacy and safety of intravitreal ranibizumab compared with laser therapy in treatment of ROP. Methods This randomised, open-label, superiority multicentre, three-arm, parallel group trial was done in 87 neonatal and ophthalmic centres in 26 countries. We screened infants with birthweight less than 1500 g who met criteria for treatment for retinopathy, and randomised patients equally (1:1:1) to receive a single bilateral intravitreal dose of ranibizumab 0.2 mg or ranibizumab 0.1 mg, or laser therapy. Individuals were stratified by disease zone and geographical region using computer interactive response technology. The primary outcome was survival with no active retinopathy, no unfavourable structural outcomes, or need for a different treatment modality at or before 24 weeks (two-sided alpha=0.05 for superiority of ranibizumab 0.2 mg against laser therapy). Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, NCT02375971. Interpretation Between Dec 31, 2015, and June 29, 2017, 225 participants (ranibizumab 0.2 mg n=74, ranibizumab 0.1 mg n=77, laser therapy n=74) were randomly assigned. Seven were withdrawn before treatment (n=1, n=1, n=5, respectively) and 17 did not complete follow-up to 24 weeks, including four deaths in each group. 214 infants were assessed for the primary outcome (n=70, n=76, n=68, respectively). Treatment success occurred in 56 (80%) of 70 infants receiving ranibizumab 0.2 mg compared with 57 (75%) of 76 infants receiving ranibizumab 0.1 mg and 45 (66%) of 68 infants after laser therapy. Using a hierarchical testing strategy, compared with laser therapy the odds ratio (OR) of treatment success following ranibizumab 0.2 mg was 2.19 (95% Cl 0.99-4.82, p=0.051), and following ranibizumab 0.1 mg was 1.57 (95% Cl 0.76-3.26); for ranibizumab 0.2 mg compared with 0.1 mg the OR was 1.35 (95% Cl 0.61-2.98). One infant had an unfavourable structural outcome following ranibizumab 0.2 mg, compared with five following ranibizumab 0.1 mg and seven after laser therapy. Death, serious and non-serious systemic adverse events, and ocular adverse events were evenly distributed between the three groups. Findings In the treatment of ROP, ranibizumab 0.2 mg might be superior to laser therapy, with fewer unfavourable ocular outcomes than laser therapy and with an acceptable 24-week safety profile.	[Stahl, Andreas] Univ Med Ctr, Dept Ophthalmol, Greifswald, Germany; [Lepore, Domenico] Univ Cattolica Sacro Cuore, Gemelli Fdn IRCSS, Dept Ophthalmol, Rome, Italy; [Fielder, Alistair] City Univ London, Dept Optometry & Visual Sci, London, England; [Fleck, Brian] Univ Edinburgh, Royal Hosp Sick Children, Edinburgh, Midlothian, Scotland; [Reynolds, James D.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Ross Eye Inst, Buffalo, NY USA; [Chiang, Michael F.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Li, Jun; Liew, Melissa; Maier, Rainer] Novartis Pharmaceut, Basel, Switzerland; [Zhu, Qi] China Novartis Inst BioMed Res Co, Shanghai, Peoples R China; [Marlow, Neil] UCL, Acad Neonatol, UCL Elizabeth Garrett Anderson Inst Womens Hlth, London, England	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; City University London; University of Edinburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Oregon Health & Science University; Novartis; University of London; University College London	Marlow, N (corresponding author), UCL Elizabeth Garrett Anderson Inst Womens Hlth, Acad Neonatol, London WC1E 6AU, England.	n.marlow@ucl.ac.uk	Lepore, Domenico/AAS-6587-2020; Marlow, Neil/D-2918-2009	Lepore, Domenico/0000-0002-2104-9239; Marlow, Neil/0000-0001-5890-2953	Novartis	Novartis(Novartis)	Novartis.	Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Darlow BA, 2013, ARCH DIS CHILD-FETAL, V98, pF170, DOI 10.1136/archdischild-2011-301148; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Huang QJ, 2017, OPHTHALMOLOGY, V124, P1156, DOI 10.1016/j.ophtha.2017.03.018; Hwang CK, 2015, OPHTHALMOLOGY, V122, P1008, DOI 10.1016/j.ophtha.2014.12.017; Karkhaneh R, 2016, ACTA OPHTHALMOL, V94, pE417, DOI 10.1111/aos.13008; Kennedy KA, 2018, J AAPOS, V22, P61, DOI 10.1016/j.jaapos.2017.10.006; Kong LK, 2015, INVEST OPHTH VIS SCI, V56, P956, DOI 10.1167/iovs.14-15842; Lepore D, 2018, OPHTHALMOLOGY, V125, P218, DOI 10.1016/j.ophtha.2017.08.005; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Lien RY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148019; Lyu J, 2017, INVEST OPHTH VIS SCI, V58, P1719, DOI 10.1167/iovs.16-20680; Mintz-Hittner HA, 2016, OPHTHALMOLOGY, V123, P1845, DOI 10.1016/j.ophtha.2016.04.028; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; PALMER EA, 1988, ARCH OPHTHALMOL-CHIC, V106, P471; Pocock SJ, 2009, LANCET, V373, P1926, DOI 10.1016/S0140-6736(09)60499-2; Sankar MJ, 2018, COCHRANE DB SYST REV, V1; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Stahl A, 2018, JAMA PEDIATR, V172, P278, DOI 10.1001/jamapediatrics.2017.4838; Storey PP, 2019, AM J OPHTHALMOL, V199, P200, DOI 10.1016/j.ajo.2018.11.023; Tinning AR, 2016, AM J PHYSIOL-RENAL, V311, pF586, DOI 10.1152/ajprenal.00221.2016; Wallace DK, 2017, JAMA OPHTHALMOL, V135, P654, DOI 10.1001/jamaophthalmol.2017.1055; Walz JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145375; Wilkinson AR, 2008, EARLY HUM DEV, V84, P71, DOI 10.1016/j.earlhumdev.2007.12.004; Woik N, 2015, CELL MOL LIFE SCI, V72, P2709, DOI 10.1007/s00018-015-1907-1; World Health Organization, 2014, WORLD HLTH STAT 2014; Xu L, 2013, INVEST OPHTH VIS SCI, V54, P1616, DOI 10.1167/iovs.12-10260; Zhang GM, 2017, RETINA-J RET VIT DIS, V37, P710, DOI 10.1097/IAE.0000000000001241	32	135	140	6	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2019	394	10208					1551	1559		10.1016/S0140-6736(19)31344-3	http://dx.doi.org/10.1016/S0140-6736(19)31344-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI3WL	31522845	Green Submitted			2022-12-28	WOS:000493399500026
J	Celli, BR; Wedzicha, JA				Celli, Bartolome R.; Wedzicha, Jadwiga A.			Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							AIR-FLOW OBSTRUCTION; ACUTE EXACERBATIONS; NORMAL SPIROMETRY; RISK-FACTORS; COPD; MORTALITY; OUTCOMES; SMOKERS; FLUTICASONE; PREVENTION	A pair of review articles examines our current understanding of the biology, diagnosis, and treatment of chronic obstructive pulmonary disease. This article focuses on the clinical aspects of COPD.	[Celli, Bartolome R.] Brigham & Womens Hosp, Pulm & Crit Care Div, 75 Francis St, Boston, MA 02115 USA; [Celli, Bartolome R.] Harvard Med Sch, Boston, MA 02115 USA; [Wedzicha, Jadwiga A.] Imperial Coll London, Natl Heart & Lung Inst, London, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Imperial College London	Celli, BR (corresponding author), 31 River Glen Rd, Wellesley, MA 02481 USA.	bcelli@copdnet.org		Wedzicha, Jadwiga/0000-0001-9642-1261	Medical Research Council [G0800570, G1001372, G1001365] Funding Source: Medline; MRC [G1001372, G0800570, G1001365] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agusti A, 2011, EUR RESPIR J, V38, P749, DOI 10.1183/09031936.00062211; Agusti A, 2019, NEW ENGL J MED, V381, P1248, DOI 10.1056/NEJMra1900475; Agusti A, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01219-2018; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Albert RK, 2016, NEW ENGL J MED, V375, P1617, DOI 10.1056/NEJMoa1604344; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Allinson JP, 2016, AM J RESP CRIT CARE, V193, P662, DOI 10.1164/rccm.201511-2210OC; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bhatt SP, 2019, AM J RESP CRIT CARE, V199, P286, DOI 10.1164/rccm.201807-1351SO; Bhatt SP, 2017, ANN AM THORAC SOC, V14, P643, DOI 10.1513/AnnalsATS.201610-775BC; Boucher RC, 2019, NEW ENGL J MED, V380, P1941, DOI 10.1056/NEJMra1813799; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2018, LANCET RESP MED, V6, P337, DOI 10.1016/S2213-2600(18)30102-4; Calzetta L, 2016, CHEST, V149, P1181, DOI 10.1016/j.chest.2016.02.646; Casaburi R, 2009, NEW ENGL J MED, V360, P1329, DOI 10.1056/NEJMct0804632; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Castaldi PJ, 2014, THORAX, V69, P415, DOI 10.1136/thoraxjnl-2013-203601; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Celli BR, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00132-2017; Celli BR, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02146-2017; Celli BR, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01432-2017; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cote CG, 2007, CHEST, V131, P696, DOI 10.1378/chest.06-1610; Criner GJ, 2018, AM J RESP CRIT CARE, V198, P1151, DOI 10.1164/rccm.201803-0590OC; Criner GJ, 2015, CHEST, V147, P894, DOI 10.1378/chest.14-1676; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; de-Torres JP, 2016, CHEST, V149, P936, DOI 10.1378/chest.15-1868; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Divo MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193143; Donaldson GC, 2015, AM J RESP CRIT CARE, V192, P943, DOI 10.1164/rccm.201412-2269OC; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Gauderman WJ, 2015, NEW ENGL J MED, V372, P905, DOI 10.1056/NEJMoa1414123; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Harvey BG, 2015, EUR RESPIR J, V46, P1589, DOI 10.1183/13993003.02377-2014; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lipson DA, 2018, NEW ENGL J MED, V378, P1671, DOI 10.1056/NEJMoa1713901; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Martinez FJ, 2017, AM J RESP CRIT CARE, V195, P881, DOI 10.1164/rccm.201607-1421OC; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Morice AH, 2010, RESP MED, V104, P1659, DOI 10.1016/j.rmed.2010.07.016; Muellerova H, 2015, CHEST, V147, P999, DOI 10.1378/chest.14-0655; Murphy PB, 2017, JAMA-J AM MED ASSOC, V317, P2177, DOI 10.1001/jama.2017.4451; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; O'Donnell Denis E, 2006, COPD, V3, P219, DOI 10.1080/15412550600977478; Papi A, 2018, LANCET, V391, P783, DOI 10.1016/S0140-6736(17)33311-1; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pavord ID, 2016, LANCET RESP MED, V4, P731, DOI 10.1016/S2213-2600(16)30148-5; Petersen H, 2018, AM J RESP CRIT CARE, V198, P1449, DOI 10.1164/rccm.201805-0861LE; Pinto-Plata VM, 2007, CHEST, V131, P37, DOI 10.1378/chest.06-0668; Puente-Maestu L, 2016, EUR RESPIR J, V47, P429, DOI 10.1183/13993003.00745-2015; Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9; Ramirez-Venegas A, 2014, AM J RESP CRIT CARE, V190, P996, DOI 10.1164/rccm.201404-0720OC; Rochester CL, 2015, AM J RESP CRIT CARE, V192, P1373, DOI 10.1164/rccm.201510-1966ST; Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Rodriguez-Roisin R, 2017, AM J RESP CRIT CARE, V195, P17, DOI 10.1164/rccm.201607-1376PP; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Silverman EK, 2009, NEW ENGL J MED, V360, P2749, DOI 10.1056/NEJMcp0900449; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Stockley RA, 2000, CHEST, V117, P1638, DOI 10.1378/chest.117.6.1638; Suzuki M, 2016, AM J RESP CRIT CARE, V194, P1358, DOI 10.1164/rccm.201602-0353OC; Troosters T, 2010, EUR RESPIR J, V36, P65, DOI 10.1183/09031936.00127809; Vogelmeier CF, 2017, EUR RESPIR J, V49, DOI [10.1111/resp.13012, 10.1183/13993003.00214-2017, 10.1016/j.arbres.2017.02.001, 10.1164/rccm.201701-0218PP]; Washko George R, 2011, N Engl J Med, V364, P897, DOI 10.1056/NEJMoa1007285; Wedzicha JA, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02265-2016; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Woodruff PG, 2016, NEW ENGL J MED, V375, P896, DOI 10.1056/NEJMc1608235; Zhou YM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001621	75	154	160	36	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1257	1266		10.1056/NEJMra1900500	http://dx.doi.org/10.1056/NEJMra1900500			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OT	31553837	Green Published			2022-12-28	WOS:000489333500010
J	Dreyer, BP				Dreyer, Benard P.			Sustained Animus toward Latino Immigrants - Deadly Consequences for Children and Families	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								U.S. policies are inflicting ongoing harm on migrant children, enacting an animus against immigrants that is baked into our history. U.S. physicians can advocate for immigrants' basic human rights and can support, counsel, and nurture resilience in our Latino patients.						Dreyer, Benard/0000-0001-5299-5634				Balderrama Francisco E., 2006, DECADE BETRAYAL MEXI; Danaher F, 2018, NEW ENGL J MED, V379, DOI 10.1056/NEJMp1808443; Jacobson MatthewFrye., 1999, WHITENESS DIFFERENT; Matlow R, 2019, NEW ENGL J MED, V380, P5, DOI 10.1056/NEJMp1814340; Thebault R., 2019, WASHINGTON POST	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1196	1198		10.1056/NEJMp1908995	http://dx.doi.org/10.1056/NEJMp1908995			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC5OT	31509670	Bronze			2022-12-28	WOS:000489333500003
J	Iacobucci, G				Iacobucci, Gareth			Treat obesity with the same effort used to reduce smoking, says lead psychologist	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		British Psychological Society, 2019, PSYCHOL PERSPECTIVES	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5713	10.1136/bmj.l5713	http://dx.doi.org/10.1136/bmj.l5713			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551307				2022-12-28	WOS:000488488300017
J	Kuehn, B				Kuehn, Bridget			Uptick in Neuroinvasive West Nile	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1135	1135		10.1001/jama.2019.14682	http://dx.doi.org/10.1001/jama.2019.14682			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550041				2022-12-28	WOS:000488822800012
J	Fontana, G; Flott, K; Dhingra-Kumar, N; Durkin, M; Darzi, A				Fontana, Gianluca; Flott, Kelsey; Dhingra-Kumar, Neelam; Durkin, Mike; Darzi, Ara			Five reasons for optimism on World Patient Safety Day	LANCET			English	Editorial Material							CARE		[Fontana, Gianluca; Flott, Kelsey; Durkin, Mike; Darzi, Ara] Imperial Coll London, Inst Global Hlth Innovat, NIHR Imperial Patient Safety Translat Res Ctr, London W2 1NY, England; [Dhingra-Kumar, Neelam] WHO, Patient Safety & Risk Management Unit, Geneva, Switzerland	Imperial College London; World Health Organization	Fontana, G (corresponding author), Imperial Coll London, Inst Global Hlth Innovat, NIHR Imperial Patient Safety Translat Res Ctr, London W2 1NY, England.	g.fontana@imperial.ac.uk	Fontana, Gianluca/AAB-1960-2021		UK Department of Health and Social Care; Foreign and Commonwealth Office	UK Department of Health and Social Care; Foreign and Commonwealth Office	The team at Imperial College London's NIHR Imperial Patient Safety Translational Research Centre is organising an event for World Patient Safety Day with funding from the UK Department of Health and Social Care and Foreign and Commonwealth Office, and is the delivery partner for the Global Patient Safety Collaborative. We declare no other competing interests.	[Anonymous], 2016, LANCET, V387, P1133, DOI 10.1016/S0140-6736(16)30003-4; CurvedThinking Understanding Patient Data One London., 2019, UNDERSTANDING PATIEN; Flott K., 2019, GLOBAL STATE PATIENT; Flott K, 2017, LANCET, V389, P1279, DOI 10.1016/S0140-6736(17)30868-1; Ghafur S, 2019, IMPROVING CYBER SECU; Hancock M, 2018, PATIENT SAFETY NO RO; Hollnagel E, 2015, FROM SAFETY I TO SAF, pI; Hunt J, 2017, PATIENT SAFETY VISIT; Jha AK, 2013, BMJ QUAL SAF, V22, P809, DOI 10.1136/bmjqs-2012-001748; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; National Academies of Sciences Engineering and Medicine Health and Medicine Division Board on Health Care Services, 2019, CROSS GLOB QUAL CHAS; Slawomirski L, 2019, EC PATIENT SAFETY; WHO, 2019, GLOB ACT PAT SAF WHO; WHO, 2019, WHA 72 ACH COMM ACC; World Health Organization, 2019, GLOB PAT SAF COLL; Yu A, 2016, PATIENT SAFETY 2030	16	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					993	995		10.1016/S0140-6736(19)32134-8	http://dx.doi.org/10.1016/S0140-6736(19)32134-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31522844	Green Submitted			2022-12-28	WOS:000487038700011
J	Mahase, E				Mahase, Elisabeth			Sertraline is better at reducing anxiety than depressive symptoms	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lewis G, 2019, LANCET PSYCHIAT	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2019	366								l5655	10.1136/bmj.l5655	http://dx.doi.org/10.1136/bmj.l5655			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WG	31540907				2022-12-28	WOS:000487759700005
J	Eisenstein, M				Eisenstein, Michael			A shot for all seasons	NATURE			English	Editorial Material																		Bangaru S, 2019, CELL, V177, P1136, DOI 10.1016/j.cell.2019.04.011; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	3	13	13	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					S50	S52		10.1038/d41586-019-02751-w	http://dx.doi.org/10.1038/d41586-019-02751-w			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534251				2022-12-28	WOS:000486647800004
J	Patnode, ML; Beller, ZW; Han, ND; Cheng, JY; Peters, SL; Terrapon, N; Henrissat, B; Le Gall, S; Saulnier, L; Hayashi, DK; Meynier, A; Vinoy, S; Giannone, RJ; Hettich, RL; Gordon, JI				Patnode, Michael L.; Beller, Zachary W.; Han, Nathan D.; Cheng, Jiye; Peters, Samantha L.; Terrapon, Nicolas; Henrissat, Bernard; Le Gall, Sophie; Saulnier, Luc; Hayashi, David K.; Meynier, Alexandra; Vinoy, Sophie; Giannone, Richard J.; Hettich, Robert L.; Gordon, Jeffrey I.			Interspecies Competition Impacts Targeted Manipulation of Human Gut Bacteria by Fiber-Derived Glycans	CELL			English	Article						microbiota-directed foods; polysaccharide utilization; community ecology; interspecies competition; biosensors	PEPTIDE IDENTIFICATION; DIETARY FIBER; POLYSACCHARIDE; DIVERSITY	Development of microbiota-directed foods (MDFs) that selectively increase the abundance of beneficial human gut microbes, and their expressed functions, requires knowledge of both the bioactive components of MDFs and the mechanisms underlying microbe-microbe interactions. Here, gnotobiotic mice were colonized with a defined consortium of human-gut-derived bacterial strains and fed different combinations of 34 food-grade fibers added to a representative low-fiber diet consumed in the United States. Bioactive carbohydrates in fiber preparations targeting particular Bacteroides species were identified using community-wide quantitative proteomic analyses of bacterial gene expression coupled with forward genetic screens. Deliberate manipulation of community membership combined with administration of retrievable artificial food particles, consisting of paramagnetic microscopic beads coated with dietary polysaccharides, disclosed the contributions of targeted species to fiber degradation. Our approach, including the use of bead-based biosensors, defines nutrient-harvesting strategies that underlie, as well as alleviate, competition between Bacteroides and control the selectivity of MDF components.	[Patnode, Michael L.; Beller, Zachary W.; Han, Nathan D.; Cheng, Jiye; Gordon, Jeffrey I.] Washington Univ, Sch Med St Louis, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Patnode, Michael L.; Beller, Zachary W.; Han, Nathan D.; Cheng, Jiye; Gordon, Jeffrey I.] Washington Univ, Sch Med St Louis, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA; [Terrapon, Nicolas; Henrissat, Bernard] CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille 9, France; [Terrapon, Nicolas; Henrissat, Bernard] Aix Marseille Univ, F-13288 Marseille 9, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia; [Le Gall, Sophie; Saulnier, Luc] Inst Natl Rech Agronom, UR1268 BIA, F-44316 Nantes, France; [Hayashi, David K.; Meynier, Alexandra; Vinoy, Sophie] Mondelez Int, Deerfield, IL 60015 USA; [Peters, Samantha L.; Giannone, Richard J.; Hettich, Robert L.] Oak Ridge Natl Lab, Chem Sci Div, Oak Ridge, TN 37830 USA	Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; INRAE; Mondelez International; United States Department of Energy (DOE); Oak Ridge National Laboratory	Gordon, JI (corresponding author), Washington Univ, Sch Med St Louis, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.; Gordon, JI (corresponding author), Washington Univ, Sch Med St Louis, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63110 USA.	jgordon@wustl.edu	/AAD-2075-2020; Hettich, Robert L/N-1458-2016; Giannone, Richard/ABC-8247-2020; Henrissat, Bernard/J-2475-2012; Terrapon, Nicolas/AAA-9033-2019	Hettich, Robert L/0000-0001-7708-786X; Giannone, Richard/0000-0001-8551-0138; Henrissat, Bernard/0000-0002-3434-8588; Terrapon, Nicolas/0000-0002-3693-6017; Meynier, Alexandra/0000-0002-9567-0351; Patnode, Michael/0000-0003-1981-5261; Peters, Samantha/0000-0002-3755-9786	NIH [DK070977, DK078669, F32DK107158]; Mondelez International; US Department of Energy [DE-SC0015662]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, R01DK070977, P30DK056341, F32DK107158] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mondelez International; US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank David O'Donnell, Maria Karlsson, Marty Meier, Justin Serugo, Sabrina Wagoner, Janaki Lelwala-Guruge, and J. Hoisington-Lopez for superb technical assistance, Brigitte Laillet and Marie-Jeanne Crepeau for technical assistance in fiber characterization, and Michael Barratt, Darryl Wesener, and Jennifer Bando for helpful discussions. Pierre Aymard, Dominic Vellucci, and Luca Dimartino sourced fibers, processed freeze-dried diets, and assisted with proximate analysis of fibers. This work was supported by grants from the NIH (DK070977, DK078669, and F32DK107158), Mondelez International, and the US Department of Energy (DE-SC0015662).	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Buffetto F, 2015, PLANT CELL PHYSIOL, V56, P2181, DOI 10.1093/pcp/pcv128; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarkson SM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01313-17; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ENGLYST HN, 1988, J ASSOC OFF ANA CHEM, V71, P808; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; FILISETTICOZZI TMCC, 1991, ANAL BIOCHEM, V197, P157, DOI 10.1016/0003-2697(91)90372-Z; Fragiadakis GK, 2019, GUT MICROBES, V10, P216, DOI 10.1080/19490976.2018.1494103; Glenwright AJ, 2017, NATURE, V541, P407, DOI 10.1038/nature20828; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; Hibberd MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4069; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; KOTARSKI SF, 1984, J BACTERIOL, V158, P102, DOI 10.1128/JB.158.1.102-109.1984; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Levigne S, 2002, FOOD HYDROCOLLOID, V16, P547, DOI 10.1016/S0268-005X(02)00015-2; Luis AS, 2018, NAT MICROBIOL, V3, P210, DOI 10.1038/s41564-017-0079-1; Lynch JB, 2012, MOL MICROBIOL, V85, P478, DOI 10.1111/j.1365-2958.2012.08123.x; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; Menni C, 2017, INT J OBESITY, V41, P1099, DOI 10.1038/ijo.2017.66; Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Porter NT, 2017, ANNU REV MICROBIOL, V71, P349, DOI 10.1146/annurev-micro-102215-095316; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Santander J, 2013, MICROBIOL-SGM, V159, P1471, DOI 10.1099/mic.0.066639-0; Schwalm ND, 2016, MBIO, V7, DOI 10.1128/mBio.01342-16; Shepherd ES, 2018, NATURE, V557, P434, DOI 10.1038/s41586-018-0092-4; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tauzin AS, 2016, MOL MICROBIOL, V102, P579, DOI 10.1111/mmi.13480; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; Ting L, 2009, MOL CELL PROTEOMICS, V8, P2227, DOI 10.1074/mcp.M800462-MCP200; Wu M, 2015, SCIENCE, V350, DOI 10.1126/science.aac5992; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	47	121	125	13	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					59	+		10.1016/j.cell.2019.08.011	http://dx.doi.org/10.1016/j.cell.2019.08.011			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539500	Green Accepted, Bronze			2022-12-28	WOS:000486618500014
J	Shindell, D; Smith, CJ				Shindell, Drew; Smith, Christopher J.			Climate and air-quality benefits of a realistic phase-out of fossil fuels	NATURE			English	Article							IMPULSE-RESPONSE; CARBON-DIOXIDE; EMISSIONS; MODEL; POLLUTION; TEMPERATURE; IMPACTS; TRENDS; OCEAN	The combustion of fossil fuels produces emissions of the long-lived greenhouse gas carbon dioxide and of short-lived pollutants, including sulfur dioxide, that contribute to the formation of atmospheric aerosols(1). Atmospheric aerosols can cool the climate, masking some of the warming effect that results from the emission of greenhouse gases(1). However, aerosol particulates are highly toxic when inhaled, leading to millions of premature deaths per year(2,3). The phasing out of unabated fossil-fuel combustion will therefore provide health benefits, but will also reduce the extent to which the warming induced by greenhouse gases is masked by aerosols. Because aerosol levels respond much more rapidly to changes in emissions relative to carbon dioxide, large near-term increases in the magnitude and rate of climate warming are predicted in many idealized studies that typically assume an instantaneous removal of all anthropogenic or fossil-fuel-related emissions(1,4-9). Here we show that more realistic modelling scenarios do not produce a substantial near-term increase in either the magnitude or the rate of warming, and in fact can lead to a decrease in warming rates within two decades of the start of the fossil-fuel phase-out. Accounting for the time required to transform power generation, industry and transportation leads to gradually increasing and largely offsetting climate impacts of carbon dioxide and sulfur dioxide, with the rate of warming further slowed by reductions in fossil-methane emissions. Our results indicate that even the most aggressive plausible transition to a clean-energy society provides benefits for climate change mitigation and air quality at essentially all decadal to centennial timescales.	[Shindell, Drew] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Shindell, Drew] Duke Univ, Duke Global Hlth Initiat, Durham, NC 27708 USA; [Shindell, Drew] Tel Aviv Univ, Porter Sch Environm & Earth Sci, Tel Aviv, Israel; [Smith, Christopher J.] Univ Leeds, Priestley Int Ctr Climate, Leeds, W Yorkshire, England	Duke University; Duke University; Tel Aviv University; University of Leeds	Shindell, D (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.; Shindell, D (corresponding author), Duke Univ, Duke Global Hlth Initiat, Durham, NC 27708 USA.; Shindell, D (corresponding author), Tel Aviv Univ, Porter Sch Environm & Earth Sci, Tel Aviv, Israel.	drew.shindell@duke.edu	Shindell, Drew/D-4636-2012; Smith, Christopher/AHD-0991-2022	Shindell, Drew/0000-0003-1552-4715; Smith, Christopher/0000-0003-0599-4633				Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Andrews T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051607; Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; Brasseur GP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023902; Butt EW, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa87be; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6]; Collins M., 2013, CLIM CHANG 2013 PHYS; Connors S., 2018, GLOBAL WARMING 15 C; Cowtan K, 2014, Q J ROY METEOR SOC, V140, P1935, DOI 10.1002/qj.2297; Etminan M, 2016, GEOPHYS RES LETT, V43, P12614, DOI 10.1002/2016GL071930; Fitzpatrick B., 2018, NATL POST; Forster PM, 2013, J GEOPHYS RES-ATMOS, V118, P1139, DOI 10.1002/jgrd.50174; Ghan SJ, 2013, J GEOPHYS RES-ATMOS, V118, P6688, DOI 10.1002/jgrd.50567; Haegel NM, 2017, SCIENCE, V356, P141, DOI 10.1126/science.aal1288; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hare B, 2006, CLIMATIC CHANGE, V75, P111, DOI 10.1007/s10584-005-9027-9; Hienola A, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab1b2; Huppmann D., 2018, IAMC 1 5 C SCENARIO, DOI [10.22022/SR15/08-2018.15429http://doi.org/, DOI 10.22022/SR15/08-2018.15429HTTP://DOI.ORG, 10.22022/SR15/08-2018.15429, DOI 10.22022/SR15/08-2018.15429]; Huppmann D, 2018, NAT CLIM CHANGE, V8, P1027, DOI 10.1038/s41558-018-0317-4; Joos F, 2013, ATMOS CHEM PHYS, V13, P2793, DOI 10.5194/acp-13-2793-2013; Kloster S, 2010, CLIM DYNAM, V34, P1177, DOI 10.1007/s00382-009-0573-0; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Leach NJ, 2018, NAT GEOSCI, V11, P574, DOI 10.1038/s41561-018-0156-y; Leibensperger EM, 2012, ATMOS CHEM PHYS, V12, P3349, DOI 10.5194/acp-12-3349-2012; Lelieveld J, 2019, P NATL ACAD SCI USA, V116, P7192, DOI 10.1073/pnas.1819989116; Li BG, 2016, NATURE, V531, P357, DOI 10.1038/nature17165; Matthews HD, 2012, NAT CLIM CHANGE, V2, P338, DOI [10.1038/nclimate1424, 10.1038/NCLIMATE1424]; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Millar RJ, 2017, ATMOS CHEM PHYS, V17, P7213, DOI 10.5194/acp-17-7213-2017; Millar RJ, 2015, CLIMATIC CHANGE, V131, P199, DOI 10.1007/s10584-015-1384-4; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Myhre G, 2013, ATMOS CHEM PHYS, V13, P1853, DOI 10.5194/acp-13-1853-2013; Myhre G., 2013, CLIM CHANG 2013 PHYS; OECD, 2016, EC CONSEQUENCES OUTD, DOI 10.1787/9789264257474-en; Philipona R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036350; Raes F, 2009, ATMOS ENVIRON, V43, P5132, DOI 10.1016/j.atmosenv.2009.06.001; Ramanathan V, 2008, P NATL ACAD SCI USA, V105, P14245, DOI 10.1073/pnas.0803838105; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rogelj J., 2018, GLOBAL WARMING 1 5 C; Rohde R, 2013, GEOINFOR GEOSTAT OVE, V1, DOI 10.4172/2327-4581.1000103; Samset BH, 2018, GEOPHYS RES LETT, V45, P1020, DOI 10.1002/2017GL076079; Schellnhuber HJ, 2008, P NATL ACAD SCI USA, V105, P14239, DOI 10.1073/pnas.0807331105; Shindell D, 2018, NAT CLIM CHANGE, V8, P291, DOI 10.1038/s41558-018-0108-y; Shindell DT, 2016, NAT CLIM CHANGE, V6, P503, DOI [10.1038/nclimate2935, 10.1038/NCLIMATE2935]; Silva RA, 2016, ATMOS CHEM PHYS, V16, P9847, DOI 10.5194/acp-16-9847-2016; Smith CJ, 2018, GEOSCI MODEL DEV, V11, P2273, DOI 10.5194/gmd-11-2273-2018; Smithes CJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07999-w; Thompson DWJ, 2015, J CLIMATE, V28, P6443, DOI 10.1175/JCLI-D-14-00830.1; Vose RS, 2012, B AM METEOROL SOC, V93, P1677, DOI 10.1175/BAMS-D-11-00241.1; Zheng B, 2018, ATMOS CHEM PHYS, V18, P14095, DOI 10.5194/acp-18-14095-2018	51	157	161	49	302	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					408	+		10.1038/s41586-019-1554-z	http://dx.doi.org/10.1038/s41586-019-1554-z			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31534245	Green Accepted			2022-12-28	WOS:000486647800048
J	Dyer, C				Dyer, Clare			Doctor is charged with four counts of sexual assault	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l5575	10.1136/bmj.l5575	http://dx.doi.org/10.1136/bmj.l5575			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VP	31527145				2022-12-28	WOS:000487758000009
J	Encalada, AC; Flecker, AS; Poff, NL; Suarez, E; Herrera-R, GA; Rios-Touma, B; Jumani, S; Larson, EI; Anderson, EP				Encalada, Andrea C.; Flecker, Alexander S.; Poff, N. LeRoy; Suarez, Esteban; Herrera-R, Guido A.; Rios-Touma, Blanca; Jumani, Suman; Larson, Erin I.; Anderson, Elizabeth P.			A global perspective on tropical montane rivers	SCIENCE			English	Review							CLIMATE-CHANGE; WESTERN-GHATS; CONSERVATION; BIODIVERSITY; DIVERSITY; ANDES; FLOW; TEMPERATURE; MOUNTAINS; EVOLUTION	Tropical montane rivers (TMR) are born in tropical mountains, descend through montane forests, and feed major rivers. floodplains, and oceans. They are characterized by rapid temperature dines and varied flow disturbance regimes, both of which promote habitat heterogeneity, high biological diversity and endemism, and distinct organisms' life-history adaptations. Production, transport, and processing of sediments, nutrients, and carbon are key ecosystem processes connecting high-elevation streams with lowland floodplains, in turn influencing soil fertility and biotic productivity downstream.TMR provide key ecosystem services to hundreds of millions of people in tropical nations. In light of existing human-induced disturbances, including climate change, TMR can be used as natural model systems to examine the effects of rapid changes in abiotic drivers and their influence on biodiversity and ecosystem function.	[Encalada, Andrea C.; Suarez, Esteban] Univ San Francisco Quito, Inst BIOSFERA, Colegio Ciencias Biol & Ambientales, Quito, Ecuador; [Flecker, Alexander S.; Larson, Erin I.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Poff, N. LeRoy] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Poff, N. LeRoy] Univ Canberra, Inst Appl Ecol, Canberra, ACT, Australia; [Herrera-R, Guido A.; Anderson, Elizabeth P.] Florida Int Univ, Dept Earth & Environm, Miami, FL 33199 USA; [Herrera-R, Guido A.; Anderson, Elizabeth P.] Florida Int Univ, Inst Water & Environm, Miami, FL 33199 USA; [Rios-Touma, Blanca] Univ Amer, Fac Ingn & Ciencias Aplicadas, Ingn Ambiental, Grp Invest Biodiversidad Medio Ambiente & Salud B, Quito, Ecuador; [Jumani, Suman] Univ Florida, Soil & Water Sci Dept, Gainesville, FL USA; [Larson, Erin I.] Alaska Pacific Univ, Dept Environm Sci, Anchorage, AK USA	Cornell University; Colorado State University; University of Canberra; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Universidad de Las Americas - Ecuador; State University System of Florida; University of Florida	Encalada, AC (corresponding author), Univ San Francisco Quito, Inst BIOSFERA, Colegio Ciencias Biol & Ambientales, Quito, Ecuador.	aencalada@usfq.edu.ec	Suarez, Esteban/AAP-7440-2020; Rios-Touma, Blanca/AAR-9631-2020	Suarez, Esteban/0000-0003-0425-8933; Rios-Touma, Blanca/0000-0002-3921-0908; Poff, N LeRoy/0000-0002-1390-8742; Larson, Erin/0000-0002-7797-0529; Encalada, Andrea C./0000-0003-2497-6086; Herrera-R, Guido A/0000-0001-5686-6362; Flecker, Alexander/0000-0002-4636-2109	U.S. National Science Foundation [DEB-9615349, DEB-1046408]; USAID; MacArthur Foundation [16-1607151053-CSD]; Universidad San Francisco de Quito	U.S. National Science Foundation(National Science Foundation (NSF)); USAID(United States Agency for International Development (USAID)); MacArthur Foundation; Universidad San Francisco de Quito	We acknowledge funding from the U.S. National Science Foundation (DEB-9615349, DEB-1046408), USAID-funded Partnerships for Enhanced Engagement in Research (PEER) Program managed by the National Academy of Sciences, The MacArthur Foundation (16-1607151053-CSD), and a collaboration grant from Universidad San Francisco de Quito.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Anderson EP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1642; Anderson EP, 2011, CONSERV BIOL, V25, P30, DOI 10.1111/j.1523-1739.2010.01568.x; Antonelli A, 2018, NAT GEOSCI, V11, P718, DOI 10.1038/s41561-018-0236-z; Ashagre BB, 2018, ECOSYST SERV, V32, P50, DOI 10.1016/j.ecoser.2018.05.004; Atkinson CL, 2018, OECOLOGIA, V187, P731, DOI 10.1007/s00442-018-4142-2; Barthem RB, 2017, SCI REP-UK, V7, DOI 10.1038/srep41784; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Buytaert W, 2011, GLOBAL ECOL BIOGEOGR, V20, P19, DOI 10.1111/j.1466-8238.2010.00585.x; Capps KA, 2016, FRESHW SCI, V35, P429, DOI 10.1086/684945; Carvajal-Quintero JD, 2015, ECOL EVOL, V5, P2608, DOI 10.1002/ece3.1539; Castro DMP, 2019, BIOTROPICA, V51, P399, DOI 10.1111/btp.12660; Catenazzi A, 2014, CONSERV BIOL, V28, P509, DOI 10.1111/cobi.12194; Cauvy-Fraunie S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136793; Clark KE, 2016, EARTH SURF DYNAM, V4, P47, DOI 10.5194/esurf-4-47-2016; Clausnitzer V, 2012, FRONT ECOL ENVIRON, V10, P129, DOI 10.1890/110247; Constantine JA, 2014, NAT GEOSCI, V7, P899, DOI [10.1038/ngeo2282, 10.1038/NGEO2282]; Couto TBA, 2018, FRONT ECOL ENVIRON, V16, P91, DOI 10.1002/fee.1746; Cressa C, 2008, AQUAT INSECT, V30, P127, DOI 10.1080/01650420701858764; Doria CRD, 2018, AMBIO, V47, P453, DOI 10.1007/s13280-017-0994-7; Dahanukar N., 2013, MIN NEWSLETTER IUCN, V1, P6; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; Datry T, 2014, BIOSCIENCE, V64, P229, DOI 10.1093/biosci/bit027; Douglas I., 2005, INT HYDROLOGY SERIES, P407; Duponchelle F, 2016, J APPL ECOL, V53, P1511, DOI 10.1111/1365-2664.12665; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Filizola N, 2009, HYDROL PROCESS, V23, P3207, DOI 10.1002/hyp.7394; Forsberg BR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182254; Gill BA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0553; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; JACKSON JK, 1995, J N AM BENTHOL SOC, V14, P115, DOI 10.2307/1467728; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; Jumani S, 2018, AQUAT CONSERV, V28, P979, DOI 10.1002/aqc.2904; Korner C, 2017, ALPINE BOT, V127, P1, DOI 10.1007/s00035-016-0182-6; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Lessmann Janeth, 2016, Neotropical Biodiversity, V2, P99; Lujan N. K., 2015, EXTREMOPHILE FISHES, P107, DOI DOI 10.1007/978-3-319-13362-1_6; Maldonado M., 2011, CLIMATE CHANGE BIODI, P276; Marc O, 2018, EARTH SURF DYNAM, V6, P903, DOI 10.5194/esurf-6-903-2018; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; McIntyre PB, 2016, P NATL ACAD SCI USA, V113, P12880, DOI 10.1073/pnas.1521540113; Molur S, 2011, STATUS DISTRIBUTION; Moquet JS, 2016, ENVIRON SCI POLLUT R, V23, P11405, DOI 10.1007/s11356-015-5503-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Panagos P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04282-8; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Polato NR, 2018, P NATL ACAD SCI USA, V115, P12471, DOI 10.1073/pnas.1809326115; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Restrepo JD, 2015, ANTHROPOCENE, V10, P13, DOI 10.1016/j.ancene.2015.09.001; Restrepo JD, 2006, GLOBAL PLANET CHANGE, V50, P33, DOI 10.1016/j.gloplacha.2005.09.002; Scatena F. N., 2005, INT HYDROLOGY SERIES, P489; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Shah AA, 2017, FUNCT ECOL, V31, P2118, DOI 10.1111/1365-2435.12906; Sheldon KS, 2014, ECOLOGY, V95, P2134, DOI 10.1890/13-1703.1; Syvitski JPM, 2014, GEOMORPHOLOGY, V227, P5, DOI 10.1016/j.geomorph.2014.02.029; Taylor BW, 2006, SCIENCE, V313, P833, DOI 10.1126/science.1128223; Toussaint A, 2016, BIOL INVASIONS, V18, P1295, DOI 10.1007/s10530-016-1067-8; Vigliotta TR, 2008, P ACAD NAT SCI PHILA, V157, P73, DOI 10.1635/0097-3157(2008)157[73:APSOTA]2.0.CO;2; Vimos DJ, 2015, FRESHW SCI, V34, P770, DOI 10.1086/681540; Viviroli D, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005653; von Humboldt A., 1805, ESSAI GEOGRAPHIE PLA; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Whymper E., 1894, TRAVELS GREAT ANDES	67	33	34	9	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1124	1129		10.1126/science.aax1682	http://dx.doi.org/10.1126/science.aax1682			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515386				2022-12-28	WOS:000485780800039
J	MacLean, RC; San Millan, A				MacLean, R. Craig; San Millan, Alvaro			The evolution of antibiotic resistance	SCIENCE			English	Editorial Material									[MacLean, R. Craig] Univ Oxford, Dept Zool, Oxford, England; [San Millan, Alvaro] Hosp Univ Ramon y Cajal, Dept Microbiol, IRYCIS, Madrid, Spain; [San Millan, Alvaro] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain	University of Oxford; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	MacLean, RC (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	craig.maclean@zoo.ox.ac.uk			Wellcome Trust [WT106918AIA]; European Research Council (ERC) [757440-PLASREVOLUTION]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission)	R.C.M. is supported by the Wellcome Trust (WT106918AIA), and A.S.M. is supported by the European Research Council (ERC grant 757440-PLASREVOLUTION).	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Baker S, 2018, SCIENCE, V360, P733, DOI 10.1126/science.aar3777; Baym M, 2016, SCIENCE, V353, P1147, DOI 10.1126/science.aag0822; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Chen J, 2018, SCIENCE, V362, P207, DOI 10.1126/science.aat5867; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; O'Neill J., 2016, REV ANTIMICROBIAL RE; Partridge SR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00088-17; Rosenkilde CEH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08529-y; San Millan AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6208; San Millan A, 2018, ISME J, V12, P3014, DOI 10.1038/s41396-018-0224-8; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Vogwill T, 2015, EVOL APPL, V8, P284, DOI 10.1111/eva.12202	15	115	120	21	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1082	1083		10.1126/science.aax3879	http://dx.doi.org/10.1126/science.aax3879			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515374	Green Submitted			2022-12-28	WOS:000485780800025
J	Mehrabi, P; Schulz, EC; Dsouza, R; Muller-Werkmeister, HM; Tellkamp, F; Miller, RJD; Pai, EF				Mehrabi, Pedram; Schulz, Eike C.; Dsouza, Raison; Mueller-Werkmeister, Henrike M.; Tellkamp, Friedjof; Miller, R. J. Dwayne; Pai, Emil F.			Time-resolved crystallography reveals allosteric communication aligned with molecular breathing	SCIENCE			English	Article							GENERAL FORCE-FIELD; CONFORMATIONAL-CHANGE; ORGANOFLUORINE CHEMISTRY; CRYSTALS; PROTEIN; CELL; HETEROGENEITY; SYNCHROTRON; DYNAMICS; ENZYMES	A comprehensive understanding of protein function demands correlating structure and dynamic changes. Using time-resolved serial synchrotron crystallography, we visualized half-of-the-sites reactivity and correlated molecular-breathing motions in the enzyme fluoroacetate dehalogenase. Eighteen time points from 30 milliseconds to 30 seconds cover four turnover cycles of the irreversible reaction. They reveal sequential substrate binding, covalent-intermediate formation, setup of a hydrolytic water molecule. and product release. Small structural changes of the protein mold and variations in the number and placement of water molecules accompany the various chemical steps of catalysis. Triggered by enzyme-ligand interactions, these repetitive changes in the protein framework's dynamics and entropy constitute crucial components of the catalytic machinery.	[Mehrabi, Pedram; Schulz, Eike C.; Dsouza, Raison; Mueller-Werkmeister, Henrike M.; Miller, R. J. Dwayne] Max Planck Inst Struct & Dynam Matter, Dept Atomically Resolved Dynam, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Mehrabi, Pedram; Pai, Emil F.] Univ Toronto, Dept Med Biophys, 101 Coll St, Toronto, ON M5G 1L7, Canada; [Mehrabi, Pedram; Pai, Emil F.] Ontario Canc Inst, Campbell Family Canc Res Inst, 101 Coll St, Toronto, ON M5G 1L7, Canada; [Dsouza, Raison] Univ Hamburg, Dept Phys, Jungiusstr 9, D-20355 Hamburg, Germany; [Mueller-Werkmeister, Henrike M.] Univ Potsdam, Inst Chem Phys Chem, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany; [Tellkamp, Friedjof] Max Planck Inst Struct & Dynam Matter, Sci Support Unit Machine Phys, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Miller, R. J. Dwayne] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada; [Miller, R. J. Dwayne] Univ Toronto, Dept Phys, 80 St George St, Toronto, ON M5S 3H6, Canada; [Pai, Emil F.] Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	Max Planck Society; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Hamburg; University of Potsdam; Max Planck Society; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Miller, RJD (corresponding author), Max Planck Inst Struct & Dynam Matter, Dept Atomically Resolved Dynam, Luruper Chaussee 149, D-22761 Hamburg, Germany.; Pai, EF (corresponding author), Univ Toronto, Dept Med Biophys, 101 Coll St, Toronto, ON M5G 1L7, Canada.; Pai, EF (corresponding author), Ontario Canc Inst, Campbell Family Canc Res Inst, 101 Coll St, Toronto, ON M5G 1L7, Canada.; Miller, RJD (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.; Miller, RJD (corresponding author), Univ Toronto, Dept Phys, 80 St George St, Toronto, ON M5S 3H6, Canada.; Pai, EF (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.; Pai, EF (corresponding author), Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	dwayne.miller@mpsd.mpg.de; emil.pai@utoronto.ca	Pai, Emil/R-8908-2019	Pai, Emil/0000-0002-1162-7242; Dsouza, Raison/0000-0003-4404-936X; Tellkamp, Friedjof/0000-0002-5670-3544	Max Planck Society; Cluster of Excellence "The Hamburg Centre for Ultrafast Imaging" of the Deutsche Forschungsgemeinschaft (DFG) [EXC 1074, 194651731]; European Union [623994]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-04877]; Canada Research Chairs program; Burroughs Wellcome Fund; Alexander von Humboldt-Stiftung	Max Planck Society(Max Planck SocietyFoundation CELLEX); Cluster of Excellence "The Hamburg Centre for Ultrafast Imaging" of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation)	Support was provided by the Max Planck Society and by the Cluster of Excellence "The Hamburg Centre for Ultrafast Imaging" of the Deutsche Forschungsgemeinschaft (DFG) -EXC 1074 -project ID 194651731 (R.J.D.M.), the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant no. 623994 (H. M. M.-W.), the Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-04877), the Canada Research Chairs program, and the Burroughs Wellcome Fund via a Collaborative Research Travel Grant (E. F. P.). P. M. was the recipient of an Alexander von Humboldt-Stiftung postdoctoral research award.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ball P, 2017, P NATL ACAD SCI USA, V114, P13327, DOI 10.1073/pnas.1703781114; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Chan PWY, 2011, J AM CHEM SOC, V133, P7461, DOI 10.1021/ja200277d; Chapman HN, 2019, ANNU REV BIOCHEM, V88, P35, DOI 10.1146/annurev-biochem-013118-110744; Cohen AE, 2016, PROTEIN PEPTIDE LETT, V23, P283, DOI 10.2174/0929866523666160107115015; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fenwick RB, 2018, J AM CHEM SOC, V140, P675, DOI 10.1021/jacs.7b09974; Givens RS, 2011, CAN J CHEM, V89, P364, DOI 10.1139/V10-143; GOLDMAN P, 1965, J BIOL CHEM, V240, P3434; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kabsch W, 2014, ACTA CRYSTALLOGR D, V70, P2204, DOI 10.1107/S1399004714013534; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kamachi T, 2009, CHEM-EUR J, V15, P7394, DOI 10.1002/chem.200801813; Keedy DA, 2014, STRUCTURE, V22, P899, DOI 10.1016/j.str.2014.04.016; Kim TH, 2017, SCIENCE, V355, DOI 10.1126/science.aag2355; Lemkul J, 2019, LIVING J COMPUT MOL, V1, P5068, DOI [10.33011/livecoms.1.1.5068, DOI 10.33011/LIVECOMS.1.1.5068]; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; MAKINEN MW, 1977, ANNU REV BIOPHYS BIO, V6, P301, DOI 10.1146/annurev.bb.06.060177.001505; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehrabi P, 2019, J AM CHEM SOC, V141, P11540, DOI 10.1021/jacs.9b03703; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; Moffat K, 2001, CHEM REV, V101, P1569, DOI 10.1021/cr990039q; Moffat K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0568; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; Nussinov R, 2014, J AM CHEM SOC, V136, P17692, DOI 10.1021/ja510028c; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Okazoe T, 2009, P JPN ACAD B-PHYS, V85, P276, DOI 10.2183/pjab.85.276; Owen RL, 2017, ACTA CRYSTALLOGR D, V73, P373, DOI 10.1107/S2059798317002996; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REDDY MR, 1989, CHEM PHYS LETT, V155, P173, DOI 10.1016/0009-2614(89)85344-8; Ren Z, 2013, ACTA CRYSTALLOGR D, V69, P946, DOI 10.1107/S0907444913003454; Russi S, 2017, J SYNCHROTRON RADIAT, V24, P73, DOI 10.1107/S1600577516017343; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; Schlichting I, 2015, IUCRJ, V2, P246, DOI 10.1107/S205225251402702X; Schmidt M., 2013, ADV COND MATTER PHYS, V2013, P1; Schulz EC, 2018, NAT METHODS, V15, P901, DOI 10.1038/s41592-018-0180-2; Schulz EC, 2017, J APPL CRYSTALLOGR, V50, P1773, DOI 10.1107/S1600576717014479; Sekhar A, 2019, ANNU REV BIOPHYS, V48, P297, DOI 10.1146/annurev-biophys-052118-115647; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Spence JCH, 2017, IUCRJ, V4, P322, DOI 10.1107/S2052252517005760; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wierman JL, 2019, IUCRJ, V6, P305, DOI 10.1107/S2052252519001453; Wodak SJ, 2019, STRUCTURE, V27, P566, DOI 10.1016/j.str.2019.01.003; Yu WB, 2012, J COMPUT CHEM, V33, P2451, DOI 10.1002/jcc.23067	57	44	44	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1167	+		10.1126/science.aaw9904	http://dx.doi.org/10.1126/science.aaw9904			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515393				2022-12-28	WOS:000485780800047
J	Zhao, H; Qiao, XD; Wu, TW; Midya, B; Longhi, S; Feng, L				Zhao, Han; Qiao, Xingdu; Wu, Tianwei; Midya, Bikashkali; Longhi, Stefano; Feng, Liang			Non-Hermitian topological light steering	SCIENCE			English	Article							STATES	Photonic topological insulators provide a route for disorder-immune light transport, which holds promise for practical applications. Flexible reconfiguration of topological light pathways can enable high-density photonics routing, thus sustaining the growing demand for data capacity. By strategically interfacing non-Hermitian and topological physics, we demonstrate arbitrary, robust light steering in reconfigurable non-Hermitian junctions, in which chiral topological states can propagate at an interface of the gain and loss domains. Our non-Hermitian-controlled topological state can enable the dynamic control of robust transmission links of light inside the bulk, fully using the entire footprint of a photonic topological insulator.	[Zhao, Han; Feng, Liang] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Qiao, Xingdu; Wu, Tianwei; Midya, Bikashkali; Feng, Liang] Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA; [Longhi, Stefano] Politecn Milan, Dipartimento Fis, Piazza L da Vinci 32, I-20133 Milan, Italy; [Longhi, Stefano] CNR, Ist Foton & Nanotecnol, Piazza L da Vinci 32, I-20133 Milan, Italy	University of Pennsylvania; University of Pennsylvania; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR)	Feng, L (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.; Feng, L (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.	fenglia@seas.upenn.edu	Longhi, Stefano/AAY-7537-2021; Zhao, Han/AAA-4556-2022; Longhi, Stefano/A-4215-2016	Longhi, Stefano/0000-0002-8739-3542; Longhi, Stefano/0000-0002-8739-3542; Zhao, Han/0000-0003-3181-5926	U.S. Army Research Office (ARO) [W911NF-19-1-0249]; National Science Foundation (NSF) [ECCS-1846766, CMMI-1635026]; NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC) [DMR-1720530]; NSF National Nanotechnology Coordinated Infrastructure Program [NNCI-1542153]	U.S. Army Research Office (ARO); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); NSF National Nanotechnology Coordinated Infrastructure Program	We acknowledge the support from U.S. Army Research Office (ARO) (W911NF-19-1-0249) and the National Science Foundation (NSF) (ECCS-1846766 and CMMI-1635026). This research was partially supported by NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC) (DMR-1720530). This work was carried out in part at the Singh Center for Nanotechnology, which is supported by the NSF National Nanotechnology Coordinated Infrastructure Program under grant NNCI-1542153.	Bahari B, 2017, SCIENCE, V358, P636, DOI 10.1126/science.aao4551; Bandres MA, 2018, SCIENCE, V359, DOI 10.1126/science.aar4005; Barik S, 2018, SCIENCE, V359, P666, DOI 10.1126/science.aaq0327; Blanco-Redondo A, 2018, SCIENCE, V362, P568, DOI 10.1126/science.aau4296; Cheng XJ, 2016, NAT MATER, V15, P542, DOI [10.1038/NMAT4573, 10.1038/nmat4573]; Dally W. J., 2004, PRINCIPLES PRACTICES; Dong JW, 2017, NAT MATER, V16, P298, DOI [10.1038/nmat4807, 10.1038/NMAT4807]; Doppler J, 2016, NATURE, V537, P76, DOI 10.1038/nature18605; Feng L, 2017, NAT PHOTONICS, V11, P752, DOI 10.1038/s41566-017-0031-1; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Jung M, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.086807; Khanikaev AB, 2013, NAT MATER, V12, P233, DOI [10.1038/nmat3520, 10.1038/NMAT3520]; Klembt S, 2018, NATURE, V562, P552, DOI 10.1038/s41586-018-0601-5; Kudyshev ZA, 2019, NANOPHOTONICS-BERLIN, V8, P1349, DOI 10.1515/nanoph-2019-0043; Leykam D, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.023901; Leykam D, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.040401; Mittal S, 2018, NATURE, V561, P502, DOI 10.1038/s41586-018-0478-3; Ozawa T, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.015006; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Poli C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7710; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Shalaev MI, 2019, OPTICA, V6, P839, DOI 10.1364/OPTICA.6.000839; Shalaev MI, 2019, NAT NANOTECHNOL, V14, P31, DOI 10.1038/s41565-018-0297-6; St-Jean P, 2017, NAT PHOTONICS, V11, P651, DOI 10.1038/s41566-017-0006-2; Takata K, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.213902; Testa F., 2017, OPTICAL SWITCHING NE; Yang B, 2018, SCIENCE, V359, P1013, DOI 10.1126/science.aaq1221; Zhou HY, 2018, SCIENCE, V359, P1009, DOI 10.1126/science.aap9859	29	170	171	16	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1163	+		10.1126/science.aay1064	http://dx.doi.org/10.1126/science.aay1064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515392				2022-12-28	WOS:000485780800046
J	Campanelli, A; Lubbe, J				Campanelli, Alexandre; Lubbe, Jann			Palmar Squamous-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 56-year-old man with a history of radiation therapy to the hands presented with a 2-cm ulcerated lesion on his right palm. Biopsy revealed squamous-cell carcinoma.	[Campanelli, Alexandre] Dermatol La Colline, Geneva, Switzerland		Campanelli, A (corresponding author), Dermatol La Colline, Geneva, Switzerland.	ac@derma-ge.ch							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					1058	1058		10.1056/NEJMicm1814119	http://dx.doi.org/10.1056/NEJMicm1814119			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY2MW	31509676				2022-12-28	WOS:000486225900013
J	Magaziner, J; Mangione, KK; Orwig, D; Baumgarten, M; Magder, L; Terrin, M; Fortinsky, RH; Gruber-Baldini, AL; Beamer, BA; Tosteson, ANA; Kenny, AM; Shardell, M; Binder, EF; Koval, K; Resnick, B; Miller, R; Forman, S; McBride, R; Craik, RL				Magaziner, Jay; Mangione, Kathleen K.; Orwig, Denise; Baumgarten, Mona; Magder, Laurence; Terrin, Michael; Fortinsky, Richard H.; Gruber-Baldini, Ann L.; Beamer, Brock A.; Tosteson, Anna N. A.; Kenny, Anne M.; Shardell, Michelle; Binder, Ellen F.; Koval, Kenneth; Resnick, Barbara; Miller, Ram; Forman, Sandra; McBride, Ruth; Craik, Rebecca L.			Effect of a Multicomponent Home-Based Physical Therapy Intervention on Ambulation After Hip Fracture in Older Adults: The CAP Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI NUTRITIONAL ASSESSMENT; PERFORMANCE-MEASURES; SAMPLE-SIZE; PROGRAM; REHABILITATION; RECOVERY; IDENTIFICATION; NONADHERENCE; VALIDATION; VELOCITY	ImportanceDisability persists after hip fracture in older persons. Current rehabilitation may not be sufficient to restore ability to walk in the community. ObjectiveTo compare a multicomponent home-based physical therapy intervention (training) with an active control on ability to walk in the community. Design, Setting, and ParticipantsParallel, 2-group randomized clinical trial conducted at 3 US clinical centers (Arcadia University, University of Connecticut Health Center, and University of Maryland, Baltimore). Randomization began on September 16, 2013, and ended on June 20, 2017; follow-up ended on October 17, 2017. Patients aged 60 years and older were enrolled after nonpathologic, minimal trauma hip fracture, if they were living in the community and walking without human assistance before the fracture, were assessed within 26 weeks of hospitalization, and were not able to walk during daily activities at the time of enrollment. A total of 210 participants were randomized and reassessed 16 and 40 weeks later. InterventionsThe training intervention (active treatment) (n=105) included aerobic, strength, balance, and functional training. The active control group (n=105) received transcutaneous electrical nerve stimulation and active range-of-motion exercises. Both groups received 2 to 3 home visits from a physical therapist weekly for 16 weeks; nutritional counseling; and daily vitamin D (2000 IU), calcium (600 mg), and multivitamins. Main Outcomes and MeasuresThe primary outcome (community ambulation) was defined as walking 300 m or more in 6 minutes at 16 weeks after randomization. The study was designed to test a 1-sided hypothesis of superiority of training compared with active control. ResultsAmong 210 randomized participants (mean age, 80.8 years; 161 women [76.7%]), 197 (93.8%) completed the trial (187 [89.0%] by completing the 6-minute walk test at 16 weeks and 10 [4.8%] by adjudication of the primary outcome). Among these, 22 of 96 training participants (22.9%) and 18 of 101 active control participants (17.8%) (difference, 5.1% [1-sided 97.5% CI, -infinity to 16.3%]; 1-sided P=.19) became community ambulators. Seventeen training participants (16.2%) and 15 control participants (14.3%) had 1 or more reportable adverse events during the intervention period. The most common reportable adverse events reported were falls (training: 6 [5.7%], control: 4 [3.8%]), femur/hip fracture (2 in each group), pneumonia (training: 2, control: 0), urinary tract infection (training: 2, control: 0), dehydration (training: 0, control: 2), and dyspnea (training: 0, control: 2). Conclusions and RelevanceAmong older adults with a hip fracture, a multicomponent home-based physical therapy intervention compared with an active control that included transcutaneous electrical nerve stimulation and active range-of-motion exercises did not result in a statistically significant improvement in the ability to walk 300 m or more in 6 minutes after 16 weeks.	[Magaziner, Jay; Orwig, Denise; Baumgarten, Mona; Magder, Laurence; Terrin, Michael; Gruber-Baldini, Ann L.; Shardell, Michelle; Forman, Sandra] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 660 W Redwood St,Ste 200, Baltimore, MD 21201 USA; [Mangione, Kathleen K.; Craik, Rebecca L.] Arcadia Univ, Coll Hlth Sci, Dept Phys Therapy, Glenside, PA USA; [Fortinsky, Richard H.] UConn Hlth, UConn Ctr Aging, Farmington, CT USA; [Beamer, Brock A.] Baltimore Vet Affairs Med Ctr, GRECC, Baltimore, MD USA; [Beamer, Brock A.] Univ Maryland, Sch Med, Div Gerontol & Geriatr Med, Baltimore, MD 21201 USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, Dept Med, Hanover, NH USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; [Kenny, Anne M.] UConn Hlth, Dept Med, Farmington, CT USA; [Shardell, Michelle] NIA, NIH, Baltimore, MD 21224 USA; [Binder, Ellen F.] Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO USA; [Koval, Kenneth] Orlando Reg Med Ctr Inc, Dept Orthopaed Surg, Orlando, FL USA; [Resnick, Barbara] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Miller, Ram] Novartis Inst BioMed Res, Cambridge, MA USA; [McBride, Ruth] Axio Res LLC, Seattle, WA USA	University System of Maryland; University of Maryland Baltimore; University of Connecticut; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore; Dartmouth College; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Washington University (WUSTL); Orlando Regional Medical Center; University System of Maryland; University of Maryland Baltimore; Novartis	Magaziner, J (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 660 W Redwood St,Ste 200, Baltimore, MD 21201 USA.			Mangione, Kathleen/0000-0003-1214-4426	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Aging at the National Institutes of Health [R01 AG035009, R21 HD043269, R37 AG09901, T32 AG00262, P30 AG028747]; University of Maryland, Baltimore, Institute for Clinical and Translational Research; VA Maryland Health Care System; Baltimore VA Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028747, T32AG000262, R01AG035009, R37AG009901, R01AG048069] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Maryland, Baltimore, Institute for Clinical and Translational Research; VA Maryland Health Care System; Baltimore VA Medical Center(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute on Aging at the National Institutes of Health (R01 AG035009, R21 HD043269, R37 AG09901, T32 AG00262, and P30 AG028747). We also acknowledge support from the University of Maryland, Baltimore, Institute for Clinical and Translational Research. This material is the result of work supported with resources and the use of facilities at the VA Maryland Health Care System and Baltimore VA Medical Center.	Alley DE, 2011, J AM GERIATR SOC, V59, P1650, DOI 10.1111/j.1532-5415.2011.03560.x; [Anonymous], 2016, PACKAGE GSDESIGN GRO; Picorelli AMA, 2014, J PHYSIOTHER, V60, P151, DOI 10.1016/j.jphys.2014.06.012; Babatunde F, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2311-3; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; Brown CA, 2012, J ORTHOP TRAUMA, V26, P117, DOI 10.1097/BOT.0b013e318219c61a; Brown M, 2000, J GERONTOL A-BIOL, V55, pM350, DOI 10.1093/gerona/55.6.M350; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dyer SM, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0332-0; Fay MP, 2007, BIOMETRICS, V63, P465, DOI 10.1111/j.1541-0420.2006.00703.x; Freedman VA, 2011, J GERONTOL A-BIOL, V66, P1013, DOI 10.1093/gerona/glr087; Guigoz Y, 1996, NUTR REV, V54, pS59; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Handoll HHG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001704.pub3; Hauer K, 2002, AGE AGEING, V31, P49, DOI 10.1093/ageing/31.1.49; HWANG IK, 1990, STAT MED, V9, P1439, DOI 10.1002/sim.4780091207; Jones TG, 2002, ARCH CLIN NEUROPSYCH, V17, P171, DOI 10.1016/S0887-6177(00)00108-6; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Langlois JA, 1997, AM J PUBLIC HEALTH, V87, P393, DOI 10.2105/AJPH.87.3.393; Latham NK, 2014, JAMA-J AM MED ASSOC, V311, P700, DOI 10.1001/jama.2014.469; Lavin KM, 2019, PHYSIOLOGY, V34, P112, DOI 10.1152/physiol.00044.2018; Lee KB, 2015, TOP STROKE REHABIL, V22, P63, DOI 10.1179/1074935714Z.0000000001; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Orwig D, 2017, J Physiother, V63, P45, DOI 10.1016/j.jphys.2016.10.001; Osho O, 2018, J AGING PHYS ACTIV, V26, P304, DOI 10.1123/japa.2016-0326; Palombaro KM, 2006, PHYS THER, V86, P809, DOI 10.1093/ptj/86.6.809; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Resnick B, 2007, ANN BEHAV MED, V34, P67, DOI 10.1007/BF02879922; ROBINETT CS, 1988, PHYS THER, V68, P1371, DOI 10.1093/ptj/68.9.1371; Salpakoski A, 2014, J AM MED DIR ASSOC, V15, P361, DOI 10.1016/j.jamda.2013.12.083; Sayers SP, 2005, J AM GERIATR SOC, V53, P467, DOI 10.1111/j.1532-5415.2005.53166.x; Shardell MD, 2009, BIOMETRICS, V65, P635, DOI 10.1111/j.1541-0420.2008.01114.x; Stevens JA, 2013, OSTEOPOROSIS INT, V24, P2725, DOI 10.1007/s00198-013-2375-9; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; WINTER DA, 1995, GAIT ANAL THEORY APP, P252	40	35	36	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					946	956		10.1001/jama.2019.12964	http://dx.doi.org/10.1001/jama.2019.12964			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY6YZ	31503309	Green Published, Bronze			2022-12-28	WOS:000486543500016
J	Flannery, AM				Flannery, Ann Marie			Comparing antibiotic, silver, and standard ventriculoperitoneal shunts	LANCET			English	Editorial Material							SYSTEMS		[Flannery, Ann Marie] Our Lady Lourdes Womens & Childrens Hosp, Kids Specialty Ctr, Lafayette, LA 70508 USA		Flannery, AM (corresponding author), Our Lady Lourdes Womens & Childrens Hosp, Kids Specialty Ctr, Lafayette, LA 70508 USA.	annmarie.flannery@fmolhs.org						Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Klimo P, 2014, J NEUROSURG-PEDIATR, V14, P53, DOI 10.3171/2014.7.PEDS14327; Klimo P, 2011, J NEUROSURG-PEDIATR, V8, P600, DOI 10.3171/2011.8.PEDS11346; Mallucci CL, 2019, LANCET, V394, P1530, DOI 10.1016/S0140-6736(19)31603-4; Vinchon M, 2006, CHILD NERV SYST, V22, P692, DOI 10.1007/s00381-005-0037-8	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2019	394	10208					1485	1486		10.1016/S0140-6736(19)32085-9	http://dx.doi.org/10.1016/S0140-6736(19)32085-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JI3WL	31522850	hybrid			2022-12-28	WOS:000493399500006
J	Hecht, J				Hecht, Jeff			Fixing a broken record	NATURE			English	Editorial Material																		Arndt BG, 2017, ANN FAM MED, V15, P419, DOI 10.1370/afm.2121; Dinov Ivo D, 2016, J Med Stat Inform, V4; Liberatore K, 2018, PA PATIENT SAF ADV S, V15, P16; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023	4	14	15	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					S114	S116		10.1038/d41586-019-02876-y	http://dx.doi.org/10.1038/d41586-019-02876-y			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554991	Bronze			2022-12-28	WOS:000488247600018
J	Segal, M				Segal, Michael			An operating system for the biology lab	NATURE			English	Editorial Material																			0	3	3	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					S112	S113		10.1038/d41586-019-02875-z	http://dx.doi.org/10.1038/d41586-019-02875-z			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554992	Bronze			2022-12-28	WOS:000488247600017
J	O'Donnell, A; Anderson, P; Jane-Llopis, E; Manthey, J; Kaner, E; Rehm, J				O'Donnell, Amy; Anderson, Peter; Jane-Llopis, Eva; Manthey, Jakob; Kaner, Eileen; Rehm, Juergen			Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COST-EFFECTIVENESS; CONSUMPTION; DRINKERS; POLICIES; HEALTH; TAX; INTERVENTIONS; DRINKING; SALES	OBJECTIVE To assess the immediate impact of the introduction of minimum unit pricing in Scotland on household alcohol purchases. DESIGN Controlled interrupted time series analysis. SETTING Purchase data from Kantar Worldpanel's household shopping panel for 2015-18. PARTICIPANTS 5325 Scottish households, 54807 English households as controls, and 10040 households in northern England to control for potential cross border effects. INTERVENTIONS Introduction of a minimum price of 50p ((sic)0.55; $0.61) per UK unit (6.25p per gram) for the sale of alcohol in Scotland on 1 May 2018. MAIN OUTCOME MEASURES Price per gram of alcohol, number of grams of alcohol purchased from off-trade by households, and weekly household expenditure on alcohol. RESULTS The introduction of minimum unit pricing in Scotland was associated with an increase in purchase price of 0.64p per gram of alcohol (95% confidence interval 0.54 to 0.75), a reduction in weekly purchases of 9.5 g of alcohol per adult per household (5.1 to 13.9), and a non-significant increase in weekly expenditure on alcohol per household of 61p (-5 to 127). The increase in purchase price was higher in lower income households and in households that purchased the largest amount of alcohol. The reduction in purchased grams of alcohol was greater in lower income households and only occurred in the top fifth of households by income that purchased the greatest amount of alcohol, where the reduction was 15 g of alcohol per week (6 to 24). Changes in weekly expenditure were not systematically related to household income but increased with increasing household purchases. CONCLUSIONS In terms of immediate impact, the introduction of minimum unit pricing appears to have been successful in reducing the amount of alcohol purchased by households in Scotland. The action was targeted, in that reductions of purchased alcohol only occurred in the households that bought the most alcohol.	[O'Donnell, Amy; Anderson, Peter; Kaner, Eileen] Newcastle Univ, Inst Hlth & Soc, Baddiley Clark Bldg, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Anderson, Peter; Jane-Llopis, Eva] Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Jane-Llopis, Eva; Rehm, Juergen] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON, Canada; [Jane-Llopis, Eva] Ramon Llull Univ, ESADE Business Sch, Barcelona, Spain; [Manthey, Jakob; Rehm, Juergen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Manthey, Jakob] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Ctr Interdisciplinary Addict Res, Hamburg, Germany; [Rehm, Juergen] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Rehm, Juergen] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] IM Sechenov First Moscow State Med Univ, Inst Leadership & Hlth Management, Dept Int Hlth Projects, Moscow, Russia	Newcastle University - UK; Maastricht University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Universitat Ramon Llull; Escuela Superior de Administracion y Direccion de Empresas (ESADE); Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Sechenov First Moscow State Medical University	Anderson, P (corresponding author), Newcastle Univ, Inst Hlth & Soc, Baddiley Clark Bldg, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.; Anderson, P (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands.	peter.anderson@newcastle.ac.uk	Kaner, Eileen/ABF-2444-2020	O'Donnell, Amy/0000-0003-4071-9434; Jane Llopis, Eva/0000-0002-1739-3635				Adams J, 2012, ALCOHOL ALCOHOLISM, V47, P187, DOI 10.1093/alcalc/agr159; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Angus C., 2016, MODEL BASED APPRAISA; Beard E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160666; Bernal JL, 2018, INT J EPIDEMIOL, V47, P2082, DOI 10.1093/ije/dyy135; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Biglan A, 2000, Prev Sci, V1, P31, DOI 10.1023/A:1010024016308; Black H, 2011, ADDICTION, V106, P729, DOI 10.1111/j.1360-0443.2010.03225.x; Boniface Sadie, 2017, BMJ Open, V7, pe013497, DOI 10.1136/bmjopen-2016-013497; Booth A, 2008, INDEPENDENT REV EF A; Box G. E. P., 1970, Time series analysis, forecasting and control; Burton R, 2017, LANCET, V389, P1558, DOI 10.1016/S0140-6736(16)32420-5; Chisholm D, 2018, J STUD ALCOHOL DRUGS, V79, P514, DOI 10.15288/jsad.2018.79.514; CHRISTIE B, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5302; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Ejebu O-Z, 2018, NORDIC J HLTH EC; Elder RW, 2010, AM J PREV MED, V38, P217, DOI 10.1016/j.amepre.2009.11.005; Erickson RA, 2018, DRUG ALCOHOL REV, V37, pS174, DOI 10.1111/dar.12649; Forsyth AJM, 2014, ALCOHOL ALCOHOLISM, V49, P96, DOI 10.1093/alcalc/agt175; Fretheim A, 2013, J CLIN EPIDEMIOL, V66, P883, DOI 10.1016/j.jclinepi.2013.03.016; Giles L, 2018, 6 MONTHS IMPLEMENTAT; Gill J, 2017, ALCOHOL ALCOHOLISM, V52, P722, DOI 10.1093/alcalc/agx060; Gilmore I, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g23; Gorman E, 2014, AM J EPIDEMIOL, V180, P941, DOI 10.1093/aje/kwu207; Gruenewald PJ, 2006, ALCOHOL CLIN EXP RES, V30, P96, DOI 10.1111/j.1530-0277.2006.00011.x; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; Leicester A, 2012, MIGHT IN HOME SCANNE, DOI [10.1920/wp.ifs.2012.1201, DOI 10.1920/WP.IFS.2012.1201]; Lewer D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3265-9; Ludbrook A, 2012, APPL HEALTH ECON HEA, V10, P51, DOI 10.2165/11594840-000000000-00000; Makela P, 2008, J EPIDEMIOL COMMUN H, V62, P728, DOI 10.1136/jech.2007.065672; Makridakis S, 1983, FORECASTING METHODS; Martineau F, 2013, PREV MED, V57, P278, DOI 10.1016/j.ypmed.2013.06.019; Meier PS, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001963; National Readership Survey, 2019, SOC GRAD LOND NAT RE; National Records of Scotland, 2018, EST HOUS DWELL SCOTL; NHS Health Scotland, 2016, MESAS ALC SAL PRIC U; NHS Health Scotland, 2017, MIN UN PRIC MUP EV E; O'May F, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016657141; ODOWD A, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F4622; Patra J., 2012, CONT DRUG PROBL, V39, P7, DOI [10.1177/009145091203900103, DOI 10.1177/009145091203900103]; Pechey R, 2013, SOC SCI MED, V92, P22, DOI 10.1016/j.socscimed.2013.05.012; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Scotland NH, 2016, MON EV SCOTL ALC STR; Shadish W. R., 2001, EXPT QUASIEXPERIMENT, V2nd; Sheffield Alcohol Research Group, 2017, EV IMP MIN UN PRIC S; Sherk A, 2018, DRUG ALCOHOL REV, V37, pS357, DOI 10.1111/dar.12670; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; Stockwell T, 2017, DRUG ALCOHOL REV, V36, P492, DOI 10.1111/dar.12471; Stockwell T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5617; Stockwell T, 2013, AM J PUBLIC HEALTH, V103, P2014, DOI 10.2105/AJPH.2013.301289; Stockwell Tim, 2012, Am J Public Health, V102, pe103, DOI 10.2105/AJPH.2012.301094; Stockwell T, 2012, ADDICTION, V107, P912, DOI 10.1111/j.1360-0443.2011.03763.x; Vandenberg B, 2016, ALCOHOL ALCOHOLISM, V51, P493, DOI 10.1093/alcalc/agv133; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Welsh Government, 2019, WRITT STAT WELSH GOV; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X; Zhao JH, 2017, ADDICTION, V112, P1942, DOI 10.1111/add.13902; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	60	83	83	6	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2019	366								l5274	10.1136/bmj.l5274	http://dx.doi.org/10.1136/bmj.l5274			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB3WY	31554617	hybrid, Green Published			2022-12-28	WOS:000488488700002
J	Iacobucci, G				Iacobucci, Gareth			New GP leader Martin Marshall: "We're definitely heading in the right direction"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com						Bostock N., HANCOCK SET NEW DEAD; Department of Health and Social Care, NHS LONG TERM PLAN; Hancock M., 2018, MY PRIORITIES HLTH S; HAWKES N, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2393; IACOBUCCI G, 2019, BMJ-BRIT MED J, V366, P72997, DOI DOI 10.1136/BMJ.L4557; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, P5083, DOI DOI 10.1136/BMJ.L521; IACOBUCCI G, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K4045; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, P17145, DOI DOI 10.1136/BMJ.L85; MAHASE E, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L4829; Moberly Tom, 2018, BMJ, V360, pk1367, DOI 10.1136/bmj.k1367; ODOWD A, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K3934	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5586	10.1136/bmj.l5586	http://dx.doi.org/10.1136/bmj.l5586			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551316				2022-12-28	WOS:000488488300005
J	Slomski, A				Slomski, Anita			Adjuvant Therapy for HER2-Positive Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1134	1134		10.1001/jama.2019.14757	http://dx.doi.org/10.1001/jama.2019.14757			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550031				2022-12-28	WOS:000488822800011
J	[Anonymous]				[Anonymous]			Miscellany (Reprinted from JAMA, vol 23, pg 520, 1894)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1894, JAMA, V23, P520	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1217	1217		10.1001/jama.2018.15528	http://dx.doi.org/10.1001/jama.2018.15528			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550018				2022-12-28	WOS:000488822800029
J	Krishnan, L; Marchalik, D				Krishnan, Lakshmi; Marchalik, Daniel			Physicians, oaths, and vampires	LANCET			English	Editorial Material									[Krishnan, Lakshmi] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Krishnan, Lakshmi] Johns Hopkins Univ, Sch Med, Inst Hist Med, Baltimore, MD USA; [Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA	Johns Hopkins University; Johns Hopkins University; Georgetown University	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					1001	1001		10.1016/S0140-6736(19)32098-7	http://dx.doi.org/10.1016/S0140-6736(19)32098-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31544738				2022-12-28	WOS:000487038700014
J	Aronowitz, R; Greene, JA				Aronowitz, Robert; Greene, Jeremy A.			Contingent Knowledge and Looping Effects - A 66-Year-Old Man with PSA-Detected Prostate Cancer and Regrets	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 66-year-old man with PSA-detected prostate cancer undergoes prostatectomy that leaves him impotent - a decision he regrets when new evidence becomes available. How can the largely social processes by which we identify diseases transform diseases themselves?	[Aronowitz, Robert] Univ Penn, Philadelphia, PA 19104 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Baltimore, MD USA	University of Pennsylvania; Johns Hopkins University	Aronowitz, R (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.							Aronowitz Robert, 2015, RISKY MED OUR QUEST; Esserman LJ, 2014, LANCET ONCOL, V15, pE234, DOI 10.1016/S1470-2045(13)70598-9; Prasad Vinay, 2011, Yale Journal of Biology and Medicine, V84, P471; ROSENBERG CE, 1977, PERSPECT BIOL MED, V20, P485; 2006, LONDON REV BOOKS, V28, P23	5	2	2	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1093	1096		10.1056/NEJMp1811521	http://dx.doi.org/10.1056/NEJMp1811521			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4PY	31532956				2022-12-28	WOS:000487066900002
J	Garcia, KC				Garcia, K. Christopher			Dual Arms of Adaptive Immunity: Division of Labor and Collaboration between B and T Cells	CELL			English	Editorial Material							THYMUS; BURSA; SYSTEM	This year's Lasker Basic Medical Research Award honors Max Cooper and Jacques Miller for discoveries that revealed the organizing principles of adaptive immunity. Their collective contributions have had broad clinical impact in the treatment of immune disease.	[Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Beckman B171B,279 Campus Dr, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Struct Biol, Beckman B171B,279 Campus Dr, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Beckman B171B,279 Campus Dr, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Struct Biol, Beckman B171B,279 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu			Howard Hughes Medical Institute; Parker Institute for Cancer Immunotherapy; NIH	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Parker Institute for Cancer Immunotherapy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	author gratefully acknowledges helpful discussions with Michel Nussenzweig, Jeff Ravetch, and Craig Thompson. The author is supported by Howard Hughes Medical Institute, NIH, and the Parker Institute for Cancer Immunotherapy.	[Anonymous], 1960, Science, V132, P1300; CHASE MW, 1985, ANNU REV IMMUNOL, V3, P1; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; KINCADE PW, 1970, P NATL ACAD SCI USA, V67, P1918, DOI 10.1073/pnas.67.4.1918; MILLER JF, 1961, LANCET, V2, P748; MILLER JF, 1961, NATURE, V191, P248, DOI 10.1038/191248a0; MILLER JFA, 1967, NATURE, V216, P659, DOI 10.1038/216659a0; MILLER JFA, 1968, J EXP MED, V128, P801, DOI 10.1084/jem.128.4.801; MILLER JFAP, 1962, PROC R SOC SER B-BIO, V156, P415, DOI 10.1098/rspb.1962.0048; MITCHELL BG, 1968, P NATL ACAD SCI USA, V59, P296, DOI 10.1073/pnas.59.1.296; NOSSAL GJV, 1958, NATURE, V181, P1419, DOI 10.1038/1821383a0; OWEN JJT, 1974, NATURE, V249, P361, DOI 10.1038/249361a0; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740	16	7	8	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					3	7		10.1016/j.cell.2019.08.022	http://dx.doi.org/10.1016/j.cell.2019.08.022			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31519306	Bronze			2022-12-28	WOS:000486618500002
J	Leslie, BR; Gerwin, LE; Taylor, SI				Leslie, Bruce R.; Gerwin, Leslie E.; Taylor, Simeon I.			Sodium-Glucose Cotransporter-2 Inhibitors: Lack of a Complete History Delays Diagnosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TYPE-2 DIABETES-MELLITUS; SGLT2 INHIBITOR; JAPANESE PATIENTS; RENAL GLYCOSURIA; POOLED ANALYSIS; DAPAGLIFLOZIN; PHLORHIZIN; METABOLISM; SAFETY; CANAGLIFLOZIN	On 15 May 2015, the U.S. Food and Drug Administration (FDA) warned that administration of sodium-glucose cotransporter-2 (SGLT2) inhibitors could lead to ketoacidosis in patients with diabetes mellitus. This announcement came more than 2 years after the FDA's first approval of an SGLT2 inhibitor, although the phenomenon had been known for more than 125 years. Luminaries of diabetes research (including Josef von Mering, Frederick Allen, I. Arthur Mirsky, and George Cahill) had described ketosis and ketoacidosis induced by administration of the phyto-chemical phlorizin, the prototypical SGLT inhibitor, as well as in patients with familial renal glucosuria, a condition that is considered a natural model of SGLT2 inhibition. Neither government regulators nor manufacturers of SGLT2 inhibitors evinced an awareness of this extensive historical record. The absence of historical inquiry delayed notice of ketoacidosis as an adverse reaction, which could have reduced the burden of illness from these drugs.	[Leslie, Bruce R.] Seventh Doctor Consulting, 213 Carnegie Ctr 3023, Princeton, NJ 08543 USA; [Gerwin, Leslie E.] Princeton Univ, Program Law & Publ Affairs, 343 Wallace Hall, Princeton, NJ 08544 USA; [Taylor, Simeon I.] Univ Maryland, Sch Med, MSTF 357-B,655 West Baltimore St, Baltimore, MD 21201 USA	Princeton University; University System of Maryland; University of Maryland Baltimore	Leslie, BR (corresponding author), Seventh Doctor Consulting, 213 Carnegie Ctr 3023, Princeton, NJ 08543 USA.	seventhdoctor@gmail.com						Achard C, 1899, B MEM SOC MED HOP P, V16, P379; Allan FN, 1930, AM J MED SCI, V180, P670, DOI 10.1097/00000441-193011000-00011; Allen F.M., 1919, MONOGRAPHS ROCKEFELL, V11; Allen FM, 1923, J METAB RES, V4, P223; AMARALPHILLIPS DM, 1993, J DAIRY SCI, V76, P752, DOI 10.3168/jds.S0022-0302(93)77399-3; AMATRUDA THOMAS T., 1959, YALE JOUR BIOL AND MED, V31, P303; [Anonymous], 1918, JAMA-J AM MED ASSOC, V71, P694; Babson SG, 1940, J PEDIATR-US, V17, P781, DOI 10.1016/S0022-3476(40)80023-1; Baer J, 1904, ARCH EXP PATHOL PHAR, V51, P271, DOI 10.1007/BF02134610; Benedict SR, 1914, P SOC EXP BIOL MED, V12, P45; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Center for Drug Evaluation and Research, 2013, APPL 204042ORIG1S000; Center for Drug Evaluation and Research, 2013, APPL 204629ORIG1S000; Chamberlain CE, 2014, 2014530 OSE RCM FDA; Chamberlain CE, 2015, 2014530 OSE RCM FDA; Chasis H, 1933, J CLIN INVEST, V12, P1083, DOI 10.1172/JCI100559; de Koninck L, 1835, ANN PHARM, V15, P75, DOI [DOI 10.1002/JLAC.18350150105, 10.1002/jlac.18350150105]; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Erondu N, 2015, DIABETES CARE, V38, P1680, DOI 10.2337/dc15-1251; Ets HN, 1924, AM J PHYSIOL, V70, P240; Evaluation and Licensing Division Pharmaceutical and Food Safety Bureau, 2014, REP DEL RES FORX TAB; Evaluation and Licensing Division Pharmaceutical and Food Safety Bureau, 2013, REP DEL RES SUGL TAB; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; FRANCOIS R, 1953, CR HEBD ACAD SCI, V236, P238; Gallo LA, 2015, DIABETES VASC DIS RE, V12, P78, DOI 10.1177/1479164114561992; GAMMELTOFT A, 1950, ACTA PHYSIOL SCAND, V19, P270; Geelmuyden HC, 1898, H-S Z PHYSIOL CHEM, V26, P381; Ghezzi C, 2018, DIABETOLOGIA, V61, P2087, DOI 10.1007/s00125-018-4656-5; GRAHAM G, 1956, Practitioner, V177, P639; Hamblin PS, 2019, J CLIN ENDOCR METAB, V104, P3077, DOI 10.1210/jc.2019-00139; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Inagaki N, 2013, DIABETES OBES METAB, V15, P1136, DOI 10.1111/dom.12149; Inagaki N, 2015, J DIABETES INVEST, V6, P210, DOI 10.1111/jdi.12266; Jabbour S, 2018, DIABETES OBES METAB, V20, P620, DOI 10.1111/dom.13124; JACKSON HD, 1966, AM J VET RES, V27, P885; Kaku K, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-65; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Kohler S, 2017, ADV THER, V34, P1707, DOI 10.1007/s12325-017-0573-0; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P520, DOI 10.1038/clpt.2008.251; LEMIEUX G, 1968, METABOLISM, V17, P620, DOI 10.1016/0026-0495(68)90021-8; LYLE RR, 1984, J DAIRY SCI, V67, P2255, DOI 10.3168/jds.S0022-0302(84)81573-8; MCKEE FW, 1945, PHYSIOL REV, V25, P255, DOI 10.1152/physrev.1945.25.2.255; Meng W, 2008, J MED CHEM, V51, P1145, DOI 10.1021/jm701272q; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Mirsky IA, 1937, AM J PHYSIOL, V118, P290, DOI 10.1152/ajplegacy.1937.118.2.290; Mirsky IA, 1942, J AMER MED ASSOC, V118, P690, DOI 10.1001/jama.1942.02830090008002; Mirsky IA, 1941, ENDOCRINOLOGY, V28, P358; Mirsky IA., 1941, PROC AM DIABETES ASS, V1, P49; Overton TR, 1998, J ANIM SCI, V76, P2938; Peters AL, 2015, DIABETES CARE, V38, P1687, DOI 10.2337/dc15-0843; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; Savage MW, 2011, DIABETIC MED, V28, P508, DOI 10.1111/j.1464-5491.2011.03246.x; SHAW JC, 1956, J DAIRY SCI, V39, P402, DOI 10.3168/jds.S0022-0302(56)94765-8; Shetty KD, 2011, J AM MED INFORM ASSN, V18, P668, DOI 10.1136/amiajnl-2011-000096; Squibb Bristol-Myers, 2011, JUL 19 2011 M END ME; Tsujihara K, 1999, J MED CHEM, V42, P5311, DOI 10.1021/jm990175n; U. S. Food and Drug Administration, 2013 M MAT END MET D; U. S. Food and Drug Administration, 2014, DRUG APPR PACK FARX; U. S. Food and Drug Administration, 2013, DRUG APPR PACK INV C; U. S. Food and Drug Administration, 2014, DRUG APPR PACK JARD; U. S. Food and Drug Administration, 2011 M MAT END MET D; US Food and Drug Administration, 2015, FDA DRUG SAF COMM FD; Von Mering J, 1893, THERAPEUT MONATSSCHR, V7, P577; von Mering J., 1887, VERHANDL C INNERE ME, V6, P349; von Mering J., 1886, VERH K INN MED, V5, P185; von Mering J., 1890, ARCH EXP PATHOL PH, V26, P371, DOI DOI 10.1007/BF01831214; VONMERING J, 1889, Z KLIN MED, V16, P431; Wang YT, 2017, DIABETES RES CLIN PR, V128, P83, DOI 10.1016/j.diabres.2017.04.004; Wierzuchowski M, 1927, J BIOL CHEM, V73, P445; Yokono M, 2014, EUR J PHARMACOL, V727, P66, DOI 10.1016/j.ejphar.2014.01.040	72	6	6	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					421	+		10.7326/M19-1463	http://dx.doi.org/10.7326/M19-1463			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525753				2022-12-28	WOS:000486101400016
J	Sancar, F				Sancar, Feyza			Textured Breast Implant Recall	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1036	1036		10.1001/jama.2019.14152	http://dx.doi.org/10.1001/jama.2019.14152			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31528994				2022-12-28	WOS:000488821100009
J	Wickramage, K; Simpson, PJ; Abbasi, K				Wickramage, Kolitha; Simpson, Paul J.; Abbasi, Kamran			Improving the health of migrants Toxic narratives complicate rational debates and hinder workable solutions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MIGRATION		[Wickramage, Kolitha] Int Org Migrat, Geneva, Switzerland; [Simpson, Paul J.; Abbasi, Kamran] BMJ, London, England	International Organization for Migration	Wickramage, K (corresponding author), Int Org Migrat, Geneva, Switzerland.	kwickramage@iom.int		Simpson, Paul/0000-0002-5069-8588				Abubakar I, 2018, LANCET, V392, P2606, DOI 10.1016/S0140-6736(18)32114-7; IOM, 2017, MIGR HLTH RES ADV EV; IOM, 2018, DAT B SER INF IMPL G; IOM WHO Government of Sri Lanka, 2017, REP 2 GLOB CONS MIGR; Juarez SP, 2019, LANCET GLOB HEALTH, V7, pE420, DOI 10.1016/S2214-109X(18)30560-6; Legido-Quigley H, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4160; Lougarre C, 2016, HEALTH HUM RIGHTS, V18, P35; Spitzer D, 2019, BMJ-BRIT MED J, V366, pl4526; Suphanchaimat R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061016; Sweileh WM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5689-x; Trummer U, 2017, EUR J PUBLIC HEALTH, V27, P590, DOI 10.1093/eurpub/ckx087; Vearey J, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4143; WHO, 2018, REP SIT AN PRACT ADD; Wickramage K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5932-5	14	7	7	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l5324	10.1136/bmj.l5324	http://dx.doi.org/10.1136/bmj.l5324			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VP	31527076	hybrid, Green Published			2022-12-28	WOS:000487758000004
J	Galton, R				Galton, Riley			The parent trap	SCIENCE			English	Editorial Material									[Galton, Riley] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Galton, R (corresponding author), CALTECH, Pasadena, CA 91125 USA.								0	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1214	1214		10.1126/science.365.6458.1214	http://dx.doi.org/10.1126/science.365.6458.1214			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515396				2022-12-28	WOS:000485780800051
J	Kremer, TM; Lindsay, ME; Kinane, TB; Hawley, MH; Little, BP; Mino-Kenudson, M				Kremer, Ted M.; Lindsay, Mark E.; Kinane, T. Bernard; Hawley, Megan H.; Little, Brent P.; Mino-Kenudson, Mari			Case 28-2019: A 22-Year-Old Woman with Dyspnea and Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EHLERS-DANLOS-SYNDROME; INTERSTITIAL LUNG-DISEASE; PERIVENTRICULAR HETEROTOPIA; FILAMIN; EMPHYSEMA; DYSPLASIA	A 22-year-old woman with congenital heart disease and joint laxity presented to the hospital because of chest pain, cough, and dyspnea. When she was 2 months of age, bronchiolitis had developed, and at 24 months she had undergone a right upper lobectomy for congenital lobar emphysema. A diagnostic test was performed.	[Kremer, Ted M.] Univ Massachusetts, Med Ctr, Dept Pediat, UMass Mem Med Ctr, Worcester, MA 01655 USA; [Kremer, Ted M.] Univ Massachusetts, Med Ctr, Dept Pediat, Worcester, MA 01655 USA; [Kremer, Ted M.; Lindsay, Mark E.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Little, Brent P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lindsay, Mark E.; Kinane, T. Bernard] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Little, Brent P.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Mino-Kenudson, Mari] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Hawley, Megan H.] Partners HealthCare Personalized Med, Lab Mol Med, Cambridge, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Partners Healthcare System	Kremer, TM (corresponding author), Univ Massachusetts, Med Ctr, Dept Pediat, UMass Mem Med Ctr, Worcester, MA 01655 USA.; Kremer, TM (corresponding author), Univ Massachusetts, Med Ctr, Dept Pediat, Worcester, MA 01655 USA.; Kremer, TM (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							[Anonymous], 1994, Chest, V106, P1223; [Anonymous], 2017, NEW ENGL J MED, V376, P562; Attias D, 2009, CIRCULATION, V120, P2541, DOI 10.1161/CIRCULATIONAHA.109.887042; AYRES JG, 1985, THORAX, V40, P300, DOI 10.1136/thx.40.4.300; Black H, 2007, CHEST, V131, P524, DOI 10.1378/chest.06-1074; Burrage LC, 2017, J PEDIATR-US, V186, P118, DOI 10.1016/j.jpeds.2017.03.045; Calcaterra V, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013033; Cannaerts E, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0655-0; Chen MH., 2015, GENEREVIEWS; Colom AJ, 2006, THORAX, V61, P503, DOI 10.1136/thx.2005.044909; CUPO LN, 1981, AM J MED, V71, P1051, DOI 10.1016/0002-9343(81)90341-7; de Wit MCY, 2011, EUR J MED GENET, V54, P299, DOI 10.1016/j.ejmg.2010.12.009; Dowton SB, 1996, CLIN GENET, V50, P510; Eltahir Safa, 2016, J Med Case Rep, V10, P97, DOI 10.1186/s13256-016-0871-1; Kurland G, 2013, AM J RESP CRIT CARE, V188, P376, DOI 10.1164/rccm.201305-0923ST; Lange M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0331-9; Lord A, 2014, RESP CARE, V59, pE171, DOI 10.4187/respcare.02847; Masurel-Paulet A, 2011, EUR J MED GENET, V54, P25, DOI 10.1016/j.ejmg.2010.09.010; Myers JA, 2015, AM J RESP CRIT CARE, V191; Parrini E, 2006, BRAIN, V129, P1892, DOI 10.1093/brain/awl125; Pepe G, 2016, APPL CLIN GENET, V9, P55, DOI 10.2147/TACG.S96233; Reinstein E, 2013, EUR J HUM GENET, V21, P494, DOI 10.1038/ejhg.2012.209; Robertson SP, 2007, EUR J HUM GENET, V15, P3, DOI 10.1038/sj.ejhg.5201654; Ruggeri P, 2015, RESPIR MED CASE REP, V14, P40, DOI 10.1016/j.rmcr.2014.12.002; Sasaki E, 2019, EUR J PEDIATR, V178, P121, DOI 10.1007/s00431-018-3301-0; Shelmerdine SC, 2017, PEDIATR PULM, V52, P1306, DOI 10.1002/ppul.23695; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Vounotrypidis P, 2009, GASTROENT RES PRACT, V2009; WOOD JR, 1984, THORAX, V39, P780, DOI 10.1136/thx.39.10.780	29	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					1059	1067		10.1056/NEJMcpc1904041	http://dx.doi.org/10.1056/NEJMcpc1904041			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY2MW	31509678	Green Published			2022-12-28	WOS:000486225900014
J	Schulten, SFM; Detollenaere, RJ; Stekelenburg, J; IntHout, J; Kluivers, KB; van Eijndhoven, HWF				Schulten, Sascha F. M.; Detollenaere, Renee J.; Stekelenburg, Jelle; IntHout, Joanna; Kluivers, Kirsten B.; van Eijndhoven, Hugo W. F.			Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse stage 2 or higher: observational follow-up of a multicentre randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PELVIC ORGAN PROLAPSE; QUALITY-OF-LIFE; INCONTINENCE; METAANALYSIS; ATTITUDES; SURGERY	OBJECTIVE To evaluate the effectiveness and success of uterus preserving sacrospinous hysteropexy as an alternative to vaginal hysterectomy with uterosacral ligament suspension in the surgical treatment of uterine prolapse five years after surgery. DESIGN Observational follow-up of SAVE U (sacrospinous fixation versus vaginal hysterectomy in treatment of uterine prolapse >= 2) randomised controlled trial. SETTING Four non-university teaching hospitals, the Netherlands. PARTICIPANTS 204 of 208 healthy women in the initial trial (2009-12) with uterine prolapse stage 2 or higher requiring surgery and no history of pelvic floor surgery who had been randomised to sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension. The women were followed annually for five years after surgery. This extended trial reports the results at five years. MAIN OUTCOME MEASURES Prespecified primary outcome evaluated at five year follow-up was recurrent prolapse of the uterus or vaginal vault (apical compartment) stage 2 or higher evaluated by pelvic organ prolapse quantification system in combination with bothersome bulge symptoms or repeat surgery for recurrent apical prolapse. Secondary outcomes were overall anatomical failure (recurrent prolapse stage 2 or higher in apical, anterior, or posterior compartment), composite outcome of success (defined as no prolapse beyond the hymen, no bothersome bulge symptoms, and no repeat surgery or pessary use for recurrent prolapse), functional outcome, quality of life, repeat surgery, and sexual functioning. RESULTS At five years, surgical failure of the apical compartment with bothersome bulge symptoms or repeat surgery occurred in one woman (1%) after sacrospinous hysteropexy compared with eight women (7.8%) after vaginal hysterectomy with uterosacral ligament suspension (difference-6.7%, 95% confidence interval -12.8% to -0.7%). A statistically significant difference was found in composite outcome of success between sacrospinous hysteropexy and vaginal hysterectomy (89/102 (87%) v 77/102 (76%). The other secondary outcomes did not differ. Time-to-event analysis at five years showed no differences between the interventions. CONCLUSIONS At five year follow-up significantly less anatomical recurrences of the apical compartment with bothersome bulge symptoms or repeat surgery were found after sacrospinous hysteropexy compared with vaginal hysterectomy with uterosacral ligament suspension. After hysteropexy a higher proportion of women had a composite outcome of success. Time-to-event analysis showed no differences in outcomes between the procedures.	[Schulten, Sascha F. M.; Detollenaere, Renee J.; van Eijndhoven, Hugo W. F.] Isala Clin, Dept Obstet & Gynaecol, POB 10400, NL-8000 GK Zwolle, Netherlands; [Schulten, Sascha F. M.; IntHout, Joanna] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands; [Stekelenburg, Jelle] Med Ctr Leeuwarden, Dept Obstet & Gynaecol, Leeuwarden, Netherlands; [Stekelenburg, Jelle] Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth, Groningen, Netherlands; [Kluivers, Kirsten B.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, Nijmegen, Netherlands	Isala Clinics; Radboud University Nijmegen; Medical Center Leeuwarden; University of Groningen; Radboud University Nijmegen	Detollenaere, RJ (corresponding author), Isala Clin, Dept Obstet & Gynaecol, POB 10400, NL-8000 GK Zwolle, Netherlands.	r.j.detollenaere@isala.nl	Schulten, Sascha/A-7701-2018; IntHout, Joanna/A-1863-2016; Stekelenburg, Jelle/B-3129-2017	Schulten, Sascha/0000-0003-0958-1422; IntHout, Joanna/0000-0002-6127-0747; Stekelenburg, Jelle/0000-0002-2732-6620	Isala research foundation	Isala research foundation	The SAVE U trial received an unrestricted grant from the Isala research foundation. The funder did not play any role in the design and conduct of the study; in the collection, management, analysis, or interpretation of the data; or in the preparation, review, or approval of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Barber MD, 2009, OBSTET GYNECOL, V114, P600, DOI 10.1097/AOG.0b013e3181b2b1ae; Bradley CS, 2008, OBSTET GYNECOL, V111, P1148, DOI 10.1097/AOG.0b013e31816a3b96; CRUIKSHANK SH, 1987, AM J OBSTET GYNECOL, V156, P1433, DOI 10.1016/0002-9378(87)90013-5; Detollenaere RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3717; Detollenaere RJ, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-4; Frick AC, 2013, FEMALE PELVIC MED RE, V19, P103, DOI 10.1097/SPV.0b013e31827d8667; Giri A, 2017, AM J OBSTET GYNECOL, V217, P11, DOI 10.1016/j.ajog.2017.01.039; Jha S, 2018, INT UROGYNECOL J, V29, P795, DOI 10.1007/s00192-017-3476-3; Kapoor S, 2017, INT UROGYNECOL J, V28, P1285, DOI 10.1007/s00192-017-3291-x; Korbly NB, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.003; Kowalski JT, 2018, INT UROGYNECOL J, V29, P1697, DOI 10.1007/s00192-018-3755-7; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lowenstein E, 2018, INT UROGYNECOL J, V29, P119, DOI 10.1007/s00192-017-3395-3; Maggiore ULR, 2013, ARCH GYNECOL OBSTET, V287, P267, DOI 10.1007/s00404-012-2540-y; Maher C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012376; Meriwether KV, 2018, AM J OBSTET GYNECOL, V219, P129, DOI 10.1016/j.ajog.2018.01.018; Miller BJ, 2019, AUST NZ J OBSTET GYN, V59, P117, DOI 10.1111/ajo.12835; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Rappa C, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.022; Roovers JPWR, 2005, BJOG-INT J OBSTET GY, V112, P1547, DOI 10.1111/j.1471-0528.2005.00734.x; Saripanidis S., 2019, BMJ; Schweitzer KJ, 2008, NTOG, V121, P79; Smith FJ, 2010, OBSTET GYNECOL, V116, P1096, DOI 10.1097/AOG.0b013e3181f73729; van der Vaart CH, 2003, NEUROUROL URODYNAM, V22, P97, DOI 10.1002/nau.10038; van Ijsselmuiden MN, 2018, EUR J OBSTET GYN R B, V220, P79, DOI 10.1016/j.ejogrb.2017.11.016; van IJsselmuiden MN, 2015, INT UROGYNECOL J, V26, P1649, DOI 10.1007/s00192-015-2755-0; van IJsselmuiden MN, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-112; Ware JE., 1994, SF 36 PHYS MENTAL CO; Wu JM, 2009, OBSTET GYNECOL, V114, P1278, DOI 10.1097/AOG.0b013e3181c2ce96; Zacche MM, 2018, INT UROGYNECOL J, V29, P1689, DOI 10.1007/s00192-018-3731-2	31	45	46	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5149	10.1136/bmj.l5149	http://dx.doi.org/10.1136/bmj.l5149			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506252	hybrid, Green Published			2022-12-28	WOS:000486648900003
J	McMurray, JJV; Solomon, SD; Inzucchi, SE; Kober, L; Kosiborod, MN; Martinez, FA; Ponikowski, P; Sabatine, MS; Anand, IS; Belohlavek, J; Bohm, M; Chiang, CE; Chopra, VK; de Boer, RA; Desai, AS; Diez, M; Drozdz, J; Dukat, A; Ge, J; Howlett, JG; Katova, T; Kitakaze, M; Ljungman, CEA; Merkely, B; Nicolau, JC; O'Meara, E; Petrie, MC; Vinh, PN; Schou, M; Tereshchenko, S; Verma, S; Held, C; DeMets, DL; Docherty, KF; Jhund, PS; Bengtsson, O; Sjostrand, M; Langkilde, AM				McMurray, J. J. V.; Solomon, S. D.; Inzucchi, S. E.; Kober, L.; Kosiborod, M. N.; Martinez, F. A.; Ponikowski, P.; Sabatine, M. S.; Anand, I. S.; Belohlavek, J.; Bohm, M.; Chiang, C. -E.; Chopra, V. K.; de Boer, R. A.; Desai, A. S.; Diez, M.; Drozdz, J.; Dukat, A.; Ge, J.; Howlett, J. G.; Katova, T.; Kitakaze, M.; Ljungman, C. E. A.; Merkely, B.; Nicolau, J. C.; O'Meara, E.; Petrie, M. C.; Vinh, P. N.; Schou, M.; Tereshchenko, S.; Verma, S.; Held, C.; DeMets, D. L.; Docherty, K. F.; Jhund, P. S.; Bengtsson, O.; Sjostrand, M.; Langkilde, A. -M.		DAPA-HF Trial Comm Investigators	Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COTRANSPORTER 2 INHIBITORS; CARDIOVASCULAR OUTCOMES; NEPRILYSIN INHIBITION; EMPAGLIFLOZIN; MECHANISM	BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through glucose-independent mechanisms. More data are needed regarding the effects of SGLT2 inhibitors in patients with established heart failure and a reduced ejection fraction, regardless of the presence or absence of type 2 diabetes. METHODS In this phase 3, placebo-controlled trial, we randomly assigned 4744 patients with New York Heart Association class II, III, or IV heart failure and an ejection fraction of 40% or less to receive either dapagliflozin (at a dose of 10 mg once daily) or placebo, in addition to recommended therapy. The primary outcome was a composite of worsening heart failure (hospitalization or an urgent visit resulting in intravenous therapy for heart failure) or cardiovascular death. RESULTS Over a median of 18.2 months, the primary outcome occurred in 386 of 2373 patients (16.3%) in the dapagliflozin group and in 502 of 2371 patients (21.2%) in the placebo group (hazard ratio, 0.74; 95% confidence interval [CI], 0.65 to 0.85; P<0.001). A first worsening heart failure event occurred in 237 patients (10.0%) in the dapagliflozin group and in 326 patients (13.7%) in the placebo group (hazard ratio, 0.70; 95% CI, 0.59 to 0.83). Death from cardiovascular causes occurred in 227 patients (9.6%) in the dapagliflozin group and in 273 patients (11.5%) in the placebo group (hazard ratio, 0.82; 95% CI, 0.69 to 0.98); 276 patients (11.6%) and 329 patients (13.9%), respectively, died from any cause (hazard ratio, 0.83; 95% CI, 0.71 to 0.97). Findings in patients with diabetes were similar to those in patients without diabetes. The frequency of adverse events related to volume depletion, renal dysfunction, and hypoglycemia did not differ between treatment groups. CONCLUSIONS Among patients with heart failure and a reduced ejection fraction, the risk of worsening heart failure or death from cardiovascular causes was lower among those who received dapagliflozin than among those who received placebo, regardless of the presence or absence of diabetes.	[McMurray, J. J. V.; Petrie, M. C.; Docherty, K. F.; Jhund, P. S.] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Solomon, S. D.; Desai, A. S.] Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA; [Sabatine, M. S.] Brigham & Womens Hosp, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA; [Sabatine, M. S.] Harvard Med Sch, Boston, MA 02115 USA; [Inzucchi, S. E.] Yale Univ, Sch Med, Sect Endocrinol, New Haven, CT USA; [Kober, L.] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark; [Schou, M.] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Bohm, M.] Saarland Univ Hosp, Dept Med, Homburg, Germany; [Kosiborod, M. N.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA; [Martinez, F. A.] Natl Univ Cordoba, Cordoba, Argentina; [Diez, M.] Inst Cardiovasc Buenos Aires, Div Cardiol, Buenos Aires, DF, Argentina; [Ponikowski, P.] Wroclaw Med Univ, Wroclaw, Poland; [Drozdz, J.] Med Univ Lodz, Dept Cardiol, Lodz, Poland; [Anand, I. S.] Univ Minnesota, Dept Cardiol, Minneapolis, MN USA; [Belohlavek, J.] Charles Univ Prague, Gen Teaching Hosp, Dept Internal Med 2, Cardiovasc Med, Prague, Czech Republic; Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Chiang, C. -E.] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Chiang, C. -E.] Natl Yang Ming Univ, Taipei, Taiwan; [Chopra, V. K.] Medanta, Dept Cardiol, Gurgaon, India; [de Boer, R. A.] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [de Boer, R. A.] Univ Groningen, Groningen, Netherlands; [Dukat, A.] Comenius Univ, Dept Internal Med 5, Bratislava, Slovakia; [Ge, J.] Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai, Peoples R China; [Ge, J.] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China; [Howlett, J. G.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Howlett, J. G.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [O'Meara, E.] Montreal Heart Inst, Dept Cardiol, Montreal, PQ, Canada; [Verma, S.] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Toronto, ON, Canada; [Katova, T.] Natl Cardiol Hosp, Clin Cardiol, Sofia, Bulgaria; [Kitakaze, M.] Natl Cerebral & Cardiovasc Ctr, Cardiovasc Div Med, Osaka, Japan; [Ljungman, C. E. A.] Sahlgrens Acad, Dept Mol & Clin Med & Cardiol, Gothenburg, Sweden; [Bengtsson, O.; Sjostrand, M.; Langkilde, A. -M.] AstraZeneca, Gothenburg, Sweden; [Held, C.] Uppsala Univ, Uppsala Clin Res Ctr, Dept Med Sci, Cardiol, Uppsala, Sweden; [Merkely, B.] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary; [Nicolau, J. C.] Univ Sao Paolo, Fac Med, Hosp Clin, Sao Paulo, Brazil; [Vinh, P. N.] Tan Tao Univ, Dept Internal Med, Tan Duc, Vietnam; [Tereshchenko, S.] Natl Med Res Ctr Cardiol, Dept Myocardial Dis & Heart Failure, Moscow, Russia; [DeMets, D. L.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA	University of Glasgow; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Universitatsklinikum des Saarlandes; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; National University of Cordoba; Instituto Cardiovascular de Buenos Aires (ICBA); Wroclaw Medical University; Medical University Lodz; University of Minnesota System; University of Minnesota Twin Cities; Charles University Prague; General University Hospital Prague; Charles University Prague; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; University of Groningen; University of Groningen; Comenius University Bratislava; Fudan University; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Universite de Montreal; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Medical University Sofia; National Cerebral & Cardiovascular Center - Japan; University of Gothenburg; AstraZeneca; Uppsala University; Semmelweis University; Universidade de Sao Paulo; National Medical Research Center of Cardiology; University of Wisconsin System; University of Wisconsin Madison	McMurray, JJV (corresponding author), Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	john.mcmurray@glasgow.ac.uk	de Boer, Rudolf/ABE-9879-2020; Sabatine, Marc/AAJ-6751-2020; Kosiborod, Mikhail/HDO-1541-2022; Ljungman, Charlotta Eva Anna/GMW-4955-2022; Sergey, Tereshchenko/AAA-9455-2021; Nicolau, Jose C/E-1487-2012; Drozdz, Jaroslaw/K-8951-2012; Docherty, Kieran/ABD-8183-2021; Jhund, Pardeep/GLS-9508-2022; Held, Claes/AAA-3973-2021; Boldueva, Svetlana/AAH-3862-2019; Chopra, Vijay/AAW-1853-2020; Inzucchi, Silvio/ABF-4121-2021; Desai, Akshay/ABE-7250-2020; Gislason, Gunnar/B-7561-2009	Sabatine, Marc/0000-0002-0691-3359; Kosiborod, Mikhail/0000-0002-3750-9789; Sergey, Tereshchenko/0000-0001-9234-6129; Nicolau, Jose C/0000-0002-9680-3689; Jhund, Pardeep/0000-0003-4306-5317; Held, Claes/0000-0001-9402-7404; Boldueva, Svetlana/0000-0002-1898-084X; Hove, Jens/0000-0002-5600-5623; Gislason, Gunnar/0000-0002-0548-402X; Howlett, Jonathan/0000-0002-0535-9771; Olexa, Peter/0000-0002-1846-4554; mcmurray, john/0000-0002-6317-3975; OGUNNIYI, MODELE/0000-0001-9545-3675; Docherty, Kieran/0000-0002-5446-9969; Merkely, Bela/0000-0001-6514-0723; Drozdz, Jaroslaw/0000-0002-0732-2104; Kober, Lars/0000-0002-6635-1466	AstraZeneca; Alnylam Pharmaceuticals; Amgen; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; MyoKardia; Novartis; Theracos; Bayer; Cytokinetics; Bellerophon Therapeutics; Celladon; Ionis Pharmaceuticals; Lonestar Heart; Mesoblast; Sanofi Pasteur; Eidos Therapeutics; Boehringer Ingelheim; Vifor Pharma	AstraZeneca(AstraZeneca); Alnylam Pharmaceuticals; Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); MyoKardia; Novartis(Novartis); Theracos; Bayer(Bayer AG); Cytokinetics; Bellerophon Therapeutics; Celladon; Ionis Pharmaceuticals; Lonestar Heart; Mesoblast; Sanofi Pasteur; Eidos Therapeutics; Boehringer Ingelheim(Boehringer Ingelheim); Vifor Pharma	Supported by AstraZeneca.r Dr. McMurray reports receiving fees (all fees listed paid to Glasgow University) for serving on a steering committee from Bayer, fees for serving on a steering committee, fees for serving on an end-point committee, and travel support from Cardiorentis, fees for serving on a steering committee and travel support from Amgen, fees for serving on a steering committee and travel support from Oxford University-Bayer, fees for serving as principal investigator of a trial and travel support from Theracos, fees for serving on a steering committee and travel support from AbbVie, fees for serving on a steering committee from DalCor Pharmaceuticals, fees for serving on a data and safety monitoring committee from Pfizer, fees for serving on a data and safety monitoring committee from Merck, fees for serving on an executive committee, fees for serving as co-principal investigator of a trial, fees for serving on a steering committee, fees for serving on an executive committee, travel support, and advisory board fees from Novartis, fees for serving as co-principal investigator for a trial, fees for serving on a steering committee, and travel support from GlaxoSmithKline, fees for serving on a steering committee from Bristol-Myers Squibb, and fees for serving on a steering committee, fees for serving on an endpoint adjudication committee, and travel support from Vifor Pharma-Fresenius; Dr. Solomon, receiving grant support and consulting fees (all fees listed paid to Brigham and Women's Hospital) from Alnylam Pharmaceuticals, Amgen, AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, MyoKardia, Novartis, Theracos, Bayer, and Cytokinetics, grant support from Bellerophon Therapeutics, Celladon, Ionis Pharmaceuticals, Lonestar Heart, Mesoblast, Sanofi Pasteur, and Eidos Therapeutics, consulting fees from Akros Pharma, Corvia Medical, Ironwood Pharma, Merck, Roche, Takeda Pharmaceutical, Quantum Genomics, AOBiome, Cardiac Dimensions, Tenaya Therapeutics, and Daiichi Sankyo, and fees for serving on a data and safety monitoring board from Janssen; Dr. Inzucchi, receiving advisory fees from AstraZeneca and Zafgen, lecture fees, consulting fees, fees for serving as a clinical-trial publications committee member, reimbursement for medical writing, and travel support from Boehringer Ingelheim, fees for serving on a steering committee and travel support from Sanofi-Lexicon, lecture fees, consulting fees, and travel support from Merck, and advisory fees and travel support from vTv Therapeutics and AbbottAlere; Dr. Kober, receiving lecture fees from Novartis and BristolMyers Squibb; Dr. Kosiborod, receiving grant support, honoraria, and research support from AstraZeneca, grant support and honoraria from Boehringer Ingelheim, and honoraria from Sanofi, Amgen, Novo Nordisk, Merck (Diabetes), Eisai, Janssen, Bayer, GlaxoSmithKline, Glytec, Intarcia Therapeutics, Novartis, Applied Therapeutics, Amarin, and Eli Lilly; Dr.; r Ponikowski, receiving consulting fees, fees for serving on a speakers bureau, and fees (paid to himself and to his institution) for serving as an investigator and steering or executive committee member for clinical trials from Boehringer Ingelheim, lecture fees from Pfizer, fees (paid to himself and to his institution) for serving as an investigator and steering or executive committee member for clinical trials from Amgen, grant support (paid to his institution), fees for serving on a speakers bureau, consulting fees, and fees (paid to himself and to his institution) for serving as an investigator and steering or executive committee member for clinical trials from Vifor Pharma, fees for serving on a speakers bureau and consulting fees from Servier, fees for serving on a speakers bureau, consulting fees, and fees (paid to himself and to his institution) for serving as an investigator and steering or executive committee member for clinical trials from Bayer, fees for serving on a speakers bureau, consulting fees, and fees (paid to himself and to his institution) for serving as an investigator and steering or executive committee member for clinical trials from Bristol-Myers Squibb, fees for serving on a speakers bureau and consulting fees from Respicardia, fees for serving on a speakers bureau from Berlin-Chemie, fees for serving on a speakers bureau, consulting fees, and fees (paid to himself and to his institution) for serving as an investigator and steering or executive committee member for clinical trials from Cibiem, fees for serving on a speakers bureau, consulting fees, and fees (paid to himself and to his institution) for serving as an investigator and steering or executive committee member for clinical trials from Novartis, and fees for serving on a speakers bureau, consulting fees, and fees (paid to himself and to his institution) for serving (M. Schou), Copenhagen; the Department of Medicine, Saarland University Hospital, Homburg-Saar, Germany (M.B.); Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.); National University of Cordoba, Cordoba (F.A.M.), and the Division of Cardiology, Instituto Cardiovascular de Buenos Aires, Buenos Aires (M.D.) -both in Argentina; Wroclaw Medical University, Wroclaw (P.P.), and the Department of Cardiology, Medical University of Lodz, Lodz (J.D.) -both in Poland; the Department of Cardiology, University of Minnesota, Minneapolis (I.S.A.); 2nd Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic (J.B.); the Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan (C.-E.C.); the Department of Cardiology, Medanta, Gurgaon, India (V.K.C.); the Department of Cardiology, University Medical Center and University of Groningen, Groningen, the Netherlands (R.A.B.); the 5th Department of Internal Medicine, Comenius University in Bratislava, Bratislava, Slovakia (A.D.); the Department of Cardiology, Shanghai Institute of Cardiovascular Disease and Zhongshan Hospital Fudan University, Shanghai, China (J.G.); Cumming School of Medicine and Libin Cardiovascular Institute, University of Calgary, Calgary, AB (J.G.H.), the Department of Cardiology, Montreal Heart Institute, Montreal (E.O.), and the Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Toronto (S.V.) -all in Canada; Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.; r ); the Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.); the Department of Molecular and Clinical Medicine and Cardiology, Sahlgrenska Academy (C.E.A.L.), and AstraZeneca (O.B., M. Sjostrand, A.M.L.), Gothenburg, and the Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University (C.H.), Uppsala -all in Sweden; the Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.); Instituto do Coracao, Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paolo, Sao Paolo (J.C.N.); the Department of Internal Medicine, Tan Tao University, Tan Duc, Vietnam (P.N.V.); the Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology, Moscow (S.T.); and the Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison (D.L.D.).	Bonnet F, 2018, DIABETES METAB, V44, P457, DOI 10.1016/j.diabet.2018.09.005; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Hicks KA, 2018, J AM COLL CARDIOL, V71, P1021, DOI 10.1016/j.jacc.2017.12.048; Inzucchi SE, 2018, CIRCULATION, V138, P1904, DOI 10.1161/CIRCULATIONAHA.118.035759; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Lytvyn Y, 2017, CIRCULATION, V136, P1643, DOI 10.1161/CIRCULATIONAHA.117.030012; McMurray JJV, 2019, EUR J HEART FAIL, V21, P1402, DOI 10.1002/ejhf.1548; McMurray JJV, 2019, EUR J HEART FAIL, V21, P665, DOI 10.1002/ejhf.1432; McMurray JJV, 2015, EUR J HEART FAIL, V17, P242, DOI 10.1002/ejhf.250; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Packer M, 2019, CIRCULATION, V140, P443, DOI 10.1161/CIRCULATIONAHA.119.040909; Packer M, 2017, JAMA CARDIOL, V2, P1025, DOI 10.1001/jamacardio.2017.2275; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Verma S, 2018, DIABETOLOGIA, V61, P2108, DOI 10.1007/s00125-018-4670-7; Wang DL, 2016, PHARM STAT, V15, P238, DOI 10.1002/pst.1743; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	20	2489	2571	24	185	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2019	381	21					1995	2008		10.1056/NEJMoa1911303	http://dx.doi.org/10.1056/NEJMoa1911303			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JZ6NB	31535829	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000505218800004
J	Butler, J; Anker, SD; Packer, M				Butler, Javed; Anker, Stefan D.; Packer, Milton			Redefining Heart Failure With a Reduced Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION; MIDRANGE	In this Viewpoint, Milton Packer and colleagues argue that reliance on a threshold of LVEF <= 40% to define heart failure with reduced ejection fraction (HFrEF) may exclude patients with impaired systolic function and subnormal LVEF from evidence-based treatments that reduce morbidity and mortality, and the authors propose that the LVEF threshold for HFrEF treatment be increased to <= 50%.	[Butler, Javed] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Anker, Stefan D.] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Anker, Stefan D.] Charite Univ Med Berlin, Dept Cardiol, German Ctr Cardiovasc Res Berlin, Berlin, Germany; [Packer, Milton] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA; [Packer, Milton] Imperial Coll, London, England	University of Mississippi; University of Mississippi Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Baylor University; Baylor University Medical Center; Imperial College London	Packer, M (corresponding author), Baylor Heart & Vasc Inst, 621 N Hall St, Dallas, TX 75226 USA.	milton.packer@baylorhealth.edu			NIGMS NIH HHS [U54 GM115428] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cleland JGF, 2018, EUR HEART J, V39, P26, DOI 10.1093/eurheartj/ehx564; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lund LH, 2018, EUR J HEART FAIL, V20, P1230, DOI 10.1002/ejhf.1149; Moliner P, 2018, INT J CARDIOL, V257, P188, DOI 10.1016/j.ijcard.2018.01.119; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Solomon SD, 2019, NEW ENGL J MED, V381, P1609, DOI 10.1056/NEJMoa1908655; Solomon SD, 2016, EUR HEART J, V37, P455, DOI 10.1093/eurheartj/ehv464; Tsao CW, 2018, JACC-HEART FAIL, V6, P678, DOI 10.1016/j.jchf.2018.03.006; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	9	34	34	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2019	322	18					1761	1762		10.1001/jama.2019.15600	http://dx.doi.org/10.1001/jama.2019.15600			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0WO	31517955				2022-12-28	WOS:000498675500011
J	Paul, JD; Cifu, AS				Paul, Jonathan D.; Cifu, Adam S.			Prevention and Management of Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEMATOLOGY 2018 GUIDELINES; AMERICAN SOCIETY; METAANALYSIS	This JAMA Clinical Guidelines Synopsis summarizes the 2018 American Society of Hematology guidelines for management of venous thromboembolism.	[Paul, Jonathan D.; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Alhazzani W, 2013, CRIT CARE MED, V41, P2088, DOI 10.1097/CCM.0b013e31828cf104; Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016; Bates SM, 2018, BLOOD ADV, V2, P3317, DOI 10.1182/bloodadvances.2018024802; Heit JA, 2015, NAT REV CARDIOL, V12, P464, DOI 10.1038/nrcardio.2015.83; Lim W, 2018, BLOOD ADV, V2, P3226, DOI 10.1182/bloodadvances.2018024828; Romualdi E, 2013, J THROMB HAEMOST, V11, P270, DOI 10.1111/jth.12085; Schunemann HJ, 2018, BLOOD ADV, V2, P3198, DOI 10.1182/bloodadvances.2018022954; Witt DM, 2018, BLOOD ADV, V2, P3257, DOI 10.1182/bloodadvances.2018024893	8	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2019	322	16					1602	1603		10.1001/jama.2019.13853	http://dx.doi.org/10.1001/jama.2019.13853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0VU	31545338				2022-12-28	WOS:000498673500020
J	Cappellini, E; Welker, F; Pandolfi, L; Ramos-Madrigal, J; Samodova, D; Ruther, PL; Fotakis, AK; Lyon, D; Moreno-Mayar, JV; Bukhsianidze, M; Jersie-Christensen, RR; Mackie, M; Ginolhac, A; Ferring, R; Tappen, M; Palkopoulou, E; Dickinson, MR; Stafford, TW; Chan, YL; Gotherstrom, A; Nathan, SKSS; Heintzman, PD; Kapp, JD; Kirillova, I; Moodley, Y; Agusti, J; Kahlke, RD; Kiladze, G; Martinez-Navarro, B; Liu, SL; Velasco, MS; Sinding, MHS; Kelstrup, CD; Allentoft, ME; Orlando, L; Penkman, K; Shapiro, B; Rook, L; Dalen, L; Gilbert, MTP; Olsen, JV; Lordkipanidze, D; Willerslev, E				Cappellini, Enrico; Welker, Frido; Pandolfi, Luca; Ramos-Madrigal, Jazmin; Samodova, Diana; Ruther, Patrick L.; Fotakis, Anna K.; Lyon, David; Moreno-Mayar, J. Victor; Bukhsianidze, Maia; Jersie-Christensen, Rosa Rakownikow; Mackie, Meaghan; Ginolhac, Aurelien; Ferring, Reid; Tappen, Martha; Palkopoulou, Eleftheria; Dickinson, Marc R.; Stafford, Thomas W., Jr.; Chan, Yvonne L.; Gotherstrom, Anders; Nathan, Senthilvel K. S. S.; Heintzman, Peter D.; Kapp, Joshua D.; Kirillova, Irina; Moodley, Yoshan; Agusti, Jordi; Kahlke, Ralf-Dietrich; Kiladze, Gocha; Martinez-Navarro, Bienvenido; Liu, Shanlin; Velasco, Marcela Sandoval; Sinding, Mikkel-Holger S.; Kelstrup, Christian D.; Allentoft, Morten E.; Orlando, Ludovic; Penkman, Kirsty; Shapiro, Beth; Rook, Lorenzo; Dalen, Love; Gilbert, M. Thomas P.; Olsen, Jesper V.; Lordkipanidze, David; Willerslev, Eske			Early Pleistocene enamel proteome from Dmanisi resolves Stephanorhinus phylogeny	NATURE			English	Article							DNA-SEQUENCES; ANCIENT; PROTEINS; IDENTIFICATION; EVOLUTION; BONE; GENERATION; EXPANSION; ALIGNMENT; DATABASE	The sequencing of ancient DNA has enabled the reconstruction of speciation, migration and admixture events for extinct taxa(1). However, the irreversible post-mortem degradation(2) of ancient DNA has so far limited its recovery-outside permafrost areasto specimens that are not older than approximately 0.5 million years (Myr)(3). By contrast, tandem mass spectrometry has enabled the sequencing of approximately 1.5-Myr-old collagen type I-4. and suggested the presence of protein residues in fossils of the Cretaceous period(5)-although with limited phylogenetic use(6). In the absence of molecular evidence, the speciation of several extinct species of the Early and Middle Pleistocene epoch remains contentious. Here we address the phylogenetic relationships of the Eurasian Rhinocerotidae of the Pleistocene epoch(7-9), using the proteome of dental enamel from a Stephanorhinus tooth that is approximately 1.77-Myr old, recovered from the archaeological site of Dmanisi (South Caucasus, Georgia)(10). Molecular phylogenetic analyses place this Stephanorhinus as a sister group to the Glade formed by the woolly rhinoceros (Coelodonta antiquitatis) and Merck's rhinoceros (Stephanorhinus kirchbergensis). We show that Coelodonta evolved from an early Stephanorhinus lineage, and that this latter genus includes at least two distinct evolutionary lines. The genus Stephanorhinus is therefore currently paraphyletic, and its systematic revision is needed. We demonstrate that sequencing the proteome of Early Pleistocene dental enamel overcomes the limitations of phylogenetic inference based on ancient collagen or DNA. Our approach also provides additional information about the sex and taxonomic assignment of other specimens from Dmanisi. Our findings reveal that proteomic investigation of ancient dental enamel-which is the hardest tissue in vertebrates(11), and is highly abundant in the fossil record-can push the reconstruction of molecular evolution further back into the Early Pleistocene epoch, beyond the currently known limits of ancient DNA preservation.	[Cappellini, Enrico; Moreno-Mayar, J. Victor; Allentoft, Morten E.; Orlando, Ludovic; Willerslev, Eske] Univ Copenhagen, Globe Inst, Lundbeck Fdn GeoGenet Ctr, Copenhagen, Denmark; [Cappellini, Enrico; Welker, Frido; Ramos-Madrigal, Jazmin; Fotakis, Anna K.; Mackie, Meaghan; Liu, Shanlin; Velasco, Marcela Sandoval; Sinding, Mikkel-Holger S.; Gilbert, M. Thomas P.] Univ Copenhagen, Globe Inst, Evolutionary Genom Sect, Copenhagen, Denmark; [Welker, Frido] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Pandolfi, Luca; Rook, Lorenzo] Univ Firenze, Dipartimento Sci Terra, Florence, Italy; [Samodova, Diana; Ruther, Patrick L.; Lyon, David; Jersie-Christensen, Rosa Rakownikow; Mackie, Meaghan; Kelstrup, Christian D.; Olsen, Jesper V.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Copenhagen, Denmark; [Bukhsianidze, Maia; Lordkipanidze, David] Georgian Natl Museum, Tbilisi, Georgia; [Ginolhac, Aurelien] Univ Luxembourg, Life Sci Res Unit, Belvaux, Luxembourg; [Ferring, Reid] Univ North Texas, Dept Geog & Environm, Denton, TX 76203 USA; [Tappen, Martha] Univ Minnesota, Dept Anthropol, Minneapolis, MN USA; [Palkopoulou, Eleftheria] Harvard Med Sch, Dept Genet, Cambridge, MA USA; [Dickinson, Marc R.; Penkman, Kirsty] Univ York, Dept Chem, York, N Yorkshire, England; [Stafford, Thomas W., Jr.] Stafford Res, Lafayette, CO USA; [Chan, Yvonne L.; Dalen, Love] Swedish Museum Nat Hist, Dept Bioinformat & Genet, Stockholm, Sweden; [Gotherstrom, Anders] Stockholm Univ, Dept Archaeol & Class Studies, Stockholm, Sweden; [Nathan, Senthilvel K. S. S.] Sabah Wildlife Dept, Kota Kinabalu, Malaysia; [Heintzman, Peter D.; Kapp, Joshua D.; Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Heintzman, Peter D.] Arctic Univ Norway UiT, Tromso Univ Museum, Tromso, Norway; [Kirillova, Irina] Natl Alliance Shidlovskiy Ice Age, Ice Age Museum, Moscow, Russia; [Moodley, Yoshan] Univ Venda, Dept Zool, Thohoyandou, South Africa; [Agusti, Jordi; Martinez-Navarro, Bienvenido] ICREA, Barcelona, Spain; [Agusti, Jordi; Martinez-Navarro, Bienvenido] Univ Rovira & Virgili, Inst Catala Paleoecol Humana & Evolucio Social, Tarragona, Spain; [Kahlke, Ralf-Dietrich] Senckenberg Res Stn Quaternary Palaeontol, Weimar, Germany; [Kiladze, Gocha] Tbilisi State Univ, Dept Geol, Tbilisi, Georgia; [Martinez-Navarro, Bienvenido] Univ Rovira & Virgili, Dept Hist & Geog, Tarragona, Spain; [Liu, Shanlin] BGI Shenzhen, Shenzhen, Peoples R China; [Sinding, Mikkel-Holger S.] Greenland Inst Nat Resources, Nuuk, Greenland; [Orlando, Ludovic] Univ Paul Sabatier, Lab Anthropol Mol & Imagerie Synth, Toulouse, France; [Shapiro, Beth] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Gilbert, M. Thomas P.] Norwegian Univ Sci & Technol, Univ Museum, Trondheim, Norway; [Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge, England; [Willerslev, Eske] Wellcome Trust Sanger Inst, Hinxton, England; [Willerslev, Eske] Univ Southern Denmark, Danish Inst Adv Study, Odense, Denmark	University of Copenhagen; University of Copenhagen; Max Planck Society; University of Florence; Novo Nordisk Foundation; University of Copenhagen; University of Luxembourg; University of North Texas System; University of North Texas Denton; University of Minnesota System; University of Minnesota Twin Cities; University of York - UK; Swedish Museum of Natural History; Stockholm University; University of California System; University of California Santa Cruz; UiT The Arctic University of Tromso; University of Venda; ICREA; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Ivane Javakhishvili Tbilisi State University; Universitat Rovira i Virgili; Beijing Genomics Institute (BGI); Greenland Institute of Natural Resources; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Norwegian University of Science & Technology (NTNU); University of Cambridge; Wellcome Trust Sanger Institute; University of Southern Denmark	Cappellini, E; Willerslev, E (corresponding author), Univ Copenhagen, Globe Inst, Lundbeck Fdn GeoGenet Ctr, Copenhagen, Denmark.; Cappellini, E (corresponding author), Univ Copenhagen, Globe Inst, Evolutionary Genom Sect, Copenhagen, Denmark.; Olsen, JV (corresponding author), Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Copenhagen, Denmark.; Willerslev, E (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.; Willerslev, E (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.; Willerslev, E (corresponding author), Univ Southern Denmark, Danish Inst Adv Study, Odense, Denmark.	ecappellini@bio.ku.dk; jesper.olsen@cpr.ku.dk; ewillerslev@bio.ku.dk	Rook, Lorenzo/D-9675-2011; Olsen, Jesper/ABH-4638-2020; Moreno-Mayar, J. Víctor/AAB-3732-2022; Willerslev, Eske/A-9619-2011; Dalén, Love/A-6686-2008; Pandolfi, Luca/AAH-7964-2020; Orlando, Ludovic/A-8932-2013; Samodova, Diana/ABF-5904-2021; Martinez-Navarro, Bienvenido/L-5950-2014; Liu, Shanlin/GNH-3256-2022; Martínez-Navarro, Bienvenido/ABE-3563-2021; Willerslev, Eske/AAA-5686-2019; Cappellini, Enrico/F-9346-2013; Liu, Shanlin/HGA-2841-2022; Sandoval-Velasco, Marcela/AAS-6478-2021; Lordkipanidze, David/AAH-6472-2020; Heintzman, Peter D./I-6768-2013; Ramos-Madrigal, Jazmin/C-1576-2015; Gilbert, Marcus/A-8936-2013; Strander Sinding, Mikkel Holger/B-9450-2015	Rook, Lorenzo/0000-0001-8923-5428; Olsen, Jesper/0000-0002-4747-4938; Moreno-Mayar, J. Víctor/0000-0002-7712-4496; Willerslev, Eske/0000-0002-7081-6748; Dalén, Love/0000-0001-8270-7613; Pandolfi, Luca/0000-0002-4186-4126; Orlando, Ludovic/0000-0003-3936-1850; Martinez-Navarro, Bienvenido/0000-0002-8374-5109; Liu, Shanlin/0000-0001-8118-8313; Martínez-Navarro, Bienvenido/0000-0002-8374-5109; Cappellini, Enrico/0000-0001-7885-7811; Liu, Shanlin/0000-0001-8118-8313; Sandoval-Velasco, Marcela/0000-0002-4635-6171; Heintzman, Peter D./0000-0002-6449-0219; Ruther, Patrick Leopold/0000-0003-4461-9828; Fotakis, Anna/0000-0002-4585-4662; Dickinson, Marc/0000-0003-0465-1612; Moodley, Yoshan/0000-0003-4216-2924; Ramos-Madrigal, Jazmin/0000-0002-1661-7991; Samodova, Diana/0000-0001-9943-931X; Lyon, David/0000-0001-5794-0456; Mackie, Meaghan/0000-0003-0763-7592; Gilbert, Marcus/0000-0002-5805-7195; Kelstrup, Christian Dahl/0000-0003-4647-1425; Allentoft, Morten/0000-0003-4424-3568; Strander Sinding, Mikkel Holger/0000-0003-1371-219X	VILLUM FONDEN [17649]; European Commission [795569]; Lundbeck Foundation; Danish National Research Foundation; Novo Nordisk Foundation; Carlsberg Foundation; KU2016; Wellcome Trust; European Commission through the MSC European Training Network 'TEMPERA' [722606]; University of Copenhagen; Danish National Research Foundation [DNRF128]; Novo Nordisk Foundation [NNF14CC0001]; NERC; Natural History Museum [NE/K500987/1, NE/L501761/1]; Leverhulme Trust [PLP -2012-116]; Italian Ministry for Foreign Affairs (MAECI, DGSP-VI); EU-SYNTHESYS project - European Commission [AT-TAF-2550, DE-TAF-3049, GB-TAF-2825, HU-TAF-3593, ES-TAF-2997]; Swedish Research Council [2017-04647]; FORMAS [2015-676]; ERC [681396, 681605]; Gordon and Betty Moore foundation; Spanish Ministry of Sciences [CGL2016-80975-P, CGL2016-80000-P]; Generalitat de Catalunya, Spain [2017SGR 859]; National Science Foundation [1025245]; John Templeton Foundation [52935]; Shota Rustaveli Science Foundation [18-27262]	VILLUM FONDEN(Villum Fonden); European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); KU2016; Wellcome Trust(Wellcome Trust); European Commission through the MSC European Training Network 'TEMPERA'; University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural History Museum; Leverhulme Trust(Leverhulme Trust); Italian Ministry for Foreign Affairs (MAECI, DGSP-VI); EU-SYNTHESYS project - European Commission(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas); ERC(European Research Council (ERC)European Commission); Gordon and Betty Moore foundation(Gordon and Betty Moore Foundation); Spanish Ministry of Sciences(Spanish Government); Generalitat de Catalunya, Spain(Generalitat de Catalunya); National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Shota Rustaveli Science Foundation	E.C. and F.W. are supported by the VILLUM FONDEN (grant number 17649) and by the European Commission through a Marie Sklodowska Curie (MSC) Individual Fellowship (grant number 795569). E.W. is supported by the Lundbeck Foundation, the Danish National Research Foundation, the Novo Nordisk Foundation, the Carlsberg Foundation, KU2016 and the Wellcome Trust. E.C., C.K., J.V.O., P.R. and D.S. are supported by the European Commission through the MSC European Training Network 'TEMPERA' (grant number 722606). M.M. and R.R.J.-C. are supported by the University of Copenhagen KU2016 (UCPH Excellence Programme) grant. M.M. is also supported by the Danish National Research Foundation award PROTEIOS (DNRF128). Work at the Novo Nordisk Foundation Center for Protein Research is funded in part by a donation from the Novo Nordisk Foundation (grant number NNF14CC0001). M.R.D. is supported by a PhD DTA studentship from NERC and the Natural History Museum (NE/K500987/1 & NE/L501761/1). K.P. is supported by the Leverhulme Trust (PLP -2012-116). L.R. and L.P. are supported by the Italian Ministry for Foreign Affairs (MAECI, DGSP-VI). L.P. was also supported by the EU-SYNTHESYS project (AT-TAF-2550, DE-TAF-3049, GB-TAF-2825, HU-TAF-3593 and ES-TAF-2997) funded by the European Commission. L.D. is supported by the Swedish Research Council (grant number 2017-04647) and FORMAS (grant number 2015-676). M.T.P.G. is supported by ERC Consolidator Grant 'Extinction genomics' (grant number 681396). L.O. is supported by the ERC Consolidator Grant 'PEGASUS' (grant agreement number 681605). B.S., J.K. and P.D.H. are supported by the Gordon and Betty Moore foundation. B.M.-N. is supported by the Spanish Ministry of Sciences (grant number CGL2016-80975-P) and the Generalitat de Catalunya, Spain (grant number 2017SGR 859). J.A. is supported by the Spanish Ministry of Sciences (grant number CGL2016-80000-P). R.F. is supported by National Science Foundation (grant number 1025245). The ancient DNA analysis was carried out using the facilities of the University of Luxembourg, the Swedish Museum of Natural History and UC Santa Cruz. We acknowledge support from the Science for Life Laboratory, the National Genomics Infrastructure (Sweden) and UPPMAX for providing assistance with massive parallel sequencing and computational infrastructure. Research at Dmanisi is supported by the John Templeton Foundation (grant number 52935), and the Shota Rustaveli Science Foundation (grant number 18-27262). We thank B. Triozzi and K. Murphy Gregersen for technical support.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antoine PO, 2010, ZOOL J LINN SOC-LOND, V160, P139, DOI 10.1111/j.1096-3642.2009.00597.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Buckley M, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0544; Cappellini E, 2014, ZOOL J LINN SOC-LOND, V170, P222, DOI 10.1111/zoj12084; Cappellini E, 2018, ANNU REV BIOCHEM, V87, P1029, DOI 10.1146/annurev-biochem-062917-012002; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Castiblanco GA, 2015, EUR J ORAL SCI, V123, P390, DOI 10.1111/eos.12214; Catak S, 2008, J PHYS CHEM A, V112, P8752, DOI 10.1021/jp8015497; Chen FH, 2019, NATURE, V569, P409, DOI 10.1038/s41586-019-1139-x; Cleland TP, 2018, J PROTEOME RES, V17, P536, DOI 10.1021/acs.jproteome.7b00670; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Demarchi B, 2016, ELIFE, V5, DOI 10.7554/eLife.17092; Deng T, 2011, SCIENCE, V333, P1285, DOI 10.1126/science.1206594; Dickinson MR, 2019, QUAT GEOCHRONOL, V50, P29, DOI 10.1016/j.quageo.2018.11.005; EASTOE JE, 1960, NATURE, V187, P411, DOI 10.1038/187411b0; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Gabriels R, 2019, NUCLEIC ACIDS RES, V47, pW295, DOI 10.1093/nar/gkz299; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Guerin C, 1980, DOCUMENTS LAB GEOLOG, V79; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hendy J, 2018, NAT ECOL EVOL, V2, P791, DOI 10.1038/s41559-018-0510-x; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Hu JCC, 2005, CELLS TISSUES ORGANS, V181, P219, DOI 10.1159/000091383; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; Katoh K, 2012, BIOINFORMATICS, V28, P3144, DOI 10.1093/bioinformatics/bts578; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirillova IV, 2017, QUATERNARY RES, V88, P537, DOI 10.1017/qua.2017.53; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Mackie M, 2018, ANGEW CHEM INT EDIT, V57, P7369, DOI 10.1002/anie.201713020; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Nei M., 1987, MOL EVOLUTIONARY GEN, V75, P39; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Penkman KEH, 2008, QUAT GEOCHRONOL, V3, P2, DOI 10.1016/j.quageo.2007.07.001; Rieseberg LH, 2009, CURR BIOL, V19, pR119, DOI 10.1016/j.cub.2008.12.016; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schroeter ER, 2017, J PROTEOME RES, V16, P920, DOI 10.1021/acs.jproteome.6b00873; Schubert M, 2014, NAT PROTOC, V9, P1056, DOI 10.1038/nprot.2014.063; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Steiner CC, 2011, ZOOL J LINN SOC-LOND, V163, P1289, DOI 10.1111/j.1096-3642.2011.00752.x; Stewart NA, 2016, RSC ADV, V6, P61673, DOI 10.1039/c6ra05120k; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; van Doorn NL, 2012, RAPID COMMUN MASS SP, V26, P2319, DOI 10.1002/rcm.6351; Wadsworth C, 2014, RAPID COMMUN MASS SP, V28, P605, DOI 10.1002/rcm.6821; Welker F, 2017, PEERJ, V5, DOI 10.7717/peerj.3033; Welker F, 2016, P NATL ACAD SCI USA, V113, P11162, DOI 10.1073/pnas.1605834113; Welker F, 2015, NATURE, V522, P81, DOI 10.1038/nature14249; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yuan JX, 2014, SCI CHINA EARTH SCI, V57, P388, DOI 10.1007/s11430-013-4702-6; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]	64	80	81	0	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					103	+		10.1038/s41586-019-1555-y	http://dx.doi.org/10.1038/s41586-019-1555-y			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31511700	Green Submitted, Green Accepted			2022-12-28	WOS:000488832500039
J	Sands, BE; Peyrin-Biroulet, L; Loftus, EV; Danese, S; Colombel, JF; Toruner, M; Jonaitis, L; Abhyankar, B; Chen, J; Rogers, R; Lirio, RA; Bornstein, JD; Schreiber, S				Sands, Bruce E.; Peyrin-Biroulet, Laurent; Loftus, Edward V., Jr.; Danese, Silvio; Colombel, Jean-Frederic; Toruner, Murat; Jonaitis, Laimas; Abhyankar, Brihad; Chen, Jingjing; Rogers, Raquel; Lirio, Richard A.; Bornstein, Jeffrey D.; Schreiber, Stefan		VARSITY Study Grp	Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EFFICACY; THERAPY; DISEASE; SCORE	BackgroundBiologic therapies are widely used in patients with ulcerative colitis. Head-to-head trials of these therapies in patients with inflammatory bowel disease are lacking. MethodsIn a phase 3b, double-blind, double-dummy, randomized trial conducted at 245 centers in 34 countries, we compared vedolizumab with adalimumab in adults with moderately to severely active ulcerative colitis to determine whether vedolizumab was superior. Previous exposure to a tumor necrosis factor inhibitor other than adalimumab was allowed in up to 25% of patients. The patients were assigned to receive infusions of 300 mg of vedolizumab on day 1 and at weeks 2, 6, 14, 22, 30, 38, and 46 (plus injections of placebo) or subcutaneous injections of 40 mg of adalimumab, with a total dose of 160 mg at week 1, 80 mg at week 2, and 40 mg every 2 weeks thereafter until week 50 (plus infusions of placebo). Dose escalation was not permitted in either group. The primary outcome was clinical remission at week 52 (defined as a total score of <= 2 on the Mayo scale [range, 0 to 12, with higher scores indicating more severe disease] and no subscore >1 [range, 0 to 3] on any of the four Mayo scale components). To control for type I error, efficacy outcomes were analyzed with a hierarchical testing procedure, with the variables in the following order: clinical remission, endoscopic improvement (subscore of 0 to 1 on the Mayo endoscopic component), and corticosteroid-free remission at week 52. ResultsA total of 769 patients underwent randomization and received at least one dose of vedolizumab (383 patients) or adalimumab (386 patients). At week 52, clinical remission was observed in a higher percentage of patients in the vedolizumab group than in the adalimumab group (31.3% vs. 22.5%; difference, 8.8 percentage points; 95% confidence interval [CI], 2.5 to 15.0; P=0.006), as was endoscopic improvement (39.7% vs. 27.7%; difference, 11.9 percentage points; 95% CI, 5.3 to 18.5; P<0.001). Corticosteroid-free clinical remission occurred in 12.6% of the patients in the vedolizumab group and in 21.8% in the adalimumab group (difference, -9.3 percentage points; 95% CI, -18.9 to 0.4). Exposure-adjusted incidence rates of infection were 23.4 and 34.6 events per 100 patient-years with vedolizumab and adalimumab, respectively, and the corresponding rates for serious infection were 1.6 and 2.2 events per 100 patient-years. ConclusionsIn this trial involving patients with moderately to severely active ulcerative colitis, vedolizumab was superior to adalimumab with respect to achievement of clinical remission and endoscopic improvement, but not corticosteroid-free clinical remission. (Funded by Takeda; VARSITY ClinicalTrials.gov number, NCT02497469; EudraCT number, 2015-000939-33.)	[Sands, Bruce E.; Colombel, Jean-Frederic] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Peyrin-Biroulet, Laurent] Nancy Univ Hosp, Nancy, France; [Loftus, Edward V., Jr.] Mayo Clin, Coll Med, Rochester, MN USA; [Danese, Silvio] Humanitas Univ, Milan, Italy; [Toruner, Murat] Ankara Univ, Sch Med, Ankara, Turkey; [Jonaitis, Laimas] Lithuanian Univ Hlth Sci, Kaunas, Lithuania; [Abhyankar, Brihad] Takeda Dev Ctr Europe, London, England; [Chen, Jingjing; Rogers, Raquel; Lirio, Richard A.; Bornstein, Jeffrey D.] Takeda Dev Ctr Amer, Cambridge, MA USA; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Kiel, Germany	Icahn School of Medicine at Mount Sinai; CHU de Nancy; Mayo Clinic; Humanitas University; Ankara University; Lithuanian University of Health Sciences; Takeda Pharmaceutical Company Ltd; Takeda Development Centre Europe Ltd.; Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.; University of Kiel; Schleswig Holstein University Hospital	Sands, BE (corresponding author), Icahn Sch Med Mt Sinai, Div Gastroenterol, 1 Gustave L Levy Pl,Box 1069, New York, NY 10029 USA.; Schreiber, S (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 1, Rosalind Franklin Str 12,Haus 5, D-24105 Kiel, Germany.	bruce.sands@mssm.edu; s.schreiber@mucosa.de	Rafalskiy, Vladimir V/G-3172-2013; chen, jingjing/GMX-3026-2022; Beales, Ian/M-5161-2014; Danese, Silvio/ABH-9571-2020; ALTINTAS, Engin/R-2585-2019; Törüner, Murat/AAQ-1826-2020; ALTINTAS, ENGIN/A-9651-2011; Leong, Rupert WL/J-7839-2012; Loftus, Edward/E-8304-2011	Rafalskiy, Vladimir V/0000-0002-2503-9580; chen, jingjing/0000-0003-4252-9255; Beales, Ian/0000-0003-1923-3237; Danese, Silvio/0000-0001-7341-1351; ALTINTAS, Engin/0000-0003-0796-1456; ALTINTAS, ENGIN/0000-0003-0796-1456; Leong, Rupert WL/0000-0001-5944-3488; CASTIGLIONE, FABIANA/0000-0002-1099-442X; Regula, Jaroslaw/0000-0001-7071-3151; peyrin-biroulet, laurent/0000-0003-2536-6618; Gonen, Can/0000-0002-8882-9272; Roblin, Xavier/0000-0002-7929-4878; Sands, Bruce/0000-0001-5762-5042; TOLMANIS, IVARS/0000-0003-0783-6460; Kohout, Pavel/0000-0002-3957-7005; Loftus, Edward/0000-0001-7199-6851; Djuranovic, Srdjan/0000-0002-5775-9160; Theede, Klaus/0000-0003-2692-6840	Takeda	Takeda(Takeda Pharmaceutical Company Ltd)	Supported by Takeda.	Colombel JF, 2017, ALIMENT PHARM THER, V45, P50, DOI 10.1111/apt.13838; Cui L, 1999, BIOMETRICS, V55, P853, DOI 10.1111/j.0006-341X.1999.00853.x; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Gordon KB, 2015, NEW ENGL J MED, V373, P136, DOI 10.1056/NEJMoa1501646; Harbord M, 2017, J CROHNS COLITIS, V11, P769, DOI 10.1093/ecco-jcc/jjx009; Irvine EJ, 1999, J PEDIATR GASTR NUTR, V28, pS23, DOI 10.1097/00005176-199904001-00003; Jauregui-Amezaga A, 2017, J CROHNS COLITIS, V11, P305, DOI 10.1093/ecco-jcc/jjw154; Lamb CA, 2018, J CROHNS COLITIS, V12, pS653, DOI 10.1093/ecco-jcc/jjy060; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Mehta CR, 2011, STAT MED, V30, P3267, DOI 10.1002/sim.4102; Mosli MH, 2017, GUT, V66, P50, DOI 10.1136/gutjnl-2015-310393; Rubin DT, 2019, AM J GASTROENTEROL, V114, P384, DOI 10.14309/ajg.0000000000000152; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Schreiber S, 2018, J GASTROENTEROL, V53, P1048, DOI 10.1007/s00535-018-1480-0; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; Ungaro R, 2017, LANCET, V389, P1756, DOI 10.1016/S0140-6736(16)32126-2; Van de Vondel S, 2018, INFLAMM BOWEL DIS, V24, P1099, DOI 10.1093/ibd/izx103; Wyant T, 2016, J CROHNS COLITIS, V10, P1437, DOI 10.1093/ecco-jcc/jjw092	19	282	293	10	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1215	1226		10.1056/NEJMoa1905725	http://dx.doi.org/10.1056/NEJMoa1905725			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OT	31553834	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000489333500006
J	Sharma, K; Patel, A				Sharma, Konika; Patel, Anush			Livedo Reticularis in Cold Agglutinin Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 70-year-old woman presented with dizziness, rash, and hemolytic anemia 2 weeks after the onset of a viral respiratory tract infection. The rash was consistent with livedo reticularis, and a diagnosis of cold agglutinin disease was made.	[Sharma, Konika; Patel, Anush] Bassett Med Ctr, Cooperstown, NY 13326 USA		Sharma, K (corresponding author), Bassett Med Ctr, Cooperstown, NY 13326 USA.	drkonika@gmail.com		Sharma, Konika/0000-0003-4808-4605					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					E27	E27		10.1056/NEJMicm1902289	http://dx.doi.org/10.1056/NEJMicm1902289			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC5OT	31553839				2022-12-28	WOS:000489333500001
J	Svoboda, E				Svoboda, Elizabeth			Your robot surgeon will see you now	NATURE			English	Editorial Material																		Anderson JG, 2017, STUD HEALTH TECHNOL, V234, P13, DOI 10.3233/978-1-61499-742-9-13; Fagogenis G, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aaw1977; Opfermann J. D., 2017, PROC IEEE RSJ INT CO; Shademan A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9398	4	11	11	5	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					S110	S111		10.1038/d41586-019-02874-0	http://dx.doi.org/10.1038/d41586-019-02874-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554995	Bronze			2022-12-28	WOS:000488247600016
J	Tao, F; Qi, QL				Tao, Fei; Qi, Qinglin			Make more digital twins	NATURE			English	Editorial Material									[Tao, Fei; Qi, Qinglin] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China	Beihang University	Tao, F (corresponding author), Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China.	ftao@buaa.edu.cn; kylin3366@buaa.edu.cn	Tao, Fei/F-8944-2012; Qi, Qinglin/N-3496-2018	Tao, Fei/0000-0002-9020-0633; Qi, Qinglin/0000-0002-3247-0440				Gartner, 2017, PREPARE IMPACT DIGIT; Kusiak A, 2017, NATURE, V544, P23, DOI 10.1038/544023a; Tao F., 2019, DIGITAL TWIN DRIVEN	3	137	161	88	321	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					490	491		10.1038/d41586-019-02849-1	http://dx.doi.org/10.1038/d41586-019-02849-1			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554984	Bronze			2022-12-28	WOS:000488247600031
J	Woo, M				Woo, Marcus			Trial by artificial intelligence	NATURE			English	Editorial Material							LUMPECTOMY PLUS TAMOXIFEN; IRRADIATION; OLDER; AGE											Bain EE, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7030; Bennette CS, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv324; Haddad TC, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.6550; Hughes KS, 2013, J CLIN ONCOL, V31, P2382, DOI 10.1200/JCO.2012.45.2615; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; Knepper TC, 2018, NATURE, V557, P157, DOI 10.1038/d41586-018-05049-5; Liu C, 2019, J AM MED INFORM ASSN, V26, P1333, DOI 10.1093/jamia/ocz121; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Wong CH, 2019, BIOSTATISTICS, V20, P273, DOI 10.1093/biostatistics/kxx069; Yuan C, 2019, J AM MED INFORM ASSN, V26, P294, DOI 10.1093/jamia/ocy178	10	31	32	2	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					S100	S102		10.1038/d41586-019-02871-3	http://dx.doi.org/10.1038/d41586-019-02871-3			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554996	Bronze			2022-12-28	WOS:000488247600013
J	Patel, V; Saxena, S				Patel, Vikram; Saxena, Shekhar			Achieving universal health coverage for mental disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MIDDLE-INCOME COUNTRIES; DEPRESSION; MANAGEMENT; DISEASE; CARE		[Patel, Vikram; Saxena, Shekhar] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Patel, V (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	vikram_patel@hms.harvard.edu						Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; CHISHOLM D, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.E612; Chisholm D, 2016, LANCET PSYCHIAT, V3, P415, DOI 10.1016/S2215-0366(16)30024-4; Collins PY, 2016, NATURE, V532, P25, DOI 10.1038/532025a; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Geuter S, 2017, ANNU REV NEUROSCI, V40, P167, DOI 10.1146/annurev-neuro-072116-031132; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Kebede S, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4045; Kleinman A, 2009, LANCET, V374, P603, DOI 10.1016/S0140-6736(09)61510-5; Lund C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001359; Naslund JA, 2017, LANCET PSYCHIAT, V4, P486, DOI 10.1016/S2215-0366(17)30096-2; Patel V, 2018, LANCET, V392, P1553, DOI 10.1016/S0140-6736(18)31612-X; Patel V, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002257; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Patel V, 2015, HEALTH AFFAIR, V34, P1498, DOI 10.1377/hlthaff.2015.0791; Patel V, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001448; Shidhaye R, 2017, LANCET PSYCHIAT, V4, P128, DOI 10.1016/S2215-0366(16)30424-2; Singla DR, 2017, ANNU REV CLIN PSYCHO, V13, P149, DOI 10.1146/annurev-clinpsy-032816-045217; Thornicroft G, 2017, BRIT J PSYCHIAT, V210, P119, DOI 10.1192/bjp.bp.116.188078; van Ginneken N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178954; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; World Health Organization, 2015, MENT HLTH ATLAS 2014	22	16	16	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l4516	10.1136/bmj.l4516	http://dx.doi.org/10.1136/bmj.l4516			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB3WS	31548204	Green Published, hybrid			2022-12-28	WOS:000488488000001
J	Sashital, D; Blanpain, C; Cannon, B; Keeling, P; Ruffell, B; Rothenberg, EV; Siekhaus, D; Schlessinger, A; Malumbres, M; Brookfield, J; Arber, S; Morris, S; Hess, C; Qian, L; Martin-Villalba, A; Ffrench-Constant, C				Sashital, Dipali; Blanpain, Cedric; Cannon, Barbara; Keeling, Patrick; Ruffell, Brian; Rothenberg, Ellen V.; Siekhaus, Daria; Schlessinger, Avner; Malumbres, Marcos; Brookfield, John; Arber, Silvia; Morris, Samantha; Hess, Christoph; Qian, Li; Martin-Villalba, Ana; Ffrench-Constant, Charles			Advice from Cell Press Reviewers	CELL			English	Editorial Material								To celebrate this year's Peer Review Week theme, "Quality in Peer Review,'' we asked editors across Cell Press to nominate some of their best reviewers to give their philosophies on peer reviewing.	[Sashital, Dipali] Iowa State Univ, Ames, IA 50011 USA; [Blanpain, Cedric] Univ Libre Bruxelles, Brussels, Belgium; [Cannon, Barbara] Stockholm Univ, Stockholm, Sweden; [Keeling, Patrick] Univ British Columbia, Vancouver, BC, Canada; [Ruffell, Brian] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Rothenberg, Ellen V.] CALTECH, Pasadena, CA 91125 USA; [Siekhaus, Daria] IST Austria, Klosterneuburg, Austria; [Schlessinger, Avner] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Malumbres, Marcos] CNIO Madrid, Madrid, Spain; [Brookfield, John] Univ Nottingham, Nottingham, England; [Arber, Silvia] Biozentrum, Basel, Switzerland; [Arber, Silvia] FMI, Basel, Switzerland; [Morris, Samantha] Washington Univ St Louis, St Louis, MO USA; [Hess, Christoph] Univ Cambridge, Cambridge, England; [Hess, Christoph] Univ Basel, Basel, Switzerland; [Qian, Li] Univ N Carolina, Chapel Hill, NC USA; [Martin-Villalba, Ana] DKFZ Heidelberg, Heidelberg, Germany; [Ffrench-Constant, Charles] Univ Edinburgh, Edinburgh, Midlothian, Scotland	Iowa State University; Universite Libre de Bruxelles; Stockholm University; University of British Columbia; H Lee Moffitt Cancer Center & Research Institute; California Institute of Technology; Institute of Science & Technology - Austria; Icahn School of Medicine at Mount Sinai; University of Nottingham; Friedrich Miescher Institute for Biomedical Research; Washington University (WUSTL); University of Cambridge; University of Basel; University of North Carolina; University of North Carolina Chapel Hill; Helmholtz Association; German Cancer Research Center (DKFZ); University of Edinburgh	Sashital, D (corresponding author), Iowa State Univ, Ames, IA 50011 USA.		Siekhaus, Daria/AAN-1779-2020; Malumbres, Marcos/E-8834-2011; Blanpain, Cedric/ABD-8392-2021	Siekhaus, Daria/0000-0001-8323-8353; Malumbres, Marcos/0000-0002-0829-6315; 					0	0	0	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					40	45		10.1016/j.cell.2019.08.044	http://dx.doi.org/10.1016/j.cell.2019.08.044			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31526487	Bronze			2022-12-28	WOS:000486618500009
J	Shepard, HM				Shepard, H. Michael			The Team that Just Wouldn't Quit and a New Paradigm in Cancer Drug Discovery	CELL			English	Editorial Material								Receiving the Lasker award for Clinical Medical Research is a staggering event. Perhaps equally staggering is the fact that as many as 2 million women worldwide have now been treated with Herceptin (trastuzumab), many of whom benefited from the treatment. This accomplishment is wonderfully rewarding for everyone who has been involved.	[Shepard, H. Michael] Biooncol Consultants, San Diego, CA 90095 USA		Shepard, HM (corresponding author), Biooncol Consultants, San Diego, CA 90095 USA.	hms@biologics21.net						HUDZIAK RM, 1988, P NATL ACAD SCI USA, V85, P5102, DOI 10.1073/pnas.85.14.5102; SUGARMAN BJ, 1987, CANCER RES, V47, P780; URBAN JL, 1983, J EXP MED, V157, P642, DOI 10.1084/jem.157.2.642	3	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					27	32		10.1016/j.cell.2019.08.028	http://dx.doi.org/10.1016/j.cell.2019.08.028			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31519309	Bronze			2022-12-28	WOS:000486618500006
J	Dyer, O				Dyer, Owen			Assisted dying: Quebec court strikes down imminent death requirement in Canada's law	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h764; Grant K., 2018, GLOBE MAIL	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5566	10.1136/bmj.l5566	http://dx.doi.org/10.1136/bmj.l5566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519709				2022-12-28	WOS:000486649800015
J	Karbstein, K				Karbstein, Katrin			Mitochondria teach ribosome assembly	SCIENCE			English	Editorial Material									[Karbstein, Katrin] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Jupiter, FL 33458 USA	Scripps Research Institute	Karbstein, K (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, Jupiter, FL 33458 USA.	kkarbst@scripps.edu			NIH [R01-GM086451, R01-GM117093]; HHMI Faculty Scholar grant [55108536]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086451, R01GM117093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Faculty Scholar grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants R01-GM086451 and R01-GM117093 and by HHMI Faculty Scholar grant 55108536.	Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Barandun J, 2017, NAT STRUCT MOL BIOL, V24, P944, DOI 10.1038/nsmb.3472; Cheng JD, 2017, NAT STRUCT MOL BIOL, V24, P954, DOI 10.1038/nsmb.3476; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; Ramrath DJF, 2018, SCIENCE, V362, DOI 10.1126/science.aau7735; Razi A., 2019, NUCLEIC ACIDS RES, V47; Russell R, 2007, BIOCHEMISTRY-US, V46, P4951, DOI 10.1021/bi0620149; Sashital DG, 2014, ELIFE, V3, DOI 10.7554/eLife.04491; Saurer M, 2019, SCIENCE, V365, P1144, DOI 10.1126/science.aaw5570; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261	13	2	2	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1077	1078		10.1126/science.aay7771	http://dx.doi.org/10.1126/science.aay7771			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515371	Green Accepted			2022-12-28	WOS:000485780800022
J	Else, H				Else, Holly			MAKING MEETINGS MORE EQUAL	NATURE			English	News Item																			0	16	16	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					184	186		10.1038/d41586-019-02658-6	http://dx.doi.org/10.1038/d41586-019-02658-6			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31506631	Bronze			2022-12-28	WOS:000485415400028
J	Mahase, E				Mahase, Elisabeth			Euthanasia: Dutch doctor is acquitted in landmark test case	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		District Court of the Hague, 2019, SPEC GER MED DISM AL	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2019	366								l5555	10.1136/bmj.l5555	http://dx.doi.org/10.1136/bmj.l5555			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MV	31515221				2022-12-28	WOS:000486649600012
J	Wise, J				Wise, Jacqui			Don't charge migrants for maternity care, say midwives	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Maternity Action, 2019, DUT CAR IMP MIDW NHS	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5487	10.1136/bmj.l5487	http://dx.doi.org/10.1136/bmj.l5487			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501159				2022-12-28	WOS:000486648500010
J	Osei-Owusu, P; Charlton, TM; Kim, HK; Missiakas, D; Schneewind, O				Osei-Owusu, Patrick; Charlton, Thomas M.; Kim, Hwan Keun; Missiakas, Dominique; Schneewind, Olaf			FPR1 is the plague receptor on host immune cells	NATURE			English	Article							N-FORMYLPEPTIDE RECEPTOR; FORMYL-PEPTIDE RECEPTORS; YERSINIA-PESTIS; III SECRETION; PNEUMONIC PLAGUE; NONHUMAN-PRIMATES; ESCHERICHIA-COLI; YOP PROTEINS; V-ANTIGEN; RESISTANCE	The causative agent of plague, Yersinia pestis, uses a type III secretion system to selectively destroy immune cells in humans, thus enabling Y. pestis to reproduce in the bloodstream and be transmitted to new hosts through fleabites. The host factors that are responsible for the selective destruction of immune cells by plague bacteria are unknown. Here we show that LcrV, the needle cap protein of the Y. pestis type III secretion system, binds to the N-formylpeptide receptor (FPR1) on human immune cells to promote the translocation of bacterial effectors. Plague infection in mice is characterized by high mortality; however, Fpr1-deficient mice have increased survival and antibody responses that are protective against plague. We identified FPR1(R190W) as a candidate resistance allele in humans that protects neutrophils from destruction by the Y. pestis type III secretion system. Thus, FPR1 is a plague receptor on immune cells in both humans and mice, and its absence or mutation provides protection against Y. pestis. Furthermore, plague selection of FPR1 alleles appears to have shaped human immune responses towards other infectious diseases and malignant neoplasms.	[Osei-Owusu, Patrick; Charlton, Thomas M.; Kim, Hwan Keun; Missiakas, Dominique; Schneewind, Olaf] Argonne Natl Lab, Howard Taylor Ricketts Lab, Lemont, IL 60439 USA; [Osei-Owusu, Patrick; Charlton, Thomas M.; Kim, Hwan Keun; Missiakas, Dominique; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Missiakas, D (corresponding author), Argonne Natl Lab, Howard Taylor Ricketts Lab, Lemont, IL 60439 USA.; Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	dmissiak@bsd.uchicago.edu		Kim, Hwan Keun/0000-0003-2095-9705	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [AI107792, AI057153, AI042797]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI107792] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.A. van Strijp for providing CHIPS, G.V. Plano and D. Anderson for sharing and providing strains Y. pestis KIM 8 and KIM 8(.1234), P.M. Murphy for providing breeding pairs of FPR1 and FPR2 mice, C. Tam and D. Elli for experimental assistance, J. Andrade and Y. Li for assistance with bioinformatics analysis of sequence data, C. Ober, T. Golovkina and members of our laboratory for discussion. O.S. is grateful to P. Model for his lifelong support and friendship. This project has been supported by funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under awards AI107792, AI057153 and AI042797.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Baeten LA, 2013, J WILDLIFE DIS, V49, P932, DOI 10.7589/2013-02-040; Bardoel BW, 2012, CELL MICROBIOL, V14, P902, DOI 10.1111/j.1462-5822.2012.01765.x; Bartra SS, 2006, INFECT IMMUN, V74, P1381, DOI 10.1128/IAI.74.2.1381-1386.2006; Benedictow O.J., 2004, BLACK DEATH 1346 135; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cornelis GR, 1998, J BACTERIOL, V180, P5495, DOI 10.1128/JB.180.21.5495-5504.1998; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; DeBord KL, 2006, INFECT IMMUN, V74, P4910, DOI 10.1128/IAI.01860-05; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Dorward DA, 2015, AM J PATHOL, V185, P1172, DOI 10.1016/j.ajpath.2015.01.020; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elvin SJ, 2004, NATURE, V430, P417, DOI 10.1038/nature02822; FORSBERG A, 1987, MICROB PATHOGENESIS, V2, P123, DOI 10.1016/0882-4010(87)90104-5; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; GALLAGHER R, 1979, BLOOD, V54, P713; GIRARD G, 1955, ANNU REV MICROBIOL, V9, P253, DOI 10.1146/annurev.mi.09.100155.001345; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hartt JK, 1999, J EXP MED, V190, P741, DOI 10.1084/jem.190.5.741; HIGUCHI K, 1970, J CELL PHYSIOL, V75, P65, DOI 10.1002/jcp.1040750108; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Liang XY, 2014, EYE, V28, P1502, DOI 10.1038/eye.2014.226; Ligtenberg KG, 2013, J BACTERIOL, V195, P777, DOI 10.1128/JB.02021-12; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mecsas J, 2004, NATURE, V427, P606, DOI 10.1038/427606a; MEYER KF, 1974, J INFECT DIS, V129, pS85, DOI 10.1093/infdis/129.Supplement_1.S85; Miettinen HM, 1997, J IMMUNOL, V159, P4045; Mitchell A, 2017, MBIO, V8, DOI [10.1128/mbio.00646-17, 10.1128/mBio.00646-17]; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Muto Y, 2015, J MOL EVOL, V80, P130, DOI 10.1007/s00239-015-9666-z; Otani T, 2011, BIOCHEM BIOPH RES CO, V405, P356, DOI 10.1016/j.bbrc.2010.12.136; Pechous RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003679; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Quenee LE, 2011, VACCINE, V29, P6572, DOI 10.1016/j.vaccine.2011.06.119; Quenee LE, 2009, HUM VACCINES, V5, P817, DOI 10.4161/hv.9866; Quignon P, 2012, MAMM GENOME, V23, P132, DOI 10.1007/s00335-011-9371-1; Sahagun-Ruiz A, 2001, GENES IMMUN, V2, P335, DOI 10.1038/sj.gene.6363787; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schaffrath R, 2014, MICROB CELL, V1, P203, DOI 10.15698/mic2014.06.151; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shannon JG, 2013, MBIO, V4, DOI 10.1128/mBio.00170-13; Sheahan KL, 2015, MBIO, V6, DOI 10.1128/mBio.02023-14; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stempel H, 2016, J BIOL CHEM, V291, P9762, DOI 10.1074/jbc.M116.714493; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; Valtuena AA, 2017, CURR BIOL, V27, P3683, DOI 10.1016/j.cub.2017.10.025; Welkos S, 1998, MICROB PATHOGENESIS, V24, P185, DOI 10.1006/mpat.1997.0188; WENZELSEIFERT K, 1991, J IMMUNOL, V147, P1940; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	66	29	29	1	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					57	+		10.1038/s41586-019-1570-z	http://dx.doi.org/10.1038/s41586-019-1570-z			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31534221	Green Accepted			2022-12-28	WOS:000488832500029
J	Shepard, HM				Shepard, H. Michael			Biomarker-Driven Drug Discovery in Cancer-Trastuzumab Development 2019 Lasker-DeBakey Clinical Medical Research Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TUMOR-NECROSIS-FACTOR; BREAST-CANCER; FACTOR-ALPHA; ANTIBODY; CELLS		[Shepard, H. Michael] Biooncol Consultants, San Diego, CA USA		Shepard, HM (corresponding author), 13225 Bavarian Dr, San Diego, CA 92129 USA.	HMS@betteroutcomes4cancer.com						CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; FENDLY BM, 1990, J BIOL RESP MODIF, V9, P449; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HUDZIAK RM, 1988, P NATL ACAD SCI USA, V85, P5102, DOI 10.1073/pnas.85.14.5102; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; SUGARMAN BJ, 1987, CANCER RES, V47, P780; URBAN JL, 1986, P NATL ACAD SCI USA, V83, P5233, DOI 10.1073/pnas.83.14.5233	10	2	2	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1249	1250		10.1001/jama.2019.13963	http://dx.doi.org/10.1001/jama.2019.13963			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31503281	Bronze			2022-12-28	WOS:000489331900008
J	Chen, SA; Michaelides, K; Grieve, SWD; Singer, MB				Chen, Shiuan-An; Michaelides, Katerina; Grieve, Stuart W. D.; Singer, Michael Bliss			Aridity is expressed in river topography globally	NATURE			English	Article							CLIMATE; PROFILE; INCISION; BEDROCK; CONCAVITY; EVOLUTION	It has long been suggested that climate shapes land surface topography through interactions between rainfall, runoff and erosion in drainage basins(1-4). The longitudinal profile of a river (elevation versus distance downstream) is a key morphological attribute that reflects the history of drainage basin evolution, so its form should be diagnostic of the regional expression of climate and its interaction with the land surface(5-9). However, both detecting climatic signatures in longitudinal profiles and deciphering the climatic mechanisms of their development have been challenging, owing to the lack of relevant global data and to the variable effects of tectonics, lithology, land surface properties and human activities(10,11). Here we present a global dataset of 333,502 river longitudinal profiles, and use it to explore differences in overall profile shape (concavity) across climate zones. We show that river profiles are systematically straighter with increasing aridity. Through simple numerical modelling, we demonstrate that these global patterns in longitudinal profile shape can be explained by hydrological controls that reflect rainfall-runoff regimes in different climate zones. The most important of these is the downstream rate of change in streamflow, independent of the area of the drainage basin. Our results illustrate that river topography expresses a signature of aridity, suggesting that climate is a first-order control on the evolution of the drainage basin.	[Chen, Shiuan-An; Michaelides, Katerina] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Michaelides, Katerina; Singer, Michael Bliss] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Grieve, Stuart W. D.] Queen Mary Univ London, Sch Geog, London, England; [Singer, Michael Bliss] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, S Glam, Wales; [Singer, Michael Bliss] Cardiff Univ, Water Res Inst, Cardiff, S Glam, Wales	University of Bristol; University of California System; University of California Santa Barbara; University of London; Queen Mary University London; Cardiff University; Cardiff University	Chen, SA; Michaelides, K (corresponding author), Univ Bristol, Sch Geog Sci, Bristol, Avon, England.; Michaelides, K (corresponding author), Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA.	sc16970@bristol.ac.uk; katerina.michaelides@bristol.ac.uk		Grieve, Stuart/0000-0003-1893-7363; Michaelides, Katerina/0000-0002-7996-0543; Chen, Shiuan-An/0000-0003-2642-7179	NSF [BCS-1660490, EAR-1700555]	NSF(National Science Foundation (NSF))	M.B.S. was supported in part by the NSF (grants BCS-1660490 and EAR-1700555). We acknowledge the use of the UCL Legion High Performance Computing Facility (Legion@UCL), and associated support services, in the completion of this work. We thank R. Slingerland for sharing the code and providing advice on the LONGPRO model. We thank J. Willenbring for comments on an early version of the manuscript.	Al-Masrahy MA, 2015, AEOLIAN RES, V17, P67, DOI 10.1016/j.aeolia.2015.01.010; Bonnet S, 2009, NAT GEOSCI, V2, P766, DOI 10.1038/NGEO666; Braun J, 2013, GEOMORPHOLOGY, V180, P170, DOI 10.1016/j.geomorph.2012.10.008; Collins DBG, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008615; Fan Y, 2013, SCIENCE, V339, P940, DOI 10.1126/science.1229881; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Ferrier KL, 2013, NATURE, V496, P206, DOI 10.1038/nature11982; FLINT JJ, 1974, WATER RESOUR RES, V10, P969, DOI 10.1029/WR010i005p00969; Grieve SWD, 2016, EARTH SURF DYNAM, V4, P627, DOI 10.5194/esurf-4-627-2016; Hack J. T, 1957, 294B; Han JW, 2014, J GEOPHYS RES-EARTH, V119, P1418, DOI 10.1002/2013JF002961; Harel MA, 2016, GEOMORPHOLOGY, V268, P184, DOI 10.1016/j.geomorph.2016.05.035; Jaeger KL, 2017, INTERMITTENT RIVERS AND EPHEMERAL STREAMS: ECOLOGY AND MANAGEMENT, P21, DOI 10.1016/B978-0-12-803835-2.00002-4; Knighton A., 1997, ARID ZONE GEOMORPHOL, P185; Lague D, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000259; Leopold L.B., 1992, FLUVIAL PROCESSES GE; Michaelides K, 2018, EARTH SURF PROC LAND, V43, P1608, DOI 10.1002/esp.4340; Molnar P, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000310; MONTGOMERY DR, 1988, NATURE, V336, P232, DOI 10.1038/336232a0; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perron JT, 2012, NATURE, V492, P100, DOI 10.1038/nature11672; Phillips JD, 2008, GEOMORPHOLOGY, V102, P554, DOI 10.1016/j.geomorph.2008.05.042; Roe GH, 2002, GEOLOGY, V30, P143, DOI 10.1130/0091-7613(2002)030<0143:EOOPVO>2.0.CO;2; Royden L.H., 2000, EOS T AM GEOPHYS UN, V81; Seybold H, 2017, GEOPHYS RES LETT, V44, P2272, DOI 10.1002/2016GL072089; Singer MB, 2014, GEOLOGY, V42, P1091, DOI 10.1130/G36267.1; Slingerland R, 1994, SIMULATION CLASTIC S; SNOW RS, 1987, J GEOL, V95, P15, DOI 10.1086/629104; Solyom PB, 2004, J GEOPHYS RES-EARTH, V109, DOI 10.1029/2003JF000032; TARBOTON DG, 1991, HYDROL PROCESS, V5, P81, DOI 10.1002/hyp.3360050107; Trabucco A, 2009, GLOBAL ARIDITY PET D; Tucker GE, 1998, WATER RESOUR RES, V34, P2751, DOI 10.1029/98WR01474; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; VOGEL JC, 1989, PALAEOGEOGR PALAEOCL, V70, P355, DOI 10.1016/0031-0182(89)90113-2; Wang L, 2006, INT J GEOGR INF SCI, V20, P193, DOI 10.1080/13658810500433453; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Wickert A. D., 2018, AGU FALL M; WOLMAN MG, 1978, EARTH SURF PROC LAND, V3, P189, DOI 10.1002/esp.3290030207; Yair A., 1978, Z GEOMORPHOL S, V29, P71; Yang C. T., 1973, J HYDRAULIC DIV ASCE, V99, P1679, DOI [10.1061/JYCEAJ.0003766, DOI 10.1061/JYCEAJ.0003766]; Zaprowski BJ, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000138	41	46	51	11	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					573	+		10.1038/s41586-019-1558-8	http://dx.doi.org/10.1038/s41586-019-1558-8			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31527826	Green Accepted, Green Submitted			2022-12-28	WOS:000488247600056
J	Al-Jebari, Y; Elenkov, A; Wirestrand, E; Schutz, I; Giwercman, A; Giwercman, YL				Al-Jebari, Yahia; Elenkov, Angel; Wirestrand, Elin; Schutz, Indra; Giwercman, Aleksander; Giwercman, Yvonne Lundberg			Risk of prostate cancer for men fathering through assisted reproduction: nationwide population based register study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FATHERHOOD STATUS	OBJECTIVE To compare the risk and severity of prostate cancer between men achieving fatherhood by assisted reproduction and men conceiving naturally. DESIGN National register based cohort study. SETTING Sweden from January 1994 to December 2014. PARTICIPANTS 1 181 490 children born alive in Sweden during 1994-2014 to the same number of fathers. Fathers were grouped according to fertility status by mode of conception: 20618 by in vitro fertilisation (IVF), 14 882 by intra-cytoplasmic sperm injection (ICSI), and 1 145 990 by natural conception. MAIN OUTCOME MEASURES Prostate cancer diagnosis, age of onset, and androgen deprivation therapy (serving as proxy for advanced or metastatic malignancy). RESULTS Among men achieving fatherhood by IVF, by ICSI, and by non-assisted means, 77 (0.37%), 63 (0.42%), and 3244 (0.28%), respectively, were diagnosed as having prostate cancer. Mean age at onset was 55.9, 55.1, and 57.1 years, respectively. Men who became fathers through assisted reproduction had a statistically significantly increased risk of prostate cancer compared with men who conceived naturally (hazard ratio 1.64, 95% confidence interval 1.25 to 2.15, for ICSI; 1.33, 1.06 to 1.66, for IVF). They also had an increased risk of early onset disease (that is, diagnosis before age 55 years) (hazard ratio 1.86, 1.25 to 2.77, for ICSI; 1.51, 1.09 to 2.08, for IVF). Fathers who conceived through ICSI and developed prostate cancer received androgen deprivation therapy to at least the same extent as the reference group (odds ratio 1.91; P=0.07). CONCLUSIONS Men who achieved fatherhood through assisted reproduction techniques, particularly through ICSI, are at increased risk for early onset prostate cancer and thus constitute a risk group in which testing and careful long term follow-up for prostate cancer may be beneficial.	[Al-Jebari, Yahia; Elenkov, Angel; Wirestrand, Elin; Schutz, Indra; Giwercman, Aleksander; Giwercman, Yvonne Lundberg] Lund Univ, Dept Translat Med, Malmo, Sweden; [Elenkov, Angel] Med Univ Sofia, Dept Urol, Sofia, Bulgaria; [Elenkov, Angel; Giwercman, Aleksander] Skane Univ Hosp Malmo, Reprod Med Ctr, Malmo, Sweden	Lund University; Medical University Sofia; Lund University; Skane University Hospital	Al-Jebari, Y (corresponding author), Lund Univ, Dept Translat Med, Malmo, Sweden.	yahia.al-jebari@med.lu.se		Al-Jebari, Yahia/0000-0002-2474-0471	Swedish Cancer Foundation [CAN 2014/360, 2017/392]; ALF government [F2014/354]; Malmo University Hospital Cancer Research Fund; Swedish Prostate Cancer Federation; European Association of Urology [EUSP/REPRO-02-2017]	Swedish Cancer Foundation; ALF government; Malmo University Hospital Cancer Research Fund; Swedish Prostate Cancer Federation; European Association of Urology	The study was funded by the Swedish Cancer Foundation (CAN 2014/360 and 2017/392), an ALF government grant (F2014/354), the Malmo University Hospital Cancer Research Fund, the Swedish Prostate Cancer Federation, and the European Association of Urology (scholarship EUSP/REPRO-02-2017). Funders had no role in study design, results, or write up or manuscript submission decisions other than to provide funding. The researchers were independent of the funders.	Aus G, 2005, EUR UROL, V48, P546, DOI 10.1016/j.eururo.2005.06.001; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bobjer J, 2016, CLIN ENDOCRINOL, V85, P189, DOI 10.1111/cen.13038; Cox B, 2006, INT J CANCER, V119, P1690, DOI 10.1002/ijc.22022; Eisenberg ML, 2015, J UROLOGY, V193, P1596, DOI 10.1016/j.juro.2014.11.080; Eisenberg ML, 2011, INT J EPIDEMIOL, V40, P480, DOI 10.1093/ije/dyq163; Gannon JR, 2015, BIENNIAL REV INFERTI, P1, DOI DOI 10.1007/978-3-319-17849-3_1; Giwercman A, 2005, INT J CANCER, V115, P994, DOI 10.1002/ijc.20963; Hamberger L, 1998, HUM REPROD, V13, P128, DOI 10.1093/humrep/13.suppl_1.128; Hanson HA, 2016, FERTIL STERIL, V105, P322, DOI 10.1016/j.fertnstert.2015.10.027; Hill M., 1993, EUR J CANCER PREV, V2, P419, DOI [10.1097/00008469-199309000-00010, DOI 10.1097/00008469-199309000-00010]; Jorgensen KT, 2008, CANCER-AM CANCER SOC, V112, P919, DOI 10.1002/cncr.23230; Lightfoot N, 2004, ANN EPIDEMIOL, V14, P655, DOI 10.1016/j.annepidem.2003.11.006; Mao YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19210; Negri E, 2006, INT J CANCER, V118, P786, DOI 10.1002/ijc.21369; Palermo GD, 2015, SEMIN REPROD MED, V33, P92, DOI 10.1055/s-0035-1546825; Rosenblatt KA, 2001, AM J EPIDEMIOL, V153, P1152, DOI 10.1093/aje/153.12.1152; Ruhayel Y, 2010, CANCER CAUSE CONTROL, V21, P1635, DOI 10.1007/s10552-010-9592-8; Salinas CA, 2014, NAT REV UROL, V11, P317, DOI 10.1038/nrurol.2014.91; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Walsh TJ, 2010, CANCER-AM CANCER SOC, V116, P2140, DOI 10.1002/cncr.25075; Wiren SM, 2013, INT J CANCER, V133, P937, DOI 10.1002/ijc.28057	22	16	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2019	366								15214	10.1136/bmj.l5214	http://dx.doi.org/10.1136/bmj.l5214			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WY	31554611	Green Published, hybrid			2022-12-28	WOS:000488488700001
J	Mahase, E				Mahase, Elisabeth			Having a named GP doesn't improve older patients' continuity of care, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Tammes P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029103	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5682	10.1136/bmj.l5682	http://dx.doi.org/10.1136/bmj.l5682			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551232				2022-12-28	WOS:000488488300010
J	Moberly, T				Moberly, Tom			Children strike for their future	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5704	10.1136/bmj.l5704	http://dx.doi.org/10.1136/bmj.l5704			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551257				2022-12-28	WOS:000488488300014
J	Slomski, A				Slomski, Anita			CBT Curbs Internet and Gaming Addiction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1134	1134		10.1001/jama.2019.14754	http://dx.doi.org/10.1001/jama.2019.14754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550028				2022-12-28	WOS:000488822800008
J	Kim, LHY; Chu, DK; Alhazzani, W				Kim, Lisa H. Y.; Chu, Derek K.; Alhazzani, Waleed			Inpatient Notes: Rethinking Oxygen Therapy for Hospitalized Patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kim, Lisa H. Y.; Chu, Derek K.; Alhazzani, Waleed] McMaster Univ, Hamilton, ON, Canada; [Kim, Lisa H. Y.; Chu, Derek K.; Alhazzani, Waleed] St Josephs Healthcare Hamilton, 50 Charlton Ave, Hamilton, ON L8N 4A6, Canada; [Kim, Lisa H. Y.] St Josephs Healthcare Hamilton, Div Respirol, 50 Charlton Ave, Hamilton, ON L8N 4A6, Canada; [Chu, Derek K.] McMaster Univ, Med Ctr, HSC 3V49,1280 Main St West, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Kim, LHY (corresponding author), St Josephs Healthcare Hamilton, Div Respirol, 50 Charlton Ave, Hamilton, ON L8N 4A6, Canada.	lisa.kim@medportal.ca	T, E/HII-8943-2022	Chu, Derek/0000-0001-8269-4496				Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; O'Driscoll BR, 2017, THORAX, V72, DOI 10.1136/thoraxjnl-2016-209729; Siemieniuk RAC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4169	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					HO2	HO3		10.7326/M19-2502	http://dx.doi.org/10.7326/M19-2502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT7IV	31525758				2022-12-28	WOS:000501160500001
J	Mahase, E				Mahase, Elisabeth			Vaccination uptake: access is still biggest barrier, experts warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department for Health and Social Care, 2019, PRIM MIN ORD URG ACT; Hartley-Parkinson R., 2019, B JOHNSON TAKES ANTI; Larson H., 2018, REPORT EUROPEAN COMM, DOI DOI 10.2875/241099; MAHASE E, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2351; MAHASE E, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2335; NHS Digital, 2018, CHILDH VACC COV STAT; Public Health England, 2019, PUBL HLTH MATT MEASL	7	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5576	10.1136/bmj.l5576	http://dx.doi.org/10.1136/bmj.l5576			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530539				2022-12-28	WOS:000487758600008
J	Singh, S; Bougie, O				Singh, Sukhbir; Bougie, Olga			HEALTH for heavy menstrual bleeding: real-world implications	LANCET			English	Editorial Material							HYSTERECTOMY		[Singh, Sukhbir] Univ Ottawa, Dept Obstet & Gynecol, Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada; [Bougie, Olga] Queens Univ, Dept Obstet & Gynaecol, Kingston Gen Hosp, Kingston, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada	Singh, S (corresponding author), Univ Ottawa, Dept Obstet & Gynecol, Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada.	susingh@toh.ca						Bennett A, 2019, J OBSTET GYNAECOL CA, V41, P930, DOI 10.1016/j.jogc.2018.10.002; Cooper K, 2019, LANCET, V394, P1425, DOI 10.1016/S0140-6736(19)31790-8; Desai VB, 2019, OBSTET GYNECOL, V134, P227, DOI 10.1097/AOG.0000000000003375; Gale J, 2018, J OBSTET GYNAECOL CA, V40, P1154, DOI 10.1016/j.jogc.2017.11.039; Halaska MJ, 2017, INT J GYNECOL CANCER, V27, P189, DOI 10.1097/IGC.0000000000000911; Lethaby A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004993.pub3; Liu ZM, 2007, VALUE HEALTH, V10, P183, DOI 10.1111/j.1524-4733.2007.00168.x; National Institute for Health and Care Excellence, 2018, HEAVY MENSTRUAL BLEE; Reinders IMA, 2017, BJOG-INT J OBSTET GY, V124, P190, DOI 10.1111/1471-0528.14395; U.S. Food and Drug Administration (FDA), 2014, LAPAR POW MORC; van Evert JS, 2010, GYNECOL SURG, V7, P9, DOI 10.1007/s10397-009-0529-8; Wallwiener M, 2013, ARCH GYNECOL OBSTET, V288, P1329, DOI 10.1007/s00404-013-2921-x	12	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2019	394	10207					1390	1392		10.1016/S0140-6736(19)32086-0	http://dx.doi.org/10.1016/S0140-6736(19)32086-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JE5IX	31522847	hybrid			2022-12-28	WOS:000490727200006
J	Akinwande, D; Huyghebaert, C; Wang, CH; Serna, MI; Goossens, S; Li, LJ; Wong, HSP; Koppens, FHL				Akinwande, Deji; Huyghebaert, Cedric; Wang, Ching-Hua; Serna, Martha I.; Goossens, Stijn; Li, Lain-Jong; Wong, H. -S. Philip; Koppens, Frank H. L.			Graphene and two-dimensional materials for silicon technology	NATURE			English	Review							TRANSITION-METAL DICHALCOGENIDES; LARGE-AREA SYNTHESIS; PHASE-CHANGE MEMORY; MOS2 TRANSISTORS; HIGH-QUALITY; GENERATION; SINGLE; FILMS; DEPOSITION; MODULATORS	The development of silicon semiconductor technology has produced breakthroughs in electronics-from the microprocessor in the late 1960s to early 1970s, to automation, computers and smartphones-by downscaling the physical size of devices and wires to the nanometre regime. Now, graphene and related two-dimensional (2D) materials offer prospects of unprecedented advances in device performance at the atomic limit, and a synergistic combination of 2D materials with silicon chips promises a heterogeneous platform to deliver massively enhanced potential based on silicon technology. Integration is achieved via three-dimensional monolithic construction of multifunctional high-rise 2D silicon chips, enabling enhanced performance by exploiting the vertical direction and the functional diversification of the silicon platform for applications in opto-electronics and sensing. Here we review the opportunities, progress and challenges of integrating atomically thin materials with silicon-based nanosystems, and also consider the prospects for computational and non-computational applications.	[Akinwande, Deji; Serna, Martha I.] Univ Texas Austin, Microelect Res Ctr, Dept Elect & Comp Engn, Austin, TX 78712 USA; [Huyghebaert, Cedric] IMEC, Leuven, Belgium; [Wang, Ching-Hua; Wong, H. -S. Philip] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Goossens, Stijn; Koppens, Frank H. L.] Barcelona Inst Sci & Technol Castelldefels Barcel, ICFO Inst Ciencies Foton, Barcelona, Spain; [Li, Lain-Jong; Wong, H. -S. Philip] TSMC, Corporate Res, Hsinchu, Taiwan; [Koppens, Frank H. L.] ICREA, Barcelona, Spain	University of Texas System; University of Texas Austin; IMEC; Stanford University; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Taiwan Semiconductor Manufacturing Company; ICREA	Akinwande, D (corresponding author), Univ Texas Austin, Microelect Res Ctr, Dept Elect & Comp Engn, Austin, TX 78712 USA.	deji@ece.utexas.edu	Li, Lain-Jong/D-5244-2011	Li, Lain-Jong/0000-0002-4059-7783	US National Science Foundation (NSF); US Office of Naval Research (ONR); Presidential Early Career Award for Scientists and Engineers (PECASE) through the US Army Research Office; NSF; AFOSR MURI; Semiconductor Research Corporation (SRC) STARnet FAME; SRC JUMP ASCENT; Logic Imec Industrial Affiliation Program; Graphene Flagship initiative; Government of Catalonia through an SGR grant (2017) [1656]; Spanish Ministry of Economy and Competitiveness through the "Severo Ochoa" Programme for Centres of Excellence in RD [SEV-2015-0522]; Fundacio Cellex Barcelona; CERCA Programme/Generalitat de Catalunya; European Union [785219]; Stanford SystemX Alliance; Stanford Non-Volatile Memory Technology Research Initiative (NMTRI)	US National Science Foundation (NSF)(National Science Foundation (NSF)); US Office of Naval Research (ONR)(Office of Naval Research); Presidential Early Career Award for Scientists and Engineers (PECASE) through the US Army Research Office; NSF(National Science Foundation (NSF)); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Semiconductor Research Corporation (SRC) STARnet FAME; SRC JUMP ASCENT; Logic Imec Industrial Affiliation Program; Graphene Flagship initiative; Government of Catalonia through an SGR grant (2017); Spanish Ministry of Economy and Competitiveness through the "Severo Ochoa" Programme for Centres of Excellence in RD; Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission); CERCA Programme/Generalitat de Catalunya; European Union(European Commission); Stanford SystemX Alliance; Stanford Non-Volatile Memory Technology Research Initiative (NMTRI)	D. A. acknowledges support from the US National Science Foundation (NSF), the US Office of Naval Research (ONR), and the Presidential Early Career Award for Scientists and Engineers (PECASE) through the US Army Research Office. C.-H.W. and H.-S.P.W. acknowledge support from the NSF, AFOSR MURI, the Semiconductor Research Corporation (SRC) STARnet FAME and SRC JUMP ASCENT, and member companies of the Stanford SystemX Alliance and the Stanford Non-Volatile Memory Technology Research Initiative (NMTRI). L.-J. L. and H.-S.P.W. acknowledge substantial management support from TSMC. C.H. acknowledges support from the Logic Imec Industrial Affiliation Program and funding from the Graphene Flagship initiative. F.H.L.K. acknowledges financial support from the Government of Catalonia through an SGR grant (2017, 1656), from the Spanish Ministry of Economy and Competitiveness through the "Severo Ochoa" Programme for Centres of Excellence in R&D (SEV-2015-0522), from Fundacio Cellex Barcelona, and from the CERCA Programme/Generalitat de Catalunya. Furthermore, the research leading to these results has received funding from the European Union Seventh Framework Programme under grant agreement no. 785219, Graphene Flagship.	Ago H, 2010, ACS NANO, V4, P7407, DOI 10.1021/nn102519b; Ahn CY, 2015, NANO LETT, V15, P6809, DOI 10.1021/acs.nanolett.5b02661; Akinwande D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6678; Aly MMS, 2015, COMPUTER, V48, P24, DOI 10.1109/MC.2015.376; Amani M, 2015, SCIENCE, V350, P1065, DOI 10.1126/science.aad2114; Antonio R., 2016, 2D MATER, V3; Arakawa Y, 2013, IEEE COMMUN MAG, V51, P72, DOI 10.1109/MCOM.2013.6476868; Auth C., 2012, 2012 IEEE Symposium on VLSI Technology, P131, DOI 10.1109/VLSIT.2012.6242496; Auth C., 2017, INT EL DEVICES MEET, p.1.4, DOI [DOI 10.1109/IEDM.2017.8268472, 10.1109/IEDM.2017.8268472]; Boyd DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7620; Braeuninger-Weimer P, 2018, ACS NANO, V12, P8555, DOI 10.1021/acsnano.8b04167; Buron JD, 2015, OPT EXPRESS, V23, P30721, DOI 10.1364/OE.23.030721; Cao W, 2014, IEEE T ELECTRON DEV, V61, P3456, DOI 10.1109/TED.2014.2350483; Chen MG, 2017, MATER HORIZ, V4, P1054, DOI 10.1039/c7mh00485k; Cheng CT, 2017, NANOPHOTONICS-BERLIN, V6, P1343, DOI 10.1515/nanoph-2017-0023; Chhowalla M, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats2016.52; Choi W, 2017, MATER TODAY, V20, P116, DOI 10.1016/j.mattod.2016.10.002; Delabie A, 2015, CHEM COMMUN, V51, P15692, DOI 10.1039/c5cc05272f; DENNARD RH, 1974, IEEE J SOLID-ST CIRC, VSC 9, P256, DOI 10.1109/JSSC.1974.1050511; Desai SB, 2016, SCIENCE, V354, P99, DOI 10.1126/science.aah4698; English C. D., 2016, IEDM, P131; English CD, 2016, NANO LETT, V16, P3824, DOI 10.1021/acs.nanolett.6b01309; Ferrari AC, 2015, NANOSCALE, V7, P4598, DOI 10.1039/c4nr01600a; Fiori G, 2014, NAT NANOTECHNOL, V9, P1063, DOI 10.1038/NNANO.2014.283; Frank DJ, 1998, IEEE ELECTR DEVICE L, V19, P385, DOI 10.1109/55.720194; Fujita JI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12380-w; Fuller SH, 2011, COMPUTER, V44, P31, DOI 10.1109/MC.2011.15; Gao L, 2010, NANO LETT, V10, P3512, DOI 10.1021/nl1016706; Ge RJ, 2018, NANO LETT, V18, P434, DOI 10.1021/acs.nanolett.7b04342; Goldsmith BR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38700-w; Goossens S, 2017, NAT PHOTONICS, V11, P366, DOI [10.1038/nphoton.2017.75, 10.1038/NPHOTON.2017.75]; Guimaraes MHD, 2016, ACS NANO, V10, P6392, DOI 10.1021/acsnano.6b02879; Haastrup S, 2018, 2D MATER, V5, DOI 10.1088/2053-1583/aacfc1; Hu Y. T., 2014, IEEE INT EL DEV M IE, P128; Huang JK, 2014, ACS NANO, V8, P923, DOI 10.1021/nn405719x; Huang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05548; Huang M, 2018, ACS NANO, V12, P6117, DOI 10.1021/acsnano.8b02444; Iannaccone G, 2018, NAT NANOTECHNOL, V13, P520, DOI 10.1038/s41565-018-0136-9; Jang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17955; Jiang JK, 2017, NANO LETT, V17, P1482, DOI 10.1021/acs.nanolett.6b04516; Joshi N, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-2750-5; Jurca T, 2017, ANGEW CHEM INT EDIT, V56, P4991, DOI 10.1002/anie.201611838; Kang K, 2017, NATURE, V550, P229, DOI 10.1038/nature23905; Kang K, 2015, NATURE, V520, P656, DOI 10.1038/nature14417; Kim J, 2019, NANO LETT, V19, P739, DOI 10.1021/acs.nanolett.8b03769; Kiriya D, 2014, J AM CHEM SOC, V136, P7853, DOI 10.1021/ja5033327; Ko C, 2016, ADV MATER, V28, P2923, DOI 10.1002/adma.201504779; Koppens FHL, 2014, NAT NANOTECHNOL, V9, P780, DOI [10.1038/NNANO.2014.215, 10.1038/nnano.2014.215]; Kshirsagar CU, 2016, ACS NANO, V10, P8457, DOI 10.1021/acsnano.6b03440; Lee C.-S., 2016, IEDM, P691; Lee E, 2016, ADV FUNCT MATER, V26, P562, DOI 10.1002/adfm.201504194; Lee JH, 2014, SCIENCE, V344, P286, DOI 10.1126/science.1252268; Lee JE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2022; Lee J, 2011, IEEE ELECTR DEVICE L, V32, P1113, DOI 10.1109/LED.2011.2157075; Lee K, 2016, NANOSCALE, V8, P7755, DOI 10.1039/c5nr08954a; Lemme MC, 2011, NANO LETT, V11, P4134, DOI 10.1021/nl2019068; Li H, 2013, ACS NANO, V7, P10344, DOI 10.1021/nn4047474; Li HN, 2016, ACS NANO, V10, P10516, DOI 10.1021/acsnano.6b06496; Li L., 2017, P 2017 IEEE INT EL D, P240; Li L, 2015, ACS NANO, V9, P8361, DOI 10.1021/acsnano.5b03038; Li MY, 2019, NATURE, V567, P169, DOI 10.1038/d41586-019-00793-8; Li XS, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604053; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liang XL, 2011, ACS NANO, V5, P9144, DOI 10.1021/nn203377t; Liu M, 2012, NANO LETT, V12, P1482, DOI 10.1021/nl204202k; Liu Y, 2018, CHEM SOC REV, V47, P6388, DOI 10.1039/c8cs00318a; Lo CL, 2017, NPJ 2D MATER APPL, V1, DOI 10.1038/s41699-017-0044-0; Loubet N, 2017, S VLSI TECH, pT230, DOI 10.23919/VLSIT.2017.7998183; Lui CH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.127404; McGuire FA, 2017, NANO LETT, V17, P4801, DOI 10.1021/acs.nanolett.7b01584; Mennel L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02830-y; Meric I, 2013, P IEEE, V101, P1609, DOI 10.1109/JPROC.2013.2257634; Mignuzzi S, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.195411; Mishra V, 2017, IEEE ELECTR DEVICE L, V38, P1755, DOI 10.1109/LED.2017.2762158; Mistry K, 2007, INT EL DEVICES MEET, P247, DOI 10.1109/IEDM.2007.4418914; Molle A, 2017, NAT MATER, V16, P163, DOI [10.1038/NMAT4802, 10.1038/nmat4802]; Mounet N, 2018, NAT NANOTECHNOL, V13, P246, DOI 10.1038/s41565-017-0035-5; Next Generation Mobile Networks Alliance, 2015, NGMN 5G WHIT PAP; Pan CB, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604811; Rahimi S, 2014, ACS NANO, V8, P10471, DOI 10.1021/nn5038493; Rai A, 2015, NANO LETT, V15, P4329, DOI 10.1021/acs.nanolett.5b00314; Resta GV, 2018, ACS NANO, V12, P7039, DOI 10.1021/acsnano.8b02739; Romagnoli M, 2018, NAT REV MATER, V3, P392, DOI 10.1038/s41578-018-0040-9; Sangwan VK, 2015, NAT NANOTECHNOL, V10, P403, DOI [10.1038/NNANO.2015.56, 10.1038/nnano.2015.56]; Sarkar D, 2015, NATURE, V526, P91, DOI 10.1038/nature15387; Schall D, 2018, 2018 OPTICAL FIBER COMMUNICATIONS CONFERENCE AND EXPOSITION (OFC); Schuler S, 2016, NANO LETT, V16, P7107, DOI 10.1021/acs.nanolett.6b03374; Shiue RJ, 2015, NANO LETT, V15, P7288, DOI 10.1021/acs.nanolett.5b02368; Si MW, 2018, NAT NANOTECHNOL, V13, P24, DOI 10.1038/s41565-017-0010-1; SOHN J, 2014, IEEE INT EL DEV M, V2014, P116, DOI DOI 10.1109/IEDM.2014.7046988; Sorianello V, 2018, NAT PHOTONICS, V12, P40, DOI 10.1038/s41566-017-0071-6; Sorianello V, 2015, OPT EXPRESS, V23, P6478, DOI 10.1364/OE.23.006478; Steinhogl W, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075414; Sun ZP, 2016, NAT PHOTONICS, V10, P227, DOI [10.1038/NPHOTON.2016.15, 10.1038/nphoton.2016.15]; SUZUKI K, 1993, IEEE T ELECTRON DEV, V40, P2326, DOI 10.1109/16.249482; Taur Y, 1998, INTERNATIONAL ELECTRON DEVICES MEETING 1998 - TECHNICAL DIGEST, P789, DOI 10.1109/IEDM.1998.746474; Teitz L, 2019, CERAM INT, V45, P9339, DOI 10.1016/j.ceramint.2018.07.193; Theis TN, 2017, COMPUT SCI ENG, V19, P41, DOI 10.1109/MCSE.2017.29; Thompson S, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P61, DOI 10.1109/IEDM.2002.1175779; van Uden RGH, 2014, NAT PHOTONICS, V8, P865, DOI [10.1038/NPHOTON.2014.243, 10.1038/nphoton.2014.243]; Verguts K, 2018, NANOSCALE, V10, P5515, DOI 10.1039/c8nr00335a; Verguts K, 2017, ACS APPL MATER INTER, V9, P37484, DOI 10.1021/acsami.7b12573; Wang B, 2016, ACS NANO, V10, P1404, DOI 10.1021/acsnano.5b06842; Wang YH, 2017, BIOSENS BIOELECTRON, V97, P305, DOI 10.1016/j.bios.2017.06.011; Wong H. S, 2015, NAT NANOTECHNOL, V10, P660; Wong HSP, 2015, NAT NANOTECHNOL, V10, P191, DOI 10.1038/nnano.2015.29; Wu XH, 2019, ADV MATER, V31, DOI 10.1002/adma.201805544; Xia FN, 2014, NAT PHOTONICS, V8, P899, DOI [10.1038/nphoton.2014.271, 10.1038/nphoton.2010.271]; Xie SE, 2018, SCIENCE, V359, P1131, DOI 10.1126/science.aao5360; YAN RH, 1992, IEEE T ELECTRON DEV, V39, P1704, DOI 10.1109/16.141237; Yang C., 2016, 2016 IEEE INT INSTRU, P1, DOI DOI 10.1109/VLSIT.2016.7573448; Yang LM, 2017, ACS OMEGA, V2, P4173, DOI 10.1021/acsomega.7b00634; Yum JH, 2011, IEEE T ELECTRON DEV, V58, P4384, DOI 10.1109/TED.2011.2170073; Zanjani SMM, 2017, NPJ 2D MATER APPL, V1, DOI 10.1038/s41699-017-0036-0; Zhang F, 2019, NAT MATER, V18, P55, DOI 10.1038/s41563-018-0234-y; Zhou JD, 2018, NATURE, V556, P355, DOI 10.1038/s41586-018-0008-3; Zhu CZ, 2017, BIOSENS BIOELECTRON, V89, P43, DOI 10.1016/j.bios.2016.06.045; Zuzak K, 2019, SPIE NEWS	118	546	550	126	1038	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					507	518		10.1038/s41586-019-1573-9	http://dx.doi.org/10.1038/s41586-019-1573-9			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31554977				2022-12-28	WOS:000488247600046
J	Wang, JF; Johnson, AG; Lapointe, CP; Choi, J; Prabhakar, A; Chen, DH; Petrov, AN; Puglisi, JD				Wang, Jinfan; Johnson, Alex G.; Lapointe, Christopher P.; Choi, Junhong; Prabhakar, Arjun; Chen, Dong-Hua; Petrov, Alexey N.; Puglisi, Joseph D.			eIF5B gates the transition from translation initiation to elongation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; RNA; RIBOSOME; CAP; RECOGNITION; MECHANISM; PATHWAYS; DYNAMICS; SUBUNITS; SEQUENCE	Translation initiation determines both the quantity and identity of the protein that is encoded in an mRNA by establishing the reading frame for protein synthesis. In eukaryotic cells, numerous translation initiation factors prepare ribosomes for polypeptide synthesis; however, the underlying dynamics of this process remain unclear(1,2). A central question is how eukaryotic ribosomes transition from translation initiation to elongation. Here we use in vitro single-molecule fluorescence microscopy approaches in a purified yeast Saccharomyces cerevisiae translation system to monitor directly, in real time, the pathways of late translation initiation and the transition to elongation. This transition was slower in our eukaryotic system than that reported for Escherichia coli(3-5). The slow entry to elongation was defined by a long residence time of eukaryotic initiation factor 5B (eIF5B) on the 80S ribosome after the joining of individual ribosomal subunits-a process that is catalysed by this universally conserved initiation factor. Inhibition of the GTPase activity of eIF5B after the joining of ribosomal subunits prevented the dissociation of eIF5B from the 80S complex, thereby preventing elongation. Our findings illustrate how the dissociation of eIF5B serves as a kinetic checkpoint for the transition from initiation to elongation, and how its release may be governed by a change in the conformation of the ribosome complex that triggers GTP hydrolysis.	[Wang, Jinfan; Johnson, Alex G.; Lapointe, Christopher P.; Choi, Junhong; Prabhakar, Arjun; Chen, Dong-Hua; Petrov, Alexey N.; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Johnson, Alex G.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Choi, Junhong] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Prabhakar, Arjun] Stanford Univ, Program Biophys, Stanford, CA 94305 USA; [Petrov, Alexey N.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Stanford University; Stanford University; Stanford University; Stanford University; Auburn University System; Auburn University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu	Wang, Jinfan/AHE-0189-2022; Wang, Jinfan/AAX-4026-2021	Wang, Jinfan/0000-0003-4170-9289; Johnson, Alexander/0000-0002-4040-9797; Lapointe, Christopher/0000-0002-0406-105X; Prabhakar, Arjun/0000-0002-5589-2558	US National Institutes of Health (NIH) [GM113078, AI047365]; Knut and Alice Wallenberg Foundation postdoctoral scholarship [KAW 2015.0406]; National Science Foundation Graduate Research Fellowship [DGE-114747]; Damon Runyon Fellowship - Damon Runyon Cancer Research Foundation [DRG-2321-18]; Stanford Bio-X fellowship; Stanford Interdisciplinary Graduate Fellowship; NIH Molecular Biophysics Training Grant [T32-GM008294]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, R01GM113078] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knut and Alice Wallenberg Foundation postdoctoral scholarship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Damon Runyon Fellowship - Damon Runyon Cancer Research Foundation; Stanford Bio-X fellowship; Stanford Interdisciplinary Graduate Fellowship; NIH Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Lorsch, T. Dever, J. Dinman, J. Yin and C. Aitken for sharing constructs, strains and protocols; C. Sitron and O. Brandman for sharing equipment and knowledge for use of their Freezer/Mill cryogenic mill for yeast lysis; the Stanford PAN facility for mass spectrometry analyses of proteins; and members of the Puglisi laboratory for discussion and input. This work was supported by the US National Institutes of Health (NIH) grants GM113078 and AI047365 to J. D. P.; a Knut and Alice Wallenberg Foundation postdoctoral scholarship (KAW 2015.0406) to J. W.; a National Science Foundation Graduate Research Fellowship (DGE-114747) to A. G. J.; a Damon Runyon Fellowship funded by the Damon Runyon Cancer Research Foundation (DRG-2321-18) to C. P. L.; a Stanford Bio-X fellowship to J. C.; and a Stanford Interdisciplinary Graduate Fellowship and NIH Molecular Biophysics Training Grant T32-GM008294 to A. P.	Acker MG, 2006, J BIOL CHEM, V281, P8469, DOI 10.1074/jbc.M600210200; Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Acker MG, 2009, J MOL BIOL, V385, P491, DOI 10.1016/j.jmb.2008.10.029; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bowen AM, 2015, TRANSLATION, V3, DOI 10.1080/21690731.2015.1117703; Chen J, 2014, P NATL ACAD SCI USA, V111, P664, DOI 10.1073/pnas.1315735111; Choi SK, 2000, MOL CELL BIOL, V20, P7183, DOI 10.1128/MCB.20.19.7183-7191.2000; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Goyal A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv869; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; Heyer EE, 2016, CELL, V164, P757, DOI 10.1016/j.cell.2016.01.003; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Ikeuchi K, 2019, EMBO J, V38, DOI 10.15252/embj.2018100276; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Juszkiewicz S, 2018, MOL CELL, V72, P469, DOI 10.1016/j.molcel.2018.08.037; Kaledhonkar S, 2019, NATURE, V570, P400, DOI 10.1038/s41586-019-1249-5; Kuhle B, 2014, EMBO J, V33, P1177, DOI 10.1002/embj.201387344; Lee JH, 2002, P NATL ACAD SCI USA, V99, P16689, DOI 10.1073/pnas.262569399; Li JJ, 2017, NUCLEIC ACIDS RES, V45, P11821, DOI 10.1093/nar/gkx898; Llacer JL, 2015, MOL CELL, V59, P399, DOI 10.1016/j.molcel.2015.06.033; Lorsch JR, 1999, EMBO J, V18, P6705, DOI 10.1093/emboj/18.23.6705; Maniatis T., 1982, MOL CLONING; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; O'Leary SE, 2013, STRUCTURE, V21, P2197, DOI 10.1016/j.str.2013.09.016; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Petrov A, 2016, MOL CELL, V62, P92, DOI 10.1016/j.molcel.2016.03.020; Pisareva VP, 2014, NUCLEIC ACIDS RES, V42, P12052, DOI 10.1093/nar/gku877; Rinaldi AJ, 2015, METHODS MOL BIOL, V1240, P63, DOI 10.1007/978-1-4939-1896-6_6; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; Shin BS, 2011, RNA, V17, P687, DOI 10.1261/rna.2412511; Sokabe M, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032706; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsai A, 2012, NATURE, V487, P390, DOI 10.1038/nature11172; WALSH RM, 1977, J I BREWING, V83, P169, DOI 10.1002/j.2050-0416.1977.tb06813.x; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	50	27	27	1	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					605	+		10.1038/s41586-019-1561-0	http://dx.doi.org/10.1038/s41586-019-1561-0			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31534220	Green Submitted, Green Accepted			2022-12-28	WOS:000488247600063
J	Mahase, E				Mahase, Elisabeth			NHS long term plan is a "fantastic opportunity" to reduce variation in cancer care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, 2019, LONG TERM PLAN IMPL; NHS England, 2019, WAIT TIM SUSP DIAGN; NHS England, 2019, LONG TERM PLAN; NHS England, 2019, PROV BAS CANC WAIT T	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5687	10.1136/bmj.l5687	http://dx.doi.org/10.1136/bmj.l5687			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WS	31548264				2022-12-28	WOS:000488488000018
J	Fu, MM; McAlear, TS; Nguyen, H; Oses-Prieto, JA; Valenzuela, A; Shi, RD; Perrino, JJ; Huang, TT; Burlingame, AL; Bechstedt, S; Barres, BA				Fu, Meng-meng; McAlear, Thomas S.; Huy Nguyen; Oses-Prieto, Juan A.; Valenzuela, Alex; Shi, Rebecca D.; Perrino, John J.; Huang, Ting-Ting; Burlingame, Alma L.; Bechstedt, Susanne; Barres, Ben A.			The Golgi Outpost Protein TPPP Nucleates Microtubules and Is Critical for Myelination	CELL			English	Article							MESSENGER-RNA; GAMMA-TUBULIN; IN-VITRO; GROWTH; OLIGODENDROCYTES; POLARITY; NEURONS; AXON; EXPRESSION; TRANSPORT	Oligodendrocytes extend elaborate microtubule arbors that contact up to 50 axon segments per cell, then spiral around myelin sheaths, penetrating from outer to inner layers. However, how they establish this complex cytoarchitecture is unclear. Here, we show that oligodendrocytes contain Golgi outposts, an organelle that can function as an acentrosomal microtubule-organizing center (MTOC). We identify a specific marker for Golgi outposts-TPPP (tubulin polymerization promoting protein)-that we use to purify this organelle and characterize its proteome. In in vitro cell-free assays, recombinant TPPP nucleates microtubules. Primary oligodendrocytes from Tppp knockout (KO) mice have aberrant microtubule branching, mixed microtubule polarity, and shorter myelin sheaths when cultured on 3-dimensional (3D) microfibers. Tppp KO mice exhibit hypomyelination with shorter, thinner myelin sheaths and motor coordination deficits. Together, our data demonstrate that microtubule nucleation outside the cell body at Golgi outposts by TPPP is critical for elongation of the myelin sheath.	[Fu, Meng-meng; Valenzuela, Alex; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [McAlear, Thomas S.; Bechstedt, Susanne] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Huy Nguyen; Huang, Ting-Ting] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Oses-Prieto, Juan A.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Shi, Rebecca D.] Stanford Univ, Sch Med, Neurosci Grad Program, Stanford, CA 94305 USA; [Perrino, John J.] Stanford Univ, Sch Med, Cell Sci Imaging Facil, Stanford, CA 94305 USA; [Huang, Ting-Ting] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Care Ctr, Palo Alto, CA 94304 USA	Stanford University; McGill University; Stanford University; University of California System; University of California San Francisco; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Fu, MM (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.; Bechstedt, S (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada.	mengmengfu@gmail.com; susanne.bechstedt@mcgill.ca	Nguyen, Huy/GWQ-6433-2022; fu, meng/GZG-3120-2022; huang, ting/GRR-3141-2022; Nguyen, Huy/AAF-9560-2019	Nguyen, Huy/0000-0002-5896-9661; Fu, Meng-meng/0000-0003-4958-0424	National Multiple Sclerosis Society (NMSS); National Institute of Neurological Disorders and Stroke (NINDS) [F32 NS90721]; National Institute of Child Health and Human Development (NICHD) [T32 HD7249]; NCRR ARRA Award [1S10RR026780]; National Institute of General Medical Sciences (NIGMS) [P41 GM103481]; NSERC [RGPIN-2017-04649]; CIHR [PJT-156193]; Neuroscience Microscopy Service [NIH NS069375]; National Center for Research Resources [NCRR] [1S10OD01227601]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR ARRA Award; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Neuroscience Microscopy Service; National Center for Research Resources [NCRR](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge the mentorship and friendship of Ben Barres, who dedicated his life to making fundamental discoveries in glial cell biology and advocating for underrepresented people in science. We miss him very much. We are grateful for mentorship from William Talbot, Thomas Clandinin, Mary Hynes, and Marc Tessier-Lavigne, technical assistance from Cheng-Yun Lee, Madhuri Nori, and Lynn Serizawa, advice on EM technique and interpretation from Steve Scherer, Jian Li, and Ian Duncan, and advice on microfiber cultures from the Charles ffrench-Constant Lab (Marie Bechler). We thank Stanford core facilities: Transgenic Center (Hong Zeng), Neuroscience Microscopy Service (Andrew Olson, NIH NS069375), Cell Sciences Imaging Facility (Anum Khan, Jon Mulholland, National Center for Research Resources [NCRR] 1S10OD01227601), MS Core (Chris Adams, Ryan Leibs), Behavioral and Functional Neuroscience Laboratory (Mehrdad Shamloo, Nay Saw). We thank the Microbiology Department (Lisa Selzer), the Roger Kornberg Lab (Ralph and Barbara Davis) for ultracentrifuge use, and the Thomas Sudhof Lab (Mu Zhou and Karthik Raju) for behavioral equipment use. We are especially grateful to the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to B.A.B. and A.L.B.) and the Myra Reinhard Foundation (to B.A.B.); we could not have finished this research without their funding. Funding sources include National Multiple Sclerosis Society (NMSS) (fellowship to M.-m.F.), the National Institute of Neurological Disorders and Stroke (NINDS) (F32 NS90721 to M.-m. F), National Institute of Child Health and Human Development (NICHD) (T32 HD7249 to M.-m.F), NCRR ARRA Award (1S10RR026780 to J.J.P.), the National Institute of General Medical Sciences (NIGMS) (P41 GM103481 to A.L.B., Director, UCSF Bio-Organic Biomedical MS Resource), NSERC (RGPIN-2017-04649 to S.B.), and CIHR (PJT-156193 to S.B.).	Ashford A. J., 2006, CELL BIOL, P155; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Baraban M, 2018, NAT NEUROSCI, V21, P19, DOI 10.1038/s41593-017-0040-x; Bechler ME, 2015, CURR BIOL, V25, P2411, DOI 10.1016/j.cub.2015.07.056; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; BURTON PR, 1981, P NATL ACAD SCI-BIOL, V78, P3269, DOI 10.1073/pnas.78.5.3269; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841; DEVRIES H, 1993, J NEUROSCI RES, V36, P336, DOI 10.1002/jnr.490360311; Dugas Jason C, 2013, Cold Spring Harb Protoc, V2013, P745, DOI 10.1101/pdb.prot070862; Duncan ID, 2017, ANN NEUROL, V81, P690, DOI 10.1002/ana.24930; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Frykman S, 2012, NEUROCHEM INT, V61, P108, DOI 10.1016/j.neuint.2012.03.016; Furusho M, 2012, J NEUROSCI, V32, P6631, DOI 10.1523/JNEUROSCI.6005-11.2012; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gimpel P, 2017, CURR BIOL, V27, P2999, DOI 10.1016/j.cub.2017.08.031; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Gunn PA, 2011, BIOL CELL, V103, P559, DOI 10.1042/BC20110074; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Herbert AL, 2017, P NATL ACAD SCI USA, V114, pE9153, DOI 10.1073/pnas.1711088114; Hochgerner H, 2018, NAT NEUROSCI, V21, P290, DOI 10.1038/s41593-017-0056-2; Hoftberger R, 2010, GLIA, V58, P1847, DOI 10.1002/glia.21054; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Hughes EG, 2018, NAT NEUROSCI, V21, P696, DOI 10.1038/s41593-018-0121-5; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kohl R, 2000, J BIOL CHEM, V275, P15741, DOI 10.1074/jbc.M903271199; Koudelka S, 2016, CURR BIOL, V26, P1447, DOI 10.1016/j.cub.2016.03.070; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li BZ, 2006, ICICIC 2006: FIRST INTERNATIONAL CONFERENCE ON INNOVATIVE COMPUTING, INFORMATION AND CONTROL, VOL 3, PROCEEDINGS, P2; Lin JP, 2017, ELIFE, V6, DOI 10.7554/eLife.30498; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lunn KF, 1997, J NEUROSCI, V17, P4921; Nguyen MM, 2014, MOL BIOL CELL, V25, P2039, DOI 10.1091/mbc.E13-09-0515; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Oddoux S, 2013, J CELL BIOL, V203, P205, DOI 10.1083/jcb.201304063; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Perrin J, 2015, J INNATE IMMUN, V7, P37, DOI 10.1159/000365112; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Procter DJ, 2018, DEV CELL, V45, P83, DOI 10.1016/j.devcel.2018.03.010; Quassollo G, 2015, CURR BIOL, V25, P971, DOI 10.1016/j.cub.2015.01.075; Reuter MS, 2017, JAMA PSYCHIAT, V74, P293, DOI 10.1001/jamapsychiatry.2016.3798; Sanchez-Huertas C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12187; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHULTZ RL, 1965, J ULTRA MOL STRUCT R, V12, P187, DOI 10.1016/S0022-5320(65)80015-6; Simons C, 2013, AM J HUM GENET, V92, P767, DOI 10.1016/j.ajhg.2013.03.018; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; TAKAHASHI M, 1993, J NEUROCHEM, V60, P228, DOI 10.1111/j.1471-4159.1993.tb05842.x; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3; Yau KW, 2016, J NEUROSCI, V36, P1071, DOI 10.1523/JNEUROSCI.2430-15.2016; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zenker J, 2017, SCIENCE, V357, P925, DOI 10.1126/science.aam9335; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhou W, 2014, CURR BIOL, V24, P1227, DOI 10.1016/j.cub.2014.04.008; Zuber ME, 1997, J CELL PHYSIOL, V170, P217	75	49	54	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					132	+		10.1016/j.cell.2019.08.025	http://dx.doi.org/10.1016/j.cell.2019.08.025			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31522887	Green Accepted, Bronze			2022-12-28	WOS:000486618500019
J	[Anonymous]				[Anonymous]			Seven days in medicine: 4-10 September 2019	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lynskey NN, 2019, LANCET INFECT DIS	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2019	366								l5485	10.1136/bmj.l5485	http://dx.doi.org/10.1136/bmj.l5485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MV	31515208				2022-12-28	WOS:000486649600006
J	Dyer, C				Dyer, Clare			Trust's refusal to allow girl on life support to go to Italy for treatment breaches EU law, court hears	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L5097	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5494	10.1136/bmj.l5494	http://dx.doi.org/10.1136/bmj.l5494			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501161				2022-12-28	WOS:000486648500013
J	Gishen, F				Gishen, Faye			Suicide among medical students	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IDEATION		[Gishen, Faye] UCL Med Sch, London, England	University of London; University College London	Gishen, F (corresponding author), UCL Med Sch, London, England.	f.gishen@ucl.ac.uk						CLARKE R, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J2527; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Hay LR, 1996, AM J PSYCHIAT, V153, P553; Iannelli RJ, 2014, GEN HOSP PSYCHIAT, V36, P732, DOI 10.1016/j.genhosppsych.2014.06.008; Schwenk TL, 2010, JAMA-J AM MED ASSOC, V304, P1181, DOI 10.1001/jama.2010.1300	5	6	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5465	10.1136/bmj.l5465	http://dx.doi.org/10.1136/bmj.l5465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501160				2022-12-28	WOS:000486648500005
J	Dai, HY; Leventhal, AM				Dai, Hongying; Leventhal, Adam M.			Prevalence of e-Cigarette Use Among Adults in the United States, 2014-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							TOBACCO PRODUCT USE	This population epidemiology study uses 2014-2018 data from National Health Interview Surveys to assess trends in prevalence of current and daily e-cigarette use by US adults and to characterize trends by sociodemographic and smoking status among young adults (18-24 years).	[Dai, Hongying] Univ Nebraska Med Ctr, Coll Publ Hlth, Omaha, NE USA; [Leventhal, Adam M.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA	University of Nebraska System; University of Nebraska Medical Center; University of Southern California	Dai, HY (corresponding author), Univ Nebraska Med Ctr, 984375 Nebraska Med Ctr, Omaha, NE 68198 USA.	daisy.dai@unmc.edu			National Cancer Institute (NCI); US Food and Drug Administration (FDA) Center for Tobacco Products [R03CA228909, U54CA180905]; NATIONAL CANCER INSTITUTE [R03CA228909] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Food and Drug Administration (FDA) Center for Tobacco Products; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute (NCI) and the US Food and Drug Administration (FDA) Center for Tobacco Products under awards R03CA228909 (Dr Dai) and U54CA180905 (Dr Leventhal).	Bao W, 2018, JAMA-J AM MED ASSOC, V319, P2039, DOI 10.1001/jama.2018.4658; Centers for Disease Control and Prevention, 2018 NAT HLTH INT SU; Department of Health and Human Services, 2016, E CIG US YOUTH YOUNG; Gentzke AS, 2019, MMWR-MORBID MORTAL W, V68, P157, DOI 10.15585/mmwr.mm6806e1; Romberg AR, 2019, DRUG ALCOHOL DEPEN, V203, P1, DOI 10.1016/j.drugalcdep.2019.05.029; Wang TW, 2018, MMWR-MORBID MORTAL W, V67, P1225, DOI 10.15585/mmwr.mm6744a2	6	230	232	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2019	322	18					1824	1827		10.1001/jama.2019.15331	http://dx.doi.org/10.1001/jama.2019.15331			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0WO	31524940	Bronze, Green Published			2022-12-28	WOS:000498675500026
J	Casalino, LP; Khullar, D				Casalino, Lawrence P.; Khullar, Dhruv			Value-Based Purchasing and Physician Professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE; QUALITY; INCENTIVES	This Viewpoint discusses the importance of structuring value-based purchasing models around principles of physician professionalism to ensure that measures that lead to more payment are clinically meaningful, do not increase administrative burden, do not displace clinicians' intrinsic motivation to help patients with financial motivations, and do not incentivize physicians to avoid sicker, more complicated patients.	[Casalino, Lawrence P.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, Div Hlth Policy & Econ, New York, NY USA; [Khullar, Dhruv] Weill Cornell Med Coll, Dept Healthcare Policy & Res, 402 E 67th St,Room 217, New York, NY 10065 USA; [Khullar, Dhruv] Weill Cornell Med Coll, Dept Med, New York, NY USA	Cornell University; Cornell University; Cornell University	Casalino, LP (corresponding author), Weill Cornell Med Coll, Dept Healthcare Policy & Res, 402 E 67th St,Room 217, New York, NY 10065 USA.	lac2021@med.cornell.edu	Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859	Physicians Foundation through its funding of the Center for Physician Practice and Leadership at Weill Cornell Medical College	Physicians Foundation through its funding of the Center for Physician Practice and Leadership at Weill Cornell Medical College	This work was supported in part by the Physicians Foundation through its funding of the Center for Physician Practice and Leadership at Weill Cornell Medical College.	ARROW KJ, 1963, AM ECON REV, V53, P941; Berenson RA, 2015, HEALTH SERV RES, V50, P2155, DOI 10.1111/1475-6773.12413; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Conrad DA, 2015, HEALTH SERV RES, V50, P2057, DOI 10.1111/1475-6773.12408; Glied S, 2015, HEALTH SERV RES, V50, P2223, DOI 10.1111/1475-6773.12412; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Medicare Payment Advisory Commission, REP C MED PAYM POL M; Nyweide DJ, 2009, JAMA-J AM MED ASSOC, V302, P2444, DOI 10.1001/jama.2009.1810; Shah SD, 2018, JAMA-J AM MED ASSOC, V319, P1207, DOI 10.1001/jama.2018.1666	9	3	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2019	322	17					1647	1648		10.1001/jama.2019.14990	http://dx.doi.org/10.1001/jama.2019.14990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0WD	31539021				2022-12-28	WOS:000498674400007
J	Gantner, ML; Eade, K; Wallace, M; Handzlik, MK; Fallon, R; Trombley, J; Bonelli, R; Giles, S; Harkins-Perry, S; Heeren, TFC; Sauer, L; Ideguchi, Y; Baldini, M; Scheppke, L; Dorrell, MI; Kitano, M; Hart, BJ; Cai, C; Nagasaki, T; Badur, MG; Okada, M; Woods, SM; Egan, C; Gillies, M; Guymer, R; Eichler, F; Bahlo, M; Fruttiger, M; Allikmets, R; Bernstein, PS; Metallo, CM; Friedlander, M				Gantner, Marin L.; Eade, Kevin; Wallace, Martina; Handzlik, Michal K.; Fallon, Regis; Trombley, Jennifer; Bonelli, Roberto; Giles, Sarah; Harkins-Perry, Sarah; Heeren, Tjebo F. C.; Sauer, Lydia; Ideguchi, Yoichiro; Baldini, Michelle; Scheppke, Lea; Dorrell, Michael I.; Kitano, Maki; Hart, Barbara J.; Cai, Carolyn; Nagasaki, Takayuki; Badur, Mehmet G.; Okada, Mali; Woods, Sasha M.; Egan, Catherine; Gillies, Mark; Guymer, Robyn; Eichler, Florian; Bahlo, Melanie; Fruttiger, Marcus; Allikmets, Rando; Bernstein, Paul S.; Metallo, Christian M.; Friedlander, Martin			Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TELANGIECTASIA TYPE-2; 1-DEOXYSPHINGOLIPIDS; PALMITOYLTRANSFERASE; DEOXYSPHINGOLIPIDS; ACCUMULATION; PROGRESSION; BIOMARKERS; MUTATIONS; VARIANTS; SUBUNIT	Background Identifying mechanisms of diseases with complex inheritance patterns, such as macular telangiectasia type 2, is challenging. A link between macular telangiectasia type 2 and altered serine metabolism has been established previously. Methods Through exome sequence analysis of a patient with macular telangiectasia type 2 and his family members, we identified a variant in SPTLC1 encoding a subunit of serine palmitoyltransferase (SPT). Because mutations affecting SPT are known to cause hereditary sensory and autonomic neuropathy type 1 (HSAN1), we examined 10 additional persons with HSAN1 for ophthalmologic disease. We assayed serum amino acid and sphingoid base levels, including levels of deoxysphingolipids, in patients who had macular telangiectasia type 2 but did not have HSAN1 or pathogenic variants affecting SPT. We characterized mice with low serine levels and tested the effects of deoxysphingolipids on human retinal organoids. Results Two variants known to cause HSAN1 were identified as causal for macular telangiectasia type 2: of 11 patients with HSAN1, 9 also had macular telangiectasia type 2. Circulating deoxysphingolipid levels were 84.2% higher among 125 patients with macular telangiectasia type 2 who did not have pathogenic variants affecting SPT than among 94 unaffected controls. Deoxysphingolipid levels were negatively correlated with serine levels, which were 20.6% lower than among controls. Reduction of serine levels in mice led to increases in levels of retinal deoxysphingolipids and compromised visual function. Deoxysphingolipids caused photoreceptor-cell death in retinal organoids, but not in the presence of regulators of lipid metabolism. Conclusions Elevated levels of atypical deoxysphingolipids, caused by variant SPTLC1 or SPTLC2 or by low serine levels, were risk factors for macular telangiectasia type 2, as well as for peripheral neuropathy. (Funded by the Lowy Medical Research Institute and others.) Macular telangiectasia is an etiologically complex phenotype. This study used a combination of approaches to identify both genetic and environmental risk factors of the disease, both of which affect lipid metabolism.	[Gantner, Marin L.; Eade, Kevin; Fallon, Regis; Trombley, Jennifer; Giles, Sarah; Harkins-Perry, Sarah; Ideguchi, Yoichiro; Scheppke, Lea; Dorrell, Michael I.; Kitano, Maki; Friedlander, Martin] Lowy Med Res Inst, 3366 N Torrey Pines Ct,Suite 300, La Jolla, CA 92037 USA; [Wallace, Martina; Handzlik, Michal K.; Baldini, Michelle; Badur, Mehmet G.; Metallo, Christian M.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Harkins-Perry, Sarah; Ideguchi, Yoichiro; Kitano, Maki; Friedlander, Martin] Scripps Res Inst, La Jolla, CA 92037 USA; [Friedlander, Martin] Scripps Clin Med Grp, La Jolla, CA USA; [Dorrell, Michael I.] Point Loma Nazarene Univ, San Diego, CA USA; [Sauer, Lydia; Hart, Barbara J.; Bernstein, Paul S.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA; [Heeren, Tjebo F. C.; Egan, Catherine] Moorfields Eye Hosp, London, England; [Woods, Sasha M.; Fruttiger, Marcus] UCL, Inst Ophthalmol, London, England; [Cai, Carolyn; Nagasaki, Takayuki; Allikmets, Rando] Columbia Univ, New York, NY USA; [Bonelli, Roberto; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Okada, Mali] Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia; [Guymer, Robyn] Univ Melbourne, Ctr Eye Res, Melbourne, Vic, Australia; [Gillies, Mark] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia; [Eichler, Florian] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of California System; University of California San Diego; Scripps Research Institute; Utah System of Higher Education; University of Utah; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Columbia University; Walter & Eliza Hall Institute; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Sydney; Harvard University; Massachusetts General Hospital	Gantner, ML (corresponding author), Lowy Med Res Inst, 3366 N Torrey Pines Ct,Suite 300, La Jolla, CA 92037 USA.	friedlan@scripps.edu	Heeren, Tjebo/R-5055-2019; Handzlik, Michal/AAR-9703-2020; Metallo, Christian/HCH-3476-2022; Allikmets, Rando/ABD-4533-2021	Heeren, Tjebo/0000-0001-5297-2301; Handzlik, Michal/0000-0002-4653-1902; Metallo, Christian/0000-0003-2404-3040; Fallon, Regis/0000-0002-2391-2534; Woods, Sasha/0000-0001-5101-3053; Wallace, Martina/0000-0001-8272-5678; Fruttiger, Marcus/0000-0002-6962-5485; Bahlo, Melanie/0000-0001-5132-0774	Lowy Medical Research Institute; National Health and Medical Research Council of Australia; National Eye Institute [EY14800]; University of Melbourne Research Scholarship Program; National Science Foundation [1454425]; National Institutes of Health [NCI R01CA188652]; NATIONAL CANCER INSTITUTE [R01CA188652] Funding Source: NIH RePORTER	Lowy Medical Research Institute; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); University of Melbourne Research Scholarship Program; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Lowy Medical Research Institute, with supplementary funding from the National Health and Medical Research Council of Australia (to Dr. Bahlo), a core grant from the National Eye Institute (EY14800, to Dr. Bernstein), the University of Melbourne Research Scholarship Program (to Mr. Bonelli), a grant from the National Science Foundation (1454425, to Dr. Metallo), and a grant from the National Institutes of Health (NCI R01CA188652, to Dr. Metallo). Heidelberg Engineering provided a Heidelberg Spectralis confocal imaging system to Dr. Bernstein free of charge for use in this study.	Alecu I, 2017, J LIPID RES, V58, P60, DOI 10.1194/jlr.M072421; Alecu I, 2017, J LIPID RES, V58, P42, DOI 10.1194/jlr.M068676; Aung KZ, 2010, RETINA-J RET VIT DIS, V30, P473, DOI 10.1097/IAE.0b013e3181bd2c71; Bertea M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-84; Chew EY, 2019, OPHTHALMOLOGY, V126, P540, DOI 10.1016/j.ophtha.2018.09.041; Clemons TE, 2013, OPHTHAL EPIDEMIOL, V20, P109, DOI 10.3109/09286586.2013.766757; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Duan JJ, 2015, J BIOL CHEM, V290, P15380, DOI 10.1074/jbc.R115.658823; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Ernst D, 2015, NEUROMOL MED, V17, P47, DOI 10.1007/s12017-014-8339-1; Esaki K, 2015, J BIOL CHEM, V290, P14595, DOI 10.1074/jbc.M114.603860; Garofalo K, 2011, J CLIN INVEST, V121, P4735, DOI 10.1172/JCI57549; GASS JDM, 1993, OPHTHALMOLOGY, V100, P1536; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Guntert T, 2016, NEUROPHARMACOLOGY, V110, P211, DOI 10.1016/j.neuropharm.2016.03.033; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Heeren TFC, 2018, RETINA-J RET VIT DIS, V38, pS20, DOI 10.1097/IAE.0000000000001715; Klein R, 2010, AM J OPHTHALMOL, V150, P55, DOI 10.1016/j.ajo.2010.02.013; Lone MA, 2019, BBA-MOL CELL BIOL L, V1864, P512, DOI 10.1016/j.bbalip.2018.12.013; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mukherjee D, 2017, INVEST OPHTH VIS SCI, V58, P291, DOI 10.1167/iovs.17-21834; Othman A, 2015, J CLIN LIPIDOL, V9, P568, DOI 10.1016/j.jacl.2015.03.011; Parmalee NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024268; Parmalee NL, 2010, MOL VIS, V16, P2718; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Peto T, 2018, RETINA-J RET VIT DIS, V38, pS8, DOI 10.1097/IAE.0000000000001697; Powner MB, 2013, OPHTHALMOLOGY, V120, P2344, DOI 10.1016/j.ophtha.2013.04.013; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ronquillo CC, 2018, JAMA OPHTHALMOL, V136, P1158, DOI 10.1001/jamaophthalmol.2018.3283; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P6145, DOI 10.1167/iovs.12-10580; Sauer L, 2018, OPHTHALMOL RETINA, V2, P587, DOI 10.1016/j.oret.2017.10.008; Scerri TS, 2017, NAT GENET, V49, P559, DOI 10.1038/ng.3799; Wilson ER, 2018, NEUROBIOL DIS, V117, P1, DOI 10.1016/j.nbd.2018.05.008; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200; Zuellig RA, 2014, DIABETES, V63, P1326, DOI 10.2337/db13-1042	37	93	95	4	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2019	381	15					1422	1433		10.1056/NEJMoa1815111	http://dx.doi.org/10.1056/NEJMoa1815111			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC9YG	31509666	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000489631900007
J	Kang, YL; Liu, R; Wu, JX; Chen, L				Kang, Yunlu; Liu, Rui; Wu, Jing-Xiang; Chen, Lei			Structural insights into the mechanism of human soluble guanylate cyclase	NATURE			English	Article							NITRIC-OXIDE; ACTIVATION; DOMAIN; ATP; RECEPTOR; SUBUNIT; HEALTH; YC-1; SGC	Soluble guanylate cyclase (sGC) is the primary sensor of nitric oxide. It has a central role in nitric oxide signalling and has been implicated in many essential physiological processes and disease conditions. The binding of nitric oxide boosts the enzymatic activity of sGC. However, the mechanism by which nitric oxide activates the enzyme is unclear. Here we report the cryo-electron microscopy structures of the human sGC alpha 1 beta 1 heterodimer in different functional states. These structures revealed that the transducer module bridges the nitric oxide sensor module and the catalytic module. Binding of nitric oxide to the beta 1 haem-nitric oxide and oxygen binding (H-NOX) domain triggers the structural rearrangement of the sensor module and a conformational switch of the transducer module from bending to straightening. The resulting movement of the N termini of the catalytic domains drives structural changes within the catalytic module, which in turn boost the enzymatic activity of sGC.	[Kang, Yunlu; Liu, Rui; Wu, Jing-Xiang; Chen, Lei] Peking Univ, Inst Mol Med, State Key Lab Membrane Biol, Beijing Key Lab Cardiometab Mol Med, Beijing, Peoples R China; [Chen, Lei] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Chen, Lei] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China	Peking University; Peking University; Peking University	Chen, L (corresponding author), Peking Univ, Inst Mol Med, State Key Lab Membrane Biol, Beijing Key Lab Cardiometab Mol Med, Beijing, Peoples R China.; Chen, L (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Chen, L (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China.	chenlei2016@pku.edu.cn		Kang, Yunlu/0000-0001-8179-4487	Ministry of Science and Technology of China (National Key R&D Program of China) [2016YFA0502004]; National Natural Science Foundation of China [91857000, 31622021, 31821091, 31870833]; Beijing Natural Science Foundation [5192009]; Young Thousand Talents Program of China; China Postdoctoral Science Foundation [2016M600856, 2017T100014, 2019M650324, 2019T120014]; Boya Postdoctoral Fellowship of Peking University	Ministry of Science and Technology of China (National Key R&D Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Young Thousand Talents Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Boya Postdoctoral Fellowship of Peking University	We thank all members of the Chen laboratory for their help; J. Han for sharing the human sGC cDNA; and D. B. Morton for sharing Drosophila and mouse sGC cDNAs. Cryo-EM data collection was supported by the Electron Microscopy Laboratory and Cryo-EM Platform of Peking University with the assistance of X. Li, Z. Guo, B. Shao, X. Pei and G. Wang. Part of the structural computation was also performed on the Computing Platform of the Center for Life Science and High-performance Computing Platform of Peking University. The work was supported by grants from the Ministry of Science and Technology of China (National Key R&D Program of China, 2016YFA0502004 to L.C.), National Natural Science Foundation of China (91857000, 31622021, 31821091 and 31870833 to L.C.), Beijing Natural Science Foundation (5192009 to L.C.), Young Thousand Talents Program of China (to L.C.) and the China Postdoctoral Science Foundation (2016M600856, 2017T100014 and 2019M650324, and 2019T120014 to J.-X.W.). J.-X.W. is supported by the Boya Postdoctoral Fellowship of Peking University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allerston CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057644; Artz JD, 2001, BIOCHEMISTRY-US, V40, P9256, DOI 10.1021/bi002885x; BRANDWEIN HJ, 1982, J BIOL CHEM, V257, P1309; Campbell MG, 2014, P NATL ACAD SCI USA, V111, P2960, DOI 10.1073/pnas.1400711111; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Dasgupta A, 2015, CLIN PHARMACOL THER, V97, P88, DOI 10.1002/cpt.10; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Denninger JW, 2000, BIOCHEMISTRY-US, V39, P4191, DOI 10.1021/bi992332q; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farah C, 2018, NAT REV CARDIOL, V15, P292, DOI 10.1038/nrcardio.2017.224; Fernhoff NB, 2012, J BIOL CHEM, V287, P43053, DOI 10.1074/jbc.M112.393892; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Herve D, 2014, AM J HUM GENET, V94, P385, DOI 10.1016/j.ajhg.2014.01.018; Hollenberg SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7706; Horst BG, 2018, NITRIC OXIDE-BIOL CH, V77, P65, DOI 10.1016/j.niox.2018.04.011; Jurcik A, 2018, BIOINFORMATICS, V34, P3586, DOI 10.1093/bioinformatics/bty386; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koesling D, 2016, CURR MED CHEM, V23, P2653, DOI 10.2174/0929867323666160812145050; Koglin M, 2003, J BIOL CHEM, V278, P12590, DOI 10.1074/jbc.M212740200; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Mayer B, 2009, MOL PHARMACOL, V75, P886, DOI 10.1124/mol.108.052142; Montfort WR, 2017, ANTIOXID REDOX SIGN, V26, P107, DOI 10.1089/ars.2016.6693; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Purohit R, 2013, PROTEIN SCI, V22, P1439, DOI 10.1002/pro.2331; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ruiz-Stewart I, 2004, P NATL ACAD SCI USA, V101, P37, DOI 10.1073/pnas.0305080101; Sandner P, 2018, BIOL CHEM, V399, P679, DOI 10.1515/hsz-2018-0155; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Seeger F, 2014, BIOCHEMISTRY-US, V53, P2153, DOI 10.1021/bi500129k; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tsai AL, 2011, J BIOL CHEM, V286, P43182, DOI 10.1074/jbc.M111.290304; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; Vermehren-Schmaedick A, 2010, GENETICS, V186, P183, DOI 10.1534/genetics.110.118166; Wallace S, 2016, CLIN GENET, V90, P351, DOI 10.1111/cge.12739; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	50	56	56	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2019	574	7777					206	+		10.1038/s41586-019-1584-6	http://dx.doi.org/10.1038/s41586-019-1584-6			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD2DB	31514202	Green Submitted			2022-12-28	WOS:000489784200038
J	Voelker, R				Voelker, Rebecca			How Old Is Too Old to Be President?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1240	1241		10.1001/jama.2019.14329	http://dx.doi.org/10.1001/jama.2019.14329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31509159				2022-12-28	WOS:000489331900002
J	Kaiser, D				Kaiser, David			Discovery is always political	NATURE			English	Editorial Material							WORLD		[Kaiser, David] MIT, Hist Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kaiser, David] MIT, Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kaiser, D (corresponding author), MIT, Hist Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kaiser, D (corresponding author), MIT, Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dikaiser@mit.edu						Biagioli M, 1992, GALILEO COURTIER PRA; Cahan D., 1989, PHYSIKALISCH TECHNIS; Clark W., 2006, ACAD CHARISMA ORIGIN; Coen D.R., 2018, CLIMATE MOTION SCI E, DOI 10.7208/chicago/9780226555027.001.0001; DRAKE S, 1959, ISIS, V50, P245, DOI 10.1086/348776; FORMAN P, 1987, HIST STUD PHYS BIOL, V18, P149, DOI 10.2307/27757599; Gordin M. D., 2004, WELL ORDERED THING D; Kaiser D, 2002, HIST STUD PHYS BIOL, V33, P131, DOI 10.1525/hsps.2002.33.1.131; Kaiser D, 2005, DRAWING THEORIES APA; Kikuchi Yoshi, 2013, ANGLO AM CONNECTIONS; Krige John, 2006, AM HEGEMONY POSTWAR; Mirowski Philip, 2011, SCI MART PRIVATIZING; Moore Kelly, 2008, DISRUPTING SCI SOCIA; Morus Iwan R., 2005, PHYS BECAME KING; Oreskes N, 2013, NATURE, V501, P27, DOI 10.1038/501027a; Rigden J. S, 1987, RABI SCI CITIZEN, P4; Wilson B, 2015, HIST STUD NAT SCI, V45, P758, DOI 10.1525/hsns.2015.45.5.758	17	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					487	490		10.1038/d41586-019-02848-2	http://dx.doi.org/10.1038/d41586-019-02848-2			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31551560				2022-12-28	WOS:000488247600030
J	Samir, P; Kesavardhana, S; Patmore, DM; Gingras, S; Malireddi, RKS; Karki, R; Guy, CS; Briard, B; Place, DE; Bhattacharya, A; Sharma, BR; Nourse, A; King, SV; Pitre, A; Burton, AR; Pelletier, S; Gilbertson, RJ; Kanneganti, TD				Samir, Parimal; Kesavardhana, Sannula; Patmore, Deanna M.; Gingras, Sebastien; Malireddi, R. K. Subbarao; Karki, Rajendra; Guy, Clifford S.; Briard, Benoit; Place, David E.; Bhattacharya, Anannya; Sharma, Bhesh Raj; Nourse, Amanda; King, Sharon V.; Pitre, Aaron; Burton, Amanda R.; Pelletier, Stephane; Gilbertson, Richard J.; Kanneganti, Thirumala-Devi			DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome	NATURE			English	Article							RNA HELICASE DDX3; K+ EFFLUX; ACTIVATION; ASC; GRANULES; PROTEIN; ROLES; GENE; TRANSLATION; CASPASE-1	The cellular stress response has a vital role in regulating homeostasis by modulating cell survival and death. Stress granules are cytoplasmic compartments that enable cells to survive various stressors. Defects in the assembly and disassembly of stress granules are linked to neurodegenerative diseases, aberrant antiviral responses and cancer(1-5). Inflammasomes are multi-protein heteromeric complexes that sense molecular patterns that are associated with damage or intracellular pathogens, and assemble into cytosolic compartments known as ASC specks to facilitate the activation of caspase-1. Activation of inflammasomes induces the secretion of interleukin (IL)-1 beta and IL-18 and drives cell fate towards pyroptosis-a form of programmed inflammatory cell death that has major roles in health and disease(6-12). Although both stress granules and inflammasomes can be triggered by the sensing of cellular stress, they drive contrasting cell-fate decisions. The crosstalk between stress granules and inflammasomes and how this informs cell fate has not been well-studied. Here we show that the induction of stress granules specifically inhibits NLRP3 inflammasome activation, ASC speck formation and pyroptosis. The stress granule protein DDX3X interacts with NLRP3 to drive inflammasome activation. Assembly of stress granules leads to the sequestration of DDX3X, and thereby the inhibition of NLRP3 inflammasome activation. Stress granules and the NLRP3 inflammasome compete for DDX3X molecules to coordinate the activation of innate responses and subsequent cell-fate decisions under stress conditions. Induction of stress granules or loss of DDX3X in the myeloid compartment leads to a decrease in the production of inflammasome-dependent cytokines in vivo. Our findings suggest that macrophages use the availability of DDX3X to interpret stress signals and choose between pro-survival stress granules and pyroptotic ASC specks. Together, our data demonstrate the role of DDX3X in driving NLRP3 inflammasome and stress granule assembly, and suggest a rheostat-like mechanistic paradigm for regulating live-or-die cell-fate decisions under stress conditions.	[Samir, Parimal; Kesavardhana, Sannula; Gingras, Sebastien; Malireddi, R. K. Subbarao; Karki, Rajendra; Guy, Clifford S.; Briard, Benoit; Place, David E.; Bhattacharya, Anannya; Sharma, Bhesh Raj; Burton, Amanda R.; Pelletier, Stephane; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Patmore, Deanna M.; Gilbertson, Richard J.] Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Nourse, Amanda] St Jude Childrens Res Hosp, Mol Interact Shared Resource, 332 N Lauderdale St, Memphis, TN 38105 USA; [King, Sharon V.; Pitre, Aaron] St Jude Childrens Res Hosp, Light Microscopy Div, Cell & Tissue Imaging Ctr, 332 N Lauderdale St, Memphis, TN 38105 USA; [Gingras, Sebastien] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA	St Jude Children's Research Hospital; Cancer Research UK; CRUK Cambridge Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Gilbertson, RJ (corresponding author), Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England.	richard.gilbertson@cruk.cam.ac.uk; Thirumala-Devi.Kanneganti@stjude.org	Place, David/ABD-6703-2021; Sharma, Bhesh/AAJ-5150-2020; Gilbertson, Richard James/ABE-1346-2021; Kanneganti, Thirumala-Devi/Y-2503-2019; Samir, Parimal/N-4144-2014; Malireddi, RKSubbarao/C-5804-2013; Bhattacharya, Anannya/J-4555-2019; Karki, Rajendra/H-6647-2019; Briard, Benoit/AAH-9650-2019; Pitre, Aaron/C-3423-2016	Place, David/0000-0002-1904-4164; Sharma, Bhesh/0000-0003-3609-833X; Gilbertson, Richard James/0000-0001-7539-9472; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Samir, Parimal/0000-0001-7655-5713; Malireddi, RKSubbarao/0000-0001-8855-9447; Karki, Rajendra/0000-0003-4436-9128; Bhattacharya, Anannya/0000-0001-6385-4028; Nourse, Amanda/0000-0003-4595-5321; Briard, Benoit/0000-0002-1496-9408; Pitre, Aaron/0000-0002-3017-2140	NIH [AI101935, AI124346, AR056296, CA163507, P01CA96832, R0CA1129541]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital Cell and Tissue Imaging Center - St. Jude Children's Research Hospital; National Cancer Institute [P30 CA021765-35]; Cancer Research UK; Mathile Family Foundation; Cure Search; Sohn Foundation; NATIONAL CANCER INSTITUTE [R01CA163507, P01CA096832, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935, R01AI124346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital Cell and Tissue Imaging Center - St. Jude Children's Research Hospital; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Mathile Family Foundation; Cure Search; Sohn Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank all the members of the Kanneganti laboratory for their comments and suggestions; F. Phillips and N. Lantz for their help with generating BMDMs and with mouse husbandry; K. A. Laycock and R. Tweedell for scientific editing of the manuscript; K. Kodali and V. Pagala for their help with affinity purification mass spectrometry analysis; and S. Miller and S. Sakurada for helping with the CRISPR-Cas9-mediated gene disruption experiment. psPAX2 (Addgene plasmid 12260) and pMD2. G (Addgene plasmid 1225) were gifts from D. Trono. T.-D. K. is supported by NIH grants AI101935, AI124346, AR056296 and CA163507 and by the American Lebanese Syrian Associated Charities; the St. Jude Children's Research Hospital Cell and Tissue Imaging Center is supported by St. Jude Children's Research Hospital and by National Cancer Institute grant P30 CA021765-35; R.J.G. is supported by Cancer Research UK, the Mathile Family Foundation, Cure Search, the Sohn Foundation and NIH grants P01CA96832 and R0CA1129541.	Aditi, 2015, MOL BIOL CELL, V26, P1476, DOI 10.1091/mbc.E14-11-1523; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Chen CY, 2016, HUM MOL GENET, V25, P2905, DOI 10.1093/hmg/ddw143; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; Ditton HJ, 2004, HUM MOL GENET, V13, P2333, DOI 10.1093/hmg/ddh240; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franklin BS, 2018, IMMUNOL REV, V281, P74, DOI 10.1111/imr.12611; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gross CJ, 2016, IMMUNITY, V45, P761, DOI 10.1016/j.immuni.2016.08.010; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2013, IMMUNITY, V38, P1085, DOI 10.1016/j.immuni.2013.06.001; Karki R, 2019, NAT REV CANCER, V19, P197, DOI 10.1038/s41568-019-0123-y; Karki R, 2018, CELL, V173, P920, DOI 10.1016/j.cell.2018.02.055; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Li Q, 2014, J BIOMED RES, V28, P282, DOI 10.7555/JBR.27.20130047; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Malireddi RKS, 2018, J EXP MED, V215, P1023, DOI 10.1084/jem.20171922; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Stunnenberg M, 2018, CYTOKINE GROWTH F R, V40, P32, DOI 10.1016/j.cytogfr.2018.03.001; Szaflarski W, 2016, ONCOTARGET, V7, P30307, DOI 10.18632/oncotarget.8728; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Vakilian H, 2015, J PROTEOME RES, V14, P3474, DOI 10.1021/acs.jproteome.5b00512; Van Gorp H, 2016, P NATL ACAD SCI USA, V113, P14384, DOI 10.1073/pnas.1613156113; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56	43	143	149	5	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					590	+		10.1038/s41586-019-1551-2	http://dx.doi.org/10.1038/s41586-019-1551-2			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31511697	Green Submitted, Green Accepted			2022-12-28	WOS:000488247600060
J	Mahase, E				Mahase, Elisabeth			Private screening: GPs shouldn't have to deal with results, says RCGP	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cosgrove J., 2019, RCGP COUNC M 21 SEPT	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5707	10.1136/bmj.l5707	http://dx.doi.org/10.1136/bmj.l5707			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551290				2022-12-28	WOS:000488488300015
J	Roumie, CL; Chipman, J; Min, JY; Hackstadt, AJ; Hung, AM; Greevy, RA; Grijalva, CG; Elasy, T; Griffin, MR				Roumie, Christianne L.; Chipman, Jonathan; Min, Jea Young; Hackstadt, Amber J.; Hung, Adriana M.; Greevy, Robert A., Jr.; Grijalva, Carlos G.; Elasy, Tom; Griffin, Marie R.			Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-GLUCOSE CONTROL; HEART-FAILURE; HAZARDS MODEL; FOLLOW-UP; DISEASE; VETERANS; OUTCOMES; SUBDISTRIBUTION; COMPLICATIONS; EQUATION	Key PointsQuestionIs there an association between treatment with metformin vs sulfonylureas and major adverse cardiovascular events (MACE) among patients with diabetes and reduced kidney function? FindingsIn this retrospective cohort study of 49478 patients with diabetes and reduced kidney function, the incidence of MACE for those treated with metformin vs sulfonylurea monotherapy was 23.0 per 1000 person-years vs 29.2 per 1000 person-years, a difference that was statistically significant. MeaningMonotherapy treatment with metformin, compared with a sulfonylurea, was associated with a lower risk of MACE among patients with diabetes and reduced kidney function. ImportanceBefore 2016, safety concerns limited metformin use in patients with kidney disease; however, the effectiveness of metformin on clinical outcomes in patients with reduced kidney function remains unknown. ObjectiveTo compare major adverse cardiovascular events (MACE) among patients with diabetes and reduced kidney function who continued treatment with metformin or a sulfonylurea. Design, Setting, and ParticipantsRetrospective cohort study of US veterans receiving care within the national Veterans Health Administration, with data supplemented by linkage to Medicare, Medicaid, and National Death Index data from 2001 through 2016. There were 174882 persistent new users of metformin and sulfonylureas who reached a reduced kidney function threshold (estimated glomerular filtration rate <60 mL/min/1.73 m(2) or creatinine >= 1.4 mg/dL for women or >= 1.5 mg/dL for men). Patients were followed up from reduced kidney function threshold until MACE, treatment change, loss to follow-up, death, or study end (December 2016). ExposuresNew users of metformin or sulfonylurea monotherapy who continued treatment with their glucose-lowering medication after reaching reduced kidney function. Main Outcomes and MeasuresMACE included hospitalization for acute myocardial infarction, stroke, transient ischemic attack, or cardiovascular death. The analyses used propensity score weighting to compare the cause-specific hazard of MACE between treatments and estimate cumulative risk accounting for the competing risks of changing therapy or noncardiovascular death. ResultsThere were 67749 metformin and 28976 sulfonylurea persistent monotherapy users; the weighted cohort included 24679 metformin and 24799 sulfonylurea users (median age, 70 years [interquartile range {IQR}, 62.8-77.8]; 48497 men [98%]; and 40476 white individuals [82%], with median estimated glomerular filtration rate of 55.8 mL/min/1.73 m(2) [IQR, 51.6-58.2] and hemoglobin A(1c) level of 6.6% [IQR, 6.1%-7.2%] at cohort entry). During follow-up (median, 1.0 year for metformin vs 1.2 years for sulfonylurea), there were 1048 MACE outcomes (23.0 per 1000 person-years) among metformin users and 1394 events (29.2 per 1000 person-years) among sulfonylurea users. The cause-specific adjusted hazard ratio of MACE for metformin was 0.80 (95% CI, 0.75-0.86) compared with sulfonylureas, yielding an adjusted rate difference of 5.8 (95% CI, 4.1-7.3) fewer events per 1000 person-years of metformin use compared with sulfonylurea use. Conclusions and RelevanceAmong patients with diabetes and reduced kidney function persisting with monotherapy, treatment with metformin, compared with a sulfonylurea, was associated with a lower risk of MACE. This cohort study uses data from the National Veterans Health Administration, Medicare, Medicaid, and National Death Index to compare major adverse cardiovascular events among patients with diabetes and reduced kidney function who continued treatment with metformin or sulfonylurea.	[Roumie, Christianne L.; Min, Jea Young; Hung, Adriana M.; Grijalva, Carlos G.; Elasy, Tom; Griffin, Marie R.] Vet Adm Tennessee Valley VA Hlth Care Syst, Geriatr Res Educ Clin Ctr, Nashville, TN USA; [Roumie, Christianne L.; Hung, Adriana M.; Elasy, Tom; Griffin, Marie R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Chipman, Jonathan; Hackstadt, Amber J.; Greevy, Robert A., Jr.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Min, Jea Young; Grijalva, Carlos G.; Griffin, Marie R.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Geriatric Research Education & Clinical Center; Vanderbilt University; Vanderbilt University; Vanderbilt University	Roumie, CL (corresponding author), Nashville VA Med Ctr, Geriatr Res Educ Clin Ctr, 1310 24th Ave S, Nashville, TN 37212 USA.	christianne.roumie@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	VA Clinical Science Research and Development investigator-initiated grant [CX000570-07, CX000982]; Center for Diabetes Translation Research [P30DK092986]; VA Office of Academic Affiliations Quality Scholars Program; Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service; Veterans Affairs Information Resource Center [SDR 02-237, 98-004]	VA Clinical Science Research and Development investigator-initiated grant; Center for Diabetes Translation Research; VA Office of Academic Affiliations Quality Scholars Program; Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); Veterans Affairs Information Resource Center	This study was funded by the VA Clinical Science Research and Development investigator-initiated grant CX000570-07 (Dr Roumie). Drs Roumie and Elasy were supported in part by the Center for Diabetes Translation Research (P30DK092986). Dr Min was supported by the VA Office of Academic Affiliations Quality Scholars Program. Dr Hung was supported by a VA Clinical Science Research and Development investigator-initiated grant (CX000982). Support for Veterans Affairs/Centers for Medicare & Medicaid Services data was provided by the Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, and Veterans Affairs Information Resource Center (project No. SDR 02-237 and 98-004).	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Azoulay L, 2017, DIABETES CARE, V40, P706, DOI 10.2337/dc16-1943; Center of Excellence in Suicide Prevention, JOINT DEP VET AFF VA; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Crowley MJ, 2017, ANN INTERN MED, V166, P191, DOI 10.7326/M16-1901; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; Diabetes Canada, 2018, CANADIAN JOURNAL OF; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076; European Medicines Agency, US METF TREAT DIAB N; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Flory JH, 2015, JAMA INTERN MED, V175, P458, DOI 10.1001/jamainternmed.2014.6936; Food and Drug Administration, 2016, FDA DRUG SAF COMM FD; Food Drug Administration, CTR DRUG EV RES APPL; Franklin JM, 2017, STAT MED, V36, P1946, DOI 10.1002/sim.7250; Geiss LS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173428; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greevy RA, 2011, CLIN PHARMACOL THER, V90, P813, DOI 10.1038/clpt.2011.228; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Huizinga Mary Margaret, 2007, Diabetes Care, V30, pe85, DOI 10.2337/dc07-0650; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li JN, 2015, LIFETIME DATA ANAL, V21, P197, DOI 10.1007/s10985-014-9313-9; llensky J, 2012, MED MED RES REV, V2; Masoudi FA, 2005, CIRCULATION, V111, P583, DOI 10.1161/01.CIR.0000154542.13412.B1; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; Niesner K, 2013, EPIDEMIOLOGY, V24, P334, DOI 10.1097/EDE.0b013e3182821e75; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Roumie CL, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0101-2; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259	39	43	44	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1167	1177		10.1001/jama.2019.13206	http://dx.doi.org/10.1001/jama.2019.13206			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31536102	Green Published, Bronze			2022-12-28	WOS:000488822800023
J	Mahase, E				Mahase, Elisabeth			Labour pledges to increase GP training places to 5000 and scrap prescription charges	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, BMJ, V366; Health Education England, 2019, REC BREAK NUMB RECR; Health Education England, 2019, ANN REP ACC 2018 19; NHS, 2017, AM I ENT FREE PRESCR; RCGP, 2019, RCGP CALLS 5000 GPS	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5684	10.1136/bmj.l5684	http://dx.doi.org/10.1136/bmj.l5684			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WS	31548206				2022-12-28	WOS:000488488000016
J	Borders, WA; Pervaiz, AZ; Fukami, S; Camsari, KY; Ohno, H; Datta, S				Borders, William A.; Pervaiz, Ahmed Z.; Fukami, Shunsuke; Camsari, Kerem Y.; Ohno, Hideo; Datta, Supriyo			Integer factorization using stochastic magnetic tunnel junctions	NATURE			English	Article							ALGORITHM; SPIN	Conventional computers operate deterministically using strings of zeros and ones called bits to represent information in binary code. Despite the evolution of conventional computers into sophisticated machines, there are many classes of problems that they cannot efficiently address, including inference, invertible logic, sampling and optimization, leading to considerable interest in alternative computing schemes. Quantum computing, which uses qubits to represent a superposition of 0 and 1, is expected to perform these tasks efficiently(1-3). However, decoherence and the current requirement for cryogenic operation(4), as well as the limited many-body interactions that can be implemented, pose considerable challenges. Probabilistic computing(1,5-7) is another unconventional computation scheme that shares similar concepts with quantum computing but is not limited by the above challenges. The key role is played by a probabilistic bit (a p-bit)-a robust, classical entity fluctuating in time between 0 and 1, which interacts with other p-bits in the same system using principles inspired by neural networks(8). Here we present a proof-of-concept experiment for probabilistic computing using spintronics technology, and demonstrate integer factorization, an illustrative example of the optimization class of problems addressed by adiabatic(9) and gated(2) quantum computing. Nanoscale magnetic tunnel junctions showing stochastic behaviour are developed by modifying market-ready magnetoresistive random-access memory technology(10,11) and are used to implement three-terminal p-bits that operate at room temperature. The p-bits are electrically connected to form a functional asynchronous network, to which a modified adiabatic quantum computing algorithm that implements three- and four-body interactions is applied. Factorization of integers up to 945 is demonstrated with this rudimentary asynchronous probabilistic computer using eight correlated p-bits, and the results show good agreement with theoretical predictions, thus providing a potentially scalable hardware approach to the difficult problems of optimization and sampling.	[Borders, William A.; Fukami, Shunsuke; Ohno, Hideo] Tohoku Univ, Res Inst Elect Commun, Lab Nanoelect & Spintron, Sendai, Miyagi, Japan; [Pervaiz, Ahmed Z.; Camsari, Kerem Y.; Datta, Supriyo] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Fukami, Shunsuke; Ohno, Hideo] Tohoku Univ, Ctr Spintron Integrated Syst, Sendai, Miyagi, Japan; [Fukami, Shunsuke; Ohno, Hideo] Tohoku Univ, Ctr Innovat Integrated Elect Syst, Sendai, Miyagi, Japan; [Fukami, Shunsuke; Ohno, Hideo] Tohoku Univ, Ctr Spintron Res Network, Sendai, Miyagi, Japan; [Fukami, Shunsuke; Ohno, Hideo] Tohoku Univ, Ctr Sci & Innovat Spintron, Core Res Cluster, Sendai, Miyagi, Japan; [Fukami, Shunsuke; Ohno, Hideo] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi, Japan	Tohoku University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Fukami, S (corresponding author), Tohoku Univ, Res Inst Elect Commun, Lab Nanoelect & Spintron, Sendai, Miyagi, Japan.; Camsari, KY (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.; Fukami, S (corresponding author), Tohoku Univ, Ctr Spintron Integrated Syst, Sendai, Miyagi, Japan.; Fukami, S (corresponding author), Tohoku Univ, Ctr Innovat Integrated Elect Syst, Sendai, Miyagi, Japan.; Fukami, S (corresponding author), Tohoku Univ, Ctr Spintron Res Network, Sendai, Miyagi, Japan.; Fukami, S (corresponding author), Tohoku Univ, Ctr Sci & Innovat Spintron, Core Res Cluster, Sendai, Miyagi, Japan.; Fukami, S (corresponding author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi, Japan.	s-fukami@riec.tohoku.ac.jp; kcamsari@purdue.edu	Ohno, Hideo/E-6453-2010; Fukami, Shunsuke/T-6938-2019	Ohno, Hideo/0000-0001-9688-8259; Camsari, Kerem/0000-0002-6876-8812; Fukami, Shunsuke/0000-0001-5750-2990	ImPACT Program of CSTI; JSPS KAKENHI [17H06093, 19J12206]; Cooperative Research Project of RIEC, one of six centres in JUMP, an SRC program - DARPA; Cooperative Research Project of ASCENT, one of six centres in JUMP, an SRC program - DARPA	ImPACT Program of CSTI; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project of RIEC, one of six centres in JUMP, an SRC program - DARPA; Cooperative Research Project of ASCENT, one of six centres in JUMP, an SRC program - DARPA	We thank H. Sato, M. Bersweiler, T. Hirata, H. Iwanuma, K. Goto, C. Igarashi, I. Morita, R. Ono and M. Musya for technical support. We thank O. Hassan and S. Chowdhury for their help with the Methods sections comparing CMOS alternatives and quantum computing, respectively. A portion of this work was supported by ImPACT Program of CSTI, JSPS KAKENHI grant numbers 17H06093 and 19J12206, Cooperative Research Projects of RIEC, and ASCENT, one of six centres in JUMP, an SRC program sponsored by DARPA. W.A.B. acknowledges JST-OPERA.	Albash T, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.015002; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Biamonte JD, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052331; Brataas A, 2012, NAT MATER, V11, P372, DOI [10.1038/NMAT3311, 10.1038/nmat3311]; BROWN WF, 1963, PHYS REV, V130, P1677, DOI 10.1103/PhysRev.130.1677; Burges C. J. C., 2002, MSRTR200283 MICR RES; Camsari K. Y., 2018, PREPRINT; Camsari KY, 2017, IEEE ELECTR DEVICE L, V38, P1767, DOI 10.1109/LED.2017.2768321; Camsari KY, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.031014; Chaves-O'Flynn GD, 2015, PHYS REV APPL, V4, DOI 10.1103/PhysRevApplied.4.024010; Datta D, 2012, IEEE T NANOTECHNOL, V11, P261, DOI 10.1109/TNANO.2011.2163147; Dridi R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44963; Endo M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3429592; Enobio ECI, 2018, JPN J APPL PHYS, V57, DOI 10.7567/JJAP.57.04FN08; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fukushima A, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.083001; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Henelius P., 2011, PREPRINT; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/NMAT2804, 10.1038/nmat2804]; Jiang SX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36058-z; JULLIERE M, 1975, PHYS LETT A, V54, P225, DOI 10.1016/0375-9601(75)90174-7; Kent AD, 2015, NAT NANOTECHNOL, V10, P187, DOI 10.1038/nnano.2015.24; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kleinjung T, 2010, LECT NOTES COMPUT SC, V6223, P333, DOI 10.1007/978-3-642-14623-7_18; Lee YK, 2018, 2018 IEEE SYMPOSIUM ON VLSI TECHNOLOGY, P181; Lucas A, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00005; Mathew SK, 2016, IEEE J SOLID-ST CIRC, V51, P1695, DOI 10.1109/JSSC.2016.2558490; Mizrahi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03963-w; Park C, 2018, 2018 IEEE SYMPOSIUM ON VLSI TECHNOLOGY, P185; Pervaiz AZ, 2019, IEEE T NEUR NET LEAR, V30, P1920, DOI 10.1109/TNNLS.2018.2874565; Pervaiz AZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11011-8; Preskill J, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-08-06-79; Roberts GO, 1997, J ROY STAT SOC B MET, V59, P291, DOI 10.1111/1467-9868.00070; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Sutton B, 2017, SCI REP-UK, V7, DOI 10.1038/srep44370; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Xu NY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.130501; Zand R, 2019, ACM J EMERG TECH COM, V15, DOI 10.1145/3304105; Zhao W, 2006, IEEE T ELECTRON DEV, V53, P2816, DOI 10.1109/TED.2006.884077	43	169	168	15	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					390	+		10.1038/s41586-019-1557-9	http://dx.doi.org/10.1038/s41586-019-1557-9			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31534247				2022-12-28	WOS:000486647800044
J	Puno, MR; Weick, EM; Das, M; Lima, CD				Puno, M. Rhyan; Weick, Eva-Maria; Das, Mom; Lima, Christopher D.			SnapShot: The RNA Exosome	CELL			English	Editorial Material									[Puno, M. Rhyan; Weick, Eva-Maria; Das, Mom; Lima, Christopher D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Lima, Christopher D.] Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Puno, MR (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA.			Das, Mom/0000-0002-9436-6809; Weick, Eva-Maria/0000-0002-3504-2572; Puno, Marc Rhyan/0000-0001-9653-3220; Lima, Christopher/0000-0002-9163-6092	National Institute of General Medical Sciences of the National Institutes of Health [R35GM118080]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118080] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health (R35GM118080, C.D.L.). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. E.-M.W. is supported by the Human Frontier Science Program. C.D.L. is an investigator of the Howard Hughes Medical Institute.	Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Kilchert C, 2016, NAT REV MOL CELL BIO, V17, P227, DOI 10.1038/nrm.2015.15; Makino DL, 2013, NAT REV MOL CELL BIO, V14, P654, DOI 10.1038/nrm3657; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Molleston JM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010002; Ogami Koichi, 2018, Non-Coding RNA, V4, P8, DOI 10.3390/ncrna4010008; Schaeffer D., 2010, FUNCTIONS CYTOPLASMI, P79; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Zinder JC, 2017, GENE DEV, V31, P88, DOI 10.1101/gad.294769.116	10	17	17	3	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					282	+		10.1016/j.cell.2019.09.005	http://dx.doi.org/10.1016/j.cell.2019.09.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539497	Bronze			2022-12-28	WOS:000486618500029
J	Zarocostas, J				Zarocostas, John			Health providers urged to help to eradicate modern slavery	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					905	906		10.1016/S0140-6736(19)32083-5	http://dx.doi.org/10.1016/S0140-6736(19)32083-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX7CE	31526725				2022-12-28	WOS:000485840600009
J	Blanchard, AT; Salaita, K				Blanchard, Aaron T.; Salaita, Khalid			Emerging uses of DNA mechanical devices	SCIENCE			English	Editorial Material									[Blanchard, Aaron T.; Salaita, Khalid] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Blanchard, Aaron T.; Salaita, Khalid] Emory Univ, Atlanta, GA 30322 USA; [Salaita, Khalid] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Salaita, K (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.; Salaita, K (corresponding author), Emory Univ, Atlanta, GA 30322 USA.; Salaita, K (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	k.salaita@emory.edu	salaita, khalid/C-4414-2008; Blanchard, Aaron/AAN-7808-2021	Blanchard, Aaron/0000-0002-3129-6591	NIH [R01GM124472, R01GM131099]; NSF [1611102]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124472, R01GM131099] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. K. Jones for help with the figure; A. V. Kellner, I. C. Miller, and J. M. Brockman for helpful discussions. Supported by NIH grants R01GM124472 and R01GM131099 and by NSF grant 1611102.	Blanchard AT, 2019, NANO LETT, V19, P6977, DOI 10.1021/acs.nanolett.9b02311; Brockman JM, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00014; Brockman JM, 2018, NAT METHODS, V15, P115, DOI 10.1038/nmeth.4536; Cangialosi A, 2017, SCIENCE, V357, P1126, DOI 10.1126/science.aan3925; Castro CE, 2015, NANOSCALE, V7, P5913, DOI 10.1039/c4nr07153k; Dutta PK, 2018, NANO LETT, V18, P4803, DOI 10.1021/acs.nanolett.8b01374; Gerling T, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau1157; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; Kopperger E, 2018, SCIENCE, V359, P296, DOI 10.1126/science.aao4284; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Ma R, 2019, P NATL ACAD SCI USA, V116, P16949, DOI 10.1073/pnas.1904034116; Nickels PC, 2016, SCIENCE, V354, P305, DOI 10.1126/science.aah5974; Spillane KM, 2017, J CELL BIOL, V216, P217, DOI 10.1083/jcb.201607064; Thubagere AJ, 2017, SCIENCE, V357, DOI 10.1126/science.aan6558	15	51	51	4	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1080	1081		10.1126/science.aax3343	http://dx.doi.org/10.1126/science.aax3343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515373	Green Accepted			2022-12-28	WOS:000485780800024
J	Huang, LL; Liu, M; Lin, HX; Xu, YB; Wu, JS; Dravid, VP; Wolverton, C; Mirkin, CA				Huang, Liliang; Liu, Mohan; Lin, Haixin; Xu, Yaobin; Wu, Jinsong; Dravid, Vinayak P.; Wolverton, Chris; Mirkin, Chad A.			Shape regulation of high-index facet nanoparticles by dealloying	SCIENCE			English	Article							TOTAL-ENERGY CALCULATIONS; FORMIC-ACID; METAL-CATALYSTS; SURFACE-ENERGY; FCC METALS; CRYSTAL; NANOCRYSTALS; ELECTROOXIDATION; PERFORMANCE; ELECTRODES	Tetrahexahedral particles (similar to 10 to similar to 500 nanometers) composed of platinum (Pt), palladium, rhodium, nickel, and cobalt, as well as a library of bimetallic compositions, were synthesized on silicon wafers and on catalytic supports by a ligand-free, solid-state reaction that used trace elements [antimony (Sb), bismuth (Bi), lead, or tellurium] to stabilize high-index facets. Both simulation and experiment confirmed that this method stabilized the {210} planes. A study of the PtSb system showed that the tetrahexahedron shape resulted from the evaporative removal of Sb from the initial alloy-a shape-regulating process fundamentally different from solution-phase, ligand-dependent processes. The current density at a fixed potential for the electro-oxidation of formic acid with a commercial Pt/carbon catalyst increased by a factor of 20 after transformation with Bi into tetrahexahedral particles.	[Huang, Liliang; Liu, Mohan; Xu, Yaobin; Wu, Jinsong; Dravid, Vinayak P.; Wolverton, Chris; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Lin, Haixin; Dravid, Vinayak P.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Lin, Haixin; Mirkin, Chad A.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010; Wolverton, Chris/AAZ-3899-2020; Wolverton, Christopher/B-7542-2009; Dravid, Vinayak/B-6688-2009; Lin, Haixin/C-4097-2017; Xu, Yao-bin/N-5641-2016	Lin, Haixin/0000-0003-4650-0062; Liu, Mohan/0000-0002-4777-3102; Xu, Yao-bin/0000-0002-9945-3514; Mirkin, Chad/0000-0002-6634-7627; Huang, Liliang/0000-0002-3474-0846	Kairos Ventures; Toyota Research Institute; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource [NSF ECCS-1542205]; MRSEC program at the Materials Research Center [NSF DMR1720139]; International Institute for Nanotechnology (IIN); Keck Foundation; State of Illinois, through the IIN; MRSEC; SHyNE; Sherman Fairchild Foundation Inc.; Center for Bio-Inspired Energy Science, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0000989]	Kairos Ventures; Toyota Research Institute; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource; MRSEC program at the Materials Research Center; International Institute for Nanotechnology (IIN); Keck Foundation(W.M. Keck Foundation); State of Illinois, through the IIN; MRSEC(National Science Foundation (NSF)); SHyNE; Sherman Fairchild Foundation Inc.; Center for Bio-Inspired Energy Science, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE))	Supported by the Sherman Fairchild Foundation Inc. synthesis and characterization of monometallic particles), the Center for Bio-Inspired Energy Science, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences under award DE-SC0000989 (synthesis of electrocatalysts), and Kairos Ventures (synthesis and characterization of bimetallic nanoparticles). M.L. and C.W. acknowledge support from the Toyota Research Institute. This project made use of the EPIC facility of Northwestern University's NUANCE Center, which has received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-1542205); the MRSEC program (NSF DMR1720139) at the Materials Research Center; the International Institute for Nanotechnology (IIN); the Keck Foundation; and the State of Illinois, through the IIN. This project made use of the J. B. Cohen X-Ray Diffraction Facility supported by MRSEC and SHyNE. This project made use of resources in National Energy Research Scientific Computing Center and Northwestern University's Quest high-performance computing system.	An L, 2015, NANO ENERGY, V15, P24, DOI 10.1016/j.nanoen.2015.03.031; Avanesian T, 2017, J AM CHEM SOC, V139, P4551, DOI 10.1021/jacs.7b01081; Barnard AS, 2009, ACS NANO, V3, P1431, DOI 10.1021/nn900220k; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Chen QS, 2011, J AM CHEM SOC, V133, P12930, DOI 10.1021/ja2042029; CLAVILIER J, 1989, J ELECTROANAL CHEM, V258, P89, DOI 10.1016/0022-0728(89)85164-2; Ermanoski I, 2005, SURF SCI, V596, P89, DOI 10.1016/j.susc.2005.08.024; Feng LG, 2016, NANO ENERGY, V30, P355, DOI 10.1016/j.nanoen.2016.10.023; Grzelczak M, 2008, CHEM SOC REV, V37, P1783, DOI 10.1039/b711490g; Ha S, 2005, J POWER SOURCES, V144, P28, DOI 10.1016/j.jpowsour.2004.12.031; HERRERO E, 1995, J ELECTROANAL CHEM, V394, P161, DOI 10.1016/0022-0728(95)03963-H; Kang YJ, 2012, ACS NANO, V6, P2818, DOI 10.1021/nn3003373; Kirklin S, 2015, NPJ COMPUT MATER, V1, DOI 10.1038/npjcompumats.2015.10; Kolthoff D, 2000, SURF SCI, V447, P259, DOI 10.1016/S0039-6028(99)01198-X; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lee H, 2006, ANGEW CHEM INT EDIT, V45, P7824, DOI 10.1002/anie.200603068; Lee JK, 2008, ELECTROCHIM ACTA, V53, P6089, DOI 10.1016/j.electacta.2008.02.089; LOFFLER DG, 1976, SURF SCI, V59, P195, DOI 10.1016/0039-6028(76)90300-9; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Morgan K, 2015, ACS CATAL, V5, P3430, DOI 10.1021/acscatal.5b00535; Niu WX, 2008, CRYST GROWTH DES, V8, P4440, DOI 10.1021/cg8002433; Niu ZQ, 2014, CHEM MATER, V26, P72, DOI 10.1021/cm4022479; OTTE HM, 1965, PHYS TODAY, V18, P67; Personick ML, 2011, NANO LETT, V11, P3394, DOI 10.1021/nl201796s; Saal JE, 2013, JOM-US, V65, P1501, DOI 10.1007/s11837-013-0755-4; SUN SG, 1994, J ELECTROANAL CHEM, V370, P273; Tao F, 2010, SCIENCE, V327, P850, DOI 10.1126/science.1182122; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Tian N, 2008, J PHYS CHEM C, V112, P19801, DOI 10.1021/jp804051e; Tran R, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.80; Twigg M.V., 1989, CATALYST HDB, P34; Uhm SY, 2007, ELECTROCHEM COMMUN, V9, P2027, DOI 10.1016/j.elecom.2007.05.029; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wen YN, 2007, SOLID STATE COMMUN, V144, P163, DOI 10.1016/j.ssc.2007.07.012; Wu YY, 2001, J AM CHEM SOC, V123, P3165, DOI 10.1021/ja0059084; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Yu XW, 2008, J POWER SOURCES, V182, P124, DOI 10.1016/j.jpowsour.2008.03.075; Yu XW, 2010, ELECTROCHIM ACTA, V55, P7354, DOI 10.1016/j.electacta.2010.07.019; Zhang JW, 2016, NANO TODAY, V11, P661, DOI 10.1016/j.nantod.2016.08.012; Zhang JM, 2004, APPL SURF SCI, V229, P34, DOI 10.1016/j.apsusc.2003.09.050	42	67	67	17	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1159	+		10.1126/science.aax5843	http://dx.doi.org/10.1126/science.aax5843			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515391				2022-12-28	WOS:000485780800045
J	Xia, XX; Afshar, A; Yang, H; Portela, CM; Kochmann, DM; Di Leo, CV; Greer, JR				Xia, Xiaoxing; Afshar, Arman; Yang, Heng; Portela, Carlos M.; Kochmann, Dennis M.; Di Leo, Claudio V.; Greer, Julia R.			Electrochemically reconfigurable architected materials	NATURE			English	Article							BAND-GAPS; SILICON; LITHIATION; DESIGN; ANODES; STRESSES	Architected materials can actively respond to external stimuli-such as mechanical forces, hydration and magnetic fields-by changing their geometries and thereby achieve novel functionalities. Such transformations are usually binary and volatile because they toggle between 'on' and 'off' states and require persistent external stimuli. Here we develop three-dimensional silicon-coated tetragonal microlattices that transform into sinusoidal patterns via cooperative beam buckling in response to an electrochemically driven silicon-lithium alloying reaction. In situ microscopy reveals a controllable, non-volatile and reversible structural transformation that forms multiple ordered buckling domains separated by distorted domain boundaries. We investigate the mechanical dynamics of individual buckling beams, cooperative coupling among neighbouring beams, and lithiation-rate-dependent distributions of domain sizes through chemo-mechanical modelling and statistical mechanics analysis. Our results highlight the critical role of defects and energy fluctuations in the dynamic response of architected materials. We further demonstrate that domain boundaries can be programmed to form particular patterns by pre-designing artificial defects, and that a variety of reconfigurational degrees of freedom can be achieved through micro-architecture design. This framework enables the design, fabrication, modelling, behaviour prediction and programming of electrochemically reconfigurable architected materials, and could open the way to beyond-intercalation battery electrodes, tunable phononic crystals and bio-implantable devices.	[Xia, Xiaoxing; Yang, Heng; Portela, Carlos M.; Kochmann, Dennis M.; Greer, Julia R.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Afshar, Arman; Di Leo, Claudio V.] CALTECH, Sch Aerosp Engn, Atlanta, GA USA; [Kochmann, Dennis M.] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Zurich, Switzerland	California Institute of Technology; California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Greer, JR (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	jrgreer@caltech.edu		Portela, Carlos M./0000-0002-2649-4235; Di Leo, Claudio/0000-0002-3410-6677; Kochmann, Dennis/0000-0002-9112-6615	Department of Defense through a Vannevar-Bush Faculty Fellowship; Caltech Innovation Initiative Grant (CI2); Samsung Global Research Outreach Grant; National Science Foundation Division of Civil, Mechanical, and Manufacturing Innovation [CMMI-1825132]; Office of Naval Research [N00014-16-1-2431]	Department of Defense through a Vannevar-Bush Faculty Fellowship(United States Department of Defense); Caltech Innovation Initiative Grant (CI2); Samsung Global Research Outreach Grant(Samsung); National Science Foundation Division of Civil, Mechanical, and Manufacturing Innovation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	We thank D. Tozier, O. A. Tertuliano, W. L. Johnson, J. Y. Chen, K. Bhattacharya, P.W. Voorhees and D. J. Srolovitz for helpful discussions, and N. S. Lee, M. S. Hunt, A. R. Wertheim, G. A. DeRose, H. A. Atwater, N. S. Lewis, B. S. Brunschwig, J. Shi and A. H. Shih for support and assistance with experiments and instruments. We gratefully acknowledge the facilities and infrastructure provided by the Kavli Nanoscience Institute and the Molecular Materials Research Center at Caltech. J.R.G. acknowledges financial support from the Department of Defense through a Vannevar-Bush Faculty Fellowship, a Caltech Innovation Initiative Grant (CI2), and a Samsung Global Research Outreach Grant. C.V.D.L. acknowledges support from the National Science Foundation Division of Civil, Mechanical, and Manufacturing Innovation (CMMI-1825132). D.M.K. acknowledges financial support from the Office of Naval Research (N00014-16-1-2431).	Babaee S, 2013, ADV MATER, V25, P5044, DOI 10.1002/adma.201301986; Baggetto L, 2011, ADV MATER, V23, P1563, DOI 10.1002/adma.201003665; Bauer J, 2016, NAT MATER, V15, P438, DOI [10.1038/NMAT4561, 10.1038/nmat4561]; Bertoldi K, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.66; Bhandakkar TK, 2012, J MECH PHYS SOLIDS, V60, P1103, DOI 10.1016/j.jmps.2012.02.012; Cha J, 2018, NAT NANOTECHNOL, V13, P1016, DOI 10.1038/s41565-018-0252-6; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Chen YY, 2017, PHYS REV APPL, V7, DOI 10.1103/PhysRevApplied.7.024012; Clausen A, 2015, ADV MATER, V27, P5523, DOI 10.1002/adma.201502485; CORNELL S, 1992, PHYS REV B, V45, P2725, DOI 10.1103/PhysRevB.45.2725; Correa DM, 2015, RAPID PROTOTYPING J, V21, P193, DOI 10.1108/RPJ-12-2014-0182; Coulais C, 2018, NAT PHYS, V14, P40, DOI 10.1038/NPHYS4269; Coulais C, 2016, NATURE, V535, P529, DOI 10.1038/nature18960; Di Leo CV, 2015, INT J SOLIDS STRUCT, V67-68, P283, DOI 10.1016/j.ijsolstr.2015.04.028; Dou NG, 2018, NANO LETT, V18, P4755, DOI 10.1021/acs.nanolett.8b01191; Fahrenkrug E, 2014, CHEM MATER, V26, P4535, DOI 10.1021/cm501752n; Fu HR, 2018, NAT MATER, V17, P268, DOI 10.1038/s41563-017-0011-3; Gladman AS, 2016, NAT MATER, V15, P413, DOI [10.1038/NMAT4544, 10.1038/nmat4544]; Haghpanah B, 2016, ADV MATER, V28, P7915, DOI 10.1002/adma.201601650; He HL, 2018, NATURE, V560, P61, DOI 10.1038/s41586-018-0367-9; Huang S, 2011, J POWER SOURCES, V196, P3664, DOI 10.1016/j.jpowsour.2010.11.155; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Kang SH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.098701; Kang SH, 2013, ADV MATER, V25, P3380, DOI 10.1002/adma.201300617; Kelly A, 2012, CRYSTALLOGRAPHY AND CRYSTAL DEFECTS, 2ND EDITION, P1, DOI 10.1002/9781119961468; Kim Y, 2018, NATURE, V558, P274, DOI 10.1038/s41586-018-0185-0; Korner C, 2015, SMART MATER STRUCT, V24, DOI 10.1088/0964-1726/24/2/025013; Krodel S, 2014, ADV ENG MATER, V16, P357, DOI 10.1002/adem.201300264; Landau D.P., 2015, GUIDE MONTE CARLO SI; Liebold-Ribeiro Y, 2014, ADV ENG MATER, V16, P328, DOI 10.1002/adem.201300064; Liu J, 2016, ADV MATER, V28, P6619, DOI 10.1002/adma.201600812; Liu JY, 2015, ACS NANO, V9, P1985, DOI 10.1021/nn507003z; Liu XH, 2013, ACS NANO, V7, P1495, DOI 10.1021/nn305282d; McDowell MT, 2013, ADV MATER, V25, P4966, DOI 10.1002/adma.201301795; Meza LR, 2014, SCIENCE, V345, P1322, DOI 10.1126/science.1255908; Nix WD, 1999, J MATER RES, V14, P3467, DOI 10.1557/JMR.1999.0468; NOWAK U, 1992, PHYS REV B, V46, P8329, DOI 10.1103/PhysRevB.46.8329; Obrovac MN, 2014, CHEM REV, V114, P11444, DOI 10.1021/cr500207g; Overvelde JTB, 2017, NATURE, V541, P347, DOI 10.1038/nature20824; Restrepo D, 2015, EXTREME MECH LETT, V4, P52, DOI 10.1016/j.eml.2015.08.001; SAHNI PS, 1983, PHYS REV B, V28, P2705, DOI 10.1103/PhysRevB.28.2705; Shan SC, 2015, ADV MATER, V27, P4296, DOI 10.1002/adma.201501708; Shokef Y, 2011, P NATL ACAD SCI USA, V108, P11804, DOI 10.1073/pnas.1014915108; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Susstrunk R, 2016, P NATL ACAD SCI USA, V113, pE4767, DOI 10.1073/pnas.1605462113; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Wang Y, 2008, SENSORS-BASEL, V8, P2043, DOI 10.3390/s8042043; Wu H, 2012, NAT NANOTECHNOL, V7, P309, DOI [10.1038/nnano.2012.35, 10.1038/NNANO.2012.35]; Xia XX, 2016, ACS ENERGY LETT, V1, P492, DOI 10.1021/acsenergylett.6b00256	49	99	102	26	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					205	+		10.1038/s41586-019-1538-z	http://dx.doi.org/10.1038/s41586-019-1538-z			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX0XA	31511685				2022-12-28	WOS:000485415400044
J	Dyer, O				Dyer, Owen			Dutch physician sues FDA for blocking her abortion services in United States	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		US Food and Drug Administration, 2019, WARN LETT	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2019	366								l5511	10.1136/bmj.l5511	http://dx.doi.org/10.1136/bmj.l5511			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MQ	31511224				2022-12-28	WOS:000486649100006
J	Hayes, DF				Hayes, Daniel F.			HER2 and Breast Cancer - A Phenomenal Success Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AMPLIFICATION; ANTIBODY	The 2019 Lasker-DeBakey Clinical Medical Research Award goes to scientists whose work on the human epidermal growth factor receptor 2 in breast cancer launched a new era in clinical research and the practice of oncology.	[Hayes, Daniel F.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hayes, DF (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.		Hayes, Daniel/ABE-1129-2020					Carpenter G, 1978, Natl Cancer Inst Monogr, P149; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Wolff AC, 2018, ARCH PATHOL LAB MED, V142, P1364, DOI [10.5858/arpa.2018-0902-SA, 10.1200/JCO.2018.77.8738]	8	61	63	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1284	1286		10.1056/NEJMcibr1909386	http://dx.doi.org/10.1056/NEJMcibr1909386			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC5OT	31502769				2022-12-28	WOS:000489333500015
J	Makin, S				Makin, Simon			A smarter way to treat	NATURE			English	Editorial Material																		Bonacini M, 2018, OPEN FORUM INFECT DI, V5, pS656, DOI [10.1093/ofid/ofy210.1873, DOI 10.1093/OFID/OFY210.1873]; Hafezi H, 2015, IEEE T BIO-MED ENG, V62, P99, DOI 10.1109/TBME.2014.2341272; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Sepah S. C, 2017, BMJ OPEN DIAB RES CA, V5	4	11	13	4	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					S106	S109		10.1038/d41586-019-02873-1	http://dx.doi.org/10.1038/d41586-019-02873-1			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31554990	Bronze			2022-12-28	WOS:000488247600015
J	Sah, R; Neupane, S				Sah, Ranjit; Neupane, Samikshya			Diphtheria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 14-year-old girl presented with fever, neck swelling, and a grayish-white membrane in the oropharynx. A throat culture grew Corynebacterium diphtheriae.	[Sah, Ranjit; Neupane, Samikshya] Tribhuvan Univ Teaching Hosp, Kathmandu, Nepal	Tribhuvan University; Institute of Medicine (IoM) - Nepal	Sah, R (corresponding author), Tribhuvan Univ Teaching Hosp, Kathmandu, Nepal.	ranjitsah57@gmail.com	sah, Ranjit/T-5865-2018	sah, Ranjit/0000-0002-2695-8714					0	1	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1267	1267		10.1056/NEJMicm1814405	http://dx.doi.org/10.1056/NEJMicm1814405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC5OT	31553838				2022-12-28	WOS:000489333500011
J	Gum, AM; Epstein-Lubow, GP; Gaudiano, BA; Wittink, M; Horvath, C				Gum, Amber M.; Epstein-Lubow, Gary P.; Gaudiano, Brandon A.; Wittink, Marsha; Horvath, Carol			Brief behaviour change strategies for distressed patients in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANXIETY DISORDERS; DEPRESSION; METAANALYSIS; PREVALENCE; THERAPY		[Gum, Amber M.] Univ S Florida, Louis de la Parte Florida Mental Hlth Inst, Dept Mental Hlth Law & Policy, Tampa, FL 33620 USA; [Epstein-Lubow, Gary P.; Gaudiano, Brandon A.] Brown Univ, Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Epstein-Lubow, Gary P.] Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA; [Epstein-Lubow, Gary P.; Gaudiano, Brandon A.] Butler Hosp, Psychosocial Res Program, Providence, RI 02906 USA; [Gaudiano, Brandon A.] Brown Univ, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA; [Wittink, Marsha] Univ Rochester, Sch Med, Dept Psychiat, Rochester, NY 14627 USA; [Wittink, Marsha] Univ Rochester, Sch Med, Dept Family Med, Rochester, NY 14627 USA	State University System of Florida; University of South Florida; Brown University; Brown University; Butler Hospital Rhode Island; Brown University; University of Rochester; University of Rochester	Gum, AM (corresponding author), Univ S Florida, Louis de la Parte Florida Mental Hlth Inst, Dept Mental Hlth Law & Policy, Tampa, FL 33620 USA.	ambergum@usf.edu			University of Washington AIMS Center	University of Washington AIMS Center	All authors have completed declarations of interests and declare: the lead author has received funds from the University of Washington AIMS Center to train primary care providers in problem-solving therapy, a type of brief goal-focused therapy cited in this manuscript. The authors further declare: no support from any organisation for the submitted work; no other financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	Bertholet N, 2005, ARCH INTERN MED, V165, P986, DOI 10.1001/archinte.165.9.986; Dowrick C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7140; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Geraghty AWA, 2017, HEALTH-LONDON, V21, P295, DOI 10.1177/1363459316674786; Harkin B, 2016, PSYCHOL BULL, V142, P198, DOI 10.1037/bul0000025; Huguet A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154248; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P237, DOI 10.1016/0163-8343(92)90094-Q; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Linde K, 2015, ANN FAM MED, V13, P56, DOI 10.1370/afm.1719; Manzoni GM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-41; McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757; National Collaborating Centre for Mental Health. (commissioned by the National Institute for Health and Clinical Excellence), 2011, COMM MENT HLTH PROBL; National Collaborating Centre for Mental Health commissioned by the National Institute for Health and Clinical Excellence (NICE), 2018, DEPR TREATM MAN DEPR; Opie RS, 2015, PUBLIC HEALTH NUTR, V18, P2074, DOI 10.1017/S1368980014002614; Rathert C, 2013, MED CARE RES REV, V70, P351, DOI 10.1177/1077558712465774; Ryan C, 2016, WAR POLIT EXP, P3; Schuch FB, 2016, J PSYCHIATR RES, V77, P42, DOI 10.1016/j.jpsychires.2016.02.023; Sherwin HN, 2013, CAN FAM PHYSICIAN, V59, P479; SINYOR M, 2016, BMJ-BRIT MED J, V352, P1617; Wiegner L, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0252-7; Wittink MN, 2018, PATIENT EDUC COUNS, V101, P214, DOI 10.1016/j.pec.2017.08.004; Wu JQ, 2015, JAMA INTERN MED, V175, P1461, DOI 10.1001/jamainternmed.2015.3006; Zhang AA, 2018, J AM BOARD FAM MED, V31, P139, DOI 10.3122/jabfm.2018.01.170270; Zimmerman M, 2012, PSYCHOTHER PSYCHOSOM, V81, P329, DOI 10.1159/000342262	25	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5360	10.1136/bmj.l5360	http://dx.doi.org/10.1136/bmj.l5360			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JB3WV	31551248				2022-12-28	WOS:000488488300001
J	Henderson, JT; Webber, EM; Bean, SI				Henderson, Jillian T.; Webber, Elizabeth M.; Bean, Sarah, I			Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLOSTRIDIUM-DIFFICILE INFECTION; ANTIMICROBIAL TREATMENT; PRETERM BIRTH; PREGNANCY; PYELONEPHRITIS; METAANALYSIS; CARDIFF; WALES; WOMEN	ImportanceScreening for asymptomatic bacteriuria can identify patients for whom treatment might be beneficial for preventing symptomatic infection and other health outcomes. ObjectiveTo systematically review benefits and harms of asymptomatic bacteriuria screening and treatment in adults, including during pregnancy, to inform the US Preventive Services Task Force. Data SourcesMEDLINE, PubMed (publisher-supplied records), and Cochrane Collaboration Central Registry of Controlled Trials; surveillance through May 24, 2019. Study SelectionRandomized clinical trials (RCTs) and observational studies on benefits and harms of screening for asymptomatic bacteriuria; RCTs on benefits and harms of asymptomatic bacteriuria treatment. Eligible populations included unselected, asymptomatic individuals without known urinary tract conditions. Data Extraction and SynthesisIndependent critical appraisal and data abstraction by 2 reviewers. Random-effects meta-analysis was conducted to estimate benefits of the interventions. Main Outcomes and MeasuresSymptomatic infection; function, morbidity, mortality; pregnancy complications and birth outcomes. ResultsNineteen studies (N=8443) meeting inclusion criteria were identified. Two cohort studies (n=5289) found fewer cases of pyelonephritis in the cohorts of screened pregnant women (0.5%) than within retrospective comparisons of unscreened cohorts (2.2% and 1.8%); the larger study estimated a statistically significant relative risk of 0.30 (95% CI, 0.15-0.60). No studies examined screening in nonpregnant populations. Among 12 trials of asymptomatic bacteriuria screening and treatment during pregnancy (n=2377; 1 conducted within past 30 years), there were reduced rates of pyelonephritis (range, 0%-16.5% for the intervention group and 2.2%-36.4% for the control group; pooled risk ratio [RR], 0.24 [95% CI, 0.14-0.40]; 12 trials) and low birth weight (range, 2.5%-14.8% for the intervention group and 6.7%-21.4% for the control group; pooled RR, 0.64 [95% CI, 0.46-0.90]; 7 trials). There was no significant difference in infant mortality (pooled RR, 0.98 [95% CI, 0.29-3.26]; 6 trials). Five RCTs of asymptomatic bacteriuria treatment in nonpregnant adults (n=777) did not report any significant differences in risk of infection, mobility, or mortality. Limited evidence on harms of screening or treatment was available, and no statistically significant differences were identified. Conclusions and RelevanceScreening and treatment for asymptomatic bacteriuria during pregnancy was associated with reduced rates of pyelonephritis and low birth weights, but the available evidence was not current, with only 1 study conducted in the past 30 years. Benefits of asymptomatic bacteriuria treatment in nonpregnant adult populations were not found. Trial evidence on harms of asymptomatic bacteriuria antibiotic treatment was limited. This systematic review to support the 2019 US Preventive Services Task Force Recommendation Statement on screening for asymptomatic bacteriuria in adults summarizes published evidence on the benefits and harms of asymptomatic bacteriuria screening and treatment in adults, including during pregnancy.	[Henderson, Jillian T.; Webber, Elizabeth M.; Bean, Sarah, I] Kaiser Permanente, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR USA	Kaiser Permanente	Henderson, JT (corresponding author), Kaiser Permanente Northwest, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	Jillian.T.Henderson@kpchr.org			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2015-00007-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2015-00007-I, Task Order 3, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the US Preventive Services Task Force (USPSTF).	ABRUTYN E, 1994, ANN INTERN MED, V120, P827, DOI 10.7326/0003-4819-120-10-199405150-00003; Antunes-Lopes T, 2020, EUR UROL FOCUS, V6, P361, DOI 10.1016/j.euf.2018.09.011; ASSCHER AW, 1969, J INFECT DIS, V120, P17, DOI 10.1093/infdis/120.1.17; BOSCIA JA, 1987, JAMA-J AM MED ASSOC, V257, P1067, DOI 10.1001/jama.257.8.1067; BRUMFITT W, 1975, KIDNEY INT, V8, pS113; Calonge N, 2008, ANN INTERN MED, V149, P43, DOI 10.7326/0003-4819-149-1-200807010-00009; Canadian Task Force on Preventive Health Care (CTFPHC), 2018, AS BACT PREGN; Cozar-Llisto A, 2016, INFECT DIS THER, V5, P253, DOI 10.1007/s40121-016-0124-z; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; DUFF P, 1984, CLIN OBSTET GYNECOL, V27, P17, DOI 10.1097/00003081-198403000-00006; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELDER HA, 1971, AM J OBSTET GYNECOL, V111, P441, DOI 10.1016/0002-9378(71)90793-9; FOLEY ME, 1987, BRIT MED J, V295, P270, DOI 10.1136/bmj.295.6592.270; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; FURNESS ET, 1975, NEW ZEAL MED J, V81, P417; Giamarellou H, 1998, CLIN DRUG INVEST, V15, P187, DOI 10.2165/00044011-199815030-00003; GOLD EM, 1966, OBSTET GYNECOL, V27, P206; GRATACOS E, 1994, J INFECT DIS, V169, P1390, DOI 10.1093/infdis/169.6.1390; Harding GKM, 2002, NEW ENGL J MED, V347, P1576, DOI 10.1056/NEJMoa021042; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hill JB, 2005, OBSTET GYNECOL, V105, P18, DOI 10.1097/01.AOG.0000149154.96285.a0; Kazemier BM, 2015, LANCET INFECT DIS, V15, P1324, DOI 10.1016/S1473-3099(15)00070-5; KINCAIDSMITH P, 1965, LANCET, V1, P395; Kuntz JL, 2010, INFECT CONT HOSP EP, V31, P532, DOI 10.1086/652454; Lin K, 2008, ANN INTERN MED, V149, pW20, DOI 10.7326/0003-4819-149-1-200807010-00009-w1; LITTLE PJ, 1966, LANCET, V2, P925; Matuszkiewicz-Rowinska J, 2015, ARCH MED SCI, V11, P67, DOI 10.5114/aoms.2013.39202; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P597, DOI 10.1016/0002-9378(95)90288-0; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P590, DOI 10.1016/0002-9378(95)90287-2; Nicolle LE, 2003, INFECT DIS CLIN N AM, V17, P367, DOI 10.1016/S0891-5520(03)00008-4; Nicolle LE, 2019, CLIN INFECT DIS, V68, P1611, DOI [10.1093/cid/ciz021, 10.1093/cid/ciy1121]; PATHAK UN, 1969, J INFECT DIS, V120, P91, DOI 10.1093/infdis/120.1.91; Ruiter-Ligeti J, 2018, OBSTET GYNECOL, V131, P387, DOI 10.1097/AOG.0000000000002422; Sanchez GV, 2016, MMWR RECOMM REP, V65, DOI 10.15585/mmwr.rr6506a1; SAVAGE WE, 1967, MEDICINE, V46, P385, DOI 10.1097/00005792-196709000-00002; Schnarr J, 2008, EUR J CLIN INVEST, V38, P50, DOI 10.1111/j.1365-2362.2008.02009.x; Smaill FM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub3; Uncu Y, 2002, Clin Exp Obstet Gynecol, V29, P281; US Preventive Services Task Force, 2004, SCREEN AS BACT REC S; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Wells G., NEWCASTLE OTTAWA SCA; WILLIAMS GL, 1969, BRIT MED J, V3, P212, DOI 10.1136/bmj.3.5664.212; Wing DA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.006; WREN BG, 1969, MED J AUSTRALIA, V2, P596, DOI 10.5694/j.1326-5377.1969.tb107290.x	45	18	18	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1195	1205		10.1001/jama.2019.10060	http://dx.doi.org/10.1001/jama.2019.10060			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550037	Bronze			2022-12-28	WOS:000488822800026
J	Keuss, SE; Bowen, J; Schott, JM				Keuss, Sarah Elisabeth; Bowen, John; Schott, Jonathan M.			Looking beyond the eyes: visual impairment in posterior cortical atrophy	LANCET			English	Editorial Material									[Keuss, Sarah Elisabeth; Bowen, John; Schott, Jonathan M.] UCL Queen Sq Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat, London WC1N 3BG, England	University of London; University College London	Schott, JM (corresponding author), UCL Queen Sq Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat, London WC1N 3BG, England.	j.schott@ucl.ac.uk	Schott, Jonathan M/A-9065-2011	Schott, Jonathan M/0000-0003-2059-024X					0	1	1	2	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					1055	1055		10.1016/S0140-6736(19)31818-5	http://dx.doi.org/10.1016/S0140-6736(19)31818-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31544747	Green Submitted			2022-12-28	WOS:000487038700032
J	Hamant, O; Saunders, T; Viasnoff, V				Hamant, Olivier; Saunders, Timothy; Viasnoff, Virgile			Celebrate sustainable travel at conferences	NATURE			English	Editorial Material									[Hamant, Olivier] Natl Inst Agr Res INRA, Plant Reprod & Dev Lab, Lyon, France; [Saunders, Timothy; Viasnoff, Virgile] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore; [Saunders, Timothy] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Viasnoff, Virgile] Natl Univ Singapore, CNRS, Singapore, Singapore	INRAE; National University of Singapore; National University of Singapore; National University of Singapore	Hamant, O (corresponding author), Natl Inst Agr Res INRA, Plant Reprod & Dev Lab, Lyon, France.	dbsste@nus.edu.sg	viasnoff, virgile/H-8832-2012	viasnoff, virgile/0000-0003-3949-2244; Hamant, Olivier/0000-0001-6906-6620				Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Grant C, 2018, ETHNOMUSICOL FORUM, V27, P123, DOI 10.1080/17411912.2018.1503063; Rozen J., 2017, NATURE, V546, P565; Steffen W, 2018, P NATL ACAD SCI USA, V115, P8252, DOI 10.1073/pnas.1810141115	5	13	13	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					451	452		10.1038/d41586-019-02747-6	http://dx.doi.org/10.1038/d41586-019-02747-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31527779	Green Submitted			2022-12-28	WOS:000486647800057
J	Maertens, J; Cordonnier, C; Jaksch, P; Poire, X; Uknis, M; Wu, JY; Wijatyk, A; Saliba, F; Witzke, O; Villano, S				Maertens, Johan; Cordonnier, Catherine; Jaksch, Peter; Poire, Xavier; Uknis, Marc; Wu, Jingyang; Wijatyk, Anna; Saliba, Faouzi; Witzke, Oliver; Villano, Stephen			Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DRUG-RESISTANT CYTOMEGALOVIRUS; LUNG-TRANSPLANT RECIPIENTS; GANCICLOVIR-RESISTANT; DOUBLE-BLIND; ORAL MARIBAVIR; RISK-FACTORS; INFECTION; DISEASE; PREVENTION; MANAGEMENT	Background Maribavir is a benzimidazole riboside with activity against cytomegalovirus (CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in transplant recipients is not known. Methods In a phase 2, open-label, maribavir dose-blinded trial, recipients of hematopoietic-cell or solid-organ transplants (>= 18 years of age, with CMV reactivation [1000 to 100,000 DNA copies per milliliter]) were randomly assigned to receive maribavir at a dose of 400, 800, or 1200 mg twice daily or the standard dose of valganciclovir for no more than 12 weeks. The primary efficacy end point was the percentage of patients with a response to treatment, defined as confirmed undetectable CMV DNA in plasma, within 3 weeks and 6 weeks after the start of treatment. The primary safety end point was the incidence of adverse events that occurred or worsened during treatment. Results Of the 161 patients who underwent randomization, 159 received treatment, and 156 had postbaseline data available - 117 in the maribavir group and 39 in the valganciclovir group. The percentage of patients with postbaseline data available who had a response to treatment within 3 weeks was 62% among those who received maribavir and 56% among those who received valganciclovir. Within 6 weeks, 79% and 67% of patients, respectively, had a response (risk ratio, 1.20; 95% confidence interval, 0.95 to 1.51). The percentages of patients with a response to treatment were similar among the maribavir dose groups. Two patients who had a response to treatment had a recurrence of CMV infection within 6 weeks after starting maribavir at a dose of 800 mg twice daily; T409M resistance mutations in CMV UL97 protein kinase developed in both patients. The incidence of serious adverse events that occurred or worsened during treatment was higher in the maribavir group than in the valganciclovir group (52 of 119 patients [44%] vs. 13 of 40 [32%]). A greater percentage of patients in the maribavir group discontinued the trial medication because of an adverse event (27 of 119 [23%] vs. 5 of 40 [12%]). A higher incidence of gastrointestinal adverse events was reported with maribavir, and a higher incidence of neutropenia was reported with valganciclovir. Conclusions Maribavir at a dose of at least 400 mg twice daily had efficacy similar to that of valganciclovir for clearing CMV viremia among recipients of hematopoietic-cell or solid-organ transplants. A higher incidence of gastrointestinal adverse events - notably dysgeusia - and a lower incidence of neutropenia were found in the maribavir group.	[Maertens, Johan] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Hematol, Leuven, Belgium; [Poire, Xavier] Clin Univ St Luc, Sect Hematol, Brussels, Belgium; [Cordonnier, Catherine] Henri Mondor Hosp, AP HP, Dept Hematol, Creteil, France; [Cordonnier, Catherine] Univ Paris Est Creteil, Creteil, France; [Saliba, Faouzi] Hop Paul Brousse, AP HP, Villejuif, France; [Jaksch, Peter] Med Univ Vienna, Gen Hosp, Vienna, Austria; [Uknis, Marc; Villano, Stephen] Shire, Wayne, PA USA; [Wu, Jingyang; Wijatyk, Anna] Shire, Lexington, MA USA; [Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Infect Dis, Essen, Germany	KU Leuven; University Hospital Leuven; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Medical University of Vienna; Shire Pharmaceuticals Limited; Shire Pharmaceuticals Limited; University of Duisburg Essen	Maertens, J (corresponding author), Univ Ziekenhuizen Leuven, Dept Hematol, Herestr 49, B-3000 Leuven, Belgium.	johan.maertens@uzleuven.be		jaksch, peter/0000-0003-4635-3242; Uknis, Marc/0000-0001-5434-9564	ViroPharma/Shire Development; EudraCT [2010-024247-32]	ViroPharma/Shire Development; EudraCT	Funded by ViroPharma/Shire Development; EudraCT number, 2010-024247-32.	Alain S, 2013, TRANSPL P, V45, P1603, DOI 10.1016/j.transproceed.2013.01.082; [Anonymous], 2015, VAL SUMM PROD CHAR; Avery RK, 2010, TRANSPL INFECT DIS, V12, P489, DOI 10.1111/j.1399-3062.2010.00550.x; Avery RK, 2016, TRANSPLANTATION, V100, pE74, DOI 10.1097/TP.0000000000001418; Biron KK, 2002, ANTIMICROB AGENTS CH, V46, P2365, DOI 10.1128/AAC.46.8.2365-2372.2002; de la Torre-Cisneros J, 2011, ENFERM INFEC MICR CL, V29, P735, DOI 10.1016/j.eimc.2011.05.022; Drew WL, 2006, J CLIN VIROL, V37, P124, DOI 10.1016/j.jcv.2006.07.010; Eid AJ, 2008, CLIN TRANSPLANT, V22, P162, DOI 10.1111/j.1399-0012.2007.00761.x; Emery V, 2013, BRIT J HAEMATOL, V162, P25, DOI 10.1111/bjh.12363; Falagas ME, 1998, TRANSPLANTATION, V66, P1020, DOI 10.1097/00007890-199810270-00010; Fisher CE, 2017, CLIN INFECT DIS, V65, P57, DOI 10.1093/cid/cix259; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Hantz S, 2010, J ANTIMICROB CHEMOTH, V65, P2628, DOI 10.1093/jac/dkq368; Jacobsen T, 2010, AM J HEALTH-SYST PH, V67, P1417, DOI 10.2146/ajhp090424; Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Krosky PM, 2003, J VIROL, V77, P905, DOI 10.1128/JVI.77.2.905-914.2003; Lalezari JP, 2002, ANTIMICROB AGENTS CH, V46, P2969, DOI 10.1128/AAC.46.9.2969-2976.2002; Limaye AP, 2002, J INFECT DIS, V185, P20, DOI 10.1086/338143; Limaye AP, 2000, LANCET, V356, P645, DOI 10.1016/S0140-6736(00)02607-6; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Ljungman P, 2011, HEMATOL ONCOL CLIN N, V25, P151, DOI 10.1016/j.hoc.2010.11.011; Martin-Gandul C, 2014, J INFECTION, V69, P500, DOI 10.1016/j.jinf.2014.07.001; Marty FM, 2011, LANCET INFECT DIS, V11, P284, DOI 10.1016/S1473-3099(11)70024-X; Minces LR, 2014, ANTIMICROB AGENTS CH, V58, P128, DOI 10.1128/AAC.00561-13; Panagou E, 2016, TRANSPL INFECT DIS, V18, P405, DOI 10.1111/tid.12542; Papanicolaou GA, 2019, CLIN INFECT DIS, V68, P1255, DOI 10.1093/cid/ciy706; Pescovitz MD, 2009, AM J TRANSPLANT, V9, P2324, DOI 10.1111/j.1600-6143.2009.02768.x; Razonable RR, 2013, AM J TRANSPLANT, V13, P93, DOI 10.1111/ajt.12103; Salzberger B, 1997, BLOOD, V90, P2502; San Juan R, 2008, CLIN INFECT DIS, V47, P875, DOI 10.1086/591532; Swan SK, 2007, J CLIN PHARMACOL, V47, P209, DOI 10.1177/0091270006296765; Teira P, 2016, BLOOD, V127, P2427, DOI 10.1182/blood-2015-11-679639; Wang LH, 2003, ANTIMICROB AGENTS CH, V47, P1334, DOI 10.1128/AAC.47.4.1334-1342.2003; Williams SL, 2003, ANTIMICROB AGENTS CH, V47, P2186, DOI 10.1128/AAC.47.7.2186-2192.2003; Winston DJ, 2012, AM J TRANSPLANT, V12, P3021, DOI 10.1111/j.1600-6143.2012.04231.x; Winston DJ, 2008, BLOOD, V111, P5403, DOI 10.1182/blood-2007-11-121558	37	52	58	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1136	1147		10.1056/NEJMoa1714656	http://dx.doi.org/10.1056/NEJMoa1714656			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ4PY	31532960	Bronze			2022-12-28	WOS:000487066900008
J	Miller, JF				Miller, Jacques F.			A Scientific Odyssey: Uncovering the Secrets of Thymus Function	CELL			English	Editorial Material									[Miller, Jacques F.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute	Miller, JF (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.								0	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					21	26		10.1016/j.cell.2019.08.023	http://dx.doi.org/10.1016/j.cell.2019.08.023			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31519307	Bronze			2022-12-28	WOS:000486618500005
J	Rosenbaum, L				Rosenbaum, Lisa			All In	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Before Joe, a psychiatry resident, was killed, distinguishing between work born of love and that born of duty was his life's theme. His struggle to practice medicine in a way that was meaningful to him may offer one antidote to the spiritual crisis of physician burnout.										Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023	2	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1099	1101		10.1056/NEJMp1908977	http://dx.doi.org/10.1056/NEJMp1908977			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4PY	31532958				2022-12-28	WOS:000487066900004
J	[Anonymous]				[Anonymous]			In poorly controlled type 2 diabetes, oral semaglutide was noninferior to liraglutide for reducing HbA(1c)	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In type 2 diabetes poorly controlled by metformin, does oral semaglutide reduce hemoglobin (Hb) A(1c) compared with subcutaneous liraglutide or placebo? Methods Design: Randomized placebo-controlled trial (Peptide Innovation for Early Diabetes Treatment [PIONEER] 4 trial). Clinical Trials. gov NCT02863419, EudraCT 2015-005210-30. Allocation: Concealed.* Blinding: Blinded* (patients and clinical center staff). Follow-up period: 52 weeks. Setting: 100 clinical centers in 12 countries. Patients: 711 adults >= 18 years of age (mean age 56 y, 52% men) who had type 2 diabetes and HbA(1c) 7.0% to 9.5%, and were receiving a stable dose of metformin (with or without a sodium - glucose cotransporter-2 [SGLT2] inhibitor). Exclusion criteria included estimated glomerular filtration rate < 60 mL/min/1.73 m(2), proliferative retinopathy or maculopathy requiring acute treatment, use of medication (other than metformin, an SGLT2 inhibitor, or short-term insulin) for diabetes or obesity in the past 90 days, or previous acute or chronic pancreatitis. Intervention: Oral semaglutide, maintenance dose 14 mg/d, plus subcutaneous placebo (n = 285), subcutaneous liraglutide, maintenance dose 1.8 mg/d, plus oral placebo (n = 284), or oral plus subcutaneous placebos (n = 142), once daily. Outcomes: Change in HbA(1c) at 26 weeks. Secondary outcomes included change in HbA(1c) at 52 weeks and change in weight at 26 and 52 weeks. The prespecified noninferiority limit for the primary outcome was 0.4 (upper limit of the 2-sided 95% CI around the mean difference between groups). Patient follow-up: 96% (intention-to-treat analysis). Main results The results are in the Table. Conclusion In type 2 diabetes poorly controlled by metformin, oral semaglutide was noninferior to subcutaneous liraglutide and superior to placebo for reducing hemoglobin A(1c) levels at 26 weeks.						Lipscombe, Lorraine/0000-0001-7412-7993					0	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC29	JC29		10.7326/ACPJ201909170-029	http://dx.doi.org/10.7326/ACPJ201909170-029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525763				2022-12-28	WOS:000486101400005
J	Magliano, DJ; Islam, RM; Barr, ELM; Gregg, EW; Pavkov, ME; Harding, JL; Tabesh, M; Koye, DN; Shaw, JE				Magliano, Dianna J.; Islam, Rakibul M.; Barr, Elizabeth L. M.; Gregg, Edward W.; Pavkov, Meda E.; Harding, Jessica L.; Tabesh, Maryam; Koye, Digsu N.; Shaw, Jonathan E.			Trends in incidence of total or type 2 diabetes: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LIFE-STYLE INTERVENTION; UNITED-STATES; INCREASING INCIDENCE; POOLED ANALYSIS; PREVALENCE; POPULATION; MORTALITY; MELLITUS; ADULTS; OBESITY	OBJECTIVE To assess what proportions of studies reported increasing, stable, or declining trends in the incidence of diagnosed diabetes. DESIGN Systematic review of studies reporting trends of diabetes incidence in adults from 1980 to 2017 according to PRISMA guidelines. DATA SOURCES Medline, Embase, CINAHL, and reference lists of relevant publications. ELIGIBILITY CRITERIA Studies of open population based cohorts, diabetes registries, and administrative and health insurance databases on secular trends in the incidence of total diabetes or type 2 diabetes in adults were included. Poisson regression was used to model data by age group and year. RESULTS Among the 22 833 screened abstracts, 47 studies were included, providing data on 121 separate sex specific or ethnicity specific populations; 42 (89%) of the included studies reported on diagnosed diabetes. In 1960-89, 36% (8/22) of the populations studied had increasing trends in incidence of diabetes, 55% (12/22) had stable trends, and 9% (2/22) had decreasing trends. In 1990-2005, diabetes incidence increased in 66% (33/50) of populations, was stable in 32% (16/50), and decreased in 2% (1/50). In 2006-14, increasing trends were reported in only 33% (11/33) of populations, whereas 30% (10/33) and 36% (12/33) had stable or declining incidence, respectively. CONCLUSIONS The incidence of clinically diagnosed diabetes has continued to rise in only a minority of populations studied since 2006, with over a third of populations having a fall in incidence in this time period. Preventive strategies could have contributed to the fall in diabetes incidence in recent years. Data are limited in low and middle income countries, where trends in diabetes incidence could be different.	[Magliano, Dianna J.; Islam, Rakibul M.; Barr, Elizabeth L. M.; Tabesh, Maryam; Koye, Digsu N.; Shaw, Jonathan E.] Baker Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Magliano, Dianna J.; Islam, Rakibul M.; Tabesh, Maryam; Koye, Digsu N.; Shaw, Jonathan E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Gregg, Edward W.; Pavkov, Meda E.; Harding, Jessica L.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; [Gregg, Edward W.] Imperial Coll London, Sch Publ Hlth Epidemiol & Biostat, London, England	Monash University; Centers for Disease Control & Prevention - USA; Imperial College London	Magliano, DJ (corresponding author), Baker Heart & Diabet Inst, Melbourne, Vic 3004, Australia.; Magliano, DJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia.	dianna.magliano@baker.edu.au		Magliano, Dianna/0000-0002-9507-6096; Gregg, Edward/0000-0003-2381-6822; harding, jessica/0000-0002-6664-8630	CDC	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the CDC. The researchers were independent from the funders.	Abouzeid M, 2015, EUR J EPIDEMIOL, V30, P649, DOI 10.1007/s10654-015-0008-7; Abraham TM, 2015, DIABETES CARE, V38, P482, DOI 10.2337/dc14-1432; Akushevich I, 2013, AGE AGEING, V42, P494, DOI 10.1093/ageing/aft032; Alangh A, 2013, DIABETES CARE, V36, P3015, DOI 10.2337/dc13-0052; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1169; Berger B, 1999, DIABETES CARE, V22, P773, DOI 10.2337/diacare.22.5.773; Blanchard JF, 1996, DIABETES CARE, V19, P807, DOI 10.2337/diacare.19.8.807; Boehme MWJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2188-1; Bolt-Evensen K, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0646-8; Brand-Miller JC, 2017, AM J CLIN NUTR, V105, P854, DOI 10.3945/ajcn.116.145318; Bromley C, 2013, SCOTTISH HLTH SURVEY; Burke JP, 2002, AM J EPIDEMIOL, V155, P859, DOI 10.1093/aje/155.9.859; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Sousa-Uva M, 2016, PRIM CARE DIABETES, V10, P329, DOI 10.1016/j.pcd.2016.05.003; Dietz WH, 2015, HEALTH AFFAIR, V34, P1456, DOI 10.1377/hlthaff.2015.0371; DOWSE GK, 1991, AM J EPIDEMIOL, V133, P1093, DOI 10.1093/oxfordjournals.aje.a115822; Dyck R, 2010, CAN MED ASSOC J, V182, P249, DOI 10.1503/cmaj.090846; Ely EK, 2017, DIABETES CARE, V40, P1331, DOI 10.2337/dc16-2099; Evans JMM, 2007, DIABETOLOGIA, V50, P729, DOI 10.1007/s00125-006-0585-9; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6; Green A, 2015, CLIN EPIDEMIOL, V7, P421, DOI 10.2147/CLEP.S88577; Green C, 2003, DIABETES CARE, V26, P1993, DOI 10.2337/diacare.26.7.1993; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Holden SE, 2013, DIABETES OBES METAB, V15, P844, DOI 10.1111/dom.12123; Horn OK, 2007, CAN J PUBLIC HEALTH, V98, P438, DOI 10.1007/BF03405434; Huber CA, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-44; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Jansson SPO, 2007, DIABETOLOGIA, V50, P703, DOI 10.1007/s00125-007-0593-4; Jansson SPO, 2015, DIABETIC MED, V32, P1319, DOI 10.1111/dme.12716; Joinpoint Regression Program, 2018, 4 6 0 0 VERS STAT ME; Karpati T, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0032-y; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koo BK, 2015, J DIABETES, V7, P465, DOI 10.1111/1753-0407.12202; LAAKSO M, 1991, AM J EPIDEMIOL, V133, P850, DOI 10.1093/oxfordjournals.aje.a115965; Lim HJ, 2018, J ACAD NUTR DIET, V118, P1228, DOI 10.1016/j.jand.2017.08.001; Lin Cheng-Chieh, 2013, BMC Public Health, V13, P318, DOI 10.1186/1471-2458-13-318; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Liu Meina, 2007, Prim Care Diabetes, V1, P123, DOI 10.1016/j.pcd.2007.05.001; Lorenzo C, 2010, DIABETES CARE, V33, P335, DOI 10.2337/dc09-1357; McBean AM, 2004, DIABETES CARE, V27, P2317, DOI 10.2337/diacare.27.10.2317; MICHAELIS D, 1993, DIABETES METAB, V19, P110; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Monesi L, 2012, DIABETIC MED, V29, P385, DOI 10.1111/j.1464-5491.2011.03446.x; Narayanan ML, 2010, INT J CIRCUMPOL HEAL, V69, P236, DOI 10.3402/ijch.v69i3.17618; Ng SW, 2014, AM J CLIN NUTR, V99, P609, DOI 10.3945/ajcn.113.072892; Nichols GA, 2015, AM J EPIDEMIOL, V181, P32, DOI 10.1093/aje/kwu255; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oster RT, 2011, CAN MED ASSOC J, V183, pE803, DOI 10.1503/cmaj.101882; Park S, 2016, MMWR-MORBID MORTAL W, V65, P169, DOI 10.15585/mmwr.mm6507a1; Pavkov ME, 2007, DIABETES CARE, V30, P1758, DOI 10.2337/dc06-2010; Qiao Q, 2010, PRIM CARE DIABETES, V4, P99, DOI 10.1016/j.pcd.2010.04.003; Quan J, 2017, DIABETIC MED, V34, P902, DOI 10.1111/dme.13284; Rasmussen SS, 2016, DIABETOLOGIA, V59, P989, DOI 10.1007/s00125-016-3887-6; Read SH, 2016, DIABETOLOGIA, V59, P2106, DOI 10.1007/s00125-016-4054-9; Ringborg A, 2008, DIABETIC MED, V25, P1178, DOI 10.1111/j.1464-5491.2008.02541.x; Ruwaard D, 1996, DIABETES CARE, V19, P214, DOI 10.2337/diacare.19.3.214; Ryan R, 2005, PUBLIC HEALTH, V119, P892, DOI 10.1016/j.puhe.2005.03.011; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; Schmittdiel JA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120146; Selvin E, 2017, DIABETES CARE, V40, P1139, DOI 10.2337/dc16-2442; Soderberg S, 2004, J INTERN MED, V256, P37, DOI 10.1111/j.1365-2796.2004.01336.x; Song SO, 2016, DIABETES METAB J, V40, P35, DOI 10.4093/dmj.2016.40.1.35; Strom H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-520; Tabaei BP, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110320; Troughton J, 2016, J PUBLIC HEALTH-UK, V38, P493, DOI 10.1093/pubmed/fdv110; Tseng CH, 2006, DIABETOLOGIA, V49, P1755, DOI 10.1007/s00125-006-0314-4; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vilbergsson S, 1997, DIABETIC MED, V14, P491, DOI 10.1002/(SICI)1096-9136(199706)14:6<491::AID-DIA365>3.0.CO;2-1; Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422; Wells G., 2014, S SYST REV BAS; Weng W, 2016, DIABETES RES CLIN PR, V117, P111, DOI 10.1016/j.diabres.2016.04.043; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zghebi SS, 2017, DIABETES OBES METAB, V19, P1537, DOI 10.1111/dom.12964; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	83	110	112	11	57	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2019	366								15003	10.1136/bmj.l5003	http://dx.doi.org/10.1136/bmj.l5003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY8MQ	31511236	Green Published, hybrid			2022-12-28	WOS:000486649100001
J	Moberly, T				Moberly, Tom			Cyclists stage climate protest "die-in"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item												tmoberly@bmj.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5507	10.1136/bmj.l5507	http://dx.doi.org/10.1136/bmj.l5507			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506276				2022-12-28	WOS:000486648900018
J	Iacobucci, G				Iacobucci, Gareth			Cash strapped CCGs ask GPs not to refer some patients to hospital	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5484	10.1136/bmj.l5484	http://dx.doi.org/10.1136/bmj.l5484			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501089				2022-12-28	WOS:000486648500009
J	Winkler, MBL; Kidmose, RT; Szomek, M; Thaysen, K; Rawson, S; Muench, SP; Wustner, D; Pedersen, BP				Winkler, Mikael B. L.; Kidmose, Rune T.; Szomek, Maria; Thaysen, Katja; Rawson, Shaun; Muench, Stephen P.; Wustner, Daniel; Pedersen, Bjorn Panyella			Structural Insight into Eukaryotic Sterol Transport through Niemann-Pick Type C Proteins	CELL			English	Article							BINDING PROTEIN; SENSING DOMAIN; SACCHAROMYCES-CEREVISIAE; CHOLESTEROL TRANSFER; CRYSTAL-STRUCTURES; NPC1; MEMBRANE; REQUIRES; REVEALS; GENE	Niemann-Pick type C (NPC) proteins are essential for sterol homeostasis, believed to drive sterol integration into the lysosomal membrane before redistribution to other cellular membranes. Here, using a combination of crystallography, cryo-electron microscopy, and biochemical and in vivo studies on the Saccharomyces cerevisiae NPC system (NCR1 and NPC2), we present a framework for sterol membrane integration. Sterols are transferred between hydrophobic pockets of vacuolar NPC2 and membrane-protein NCR1. NCR1 has its N-terminal domain (NTD) positioned to deliver a sterol to a tunnel connecting NTD to the luminal membrane leaflet 50 angstrom away. A sterol is caught inside this tunnel during transport, and a proton-relay network of charged residues in the transmembrane region is linked to this tunnel supporting a proton-driven transport mechanism. We propose a model for sterol integration that clarifies the role of NPC proteins in this essential eukaryotic pathway and that rationalizes mutations in patients with Niemann-Pick disease type C.	[Winkler, Mikael B. L.; Kidmose, Rune T.; Pedersen, Bjorn Panyella] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark; [Szomek, Maria; Thaysen, Katja; Wustner, Daniel] Univ Southern Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark; [Rawson, Shaun; Muench, Stephen P.] Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Rawson, Shaun; Muench, Stephen P.] Univ Leeds, Astbury Ctr Struct & Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Pedersen, Bjorn Panyella] Aarhus Univ, Aarhus Inst Adv Studies, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark; [Rawson, Shaun] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Aarhus University; University of Southern Denmark; University of Leeds; University of Leeds; Aarhus University; Harvard University; Harvard Medical School	Pedersen, BP (corresponding author), Aarhus Univ, Aarhus Inst Adv Studies, Hoegh Guldbergs Gade 6B, DK-8000 Aarhus C, Denmark.	bpp@mbg.au.dk	Pedersen, Bjørn/AAT-2409-2021	Pedersen, Bjørn/0000-0001-7860-7230; Winkler, Mikael Becher Lykkegaard/0000-0003-0675-7824; Wustner, Daniel/0000-0003-4995-9709; Rawson, Shaun/0000-0002-2973-2630	Wellcome Trust [108466/Z/15/Z]; iNEXT [5538]; European Research Council [637372]; Danish Council for Independent Research [DFF-4002-00052, DFF - 7014-00054]; Carlsberg Foundation [CF17-0180]; AIAS fellowship; Wellcome Trust ISSF fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); iNEXT; European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); AIAS fellowship; Wellcome Trust ISSF fellowship(Wellcome Trust)	The authors acknowledge beamlines I24, I04-1, and I04 at the Diamond Light Source, where X-ray data were collected, and Max IV Laboratory, DESY-PETRA III, ESRF, and the Swiss Light Source for screening. Final EM data were collected at the Astbury Biostructure Laboratory, supported through the Wellcome Trust (108466/Z/15/Z). Grid screening and data collections were supported by iNEXT (5538) and done at the eBIC facility at Diamond Light Source and the Core Facility for Integrated Microscopy, Faculty of Health and Medical Sciences, University of Copenhagen, and the Aarhus University Cryo-EM facility. The Villum Center for Bioanalytical Sciences is acknowledged for confocal microscopy instrumentation support. Anita Lunding (BMB, SDU) is thanked for technical assistance. Research was supported by funding from the European Research Council (grant agreement no. 637372), the Danish Council for Independent Research (grant agreement no. DFF-4002-00052), the Carlsberg Foundation (CF17-0180), and an AIAS fellowship to B.P.P., a Wellcome Trust ISSF fellowship to S.R., and the Danish Council for Independent Research (grant agreement no. DFF - 7014-00054) to D.W.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adebali O, 2016, GENET MED, V18, P1029, DOI 10.1038/gim.2015.208; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Berger AC, 2005, EUKARYOT CELL, V4, P1851, DOI 10.1128/EC.4.11.1851-1862.2005; Berger AC, 2005, TRAFFIC, V6, P907, DOI 10.1111/j.1600-0854.2005.00327.x; Bidet M, 2012, MOL CANCER RES, V10, P1496, DOI 10.1158/1541-7786.MCR-11-0578; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Buch-Pedersen MJ, 2009, PFLUG ARCH EUR J PHY, V457, P573, DOI 10.1007/s00424-008-0503-8; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enkavi G, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005831; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; Garver WS, 2010, J LIPID RES, V51, P406, DOI 10.1194/jlr.P000331; Gong X, 2018, SCIENCE, V361, DOI 10.1126/science.aas8935; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Griffa A, 2010, GIT IMAGING MICROSCO, V3, P41; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Jacquier N, 2012, J STEROID BIOCHEM, V129, P70, DOI 10.1016/j.jsbmb.2010.11.014; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kidmose RT, 2019, IUCRJ, V6, P526, DOI 10.1107/S2052252519007619; Kohut P, 2011, BIOCHEM BIOPH RES CO, V404, P233, DOI 10.1016/j.bbrc.2010.11.099; Kumar N, 2017, P NATL ACAD SCI USA, V114, P6557, DOI 10.1073/pnas.1619660114; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Li XC, 2016, P NATL ACAD SCI USA, V113, P10079, DOI 10.1073/pnas.1611956113; Li XC, 2016, P NATL ACAD SCI USA, V113, P8212, DOI 10.1073/pnas.1607795113; Loftus SK, 2002, HUM MOL GENET, V11, P3107, DOI 10.1093/hmg/11.24.3107; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Lyons JA, 2016, CURR OPIN STRUC BIOL, V38, P137, DOI 10.1016/j.sbi.2016.06.011; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; NEISS WF, 1984, HISTOCHEMISTRY, V80, P603, DOI 10.1007/BF00553724; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Ohgane K, 2013, CHEM BIOL, V20, P391, DOI 10.1016/j.chembiol.2013.02.009; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Pfeffer SR, 2019, J BIOL CHEM, V294, P1706, DOI 10.1074/jbc.TM118.004165; Qi XF, 2018, SCIENCE, V362, P52, DOI 10.1126/science.aas8843; Qi XF, 2018, NATURE, V560, P128, DOI 10.1038/s41586-018-0308-7; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Solanko LM, 2018, TRAFFIC, V19, P198, DOI 10.1111/tra.12545; Su CC, 2019, P NATL ACAD SCI USA, V116, P11241, DOI 10.1073/pnas.1901346116; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tomasiak T. M, 2014, CURR PROTOC PROTEIN, V77; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trinh MN, 2018, ELIFE, V7, DOI 10.7554/eLife.38564; Tsuji T, 2017, ELIFE, V6, DOI 10.7554/eLife.25960; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wustner D, 2008, CYTOM PART A, V73A, P727, DOI 10.1002/cyto.a.20593; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u; Zhang B, 2019, CELL, V176, P636, DOI 10.1016/j.cell.2019.01.003; Zhang Xuejun C, 2017, Biophys Rep, V3, P73, DOI 10.1007/s41048-017-0042-y; Zhang YX, 2018, CELL, V175, P1352, DOI 10.1016/j.cell.2018.10.026; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	84	63	63	4	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2019	179	2					485	+		10.1016/j.cell.2019.08.038	http://dx.doi.org/10.1016/j.cell.2019.08.038			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JB7WL	31543266	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000488775900017
J	Sands, BE; Sandborn, WJ; Panaccione, R; O'Brien, CD; Zhang, H; Johanns, J; Adedokun, OJ; Li, K; Peyrin-Biroulet, L; Van Assche, G; Danese, S; Targan, S; Abreu, MT; Hisamatsu, T; Szapary, P; Marano, C				Sands, B. E.; Sandborn, W. J.; Panaccione, R.; O'Brien, C. D.; Zhang, H.; Johanns, J.; Adedokun, O. J.; Li, K.; Peyrin-Biroulet, L.; Van Assche, G.; Danese, S.; Targan, S.; Abreu, M. T.; Hisamatsu, T.; Szapary, P.; Marano, C.		UNIFI Study Grp	Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVITY INDEXES; INFLIXIMAB; INFECTIONS; EFFICACY	BackgroundThe efficacy of ustekinumab, an antagonist of the p40 subunit of interleukin-12 and interleukin-23, as induction and maintenance therapy in patients with ulcerative colitis is unknown. MethodsWe evaluated ustekinumab as 8-week induction therapy and 44-week maintenance therapy in patients with moderate-to-severe ulcerative colitis. A total of 961 patients were randomly assigned to receive an intravenous induction dose of ustekinumab (either 130 mg [320 patients] or a weight-range-based dose that approximated 6 mg per kilogram of body weight [322]) or placebo (319). Patients who had a response to induction therapy 8 weeks after administration of intravenous ustekinumab were randomly assigned again to receive subcutaneous maintenance injections of 90 mg of ustekinumab (either every 12 weeks [172 patients] or every 8 weeks [176]) or placebo (175). The primary end point in the induction trial (week 8) and the maintenance trial (week 44) was clinical remission (defined as a total score of <= 2 on the Mayo scale [range, 0 to 12, with higher scores indicating more severe disease] and no subscore >1 [range, 0 to 3] on any of the four Mayo scale components). ResultsThe percentage of patients who had clinical remission at week 8 among patients who received intravenous ustekinumab at a dose of 130 mg (15.6%) or 6 mg per kilogram (15.5%) was significantly higher than that among patients who received placebo (5.3%) (P<0.001 for both comparisons). Among patients who had a response to induction therapy with ustekinumab and underwent a second randomization, the percentage of patients who had clinical remission at week 44 was significantly higher among patients assigned to 90 mg of subcutaneous ustekinumab every 12 weeks (38.4%) or every 8 weeks (43.8%) than among those assigned to placebo (24.0%) (P=0.002 and P<0.001, respectively). The incidence of serious adverse events with ustekinumab was similar to that with placebo. Through 52 weeks of exposure, there were two deaths (one each from acute respiratory distress syndrome and hemorrhage from esophageal varices) and seven cases of cancer (one each of prostate, colon, renal papillary, and rectal cancer and three nonmelanoma skin cancers) among 825 patients who received ustekinumab and no deaths and one case of cancer (testicular cancer) among 319 patients who received placebo. ConclusionsUstekinumab was more effective than placebo for inducing and maintaining remission in patients with moderate-to-severe ulcerative colitis. (Funded by Janssen Research and Development; UNIFI ClinicalTrials.gov number, NCT02407236.)	[Sands, B. E.] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, 1 Gustave L Levy Pl,Box 1069, New York, NY 10029 USA; [Sandborn, W. J.] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA; [Targan, S.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Panaccione, R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Panaccione, R.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [O'Brien, C. D.; Zhang, H.; Johanns, J.; Adedokun, O. J.; Li, K.; Szapary, P.; Marano, C.] Janssen Res & Dev, Spring House, PA USA; [Peyrin-Biroulet, L.] Univ Lorraine, Nancy Univ Hosp, Gastroenterol Dept, Nancy, France; [Peyrin-Biroulet, L.] Univ Lorraine, Nancy Univ Hosp, INSERM 1256, Nutr Genet & Environm Risk Exposure, Nancy, France; [Van Assche, G.] Univ Leuven, Div Gastroenterol & Hepatol, Univ Hosp Leuven, Leuven, Belgium; [Van Assche, G.] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, Leuven, Belgium; [Danese, S.] Humanitas Res Hosp, IBD Ctr, Dept Gastroenterol, Milan, Italy; [Danese, S.] Humanitas Univ, Milan, Italy; [Abreu, M. T.] Univ Miami, Miller Sch Med, Div Gastroenterol, Dept Med, Miami, FL 33136 USA; [Hisamatsu, T.] Kyorin Univ, Dept Internal Med 3, Div Gastroenterol, Sch Med, Tokyo, Japan	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; Cedars Sinai Medical Center; University of Calgary; University of Calgary; Johnson & Johnson; Janssen Pharmaceuticals; CHU de Nancy; Universite de Lorraine; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; KU Leuven; University Hospital Leuven; KU Leuven; Humanitas University; University of Miami; Kyorin University	Sands, BE (corresponding author), Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, 1 Gustave L Levy Pl,Box 1069, New York, NY 10029 USA.	bruce.sands@mssm.edu	Sandborn, William/ABE-8342-2020; Gearry, Richard B/H-3959-2019; Lichtenstein, Lev/AFP-2119-2022; Danese, Silvio/ABH-9571-2020; Apartsin, Konstantin/ACA-8088-2022; Apartsin, Konstantin/ABC-5678-2020; Apartsin, Konstantin A/B-9179-2017; Pavli, Paul/GZL-0607-2022; Leong, Rupert WL/J-7839-2012; Panaccione, Remo/ABC-1140-2021; Bilianskyi, Leonid/AAD-7323-2020	Gearry, Richard B/0000-0002-2298-5141; Danese, Silvio/0000-0001-7341-1351; Apartsin, Konstantin/0000-0003-0577-9001; Apartsin, Konstantin/0000-0003-0577-9001; Apartsin, Konstantin A/0000-0003-0577-9001; Leong, Rupert WL/0000-0001-5944-3488; Panaccione, Remo/0000-0002-5247-940X; peyrin-biroulet, laurent/0000-0003-2536-6618; Regula, Jaroslaw/0000-0001-7071-3151; Arasaradnam, Ramesh/0000-0002-2231-3062; Sands, Bruce/0000-0001-5762-5042; Glover, Sarah/0000-0002-9899-0473; Abreu, Maria T./0000-0002-7294-0574; Bouguen, Guillaume/0000-0002-7444-5905; Gasbarrini, Antonio/0000-0003-4863-6924; Roblin, Xavier/0000-0002-7929-4878	Janssen Research and Development	Janssen Research and Development	Funded by Janssen Research and Development	[Anonymous], 2017, STEL UST INTR SUBC U; Bressenot A, 2015, GUT, V64, P1412, DOI 10.1136/gutjnl-2014-307477; Bryant RV, 2016, GUT, V65, P408, DOI 10.1136/gutjnl-2015-309598; Carvalho PB, 2017, DRUGS, V77, P159, DOI 10.1007/s40265-016-0676-y; Christensen B, 2017, CLIN GASTROENTEROL H, V15, P1557, DOI 10.1016/j.cgh.2017.02.016; Colombel JF, 2011, GASTROENTEROLOGY, V141, P1194, DOI 10.1053/j.gastro.2011.06.054; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; EDWARDS FC, 1963, GUT, V4, P299, DOI 10.1136/gut.4.4.299; European Medicines Agency, 2018, GUID DEV NEW MED PRO; FDA, 2016, ULC COL CLIN TRIAL E; Feagan BG, 2016, NEW ENGL J MED, V375, P1946, DOI 10.1056/NEJMoa1602773; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Konidari Anastasia, 2014, World J Gastrointest Pharmacol Ther, V5, P63, DOI 10.4292/wjgpt.v5.i2.63; Li K, 2019, J CROHNS COLITIS, V13, P1025, DOI 10.1093/ecco-jcc/jjz022; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1051, DOI 10.1038/ajg.2012.89; Marchal-Bressenot A, 2017, GUT, V66, P43, DOI 10.1136/gutjnl-2015-310187; Peyrin-Biroulet L, 2014, CLIN GASTROENTEROLOG, V12; Rutgeerts PJ, 2001, ALIMENT PHARM THER, V15, P1515, DOI 10.1046/j.1365-2036.2001.01060.x; Sandborn WJ, 2004, GUT, V53, P780, DOI 10.1136/gut.2003.020552; Sands BE, 2014, GASTROENTEROLOGY, V147; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012; Ungaro R, 2017, LANCET, V389, P1756, DOI 10.1016/S0140-6736(16)32126-2	26	412	421	6	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1201	1214		10.1056/NEJMoa1900750	http://dx.doi.org/10.1056/NEJMoa1900750			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OT	31553833	Green Published, Bronze			2022-12-28	WOS:000489333500005
J	Kuehn, B				Kuehn, Bridget			Boosting Naloxone Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1135	1135		10.1001/jama.2019.13931	http://dx.doi.org/10.1001/jama.2019.13931			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550040				2022-12-28	WOS:000488822800013
J	Breu, AC				Breu, Anthony C.			Why Is a Cow? Curiosity, Tweetorials, and the Return to Why	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The "what" questions stressed in medical education are not as absorbing - and their answers not as gratifying - as "why" questions. Tweetorials provide a tool for physicians who aim to rekindle and stimulate curiosity about pathophysiology and mechanisms of disease.	[Breu, Anthony C.] Vet Affairs Boston Healthcare Syst, West Roxbury, MA 02132 USA; [Breu, Anthony C.] Harvard Med Sch, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School	Breu, AC (corresponding author), Vet Affairs Boston Healthcare Syst, West Roxbury, MA 02132 USA.; Breu, AC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Breu A, 2018, WHY DO PATIENTS ACUT; Centor R, 2019, SHOULD WE MOVE QUANT; Fitzgerald FT, 1999, ANN INTERN MED, V130, P70, DOI 10.7326/0003-4819-130-1-199901050-00015; Simpkin AL, 2016, NEW ENGL J MED, V375, P1713, DOI 10.1056/NEJMp1606402; Topf JM, 2017, AM J KIDNEY DIS, V69, P827, DOI 10.1053/j.ajkd.2016.12.012	5	32	32	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1097	1098		10.1056/NEJMp1906790	http://dx.doi.org/10.1056/NEJMp1906790			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4PY	31532957				2022-12-28	WOS:000487066900003
J	Korenstein, D; Mamoor, M; Bach, PB				Korenstein, Deborah; Mamoor, Maha; Bach, Peter B.			Preventive Services Offered in Executive Physicals at Top-Ranked Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study describes health services offered by USNWR best hospitals in executive physical packages, daylong comprehensive evaluations offering testing and screening of wealthy individuals and corporate leaders.	[Korenstein, Deborah] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Mamoor, Maha] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA; [Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Korenstein, D (corresponding author), Mem Sloan Kettering Canc Ctr, 485 Lexington Ave,Second Floor, New York, NY 10017 USA.	korenstd@mskcc.org			Cancer Center Support Grant from the National Cancer Institute [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Cancer Center Support Grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Drs Korenstein and Bach's work was supported in part by a Cancer Center Support Grant (P30 CA008748) from the National Cancer Institute to Memorial Sloan Kettering Cancer Center.	Comarow A, 2018, 2018 19 BEST HOSP HO; Grobart S, 2017, 2 DAY 5000 C SUITE P; Rank B, 2008, NEW ENGL J MED, V359, P1424, DOI 10.1056/NEJMp0806270	3	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1101	1103		10.1001/jama.2019.10563	http://dx.doi.org/10.1001/jama.2019.10563			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31528998	Green Published, Bronze			2022-12-28	WOS:000488821100024
J	Pal, H				Pal, Hemraj			In treatment-resistant depression, adding esketamine nasal spray to an oral antidepressant improved symptoms at 28	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In adults with treatment-resistant depression, does adding flexibly dosed esketamine nasal spray to a newly started oral antidepressant reduce symptoms at 28 days? Methods Design: Randomized controlled trial (RCT). ClinicalTrials. gov NCT02418585. Allocation: {Concealed}*.dagger Blinding: Blinded dagger (patients, investigators, center staff, outcome assessors, and data analysts). Follow-up period: 28 days (treatment period). Setting: 39 outpatient referral centers in the Czech Republic, Germany, Poland, Spain, and the USA. Patients: 227 patients 18 to 64 years of age (mean age 46 y, 62% women) who had moderate-to-severe nonpsychotic major depressive disorder and were nonresponsive to an adequate trial (dose, duration, and adherence) of >= 2 oral antidepressants during the current depression episode. Nonresponse was defined as <= 25% improvement to >= 1 oral antidepressant documented retrospectively at the start of the 4-week prerandomization screening period and <= 25% improvement to 1 oral antidepressant used for >= 2 prescreening weeks and assessed prospectively during the 4-week screening period, with a minimum score at weeks 2 and 4. Exclusion criteria included suicidal behavior in the past year; homicidal or active suicidal ideation or intent in the past 6 months; borderline, antisocial, histrionic, or narcissistic personality disorder; current obsessive-compulsive disorder; autism spectrum disorder; intellectual disability; seizures; uncontrolled hypertension; or moderate or severe substance use disorder in the past 6 months. Intervention: Esketamine nasal spray, 56 or 84 mg twice/wk, plus a daily, investigator-selected, oral antidepressant (escitalopram, sertraline, duloxetine, or venlafaxine extended-release) not previously associated with nonresponse in the current depression episode (n = 116) or placebo nasal spray plus an oral antidepressant (n = 111). Outcomes: Primary outcome was the Montgomery-Asberg Depression Rating Scale score. Secondary outcomes included onset of clinical response by day 2 with maintenance of response to day 28 Patient follow-up: 87% completed the 28-day treatment period; 98% received >= 1 study drug dose and were included in the analyses. Main results 54% of patients received duloxetine as the oral antidepressant, 17% escitalopram, 14% sertraline, and 14% venlafaxine extended-release. The main results are in the Table. Conclusion In treatment-resistant depression, adding esketamine nasal spray to a new oral antidepressant improved symptoms at 28 days.	[Pal, Hemraj] Essex Partnership Univ Fdn Trust, Colchester, Essex, England		Pal, H (corresponding author), Essex Partnership Univ Fdn Trust, Colchester, Essex, England.							Schatzberg AF, 2019, AM J PSYCHIAT, V176, P422, DOI 10.1176/appi.ajp.2019.19040423; Swainson J, 2019, EXPERT REV NEUROTHER, DOI 10.1080/14737175.2019.1640604	2	1	1	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC33	JC33		10.7326/ACPJ201909170-033	http://dx.doi.org/10.7326/ACPJ201909170-033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525767				2022-12-28	WOS:000486101400009
J	Santulli, G				Santulli, Gaetano			In type 2 diabetes, intensive glucose control for 5.6 years did not differ from usual care for major CV events at 14 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Question In patients with type 2 diabetes, does intensive glucose control for a median 5.6 years reduce major cardiovascular (CV) events over 15 years compared with usual care? Methods Design: Long-term observational follow-up of a randomized controlled trial (Veterans Affairs Diabetes Trial Follow-up [VADT-F] study). ClinicalTrials. gov NCT00032487. Allocation: Unclear allocation concealment.* Blinding: Blinded* (outcome adjudicators for patient-reported amputations and CV events). Follow-up period: Median 13.6 years for CV events; median 15 years for all-cause mortality. Setting: 20 centers in the USA. Patients: 1791 military veterans > 40 years of age (mean age 60 y, 97% men, mean diabetes duration 12 y) who had type 2 diabetes mellitus and an inadequate response (hemoglobin [HbA(1c)] level >= 7.5%) to maximum doses of >= 1 oral drug or insulin. Intervention: Intensive glucose control targeted to a normal HbA(1c) level and median level > 1.5% lower than the usual care group (n = 892) or usual care targeted to an HbA(1c) level of 8% to 9% (n = 899). Patients received randomized treatments for a median 5.6 years. Outcomes: Primary outcome was a composite of major CV events (nonfatal myocardial infarction or stroke, CV death, new or worsening congestive heart failure, or amputation for ischemic gangrene). Secondary outcomes included all-cause and CV mortality and major diabetes outcomes (primary composite outcome, end-stage renal disease, or nontraumatic amputation). Patient follow-up: 92% of patients were followed through linkage to national registries (Veterans Affairs central medical and death files, Centers for Medicare & Medicaid Services claims files, and National Death Index), and 78% provided additional data through annual surveys and chart reviews (intention-totreat analysis). Main results The main results are in the Table. Conclusion In type 2 diabetes, intensive glucose control for a median 5.6 years did not differ from usual care for major cardiovascular events at 13.6 years or all-cause mortality at 15 years.	[Santulli, Gaetano] Montefiore Univ Hosp, Einstein Coll, New York, NY 10461 USA; [Santulli, Gaetano] Univ Naples Federico II, Naples, Italy	University of Naples Federico II	Santulli, G (corresponding author), Montefiore Univ Hosp, Einstein Coll, New York, NY 10461 USA.; Santulli, G (corresponding author), Univ Naples Federico II, Naples, Italy.		Santulli, Gaetano/I-9203-2016	Santulli, Gaetano/0000-0001-7231-375X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL146691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK107895] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Deedwania P, 2019, AM J CARDIOVASC DRUG, V19, P249, DOI 10.1007/s40256-019-00325-9; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Santulli G, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00314; Zonszein J, 2018, ANN INTERN MED, V169, P512, DOI 10.7326/L18-0372	4	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2019	171	6					JC31	JC31		10.7326/ACPJ201909170-031	http://dx.doi.org/10.7326/ACPJ201909170-031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY0RW	31525765				2022-12-28	WOS:000486101400007
J	Stafford, N				Stafford, Ned			Toxicologists investigate cases of hand deformities in German babies	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2018, LOCAL           1031; Meckert PJ, 2019, EXPRESS; St Augustine Gelsenkirchen, 2019, GEB BAB HANDD STELL; Thompson A, 2018, MAIL ONLINE	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5607	10.1136/bmj.l5607	http://dx.doi.org/10.1136/bmj.l5607			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530537				2022-12-28	WOS:000487758600015
J	Fara, P				Fara, Patricia			The art of medicine Battling for life: the wartime work of Janet Vaughan	LANCET			English	Editorial Material									[Fara, Patricia] Clare Coll, Cambridge CB2 1TL, England	University of Cambridge	Fara, P (corresponding author), Clare Coll, Cambridge CB2 1TL, England.	pf10006@clare.cam.ac.uk						[Anonymous], 1945, BMJ-BRIT MED J, V1, P818; Royal College of Physicians and Oxford Brookes University, 1987, COMMUNICATION; Royal College of Physicians and Oxford Brookes University, 2002, COMMUNICATION	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					910	911		10.1016/S0140-6736(19)32090-2	http://dx.doi.org/10.1016/S0140-6736(19)32090-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX7CE	31526727				2022-12-28	WOS:000485840600011
J	Reuter, A; Hughes, J; Furin, J				Reuter, Anja; Hughes, Jennifer; Furin, Jennifer			Challenges and controversies in childhood tuberculosis	LANCET			English	Article							DRUG-RESISTANT TUBERCULOSIS; ISONIAZID PREVENTIVE THERAPY; PULMONARY TUBERCULOSIS; YOUNG-CHILDREN; XPERT MTB/RIF; INTRATHORACIC TUBERCULOSIS; URINE LIPOARABINOMANNAN; LATENT TUBERCULOSIS; IMPROVE ADHERENCE; DIAGNOSIS	Children bear a substantial burden of suffering when it comes to tuberculosis. Ironically, they are often left out of the scientific and public health advances that have led to important improvements in tuberculosis diagnosis, treatment, and prevention over the past decade. This Series paper describes some of the challenges and controversies in paediatric tuberculosis, including the epidemiology and treatment of tuberculosis in children. Two areas in which substantial challenges and controversies exist (ie, diagnosis and prevention) are explored in more detail. This Series paper also offers possible solutions for including children in all efforts to end tuberculosis, with a focus on ensuring that the proper financial and human resources are in place to best serve children exposed to, infected with, and sick from all forms of tuberculosis.	[Reuter, Anja] Medecins Sans Frontieres, Khayelitsha, South Africa; [Hughes, Jennifer] Stellenbosch Univ, Desmond Tutu TB Ctr, Stellenbosch, South Africa; [Furin, Jennifer] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA	Stellenbosch University; Harvard University; Harvard Medical School	Furin, J (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	jennifer_furin@hms.harvard.edu						Acquah R, 2019, LANCET INFECT DIS, V19, P224, DOI 10.1016/S1473-3099(18)30742-4; Adjobimey M, 2016, INT J TUBERC LUNG D, V20, P1055, DOI 10.5588/ijtld.15.0493; Aggerbeck H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204554; Amanullah F, 2014, INT J TUBERC LUNG D, V18, P520, DOI 10.5588/ijtld.13.0593; Andrews JR, 2017, LANCET RESP MED, V5, P282, DOI [10.1016/S2213-2600(17)30060-7, 10.1016/s2213-2600(17)30060-7]; [Anonymous], CHILD FRIENDL MED; [Anonymous], 2018, CAR PEOPL EXP DRUG R; Ansumana R, 2017, INT J INFECT DIS, V56, P101, DOI 10.1016/j.ijid.2016.10.010; Arscott-Mills T, 2014, J TROP PEDIATRICS, V60, P27, DOI 10.1093/tropej/fmt072; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Bassili A, 2013, AM J TROP MED HYG, V89, P271, DOI 10.4269/ajtmh.13-0004; Becerra MC, 2014, J PUBLIC HEALTH POL, V35, P425, DOI 10.1057/jphp.2014.35; Belard S, 2018, PEDIATR INFECT DIS J, V37, P637, DOI 10.1097/INF.0000000000001872; Belgaumkar V, 2018, INT J TUBERC LUNG D, V22, P1179, DOI 10.5588/ijtld.17.0848; Borisov AS, 2018, MMWR-MORBID MORTAL W, V67, P723, DOI 10.15585/mmwr.mm6725a5; Breuninger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106381; Broger T, 2019, LANCET INFECT DIS, V19, P852, DOI 10.1016/S1473-3099(19)30001-5; Chiang SS, 2017, INT J TUBERC LUNG D, V21, P154, DOI 10.5588/ijtld.16.0624; Chiappini E, 2019, PAEDIATR RESPIR REV, V32, P36, DOI 10.1016/j.prrv.2019.03.010; Churchyard GJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002787; Cruz AT, 2018, PEDIATR INFECT DIS J, V37, P1061, DOI 10.1097/INF.0000000000002135; Detjen AK, 2019, INT J INFECT DIS, V80, pS9, DOI 10.1016/j.ijid.2019.02.042; Detjen AK, 2015, LANCET RESP MED, V3, P451, DOI 10.1016/S2213-2600(15)00095-8; Dodd PJ, 2018, LANCET GLOB HEALTH, V6, pE1329, DOI 10.1016/S2214-109X(18)30401-7; Dodd PJ, 2017, LANCET GLOB HEALTH, V5, pE898, DOI [10.1016/S2214-109X(17)30289-9, 10.1016/s2214-109x(17)30289-9]; Faddoul Diala, 2015, Adv Pediatr, V62, P59, DOI 10.1016/j.yapd.2015.04.001; Fox GJ, 2017, INT J INFECT DIS, V56, P68, DOI 10.1016/j.ijid.2016.11.006; Franck C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-426; Furin J, 2015, INT J TUBERC LUNG D, V19, pS55, DOI 10.5588/ijtld.15.0380; Furin J, 2019, LANCET, V393, P1642, DOI 10.1016/S0140-6736(19)30308-3; Furin J, 2019, EXPERT REV RESP MED, V13, P301, DOI 10.1080/17476348.2019.1569518; Furin J, 2018, LANCET CHILD ADOLESC, V2, P237, DOI 10.1016/S2352-4642(18)30068-3; Garcia-Prats AJ, 2018, CLIN INFECT DIS, V67, P1777, DOI 10.1093/cid/ciy416; Gaskell KM, 2019, INT J INFECT DIS, V80, pS13, DOI 10.1016/j.ijid.2019.02.037; Ghazarian L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01837; Graham SM, 2015, CLIN INFECT DIS, V61, pS179, DOI 10.1093/cid/civ581; Harausz EP, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002591; Harausz EP, 2017, AM J RESP CRIT CARE, V195, P1300, DOI 10.1164/rccm.201606-1227CI; Hasan R, 2018, B WORLD HEALTH ORGAN, V96, P194, DOI [10.2471/BLT.17.198614, 10.2471/blt.17.198614]; Hoddinott G, 2018, INT J TUBERC LUNG D, V22, P4, DOI 10.5588/ijtld.17.0814; Huerga H, 2019, ARCH DIS CHILD, V104, P622, DOI 10.1136/archdischild-2018-315411; Ioos V, 2019, ARCH DIS CHILD, V104, P629, DOI 10.1136/archdischild-2018-315453; Jenkins H E, 2018, Int J Tuberc Lung Dis, V22, P3, DOI 10.5588/ijtld.17.0357; Jenkins HE, 2017, LANCET INFECT DIS, V17, P285, DOI [10.1016/S1473-3099(16)30474-1, 10.1016/s1473-3099(16)30474-1]; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Jonckheree S, 2017, EXPERT REV RESP MED, V11, P385, DOI 10.1080/17476348.2017.1309294; Kanters S, 2017, LANCET HIV, V4, pE31, DOI 10.1016/S2352-3018(16)30206-5; Ki-moon B, 2019, LANCET, V393, P1268, DOI 10.1016/S0140-6736(19)30433-7; Knight G, 2019, LANCET INFECT DIS, DOI [10.1016/S1473-3099(19)-30307-X, DOI 10.1016/S1473-3099(19)-30307-X]; Kruk A, 2008, PEDIATRICS, V121, pE1646, DOI 10.1542/peds.2007-3138; LaCourse SM, 2018, AIDS, V32, P69, DOI [10.1097/QAD.0000000000001662, 10.1097/qad.0000000000001662]; Li HM, 2016, PEDIATR INFECT DIS J, V35, P607, DOI 10.1097/INF.0000000000001114; Luzzati R, 2017, EUR RESPIR J, V50, P11; Malik AA, 2020, CLIN INFECT DIS, V70, P1958, DOI 10.1093/cid/ciz502; Marais B, 2018, LANCET RESP MED, V6, P235, DOI 10.1016/S2213-2600(17)30496-4; Marais B, 2015, PUBLIC HEALTH ACTION, V5, P90, DOI 10.5588/pha.15.0028; Guix-Comellas EM, 2018, J ADV NURS, V74, P1819, DOI 10.1111/jan.13692; Marks SM, 2017, CLIN INFECT DIS, V64, P1670, DOI 10.1093/cid/cix208; Martinez L, 2019, LANCET RESP MED, V7, P544, DOI 10.1016/S2213-2600(19)30137-7; Martinez L, 2018, LANCET RESP MED, V6, P276, DOI 10.1016/S2213-2600(17)30497-6; McDowell A, 2019, PLOS ONE, V13; Mesman AW, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4385-y; Meyer AJ, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10239; Monedero I, 2015, PUBLIC HEALTH ACTION, V5, P92, DOI 10.5588/pha.15.0020; Mulenga H, 2015, PEDIATR INFECT DIS J, V34, P1157, DOI 10.1097/INF.0000000000000847; Munthali Tendai, 2017, BMC Res Notes, V10, P206, DOI 10.1186/s13104-017-2529-5; Nachman S, 2015, LANCET INFECT DIS, V15, P711, DOI 10.1016/S1473-3099(15)00007-9; National Department of Health, 2018, INT CLIN GUID IMPL I; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Nguipdop-Djomo P, 2016, LANCET INFECT DIS, V16, P219, DOI 10.1016/S1473-3099(15)00400-4; Nicol MP, 2018, PEDIATR INFECT DIS J, V37, pE261, DOI [10.1097/INF.0000000000001960, 10.1097/inf.0000000000001960]; Nicol MP, 2014, LANCET GLOB HEALTH, V2, pE278, DOI 10.1016/S2214-109X(14)70195-0; Oliwa JN, 2015, LANCET RESP MED, V3, P235, DOI 10.1016/S2213-2600(15)00028-4; Rachlis B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149412; Ramos JM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7206-2; Imperiale BR, 2018, INT J MYCOBACT, V7, P162, DOI 10.4103/ijmy.ijmy_54_18; Rodriguez CA, 2017, INT J TUBERC LUNG D, V21, P935, DOI 10.5588/ijtld.17.0061; Roy RB, 2019, LANCET INFECT DIS, V19, pE96, DOI 10.1016/S1473-3099(18)30157-9; Sabi I, 2018, J INFECTION, V77, P321, DOI 10.1016/j.jinf.2018.07.002; Said K, 2019, PEDIATR INFECT DIS J, V38, P333, DOI 10.1097/INF.0000000000002131; Sandgren A, 2012, EUR RESPIR J, V40, P294, DOI 10.1183/09031936.00187711; Seddon J A, 2018, Int J Tuberc Lung Dis, V22, P24, DOI 10.5588/ijtld.17.0359; Seddon JA, 2019, LANCET INFECT DIS, V19, pE322, DOI 10.1016/S1473-3099(18)30787-4; Seki M, 2018, EUR J CLIN MICROBIOL, V37, P1405, DOI 10.1007/s10096-018-3258-y; Sharma SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169539; Snow KJ, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02352-2017; Stein CM, 2018, AM J EPIDEMIOL, V187, P1477, DOI 10.1093/aje/kwx380; Szkwarko D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182185; Taneja R, 2015, INT J TUBERC LUNG D, V19, pS61, DOI 10.5588/ijtld.15.0435; The Sentinel Project for Pediatric Drug Resistant Tuberculosis, 2019, MAN MULT RES TUB CHI; Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147397; Treatment Action Group, 2018, HIV TB HCV PIP REP; Triasih R, 2015, CLIN INFECT DIS, V60, P12, DOI 10.1093/cid/ciu748; United Nations, 2018, UN END TUB URG GLOB; United States National Library of Medicine, EV EFF 3HP VERS PER; van Cutsem G, 2016, CLIN INFECT DIS, V62, pS238, DOI 10.1093/cid/ciw012; Van der Meeren O, 2018, NEW ENGL J MED, V379, P1621, DOI 10.1056/NEJMoa1803484; Van Wyk SS, 2012, INT J TUBERC LUNG D, V16, P157, DOI 10.5588/ijtld.11.0393; Velasco-Arnaiz E, 2018, PEDIATR INFECT DIS J, V37, P1235, DOI 10.1097/INF.0000000000002015; Walters E, 2018, J CLIN MICROBIOL, V56; Walters E, 2019, PEDIATR INFECT DIS J, V38, pE128, DOI 10.1097/INF.0000000000002240; Walters E, 2017, PEDIATR INFECT DIS J, V36, P837, DOI 10.1097/INF.0000000000001563; Walzl G, 2018, LANCET INFECT DIS, V18, pE199, DOI 10.1016/S1473-3099(18)30111-7; Weaver MS, 2015, B WORLD HEALTH ORGAN, V93, P700, DOI 10.2471/BLT.14.147231; Weiss P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-333; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; Wobudeya E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6821-2; World Health Organization, 2018, IMPR QUAL PAED CAR O; World Health Organization, 2018, LAT TUB INF UPD CONS; Yuen CM, 2015, PUBLIC HEALTH ACTION, V5, P45, DOI 10.5588/pha.14.0100; Yuen CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217104; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1; Zar HJ, 2012, CLIN INFECT DIS, V55, P1088, DOI 10.1093/cid/cis598; Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2; Zawedde-Muyanja S, 2018, INT J TUBERC LUNG D, V22, P1314, DOI 10.5588/ijtld.18.0025	117	35	36	2	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					967	978		10.1016/S0140-6736(19)32045-8	http://dx.doi.org/10.1016/S0140-6736(19)32045-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IX7CE	31526740				2022-12-28	WOS:000485840600028
J	Cornwall, W				Cornwall, Warren			SUNKEN SUMMITS	SCIENCE			English	Editorial Material																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1104	1107		10.1126/science.365.6458.1104	http://dx.doi.org/10.1126/science.365.6458.1104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515382				2022-12-28	WOS:000485780800035
J	Dyer, O				Dyer, Owen			Opioid lawsuits: Sackler family and Purdue reach tentative settlement with 27 US states	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2019, BMJ-BRIT MED J, V365, P9602, DOI DOI 10.1136/BMJ.L4374; Galofaro C, 2019, AP NEWS          MAY; Murtas H., 2019, 1 PATTEGGIAMENTI CON	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5564	10.1136/bmj.l5564	http://dx.doi.org/10.1136/bmj.l5564			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519737				2022-12-28	WOS:000486649800014
J	Baker, M				Baker, Monya			ANIMAL REGISTRIES AIM TO REDUCE BIAS	NATURE			English	Editorial Material																		Wieschowski S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000391	1	9	9	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					297	298		10.1038/d41586-019-02676-4	http://dx.doi.org/10.1038/d41586-019-02676-4			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31501583	Bronze			2022-12-28	WOS:000485415400062
J	Oliver, D				Oliver, David			David Oliver: Publicity stunts and hospital food	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Age UK, 2010, STILL HUNGR BE HEARD; [Anonymous], 2019, BBC NEWS; BBC News, 2013, BBC NEWS; Department of Health and Social Care, 2013, PUTT PAT 1 GOV PUBL; Department of Health and Social Care, 2010, ESS CAR 2010; Green C., 2018, NHS 70 HOSP FOOD HAS; Honeycombe-Foster M., 2019, POLITICSHOME    0823; Local Government Association NHS Confederation Age UK, 2012, DEL DIGN SEC DIGN CA; Matthews-King Alex, 2018, INDEPENDENT; McCartney J., 2019, SUNDAY TIMES; National Audit Office, 1994, NAT HLTH SERV HOSP C; NHS, 2011, REP HIGHL LAPS PAT C; Parsons EL, 2013, P NUTR SOC, V72, P251, DOI 10.1017/S0029665113000980; Public Health England, 2019, LIST CAS BEING INV; Siddique H., 2018, GUARDIAN; Sustain, 2017, TAK PULS HOSP FOOD S	16	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2019	366								l5369	10.1136/bmj.l5369	http://dx.doi.org/10.1136/bmj.l5369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MQ	31511233	Bronze			2022-12-28	WOS:000486649100003
J	Chaturvedi, AK; Graubard, BI; Broutian, T; Xiao, W; Pickard, RKL; Kahle, L; Gillison, ML				Chaturvedi, Anil K.; Graubard, Barry I.; Broutian, Tatevik; Xiao, Weihong; Pickard, Robert K. L.; Kahle, Lisa; Gillison, Maura L.			Prevalence of Oral HPV Infection in Unvaccinated Men and Women in the United States, 2009-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HUMAN-PAPILLOMAVIRUS; VACCINATION	To estimate changes in oral human papillomavirus (HPV) prevalence attributable to vaccination vs herd immunity, this national survey study uses National Health and Nutrition Examination Survey data to compare oral HPV prevalence for 4 types targeted by HPV vaccine and 33 nonvaccine types in unvaccinated US adults aged 18 to 59 years from 2009 to 2016.	[Chaturvedi, Anil K.; Graubard, Barry I.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Broutian, Tatevik; Pickard, Robert K. L.] Ohio State Univ, Columbus, OH 43210 USA; [Xiao, Weihong; Gillison, Maura L.] MD Anderson Canc Ctr, Houston, TX USA; [Kahle, Lisa] Informat Management Serv Inc, Calverton, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; Information Management Services, Inc.	Gillison, ML (corresponding author), MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Div Canc Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mgillison@mdanderson.org			NIDCR [R01DE023175]; Intramural Research Program of the National Cancer Institute	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NIDCR grant R01DE023175 and the Intramural Research Program of the National Cancer Institute. Dr Gillison is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar.	Chaturvedi AK, 2018, J CLIN ONCOL, V36, P262, DOI 10.1200/JCO.2017.75.0141; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Malagon T, 2018, EXPERT REV VACCINES, V17, P395, DOI 10.1080/14760584.2018.1471986; Oliver SE, 2017, J INFECT DIS, V216, P594, DOI 10.1093/infdis/jix244; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300	6	30	31	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2019	322	10					977	979		10.1001/jama.2019.10508	http://dx.doi.org/10.1001/jama.2019.10508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY6YZ	31503300	Green Published, Bronze			2022-12-28	WOS:000486543500019
J	Mahase, E				Mahase, Elisabeth			Malaria could be eradicated by 2050, say global experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Feachem RGA, 2019, LANCET	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2019	366								l5501	10.1136/bmj.l5501	http://dx.doi.org/10.1136/bmj.l5501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MO	31506279				2022-12-28	WOS:000486648900015
J	Bibbins-Domingo, K				Bibbins-Domingo, Kirsten			Integrating Social Care Into the Delivery of Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint summarizes a 2019 National Academies of Sciences, Engineering, and Medicine consensus committee report defining 5 priority development areas for the US health care system to integrate social care into health care delivery: designing delivery systems and building workforce, developing digital infrastructure interoperable between health and social care organizations, and funding the integration and research into the effectiveness and implementation of social care practices in health care settings.	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St, San Francisco, CA 94158 USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St, San Francisco, CA 94158 USA.	kirsten.bibbins-domingo@ucsf.edu						Butler SM, 2019, JAMA-J AM MED ASSOC, V321, P2063, DOI 10.1001/jama.2019.6494; Butler S, 2017, JAMA-J AM MED ASSOC, V318, P1855, DOI 10.1001/jama.2017.16493; Davidson KW, 2019, JAMA-J AM MED ASSOC, V322, P1037, DOI 10.1001/jama.2019.10915; National Academies of Science Engineering and Medicine, 2019, INT SOC CAR DEL HLTH	4	32	33	3	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 12	2019	322	18					1763	1764		10.1001/jama.2019.15603	http://dx.doi.org/10.1001/jama.2019.15603			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0WO	31553407				2022-12-28	WOS:000498675500012
J	Geer, JH; Siegel, MD				Geer, Jacqueline H.; Siegel, Mark D.			Antibiotics and the Yield of Blood Cultures: Sequence Matters	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEPSIS		[Geer, Jacqueline H.; Siegel, Mark D.] Yale Sch Med, 333 Cedar St,LCI 105,POB 208057, New Haven, CT 06520 USA	Yale University	Siegel, MD (corresponding author), Yale Sch Med, 333 Cedar St,LCI 105,POB 208057, New Haven, CT 06520 USA.	mark.siegel@yale.edu						Cheng MP, 2019, ANN INTERN MED, V171, P547, DOI 10.7326/M19-1696; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Gupta S, 2016, CHEST, V150, P1251, DOI 10.1016/j.chest.2016.08.1460; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Peltan ID, 2019, CHEST, V155, P938, DOI 10.1016/j.chest.2019.02.008; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rhodes A, 2015, INTENS CARE MED, V41, P1620, DOI 10.1007/s00134-015-3906-y; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	9	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2019	171	8					587	+		10.7326/M19-2489	http://dx.doi.org/10.7326/M19-2489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD4JV	31525773				2022-12-28	WOS:000489944700022
J	Dayan, CM; Korah, M; Tatovic, D; Bundy, BN; Herold, KC				Dayan, Colin M.; Korah, Maria; Tatovic, Danijela; Bundy, Brian N.; Herold, Kevan C.			Changing the landscape for type 1 diabetes: the first step to prevention	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; HYDROLYZED INFANT FORMULA; BETA-CELL AUTOIMMUNITY; PRESERVES C-PEPTIDE; REGULATORY T-CELLS; ISLET AUTOIMMUNITY; ENTEROVIRAL VACCINATION; GENETIC SUSCEPTIBILITY; DIETARY INTERVENTION; IMMUNE-RESPONSES	Over several decades, studies have described the progression of autoimmune diabetes, from the first appearance of autoantibodies until, and after, the diagnosis of clinical disease with hyperglycaemia and insulin dependence. Despite the improved management of type 1 diabetes with exogenous insulin, most patients do not meet clinical glycaemic goals, and diabetes remains an important medical problem that affects children and adults. Clinical and preclinical studies have suggested strategies to prevent the diagnosis of type 1 diabetes in people at risk, but the outcomes of previous clinical trials have not met their primary endpoints of disease prevention or delay. The results from the TN-10 teplizumab prevention trial show that the diagnosis of type 1 diabetes can be delayed by treatment with a FcR non-binding monoclonal antibody to CD3 in people at high risk for disease. This Series paper discusses how this clinical achievement raises new questions about for whom, and when, immunological strategies might be developed to prevent type 1 diabetes, and how to achieve this goal.	[Dayan, Colin M.] Cardiff Univ, Sch Med, Diabet Res Grp, Cardiff, S Glam, Wales; [Korah, Maria; Tatovic, Danijela; Herold, Kevan C.] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Korah, Maria; Tatovic, Danijela; Herold, Kevan C.] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA; [Bundy, Brian N.] Univ S Florida, Hlth Informat Inst, Tampa, FL USA	Cardiff University; Yale University; Yale University; State University System of Florida; University of South Florida	Herold, KC (corresponding author), Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA.; Herold, KC (corresponding author), Yale Univ, Dept Internal Med, New Haven, CT 06520 USA.	kevan.herold@yale.edu	Dayan, Colin/AAH-6242-2019	Dayan, Colin/0000-0002-6557-3462; Tatovic, Danijela/0000-0002-3879-2686	Type 1 Diabetes TrialNet Study Group; US National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases; US National Institutes of Health through the National Institute of Allergy and Infectious Diseases; US National Institutes of Health through the Eunice Kennedy Shriver National Institute of Child Health and Human Development; US National Institutes of Health [U01 DK085466, R01 DK057846, UC4 DK106993]	Type 1 Diabetes TrialNet Study Group; US National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases; US National Institutes of Health through the National Institute of Allergy and Infectious Diseases; US National Institutes of Health through the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	KCH was the principal investigator of the teplizumab prevention trial. The sponsor of the anti-CD3 (teplizumab) prevention trial was the Type 1 Diabetes TrialNet Study Group. Type 1 Diabetes TrialNet Study Group is a clinical trials network funded by the US National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, and The Eunice Kennedy Shriver National Institute of Child Health and Human Development. Grant support was from the US National Institutes of Health (U01 DK085466, R01 DK057846, and UC4 DK106993).	Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Ali MA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf7779; Atkinson MA, 2019, LANCET DIABETES ENDO, V7, P52, DOI 10.1016/S2213-8587(18)30112-8; Barker JM, 2004, DIABETES CARE, V27, P1399, DOI 10.2337/diacare.27.6.1399; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Beyerlein A, 2014, DIABETES CARE, V37, pE194, DOI 10.2337/dc14-1208; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; BONIFACIO E, 1990, LANCET, V335, P147, DOI 10.1016/0140-6736(90)90013-U; Bonifacio E, 2015, JAMA-J AM MED ASSOC, V313, P1541, DOI 10.1001/jama.2015.2928; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Centers for Disease Control and Prevention (CDC), MORB MORT WEEKL REP; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; CHATENOUD L, 1992, CR ACAD SCI III-VIE, V315, P225; Danne T, 2018, DIABETES CARE, V41, P1981, DOI 10.2337/dc18-0342; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Dunne JL, 2019, DIABETOLOGIA, V62, P1100, DOI 10.1007/s00125-019-4873-6; Dunne JL, 2019, DIABETOLOGIA, V62, P744, DOI 10.1007/s00125-019-4811-7; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; FRIER BM, 1977, DIABETES, V26, P369; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gerlag DM, 2019, ANN RHEUM DIS, V78, P179, DOI 10.1136/annrheumdis-2017-212763; Gillespie KM, 2002, DIABETES, V51, P210, DOI 10.2337/diabetes.51.1.210; Greenbaum C, 2017, JAMA-J AM MED ASSOC, V318, P1891, DOI 10.1001/jama.2017.17070; Hagopian W, 2013, DIABETES, V62, P3901, DOI 10.2337/db13-0236; Haller MJ, 2019, DIABETES, V68, P1267, DOI 10.2337/db19-0057; Harms RZ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02332; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; HEROLD KC, 1992, DIABETES, V41, P385, DOI 10.2337/diabetes.41.3.385; Herold KC, 2019, NEW ENGL J MED, V381, P603, DOI 10.1056/NEJMoa1902226; Herold KC, 2013, DIABETES, V62, P3766, DOI 10.2337/db13-0345; Hommel A, 2018, HORM METAB RES, V50, P44, DOI 10.1055/s-0043-120921; Hummel S, 2011, DIABETES CARE, V34, P1301, DOI 10.2337/dc10-2456; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; Johnson SB, 2017, DIABETES CARE, V40, P1167, DOI 10.2337/dc17-0166; Keenan Hillary A, 2010, Diabetes, V59, P2846, DOI 10.2337/db10-0676; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Knip M, 2018, JAMA-J AM MED ASSOC, V319, P38, DOI 10.1001/jama.2017.19826; Knip M, 2014, JAMA-J AM MED ASSOC, V311, P2279, DOI 10.1001/jama.2014.5610; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Krischer JP, 2019, DIABETES CARE, V42, P1051, DOI 10.2337/dc18-2282; Krischer JP, 2017, DIABETES, V66, P3122, DOI 10.2337/db17-0261; Lachin JM, 2015, DIABETES, V64, P631, DOI 10.2337/db14-0930; Lachin JM, 2014, DIABETES, V63, P739, DOI 10.2337/db13-0881; Lampeter EF, 1998, DIABETES, V47, P980, DOI 10.2337/diabetes.47.6.980; Larsson HE, 2018, PEDIATR DIABETES, V19, P410, DOI 10.1111/pedi.12611; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; Long SA, 2017, CELL IMMUNOL, V319, P3, DOI 10.1016/j.cellimm.2017.07.007; Long SA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7793; Mahon JL, 2009, PEDIATR DIABETES, V10, P97, DOI 10.1111/j.1399-5448.2008.00464.x; Mathieu C, 2018, DIABETOLOGIA, V61, P2252, DOI 10.1007/s00125-018-4726-8; Mayer-Davis EJ, 2017, NEW ENGL J MED, V376, P1419, DOI 10.1056/NEJMoa1610187; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Morgan E, 2015, ACTA DIABETOL, V52, P801, DOI 10.1007/s00592-014-0702-z; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; Oram RA, 2014, DIABETOLOGIA, V57, P187, DOI 10.1007/s00125-013-3067-x; Orban T, 2014, DIABETES CARE, V37, P1069, DOI 10.2337/dc13-0604; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Ovalle F, 2018, NAT MED, V24, P1108, DOI 10.1038/s41591-018-0089-4; Patterson CC, 2007, DIABETOLOGIA, V50, P2439, DOI 10.1007/s00125-007-0824-8; Perdigoto AL, 2019, DIABETOLOGIA, V62, P655, DOI 10.1007/s00125-018-4786-9; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Rawshani A, 2018, LANCET, V392, P477, DOI 10.1016/S0140-6736(18)31506-X; Rewers M, 1996, J AUTOIMMUN, V9, P405, DOI 10.1006/jaut.1996.0055; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Rigby MR, 2015, J CLIN INVEST, V125, P3285, DOI 10.1172/JCI81722; Roep BO, 2019, LANCET DIABETES ENDO, V7, P65, DOI 10.1016/S2213-8587(18)30109-8; Rogers MAM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44193-4; Roll U, 1996, DIABETES, V45, P967, DOI 10.2337/diabetes.45.7.967; Roth R, 2015, PEDIATR DIABETES, V16, P287, DOI 10.1111/pedi.12168; SHAH SC, 1989, NEW ENGL J MED, V320, P550, DOI 10.1056/NEJM198903023200902; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Sorensen JS, 2013, DIABETES CARE, V36, P3454, DOI 10.2337/dc13-0418; Steck AK, 2019, J CLIN ENDOCR METAB, V104, P3337, DOI 10.1210/jc.2018-02196; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Takiishi T, 2017, DIABETES, V66, P448, DOI 10.2337/db15-1625; Tooley JE, 2016, EUR J IMMUNOL, V46, P230, DOI 10.1002/eji.201545708; Triolo TM, 2009, DIABETES CARE, V32, P769, DOI 10.2337/dc08-1872; Vaarala O, 2012, ARCH PEDIAT ADOL MED, V166, P608, DOI 10.1001/archpediatrics.2011.1559; Vandemeulebroucke E, 2009, DIABETES METAB, V35, P319, DOI 10.1016/j.diabet.2009.02.005; Vehik K, 2011, DIABETES CARE, V34, P1897, DOI 10.2337/dc11-0560; Waldron-Lynch F, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003401; Wasag DR, 2018, ARCH DIS CHILD, V103, P44, DOI 10.1136/archdischild-2016-312581; Willemsen RH, 2018, J CLIN ENDOCR METAB, V103, P3350, DOI 10.1210/jc.2018-00500; Winkler C, 2012, PEDIATR DIABETES, V13, P301, DOI 10.1111/j.1399-5448.2011.00829.x; You S, 2007, P NATL ACAD SCI USA, V104, P6335, DOI 10.1073/pnas.0701171104; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252; Ziegler AG, 2016, MOL METAB, V5, P255, DOI 10.1016/j.molmet.2016.02.003; Ziegler AG, 2011, J AUTOIMMUN, V37, P3, DOI 10.1016/j.jaut.2011.02.004	101	39	43	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2019	394	10205					1286	1296		10.1016/S0140-6736(19)32127-0	http://dx.doi.org/10.1016/S0140-6736(19)32127-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8XK	31533907				2022-12-28	WOS:000488862500034
J	Dai, S; Funk, LM; von Pappenheim, FR; Sautner, V; Paulikat, M; Schroder, B; Uranga, J; Mata, RA; Tittmann, K				Dai, Shaobo; Funk, Lisa-Marie; von Pappenheim, Fabian Rabe; Sautner, Viktor; Paulikat, Mirko; Schroder, Benjamin; Uranga, Jon; Mata, Ricardo A.; Tittmann, Kai			Low-barrier hydrogen bonds in enzyme cooperativity	NATURE			English	Article							COUPLED ELECTRON-TRANSFER; THIAMIN DIPHOSPHATE; PYRUVATE OXIDASE; BASIS-SETS; SITES REACTIVITY; E1 COMPONENT; ACTIVE-SITE; TRANSKETOLASE; CATALYSIS; PROTON	The underlying molecular mechanisms of cooperativity and allosteric regulation are well understood for many proteins, with haemoglobin and aspartate transcarbamoylase serving as prototypical examples(1,2). The binding of effectors typically causes a structural transition of the protein that is propagated through signalling pathways to remote sites and involves marked changes on the tertiary and sometimes even the quaternary level(1-5). However, the origin of these signals and the molecular mechanism of long-range signalling at an atomic level remain unclear(5-8). The different spatial scales and timescales in signalling pathways render experimental observation challenging; in particular, the positions and movement of mobile protons cannot be visualized by current methods of structural analysis. Here we report the experimental observation of fluctuating low-barrier hydrogen bonds as switching elements in cooperativity pathways of multimeric enzymes. We have observed these low-barrier hydrogen bonds in ultra-high-resolution X-ray crystallographic structures of two multimeric enzymes, and have validated their assignment using computational calculations. Catalytic events at the active sites switch between low-barrier hydrogen bonds and ordinary hydrogen bonds in a circuit that consists of acidic side chains and water molecules, transmitting a signal through the collective repositioning of protons by behaving as an atomistic Newton's cradle. The resulting communication synchronizes catalysis in the oligomer. Our studies provide several lines of evidence and a working model for not only the existence of low-barrier hydrogen bonds in proteins, but also a connection to enzyme cooperativity. This finding suggests new principles of drug and enzyme design, in which sequences of residues can be purposefully included to enable long-range communication and thus the regulation of engineered biomolecules.	[Dai, Shaobo; Funk, Lisa-Marie; von Pappenheim, Fabian Rabe; Sautner, Viktor; Tittmann, Kai] Georg August Univ Gottingen, Gottingen Ctr Mol Biosci, Dept Mol Enzymol, Gottingen, Germany; [Dai, Shaobo; Funk, Lisa-Marie; von Pappenheim, Fabian Rabe; Sautner, Viktor; Tittmann, Kai] Georg August Univ Gottingen, Albrecht von Haller Inst, Gottingen, Germany; [Dai, Shaobo; Funk, Lisa-Marie; von Pappenheim, Fabian Rabe; Sautner, Viktor; Tittmann, Kai] Max Planck Inst Biophys Chem Gottingen, Dept Struct Dynam, Gottingen, Germany; [Paulikat, Mirko; Schroder, Benjamin; Uranga, Jon; Mata, Ricardo A.] Georg August Univ Gottingen, Inst Phys Chem, Gottingen, Germany	University of Gottingen; University of Gottingen; Max Planck Society; University of Gottingen	Tittmann, K (corresponding author), Georg August Univ Gottingen, Gottingen Ctr Mol Biosci, Dept Mol Enzymol, Gottingen, Germany.; Tittmann, K (corresponding author), Georg August Univ Gottingen, Albrecht von Haller Inst, Gottingen, Germany.; Tittmann, K (corresponding author), Max Planck Inst Biophys Chem Gottingen, Dept Struct Dynam, Gottingen, Germany.; Mata, RA (corresponding author), Georg August Univ Gottingen, Inst Phys Chem, Gottingen, Germany.	rmata@gwdg.de; ktittma@gwdg.de	Dai, Shaobo/AAC-3450-2020; Mata, Ricardo A./AAC-4850-2020; Uranga, Jon/ABC-3945-2021	Mata, Ricardo A./0000-0002-2720-3364; Uranga, Jon/0000-0002-1256-6656; Funk, Lisa-Marie/0000-0003-2443-691X; Dai, Shaobo/0000-0002-1629-4483; Rabe von Pappenheim, Fabian/0000-0002-3925-8127; Schroder, Benjamin/0000-0002-4016-2034	Deutsche Forschungsgemeinschaft [FOR 1296/TP 3, MA 5063/2]; Gottingen Graduate Center for Neurosciences, Biophysics, and Molecular Biosciences; Max-Planck-Institute for Biophysical Chemistry Gottingen; Chinese Scholarship Council of the Chinese Government; Fundacion Ramon Areces, Spain	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gottingen Graduate Center for Neurosciences, Biophysics, and Molecular Biosciences; Max-Planck-Institute for Biophysical Chemistry Gottingen; Chinese Scholarship Council of the Chinese Government; Fundacion Ramon Areces, Spain	We thank J. P. Klinman, P. A. Frey, A. Warshel, R. Kluger, H. Stark, A. Chari, G. Bourenkhov, T. Schneider, G. Sheldrick, D. Hilvert, P. Neumann, D. Tawik, E. Pai, R. S. Prosser and G. Groenhof for discussions. We acknowledge access to beamlines P13 and P14 at DESY/EMBL Hamburg, Germany and local support by G. Bourenkhov and T. Schneider. This project was supported by grants from the Deutsche Forschungsgemeinschaft (FOR 1296/TP 3, to K. T.; MA 5063/2, to R.A.M.), the Gottingen Graduate Center for Neurosciences, Biophysics, and Molecular Biosciences (to K. T.), the Max-Planck-Institute for Biophysical Chemistry Gottingen (to K. T.), a PhD scholarship from the Chinese Scholarship Council of the Chinese Government (to S.D.) and a PostDoc scholarship from Fundacion Ramon Areces, Spain (to J.U.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Case D. A., 2021, AMBER 2022; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Elias M, 2012, NATURE, V491, P134, DOI 10.1038/nature11517; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hosur MV, 2013, CRYSTALLOGR REV, V19, P3, DOI 10.1080/0889311X.2013.771633; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KANTROWITZ ER, 1988, SCIENCE, V241, P669, DOI 10.1126/science.3041592; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Kim TH, 2017, SCIENCE, V355, DOI 10.1126/science.aag2355; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kumar P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas8667; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Ludtke S, 2013, NAT CHEM, V5, P762, DOI [10.1038/NCHEM.1728, 10.1038/nchem.1728]; Meyer D, 2013, NAT CHEM BIOL, V9, P488, DOI 10.1038/nchembio.1275; Meyer D, 2012, P NATL ACAD SCI USA, V109, P10867, DOI 10.1073/pnas.1201280109; Mitschke L, 2010, J BIOL CHEM, V285, P31559, DOI 10.1074/jbc.M110.149955; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MULLER YA, 1993, STRUCTURE, V1, P95, DOI 10.1016/0969-2126(93)90025-C; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria NS, 2010, J BIOL CHEM, V285, P11197, DOI 10.1074/jbc.M109.069179; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Neumann P, 2014, CURR OPIN STRUC BIOL, V29, P122, DOI 10.1016/j.sbi.2014.11.001; NIKKOLA M, 1994, J MOL BIOL, V238, P387, DOI 10.1006/jmbi.1994.1299; Paulikat M, 2017, BIOCHEMISTRY-US, V56, P1854, DOI 10.1021/acs.biochem.6b00984; Perrin CL, 1997, ANNU REV PHYS CHEM, V48, P511, DOI 10.1146/annurev.physchem.48.1.511; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Riplinger C, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4939030; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saha A, 2014, MOL CELL, V55, P264, DOI 10.1016/j.molcel.2014.05.028; Schroder-Tittmann K, 2013, BIOCHEMISTRY-US, V52, P2505, DOI 10.1021/bi301591e; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seifert F, 2006, BIOCHEMISTRY-US, V45, P12775, DOI 10.1021/bi061582l; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; Tittmann K, 2000, BIOCHEMISTRY-US, V39, P10747, DOI 10.1021/bi0004089; Tuckerman ME, 1997, SCIENCE, V275, P817, DOI 10.1126/science.275.5301.817; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WARSHEL A, 1995, SCIENCE, V269, P102, DOI 10.1126/science.7661987; Weigend F, 2006, PHYS CHEM CHEM PHYS, V8, P1057, DOI 10.1039/b515623h; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Wille G, 2003, BIOCHEMISTRY-US, V42, P14814, DOI 10.1021/bi035219f; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788; Zhu H, 2015, J AM CHEM SOC, V137, P5720, DOI 10.1021/ja512388n	63	37	37	13	113	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					609	+		10.1038/s41586-019-1581-9	http://dx.doi.org/10.1038/s41586-019-1581-9			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31534226				2022-12-28	WOS:000488247600064
J	Venkatesh, HS; Morishita, W; Geraghty, AC; Silverbush, D; Gillespie, SM; Arzt, M; Tam, LT; Espenel, C; Ponnuswami, A; Ni, LJ; Woo, PJ; Taylor, KR; Agarwal, A; Regev, A; Brang, D; Vogel, H; Hervey-Jumper, S; Bergles, DE; Suva, ML; Malenka, RC; Monje, M				Venkatesh, Humsa S.; Morishita, Wade; Geraghty, Anna C.; Silverbush, Dana; Gillespie, Shawn M.; Arzt, Marlene; Tam, Lydia T.; Espenel, Cedric; Ponnuswami, Anitha; Ni, Lijun; Woo, Pamelyn J.; Taylor, Kathryn R.; Agarwal, Amit; Regev, Aviv; Brang, David; Vogel, Hannes; Hervey-Jumper, Shawn; Bergles, Dwight E.; Suva, Mario L.; Malenka, Robert C.; Monje, Michelle			Electrical and synaptic integration of glioma into neural circuits	NATURE			English	Article							NEURONAL-ACTIVITY; GLUTAMATE RELEASE; GAP-JUNCTIONS; RNA-SEQ; CELLS; IMAGE; ACTIVATION; GROWTH; IDENTIFICATION; PROLIFERATION	High-grade gliomas are lethal brain cancers whose progression is robustly regulated by neuronal activity. Activity-regulated release of growth factors promotes glioma growth, but this alone is insufficient to explain the effect that neuronal activity exerts on glioma progression. Here we show that neuron and glioma interactions include electrochemical communication through bona fide AMPA receptor-dependent neuron-glioma synapses. Neuronal activity also evokes non-synaptic activity-dependent potassium currents that are amplified by gap junction-mediated tumour interconnections, forming an electrically coupled network. Depolarization of glioma membranes assessed by in vivo optogenetics promotes proliferation, whereas pharmacologically or genetically blocking electrochemical signalling inhibits the growth of glioma xenografts and extends mouse survival. Emphasizing the positive feedback mechanisms by which gliomas increase neuronal excitability and thus activity-regulated glioma growth, human intraoperative electrocorticography demonstrates increased cortical excitability in the glioma-infiltrated brain. Together, these findings indicate that synaptic and electrical integration into neural circuits promotes glioma progression.	[Venkatesh, Humsa S.; Geraghty, Anna C.; Gillespie, Shawn M.; Arzt, Marlene; Tam, Lydia T.; Ponnuswami, Anitha; Ni, Lijun; Woo, Pamelyn J.; Taylor, Kathryn R.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Morishita, Wade; Malenka, Robert C.; Monje, Michelle] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Morishita, Wade] Stanford Univ, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Silverbush, Dana] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Silverbush, Dana] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Silverbush, Dana; Regev, Aviv; Suva, Mario L.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Espenel, Cedric] Stanford Univ, Cell Sci Imaging Facil, Sch Med, Stanford, CA USA; [Agarwal, Amit; Bergles, Dwight E.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MA USA; [Regev, Aviv] MIT, Koch Inst Integrat Canc Res, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA; [Brang, David] Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48104 USA; [Vogel, Hannes; Monje, Michelle] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Vogel, Hannes; Monje, Michelle] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Hervey-Jumper, Shawn] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Monje, Michelle] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Agarwal, Amit] Heidelberg Univ, Inst Anat & Cell Biol, Chica & Heinz Schaller Res Grp, Heidelberg, Germany	Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Johns Hopkins University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan; Stanford University; Stanford University; University of California System; University of California San Francisco; Stanford University; Ruprecht Karls University Heidelberg	Monje, M (corresponding author), Stanford Univ, Dept Neurol, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mmonje@stanford.edu	Suva, Mario/AAY-7798-2020; Agarwal, Amit/B-7735-2008	Suva, Mario/0000-0001-9898-5351; espenel, cedric/0000-0002-8246-2879; Venkatesh, Humsa/0000-0003-1194-3015; Agarwal, Amit/0000-0001-7948-4498; Vogel, Otto Hannes/0000-0002-0960-3508; Tam, Lydia/0000-0002-9900-3249; Monje, Michelle/0000-0002-3547-237X	National Institutes of Health (NIH) Director's Common Fund [DP1 NS111132]; National Institute of Neurological Disorders and Stroke [R01 NS092597, K08 NS110919]; National Cancer Institute [F31 CA200273]; National Institutes of Mental Health [P50 MH086403]; Michael Mosier Defeat DIPG Foundation; ChadTough Foundation; V Foundation; Department of Defense [NF140075]; McKenna Claire Foundation; Alex's Lemonade Stand Foundation; Cure Starts Now Foundation; DIPG Collaborative; N8 Foundation; Abbie's Army Foundation; Brantley's Project - Ian's Friends Foundation; Waxman Family Research Fund; Joey Fabus Childhood Cancer Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Bio-X Institute; Maternal and Child Health Research Institute at Stanford; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; Cancer Research UK; Dr. Mildred Scheel Cancer Foundation [57406718]; Damon Runyan Foundation; Sontag Foundation Distinguished Scientist Award; Howard Hughes Medical Institute; Klarman Cell Observatory; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Chica and Heinz Schaller Research Foundation; Deutsche Forschungsgemeinschaft [AG 287/1-1]; Robert Wood Johnson Foundation [74259 RWJF]; Unravel Pediatric Cancer; NATIONAL CANCER INSTITUTE [F31CA200273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092597, P30NS069375, DP1NS111132] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director's Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Mosier Defeat DIPG Foundation; ChadTough Foundation; V Foundation; Department of Defense(United States Department of Defense); McKenna Claire Foundation; Alex's Lemonade Stand Foundation; Cure Starts Now Foundation; DIPG Collaborative; N8 Foundation; Abbie's Army Foundation; Brantley's Project - Ian's Friends Foundation; Waxman Family Research Fund; Joey Fabus Childhood Cancer Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Bio-X Institute; Maternal and Child Health Research Institute at Stanford; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; Cancer Research UK(Cancer Research UK); Dr. Mildred Scheel Cancer Foundation; Damon Runyan Foundation; Sontag Foundation Distinguished Scientist Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Chica and Heinz Schaller Research Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Unravel Pediatric Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge support from the National Institutes of Health (NIH) Director's Common Fund (DP1 NS111132 to M.M.), National Institute of Neurological Disorders and Stroke (R01 NS092597 to M. M., K08 NS110919 to S. H.-J.), National Cancer Institute (F31 CA200273 to H. S. V.), National Institutes of Mental Health (P50 MH086403 to R. C. M.), Michael Mosier Defeat DIPG Foundation (to M. M.), ChadTough Foundation (to M. M.), V Foundation (to M. M.), Department of Defense (NF140075 to M. M.), McKenna Claire Foundation (to M. M.), Alex's Lemonade Stand Foundation (to M. M.), The Cure Starts Now Foundation and DIPG Collaborative (to M. M.), Unravel Pediatric Cancer (to M. M.), N8 Foundation (to M. M.), Abbie's Army Foundation (to M. M.), Brantley's Project supported by Ian's Friends Foundation (to M. M.), Waxman Family Research Fund (to M. M.), Joey Fabus Childhood Cancer Foundation (to M. M.), Virginia and D. K. Ludwig Fund for Cancer Research (to M. M.), Bio-X Institute (to L. T. T. and A. C. G.), Maternal and Child Health Research Institute at Stanford (to M. M., A. C. G and H. S. V.), Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases (to M. M.), Cancer Research UK (to M. M.), Dr. Mildred Scheel Cancer Foundation (57406718 to M. A.), Damon Runyan Foundation (to K. R. T.), Sontag Foundation Distinguished Scientist Award (to M. L. S.), Howard Hughes Medical Institute (to A. R.), Klarman Cell Observatory (to A. R.), Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to D. E. B.), Chica and Heinz Schaller Research Foundation (to A. A.), Deutsche Forschungsgemeinschaft (AG 287/1-1 to A. A.), The Robert Wood Johnson Foundation (74259 RWJF to S. H.-J.). We thank S. Knemeyer for illustrations, and A. Olsen, S. Kakaizada and M. Shore for technical assistance.	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campbell SL, 2015, GLIA, V63, P23, DOI 10.1002/glia.22730; Campbell SL, 2012, EPILEPSIA, V53, P1360, DOI 10.1111/j.1528-1167.2012.03557.x; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Filbin MG, 2018, SCIENCE, V360, P331, DOI 10.1126/science.aao4750; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kawahara Y, 2003, EUR J NEUROSCI, V18, P23, DOI 10.1046/j.1460-9568.2003.02718.x; Kougioumtzidou E, 2017, ELIFE, V6, DOI 10.7554/eLife.28080; KUFFLER SW, 1967, PROC R SOC SER B-BIO, V168, P1, DOI 10.1098/rspb.1967.0047; Labrakakis C, 1998, EUR J NEUROSCI, V10, P2153, DOI 10.1046/j.1460-9568.1998.00226.x; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Lin GL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0553-x; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; Luk KC, 2004, DEV NEUROSCI-BASEL, V26, P218, DOI 10.1159/000082139; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Marins M, 2009, DEV NEUROBIOL, V69, P715, DOI 10.1002/dneu.20737; McKhann GM, 1997, J NEUROSCI, V17, P6850; Ohtaka-Maruyama C, 2018, SCIENCE, V360, P313, DOI 10.1126/science.aar2866; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pietzsch T, 2012, BIOINFORMATICS, V28, P3009, DOI 10.1093/bioinformatics/bts543; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Qin EY, 2017, CELL, V170, P845, DOI 10.1016/j.cell.2017.07.016; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sibille J, 2014, J PHYSIOL-LONDON, V592, P87, DOI 10.1113/jphysiol.2013.261735; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Sontheimer H, 2008, J NEUROCHEM, V105, P287, DOI 10.1111/j.1471-4159.2008.05301.x; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; Venkataramani V, 2019, NATURE, V573, P532, DOI 10.1038/s41586-019-1564-x; Venkatesh HS, 2017, NATURE, V549, P533, DOI 10.1038/nature24014; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Vinci M, 2015, JOVE-J VIS EXP, DOI 10.3791/52686; Vinci Maria, 2013, Methods Mol Biol, V986, P253, DOI 10.1007/978-1-62703-311-4_16; Wu D, 2017, NATURE, V544, P316, DOI 10.1038/nature21720; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	58	358	366	23	198	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					539	+		10.1038/s41586-019-1563-y	http://dx.doi.org/10.1038/s41586-019-1563-y			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31534222	Green Published, Green Accepted			2022-12-28	WOS:000488247600050
J	Wexler, DJ				Wexler, Deborah J.			Sulfonylureas and Cardiovascular Safety: The Final Verdict?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EVENTS; METAANALYSIS; OUTCOMES; DRUGS		[Wexler, Deborah J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Diabet, 50 Staniford St,Ste 301, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Wexler, DJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Diabet, 50 Staniford St,Ste 301, Boston, MA 02114 USA.	dwexler@mgh.harvard.edu	Wexler, Deborah/AAE-4205-2019	Wexler, Deborah/0000-0001-6979-402X				Azoulay L, 2017, DIABETES CARE, V40, P706, DOI 10.2337/dc16-1943; Bain S, 2017, DIABETES OBES METAB, V19, P329, DOI 10.1111/dom.12821; BRADLEY RF, 1975, JAMA-J AM MED ASSOC, V232, P813, DOI 10.1001/jama.232.8.813; Cefalu WT, 2018, DIABETES CARE, V41, P14, DOI 10.2337/dci17-0057; Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI 10.2337/dci18-0033; Douros A, 2017, DIABETES CARE, V40, P1506, DOI 10.2337/dc17-0595; Gangji AS, 2007, DIABETES CARE, V30, P389, DOI 10.2337/dc06-1789; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Leonard CE, 2017, TRENDS ENDOCRIN MET, V28, P561, DOI 10.1016/j.tem.2017.04.003; MEINERT CL, 1970, DIABETES, V19, P789; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V322, P1155, DOI 10.1001/jama.2019.13772; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V321, P69, DOI 10.1001/jama.2018.18269; Roumie CL, 2019, JAMA-J AM MED ASSOC, V322, P1167, DOI 10.1001/jama.2019.13206; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Wexler DJ, 2019, DIABETES CARE, DOI [10.2337/dc19-090131391203, DOI 10.2337/DC19-090131391203]; World Health Organization, GUID 2 3 LIN MED TYP	17	7	7	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1147	1149		10.1001/jama.2019.14533	http://dx.doi.org/10.1001/jama.2019.14533			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31536110				2022-12-28	WOS:000488822800019
J	Al-Mandhari, A				Al-Mandhari, Ahmed			Public health in the Eastern Mediterranean Region: profound challenges, huge opportunities	LANCET			English	Editorial Material									[Al-Mandhari, Ahmed] WHO, Reg Off Eastern Mediterranean, POB 7608, Cairo 11371, Egypt	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization	Al-Mandhari, A (corresponding author), WHO, Reg Off Eastern Mediterranean, POB 7608, Cairo 11371, Egypt.	almandharia@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Federspiel F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6227-6; Fikri M, 2018, E MEDITERR HEALTH J, V24, P3, DOI 10.26719/2018.24.1.3; Gedik FG, 2018, E MEDITERR HEALTH J, V24, P811, DOI [10.26719/2018.24.9.811, 10.26719.2018.24.9.811]; Global Alliance to Eliminate Lymphatic Filariasis (GAELF), 2019, YEM EL LF PUBL HLTH; Mere MO, 2019, MMWR-MORBID MORTAL W, V68, P505, DOI 10.15585/mmwr.mm6822a4; UN Inter-agency Group for Child Mortality Estimation, 2015, LEVELS TRENDS CHILD; United Nations Department of Economic and Social Affairs Population Division, 2019, WORLD POP PROSP; WHO, 2019, 1 M REG PARL FOR HLT; WHO, 2018, LANDM IN CONTR REG S; WHO, 2019, WHO DECL COUNTR MEAS; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization Regional Office for Eastern Mediterranean (WHO/EMRO), 2018, VIS 2023; World Health Organization (WHO), 2019, POL STAT 21 IHR EM C	13	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					992	993		10.1016/S0140-6736(19)32138-5	http://dx.doi.org/10.1016/S0140-6736(19)32138-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31544751				2022-12-28	WOS:000487038700010
J	Lubick, N; Jarhult, J				Lubick, Naomi; Jarhult, Josef			Resistance in the wild	NATURE			English	Editorial Material									[Jarhult, Josef] Uppsala Univ, Uppsala, Sweden	Uppsala University			Jarhult, Josef D./ABE-8149-2020	Jarhult, Josef D./0000-0002-7075-1059				Gillman A, 2015, APPL ENVIRON MICROB, V81, P2378, DOI 10.1128/AEM.04034-14; Jarhult JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024742; Takanami R., 2010, Journal of Water and Environment Technology, V8, P363, DOI 10.2965/jwet.2010.363	3	0	0	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					S53	S53		10.1038/d41586-019-02752-9	http://dx.doi.org/10.1038/d41586-019-02752-9			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534254				2022-12-28	WOS:000486647800005
J	Yamin, F				Yamin, Farhana			Why I broke the law for climate change	NATURE			English	Editorial Material									[Yamin, Farhana] Royal Inst Int Affairs, Chatham House, London, England		Yamin, F (corresponding author), Royal Inst Int Affairs, Chatham House, London, England.	farhana.yamin@track0.org							0	3	3	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					337	339		10.1038/d41586-019-02736-9	http://dx.doi.org/10.1038/d41586-019-02736-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31530927				2022-12-28	WOS:000486647800021
J	Nave, AH; Rackoll, T; Grittner, U; Blasing, H; Gorsler, A; Nabavi, DG; Audebert, HJ; Klostermann, F; Muller-Werdan, U; Steinhagen-Thiessen, E; Meisel, A; Endres, M; Hesse, S; Ebinger, M; Floel, A				Nave, Alexander H.; Rackoll, Torsten; Grittner, Ulrike; Blaesing, Holger; Gorsler, Anna; Nabavi, Darius G.; Audebert, Heinrich J.; Klostermann, Fabian; Mueller-Werdan, Ursula; Steinhagen-Thiessen, Elisabeth; Meisel, Andreas; Endres, Matthias; Hesse, Stefan; Ebinger, Martin; Floeel, Agnes			Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): multicentre, randomised controlled, endpoint blinded trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE PROFESSIONALS; REHABILITATION; RECOVERY; INTENSITY; EXERCISE; SURVIVORS; EFFICACY; OUTCOMES; THERAPY; WALKING	OBJECTIVE To determine the safety and efficacy of aerobic exercise on activities of daily living in the subacute phase after stroke. DESIGN Multicentre, randomised controlled, endpoint blinded trial. SETTING Seven inpatient rehabilitation sites in Germany (2013-17). PARTICIPANTS 200 adults with subacute stroke (days 5-45 after stroke) with a median National Institutes of Health stroke scale (NIHSS, range 0-42 points, higher values indicating more severe strokes) score of 8 (interquartile range 5-12) were randomly assigned (1: 1) to aerobic physical fitness training (n=105) or relaxation sessions (n=95, control group) in addition to standard care. INTERVENTION Participants received either aerobic, bodyweight supported, treadmill based physical fitness training or relaxation sessions, each for 25 minutes, five times weekly for four weeks, in addition to standard rehabilitation therapy. Investigators and endpoint assessors were masked to treatment assignment. MAIN OUTCOME MEASURES The primary outcomes were change in maximal walking speed (m/s) in the 10 m walking test and change in Barthel index scores (range 0-100 points, higher scores indicating less disability) three months after stroke compared with baseline. Safety outcomes were recurrent cardiovascular events, including stroke, hospital readmissions, and death within three months after stroke. Efficacy was tested with analysis of covariance for each primary outcome in the full analysis set. Multiple imputation was used to account for missing values. RESULTS Compared with relaxation, aerobic physical fitness training did not result in a significantly higher mean change in maximal walking speed (adjusted treatment effect 0.1 m/s (95% confidence interval 0.0 to 0.2 m/s), P=0.23) or mean change in Barthel index score (0 (-5 to 5), P=0.99) at three months after stroke. A higher rate of serious adverse events was observed in the aerobic group compared with relaxation group (incidence rate ratio 1.81, 95% confidence interval 0.97 to 3.36). CONCLUSIONS Among moderately to severely affected adults with subacute stroke, aerobic bodyweight supported, treadmill based physical fitness training was not superior to relaxation sessions for maximal walking speed and Barthel index score but did suggest higher rates of adverse events. These results do not appear to support the use of aerobic bodyweight supported fitness training in people with subacute stroke to improve activities of daily living or maximal walking speed and should be considered in future guidelines.	[Nave, Alexander H.; Rackoll, Torsten; Audebert, Heinrich J.; Meisel, Andreas; Endres, Matthias; Ebinger, Martin; Floeel, Agnes] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Nave, Alexander H.; Audebert, Heinrich J.; Klostermann, Fabian; Meisel, Andreas; Endres, Matthias] Charite Univ Med Berlin, Klin & Hsch Ambulanz Neurol, Berlin, Germany; [Nave, Alexander H.; Endres, Matthias] German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Nave, Alexander H.; Grittner, Ulrike; Endres, Matthias] Berlin Inst Hlth, Berlin, Germany; [Rackoll, Torsten; Gorsler, Anna] Kliniken Beelitz, Beelitz, Germany; [Grittner, Ulrike] Charite Univ Med Berlin, Inst Biometry & Clin Epidemiol, Berlin, Germany; [Blaesing, Holger] Median Klin Grunheide, Grunheide, Germany; [Nabavi, Darius G.] Vivantes Klinikum Neukolln, Klin Neurol, Berlin, Germany; [Mueller-Werdan, Ursula; Steinhagen-Thiessen, Elisabeth] Evangel Geriatriezentrum Berlin, Berlin, Germany; [Meisel, Andreas; Endres, Matthias] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Endres, Matthias] German Ctr Neurodegenerat Dis, Partner Site Berlin, Berlin, Germany; [Hesse, Stefan; Ebinger, Martin] Med Pk Berlin Humboldtmuhle, Berlin, Germany; [Floeel, Agnes] Univ Med Greifswald, Dept Neurol, Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany; [Floeel, Agnes] German Ctr Neurodegenerat Dis, Partner Site, Rostock, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; VIivantes Klinikum Neukolln; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Greifswald Medical School; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Floel, A (corresponding author), Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany.; Floel, A (corresponding author), Univ Med Greifswald, Dept Neurol, Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany.; Floel, A (corresponding author), German Ctr Neurodegenerat Dis, Partner Site, Rostock, Germany.	agnes.floeel@med.uni-greifswald.de	Grittner, Ulrike/I-2026-2019	Grittner, Ulrike/0000-0003-2595-0224; Audebert, Heinrich J./0000-0002-4785-0366; Endres, Matthias/0000-0001-6520-3720; Rackoll, Torsten/0000-0003-2170-5803; Meisel, Andreas/0000-0001-7233-5342	German Ministry for Health and Education through Center for Stroke Research Berlin grant [01EO0801, G.2.15]	German Ministry for Health and Education through Center for Stroke Research Berlin grant	This trial was supported by the German Ministry for Health and Education (01EO0801) through Center for Stroke Research Berlin grant G.2.15. The funder had no role in study design; data collection, analysis, or interpretation; or writing manuscript. AHN, AF, TR, MEb, and UG had full access to all the data in the study and the corresponding author had final responsibility for the decision to submit for publication.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; [Anonymous], R LANG ENV STAT COMP; Bernhardt J, 2017, INT J STROKE, V12, P444, DOI 10.1177/1747493017711816; Bernhardt J, 2017, CURR OPIN NEUROL, V30, P48, DOI 10.1097/WCO.0000000000000404; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Bushnell C, 2015, CIRC-CARDIOVASC QUAL, V8, pS163, DOI 10.1161/CIRCOUTCOMES.115.002098; Catanese L, 2017, CIRC RES, V120, P541, DOI 10.1161/CIRCRESAHA.116.309278; Collen F M, 1991, Int Disabil Stud, V13, P50; Crichton SL, 2016, J NEUROL NEUROSUR PS, V87, P1091, DOI 10.1136/jnnp-2016-313361; da Cunha IT, 2002, ARCH PHYS MED REHAB, V83, P1258, DOI 10.1053/apmr.2002.34267; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Eich HJ, 2004, CLIN REHABIL, V18, P640, DOI 10.1191/0269215504cr779oa; English C, 2015, INT J STROKE, V10, P594, DOI 10.1111/ijs.12470; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Floel A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-45; Globas C, 2012, NEUROREHAB NEURAL RE, V26, P85, DOI 10.1177/1545968311418675; IBM, REL 2016 IBM SPSS ST; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; MAHONEY F I, 1965, Md State Med J, V14, P61; Medical University of Graz, RAND; Mehrholz J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002840.pub4; Nave AH, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-197; Pohl M, 2007, CLIN REHABIL, V21, P17, DOI 10.1177/0269215506071281; Saunders DH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub6; StataCorp, 2015, STAT STAT SOFTW REL; Strommen AM, 2016, INT J REHABIL RES, V39, P145, DOI 10.1097/MRR.0000000000000158; Tyson SF, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0588-2; van Buuren S, 2011, J STAT SOFTW, V45, P1; van de Port IGL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2672; Wang Z, 2014, J STROKE CEREBROVASC, V23, pE187, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.021; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Winters C, 2017, NEUROREHAB NEURAL RE, V31, P334, DOI 10.1177/1545968316680492; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980	39	27	29	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2019	366								l5101	10.1136/bmj.l5101	http://dx.doi.org/10.1136/bmj.l5101			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VZ	31533934	Green Published, hybrid			2022-12-28	WOS:000487759000002
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: A hostile environment in the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						[Anonymous], 2018, E LONDON LINES  0926; BMA, 2019, BMA SAYS CHARG REG O; Department of Health and Social Care, 2018, OV NHS VIS IMPL CHAR; Gentleman A, 2018, GUARDIAN; O'Donnell K, 2019, BMJ OPINION	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5328	10.1136/bmj.l5328	http://dx.doi.org/10.1136/bmj.l5328			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530551	Bronze			2022-12-28	WOS:000487758600003
J	Legido-Quigley, H; Pocock, N; Tan, ST; Pajin, L; Suphanchaimat, R; Wickramage, K; McKee, M; Pottie, K				Legido-Quigley, Helena; Pocock, Nicola; Tan, Sok Teng; Pajin, Leire; Suphanchaimat, Repeepong; Wickramage, Kol; McKee, Martin; Pottie, Kevin			Healthcare is not universal if undocumented migrants are excluded	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EUROPEAN-UNION; MIGRATION; POLICIES; MEASLES; ACCESS; IMPACT; FUTURE		[Legido-Quigley, Helena; Tan, Sok Teng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Legido-Quigley, Helena; Pocock, Nicola; McKee, Martin] London Sch Hyg & Trop Med, London, England; [Legido-Quigley, Helena] Univ Lleida, Dept Nursing & Physiotherapy, Lleida, Spain; [Pocock, Nicola] United Nations Univ, Int Inst Global Hlth, Kuala Lumpur, Malaysia; [Pajin, Leire] Inst Salud Global Barcelona, Barcelona, Spain; [Suphanchaimat, Repeepong] Minist Publ Hlth, IHPP, Nonthaburi, Thailand; [Wickramage, Kol] Int Org Migrat, Geneva, Switzerland; Univ Ottawa, Dept Family Med, Ottawa, ON, Canada	National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; Universitat de Lleida; Ministry of Public Health - Thailand; International Organization for Migration; University of Ottawa	Legido-Quigley, H (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Legido-Quigley, H (corresponding author), London Sch Hyg & Trop Med, London, England.; Legido-Quigley, H (corresponding author), Univ Lleida, Dept Nursing & Physiotherapy, Lleida, Spain.	ephhlq@nus.edu.sg	Pottie, Kevin/ABC-4385-2020					Asanin J, 2008, SOC SCI MED, V66, P1271, DOI 10.1016/j.socscimed.2007.11.043; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Banzon EP, 2017, RISING MIGRATION DEM; Barajas J., 2018, 2 MIGRANT CHILD DIED; Bloom D, 2003, GENEVA PAP R I-ISS P, V28, P304, DOI 10.1111/1468-0440.00225; Bozorgmehr K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080894; Bozorgmehr K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131483; Cortes R., 2017, HUMAN RIGHTS MIGRANT; Dovidio JF, 2017, GROUP PROCESS INTERG, V20, P606, DOI 10.1177/1368430217712052; Forman L, 2016, HEALTH HUM RIGHTS, V18, P23; Harrigan NM, 2017, J IMMIGR MINOR HEALT, V19, P511, DOI 10.1007/s10903-016-0532-x; Hiam L, 2018, HEALTH ECON POLICY L, V13, P107, DOI 10.1017/S1744133117000251; Ingleby D, 2019, EUR J PUBLIC HEALTH, V29, P458, DOI 10.1093/eurpub/cky233; IOM, 2018, IOM DG SWING CALLS G; Kantayaporn T, 2013, ESTIMATION TRANSNATI; Kirmayer LJ, 2011, CAN MED ASSOC J, V183, pE959, DOI 10.1503/cmaj.090292; Legido-Quigley H, 2018, LANCET PUBLIC HEALTH, V3, pE358, DOI 10.1016/S2468-2667(18)30133-6; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; McKee R, 2016, J ETHN MIGR STUD, V42, P777, DOI 10.1080/1369183X.2015.1081055; Mendelsohn JB, 2014, AIDS BEHAV, V18, P323, DOI 10.1007/s10461-013-0494-0; Mestres AJ, 2018, DEADLY EFFECTS LOSIN; Ministry of Health IOM WHO, 2017, LEAV NO ON CALL ACT; Mladovsky P, 2012, CLIN MED, V12, P248, DOI 10.7861/clinmedicine.12-3-248; Mladovsky P, 2012, HEALTH POLICY, V105, P1, DOI 10.1016/j.healthpol.2012.01.007; Noja GG, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10030894; Noy S, 2016, J INT MIGR INTEGR, V17, P605, DOI 10.1007/s12134-015-0416-2; Odone A, 2018, INT J CARDIOL, V254, P356, DOI 10.1016/j.ijcard.2017.11.084; Odone A, 2015, EUR J PUBLIC HEALTH, V25, P506, DOI 10.1093/eurpub/cku208; Office of Foreign Workers Administration, 2015, STAT CROSS BORD MIGR; Organization for Economic Cooperation and Development (OECD), 2016, HLTH WORK FORC POL O, DOI [10.1787/9789264239517-en, DOI 10.1787/9789264239517-EN]; Prasitsiriphol O, 2013, REV HLTH INSURANCE P; Rudiger A, 2003, SOCIAL INTEGRATION M; Suphanchaimat R, 2013, EVALUATION SYSTEM MA; Suphanchaimat R, 2017, RISK MANAG HEALTHC P, V10, P49, DOI 10.2147/RMHP.S130442; Sweileh WM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5689-x; Takla A, 2012, EPIDEMIOL INFECT, V140, P1589, DOI 10.1017/S0950268811002597; Tangcharoensathien V, 2017, B WORLD HEALTH ORGAN, V95, P146, DOI [10.2471/BLT.16.179606, 10.2471/blt.16.179606]; UNHCR, 2018, US EXP US REL MIGR C; United Nations, 2017, INT MIGR REP 2017 HI; Ursula T, 2016, COST ANAL HLTH CARE; Wickramage K, 2017, J FORENSIC LEG MED, V45, P1, DOI 10.1016/j.jflm.2016.11.001; Willen SS, 2012, SOC SCI MED, V74, P805, DOI 10.1016/j.socscimed.2011.10.041; Williams GA, 2016, SCAND J PUBLIC HEALT, V44, P6, DOI 10.1177/1403494815610182; World Health Organization World Bank, 2017, TRACK UN HLTH COV 20; Zimmerman C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001034	46	38	38	3	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l4160	10.1136/bmj.l4160	http://dx.doi.org/10.1136/bmj.l4160			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JA3VP	31527060	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000487758000002
J	Tanne, JH				Tanne, Janice Hopkins			Training surgeons with clickers and warm scrotum studies win Ig Nobel awards	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							PIZZA; RISK											Bengoudifa B, 2007, HUM REPROD, V22, P2178, DOI 10.1093/humrep/dem133; Gallus S, 2006, EUR J CANCER PREV, V15, P74, DOI 10.1097/01.cej.0000186632.04625.f6; Gallus S, 2004, EUR J CLIN NUTR, V58, P1543, DOI 10.1038/sj.ejcn.1601997; Gallus S, 2003, INT J CANCER, V107, P283, DOI 10.1002/ijc.11382; Gedik H, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-22; Levy IM, 2016, CLIN ORTHOP RELAT R, V474, P945, DOI 10.1007/s11999-015-4555-8	6	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l5574	10.1136/bmj.l5574	http://dx.doi.org/10.1136/bmj.l5574			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VP	31527163				2022-12-28	WOS:000487758000008
J	Germain, RN				Germain, Ronald N.			The Cellular Determinants of Adaptive Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THYMUS	Major advances in treating cancer and autoimmune disease, not to mention the development of novel vaccines, are founded on the delineation of the adaptive immune system by Max Dale Cooper and Jacques Miller, who have been awarded the 2019 Albert Lasker Basic Medical Research Award.	[Germain, Ronald N.] NIAID, Lab Imm Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lab Imm Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Germain, Ronald/ABE-7090-2020					COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; GOWANS JL, 1962, NATURE, V196, P651, DOI 10.1038/196651a0; MILLER JF, 1961, LANCET, V2, P748; MILLER JFA, 1968, J EXP MED, V128, P801, DOI 10.1084/jem.128.4.801	5	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					1083	1085		10.1056/NEJMcibr1909387	http://dx.doi.org/10.1056/NEJMcibr1909387			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY2MW	31502768				2022-12-28	WOS:000486225900018
J	Kaski, D; Agarwal, K; Murdin, L				Kaski, Diego; Agarwal, Kiran; Murdin, Louisa			Acute vertigo	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PAROXYSMAL POSITIONAL VERTIGO; EPIDEMIOLOGY		[Kaski, Diego] Natl Hosp Neurol & Neurosurg, London, England; [Agarwal, Kiran] Eastwick Pk Med Practice, Surrey, England; [Murdin, Louisa] Guys Hosp, Guys & St Thomas NHS Fdn Trust, Ear Nose & Throat Dept, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Murdin, L (corresponding author), Guys Hosp, Guys & St Thomas NHS Fdn Trust, Ear Nose & Throat Dept, London, England.	Louisa.Murdin@gstt.nhs.uk	Kaski, Diego/GQY-5716-2022					Moreno JLB, 2019, BRIT J GEN PRACT, V69, pE52, DOI 10.3399/bjgp18X700253; Barraclough K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3493; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Amor-Dorado JC, 2012, OTOL NEUROTOL, V33, P1401, DOI 10.1097/MAO.0b013e318268d50a; Carmona S, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00125; Cousins S, 2017, ANN CLIN TRANSL NEUR, V4, P340, DOI 10.1002/acn3.386; Helminski JO, 2010, PHYS THER, V90, P663, DOI 10.2522/ptj.20090071; Kaski Diego, 2014, Pract Neurol, V14, P210, DOI 10.1136/practneurol-2013-000690; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Murdin L, 2015, J NEUROL NEUROSUR PS, V86, P585, DOI 10.1136/jnnp-2014-308331; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; Nguyen-Huynh AT, 2012, OTOLARYNG CLIN N AM, V45, P925, DOI 10.1016/j.otc.2012.06.001; Tarnutzer AA, 2011, CAN MED ASSOC J, V183, P1025, DOI 10.1503/cmaj.100174; UK government, DIZZ VERT DRIV; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; von Brevern M, 2016, HAND CLINIC, V137, P301, DOI 10.1016/B978-0-444-63437-5.00022-4	17	5	5	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2019	366								l5215	10.1136/bmj.l5215	http://dx.doi.org/10.1136/bmj.l5215			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MV	31515203				2022-12-28	WOS:000486649600002
J	Cooper, K; Breeman, S; Scott, NW; Scotland, G; Clark, J; Hawe, J; Hawthorn, R; Phillips, K; MacLennan, G; Wileman, S; McCormack, K; Hernandez, R; Norrie, J; Bhattacharya, S; Ashok, P; Karavalos, S; Paulose, M; Pirie, D; Saraswat, L; Saleh, S; Valentine, R; Wallage, S; Thakur, Y; Allen, K; Angala, P; Chan, YY; Ghobrial, M; Gupta, N; Jadhav, J; Joseph, E; Kalburg, S; Mannan, S; McCormack, C; Nicholson, A; Pepper, S; Redman, E; Southam, D; Phillips, C; Moody, J; Jones, CR; Sayer, T; Clark, TJ; Afiffi, Y; Beale, F; Galloway, A; Gupta, J; Iqbal, V; McCooty, S; Smith, P; Stevenson, H; Taylor, J; Byrne, D; Adams, B; Andrew, A; Bates, S; Bishieri, S; Dingle, J; Fouracres, A; Hammonds, F; Holmes, R; Lone, F; Lord, J; Smith-Walker, T; Summer, J; Trembath, L; Verity, L; Weeks, A; Hawe, J; Ford, J; Gallimore, E; Haddad, N; Jefferey, H; Kearsley, N; Leason, S; McCormack, MJ; Van Rij, J; Wood, S; Sengupta, P; Atikinson, V; Beukenholdt, R; Bradley, J; Dent, J; Jennings, J; Sen, S; Sindhu, V; Walton, E; Jack, S; Critchley, H; Devlin, J; Dewart, P; Hall, C; Horne, A; Whitaker, L; Lim, C; Aitken, J; Beveridge, L; Boath, K; Smith, I; Thanoon, O; Milling-Smith, O; Gardiner, J; Huda, S; Sewnauth, K; Hawthorn, R; Archibald, C; Bjornsson, S; Hardwick, C; McSorley, T; Mckay, L; Paterson, K; Phillips, K; Allen, J; Biervliet, F; Bexhell, H; Boakye, S; Brown, H; Fauvre, A; Hayes, M; Hingaroni, J; Lesny, P; Mitchelson, K; Mumdzjans, A; Oboh, A; Chappatte, M; Kovoor, E; Nolan, T; Sokolova, I; Gilmour, D; Henry, M; Chalhoub, T; Harbertson, S; Kimber, A; Lennox, K; Murtha, V; Roberts, M; Russell, M; von Widekind, C; Dudgeon, L; Hall, K; Hitchcock, R; Smith, G; Roy, S; Bage, P; Bano-Mahroo, M; Basu, D; Croft, S; Gowans, S; Jones, AM; Kelsey, S; Mostafa, H; Mullens, S; Nalawade, A; Puthuraya, S; Samuels, A; Tate, R; Wadia, R; Wilkinson, M; Carpenter, T; Chalk, A; Webster, D; Freeman, R; Frappell, J; Caukwell, S; Hollands, H; Patrick, A; Rodriguez, B; Francis, S; Gardner, A; Grossmith, A; Hughes, S; Langley, C; Murphy, L; Noor, C; Robinson, K; Sanders, K; Tattersall, M; Wilson-Theaker, W; Wittersheim, R; Yeowart, K; Baxter, T; Duffy, S; Salman, T; Pickersgill, A; Barber, L; Cochrane, H; Grindey, J; Miligkos, D; Burtt, A; Forbes, J; Rand, A; Umranikar, S; Walbridge, F; Wellstead, S; Khatri, P; Alexander, H; Croft, S; Cuthbert, H; Hebblethwaite, N; Khunda, A; Manda, P; Mohammed, D; Peatman, S; Potts, J; Rao, S; Matthews, N; Chamberlain, J; Ahmed, A; Cameron, H; Herdman, K; Hinshaw, K; Mathew, P; Ormonde, J; Scollen, J; Ullal, A; Walton, E; Yossry, M; Banerjee, S; Atkinson, C; Brown, L; Davis, M; Gilbert, R; Khazali, S; Peers, B; Sharpe, L; Odejinmi, F; Dawlatly, B; Gorry, A; Jones, P; Maseko, Z; Shahid, A; Vimplis, S; Louden, K; Behrens, R; Martin, J; Trodd, D; Brown, CW; Aust, T; Alam, A; Ashraf, K; Doyle, M; Ellard, M; Grindey, J; Mwenechanya, S; Shaw, L; Steele, G; Minas, V; Weetch, J; Thomson, A; Cashmore, V; Hughes, J; Kelly, D; Pathak, M; Waters, N; Cannons, V; Flynn-Batham, M; Funnell, S; Gkrozou, F; House, S				Cooper, Kevin; Breeman, Suzanne; Scott, Neil W.; Scotland, Graham; Clark, Justin; Hawe, Jed; Hawthorn, Robert; Phillips, Kevin; MacLennan, Graeme; Wileman, Samantha; McCormack, Kirsty; Hernandez, Rodolfo; Norrie, John; Bhattacharya, Siladitya; Ashok, Premila; Karavalos, Stamatios; Paulose, Mini; Pirie, Danielle; Saraswat, Lucky; Saleh, Sherif; Valentine, Ruth; Wallage, Sarah; Thakur, Yatin; Allen, Kellie; Angala, Preethi; Chan, Yee Yin; Ghobrial, Mamdouh; Gupta, Neerja; Jadhav, J.; Joseph, Elisabeth; Kalburg, Syathe; Mannan, Shaneen; McCormack, Claire; Nicholson, Anne; Pepper, Stacey; Redman, Emily; Southam, Donna; Phillips, Christian; Moody, Jackie; Jones, Clare Rowe; Sayer, Tim; Clark, T. Justin; Afiffi, Yousri; Beale, Fiona; Galloway, Andrea; Gupta, Janesh; Iqbal, Virginia; McCooty, Shanteela; Smith, Paul; Stevenson, Helen; Taylor, Jennifer; Byrne, Dominic; Adams, Benita; Andrew, Alyson; Bates, Susan; Bishieri, Samy; Dingle, Jacqueline; Fouracres, Anna; Hammonds, Fiona; Holmes, Rob; Lone, Farah; Lord, Jonathan; Smith-Walker, Tom; Summer, Jessica; Trembath, Lisa; Verity, Liz; Weeks, Abigail; Hawe, Jed; Ford, Jonathan; Gallimore, Elizabeth; Haddad, Nabil; Jefferey, Helen; Kearsley, Nichola; Leason, Sandra; McCormack, Michael J.; Van Rij, Janneke; Wood, Simon; Sengupta, Partha; Atikinson, Vicki; Beukenholdt, Remko; Bradley, Jonathan; Dent, Jean; Jennings, Jacqueline; Sen, Seema; Sindhu, Velur; Walton, Eileen; Jack, Stuart; Critchley, Hilary; Devlin, Jennifer; Dewart, Paul; Hall, Catherine; Horne, Andrew; Whitaker, Lucy; Lim, Chu; Aitken, Julie; Beveridge, Laura; Boath, Keith; Smith, Isla; Thanoon, Omar; Milling-Smith, Oliver; Gardiner, Jacqueline; Huda, Shahzya; Sewnauth, Kara; Hawthorn, Robert; Archibald, Carol; Bjornsson, Steingrimur; Hardwick, Chris; McSorley, Therese; Mckay, Lorna; Paterson, Kirsteen; Phillips, Kevin; Allen, Jane; Biervliet, Frank; Bexhell, Helen; Boakye, Stephen; Brown, Helen; Fauvre, Adrian; Hayes, Melony; Hingaroni, Jaishree; Lesny, Piotr; Mitchelson, Kim; Mumdzjans, Androniks; Oboh, Alexander; Chappatte, Mr; Kovoor, Elias; Nolan, Tracey; Sokolova, Inna; Gilmour, Danielle; Henry, Margo; Chalhoub, Tony; Harbertson, Sue; Kimber, Alison; Lennox, Kayleigh; Murtha, Victoria; Roberts, Mark; Russell, Michelle; von Widekind, Clemens; Dudgeon, Lucy; Hall, Kathy; Hitchcock, Rachael; Smith, Gillian; Roy, Somon; Bage, Patricia; Bano-Mahroo, Misra; Basu, Dolan; Croft, Sarah; Gowans, Sharon; Jones, Anne Marie; Kelsey, Susan; Mostafa, Hany; Mullens, Sue; Nalawade, Atul; Puthuraya, Santhosh; Samuels, Alison; Tate, Rebecca; Wadia, Ratan; Wilkinson, Maggie; Carpenter, Tyrone; Chalk, Anne; Webster, Daniel; Freeman, Robert; Frappell, Jonathan; Caukwell, Sarah; Hollands, Heidi; Patrick, Abigail; Rodriguez, Brice; Francis, Sarah; Gardner, Anne; Grossmith, Annabel; Hughes, Sean; Langley, Catherine; Murphy, Lauren; Noor, Claire; Robinson, Katie; Sanders, Katy; Tattersall, Mark; Wilson-Theaker, William; Wittersheim, Robyn; Yeowart, Katey; Baxter, Ted; Duffy, Sheila; Salman, Tarique; Pickersgill, Andrew; Barber, Lindsay; Cochrane, Helen; Grindey, Julie; Miligkos, Dimitrios; Burtt, Agnieszka; Forbes, Jane; Rand, Abby; Umranikar, Sameer; Walbridge, Fiona; Wellstead, Susan; Khatri, Pinky; Alexander, Hazel; Croft, Sarah; Cuthbert, Helen; Hebblethwaite, Neil; Khunda, Aethele; Manda, Padma; Mohammed, Dayang; Peatman, Suzie; Potts, Julie; Rao, Sanjay; Matthews, Nick; Chamberlain, Jonathan; Ahmed, Amna; Cameron, Helen; Herdman, Kirsten; Hinshaw, Kim; Mathew, Princy; Ormonde, Judith; Scollen, Janet; Ullal, Aarti; Walton, Eileen; Yossry, Menem; Banerjee, Saikat; Atkinson, Claire; Brown, Lauren; Davis, Michelle; Gilbert, Rebecca; Khazali, Shaheen; Peers, Beth; Sharpe, Lisa; Odejinmi, Funlayo; Dawlatly, Bashir; Gorry, Anwen; Jones, Prudence; Maseko, Zandile; Shahid, Anupama; Vimplis, Sotitis; Louden, Keith; Behrens, Renee; Martin, Jane; Trodd, Dawn; Brown, Caroline Wrey; Aust, Thomas; Alam, Ash; Ashraf, Khadija; Doyle, Mark; Ellard, Michael; Grindey, Julie; Mwenechanya, Stella; Shaw, Libby; Steele, Gillian; Minas, Vasileios; Weetch, Jeremy; Thomson, Angus; Cashmore, Victoria; Hughes, John; Kelly, Dawn; Pathak, Mamta; Waters, Natasha; Cannons, Vivienne; Flynn-Batham, Marian; Funnell, Sarah; Gkrozou, Fani; House, Sarah		HEALTH Study Grp	Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial	LANCET			English	Article							MENORRHAGIA; RESECTION; BURDEN	Background Heavy menstrual bleeding affects 25% of women in the UK, many of whom require surgery to treat it. Hysterectomy is effective but has more complications than endometrial ablation, which is less invasive but ultimately leads to hysterectomy in 20% of women. We compared laparoscopic supracervical hysterectomy with endometrial ablation in women seeking surgical treatment for heavy menstrual bleeding. Methods In this parallel-group, multicentre, open-label, randomised controlled trial in 31 hospitals in the UK, women younger than 50 years who were referred to a gynaecologist for surgical treatment of heavy menstrual bleeding and who were eligible for endometrial ablation were randomly allocated (1:1) to either laparoscopic supracervical hysterectomy or second generation endometrial ablation. Women were randomly assigned by either an interactive voice response telephone system or an internet-based application with a minimisation algorithm based on centre and age group (<40 years vs >= 40 years). Laparoscopic supracervical hysterectomy involves laparoscopic (keyhole) surgery to remove the upper part of the uterus (the body) containing the endometrium. Endometrial ablation aims to treat heavy menstrual bleeding by destroying the endometrium, which is responsible for heavy periods. The co-primary clinical outcomes were patient satisfaction and condition-specific quality of life, measured with the menorrhagia multi-attribute quality of life scale (MMAS), assessed at 15 months after randomisation. Our analysis was based on the intention-to-treat principle. The trial was registered with the ISRCTN registry, number ISRCTN49013893. Findings Between May 21, 2014, and March 28, 2017, we enrolled and randomly assigned 660 women (330 in each group). 616 (93%) of 660 women were operated on within the study period, 588 (95%) of whom received the allocated procedure and 28 (5%) of whom had an alternative surgery. At 15 months after randomisation, more women allocated to laparoscopic supracervical hysterectomy were satisfied with their operation compared with those in the endometrial ablation group (270 [97%] of 278 women vs 244 [87%] of 280 women; adjusted percentage difference 9.8, 95% CI 5.1-14.5; adjusted odds ratio [OR] 2.53, 95% CI 1.83-3.48; p<0.0001). Women randomly assigned to laparoscopic supracervical hysterectomy were also more likely to have the best possible MMAS score of 100 than women assigned to endometrial ablation (180 [69%] of 262 women vs 146 [54%] of 268 women; adjusted percentage difference 13.3, 95% CI 3.8-22.8; adjusted OR 1.87, 95% CI 1.31-2.67; p=0.00058). 14 (5%) of 309 women in the laparoscopic supracervical hysterectomy group and 11 (4%) of 307 women in the endometrial ablation group had at least one serious adverse event (adjusted OR 1.30, 95% CI 0.56-3.02; p=0.54). Interpretation Laparoscopic supracervical hysterectomy is superior to endometrial ablation in terms of clinical effectiveness and has a similar proportion of complications, but takes longer to perform and is associated with a longer recovery. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.	[Cooper, Kevin] Aberdeen Royal Infirm, NHS Grampian, Aberdeen, Scotland; [Breeman, Suzanne; Scotland, Graham; MacLennan, Graeme; Wileman, Samantha; McCormack, Kirsty] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Scott, Neil W.] Univ Aberdeen, Med Stat Team, Aberdeen, Scotland; [Scotland, Graham; Hernandez, Rodolfo] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [Bhattacharya, Siladitya] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Clark, Justin] Birmingham Womens & Childrens NHS Fdn Trust, Birmingham Womens & Childrens Hosp, Birmingham, W Midlands, England; [Hawe, Jed] Countess Chester Hosp NHS Fdn Trust, Chester, Cheshire, England; [Hawthorn, Robert] Southern Gen Hosp, NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland; [Phillips, Kevin] Hull & East Yorkshire Hosp NHS Trust, Castle Hill Hosp, Cottingham, England; [Norrie, John] Univ Edinburgh, Edinburgh Clin Trials Unit, Ctr Populat Hlth Sci, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen; Birmingham Women's Hospital; University of Hull; University of Edinburgh	Cooper, K (corresponding author), Aberdeen Royal Infirm, Dept Obstet & Gynaecol, Aberdeen AB25 2ZN, Scotland.	kevincooper@nhs.net	Phillips, Christian/AAN-7148-2020; Odejinmi, Funlayo/S-4064-2019; Basu, Debashis/CAA-2300-2022	Phillips, Christian/0000-0002-7238-6200; Odejinmi, Funlayo/0000-0003-0877-4564; Scott, Neil/0000-0002-8067-9660; Hernandez, Rodolfo/0000-0003-2619-8230; cooper, kevin/0000-0003-1486-0071; MacLennan, Graeme/0000-0002-1039-5646; Breeman, Suzanne/0000-0001-9950-7079	Royal College of Obstetricians and Gynaecologists Women's Network - National Institute for Health Research (NIHR) Health Technology Assessment Programme [12/35/23]; Chief Scientist Office of the Scottish Government Health and Social Care Directorates; UK National Institute for Health Research Health Technology Assessment Programme	Royal College of Obstetricians and Gynaecologists Women's Network - National Institute for Health Research (NIHR) Health Technology Assessment Programme; Chief Scientist Office of the Scottish Government Health and Social Care Directorates; UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR))	We thank the women who participated in the HEALTH study. We also thank Angela Hyde (Vice Chair of the Royal College of Obstetricians and Gynaecologists Women's Network until September, 2015, and co-applicant on the original grant application until October, 2016) for her contribution to the design of the participant facing documents and participation in trial meetings from the perspective of a patient, Jonathan Cook (statistician and co-applicant on the original grant application until April, 2014) for his contributions to the study design, Rebecca Bruce for her secretarial support and data management, members of the project management group for their ongoing advice and support of the trial, plus the independent members of the trial steering committee (Henry Kitchener [Chair], Patrick Chien, Barbara Farrell, and Isobel Montgomery) and data monitoring committee (Jane Norman [Chair], Peter O'Donovan, and Andy Vail), and the staff at the recruitment sites who facilitated recruitment, treatment, and follow-up of trial participants. The project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (project number 12/35/23). The Health Services Research Unit and the Health Economics Research Unit are funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. The views expressed herein are those of the authors and not necessarily those of the NIHR or the UK Department of Health and Social Care.; UK National Institute for Health Research Health Technology Assessment Programme.	Aarts JWM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003677.pub5; Barber EL, 2015, OBSTET GYNECOL SURV, V70, P780, DOI 10.1097/OGX.0000000000000259; Bofill Rodriguez M, 2019, COCHRANE DB SYST REV, V1; Brown JS, 2000, LANCET, V356, P535, DOI 10.1016/S0140-6736(00)02577-0; Cooper K, 2011, BJOG-INT J OBSTET GY, V118, P1171, DOI 10.1111/j.1471-0528.2011.03011.x; Cooper K, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2374-9; Cooper KG, 1999, LANCET, V354, P1859, DOI 10.1016/S0140-6736(99)04101-X; Fergusson RJ, 2013, COCHRANE DB SYST REV, V11; Food & Administration D., 2014, QUANT ASS PREV UNS U; Frick KD, 2009, WOMEN HEALTH ISS, V19, P70, DOI 10.1016/j.whi.2008.07.002; Garry R, 2004, BRIT MED J, V328, P129, DOI 10.1136/bmj.37984.623889.F6; Jenkins TR, 2004, AM J OBSTET GYNECOL, V191, P1875, DOI 10.1016/j.ajog.2004.06.096; Jensen JT, 2012, J WOMENS HEALTH, V21, P539, DOI 10.1089/jwh.2011.3147; Lethaby A, 2006, COCHRANE DB SYST REV, V2; Lieng M, 2008, BJOG-INT J OBSTET GY, V115, P1605, DOI 10.1111/j.1471-0528.2008.01854.x; Marjoribanks J, 2016, COCHRANE DB SYST REV, V19; McPherson K, 2005, J Obstet Gynaecol, V25, P469; Middleton LJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3929; Mols F, 2009, QUAL LIFE RES, V18, P403, DOI 10.1007/s11136-009-9455-5; National Institute for Health and Care Excellence, 2018, HEAVY MENSTRUAL BLEE; NHS Digital, HOSP EP STAT; NHS Health Research Authority, SAF REP SAF REP; NICE, 2007, HEAV MENSTR BLEED CG; Pattison H, 2011, BJOG-INT J OBSTET GY, V118, P1528, DOI 10.1111/j.1471-0528.2011.03057.x; Penninx JPM, 2016, EUR J OBSTET GYN R B, V196, P52, DOI 10.1016/j.ejogrb.2015.10.010; Pritts EA, 2015, GYNECOL SURG, V12, P165, DOI 10.1007/s10397-015-0894-4; ROBERTS TE, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D2202; Royal College of Obstetricians and Gynaecologists, 2014, NAT HEAV MENSTR BLEE; Sesti F, 2011, J OBSTET GYNAECOL RE, V37, P1650, DOI 10.1111/j.1447-0756.2011.01596.x; Shapley M, 2004, BRIT J GEN PRACT, V54, P359; Siedhoff MT, 2017, AM J OBSTET GYNECOL, V216, P259, DOI 10.1016/j.ajog.2016.11.1039; UK Department of Health and Social Care, 2015, CONS LED TREATM RIGH; Zupi E, 2003, AM J OBSTET GYNECOL, V188, P7, DOI 10.1067/mob.2003.60	33	16	16	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2019	394	10207					1425	1436		10.1016/S0140-6736(19)31790-8	http://dx.doi.org/10.1016/S0140-6736(19)31790-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JE5IX	31522846	hybrid, Green Published			2022-12-28	WOS:000490727200027
J	Rubin, R				Rubin, Rita			QUICK UPTAKES In Hot, Humid Weather, Fans Benefit Health and Environment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News article discusses a recent study about the effect of fans on relieving the physiological stress of high temperatures.					Rubin, Rita/AAD-1259-2020						0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2019	322	14					1340	1341		10.1001/jama.2019.14684	http://dx.doi.org/10.1001/jama.2019.14684			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JE1GT	31532453				2022-12-28	WOS:000490441900003
J	Norcia, MA; Young, AW; Eckner, WJ; Oelker, E; Ye, J; Kaufman, AM				Norcia, Matthew A.; Young, Aaron W.; Eckner, William J.; Oelker, Eric; Ye, Jun; Kaufman, Adam M.			Seconds-scale coherence on an optical clock transition in a tweezer array	SCIENCE			English	Article								Coherent control of high-quality factor optical transitions in atoms has revolutionized precision frequency metrology. Leading optical atomic clocks rely on the interrogation of such transitions in either single ions or ensembles of neutral atoms to stabilize a laser frequency at high precision and accuracy. We demonstrate a platform that combines the key strengths of these two approaches, based on arrays of individual strontium atoms held within optical tweezers. We report coherence times of 3.4 seconds, single-ensemble duty cycles up to 96% through repeated interrogation, and frequency stability of 4.7 x 10(-16) (tau/s)(-1/2). These results establish optical tweezer arrays as a powerful tool for coherent control of optical transitions for metrology and quantum information science.	[Norcia, Matthew A.; Young, Aaron W.; Eckner, William J.; Oelker, Eric; Ye, Jun; Kaufman, Adam M.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Norcia, Matthew A.; Young, Aaron W.; Eckner, William J.; Oelker, Eric; Ye, Jun; Kaufman, Adam M.] NIST, Gaithersburg, MD 20899 USA; [Norcia, Matthew A.; Young, Aaron W.; Eckner, William J.; Oelker, Eric; Ye, Jun; Kaufman, Adam M.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Kaufman, AM (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	adam.kaufman@colorado.edu	Ye, Jun/C-3312-2011	Ye, Jun/0000-0003-0076-2112; Eckner, William/0000-0003-0833-7137; Oelker, Eric/0000-0002-3916-1595; Norcia, Matthew/0000-0002-2276-9473; Young, Aaron/0000-0002-3490-4046	ARO; AFOSR; DARPA; National Science Foundation Physics Frontier Center at JILA [1734006]; NIST; NRC research associateship program	ARO; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation Physics Frontier Center at JILA; NIST(National Institute of Standards & Technology (NIST) - USA); NRC research associateship program	Supported by ARO, AFOSR, DARPA, the National Science Foundation Physics Frontier Center at JILA (1734006), and NIST. M.A.N. and E.O. acknowledge support from the NRC research associateship program.	Arvanitaki A, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.015015; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; Bloom BJ, 2014, NATURE, V506, P71, DOI 10.1038/nature12941; Campbell SL, 2017, SCIENCE, V358, P90, DOI 10.1126/science.aam5538; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Cooper A, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.041055; Covey JP, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.173201; Daley AJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.170504; Dick G. J., 1987, P PREC TIM TIM INT M, P133; Fuhrmanek A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.133003; Gibbons MJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.133002; Gil LIR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.103601; Grotti J, 2018, NAT PHYS, V14, P437, DOI 10.1038/s41567-017-0042-3; Hayes D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.070501; Hutson R. B., 2019, ARXIV190302498PHYSIC; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; Kaubruegger R., 2019, ARXIV190808343QUANTP; Koller SB, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.073601; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Madjarov I. S., 2019, ARXIV190805619PHYSIC; McGrew WF, 2018, NATURE, V564, P87, DOI 10.1038/s41586-018-0738-2; Norcia MA, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.041054; Norcia M. A., 2 SCALE COHERENCE OP, DOI [10.5281/zenodo.3381664, DOI 10.5281/ZENODO.3381664]; Norcia MA, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.023804; Oelker E, 2019, NAT PHOTONICS, V13, P714, DOI 10.1038/s41566-019-0493-4; Origlia S, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.053443; Pagano G, 2019, ADV QUANTUM TECHNOL, V2, DOI 10.1002/qute.201800067; Poli N, 2013, RIV NUOVO CIMENTO, V36, P555, DOI 10.1393/ncr/i2013-10095-x; Saskin S, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.143002; Schioppo M, 2017, NAT PHOTONICS, V11, P48, DOI [10.1038/nphoton.2016.231, 10.1038/NPHOTON.2016.231]; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Taichenachev AV, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023806; Taichenachev AV, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.083001; Takano T, 2017, APPL PHYS EXPRESS, V10, DOI 10.7567/APEX.10.072801; Ushijima I, 2015, NAT PHOTONICS, V9, P185, DOI [10.1038/NPHOTON.2015.5, 10.1038/nphoton.2015.5]; Vallet G, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa7c84; Wilk T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010502; Ye J, 2008, SCIENCE, V320, P1734, DOI 10.1126/science.1148259	41	57	57	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2019	366	6461			SI		93	+		10.1126/science.aay0644	http://dx.doi.org/10.1126/science.aay0644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JC2ZU	31515245	Green Accepted, Green Submitted			2022-12-28	WOS:000489147000062
J	Gordon, CE; Berenguer, MC; Doss, W; Fabrizi, F; Izopet, J; Jha, V; Kamar, N; Kasiske, BL; Lai, CL; Morales, JM; Patel, PR; Pol, S; Silva, MO; Balk, EM; Earley, A; Di, MY; Cheung, M; Jadoul, M; Martin, P				Gordon, Craig E.; Berenguer, Marina C.; Doss, Wahid; Fabrizi, Fabrizio; Izopet, Jacques; Jha, Vivekanand; Kamar, Nassim; Kasiske, Bertram L.; Lai, Ching-Lung; Morales, Jose M.; Patel, Priti R.; Pol, Stanislas; Silva, Marcelo O.; Balk, Ethan M.; Earley, Amy; Di, Mengyang; Cheung, Michael; Jadoul, Michel; Martin, Paul			Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; HCV GENOTYPE 1; RENAL-TRANSPLANTATION; ANTIVIRAL THERAPY; SOFOSBUVIR; GLOMERULONEPHRITIS; PIBRENTASVIR; METAANALYSIS; GLECAPREVIR	Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive update of KDIGO's 2008 guideline on HCV infection in CKD. This update reflects the major advances since the introduction of directacting antivirals (DAAs) in the management of HCV infection in the CKD population. Methods: The KDIGO work group tasked with developing the HCV and CKD guideline defined the scope of the guideline, gathered evidence, determined topics for systematic review, and graded the quality of evidence previously summarized by the evidence review team. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach was used to appraise the quality of evidence and rate the strength of the recommendations. Searches of the English-language literature were conducted through May 2017 and were supplemented with targeted searches for studies of DAA treatment and with abstracts from nephrology, hepatology, and transplantation conferences. A review process involving many stakeholders, subject matter experts, and industry and national organizations informed the guideline's final modification. Recommendation: The updated guideline comprises 66 recommendations. This synopsis focuses on 32 key recommendations pertinent to the prevention, diagnosis, treatment, and management of HCV infection in adult CKD populations.	[Gordon, Craig E.] Tufts Med Ctr, Boston, MA 02111 USA; [Berenguer, Marina C.] Hosp Univ & Politecn La Fe, Valencia, Spain; [Doss, Wahid] Cairo Univ, Cairo, Egypt; [Fabrizi, Fabrizio] Osped Maggiore, Milan, Italy; [Izopet, Jacques] Hop Purpan, Toulouse, France; [Izopet, Jacques] Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Jha, Vivekanand] George Inst Global Hlth, 310-11 Splendor Forum, New Delhi 110025, India; [Kamar, Nassim] Hop Rangueil, Toulouse, France; [Kasiske, Bertram L.] Hennepin Healthcare Res Inst, Minneapolis, MN USA; [Lai, Ching-Lung] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China; [Morales, Jose M.] Hosp 12 Octubre, Madrid, Spain; [Patel, Priti R.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Pol, Stanislas] Hop Cochin, Paris, France; [Pol, Stanislas] Univ Paris 05, Paris, France; [Silva, Marcelo O.] Hosp Univ Austral, Buenos Aires, DF, Argentina; [Silva, Marcelo O.] Latin Amer Liver Res Educ & Awareness Network, Buenos Aires, DF, Argentina; [Balk, Ethan M.] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Earley, Amy; Cheung, Michael] Kidney Dis Improving Global Outcomes, Brussels, Belgium; [Di, Mengyang] Rhode Isl Hosp, Providence, RI USA; [Di, Mengyang] Brown Univ, Providence, RI 02912 USA; [Jadoul, Michel] Catholic Univ Louvain, Brussels, Belgium; [Martin, Paul] Univ Miami, Miami, FL USA; [Gordon, Craig E.] Tufts Med Ctr, Div Nephrol, 800 Washington St,Box 391, Boston, MA 02111 USA; [Berenguer, Marina C.] Hosp Univ & Politecn La Fe, Dept Gastroenterol, Hepatol & Liver Transplantat Unit, Ave Fernando Abril Martorell 106, Valencia 46026, Spain; [Doss, Wahid] 12 Sarah El Gezira St, Cairo 11211, Egypt; [Fabrizi, Fabrizio] Osped Maggiore, Div Nefrol, Via Commenda 15, I-20122 Milan, Italy; [Izopet, Jacques] CHU Toulouse, Hop Purpan, Ctr Natl Reference Virus Hepat E, Lab Virol, F-31300 Toulouse, France; [Kamar, Nassim] CHU Rangueil, Dept Nephrol & Organ Transplantat, TSA 50032, F-31059 Toulouse 9, France; [Kasiske, Bertram L.] Hennepin Healthcare Res Inst, Sci Registry Transplant Recipients, 701 Pk Ave,Suite S4-100, Minneapolis, MN 55415 USA; [Lai, Ching-Lung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Pokfulam, Pokfulam Rd 102, Hong Kong, Peoples R China; [Morales, Jose M.] Hosp 12 Octubre, Inst Healthcare Res, Madrid 28041, Spain; [Patel, Priti R.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd, Atlanta, GA 30333 USA; [Pol, Stanislas] Univ Paris 05, Hop Cochin, APHP, Inst Pasteur,Dept Hepatol,INSERM,U1223,UMS 20, Paris, France; [Silva, Marcelo O.] Hosp Univ Austral, Hepatol & Liver Transplant Unit, Ave Juan D Peron 1500,B1629AHJ Pilar, Buenos Aires, DF, Argentina; [Balk, Ethan M.; Di, Mengyang] Brown Univ, Sch Publ Hlth, Ctr Evidence Synth Hlth, Box G-S121-8, Providence, RI 02912 USA; [Earley, Amy; Cheung, Michael] KDIGO, Ave Louise 65,Suite 11, B-1050 Brussels, Belgium; [Jadoul, Michel] Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, Ave Hippocrate 10, B-1200 Brussels, Belgium; [Martin, Paul] Univ Miami, Miller Sch Med, Div Gastroenterol & Hepatol, 1120 Northwest 14th St,Room 1115, Miami, FL 33136 USA	Tufts Medical Center; Hospital Universitari i Politecnic La Fe; Egyptian Knowledge Bank (EKB); Cairo University; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; University of Hong Kong; Hospital Universitario 12 de Octubre; Centers for Disease Control & Prevention - USA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Austral University; Hospital Universitario Austral; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Universite Catholique Louvain; University of Miami; Tufts Medical Center; Hospital Universitari i Politecnic La Fe; CHU de Toulouse; CHU de Toulouse; University of Hong Kong; Hospital Universitario 12 de Octubre; Centers for Disease Control & Prevention - USA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Austral University; Hospital Universitario Austral; Brown University; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Miami	Gordon, CE (corresponding author), Tufts Med Ctr, Div Nephrol, 800 Washington St,Box 391, Boston, MA 02111 USA.	cgordon@tuftsmedicalcenter.org	Balk, Ethan/AAJ-2547-2020; Berenguer, Marina/ABG-8602-2020; Di, Mengyang/U-4847-2018	Berenguer, Marina/0000-0001-9246-4264; Di, Mengyang/0000-0001-6165-2617; Jha, Vivekanand/0000-0002-8015-9470; Cheung, Michael/0000-0002-6233-2831; Gordon, Craig/0000-0001-6895-5127	KDIGO	KDIGO	This guideline is supported by KDIGO; no funding is accepted for the development of specific guidelines.	Abbott KC, 2004, J AM SOC NEPHROL, V15, P3166, DOI 10.1097/01.ASN.0000145439.48387.BF; Abbott KC, 2003, J AM SOC NEPHROL, V14, P2908, DOI 10.1097/01.ASN.0000090743.43034.72; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Akiba T, 2012, THER APHER DIAL, V16, P289, DOI 10.1111/j.1744-9987.2012.01078.x; American Association for the Study of Liver Diseases Infectious Diseases Society of America, HCV GUID REC TEST MA; Bersoff-Matcha SJ, 2017, ANN INTERN MED, V166, P792, DOI 10.7326/M17-0377; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bloom RD, 2005, AM J TRANSPLANT, V5, P139, DOI 10.1111/j.1600-6143.2004.00652.x; Bloom RD, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000012382.97168.E0; Bruchfeld A, 2004, TRANSPLANTATION, V78, P745, DOI 10.1097/01.TP.0000131948.29742.24; Bruchfeld A, 2017, LANCET GASTROENTEROL, V2, P585, DOI 10.1016/S2468-1253(17)30116-4; Burdick RA, 2003, KIDNEY INT, V63, P2222, DOI 10.1046/j.1523-1755.2003.00017.x; Centers for Disease Control and Prevention, TEST REC HEP C VIR I; Cohen-Bucay A, 2018, HEMODIAL INT, V22, pS61, DOI 10.1111/hdi.12643; Colombo M, 2017, ANN INTERN MED, V166, P109, DOI 10.7326/M16-1205; De Vita S, 2012, ARTHRITIS RHEUM-US, V64, P843, DOI 10.1002/art.34331; Durand CM, 2018, ANN INTERN MED, V168, P533, DOI 10.7326/M17-2871; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Fabrizi F, 2014, J VIRAL HEPATITIS, V21, P681, DOI 10.1111/jvh.12276; Fabrizi F, 2018, ANN HEPATOL, V17, P364, DOI 10.5604/01.3001.0011.7382; Fabrizi F, 2018, INT J ARTIF ORGANS, V41, P306, DOI 10.1177/0391398818762358; Fabrizi F, 2015, DIGEST DIS SCI, V60, P3801, DOI 10.1007/s10620-015-3801-y; Gane E, 2017, NEW ENGL J MED, V377, P1448, DOI 10.1056/NEJMoa1704053; Goldberg DS, 2017, NEW ENGL J MED, V376, P2394, DOI 10.1056/NEJMc1705221; Goodkin DA, 2017, CLIN J AM SOC NEPHRO, V12, P287, DOI 10.2215/CJN.07940716; Gordon CE, 2008, AM J KIDNEY DIS, V52, P811, DOI 10.1053/j.ajkd.2008.08.005; Gordon CE, 2008, AM J KIDNEY DIS, V51, P263, DOI 10.1053/j.ajkd.2007.11.003; Jadoul M, 2018, KIDNEY INT, V94, P663, DOI 10.1016/j.kint.2018.06.011; Kamar N, 2006, TRANSPLANTATION, V82, P853, DOI 10.1097/01.tp.0000238898.14393.c9; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kidney Disease, 2008, KIDNEY INT S, V109, pS1, DOI [DOI 10.1038/KI.2008.81, 10.1038/ki.2008.81]; Knoll GA, 1997, AM J KIDNEY DIS, V29, P608, DOI 10.1016/S0272-6386(97)90345-0; Meier-Kriesche HU, 2001, TRANSPLANTATION, V72, P241; Molnar MZ, 2019, AM J TRANSPLANT, V19, P3046, DOI 10.1111/ajt.15530; Morales JM, 1997, TRANSPLANTATION, V63, P1634, DOI 10.1097/00007890-199706150-00017; Morales JM, 2004, NEPHROL DIAL TRANSPL, V19, P72, DOI 10.1093/ndt/gfh1020; Pereira BJG, 1998, KIDNEY INT, V53, P1374, DOI 10.1046/j.1523-1755.1998.00883.x; Reau N, 2018, HEPATOLOGY, V68, P1298, DOI 10.1002/hep.30046; Reese PP, 2015, NEW ENGL J MED, V373, P303, DOI 10.1056/NEJMp1505074; Ridruejo E, 2018, HEMODIAL INT, V22, pS97, DOI 10.1111/hdi.12651; ROTH D, 1995, TRANSPLANTATION, V59, P1676, DOI 10.1097/00007890-199506270-00006; Roth D, 2015, LANCET, V386, P1537, DOI 10.1016/S0140-6736(15)00349-9; Saadoun D, 2016, ANN RHEUM DIS, V75, P1777, DOI 10.1136/annrheumdis-2015-208339; Sise ME, 2020, KIDNEY INT, V97, P193, DOI 10.1016/j.kint.2019.04.030; Sise ME, 2017, CLIN J AM SOC NEPHRO, V12, P1615, DOI 10.2215/CJN.02510317; Sise ME, 2016, HEPATOLOGY, V63, P408, DOI 10.1002/hep.28297; Sneller MC, 2012, ARTHRITIS RHEUM-US, V64, P835, DOI 10.1002/art.34322; Uhlig K, 2006, KIDNEY INT, V70, P2058, DOI 10.1038/sj.ki.5001875; Wheeler DC, 2018, KIDNEY INT SUPPL, V8, P91, DOI 10.1016/j.kisu.2018.06.001; Zeuzem S, 2018, NEW ENGL J MED, V378, P354, DOI 10.1056/NEJMoa1702417	50	15	15	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2019	171	7					496	+		10.7326/M19-1539	http://dx.doi.org/10.7326/M19-1539			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB4LK	31546256				2022-12-28	WOS:000488527900007
J	Scott-Dearing, E				Scott-Dearing, Emily			Academia to freelance curator	NATURE			English	Editorial Material																			0	0	0	2	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					617	618		10.1038/d41586-019-02727-w	http://dx.doi.org/10.1038/d41586-019-02727-w			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB0MC	31551541				2022-12-28	WOS:000488247600067
J	Mahase, E				Mahase, Elisabeth			Is Matt Hancock right to take credit for falling death rates?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2018, PREV IS BETT CUR OUR; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, P17145, DOI DOI 10.1136/BMJ.L85; King's Fund, 2018, HLTH CAR WORKF ENGL; Lee G, 2018, CHANNEL 4; May T, 2018, COMMUNICATION   0618; Office for National Statistics, 2019, Q MORT REP	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2019	366								l5676	10.1136/bmj.l5676	http://dx.doi.org/10.1136/bmj.l5676			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WV	31551233				2022-12-28	WOS:000488488300009
J	Brody, H				Brody, Herb			INFLUENZA	NATURE			English	Editorial Material																			0	10	11	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					S49	S49		10.1038/d41586-019-02750-x	http://dx.doi.org/10.1038/d41586-019-02750-x			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534258				2022-12-28	WOS:000486647800003
J	Rogelj, J; Huppmann, D; Krey, V; Riahi, K; Clarke, L; Gidden, M; Nicholls, Z; Meinshausen, M				Rogelj, Joeri; Huppmann, Daniel; Krey, Volker; Riahi, Keywan; Clarke, Leon; Gidden, Matthew; Nicholls, Zebedee; Meinshausen, Malte			A new scenario logic for the Paris Agreement long-term temperature goal	NATURE			English	Article							CLIMATE-CHANGE; CO2 EMISSIONS; CUMULATIVE CARBON; AIR-POLLUTION; FRAMEWORK; MITIGATION; REMOVAL; FUTURE; ENERGY; MODEL	To understand how global warming can be kept well below 2 degrees Celsius and even 1.5 degrees Celsius, climate policy uses scenarios that describe how society could reduce its greenhouse gas emissions. However, current scenarios have a key weakness: they typically focus on reaching specific climate goals in 2100. This choice may encourage risky pathways that delay action, reach higher-than-acceptable mid-century warming, and rely on net removal of carbon dioxide thereafter to undo their initial shortfall in reductions of emissions. Here we draw on insights from physical science to propose a scenario framework that focuses on capping global warming at a specific maximum level with either temperature stabilization or reversal thereafter. The ambition of climate action until carbon neutrality determines peak warming, and can be followed by a variety of long-term states with different sustainability implications. The approach proposed here closely mirrors the intentions of the United Nations Paris Agreement, and makes questions of intergenerational equity into explicit design choices.	[Rogelj, Joeri; Huppmann, Daniel; Krey, Volker; Riahi, Keywan; Gidden, Matthew] IIASA, Laxenburg, Austria; [Rogelj, Joeri] Imperial Coll, Grantham Inst Climate Change & Environm, London, England; [Rogelj, Joeri] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland; [Krey, Volker] Norwegian Univ Sci & Technol NTNU, Ind Ecol Programme, Trondheim, Norway; [Krey, Volker] Norwegian Univ Sci & Technol NTNU, Energy Transit Initiat, Trondheim, Norway; [Riahi, Keywan] Graz Univ Technol, Graz, Austria; [Clarke, Leon] Univ Maryland, Sch Publ Policy, Ctr Global Sustainabil, College Pk, MD 20742 USA; [Nicholls, Zebedee; Meinshausen, Malte] Univ Melbourne, Sch Earth Sci, Australian German Climate & Energy Coll, Melbourne, Vic, Australia; [Meinshausen, Malte] Potsdam Inst Climate Impact Res PIK, PRIMAP Grp, Potsdam, Germany	International Institute for Applied Systems Analysis (IIASA); Imperial College London; Swiss Federal Institutes of Technology Domain; ETH Zurich; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Graz University of Technology; University System of Maryland; University of Maryland College Park; University of Melbourne; Potsdam Institut fur Klimafolgenforschung	Rogelj, J (corresponding author), IIASA, Laxenburg, Austria.; Rogelj, J (corresponding author), Imperial Coll, Grantham Inst Climate Change & Environm, London, England.; Rogelj, J (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland.	j.rogelj@imperial.ac.uk	Nicholls, Zebedee/GPW-9952-2022; Meinshausen, Malte/AAG-6505-2019; Rogelj, Joeri/I-7108-2012; Meinshausen, Malte/A-7037-2011; Krey, Volker/ABD-5070-2021; Meinshausen, Malte/AAG-7985-2019; Riahi, Keywan/B-6426-2011	Nicholls, Zebedee/0000-0002-4767-2723; Meinshausen, Malte/0000-0003-4048-3521; Rogelj, Joeri/0000-0003-2056-9061; Meinshausen, Malte/0000-0003-4048-3521; Riahi, Keywan/0000-0001-7193-3498; Krey, Volker/0000-0003-0307-3515				Anderson K, 2016, SCIENCE, V354, P182, DOI 10.1126/science.aah4567; Azar C, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034004; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Boysen LR, 2017, EARTHS FUTURE, V5, P463, DOI 10.1002/2016EF000469; Burke EJ, 2017, BIOGEOSCIENCES, V14, P3051, DOI 10.5194/bg-14-3051-2017; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Clarke L, 2009, ENERG ECON, V31, pS64, DOI 10.1016/j.eneco.2009.10.013; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Connors S., 2018, GLOBAL WARMING 15 C; Creutzig F, 2015, GCB BIOENERGY, V7, P916, DOI 10.1111/gcbb.12205; Davis SJ, 2018, SCIENCE, V360, P1419, DOI 10.1126/science.aas9793; Etminan M, 2016, GEOPHYS RES LETT, V43, P12614, DOI 10.1002/2016GL071930; Field CB, 2017, SCIENCE, V356, P706, DOI 10.1126/science.aam9726; Fisher B., CLIMATE CHANGE 2007, P169; Fricko O, 2017, GLOBAL ENVIRON CHANG, V42, P251, DOI 10.1016/j.gloenvcha.2016.06.004; Fuglestvedt J, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2016.0445; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Geden O, 2019, CLIM POLICY, V19, P487, DOI 10.1080/14693062.2018.1536600; Geden O, 2016, NAT GEOSCI, V9, P340, DOI 10.1038/ngeo2699; Haites E., 2013, 124 IDDRI; Hoglund-Isaksson L, 2017, ENVIRON SCI POLICY, V75, P138, DOI 10.1016/j.envsci.2017.05.006; Huppmann D, 2019, ENVIRON MODELL SOFTW, V112, P143, DOI 10.1016/j.envsoft.2018.11.012; Huppmann D, 2018, NAT CLIM CHANGE, V8, P1027, DOI 10.1038/s41558-018-0317-4; IEA-International Energy Agency, 2015, WORLD EN OUTL 2015; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Knutti R, 2016, NAT GEOSCI, V9, P13, DOI 10.1038/NGEO2595; Knutti R, 2015, CLIMATIC CHANGE, V133, P361, DOI 10.1007/s10584-015-1340-3; Krey V., 2016, MESSAGE GLOBIOM 1 0; Krey V, 2014, CLIMATIC CHANGE, V123, P369, DOI 10.1007/s10584-013-0947-5; Kriegler E, 2014, CLIMATIC CHANGE, V123, P353, DOI 10.1007/s10584-013-0953-7; Luderer G, 2018, NAT CLIM CHANGE, V8, P626, DOI 10.1038/s41558-018-0198-6; Maier HR, 2016, ENVIRON MODELL SOFTW, V81, P154, DOI 10.1016/j.envsoft.2016.03.014; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Matthews HD, 2013, SCIENCE, V340, P438, DOI 10.1126/science.1236372; Matthews HD, 2012, PHILOS T R SOC A, V370, P4365, DOI 10.1098/rsta.2012.0064; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Minx JC, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5ee5; Morrow David R., 2016, PUBLIC AFFAIRS Q, V30, P85; O'Neill BC, 2017, NAT CLIM CHANGE, V7, P28, DOI [10.1038/NCLIMATE3179, 10.1038/nclimate3179]; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Obersteiner M, 2018, NAT CLIM CHANGE, V8, P7, DOI 10.1038/s41558-017-0045-1; Popp A, 2017, GLOBAL ENVIRON CHANG, V42, P331, DOI 10.1016/j.gloenvcha.2016.10.002; Randalls S, 2010, WIRES CLIM CHANGE, V1, P598, DOI 10.1002/wcc.62; Rao S, 2017, GLOBAL ENVIRON CHANG, V42, P346, DOI 10.1016/j.gloenvcha.2016.05.012; Reiner DM, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2015.11, 10.1038/NENERGY.2015.11]; Riahi K, 2017, GLOBAL ENVIRON CHANG, V42, P153, DOI 10.1016/j.gloenvcha.2016.05.009; Ricke KL, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/12/124002; Rogelj J., 2018, GLOBAL WARMING 1 5 C; Rogelj J, 2018, NAT CLIM CHANGE, V8, P325, DOI 10.1038/s41558-018-0091-3; Rogelj J, 2017, GEOPHYS RES LETT, V44, P10662, DOI 10.1002/2017GL075612; Rogelj J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/10/105007; Rogelj J, 2014, P NATL ACAD SCI USA, V111, P16325, DOI 10.1073/pnas.1415631111; Rogelj J, 2014, NAT CLIM CHANGE, V4, P446, DOI [10.1038/NCLIMATE2178, 10.1038/nclimate2178]; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; Sanchez DL, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.2; Schadel C, 2014, GLOBAL CHANGE BIOL, V20, P641, DOI 10.1111/gcb.12417; Schleussner CF, 2016, NAT CLIM CHANGE, V6, P827, DOI 10.1038/NCLIMATE3096; Schneider von Deimling T, 2012, BIOGEOSCIENCES, V9, P649, DOI 10.5194/bg-9-649-2012; Seneviratne SI, 2016, NATURE, V529, P477, DOI 10.1038/nature16542; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Shue H, 2017, J HUM RIGHTS ENVIRON, V8, P203, DOI 10.4337/jhre.2017.02.02; Smith P, 2016, NAT CLIM CHANGE, V6, P42, DOI [10.1038/NCLIMATE2870, 10.1038/nclimate2870]; Tokarska KB, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/094013; UNEP, 2013, EM GAP REP 2013, P64; UNFCCC, 2010, FCCCCP20107 UNFCCC; UNFCCC, 2015, FCCCCP20157 UNFCCC, P66; United Nations Framework Convention on Climate Change, 1992, UN FRAMEWORK CONVENT; van Vuuren DP, 2014, CLIMATIC CHANGE, V122, P373, DOI 10.1007/s10584-013-0906-1; Weyant JR, 2006, ENERG J, P1; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Williamson P, 2016, NATURE, V530, P153, DOI 10.1038/530153a	73	179	184	46	328	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					357	+		10.1038/s41586-019-1541-4	http://dx.doi.org/10.1038/s41586-019-1541-4			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534246	Green Submitted, Green Accepted			2022-12-28	WOS:000486647800038
J	Slamon, D				Slamon, Dennis			Moving from Cancer Genetics to Therapy	CELL			English	Editorial Material								Dennis Slamon's early interest in understanding genes that viruses co-opt to become powerful proliferative agents ultimately led him and his colleagues and collaborators to the development of trastuzumab (Herceptin) for the treatment of HER-2-positive breast cancer. His work set the stage for current "givens'' like genetic stratification of patients for treatment and using antibodies as therapeutics. Cell editor Lara Szewczak spoke with Dennis, the recipient of the 2019 Lasker-DeBakey Clinical Medical Research Award, to discuss the research leading to trastuzumab and his views on how current progress in treating cancers may impact the US health care system. Excerpts from this conversation are presented below, and the full conversation is available with the article online.	[Slamon, Dennis] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Slamon, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.								0	0	0	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					33	36		10.1016/j.cell.2019.08.029	http://dx.doi.org/10.1016/j.cell.2019.08.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31519313	Bronze			2022-12-28	WOS:000486618500007
J	Zheng, Y; Xue, XF; Shao, YE; Wang, SC; Esfahani, SN; Li, ZD; Muncie, JM; Lakins, JN; Weaver, VM; Gumucio, DL; Fu, JP				Zheng, Yi; Xue, Xufeng; Shao, Yue; Wang, Sicong; Esfahani, Sajedeh Nasr; Li, Zida; Muncie, Jonathon M.; Lakins, Johnathon N.; Weaver, Valerie M.; Gumucio, Deborah L.; Fu, Jianping			Controlled modelling of human epiblast and amnion development using stem cells	NATURE			English	Article							SELF-ORGANIZATION; PLURIPOTENT STATE; MOUSE; FATE; DIFFERENTIATION; EXPRESSION; COORDINATE; INDUCTION; MONKEYS; EMBRYO	Early human embryonic development involves extensive lineage diversification, cell-fate specification and tissue patterning(1). Despite its basic and clinical importance, early human embryonic development remains relatively unexplained owing to interspecies divergence(2,3) and limited accessibility to human embryo samples. Here we report that human pluripotent stem cells (hPSCs) in a microfluidic device recapitulate, in a highly controllable and scalable fashion, landmarks of the development of the epiblast and amniotic ectoderm parts of the conceptus, including lumenogenesis of the epiblast and the resultant pro-amniotic cavity, formation of a bipolar embryonic sac, and specification of primordial germ cells and primitive streak cells. We further show that amniotic ectoderm-like cells function as a signalling centre to trigger the onset of gastrulation-like events in hPSCs. Given its controllability and scalability, the microfluidic model provides a powerful experimental system to advance knowledge of human embryology and reproduction. This model could assist in the rational design of differentiation protocols of hPSCs for disease modelling and cell therapy, and in high-throughput drug and toxicity screens to prevent pregnancy failure and birth defects.	[Zheng, Yi; Xue, Xufeng; Shao, Yue; Wang, Sicong; Esfahani, Sajedeh Nasr; Li, Zida; Fu, Jianping] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Muncie, Jonathon M.; Lakins, Johnathon N.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Muncie, Jonathon M.] Univ Calif San Francisco, Grad Program Bioengn, San Francisco, CA 94143 USA; [Muncie, Jonathon M.] Univ Calif Berkeley, San Francisco, CA USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Gumucio, Deborah L.; Fu, Jianping] Univ Michigan, Med Sch, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fu, Jianping] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fu, JP (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Fu, JP (corresponding author), Univ Michigan, Med Sch, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.; Fu, JP (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	jpfu@umich.edu	Xue, Xufeng/AAP-4641-2020; Fu, Jianping/AAJ-7105-2020	Xue, Xufeng/0000-0002-9379-8589; Fu, Jianping/0000-0001-9629-6739; Li, Zida/0000-0002-1353-9414; Zheng, Yi/0000-0002-2685-3680; Muncie, Jonathon/0000-0002-7405-6213	University of Michigan Mechanical Engineering Faculty Support Fund; University of Michigan Mcubed Fund; National Institutes of Health [R01 DK089933]; California Institute for Regenerative Medicine [RB5-07409]; University of Michigan; Lurie Nanofabrication Facility at the University of Michigan; Michigan-Cambridge Research Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089933] Funding Source: NIH RePORTER	University of Michigan Mechanical Engineering Faculty Support Fund; University of Michigan Mcubed Fund(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); University of Michigan(University of Michigan System); Lurie Nanofabrication Facility at the University of Michigan(University of Michigan System); Michigan-Cambridge Research Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the University of Michigan Mechanical Engineering Faculty Support Fund (J.F.), the Michigan-Cambridge Research Initiative (J.F.), the University of Michigan Mcubed Fund (J.F.), the National Institutes of Health (R01 DK089933, D.L.G.) and the California Institute for Regenerative Medicine (RB5-07409, V.M.W.). Y.S. was partially supported by the University of Michigan Rackham Predoctoral Fellowship. The Lurie Nanofabrication Facility at the University of Michigan is acknowledged for support with microfabrication.	Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Beccari L, 2018, NATURE, V562, P272, DOI 10.1038/s41586-018-0578-0; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daley GQ, 2016, STEM CELL REP, V6, P787, DOI 10.1016/j.stemcr.2016.05.001; Davidson KC, 2015, DEVELOPMENT, V142, P3090, DOI 10.1242/dev.116061; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Dobreva MP, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/987185; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Harrison SE, 2017, SCIENCE, V356, DOI 10.1126/science.aal1810; Hyun I, 2016, NATURE, V533, P169, DOI 10.1038/533169a; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kobayashi T, 2017, NATURE, V546, P416, DOI 10.1038/nature22812; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Rivron N, 2018, NATURE, V564, P183, DOI 10.1038/d41586-018-07663-9; Rivron NC, 2018, NATURE, V557, P106, DOI 10.1038/s41586-018-0051-0; Rossant J, 2015, DEVELOPMENT, V142, P9, DOI 10.1242/dev.115451; Sasaki K, 2016, DEV CELL, V39, P169, DOI 10.1016/j.devcel.2016.09.007; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Shahbazi MN, 2017, NATURE, V552, P239, DOI 10.1038/nature24675; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Shao Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00236-w; Shao Y, 2017, NAT MATER, V16, P419, DOI [10.1038/nmat4829, 10.1038/NMAT4829]; Taniguchi K, 2015, STEM CELL REP, V5, P954, DOI 10.1016/j.stemcr.2015.10.015; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; van den Brink SC, 2014, DEVELOPMENT, V141, P4231, DOI 10.1242/dev.113001; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xue XF, 2018, NAT MATER, V17, P633, DOI 10.1038/s41563-018-0082-9; Zheng Y, 2019, PROTOC EXCH, DOI [10.21203/rs.2.11520/v1, DOI 10.21203/RS.2.11520/V1]	37	184	188	11	103	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					421	+		10.1038/s41586-019-1535-2	http://dx.doi.org/10.1038/s41586-019-1535-2			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY8MD	31511693	Green Accepted			2022-12-28	WOS:000486647800051
J	Matthews, DR; Paldanius, PM; Proot, P; Chiang, Y; Stumvoll, M; Del Prato, S				Matthews, David R.; Paldanius, Paivi M.; Proot, Pieter; Chiang, YannTong; Stumvoll, Michael; Del Prato, Stefano		VERIFY Study Grp	Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial	LANCET			English	Article							BLOOD-GLUCOSE CONTROL; EFFICACY; RISK; COMPLICATIONS; PIOGLITAZONE; REDUCTION; 24-WEEK	Background Early treatment intensification leading to sustained good glycaemic control is essential to delay diabetic complications. Although initial combination therapy has been suggested to offer more opportunities than a traditional stepwise approach, its validity remains to be determined. Methods Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes (VERIFY) was a randomised, double-blind, parallel-group study of newly diagnosed patients with type 2 diabetes conducted in 254 centres across 34 countries. The study consisted of a 2-week screening visit, a 3-week metformin-alone runin period, and a 5-year treatment period, which was further split into study periods 1, 2, and 3. Patients aged 18-70 years were included if they had type 2 diabetes diagnosed within 2 years prior to enrolment, and centrally confirmed glycated haemoglobin A1c (HbA(1c)) of 48-58 mmol/mol (6.5-7.5%) and a body-mass index of 22-40 kg/m(2). Patients were randomly assigned in a 1: 1 ratio either to the early combination treatment group or to the initial metformin monotherapy group, with the help of an interactive response technology system and simple randomisation without stratification. Patients, investigators, clinical staff performing the assessments, and data analysts were masked to treatment allocation. In study period 1, patients received either the early combination treatment with metformin (stable daily dose of 1000 mg, 1500 mg, or 2000 mg) and vildagliptin 50 mg twice daily, or standard-of-care initial metformin monotherapy (stable daily dose of 1000 mg, 1500 mg, or 2000 mg) and placebo twice daily. If the initial treatment did not maintain HbA(1c) below 53 mmol/mol (7.0%), confirmed at two consecutive scheduled visits which were 13 weeks apart, patients in the metformin monotherapy group received vildagliptin 50 mg twice daily in place of the placebo and entered study period 2, during which all patients received the combination therapy. The primary efficacy endpoint was the time from randomisation to initial treatment failure, defined as HbA(1c) measurement of at least 53 mmol/mol (7.0%) at two consecutive scheduled visits, 13 weeks apart from randomisation through period 1. The full analysis set included patients who received at least one randomised study medication and had at least one post-randomisation efficacy parameter assessed. The safety analysis set included all patients who received at least one dose of randomised study medication. This study is registered with ClinicalTrials.gov, NCT01528254. Findings Trial enrolment began on March 30, 2012, and was completed on April 10, 2014. Of the 4524 participants screened, 2001 eligible participants were randomly assigned to either the early combination treatment group (n=998) or the initial metformin monotherapy group (n=1003). A total of 1598 (79.9%) patients completed the 5-year study: 811 (81.3%) in the early combination therapy group and 787 (78.5%) in the monotherapy group. The incidence of initial treatment failure during period 1 was 429 (43.6%) patients in the combination treatment group and 614 (62.1%) patients in the monotherapy group. The median observed time to treatment failure in the monotherapy group was 36.1 (IQR 15.3-not reached [NR]) months, while the median time to treatment failure time for those receiving early combination therapy could only be estimated to be beyond the study duration at 61.9 (29.9-NR) months. A significant reduction in the relative risk for time to initial treatment failure was observed in the early combination treatment group compared with the monotherapy group over the 5-year study duration (hazard ratio 0.51 [95% CI 0.45-0.58]; p<0.0001). Both treatment approaches were safe and well tolerated, with no unexpected or new safety findings, and no deaths related to study treatment. Interpretation Early intervention with a combination therapy of vildagliptin plus metformin provides greater and durable long-term benefits compared with the current standard-of-care initial metformin monotherapy for patients with newly diagnosed type 2 diabetes.	[Matthews, David R.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Matthews, David R.] Harris Manchester Coll, Oxford, England; [Paldanius, Paivi M.; Proot, Pieter] Novartis Pharmaceut, Basel, Switzerland; [Chiang, YannTong] Novartis Inst BioMed Res, E Hanover, NJ USA; [Stumvoll, Michael] Univ Hosp Leipzig, Div Endocrinol & Diabet, Leipzig, Germany; [Stumvoll, Michael] Univ Leipzig, Helmholtz Zentrum Munchen, Helmholtz Inst Metab Obes & Vasc Res HIMAG, Leipzig, Germany; [Del Prato, Stefano] Univ Pisa, Dept Clin & Expt Med, Sect Metab Dis & Diabet, Pisa, Italy	University of Oxford; University of Oxford; Novartis; Novartis; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University; University of Pisa	Matthews, DR (corresponding author), Harris Manchester Coll, Oxford, England.	david.matthews@ocdem.ox.ac.uk	Kudat, Hasan/AAE-3298-2020; Del+Prato, Stefano/AAC-9197-2021; Paldanius, Päivi/AAR-6793-2020; Stumvoll, Michael/ABE-1121-2021	Kudat, Hasan/0000-0003-1936-5221; Stumvoll, Michael/0000-0001-6225-8240; Paldanius, Paivi Maria/0000-0001-5997-4879	Novartis	Novartis(Novartis)	Novartis.	Ahren B, 2008, INT J CLIN PRACT, V62, P8, DOI 10.1111/j.1742-1241.2007.01685.x; Ahren B, 2009, BEST PRACT RES CL EN, V23, P487, DOI 10.1016/j.beem.2009.03.003; Bekiari E, 2016, ENDOCRINE, V52, P458, DOI 10.1007/s12020-015-0841-1; Bolli G, 2008, DIABETES OBES METAB, V10, P82, DOI 10.1111/j.1463-1326.2007.00820.x; Bolli G, 2009, DIABETES OBES METAB, V11, P589, DOI 10.1111/j.1463-1326.2008.01023.x; Bosi E, 2007, DIABETES CARE, V30, P890, DOI 10.2337/dc06-1732; Cheng AYY, 2005, CAN MED ASSOC J, V172, P213, DOI 10.1503/cmaj.1031414; Crowley MJ, 2019, DIABETES OBES METAB, V21, P854, DOI 10.1111/dom.13589; Crowley MJ, 2017, DIABETES CARE, V40, P1787, DOI 10.2337/dc17-1528; Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI 10.2337/dci18-0033; DeFronzo RA, 2013, DIABETES CARE, V36, pS127, DOI 10.2337/dcS13-2011; Del Prato S, 2014, DIABETIC MED, V31, P1178, DOI 10.1111/dme.12508; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Evans M, 2018, DIABETES THER, V9, P27, DOI 10.1007/s13300-017-0329-5; Filozof C, 2010, DIABETIC MED, V27, P318, DOI 10.1111/j.1464-5491.2010.02938.x; Garber AJ, 2019, ENDOCR PRACT, V25, P69, DOI 10.4158/CS-2018-0535; Giannarelli R, 2003, DIABETES METAB, V29, pS28; Khunti K, 2013, DIABETES CARE, V36, P3411, DOI 10.2337/dc13-0331; Laiteerapong N, 2019, DIABETES CARE, V42, P416, DOI 10.2337/dc17-1144; Matthews DR, 2019, DIABETIC MED, V36, P505, DOI 10.1111/dme.13886; Matthews DR, 2010, DIABETES OBES METAB, V12, P780, DOI 10.1111/j.1463-1326.2010.01233.x; Matthews DR, 2019, DIABETES OBES METAB, V21, P2240, DOI 10.1111/dom.13800; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Phung OJ, 2014, DIABETES OBES METAB, V16, P410, DOI [10.1111/dom.12233, 10.1111/dom.12235]; Rosenstock J, 2007, DIABETES CARE, V30, P217, DOI 10.2337/dc06-1815; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389	31	117	129	4	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2019	394	10208					1519	1529		10.1016/S0140-6736(19)32131-2	http://dx.doi.org/10.1016/S0140-6736(19)32131-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JI3WL	31542292				2022-12-28	WOS:000493399500023
J	van Ree, R				van Ree, Ronald			Sustained unresponsiveness in peanut oral immunotherapy	LANCET			English	Editorial Material							ALLERGY		[van Ree, Ronald] Univ Amsterdam, Dept Expt Immunol, Amsterdam Univ Med Ctr, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van Ree, Ronald] Univ Amsterdam, Dept Otorhinolaryngol, Amsterdam Univ Med Ctr, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Ree, R (corresponding author), Univ Amsterdam, Dept Expt Immunol, Amsterdam Univ Med Ctr, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.; van Ree, R (corresponding author), Univ Amsterdam, Dept Otorhinolaryngol, Amsterdam Univ Med Ctr, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.	r.vanree@amsterdamumc.nl						Chinthrajah RS, 2019, LANCET, V394, P1437, DOI 10.1016/S0140-6736(19)31793-3; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Datema MR, 2019, CLIN EXP ALLERGY, V49, P216, DOI 10.1111/cea.13286; Dhami S, 2017, ALLERGY, V72, P1597, DOI 10.1111/all.13201; Freidl R, 2017, J ALLERGY CLIN IMMUN, V139, P1897, DOI 10.1016/j.jaci.2016.10.018; OPPENHEIMER JJ, 1992, J ALLERGY CLIN IMMUN, V90, P256, DOI 10.1016/0091-6749(92)90080-L; Reier-Nilsen T, 2019, ALLERGY, V74, P337, DOI 10.1111/all.13604; Santos AF, 2015, J ALLERGY CLIN IMMUN, V135, P179, DOI 10.1016/j.jaci.2014.09.001; van der Kleij HPM, 2019, ALLERGY, V74, P986, DOI 10.1111/all.13687; Wood RA, 2017, J INVEST ALLERG CLIN, V27, P151, DOI 10.18176/jiaci.0143; Wood RA, 2014, J ALLERGY CLIN IMMUN, V133, P846, DOI 10.1016/j.jaci.2013.08.047	12	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2019	394	10207					1392	1393		10.1016/S0140-6736(19)31816-1	http://dx.doi.org/10.1016/S0140-6736(19)31816-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JE5IX	31522848				2022-12-28	WOS:000490727200007
J	Hicks, CC; Cohen, PJ; Graham, NAJ; Nash, KL; Allison, EH; D'Lima, C; Mills, DJ; Roscher, M; Thilsted, SH; Thorne-Lyman, AL; MacNeil, MA				Hicks, Christina C.; Cohen, Philippa J.; Graham, Nicholas A. J.; Nash, Kirsty L.; Allison, Edward H.; D'Lima, Coralie; Mills, David J.; Roscher, Matthew; Thilsted, Shakuntala H.; Thorne-Lyman, Andrew L.; MacNeil, M. Aaron			Harnessing global fisheries to tackle micronutrient deficiencies	NATURE			English	Article							FOOD COMPOSITION DATA; FISH; WATER	Micronutrient deficiencies account for an estimated one million premature deaths annually, and for some nations can reduce gross domestic product(1,2) by up to 11%, highlighting the need for food policies that focus on improving nutrition rather than simply increasing the volume of food produced(3). People gain nutrients from a varied diet, although fish-which are a rich source of bioavailable micronutrients that are essential to human health(4)-are often overlooked. A lack of understanding of the nutrient composition of most fish(5) and how nutrient yields vary among fisheries has hindered the policy shifts that are needed to effectively harness the potential of fisheries for food and nutrition security(6). Here, using the concentration of 7 nutrients in more than 350 species of marine fish, we estimate how environmental and ecological traits predict nutrient content of marine finfish species. We use this predictive model to quantify the global spatial patterns of the concentrations of nutrients in marine fisheries and compare nutrient yields to the prevalence of micronutrient deficiencies in human populations. We find that species from tropical thermal regimes contain higher concentrations of calcium, iron and zinc; smaller species contain higher concentrations of calcium, iron and omega-3 fatty acids; and species from cold thermal regimes or those with a pelagic feeding pathway contain higher concentrations of omega-3 fatty acids. There is no relationship between nutrient concentrations and total fishery yield, highlighting that the nutrient quality of a fishery is determined by the species composition. For a number of countries in which nutrient intakes are inadequate, nutrients available in marine finfish catches exceed the dietary requirements for populations that live within 100 km of the coast, and a fraction of current landings could be particularly impactful for children under 5 years of age. Our analyses suggest that fish-based food strategies have the potential to substantially contribute to global food and nutrition security.	[Hicks, Christina C.; Graham, Nicholas A. J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Hicks, Christina C.; Cohen, Philippa J.; Graham, Nicholas A. J.; Mills, David J.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Cohen, Philippa J.; Allison, Edward H.; D'Lima, Coralie; Mills, David J.; Roscher, Matthew; Thilsted, Shakuntala H.] WorldFish, Bayan Lepas, Malaysia; [Nash, Kirsty L.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Nash, Kirsty L.] Univ Tasmania, Ctr Marine Socioecol, Hobart, Tas, Australia; [Allison, Edward H.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Thorne-Lyman, Andrew L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD USA; [MacNeil, M. Aaron] Dalhousie Univ, Dept Biol, Ocean Frontier Inst, Halifax, NS, Canada	Lancaster University; James Cook University; CGIAR; Worldfish; University of Tasmania; University of Tasmania; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Dalhousie University	Hicks, CC (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.; Hicks, CC (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia.	christina.hicks@lancaster.ac.uk	Mills, David/GXF-1821-2022; MacNeil, Aaron/E-8196-2017; Graham, Nicholas AJ/C-8360-2014; Nash, Kirsty L/B-5456-2015; Hicks, Christina/M-6182-2015; Allison, Edward Hugh/B-8615-2009; MacNeil, M. Aaron/ABD-6444-2021	MacNeil, Aaron/0000-0001-8406-325X; Graham, Nicholas AJ/0000-0002-0304-7467; Nash, Kirsty L/0000-0003-0976-3197; Hicks, Christina/0000-0002-7399-4603; MacNeil, M. Aaron/0000-0001-8406-325X; Mills, David/0000-0003-0181-843X; Roscher, Matthew/0000-0002-3408-8763; Thilsted, Shakuntala/0000-0002-4041-1651; Cohen, Philippa/0000-0002-9987-1943	European Research Council (ERC) [759457]; Lancaster University; ARC Centre of Excellence for Coral Reef Studies; Royal Society [UF140691]; NSERC; Australian Centre for International Agricultural Research [FIS/2017/003, FIS/2015/031]; USAID Feed the Future Innovation Lab for Nutrition - Asia [AIDOAA-1-10-00005]; FishBase database team; FAO/INFOODS database team	European Research Council (ERC)(European Research Council (ERC)European Commission); Lancaster University; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Royal Society(Royal Society of London); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Centre for International Agricultural Research; USAID Feed the Future Innovation Lab for Nutrition - Asia(United States Agency for International Development (USAID)); FishBase database team; FAO/INFOODS database team	This research was supported by a European Research Council Starting Grant awarded to C.C.H. (ERC grant number: 759457), Lancaster University, the ARC Centre of Excellence for Coral Reef Studies, a Royal Society University Research Fellowship to N.A.J.G. (UF140691), a NSERC Tier II Canada Research Chair awarded to M.A.M, the Australian Centre for International Agricultural Research through projects FIS/2017/003 and FIS/2015/031, and a USAID Feed the Future Innovation Lab for Nutrition - Asia (award number AIDOAA-1-10-00005) to A.L.T.-L. This work was undertaken as part of the CGIAR Research Program (CPR) on Fish Agri-Food Systems (FISH) led by WorldFish, supported by contributors to the CGIAR Trust Fund. We are grateful for the support provided by the FishBase and FAO/INFOODS database teams, J. Robinson for help with Fig. 3, and N. Swan, J. Silveira and E. Maire for help sourcing data.	Achouba A, 2016, ENVIRON INT, V96, P8, DOI 10.1016/j.envint.2016.08.015; Alder J., 2004, Journal of Environment & Development, V13, P156, DOI 10.1177/1070496504266092; Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2017, GLOB NUTR REP 2017 N; [Anonymous], 1982, POVERTY FAMINES ESSA; Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2; Asche F, 2015, WORLD DEV, V67, P151, DOI 10.1016/j.worlddev.2014.10.013; Balter M, 2002, SCIENCE, V295, P1219, DOI 10.1126/science.295.5558.1219; Barlow J, 2018, NATURE, V559, P517, DOI 10.1038/s41586-018-0301-1; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bogard JR, 2015, J FOOD COMPOS ANAL, V42, P120, DOI 10.1016/j.jfca.2015.03.002; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Budge SM, 2002, CAN J FISH AQUAT SCI, V59, P886, DOI 10.1139/F02-062; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Carr SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176013; Charrondiere UR, 2016, FOOD CHEM, V193, P75, DOI 10.1016/j.foodchem.2014.11.055; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Cunningham S, 2000, INT RELATIONS COMMON, P255; Dee LE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1435; Freon P, 2014, INT J LIFE CYCLE ASS, V19, P1068, DOI 10.1007/s11367-014-0716-3; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Haddad L, 2016, NATURE, V540, P30, DOI 10.1038/540030a; Hixson SM, 2015, ENVIRON REV, V23, P414, DOI 10.1139/er-2015-0029; Horton S, 2013, HOW MUCH HAVE GLOBAL PROBLEMS COST THE WORLD?: A SCORECARD FROM 1900 TO 2050, P247; Hotz C, 2007, J NUTR, V137, P1097, DOI 10.1093/jn/137.4.1097; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kawarazuka N, 2011, PUBLIC HEALTH NUTR, V14, P1927, DOI 10.1017/S1368980011000814; Kummu M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034010; Lal R, 2010, J PLANT NUTR SOIL SC, V173, P4, DOI 10.1002/jpln.200900290; Marinda PA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204009; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Nash KL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10723-1; National Academies of Sciences, 2017, DIET REF INT TABL AP; Parrish C.C., 2013, ISRN OCEANOGR, V2013, P604045, DOI [10.5402/2013/604045, DOI 10.5402/2013/604045]; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Rittenschober D, 2016, FOOD CHEM, V193, P112, DOI 10.1016/j.foodchem.2014.08.055; Rittenschober D, 2013, FOOD CHEM, V141, P4303, DOI 10.1016/j.foodchem.2013.07.007; Ruddle K, 2008, FISHERIES GLOBAL WEL, P399; Salvatier J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.55; Sidhu KS, 2003, REGUL TOXICOL PHARM, V38, P336, DOI 10.1016/j.yrtph.2003.07.002; Smith MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159365; Thilsted S. H., 1997, Naga, V20, P82; Thilsted SH, 2016, FOOD POLICY, V61, P126, DOI 10.1016/j.foodpol.2016.02.005; Vaitla B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06199-w; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Vedtofte MS, 2011, AM J CLIN NUTR, V94, P1097, DOI 10.3945/ajcn.111.018762; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; WILLIS JN, 1984, MAR BIOL, V80, P273, DOI 10.1007/BF00392822; Willmer P., 2009, ENV PHYSL ANIMALS	53	237	242	16	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					95	+		10.1038/s41586-019-1592-6	http://dx.doi.org/10.1038/s41586-019-1592-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31554969	Green Accepted			2022-12-28	WOS:000488832500037
J	Luo, MC; Zhao, ZL; Zhang, YL; Sun, YJ; Xing, Y; Lv, F; Yang, Y; Zhang, X; Hwang, S; Qin, YN; Ma, JY; Lin, F; Su, D; Lu, G; Guo, SJ				Luo, Mingchuan; Zhao, Zhonglong; Zhang, Yelong; Sun, Yingjun; Xing, Yi; Lv, Fan; Yang, Yong; Zhang, Xu; Hwang, Sooyeon; Qin, Yingnan; Ma, Jing-Yuan; Lin, Fei; Su, Dong; Lu, Gang; Guo, Shaojun			PdMo bimetallene for oxygen reduction catalysis	NATURE			English	Article							PLATINUM; ELECTROCATALYSTS; NANOSHEETS; ENERGY; NANOWIRES; DESIGN; SIZE	The efficient interconversion of chemicals and electricity through electrocatalytic processes is central to many renewable-energy initiatives. The sluggish kinetics of the oxygen reduction reaction (ORR) and the oxygen evolution reaction (OER)(1-4) has long posed one of the biggest challenges in this field, and electrocatalysts based on expensive platinum-group metals are often required to improve the activity and durability of these reactions. The use of alloying(5-7), surface strain(8-11) and optimized coordination environments(12) has resulted in platinum-based nanocrystals that enable very high ORR activities in acidic media; however, improving the activity of this reaction in alkaline environments remains challenging because of the difficulty in achieving optimized oxygen binding strength on platinum-group metals in the presence of hydroxide. Here we show that PdMo bimetallene-a palladium-molybdenum alloy in the form of a highly curved and sub-nanometre-thick metal nanosheet-is an efficient and stable electrocatalyst for the ORR and the OER in alkaline electrolytes, and shows promising performance as a cathode in Zn-air and Li-air batteries. The thin-sheet structure of PdMo bimetallene enables a large electrochemically active surface area (138.7 square metres per gram of palladium) as well as high atomic utilization, resulting in a mass activity towards the ORR of 16.37 amperes per milligram of palladium at 0.9 volts versus the reversible hydrogen electrode in alkaline electrolytes. This mass activity is 78 times and 327 times higher than those of commercial Pt/C and Pd/C catalysts, respectively, and shows little decay after 30,000 potential cycles. Density functional theory calculations reveal that the alloying effect, the strain effect due to the curved geometry, and the quantum size effect due to the thinness of the sheets tune the electronic structure of the system for optimized oxygen binding. Given the properties and the structure-activity relationships of PdMo metallene, we suggest that other metallene materials could show great promise in energy electrocatalysis.	[Luo, Mingchuan; Zhang, Yelong; Sun, Yingjun; Xing, Yi; Lv, Fan; Yang, Yong; Qin, Yingnan; Lin, Fei; Guo, Shaojun] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing, Peoples R China; [Luo, Mingchuan; Guo, Shaojun] Peking Univ, Coll Engn, BIC ESAT, Beijing, Peoples R China; [Zhao, Zhonglong; Zhang, Xu; Lu, Gang] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA; [Hwang, Sooyeon; Su, Dong] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Ma, Jing-Yuan] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai, Peoples R China; [Guo, Shaojun] Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing, Peoples R China; [Guo, Shaojun] Peking Univ, Coll Engn, Key Lab Theory & Technol Adv Batteries Mat, Beijing, Peoples R China	Peking University; Peking University; California State University System; California State University Northridge; United States Department of Energy (DOE); Brookhaven National Laboratory; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Peking University; Peking University	Guo, SJ (corresponding author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing, Peoples R China.; Guo, SJ (corresponding author), Peking Univ, Coll Engn, BIC ESAT, Beijing, Peoples R China.; Guo, SJ (corresponding author), Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing, Peoples R China.; Guo, SJ (corresponding author), Peking Univ, Coll Engn, Key Lab Theory & Technol Adv Batteries Mat, Beijing, Peoples R China.	guosj@pku.edu.cn	Su, Dong/A-8233-2013; Luo, Mingchuan/AAZ-1739-2020; Guo, Shaojun/A-8449-2011	Su, Dong/0000-0002-1921-6683; Guo, Shaojun/0000-0002-5941-414X; Zhang, yelong/0000-0002-2748-2869	National Key R&D Program of China [2016YFB0100200]; National Natural Science Foundation of China [51671003]; Beijing Natural Science Foundation [JQ18005]; BIC-ESAT project; China Postdoctoral Science Foundation [2017M610022]; Young Thousand Talents Program; National Science Foundation [DMR-1828019]; US Department of Energy Office of Science Facility [DE-SC0012704]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); BIC-ESAT project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Young Thousand Talents Program; National Science Foundation(National Science Foundation (NSF)); US Department of Energy Office of Science Facility(United States Department of Energy (DOE))	This work was financially supported by the National Key R&D Program of China (number 2016YFB0100200), the National Natural Science Foundation of China (number 51671003), the Beijing Natural Science Foundation (number JQ18005), the BIC-ESAT project, the China Postdoctoral Science Foundation (number 2017M610022) and the Young Thousand Talents Program. The work at California State University Northridge was supported by the National Science Foundation PREM programme (DMR-1828019). The electron microscopy work used resources of the Center for Functional Nanomaterials, which is a US Department of Energy Office of Science Facility, at Brookhaven National Laboratory under contract number DE-SC0012704.	[Anonymous], 2015, NUCL SCI TECH, V26; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bu LZ, 2016, SCIENCE, V354, P1410, DOI 10.1126/science.aah6133; Bu LZ, 2015, ADV MATER, V27, P7204, DOI 10.1002/adma.201502725; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Cui ZM, 2017, ADV MATER, V29, DOI 10.1002/adma.201702385; Cui ZM, 2017, ANGEW CHEM INT EDIT, V56, P9901, DOI 10.1002/anie.201705778; Darling RM, 2003, J ELECTROCHEM SOC, V150, pA1523, DOI 10.1149/1.1613669; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Duan HH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4093; Escudero-Escribano M, 2016, SCIENCE, V352, P73, DOI 10.1126/science.aad8892; Gilroy KD, 2016, CHEM REV, V116, P10414, DOI 10.1021/acs.chemrev.6b00211; Huang XQ, 2015, SCIENCE, V348, P1230, DOI 10.1126/science.aaa8765; Huang XQ, 2011, NAT NANOTECHNOL, V6, P28, DOI [10.1038/nnano.2010.235, 10.1038/NNANO.2010.235]; Jiang KZ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601705; Jiao Y, 2015, CHEM SOC REV, V44, P2060, DOI 10.1039/c4cs00470a; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Lee JS, 2011, ENERG ENVIRON SCI, V4, P4148, DOI 10.1039/c1ee01942b; Lee JG, 2000, J ALLOY COMPD, V298, P291, DOI 10.1016/S0925-8388(99)00664-7; Li MF, 2016, SCIENCE, V354, P1414, DOI 10.1126/science.aaf9050; Li YG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2812; Li Y, 2015, CRYSTENGCOMM, V17, P1833, DOI 10.1039/c4ce02062f; Liu X, 2015, ANGEW CHEM INT EDIT, V54, P9654, DOI 10.1002/anie.201503612; Lopes PP, 2016, ACS CATAL, V6, P2536, DOI 10.1021/acscatal.5b02920; Luo MC, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.59; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Nam G, 2015, ACS NANO, V9, P6493, DOI 10.1021/acsnano.5b02266; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Norskov JK, 2009, NAT CHEM, V1, P37, DOI [10.1038/nchem.121, 10.1038/NCHEM.121]; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Okada J, 2001, PHYS CHEM CHEM PHYS, V3, P3297, DOI 10.1039/b101093j; Paulus UA, 2002, ELECTROCHIM ACTA, V47, P3787, DOI 10.1016/S0013-4686(02)00349-3; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Perez-Alonso FJ, 2012, ANGEW CHEM INT EDIT, V51, P4641, DOI 10.1002/anie.201200586; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Saleem F, 2013, J AM CHEM SOC, V135, P18304, DOI 10.1021/ja4101968; Seh ZW, 2017, SCIENCE, V355, DOI 10.1126/science.aad4998; Shao MH, 2016, CHEM REV, V116, P3594, DOI 10.1021/acs.chemrev.5b00462; Shao MH, 2013, ELECTROCHEM COMMUN, V31, P46, DOI 10.1016/j.elecom.2013.03.011; Sheng WC, 2013, ENERG ENVIRON SCI, V6, P1509, DOI 10.1039/c3ee00045a; Stamenkovic V, 2006, ANGEW CHEM INT EDIT, V45, P2897, DOI 10.1002/anie.200504386; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Stamenkovic VR, 2017, NAT MATER, V16, P57, DOI [10.1038/nmat4738, 10.1038/NMAT4738]; Stephens IEL, 2016, SCIENCE, V354, P1378, DOI 10.1126/science.aal3303; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]; Suen NT, 2017, CHEM SOC REV, V46, P337, DOI 10.1039/c6cs00328a; van der Vliet DF, 2012, ANGEW CHEM INT EDIT, V51, P3139, DOI 10.1002/anie.201107668; Wakisaka M, 2006, J PHYS CHEM B, V110, P23489, DOI 10.1021/jp0653510; Winther-Jensen B, 2008, SCIENCE, V321, P671, DOI 10.1126/science.1159267; Yang NL, 2017, ADV MATER, V29, DOI 10.1002/adma.201700769; Zhang JT, 2015, NAT NANOTECHNOL, V10, P444, DOI [10.1038/nnano.2015.48, 10.1038/NNANO.2015.48]; Zhou XW, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144113	52	539	548	189	1732	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					81	+		10.1038/s41586-019-1603-7	http://dx.doi.org/10.1038/s41586-019-1603-7			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31554968	Green Submitted			2022-12-28	WOS:000488832500034
J	Shao, Y; Forster, SC; Tsaliki, E; Vervier, K; Strang, A; Simpson, N; Kumar, N; Stares, MD; Rodger, A; Brocklehurst, P; Field, N; Lawley, TD				Shao, Yan; Forster, Samuel C.; Tsaliki, Evdokia; Vervier, Kevin; Strang, Angela; Simpson, Nandi; Kumar, Nitin; Stares, Mark D.; Rodger, Alison; Brocklehurst, Peter; Field, Nigel; Lawley, Trevor D.			Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth	NATURE			English	Article							HUMAN GUT MICROBIOME; BACTERIAL TRANSMISSION; POPULATION-STRUCTURE; RESISTANCE GENES; BODY SITES; GENOME; TOOL; CHILDHOOD; REVEALS; VERSION	Immediately after birth, newborn babies experience rapid colonization by microorganisms from their mothers and the surrounding environment(1). Diseases in childhood and later in life are potentially mediated by the perturbation of the colonization of the infant gut microbiota(2). However, the effects of delivery via caesarean section on the earliest stages of the acquisition and development of the gut microbiota, during the neonatal period (<= 1 month), remain controversial(3,4). Here we report the disrupted transmission of maternal Bacteroides strains, and highlevel colonization by opportunistic pathogens associated with the hospital environment (including Entero coccus, Enterobacter and Klebsiella species), in babies delivered by caesarean section. These effects were also seen, to a lesser extent, in vaginally delivered babies whose mothers underwent antibiotic prophylaxis and in babies who were not breastfed during the neonatal period. We applied longitudinal sampling and whole-genome shotgun metagenomic analysis to 1,679 gut microbiota samples (taken at several time points during the neonatal period, and in infancy) from 596 full-term babies born in UK hospitals; for a subset of these babies, we collected additional matched samples from mothers (175 mothers paired with 178 babies). This analysis demonstrates that the mode of delivery is a significant factor that affects the composition of the gut microbiota throughout the neonatal period, and into infancy. Matched large-scale culturing and whole-genome sequencing of over 800 bacterial strains from these babies identified virulence factors and clinically relevant antimicrobial resistance in opportunistic pathogens that may predispose individuals to opportunistic infections. Our findings highlight the critical role of the local environment in establishing the gut microbiota in very early life, and identify colonization with antimicrobial-resistance-containing opportunistic pathogens as a previously underappreciated risk factor in hospital births.	[Shao, Yan; Forster, Samuel C.; Vervier, Kevin; Kumar, Nitin; Stares, Mark D.; Lawley, Trevor D.] Wellcome Sanger Inst, Host Microbiota Interact Lab, Hinxton, England; [Forster, Samuel C.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Forster, Samuel C.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [Tsaliki, Evdokia; Strang, Angela; Simpson, Nandi; Rodger, Alison; Field, Nigel] UCL, Inst Global Hlth, London, England; [Brocklehurst, Peter] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England	Wellcome Trust Sanger Institute; Hudson Institute of Medical Research; Monash University; University of London; University College London; University of Birmingham	Lawley, TD (corresponding author), Wellcome Sanger Inst, Host Microbiota Interact Lab, Hinxton, England.; Field, N (corresponding author), UCL, Inst Global Hlth, London, England.	nigel.field@ucl.ac.uk; tl2@sanger.ac.uk	Shao, Yan/AAE-8637-2019; Field, Nigel/ABG-3948-2020; Forster, Samuel C/F-4206-2014	Shao, Yan/0000-0002-8662-0504; Forster, Samuel C/0000-0003-4144-2537; Field, Nigel/0000-0002-2825-6652	Wellcome Trust [WT101169MA]; Wellcome Sanger core funding [WT098051]; Wellcome Trust; Australian National Health and Medical Research Council [1091097, 1159239, 1141564]; Victorian Government's Operational Infrastructure Support Program	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Sanger core funding; Wellcome Trust(Wellcome TrustEuropean Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by the Wellcome Trust (WT101169MA) and Wellcome Sanger core funding (WT098051). Y.S. is supported by a Wellcome Trust PhD Studentship. S.C.F. is supported by the Australian National Health and Medical Research Council (1091097, 1159239 and 1141564) and the Victorian Government's Operational Infrastructure Support Program. We thank the participating families for their time and contribution to the BBS; the research midwives at recruiting hospitals for recruitment and clinical metadata collection; N. Moreno, H. Ali, S. Bibi and A. Takyi for raw-sample processing; the Core Sequencing and Pathogen Informatics teams at the Wellcome Sanger Institute for informatics support; and H. Browne and A. Almeida for critical feedback of the manuscript.	Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Bailey SR, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1627-7; Baumann-Dudenhoeffer AM, 2018, NAT MED, V24, P1822, DOI 10.1038/s41591-018-0216-2; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brooks B, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0493-5; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Chen L, 2016, NUCLEIC ACIDS RES, V33, pD325; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Combellick JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33995-7; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Field N, 2013, LANCET, V382, P35; Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Jain C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07641-9; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lahti L., 2017, TOOLS MICROBIOME ANA; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Moradigaravand D, 2017, MBIO, V8; Moradigaravand D, 2017, GENOME BIOL EVOL, V9, P574, DOI 10.1093/gbe/evx019; Moradigaravand D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.173, 10.1038/nmicrobiol.2016.173]; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Ondov B. D, 2019, MASH SCREEN HIGH THR, DOI [10.1101/557314v1, DOI 10.1101/557314V1]; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Page AJ., 2016, J OPEN SOURCE SOFTW, V1, P118, DOI 10.21105/joss.00118; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000083; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Raveh-Sadka T, 2016, ISME J, V10, P2817, DOI 10.1038/ismej.2016.83; Raven KE, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.33, 10.1038/nmicrobiol.2015.33]; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shin HD, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0126-1; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Stewart CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17141; Stokholm J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02573-2; Stokholm J, 2016, J ALLERGY CLIN IMMUN, V138, P881, DOI 10.1016/j.jaci.2016.01.028; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Vandeputte D, 2017, FEMS MICROBIOL REV, V41, pS154, DOI 10.1093/femsre/fux027; Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2; Vatanen T, 2016, CELL, V165, P1551, DOI 10.1016/j.cell.2016.05.056; Wampach L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07631-x; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yassour M, 2018, CELL HOST MICROBE, V24, P146, DOI 10.1016/j.chom.2018.06.007; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zou YQ, 2019, NAT BIOTECHNOL, V37, P179, DOI 10.1038/s41587-018-0008-8	70	319	332	14	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					117	+		10.1038/s41586-019-1560-1	http://dx.doi.org/10.1038/s41586-019-1560-1			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31534227	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000488832500042
J	Abbasi, J				Abbasi, Jennifer			Cardiovascular Corner Prescription Omega-3s, Stroke Rehab, and Statins After Age 75	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2019	322	13					1241	1243		10.1001/jama.2019.14485	http://dx.doi.org/10.1001/jama.2019.14485			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OD	31509157				2022-12-28	WOS:000489331900003
J	Guiney, TE; Lopes, MS; Kalra, MK; Mooradian, MJ; Neilan, TG; Stone, JR				Guiney, Timothy E.; Lopes, Mathew S.; Kalra, Mannudeep K.; Mooradian, Meghan J.; Neilan, Tomas G.; Stone, James R.			Case 30-2019: A 65-Year-Old Woman with Lung Cancer and Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPEN-LABEL; MYOCARDITIS; DOCETAXEL; NIVOLUMAB; OUTCOMES	A 65-year-old woman presented to the hospital with chest pain and dyspnea. Three weeks earlier, treatment with nivolumab had been initiated for metastatic KRAS-positive lung adenocarcinoma. The troponin T level, d-dimer level, and white-cell count were elevated. Diagnostic tests were performed.	[Guiney, Timothy E.; Mooradian, Meghan J.; Neilan, Tomas G.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kalra, Mannudeep K.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Guiney, Timothy E.; Lopes, Mathew S.; Mooradian, Meghan J.; Neilan, Tomas G.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Kalra, Mannudeep K.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Stone, James R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Lopes, Mathew S.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Guiney, TE (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Guiney, TE (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; [Anonymous], 2017, NEW ENGL J MED, V377, P2475; Awadalla M, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0535-y; Bonaca MP, 2019, CIRCULATION, V140, P80, DOI 10.1161/CIRCULATIONAHA.118.034497; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Citrin DE, 2017, NEW ENGL J MED, V377, P1065, DOI 10.1056/NEJMra1608986; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Douglas PS, 1996, NEW ENGL J MED, V334, P1311, DOI 10.1056/NEJM199605163342007; Escudier M, 2017, CIRCULATION, V136, P2085, DOI 10.1161/CIRCULATIONAHA.117.030571; Esfahani K, 2019, NEW ENGL J MED, V380, P2375, DOI 10.1056/NEJMc1903064; Ganatra S, 2018, ONCOLOGIST, V23, P879, DOI 10.1634/theoncologist.2018-0130; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Glass CK, 2017, CARDIOVASC PATHOL, V30, P55, DOI 10.1016/j.carpath.2017.06.009; Heery CR, 2014, ASCO M, V32, P3064, DOI DOI 10.1200/JCO.2014.32.15_SUPPL.3064; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Horn L, 2017, J CLIN ONCOL, V35, P3924, DOI 10.1200/JCO.2017.74.3062; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Laubli H, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0057-1; Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; Mahmood SS, 2018, J AM COLL CARDIOL, V71, P1755, DOI 10.1016/j.jacc.2018.02.037; Moslehi JJ, 2017, NEW ENGL J MED, V376, P292, DOI 10.1056/NEJMc1615251; Moslehi JJ, 2016, NEW ENGL J MED, V375, P1457, DOI 10.1056/NEJMra1100265; Neilan TG, 2018, ONCOLOGIST, V23, P874, DOI 10.1634/theoncologist.2018-0157; Reck M, 2017, NEW ENGL J MED, V377, P849, DOI 10.1056/NEJMra1703413; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Salem JE, 2019, NEW ENGL J MED, V380, P2377, DOI 10.1056/NEJMc1901677	28	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2019	381	13					1268	1277		10.1056/NEJMcpc1900423	http://dx.doi.org/10.1056/NEJMcpc1900423			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC5OT	31553841				2022-12-28	WOS:000489333500012
J	Mahase, E				Mahase, Elisabeth			Decoding AI: five minutes with ... Lesa Wright	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2019	366								l5722	10.1136/bmj.l5722	http://dx.doi.org/10.1136/bmj.l5722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WY	31554615				2022-12-28	WOS:000488488700011
J	Slomski, A				Slomski, Anita			Cannabinoid Agonist Reduces Cannabis Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1134	1134		10.1001/jama.2019.14755	http://dx.doi.org/10.1001/jama.2019.14755			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550029				2022-12-28	WOS:000488822800009
J	Feachem, RGA; Chen, I; Akbari, O; Bertozzi-Villa, A; Bhatt, S; Binka, F; Boni, MF; Buckee, C; Dieleman, J; Dondorp, A; Eapen, A; Feachem, NS; Filler, S; Gething, P; Gosling, R; Haakenstad, A; Harvard, K; Hatefi, A; Jamison, D; Jones, KE; Karema, C; Kamwi, RN; Lal, A; Larson, E; Lees, M; Lobo, NF; Micah, AE; Moonen, B; Newby, G; Ning, X; Pate, M; Quinones, M; Roh, M; Rolfe, B; Shanks, D; Singh, B; Staley, K; Tulloch, J; Wegbreit, J; Woo, HJ; Mpanju-Shumbusho, W				Feachem, Richard G. A.; Chen, Ingrid; Akbari, Omar; Bertozzi-Villa, Amelia; Bhatt, Samir; Binka, Fred; Boni, Maciej F.; Buckee, Caroline; Dieleman, Joseph; Dondorp, Arjen; Eapen, Alex; Feachem, Neelam Sekhri; Filler, Scott; Gething, Peter; Gosling, Roly; Haakenstad, Annie; Harvard, Kelly; Hatefi, Arian; Jamison, Dean; Jones, Kate E.; Karema, Corine; Kamwi, Richard Nchabi; Lal, Altaf; Larson, Erika; Lees, Margaret; Lobo, Neil F.; Micah, Angela E.; Moonen, Bruno; Newby, Gretchen; Ning, Xiao; Pate, Muhammad; Quinones, Martha; Roh, Michelle; Rolfe, Ben; Shanks, Dennis; Singh, Balbir; Staley, Kenneth; Tulloch, James; Wegbreit, Jennifer; Woo, Hyun Ju; Mpanju-Shumbusho, Winnie			Malaria eradication within a generation: ambitious, achievable, and necessary	LANCET			English	Review							RAPID DIAGNOSTIC-TEST; EBOLA-VIRUS DISEASE; PLASMODIUM-FALCIPARUM; GENE DRIVE; HEALTH SYSTEMS; VECTOR CONTROL; ELIMINATION; AFRICA; RESISTANCE; EPIDEMIOLOGY		[Feachem, Richard G. A.; Chen, Ingrid; Gosling, Roly; Harvard, Kelly; Larson, Erika; Lobo, Neil F.; Newby, Gretchen; Roh, Michelle; Wegbreit, Jennifer; Woo, Hyun Ju] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Hatefi, Arian] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Feachem, Neelam Sekhri; Jamison, Dean] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Lees, Margaret] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Akbari, Omar] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Bertozzi-Villa, Amelia; Bhatt, Samir; Gething, Peter] Univ Oxford, Malaria Atlas Project, Oxford, England; [Bertozzi-Villa, Amelia] Inst Dis Modeling, Bellevue, WA USA; [Binka, Fred] Univ Hlth & Allied Sci, Sch Publ Hlth, Ho, Ghana; [Boni, Maciej F.] Penn State, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA USA; [Buckee, Caroline] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Dieleman, Joseph; Haakenstad, Annie; Micah, Angela E.] Univ Washington, Inst Hlth Metr, Seattle, WA 98195 USA; [Dondorp, Arjen] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Eapen, Alex] Natl Inst Malaria Res, Chennai, Tamil Nadu, India; [Filler, Scott] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Jones, Kate E.] UCL, Dept Genet Evolut & Environm, London, England; [Kamwi, Richard Nchabi] Elimination 8, Windhoek, Namibia; [Lal, Altaf] Sun Pharma Ind, Mumbai, Maharashtra, India; [Moonen, Bruno] Bill & Melinda Gates Fdn, Seattle, WA USA; [Ning, Xiao] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Beijing, Peoples R China; [Pate, Muhammad] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Quinones, Martha] Univ Nacl Colombia, Dept Publ Hlth, Bogota, Colombia; [Rolfe, Ben] Asia Pacific Leaders Malaria Alliance, Singapore, Singapore; [Shanks, Dennis] Army Malaria Inst, Brisbane, Qld, Australia; [Singh, Balbir] Univ Malaysia Sarawak, Malaria Res Ctr, Sarawak, Malaysia; [Staley, Kenneth] Presidents Malaria Initiat, Washington, DC USA; [Mpanju-Shumbusho, Winnie] RBM Partnership End Malaria, Geneva, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Mahidol Oxford Tropical Medicine Research Unit (MORU); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); University of London; University College London; Bill & Melinda Gates Foundation; Chinese Center for Disease Control & Prevention; Duke University; Universidad Nacional de Colombia; University of Malaysia Sarawak	Chen, I (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	ingrid.chen@ucsf.edu	Gething, Peter/GQR-1884-2022; Gething, Peter/ABD-2110-2020; Jones, Kate/Y-3317-2019; Bhatt, Samir/ABE-7938-2020	Gething, Peter/0000-0001-6759-5449; Jones, Kate/0000-0001-5231-3293; Bhatt, Samir/0000-0002-0891-4611	Bill & Melinda Gates Foundation (the Gates Foundation); MRC [MR/R015600/1] Funding Source: UKRI; NERC [NE/J000507/2] Funding Source: UKRI	Bill & Melinda Gates Foundation (the Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Commission was supported financially by the Bill & Melinda Gates Foundation (the Gates Foundation). The funding covered the costs of the Commission secretariat, together with travel, accommodation, and meals for the Commission meetings, as well as working group meetings and other consultations. This work benefited from contributions from many individuals. We give special thanks to Commissioner Joseph Dieleman (Institute for Health Metrics and Evaluation, University of Washington) and his team, including Abigail Chapin, Catherine Chen, Annie Haakenstad, Anton Connor Harle, Golsum Tsakalos, Angela E Micah, Tianchan Tao, and Bianca Zlavog, who did analyses of malaria eradication financing. We are also grateful to Commissioner Peter Gething (Malaria Atlas Project, University of Oxford) and his team, including Amelia Bertozzi-Villa and Samir Bhatt, who developed the global malaria risk maps. Both sets of analyses were crucial to this report. We are very grateful to colleagues around the globe who shared valuable data, information, and insights. We would like to specifically recognise contributions from Jimee Hwang (Centers for Disease Control and Prevention and University of California San Francisco [UCSF]), a Commission member, who provided several thoughtful reviews of our report and gave us critical feedback. We would also like to acknowledge the contributions of Valentina Buj, Stefan Peterson, Mark Young, David Hipgrave, and Kyaw Aung (UNICEF), and Sara Hollis (WHO) who provided content on integrated community case management; David Heymann (London School of Hygiene & Tropical Medicine) who contributed to the global health security section; Effie Espino (Asia Pacific Malaria Elimination Network), who provided content on the Philippines' malaria programme; Grant Dorsey (UCSF), and Moses Kamya (Makerere University College of Health Sciences), who provided content on the Uganda case study; Timothy Wells (Medicines for Malaria Venture), who contributed to the medicines section; Jeff Chertack (Gates Foundation) who contributed to the gene drive section; Gonzalo Domingo (PATH) and Scott Miller (Gates Foundation) who contributed to the diagnostics section; Chris Larkin, Sarah Rees, and Mathias Mondy (Innovative Vector Control Consortium) who contributed to the insecticides section; Xavier Ding (Foundation for Innovative New Diagnostics), Anthony James (University of California Irvine), Mamadou Coulibaly (Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali) and Abdoulaye Diabate (Institut de Recherche en Sciences de la Sante/Centre Muraz, Bobo-Dioulasso, Burkina Faso), who contributed to the research and development framework figure; Rose Nani Mudin and Jenarun Bin Jelip (Vector Borne Disease Sector Team, Ministry of Health, Malaysia), who contributed information on the Malaysia's MyFoci system; and Carolyn Smith Hughes (UCSF) who contributed to the gene drive ethics, economics, and finance sections. In addition, the second meeting of Commissioners benefited from the participation of Jeremy Lefroy (UK House of Commons) and James Whiting (Malaria No More UK). We received valuable contributions from colleagues at the UCSF Global Health Group, including Naomi Beyeler, Amanda Chung, Chris Cotter, Kayla Escobar, Sara Fewer, Katie Fox, Aparna Kollipara, Saehee Lee, Alistair Lindawson, Laura Newman, Joseph Njau, Allison Phillips, Sara Rossi, Hugh Sturrock, Allison Tatarsky, and Chris White.; These individuals provided valuable input and support throughout the entire process, including facilitating Commission meetings, thought partnership on eradication-related topics, writing inputs, data acquisition and analysis, and reviewing and editing report drafts. In particular, Amanda Chung provided substantial contributions to the programme management section, Katie Fox, Aparna Kollipara, and Joseph Njau provided economics and financing content, and Allison Tatarsky provided important content for the vector and universal health coverage sections. A special thanks goes to Kayla Escobar and Saehee Lee who coordinated the three Commission meetings. The Commission Co-chairs express special thanks to the UCSF Commission Secretariat, comprising Ingrid Chen, Kelly Harvard, Erika Larson, Margaret Lees, Gretchen Newby, Jennifer Wegbreit, and Hyun Ju Woo, without whose tireless work this report would not have been possible. We also thank the six anonymous peer reviewers for their very helpful comments on an earlier draft of the paper.	Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; Abuzaineh N, 2018, PPPS IN HEALTHCARE M; AccessBio, 2015, PRODUCTS CARESTART G; Adhikari B, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1366136; Afrane YA, 2016, CURRENT TOPICS IN MA; African Leaders Malaria Alliance, 2019, ALMA SCOR ACC ACT DO; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], 2017, PRODUCT INFORMATION; [Anonymous], 2017, PLOS MED, V14; [Anonymous], 2013, PRODUCTS STANDARD G6; [Anonymous], 2017, PLOS MED, V14; [Anonymous], 2011, PLOS MED; [Anonymous], 2018, TIMES OF SWAZILAND; Arinaitwe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073073; Arinaitwe E, 2009, CLIN INFECT DIS, V49, P1629, DOI 10.1086/647946; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Asia Pacific Leaders Malaria Alliance, 2015, APLMA MALARIA ELIMIN; Asia Pacific Leaders Malaria Alliance, 2014, TASK FORCE PROGRESS; Asian Development Bank, REGIONAL MALARIA OTH, DOI [10.22617/TCS189605-2, DOI 10.22617/TCS189605-2]; Atkinson JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-225; Atkinson JAM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-93; Australian Government Department of Foreign Affairs and Trade, 2017, HLTH SEC IN IND PAC; Australian High Commission Papua New Guinea, 2016, LAUNCH OF THE AUSTRA; Baird JK, 2012, ADV PARASIT, V80, P203, DOI 10.1016/B978-0-12-397900-1.00004-9; Bali S, 2017, J PUBLIC HEALTH POL, V38, P257, DOI 10.1057/s41271-016-0058-4; Barber BE, 2013, J CLIN MICROBIOL, V51, P1118, DOI 10.1128/JCM.03285-12; Barroy H, 2017, OVERVIEW OF TRENDS I; Barry AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00359; Battle KE, 2019, LANCET, V394, P332, DOI 10.1016/S0140-6736(19)31096-7; Bayer, 2018, FLUDORA FUSION; Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31; Bennett A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1901-1; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bigira V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001689; Black R, 2016, DISEASE CONTROL PRIO, V2; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; Boni MF, 2008, P NATL ACAD SCI USA, V105, P14216, DOI 10.1073/pnas.0804628105; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Bossert TJ, 2015, HEALTH SYST REFORM, V1, P276, DOI 10.1080/23288604.2015.1056330; Bousema T, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001993; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bradley EH, 2015, INT J HEALTH POLICY, V4, P411, DOI 10.15171/ijhpm.2015.101; Braveman P, 2003, B WORLD HEALTH ORGAN, V81, P539; Bridges DJ, 2012, PATHOG GLOB HEALTH, V106, P224, DOI 10.1179/2047773212Y.0000000035; Bristol N, 2018, POLIO EMERGENCY OPER; Bristol N, 2015, POWER STRAIGHT TALK; Camara S, 2018, PARASITE, V25, DOI 10.1051/parasite/2018042; Carias C, 2016, LANCET INFECT DIS, V16, P449, DOI 10.1016/S1473-3099(15)00465-X; Carter TE, 2018, ACTA TROP, V188, P180, DOI 10.1016/j.actatropica.2018.09.001; Centers for Disease Control and Prevention, 2017, UPDATES ON CDCS POLI; Centers for Disease Control and Prevention, 2012, HUM FACT MAL; Chanda P, 2011, MALARIA J, V10, DOI [10.1186/1475-2875-10-159, 10.1186/1475-2875-10-158]; Chang AY, 2019, LANCET, V393, P2233, DOI 10.1016/S0140-6736(19)30841-4; Chapman N, 2018, NEGLECTED DISEASE RE; Chaturvedi N, 2016, INDIAN J MED RES, V143, P696, DOI 10.4103/0971-5916.191927; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Chen L., 2003, J HUMAN DEV, V4, P181, DOI [10.1080/1464988032000087532, DOI 10.1080/1464988032000087532]; Chenet SM, 2016, J INFECT DIS, V213, P1472, DOI 10.1093/infdis/jiv752; Chokshi M, 2016, J PERINATOL, V36, pS9, DOI 10.1038/jp.2016.184; Cibulskis RE, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0151-8; Closser S, 2016, MED ANTHROPOL Q, V30, P321, DOI 10.1111/maq.12254; COATNEY GR, 1971, PRIMATE MALARIAS; Cochi SL, 2014, J INFECT DIS, V210, pS540, DOI 10.1093/infdis/jiu345; Cockburn IA, 2018, NAT IMMUNOL, V19, P1199, DOI 10.1038/s41590-018-0228-6; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Committee on Improving the Quality of Healthcare Globally, 2018, CROSS GLOB QUAL CHAS; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Coppola DP, 2018, STRATEGIC APPROACH T; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Das S, 2017, AM J TROP MED HYG, V97, P1540, DOI 10.4269/ajtmh.17-0245; De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563; DESOWITZ RS, 1980, B WORLD HEALTH ORGAN, V58, P897; Dharmasiri AGG, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1977-7; Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8; Eng JLV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-133; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; Espino F, 2004, INT J HEALTH PLAN M, V19, pS155, DOI 10.1002/hpm.782; European Medicines Agency, 2018, MOSQUIRIX H W 2300; European Vaccine Initiative, 2019, MULTIMALVAX A MULTI; Fang H, 2016, INT HLTH CARE SYSTEM; Faulde MK, 2014, ACTA TROP, V139, P39, DOI 10.1016/j.actatropica.2014.06.016; Feachem R, 2018, HINDU BUSINESS LINE; Feachem RGA, 2009, SHRINKING THE MALARI; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Feng J, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2444-9; Fenner F., 1988, SMALLPOX AND ITS ERA; Fernando D, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3008-y; Fetene N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210624; Foster D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-60; Foster SO, 2011, VACCINE, V29, pD22, DOI 10.1016/j.vaccine.2011.06.081; Foundation for Innovative New Diagnostics, 2019, MALARIA PROJECT PORT; Foy BD, 2019, LANCET, V393, P1517, DOI 10.1016/S0140-6736(18)32321-3; Galactionova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127818; Gallup JL, 2001, AM J TROPICAL MED HY, V64; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Garmaise D, 2018, GLOBAL FUND BOARD AP; Gates B, 2015, FROM ASPIRATION TO A; Global Polio Eradication Initiative, 2018, POL PERS SUPP LASS F; Global Polio Eradication Initiative, 2018, PAK POL FIGHT LEND H; Golding N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0491-4; Gosling J, 2015, AM J TROP MED HYG, V93, P135, DOI 10.4269/ajtmh.14-0255; Grillet ME, 2019, LANCET INFECT DIS, V19, pE149, DOI 10.1016/S1473-3099(18)30757-6; Gueye CS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1518-9; Haakenstad A, 2019, LANCET INFECT DIS, V19, P703, DOI 10.1016/S1473-3099(19)30165-3; Hagan JE, 2017, EMERG INFECT DIS, V23, pS77, DOI 10.3201/eid2313.170594; Hammanyero KI, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6193-z; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hammond AM, 2017, PATHOG GLOB HEALTH, V111, P412, DOI 10.1080/20477724.2018.1438880; Hayden EC, 2014, NATURE, V514, P15, DOI 10.1038/514015a; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Henderson DA, 1999, VACCINE, V17, pS53, DOI 10.1016/S0264-410X(99)00293-5; Hennessee I, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2038-y; Heymann DL, 2011, VACCINE, V29, pD141, DOI 10.1016/j.vaccine.2011.12.135; Hsiang MS, 2015, AM J TROP MED HYG, V93, P203, DOI 10.4269/ajtmh.15-0391; Ilunga-Iunga F, 2015, J INFECT PUBLIC HEAL, V8, P136, DOI 10.1016/j.jiph.2014.08.008; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Independent Commission for Aid Impact, 2018, UK AID RESP GLOB HLT; Innovative Vector Control Consortium, 2019, ACTIVE INGREDIENT PO; Innovative Vector Control Consortium, 2022, ZERO 40 ER MAL YEAR; Institute for Health Metrics and Evaluation, 2019, DEVELOPMENT ASSISTAN; International Union for Conservation of Nature, 2018, GENES FOR NATURE AN; Iwagami M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006244; James S, 2018, AM J TROP MED HYG, V98, P1, DOI 10.4269/ajtmh.18-0083; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jimenez A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1780-5; Johns B, 2016, GLOB HEALTH-SCI PRAC, V4, P529, DOI 10.9745/GHSP-D-16-00165; Johnson AD, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000634; Johnson AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081304; Kamya MR, 2015, AM J TROP MED HYG, V92, P903, DOI 10.4269/ajtmh.14-0312; Kaneko A, 2010, ACTA TROP, V114, P177, DOI 10.1016/j.actatropica.2010.01.012; Katrak S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-272; Kramer K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1902-0; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Larson HJ, 2011, NATURE, V473, P446, DOI 10.1038/473446a; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; LIVADAS G A, 1953, Bull World Health Organ, V8, P497; Lover AA, 2018, AM J TROP MED HYG, V99, P17, DOI 10.4269/ajtmh.17-0869; Lover AA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002401; Lu F, 2017, NEW ENGL J MED, V376, P991, DOI 10.1056/NEJMc1612765; M2030, 2018, DEFEATING MALARIA TO; Macintyre F, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2549-1; Mahendradhata Y, 2017, HEALTH SYSTEMS IN TR, V7; Malaria Free Mekong, 2018, REG MAL CSO PLATF; Malaria No More, 2018, STATEMENT ON THE COM; Malaria Policy Advisory Committee, 2018, PROPOSED EVIDENCE RE; Malaria Policy Advisory Committee, 2018, UNIVERSAL ACCESS TO; Maneerattanasak S, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1877-x; Vasquez AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201769; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Massey NC, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.14; Mata E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/282913; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; McKee M, 2013, VALUE HEALTH, V16, pS39, DOI 10.1016/j.jval.2012.10.001; McLean ARD, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1172-x; MEASURE-Evaluation, 2017, US DHIS 2 STRENGTH H; Medical University of Vienna, 2016, CONFERENCE FIGHTING; Medicines for Malaria Venture, 2019, MMV SUPPORTED PROJEC; Mills A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S11; Ministry of Health. Malaysia, 2019, ANNUAL REPORT OF MAL; Ministry of Health Malaysia WHO University of California San Francisco Global Health Group, 2012, ELIMINATING MALARIA; Ministry of Health Sri Lanka World Health Organization UCSF Global Health Group, 2012, PROGRESS TOWARDS ELI; Mintcheva R, 2013, SUB NATIONAL MALARIA; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Morel CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058205; Morgan R, 2016, LANCET, V388, P606, DOI 10.1016/S0140-6736(16)00343-3; MOUCHET J, 1988, INSECT SCI APPL, V9, P297, DOI 10.1017/S1742758400006238; Mubiru D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134767; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Nankabirwa J, 2014, TROP MED INT HEALTH, V19, P1294, DOI 10.1111/tmi.12374; Narayan P, 2018, TIMES INDIA; Natanson L, 2011, NEW REPORT SHOWS MON; National Academies of Sciences Engineering and Medicine, 2016, GENE DRIVES ON THE H; National Health Systems Resource Centre Ministry of Health and Family Welfare, 2016, HOUSEHOLD HEALTH EXP; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; Net Positive Project, 2019, NET POS PRINC; Newby G, 2016, LANCET, V387, P1775, DOI 10.1016/S0140-6736(16)00230-0; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Nishtar S, 2010, B WORLD HEALTH ORGAN, V88, P74, DOI 10.2471/BLT.09.067868; Nkumama IN, 2017, TRENDS PARASITOL, V33, P128, DOI 10.1016/j.pt.2016.11.006; Oaks S Jr, 1991, MALARIA OBSTACLES AN; Oberemok Volodymyr Volodymyrovych, 2015, Journal of Plant Protection Research, V55, P221, DOI 10.1515/jppr-2015-0033; Obermann K, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1483638; Office of the UN Secretary-General's Special Envoy for Health in Agenda 2030 and for Malaria, 2015, AFRICAN LEADERS CALL; Office of the UN Secretary-General's Special Envoy for Health in Agenda 2030 and for Malaria, 2017, GLOBAL LEADERS LAUNC; Ogola EO, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3171-3; Okell LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06708-9; Olaniran A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1272223; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Organization W.H., 1988, GLOB ER POL YEAR 200; Oroxom R, 2018, STRUCTURING AND FUND; Ortiz-Ospina E, 2018, OUR WORLD IN DATA GL; Ouattara A, 2015, VACCINE, V33, P7506, DOI 10.1016/j.vaccine.2015.09.110; Oxford Business Group, 2015, SRI LANK HIGHL EFF P; Patouillard E, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000176; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Penny MA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0864-3; Population Services International, 2018, DATA ENGAGEMENT WITH; Pradhan S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208943; President's Malaria Initiative, 2017, THAILAND LAO PDR REG; President's Malaria Initiative, 2019, CONTRACTS AGREEMENTS; President's Malaria Initiative, 2018, THE PRESIDENTS MALAR; President's Malaria Initiative US Agency for International Development Centers for Disease Control and Prevention, 2015, PRES MAL IN STRAT 20; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Product Red, 2019, HOW RED WORKS; Protopopoff N, 2018, LANCET, V391, P1577, DOI [10.1016/S0140-6736(18)30427-6, 10.1016/s0140-6736(18)30427-6]; Rabinovich RN, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002456; RBM Partnership to End Malaria, 2018, SIXTEEN COUNTRIES SI; RBM Partnership to End Malaria, 2015, ACTION AND INVESTMEN; RBM Partnership to End Malaria, 2018, SAHEL COUNTRY LEADER; Recht J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006230; Recker Mario, 2018, F1000Res, V7, DOI 10.12688/f1000research.14991.1; Regules JA, 2016, J INFECT DIS, V214, P762, DOI 10.1093/infdis/jiw237; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Roser M, 2018, OUR WORLD IN DATA GL; Roser M, 2017, OUR WORLD IN DATA GL; RTS,S Clinical Trials Partnership, 2014, PLOS MED, V11; Ruckstuhl L, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2005-7; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-56; Rutter PD, 2014, J INFECT DIS, V210, pS16, DOI 10.1093/infdis/jiu181; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Sands P, 2018, ENDING EPIDEMICS BUI; SC Johnson, 2017, THE WAR AGAINST MOSQ; Scully EJ, 2017, CURR OPIN MICROBIOL, V40, P21, DOI 10.1016/j.mib.2017.10.006; Sempowski Ian P, 2004, Can J Rural Med, V9, P82; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Shretta R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1635-5; Shukla S, 2019, GREATER MEKONG SUBRE; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Smit MR, 2018, LANCET INFECT DIS, V18, P615, DOI 10.1016/S1473-3099(18)30163-4; Smith DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0145; Sonko ST, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-449; Sougoufara S, 2017, J VECTOR DIS, V54, P4; Special Programme for Research and Training in Tropical Diseases (TDR), 2019, PROM IMPL RES ACC UN; Staedke SG, 2016, AM J TROP MED HYG, V95, P358, DOI 10.4269/ajtmh.16-0103; Strachan DL, 2012, AM J TROP MED HYG, V87, P111, DOI 10.4269/ajtmh.2012.12-0030; Sturrock HJW, 2015, AM J TROP MED HYG, V93, P139, DOI 10.4269/ajtmh.14-0256; Sunguya BF, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1667-x; Syngenta, 2016, ACTELLIC 300CS; Tanner M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0384-6; Target Malaria, 2019, OUR WORK; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Taylor RM, 2015, APPROACHES UNIVERSAL; Teklehaimanot A, 2008, ANN NY ACAD SCI, V1136, P32, DOI 10.1196/annals.1425.037; The Carter Center, 2019, GUINEA WORM ERADICAT; The CLASS Study, 2010, LANCET; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2018, ELIMINATION OF MALAR; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2016, ALLOCATION METHODOLO; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2018, REGIONAL ARTEMISININ; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2016, THE GLOBAL FUND ELIG; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2019, TUBERCULOSIS AND MAL; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2018, THE GLOBAL FUND RESU; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2017, BUILD RES SUST SYST; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2015, MALARIA ELIMINATION; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2018, PROJECTED TRANSITION; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2017, FUNDING MODEL ALLOCA; The Global Polio Eradication Initiative, 2021, POL NOW THIS WEEK; The Independent Monitoring Board of the Global Polio Eradication Initiative, 2017, EVERY LAST HIDING PL; Theobald S, 2018, LANCET, V392, P2214, DOI [10.1016/S0140-6736(18)32205-0, 10.1016/s0140-6736(18)32205-0]; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tiono AB, 2018, LANCET, V392, P569, DOI 10.1016/S0140-6736(18)31711-2; Tsofa B, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0649-0; Tuite AR, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay077; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; Twohig KA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007140; Tyagi RK, 2013, J ANTIMICROB CHEMOTH, V68, P1081, DOI 10.1093/jac/dks508; United Nations, 2018, WORLD URBANIZATION P; United Nations, 2015, SUST DEV GOALS 2015; US Agency for International Development, 2016, USAID WHAT WE DO GLO; Valea I, 2018, HUM VACC IMMUNOTHER, V14, P1489, DOI 10.1080/21645515.2018.1442996; Vaz RG, 2016, J INFECT DIS, V213, pS140, DOI 10.1093/infdis/jiv581; Vestergaard, 2014, PERMANET; Vythilingam I, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P487, DOI 10.5772/54491; Wadunde I, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2163-7; Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6; Weiss DJ, 2019, LANCET, V394, P322, DOI 10.1016/S0140-6736(19)31097-9; Welcome MO, 2011, J PHARM BIOALLIED SC, V3, P470, DOI 10.4103/0975-7406.90100; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; Were V, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2319-0; Wesolowski A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1181-9; Whidden C, 2018, MUSO LESSONS TO BE L; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; Whittaker M, 2018, PUBLIC HEALTH ACTION, V8, pS1, DOI 10.5588/pha.18.0009; WHO, 2018, ABOUT THE EMERGENCY; WHO, 2018, OPEN CONSULTATION AN; WHO, 2019, Q A ON THE MALARIA V; WHO, 2016, DEV MON EV FUNCT COR; WHO, 2019, HIGH BURD HIGH IMP T; WHO, 2017, EMERGENCY RESPONSE F; WHO, 1969, OFFICIAL RECORDS OF; WHO, 2017, IMMUNIZATION VACCINE; WHO, 2018, ANTIMALARIAL DRUG EF; WHO, 2018, WHAT IS UN COV; WHO, 2016, NEW WHO ADVISORY GRO; WHO, 2006, INDOOR RESIDUAL SPRA; WHO, 2018, MAL EL UN HLTH COV G; WHO, 2017, REACH VULN POP LESS; WHO, 2018, WHO GLOBAL INSECTICI; WHO, 2020, COVID 19 HIGH RISK G; WHO Global Malaria Programme, 2017, WHO MALARIA TERMINOL; WHO Global Malaria Programme, 2017, FALSE NEGATIVE RDT R; WHO Global Malaria Programme, 2018, WHO GLOBAL MALARIA P; WHO Global Malaria Programme, 2018, GLOBAL REPORT ON INS; WHO Global Malaria Programme, 2017, ACHIEVING AND MAINTA; WHO Global Malaria Programme, 2017, THE RACE REPORT ENDL; WHO Global Malaria Programme, 2019, THE E 2020 INITIATIV; WHO Health Emergencies Programme, 2018, ENABLING QUICK ACTIO; WHO India, 2018, TRANS ACT POL PUBL H; WHO Malaria Elimination Oversight Committee, 2019, SUMMARY OF THE MEOC; WHO Regional Office for Africa, 2018, MAL CONTR CAMP LAUNC; WHO Regional Office for Africa, 2017, PARLIAMENT OF UGANDA; WHO Regional Office for Europe, 2005, THE TASHKENT DECLARA; WHO Regional Office for Europe, 2006, REGIONAL STRATEGY FR; WHO Regional Office for South-East Asia, 2015, PROGRAMMATIC REVIEW; WHO UNICEF, 2015, ACH MAL MDG TARG REV; Wickremasinghe R, 2014, MAINTAINING ZERO AN; Wiebe A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1734-y; Williams YA, 2018, ADV PARASIT, V99, P345, DOI 10.1016/bs.apar.2018.01.003; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; Wilson ML, 2015, AM J TROP MED HYG, V93, P110, DOI 10.4269/ajtmh.14-0834; Wirth DF, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2199-3; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; World Health Organisation, 2018, MALARIA SURVEILLANCE; World Health Organization, 2017, FRAM MAL EL; World Health Organization, 2007, MALARIA ELIMINATION; World Health Organization, 2015, STRATEGY MALARIA ELI; World Health Organization, 2016, ELIMINATING MALARIA; World Health Organization, 2018, WHO GUID HLTH POL SY, DOI DOI 1157598/RETRIEVE; World health Organization, 2015, GLOBAL TECHNICAL STR; World Health Organization World Bank, 2017, TRACK UN HLTH COV 20; Worldwide Antimalarial Resistance Network, 2019, TRACKING RESISTANCE; Wu YM, 2015, VACCINE, V33, P7518, DOI 10.1016/j.vaccine.2015.09.097; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004; Zhao JZ, 2010, PEST MANAG SCI, V66, P1101, DOI 10.1002/ps.1985; Zhou SS, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0089-2; Zhu L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1012-9	343	146	149	8	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					1056	1112		10.1016/S0140-6736(19)31139-0	http://dx.doi.org/10.1016/S0140-6736(19)31139-0			57	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ4FC	31511196	Green Submitted, Green Accepted			2022-12-28	WOS:000487038700033
J	Horton, R				Horton, Richard			Offline: Transcending the guilt of global health	LANCET			English	Editorial Material												richard.horton@lancet.com							0	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2019	394	10203					996	996		10.1016/S0140-6736(19)32177-4	http://dx.doi.org/10.1016/S0140-6736(19)32177-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IZ4FC	31544752	Bronze			2022-12-28	WOS:000487038700012
J	Kim, GB; Pacheco, DRF; Saxon, D; Yang, A; Sabet, S; Dutra-Clarke, M; Levy, R; Watkins, A; Park, H; Akhtar, AA; Linesch, PW; Kobritz, N; Chandra, SS; Grausam, K; Ayala-Sarmiento, A; Molina, J; Sedivakova, K; Hoang, K; Tsyporin, J; Gareau, DS; Filbin, MG; Bannykh, S; Santiskulvong, C; Wang, YZ; Tang, J; Suva, ML; Chen, B; Danielpour, M; Breunig, JJ				Kim, Gi Bum; Pacheco, David Rincon Fernandez; Saxon, David; Yang, Amy; Sabet, Sara; Dutra-Clarke, Marina; Levy, Rachelle; Watkins, Ashley; Park, Hannah; Akhtar, Aslam Abbasi; Linesch, Paul W.; Kobritz, Naomi; Chandra, Swasty S.; Grausam, Katie; Ayala-Sarmiento, Alberto; Molina, Jessica; Sedivakova, Kristyna; Hoang, Kendy; Tsyporin, Jeremiah; Gareau, Daniel S.; Filbin, Mariella G.; Bannykh, Serguei; Santiskulvong, Chintda; Wang, Yizhou; Tang, Jie; Suva, Mario L.; Chen, Bin; Danielpour, Moise; Breunig, Joshua J.			Rapid Generation of Somatic Mouse Mosaics with Locus-Specific, Stably Integrated Transgenic Elements	CELL			English	Article							EMBRYONIC STEM; CANCER GENES; HIGH-GRADE; CELL; EXPRESSION; REVEALS; GLIOMAS; CRE; MUTATIONS; LINEAGE	In situ transgenesis methods such as viruses and electroporation can rapidly create somatic transgenic mice but lack control over copy number, zygosity, and locus specificity. Here we establish mosaic analysis by dual recombinase-mediated cassette exchange (MADR), which permits stable labeling of mutant cells expressing transgenic elements from precisely defined chromosomal loci. We provide a toolkit of MADR elements for combination labeling, inducible and reversible transgene manipulation, VCre recombinase adression, and transgenesis of human cells. Further, we demonstrate the versatility of MADR by creating glioma models with mixed reporter-identified zygosity or with "personalized" driver mutations from pediatric glioma. MADR is extensible to thousands of existing mouse lines, providing a flexible platform to democratize the generation of somatic mosaic mice.	[Kim, Gi Bum; Pacheco, David Rincon Fernandez; Saxon, David; Yang, Amy; Sabet, Sara; Dutra-Clarke, Marina; Levy, Rachelle; Watkins, Ashley; Park, Hannah; Akhtar, Aslam Abbasi; Linesch, Paul W.; Kobritz, Naomi; Chandra, Swasty S.; Grausam, Katie; Ayala-Sarmiento, Alberto; Molina, Jessica; Sedivakova, Kristyna; Danielpour, Moise; Breunig, Joshua J.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Santiskulvong, Chintda; Wang, Yizhou; Tang, Jie; Breunig, Joshua J.] Cedars Sinai Med Ctr, Ctr Neural Sci Med, Los Angeles, CA 90048 USA; [Sabet, Sara; Akhtar, Aslam Abbasi; Linesch, Paul W.; Breunig, Joshua J.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Danielpour, Moise; Breunig, Joshua J.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Bannykh, Serguei] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Danielpour, Moise] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Hoang, Kendy; Tsyporin, Jeremiah; Chen, Bin] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St, Santa Cruz, CA 95064 USA; [Gareau, Daniel S.] Rockefeller Univ, Lab Invest Dermatol, New York, NY 10065 USA; [Filbin, Mariella G.] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA; [Suva, Mario L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Suva, Mario L.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Suva, Mario L.] Harvard Med Sch, Boston, MA 02114 USA; [Filbin, Mariella G.; Suva, Mario L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Breunig, Joshua J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Santa Cruz; Rockefeller University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Breunig, JJ (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.; Breunig, JJ (corresponding author), Cedars Sinai Med Ctr, Ctr Neural Sci Med, Los Angeles, CA 90048 USA.; Breunig, JJ (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.; Breunig, JJ (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.; Breunig, JJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	joshua.breunig@cshs.org	Danielpour, Moise/AAB-2438-2020; Fernandez, David Rincon/ABH-7915-2020; wang, yizhou/CAJ-3518-2022; Suva, Mario/AAY-7798-2020	wang, yizhou/0000-0002-9378-745X; Suva, Mario/0000-0001-9898-5351; Saxon, David/0000-0002-6430-8835; Kim, Gi Bum/0000-0001-9671-0493; AYALA-SARMIENTO, ALBERTO/0000-0002-0843-6111; Rincon Fernandez Pacheco, David/0000-0002-6998-4920; Breunig, Joshua/0000-0002-3735-3390	TJ's Dream Team HEADing for a Cure; Samuel Oschin Comprehensive Cancer Institute (SOCCI) Cancer Research Forum Award; Board of Governors RMI of Cedars-Sinai; Smidt Family Foundation; Paul and Vera Guerin Family Foundation; NIH [R33CA202900, R33CA236687, R03NS101529]; American Cancer Society [RSG-16-217-01-TBG]; SOCCI; P G; Cancer Biology Awards; NATIONAL CANCER INSTITUTE [R33CA236687, R33CA202900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS101529] Funding Source: NIH RePORTER	TJ's Dream Team HEADing for a Cure; Samuel Oschin Comprehensive Cancer Institute (SOCCI) Cancer Research Forum Award; Board of Governors RMI of Cedars-Sinai; Smidt Family Foundation; Paul and Vera Guerin Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); SOCCI; P G(Procter & Gamble); Cancer Biology Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Voziyanov for the gift of Flp-Cre expression vectors. We thank D. Cai for mKate2 and dsRed antibodies and L. Luo, H. Zeng, G. Miyoshi, G. Fishell, I. Imayoshi, and J. Huang for Cre reporter strain sequencing data. We thank S. Svendsen for editing. We acknowledge support from TJ's Dream Team HEADing for a Cure, a Samuel Oschin Comprehensive Cancer Institute (SOCCI) Cancer Research Forum Award, the Board of Governors RMI of Cedars-Sinai (to M.D. and J.J.B.), the Smidt Family Foundation, and the Paul and Vera Guerin Family Foundation. J.J.B. was supported by NIH grants R33CA202900, R33CA236687, and R03NS101529, American Cancer Society grant RSG-16-217-01-TBG, and SOCCI Jack Mishkin Discovery, P& G, and Cancer Biology Awards.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Akhtar AA, 2015, STEM CELL REP, V4, P323, DOI 10.1016/j.stemcr.2015.01.013; Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Anderson RP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks027; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Breunig JJ, 2015, CELL REP, V12, P258, DOI 10.1016/j.celrep.2015.06.012; Breunig JJ, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-26; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen FY, 2015, DEVELOPMENT, V142, P3601, DOI 10.1242/dev.118836; Chen FY, 2012, J NEUROSCI METH, V207, P172, DOI 10.1016/j.jneumeth.2012.03.016; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Cordero FJ, 2017, MOL CANCER RES, V15, P1243, DOI 10.1158/1541-7786.MCR-16-0389; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; De la Rossa A, 2015, NAT PROTOC, V10, P25, DOI 10.1038/nprot.2015.001; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fang R, 2019, FAST ACCURATE CLUSTE, DOI 10.1101/615179; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Filbin MG, 2018, SCIENCE, V360, P331, DOI 10.1126/science.aao4750; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Glasgow SM, 2014, NAT NEUROSCI, V17, P1322, DOI 10.1038/nn.3790; Gonzalez-Blas CB, 2019, NAT METHODS, V16, P397, DOI 10.1038/s41592-019-0367-1; Grant GD, 2018, CELL CYCLE, V17, P2496, DOI 10.1080/15384101.2018.1547001; Hambardzumyan D, 2011, GLIA, V59, P1155, DOI 10.1002/glia.21142; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Imayoshi I, 2012, NEUROSCI RES, V73, P85, DOI 10.1016/j.neures.2012.02.003; Iwano S, 2018, SCIENCE, V359, P935, DOI 10.1126/science.aaq1067; Jadhav U, 2019, MOL CELL, V74, P542, DOI 10.1016/j.molcel.2019.02.024; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Konermann S, 2018, CELL, V173, P665, DOI 10.1016/j.cell.2018.02.033; Korsunsky I., 2018, BIORXIV, DOI DOI 10.1101/461954; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Larson JD, 2019, CANCER CELL, V35, P140, DOI 10.1016/j.ccell.2018.11.015; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Mackay A, 2017, CANCER CELL, V32, P520, DOI 10.1016/j.ccell.2017.08.017; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ortiz-Alvarez G, 2019, NEURON, V102, P159, DOI 10.1016/j.neuron.2019.01.051; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Pathania M, 2017, CANCER CELL, V32, P684, DOI 10.1016/j.ccell.2017.09.014; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakaue-Sawano A, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-2; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010; Stuart T, 2019, NAT REV GENET, V20, P257, DOI 10.1038/s41576-019-0093-7; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tillberg PW, 2016, NAT BIOTECHNOL, V34, P987, DOI 10.1038/nbt.3625; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Woods NB, 2003, BLOOD, V101, P1284, DOI 10.1182/blood-2002-07-2238; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yeo NC, 2018, NAT METHODS, V15, P611, DOI 10.1038/s41592-018-0048-5; Zafra MP, 2018, NAT BIOTECHNOL, V36, P888, DOI 10.1038/nbt.4194; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	71	19	20	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					251	+		10.1016/j.cell.2019.08.013	http://dx.doi.org/10.1016/j.cell.2019.08.013			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539496	Green Accepted, Bronze			2022-12-28	WOS:000486618500027
J	Eng, ML; Stutchbury, BJM; Morrissey, CA				Eng, Margaret L.; Stutchbury, Bridget J. M.; Morrissey, Christy A.			A neonicotinoid insecticide reduces fueling and delays migration in songbirds	SCIENCE			English	Article							TREATED SEED; RISK-ASSESSMENT; FARMLAND BIRDS; AVAILABILITY; PARTRIDGES; TOXICITY; DECLINES; EXPOSURE; ARRIVAL; TRENDS	Neonicotinoids are neurotoxic insecticides widely used as seed treatments, but little is known of their effects on migrating birds that forage in agricultural areas. We tracked the migratory movements of imidacloprid-exposed songbirds at a landscape scale using a combination of experimental dosing and automated radio telemetry. Ingestion of field-realistic quantities of imidacloprid (1.2 or 3.9 milligrams per kilogram body mass) by white-crowned sparrows (Zonotrichia leucophrys) during migratory stopover caused a rapid reduction in food consumption, mass, and fat and significantly affected their probability of departure. Birds in the high-dose treatment stayed a median of 3.5 days longer at the site of capture after exposure as compared with controls, likely to regain fuel stores or recover from intoxication. Migration delays can carry over to affect survival and reproduction: thus, these results confirm a link between sublethal pesticide exposure and adverse outcomes for migratory bird populations.	[Eng, Margaret L.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 5B3, Canada; [Stutchbury, Bridget J. M.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Morrissey, Christy A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 5E2, Canada; [Morrissey, Christy A.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5C8, Canada	University of Saskatchewan; York University - Canada; University of Saskatchewan; University of Saskatchewan	Morrissey, CA (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 5E2, Canada.; Morrissey, CA (corresponding author), Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5C8, Canada.	christy.morrissey@usask.ca		Morrissey, Christy/0000-0001-8128-4209; Eng, Margaret/0000-0002-4217-619X	Natural Sciences and Engineering Research Council of Canada (NSERC); Kenneth M. Molson Foundation; NSERC RTI grant; Mitacs Accelerate fellowship; Bird Studies Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Kenneth M. Molson Foundation; NSERC RTI grant; Mitacs Accelerate fellowship; Bird Studies Canada	Funding was provided by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to C.A.M., a Kenneth M. Molson Foundation grant to B.J.M.S., a NSERC RTI grant to C.A.M and B.J.M.S., and a Mitacs Accelerate fellowship in partnership with Bird Studies Canada to M.L.E.	Addy-Orduna LM, 2019, SCI TOTAL ENVIRON, V650, P1216, DOI 10.1016/j.scitotenv.2018.09.112; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Anderegg L, 2018, NAT PHYS, V14, P890, DOI 10.1038/s41567-018-0191-z; Anderegg L, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.103201; AVERY ML, 1993, J WILDLIFE MANAGE, V57, P652, DOI 10.2307/3809296; BAIRLEIN F, 1994, ANNU REV NUTR, V14, P187, DOI 10.1146/annurev.nu.14.070194.001155; Balakrishnan N, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4964096; Barredo D, 2016, SCIENCE, V354, P1021, DOI 10.1126/science.aah3778; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Blackmore JA, 2019, QUANTUM SCI TECHNOL, V4, DOI 10.1088/2058-9565/aaee35; Botha CJ, 2018, J S AFR VET ASSOC, V89, DOI 10.4102/jsava.v89i0.1637; Buchler HP, 2007, NAT PHYS, V3, P726, DOI 10.1038/nphys678; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Cheuk LW, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.083201; Collopy AL, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.213201; De Marco L, 2019, SCIENCE, V363, P853, DOI 10.1126/science.aau7230; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Eikenaar C, 2014, J ORNITHOL, V155, P65, DOI 10.1007/s10336-013-0987-7; Elliott John E., 2011, P447; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; Eng ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15446-x; Flahr LM, 2015, ENVIRON SCI TECHNOL, V49, P6274, DOI 10.1021/acs.est.5b01185; Fuhrmanek A, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062708; Guglielmo CG, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.165753; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Hao CY, 2018, SCI TOTAL ENVIRON, V644, P1080, DOI 10.1016/j.scitotenv.2018.06.317; Humann-Guilleminot S, 2019, SCI TOTAL ENVIRON, V660, P1091, DOI 10.1016/j.scitotenv.2019.01.068; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Karra M, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4942928; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kozyryev I, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.133002; Kozyryev I, 2016, CHEMPHYSCHEM, V17, P3641, DOI 10.1002/cphc.201601051; Krems RV, 2008, PHYS CHEM CHEM PHYS, V10, P4079, DOI 10.1039/b802322k; Lim J, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.123201; Lindstrom A, 2003, AVIAN MIGRATION, P307; Liu LR, 2018, SCIENCE, V360, P900, DOI 10.1126/science.aar7797; LIU MY, 1993, PESTIC BIOCHEM PHYS, V46, P40, DOI 10.1006/pest.1993.1034; Lopez-Antia A, 2016, J APPL ECOL, V53, P1373, DOI 10.1111/1365-2664.12668; Lopez-Antia A, 2015, ENVIRON RES, V136, P97, DOI 10.1016/j.envres.2014.10.023; Lopez-Antia A, 2014, SCI TOTAL ENVIRON, V496, P179, DOI 10.1016/j.scitotenv.2014.07.031; Lopez-Antia A, 2013, ECOTOXICOLOGY, V22, P125, DOI 10.1007/s10646-012-1009-x; McCarron DJ, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.013202; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Millot F, 2017, ENVIRON SCI POLLUT R, V24, P5469, DOI 10.1007/s11356-016-8272-y; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Ni KK, 2018, CHEM SCI, V9, P6830, DOI 10.1039/c8sc02355g; Norrgard EB, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.063004; Roy CL, 2019, SCI TOTAL ENVIRON, V682, P271, DOI 10.1016/j.scitotenv.2019.05.010; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Schlosser N, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.023005; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Stanton RL, 2018, AGR ECOSYST ENVIRON, V254, P244, DOI 10.1016/j.agee.2017.11.028; Tarbutt MR, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.053401; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Truppe S, 2017, NAT PHYS, V13, P1173, DOI 10.1038/NPHYS4241; VYAS NB, 1995, ENVIRON TOXICOL CHEM, V14, P1961, DOI [10.1897/1552-8618(1995)14[1961:AAMOOT]2.0.CO;2, 10.1002/etc.5620141118]; Williams HJ, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.163201; Ye J., 2006, AIP C P; Yelin SF, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.050301	63	78	81	8	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1177	+		10.1126/science.aaw9419	http://dx.doi.org/10.1126/science.aaw9419			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX6GK	31515394				2022-12-28	WOS:000485780800049
J	Weinstein, DF; Mangurian, C; Jagsi, R				Weinstein, Debra F.; Mangurian, Christina; Jagsi, Reshma			Parenting during Graduate Medical Training - Practical Policy Solutions to Promote Change	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESIDENT PHYSICIANS; LEAVE; FAMILY	As a substantial number of residents and fellows become parents, their struggles highlight a need for systemic solutions. Family-friendly national standards, transparent local policies, and structural resources are all critical to better supporting trainee-parents.	[Weinstein, Debra F.] Massachusetts Gen Hosp, Dept Med, Off Grad Med Educ, Partners HealthCare, Boston, MA 02114 USA; [Weinstein, Debra F.] Harvard Med Sch, Boston, MA 02115 USA; [Mangurian, Christina] Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Jagsi, Reshma] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weinstein, DF (corresponding author), Massachusetts Gen Hosp, Dept Med, Off Grad Med Educ, Partners HealthCare, Boston, MA 02114 USA.; Weinstein, DF (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							American Academy of Pediatrics, 2015, MAJ PED ASS CALL C A; Jagsi R, 2007, NEW ENGL J MED, V357, P1889, DOI 10.1056/NEJMp078163; Magudia K, 2018, JAMA-J AM MED ASSOC, V320, P2372, DOI 10.1001/jama.2018.14414; Varda BK, 2018, JAMA-J AM MED ASSOC, V320, P2374, DOI 10.1001/jama.2018.15889; [No title captured]	5	14	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2019	381	11					995	997		10.1056/NEJMp1904721	http://dx.doi.org/10.1056/NEJMp1904721			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IY2MW	31509672	Green Published			2022-12-28	WOS:000486225900006
J	Koike, H; Iwasawa, K; Ouchi, R; Maezawa, M; Giesbrecht, K; Saiki, N; Ferguson, A; Kimura, M; Thompson, WL; Wells, JM; Zorn, AM; Takebe, T				Koike, Hiroyuki; Iwasawa, Kentaro; Ouchi, Rie; Maezawa, Mari; Giesbrecht, Kirsten; Saiki, Norikazu; Ferguson, Autumn; Kimura, Masaki; Thompson, Wendy L.; Wells, James M.; Zorn, Aaron M.; Takebe, Takanori			Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary	NATURE			English	Article							HUMAN LIVER; ENDODERM; ORGAN; TISSUE; GENE; BMP; GUT; PROGENITORS; COMPETENCE; GENERATION	Organogenesis is a complex and interconnected process that is orchestrated by multiple boundary tissue interactions'. However, it remains unclear how individual, neighbouring components coordinate to establish an integral multi-organ structure. Here we report the continuous patterning and dynamic morphogenesis of hepatic, biliary and pancreatic structures, invaginating from a three-dimensional culture of human pluripotent stem cells. The boundary interactions between anterior and posterior gut spheroids differentiated from human pluripotent stem cells enables retinoic acid-dependent emergence of hepato-biliary-pancreatic organ domains specified at the foregut-midgut boundary organoids in the absence of extrinsic factors. Whereas transplant-derived tissues are dominated by midgut derivatives, long-term-cultured microdissected hepato-biliary-pancreatic organoids develop into segregated multi-organ anlages, which then recapitulate early morphogenetic events including the invagination and branching of three different and interconnected organ structures, reminiscent of tissues derived from mouse explanted foregut-midgut culture. Mis-segregation of multi-organ domains caused by a genetic mutation in HES1 abolishes the biliary specification potential in culture, as seen in vivo(8,9). In sum, we demonstrate that the experimental multi-organ integrated model can be established by the juxtapositioning of foregut and midgut tissues, and potentially serves as a tradable, manipulatable and easily accessible model for the study of complex human endoderm organogenesis.	[Koike, Hiroyuki; Iwasawa, Kentaro; Ouchi, Rie; Maezawa, Mari; Giesbrecht, Kirsten; Ferguson, Autumn; Kimura, Masaki; Thompson, Wendy L.; Takebe, Takanori] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Koike, Hiroyuki; Iwasawa, Kentaro; Ouchi, Rie; Maezawa, Mari; Giesbrecht, Kirsten; Ferguson, Autumn; Kimura, Masaki; Thompson, Wendy L.; Wells, James M.; Zorn, Aaron M.; Takebe, Takanori] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Saiki, Norikazu; Takebe, Takanori] TMDU, Inst Res, Tokyo, Japan; [Wells, James M.; Zorn, Aaron M.; Takebe, Takanori] Cincinnati Childrens Hosp Med Ctr, Ctr Stem Cell & Organoid Med CuSTOM, Cincinnati, OH 45229 USA; [Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA; [Wells, James M.; Zorn, Aaron M.; Takebe, Takanori] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Tokyo Medical & Dental University (TMDU); Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Takebe, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA.; Takebe, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.; Takebe, T (corresponding author), TMDU, Inst Res, Tokyo, Japan.; Takebe, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Stem Cell & Organoid Med CuSTOM, Cincinnati, OH 45229 USA.; Takebe, T (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	takanori.takebe@cchmc.org	Koike, Hiroyuki/AAZ-9941-2020; Koike, Hiroyuki/AAT-6065-2020; Iwasawa, Kentaro/GWQ-9649-2022	Koike, Hiroyuki/0000-0001-9934-6930; Koike, Hiroyuki/0000-0001-9934-6930; Saiki, Norikazu/0000-0002-0830-4848; Iwasawa, Kentaro/0000-0002-5387-0099; Thompson, Wendy/0000-0002-2034-2265	Cincinnati Children's Research Foundation; Ono Pharmaceutical, Ltd; Japan Science and Technology Agency (JST); NIH/NCRR [UL1TR001425]; Cincinnati Center for Autoimmune Liver Disease; PHS of the Digestive Disease Research Core Center in Cincinnati [P30 DK078392]; Takeda Science Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Cincinnati Children's Research Foundation; Ono Pharmaceutical, Ltd; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cincinnati Center for Autoimmune Liver Disease; PHS of the Digestive Disease Research Core Center in Cincinnati; Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank A. Kodaka for graphics, the Hydroid team at Amana and H. Nakazawa for video, H. Nakauchi, V. Hwa and A. Asai and Takebe, Wells, Zorn and Helmrath laboratory members for their support and technical assistance, D. Louis for administrative and technical assistance, the confocal imaging core for microscopy and the Transgenic Animal and Genome Editing Core at CCHMC for guide RNA design, construction and validation. This work was supported by Cincinnati Children's Research Foundation grant, Ono Pharmaceutical, Ltd Grant and PRESTO grant from Japan Science and Technology Agency (JST) to T.T. This work was also supported by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number UL1TR001425, Cincinnati Center for Autoimmune Liver Disease Fellowship Award, PHS Grant P30 DK078392 (Integrative Morphology Core and Pluripotent Stem Cell and Organoid Core) of the Digestive Disease Research Core Center in Cincinnati, and Takeda Science Foundation grants. T.T. is a New York Stem Cell Foundation-Robertson Investigator.	Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Bayha E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005845; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; Davenport C, 2016, STEM CELLS, V34, P2635, DOI 10.1002/stem.2428; Fukuda A, 2006, J CLIN INVEST, V116, P1484, DOI 10.1172/JCI27704; Green MD, 2011, NAT BIOTECHNOL, V29, P267, DOI 10.1038/nbt.1788; Hentsch B, 1996, GENE DEV, V10, P70, DOI 10.1101/gad.10.1.70; Higashiyama H, 2017, DEVELOPMENT, V144, P1906, DOI 10.1242/dev.147512; Jorgensen MC, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.163568; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Nielsen C, 2001, DEV BIOL, V231, P164, DOI 10.1006/dbio.2000.0151; Nissim S, 2016, DEV BIOL, V418, P108, DOI 10.1016/j.ydbio.2016.07.019; Ouchi R, 2019, CELL METAB, V30, P374, DOI 10.1016/j.cmet.2019.05.007; Palaria A, 2018, HEPATOLOGY, V68, P274, DOI 10.1002/hep.29769; Rankin SA, 2018, DEV BIOL, V434, P121, DOI 10.1016/j.ydbio.2017.11.018; Rankin SA, 2016, CELL REP, V16, P66, DOI 10.1016/j.celrep.2016.05.060; San Roman AK, 2011, EXP CELL RES, V317, P2711, DOI 10.1016/j.yexcr.2011.07.011; Shih HP, 2015, CELL REP, V13, P326, DOI 10.1016/j.celrep.2015.08.082; Smith DM, 2000, DEVELOPMENT, V127, P3671; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Sumazaki R, 2004, NAT GENET, V36, P83, DOI 10.1038/ng1273; Takebe T, 2019, PROTOC EXCH, DOI [10.21203/rs.2.13102/v1, DOI 10.21203/RS.2.13102/V1]; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; TEPASS U, 1994, DEVELOPMENT, V120, P579; Thamm K, 2008, DEV BIOL, V320, P304, DOI 10.1016/j.ydbio.2008.04.015; Udager A, 2010, PROG MOL BIOL TRANSL, V96, P35, DOI 10.1016/S1877-1173(10)96002-X; Wang ZX, 2006, DEV BIOL, V297, P433, DOI 10.1016/j.ydbio.2006.05.019; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Zhang RR, 2018, STEM CELL REP, V10, P780, DOI 10.1016/j.stemcr.2018.01.006; Zhang Z, 2016, DEV BIOL, V416, P187, DOI 10.1016/j.ydbio.2016.05.025	34	121	123	8	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2019	574	7776					112	+		10.1038/s41586-019-1598-0	http://dx.doi.org/10.1038/s41586-019-1598-0			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB8OZ	31554966	Green Accepted			2022-12-28	WOS:000488832500041
J	Zhang, J; Jin, H; Zhang, WY; Ding, C; O'Keeffe, S; Ye, MY; Zuker, CS				Zhang, Jin; Jin, Hao; Zhang, Wenyi; Ding, Cheng; O'Keeffe, Sean; Ye, Mingyu; Zuker, Charles S.			Sour Sensing from the Tongue to the Brain	CELL			English	Article							OTOCONIAL AGENESIS; CAPSAICIN RECEPTOR; MAMMALIAN SWEET; GENE-EXPRESSION; CHORDA TYMPANI; RNA-SEQ; TASTE; MICE; CHANNELS; CELLS	The ability to sense sour provides an important sensory signal to prevent the ingestion of unripe, spoiled, or fermented foods. Taste and somatosensory receptors in the oral cavity trigger avert is behaviors in response to acid stimuli. Here, we show that the ion channel Otopetrin-1, a proton-selective channel normally involved in the sensation of gravity in the vestibular system, is essential for sour sensing in the taste system. We demonstrate that knockout of Otop1 eliminates acid responses from sour-sensing taste receptor cells (TRCs). In addition, we show that mice engineered to express otopetrin-1 in sweet TRCs have sweet cells that also respond to sour stimuli. Next, we genetically identified the taste ganglion neurons mediating each of the five basic taste qualities and demonstrate that sour taste uses its own dedicated labeled line from TRCs in the tongue to finely tuned taste neurons in the brain to trigger aversive behaviors.	[Zhang, Jin; Jin, Hao; Zhang, Wenyi; Ding, Cheng; Ye, Mingyu; Zuker, Charles S.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Zhang, Jin; Jin, Hao; Zhang, Wenyi; Ding, Cheng; O'Keeffe, Sean; Ye, Mingyu; Zuker, Charles S.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Zhang, Jin; Jin, Hao; Zhang, Wenyi; Ding, Cheng; Ye, Mingyu; Zuker, Charles S.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Zhang, Jin; Jin, Hao; Zhang, Wenyi; Ding, Cheng; Ye, Mingyu; Zuker, Charles S.] Columbia Univ, Mortimer B Zukerman Mind Brain & Behav Inst, New York, NY 10027 USA; [O'Keeffe, Sean] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Regeneron	Zuker, CS (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.; Zuker, CS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.; Zuker, CS (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.; Zuker, CS (corresponding author), Columbia Univ, Mortimer B Zukerman Mind Brain & Behav Inst, New York, NY 10027 USA.	cz2195@columbia.edu	Core, Vector/CAF-4832-2022; Ye, Mingyu/R-6778-2017	Ye, Mingyu/0000-0001-8560-4345; Zhang, Wenyi/0000-0002-0132-9794	Jane Coffin Childs Memorial Fund for Medical Research	Jane Coffin Childs Memorial Fund for Medical Research	We are indebted to Zaiqi Wu for her extraordinary help with mouse engineering. We thank Nick Ryba for experimental suggestions and helpful comments, Robert Barretto and Lindsey Macpherson for help with calcium imaging, Yueqing Peng for help with nerve recording, and Hershy Fishman for help with animals and histology. We particularly acknowledge Rahul Satija and Tom Maniatis for insightful comments and generous help with scRNA-seq and analysis. We thank Yasuo Mori for the kind gift of Trpm2 gene knockout animals and Sabastian Poliak and Amy Norovich for the generous gift of Cdh13::CreER animals. We also thank members of the Zuker lab for helpful discussions; David Yarmolinsky and Nick Ryba for generating the P2rx-Cre lines and general advice; and the talented undergraduates Enoch Jiang, Helen Zhang, and Crystal Richards for their contribution to various aspects of this work. J.Z. was supported by a postdoctoral fellowship from The Jane Coffin Childs Memorial Fund for Medical Research. S.O. was a researcher in Tom Maniatis's laboratory at Columbia University. C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at the Janelia Farm Research Campus.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson B., 1972, HDB SENSORY PHYSL, P233; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Basu R, 2015, CELL ADHES MIGR, V9, P193, DOI 10.1080/19336918.2014.1000072; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Challis RC, 2016, P NATL ACAD SCI USA, V113, P246, DOI 10.1073/pnas.1523319113; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dvoryanchikov G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01095-1; Fu O, 2019, CELL REP, V27, P1650, DOI 10.1016/j.celrep.2019.04.040; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Harris DT, 2015, NEURON, V86, P1449, DOI 10.1016/j.neuron.2015.05.026; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YJA, 2011, J NEUROSCI, V31, P13654, DOI 10.1523/JNEUROSCI.3356-11.2011; Hughes I, 2004, DEV BIOL, V276, P391, DOI 10.1016/j.ydbio.2004.09.001; Hughes I, 2007, P NATL ACAD SCI USA, V104, P12023, DOI 10.1073/pnas.0705182104; Hughes I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-41; Hurle B, 2003, HUM MOL GENET, V12, P777, DOI 10.1093/hmg/ddg087; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kim E, 2011, MOL CELL NEUROSCI, V46, P655, DOI 10.1016/j.mcn.2011.01.005; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Lane PW, 1986, MOUSE NEWS LETT, V75, P28; Lee H, 2017, NATURE, V548, P330, DOI 10.1038/nature23299; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Lin W, 2004, J NEUROPHYSIOL, V92, P2909, DOI 10.1152/jn.01198.2003; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McLean JR, 2014, NEUROSCI LETT, V576, P73, DOI 10.1016/j.neulet.2014.05.044; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; Ohla K, 2019, CHEM SENSES, V44, P237, DOI 10.1093/chemse/bjz013; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Ornitz DM, 1998, HEARING RES, V122, P60, DOI 10.1016/S0378-5955(98)00080-X; Peng YQ, 2015, NATURE, V527, P512, DOI 10.1038/nature15763; PHILLIPS MI, 1970, BEHAV RES METH INSTR, V2, P124, DOI 10.3758/BF03211020; Poliak S, 2016, CELL, V164, P512, DOI 10.1016/j.cell.2015.12.049; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Roper SD, 2017, NAT REV NEUROSCI, V18, P485, DOI 10.1038/nrn.2017.68; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; Sollars SI, 2005, J PHYSIOL-LONDON, V564, P877, DOI 10.1113/jphysiol.2005.083741; Spector Alan C, 2005, Behav Cogn Neurosci Rev, V4, P143, DOI 10.1177/1534582305280031; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Tu YH, 2018, SCIENCE, V359, P1047, DOI 10.1126/science.aao3264; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Ugawa S, 2003, J NEUROSCI, V23, P3616; Umans BD, 2018, TRENDS NEUROSCI, V41, P911, DOI 10.1016/j.tins.2018.07.008; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Wang L, 2018, NATURE, V558, P127, DOI 10.1038/s41586-018-0165-4; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Xiao R, 2010, CURR BIOL, V20, pR936, DOI 10.1016/j.cub.2010.09.053; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yarmolinsky DA, 2016, NEURON, V92, P1079, DOI 10.1016/j.neuron.2016.10.021; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Ye WL, 2016, P NATL ACAD SCI USA, V113, pE229, DOI 10.1073/pnas.1514282112; Yogev S, 2014, ANNU REV CELL DEV BI, V30, P417, DOI 10.1146/annurev-cellbio-100913-012953; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	90	70	80	14	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2019	179	2					392	+		10.1016/j.cell.2019.08.031	http://dx.doi.org/10.1016/j.cell.2019.08.031			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JB7WL	31543264	Bronze			2022-12-28	WOS:000488775900010
J	Han, A; Tao, YJ; Reisman, SE				Han, Arthur; Tao, Yujia; Reisman, Sarah E.			A 16-step synthesis of the isoryanodane diterpene (+)-perseanol	NATURE			English	Article							RYANODINE; REAGENTS; CATALYST; ALCOHOLS; HALIDES; ARYL	(+)-Perseanol is an isoryanodane diterpene that is isolated from the tropical shrub Persea indica(1) and has potent antifeedant and insecticidal properties. It is structurally related to (+)-ryanodine, which is a high-affinity ligand for and modulator of ryanodine receptors-ligand-gated ion channels that are critical for intracellular Ca2+ signalling in most multicellular organisms(2). Ryanodine itself modulates ryanodine-receptor-dependent Ca2+ release in many organisms, including mammals; however, preliminary data indicate that ryanodane and isoryanodane congeners that lack the pyrrole-2-carboxylate ester-such as perseanol-may have selective activity in insects(3). Here we report a chemical synthesis of (+)-perseanol, which proceeds in 16 steps from commercially available (R)-pulegone. The synthesis involves a two-step annulation process that rapidly assembles the tetracyclic core from readily accessible cyclopentyl building blocks. This work demonstrates how convergent fragment coupling, when combined with strategic oxidation tactics, can enable the concise synthesis of complex and highly oxidized diterpene natural products.	[Han, Arthur; Tao, Yujia; Reisman, Sarah E.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Reisman, SE (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	reisman@caltech.edu		Tao, Yujia/0000-0003-4615-6409	National Institutes of Health (NIH) [5T32GM007616-37, 1F31GM120821]; NIH [NIGMS RGM097582-01, R35GM118191-01]; Eli Lilly; Novartis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R35GM118191] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly(Eli Lilly); Novartis(Novartis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge S. Virgil and the Caltech Center for Catalysis and Chemical Synthesis for access to analytical equipment; L. Henling and J. Hofstra for X-ray data collection and data refinement, respectively, for the structures of 32 and S21; Y. Zhang for providing original spectral data of perseanol; and K. Chuang for contributions to the synthetic design. Fellowship support was provided by the National Institutes of Health (NIH; Nos. 5T32GM007616-37 and 1F31GM120821, to A.H.). S.E.R. is a Heritage Medical Research Investigator. Financial support from the NIH (Nos. NIGMS RGM097582-01 and R35GM118191-01), Eli Lilly and Novartis is acknowledged.	[Anonymous], 1999, EPA000F99002; BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P736, DOI 10.1039/c39760000736; BELANGER A, 1979, CAN J CHEM, V57, P3348, DOI 10.1139/v79-547; Chai XY, 2008, TETRAHEDRON, V64, P5743, DOI 10.1016/j.tet.2008.04.022; Chuang KV, 2016, SCIENCE, V353, P912, DOI 10.1126/science.aag1028; Cordova D., 2007, PESTICIDE CHEM CROP, P121; COREY EJ, 1989, TETRAHEDRON LETT, V30, P6275, DOI 10.1016/S0040-4039(01)93871-7; Gonzalez-Coloma A., 2002, STUD NAT PROD CHEM, V26, P849; GonzalezColoma A, 1996, J AGR FOOD CHEM, V44, P296, DOI 10.1021/jf9500593; Iimura S, 2006, J AM CHEM SOC, V128, P13095, DOI 10.1021/ja0650504; Jiang X, 2014, ORG LETT, V16, P3492, DOI 10.1021/ol5014262; Koshimizu M, 2018, TETRAHEDRON, V74, P3384, DOI 10.1016/j.tet.2018.03.061; Krasovskiy A, 2006, ANGEW CHEM INT EDIT, V45, P497, DOI 10.1002/anie.200502485; Lahm G.P., 2007, PESTICIDE CHEM CROP, P111, DOI [10.1002/9783527611249.ch11, DOI 10.1002/9783527611249.CH11]; Ling SQ, 2018, PESTIC BIOCHEM PHYS, V152, P90, DOI 10.1016/j.pestbp.2018.09.005; Luparia M, 2006, ORG LETT, V8, P2147, DOI 10.1021/ol060654y; MARX JN, 1975, J ORG CHEM, V40, P1602, DOI 10.1021/jo00899a018; MEWSHAW RE, 1989, TETRAHEDRON LETT, V30, P3753, DOI 10.1016/S0040-4039(01)80646-8; Meyer C. J., 2016, LEWIS BASE CATALYSIS, P387; NOHARA T, 1980, TETRAHEDRON LETT, V21, P2647, DOI 10.1016/S0040-4039(00)92828-4; Nwoye EO, 2007, CHEM COMMUN, P1436, DOI 10.1039/b617926f; Odell LR, 2012, SYNLETT, P685, DOI 10.1055/s-0031-1290350; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Shen Y, 2015, ORG LETT, V17, P5480, DOI 10.1021/acs.orglett.5b02845; Steves JE, 2013, J AM CHEM SOC, V135, P15742, DOI 10.1021/ja409241h; Sutko JL, 1997, PHARMACOL REV, V49, P53; Ueda T, 2013, ORG LETT, V15, P5370, DOI 10.1021/ol4026815; Ueda T, 2012, ORG LETT, V14, P3100, DOI 10.1021/ol301192s; Wolleb H, 2017, ANGEW CHEM INT EDIT, V56, P10890, DOI 10.1002/anie.201705809; Wu LP, 2014, ACS CATAL, V4, P2977, DOI 10.1021/cs500922x; Xu C, 2017, ACS CENTRAL SCI, V3, P278, DOI 10.1021/acscentsci.6b00361; YASUDA A, 1979, B CHEM SOC JPN, V52, P1705, DOI 10.1246/bcsj.52.1705; Zeng JF, 2014, J NAT PROD, V77, P1948, DOI 10.1021/np500465g	33	39	38	7	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2019	573	7775					563	+		10.1038/s41586-019-1580-x	http://dx.doi.org/10.1038/s41586-019-1580-x			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0MC	31554978	Green Accepted			2022-12-28	WOS:000488247600054
J	Dyer, C				Dyer, Clare			Asylum seeker whose breast cancer treatment was delayed over eligibility has died	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2019	366								l5692	10.1136/bmj.l5692	http://dx.doi.org/10.1136/bmj.l5692			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB3WS	31548207				2022-12-28	WOS:000488488000020
J	Dyer, O				Dyer, Owen			India bans e-cigarettes by executive order	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Press Information Bureau Government of India, 2019, CAB APPR PROM PROH E	1	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2019	366								l5649	10.1136/bmj.l5649	http://dx.doi.org/10.1136/bmj.l5649			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3WD	31537546				2022-12-28	WOS:000487759400009
J	Feng, X; Huang, QH; She, QX				Feng, Xu; Huang, Qihong; She, Qunxin			Crenarchaeal 3D Genome: A Prototypical Chromosome Architecture for Eukaryotes	CELL			English	Editorial Material							ORIGIN	In this issue of Cell, Takemata et al. demonstrate that coalescin (ClsN), an archaeal condensin ortholog, facilitates higher-level organization of chromosomes in crenarchaea that bears greater similarity to metazoans than bacteria. Their study unravels biological function for chromosome organization in Archaea and provides insights into the evolution of eukaryotic chromosomal compartmentalization.	[Feng, Xu; Huang, Qihong; She, Qunxin] Shandong Univ, CRISPR, 72 Binhai Rd, Qingdao 266237, Shandong, Peoples R China; [Feng, Xu; Huang, Qihong; She, Qunxin] Shandong Univ, Archaea Biol Res Ctr, Microbial Technol Inst, 72 Binhai Rd, Qingdao 266237, Shandong, Peoples R China; [Feng, Xu; Huang, Qihong; She, Qunxin] Shandong Univ, State Key Lab Microbial Technol, 72 Binhai Rd, Qingdao 266237, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	She, QX (corresponding author), Shandong Univ, CRISPR, 72 Binhai Rd, Qingdao 266237, Shandong, Peoples R China.; She, QX (corresponding author), Shandong Univ, Archaea Biol Res Ctr, Microbial Technol Inst, 72 Binhai Rd, Qingdao 266237, Shandong, Peoples R China.; She, QX (corresponding author), Shandong Univ, State Key Lab Microbial Technol, 72 Binhai Rd, Qingdao 266237, Shandong, Peoples R China.	shequnxin@sdu.edu.cn	She, Qunxin/E-4311-2012	She, Qunxin/0000-0002-4448-6669				Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Poplawski A, 1997, J BACTERIOL, V179, P7625; Robinson NP, 2007, EMBO J, V26, P816, DOI 10.1038/sj.emboj.7601529; Takemata N, 2019, CELL, V179, P165, DOI 10.1016/j.cell.2019.08.036; Wang XD, 2017, SCIENCE, V355, P524, DOI 10.1126/science.aai8982; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Zaremba-Niedzwiedzka K, 2017, NATURE, V541, P353, DOI 10.1038/nature21031	9	1	1	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					56	58		10.1016/j.cell.2019.08.045	http://dx.doi.org/10.1016/j.cell.2019.08.045			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539499	Bronze			2022-12-28	WOS:000486618500013
J	Gokhman, D; Mishol, N; de Manuel, M; de Juan, D; Shuqrun, J; Meshorer, E; Marques-Bonet, T; Rak, Y; Carmel, L				Gokhman, David; Mishol, Nadav; de Manuel, Marc; de Juan, David; Shuqrun, Jonathan; Meshorer, Eran; Marques-Bonet, Tomas; Rak, Yoel; Carmel, Liran			Reconstructing Denisovan Anatomy Using DNA Methylation Maps	CELL			English	Article							OF-FUNCTION VARIANTS; GENOME SEQUENCE; NEANDERTHAL; PREDICTION; EVOLUTION; HISTORY; INDIVIDUALS; HOMININ; SYSTEM; GENES	Denisovans are an extinct group of humans whose morphology remains unknown. Here, we present a method for reconstructing skeletal morphology using DNA methylation patterns. Our method is based on linking unidirectional methylation changes to loss-of-function phenotypes. We tested performance by reconstructing Neanderthal and chimpanzee skeletal morphologies and obtained >85% precision in identifying divergent traits. We then applied this method to the Denisovan and offer a putative morphological profile. We suggest that Denisovans likely shared with Neanderthals traits such as an elongated face and a wide pelvis. We also identify Denisovan-derived changes, such as an increased dental arch and lateral cranial expansion. Our predictions match the only morphologically informative Denisovan bone to date, as well as the Xuchang skull, which was suggested by some to be a Denisovan. We conclude that DNA methylation can be used to reconstruct anatomical features, including some that do not survive in the fossil record.	[Gokhman, David; Mishol, Nadav; Shuqrun, Jonathan; Meshorer, Eran; Carmel, Liran] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Fac Sci, Edmond J Safra Campus, IL-91904 Jerusalem, Israel; [de Manuel, Marc; de Juan, David; Marques-Bonet, Tomas] Inst Evolutionary Biol UPF CSIC, Barcelona Biomed Res Pk PRBB,Dr Aiguader 88, Barcelona 08003, Spain; [Shuqrun, Jonathan] Hebrew Univ Jerusalem, Future Scientists Ctr, Alpha Program, Edmond J Safra Campus, IL-91904 Jerusalem, Israel; [Meshorer, Eran] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, Edmond J Safra Campus, IL-91904 Jerusalem, Israel; [Marques-Bonet, Tomas] Catalan Inst Res & Adv Studies ICREA, Passeig de Lluis Companys 23, Barcelona 08010, Spain; [Marques-Bonet, Tomas] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Natl Ctr Genom Anal CNAG CRG, Baldiri & Reixac 4, Barcelona 08028, Spain; [Marques-Bonet, Tomas] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Edifici ICTA ICP,C Columnes S-N, E-08193 Barcelona, Spain; [Rak, Yoel] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-6997801 Tel Aviv, Israel	Hebrew University of Jerusalem; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Tel Aviv University; Sackler Faculty of Medicine	Gokhman, D; Carmel, L (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Fac Sci, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	david.gokhman@mail.huji.ac.il; liran.carmel@huji.ac.il	Marques-Bonet, Tomas/ABF-3734-2020	Marques-Bonet, Tomas/0000-0002-5597-3075; Gokhman, David/0000-0002-3536-9006; Juan, David/0000-0003-1912-9667; Meshorer, Eran/0000-0003-4777-986X	National Geographic Society [HJ-111R-17]; Clore Israel Foundation; MINECO/FEDER, UE [BFU2017-86471-P]; Howard Hughes International Early Career; Obra Social "La Caixa''; Secretaria d'Universitats i Recerca and CERCA Programme del Departament d'Economia i Coneixement de la Generalitat de Catalunya [GRC 2017 SGR 880];  [U01 MH106874]	National Geographic Society(National Geographic Society); Clore Israel Foundation; MINECO/FEDER, UE; Howard Hughes International Early Career; Obra Social "La Caixa''(La Caixa Foundation); Secretaria d'Universitats i Recerca and CERCA Programme del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); 	This work has been supported by the National Geographic Society (grant HJ-111R-17 to L.C.). D.G. was supported by the Clore Israel Foundation. T.M.-B. is supported by BFU2017-86471-P (MINECO/FEDER, UE), U01 MH106874 grant, Howard Hughes International Early Career, Obra Social "La Caixa,'' and Secretaria d'Universitats i Recerca and CERCA Programme del Departament d'Economia i Coneixement de la Generalitat de Catalunya (GRC 2017 SGR 880). We would like to thank Shiran Bar, David Reich, Iain Mathieson, Chris Stringer, and members of the Fraser lab for useful advice and Maayan Harel for beautiful illustrations.	Aiello L., 2002, INTRO HUMAN EVOLUTIO; Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Bae CJ, 2010, AM J PHYS ANTHROPOL, P75, DOI 10.1002/ajpa.21442; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Been E, 2012, AM J PHYS ANTHROPOL, V147, P64, DOI 10.1002/ajpa.21633; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brinkley JF, 2016, DEVELOPMENT, V143, P2677, DOI 10.1242/dev.135434; Chen FH, 2019, NATURE, V569, P409, DOI 10.1038/s41586-019-1139-x; Chirchir H, 2015, P NATL ACAD SCI USA, V112, P366, DOI 10.1073/pnas.1411696112; Claes P, 2018, NAT GENET, V50, P414, DOI 10.1038/s41588-018-0057-4; Claes P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004224; Clement AF, 2012, J HUM EVOL, V62, P367, DOI 10.1016/j.jhevol.2011.11.014; Cole JB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006174; Constant M, 2017, J CRANIO MAXILL SURG, V45, P826, DOI 10.1016/j.jcms.2017.02.020; De Groote I. E. P. M, 2008, COMPREHENSIVE ANAL L; De Groote I, 2011, J HUM EVOL, V61, P396, DOI 10.1016/j.jhevol.2011.05.007; de Manuel M, 2016, SCIENCE, V354, P477, DOI 10.1126/science.aag2602; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Erlich Y., 2017, BIORXIV, DOI [10.1101/185330, DOI 10.1101/185330]; Ford E, 2017, FREQUENT LACK REPRES, DOI 10.1101/170506; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; Gilmore CC, 2016, J HUM EVOL, V92, P80, DOI 10.1016/j.jhevol.2015.10.011; Gokhman D, 2017, MOL BIOL EVOL, V34, P2429, DOI 10.1093/molbev/msx211; Gokhman D, 2017, NUCLEIC ACIDS RES, V45, pW138, DOI 10.1093/nar/gkx302; Gokhman D, 2016, TRENDS ECOL EVOL, V31, P290, DOI 10.1016/j.tree.2016.01.010; Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368; GOKHMAN David, 2017, BIORXIV, DOI DOI 10.1101/106955; Gomez-Olivencia A, 2013, J HUM EVOL, V64, P608, DOI 10.1016/j.jhevol.2013.02.008; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kapourani C.-A., 2016, ARXIV, P1; Klenerman L., 2006, HUMAN FOOT COMPANION; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Lee MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176566; Li AH, 2015, NAT GENET, V47, P640, DOI 10.1038/ng.3270; Li ZY, 2017, SCIENCE, V355, P969, DOI 10.1126/science.aal2482; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; Lippert C, 2017, P NATL ACAD SCI USA, V114, P10166, DOI 10.1073/pnas.1711125114; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mafessoni F, 2017, P NATL ACAD SCI USA, V114, pE10256, DOI 10.1073/pnas.1716918114; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Maureille B, 1999, J HUM EVOL, V37, P137, DOI 10.1006/jhev.1999.0312; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Ogawa T., 1970, AMUD MAN HIS CAVE SI, P411; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Pickering T. R., 2007, BREATHING LIFE INTO; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Price AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1684; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Racimo F, 2017, MOL BIOL EVOL, V34, P509, DOI 10.1093/molbev/msw283; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Raichlen DA, 2011, J HUM EVOL, V60, P299, DOI 10.1016/j.jhevol.2010.11.002; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rogers AR, 2017, P NATL ACAD SCI USA, V114, P9859, DOI 10.1073/pnas.1706426114; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Shaffer JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006149; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Slon V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700186; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; Teschendorff AE, 2018, NAT REV GENET, V19, P129, DOI 10.1038/nrg.2017.86; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P8142, DOI 10.1073/pnas.1433023100; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Weber J, 2008, EUR SPINE J, V17, pS327, DOI 10.1007/s00586-008-0640-y; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Zanolli C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183802; ZILBERMAN U, 1992, J ANAT, V180, P387; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	82	25	26	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					180	+		10.1016/j.cell.2019.08.035	http://dx.doi.org/10.1016/j.cell.2019.08.035			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539495	Bronze			2022-12-28	WOS:000486618500022
J	Sancar, F				Sancar, Feyza			New Indications for Lyme Disease Tests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1036	1036		10.1001/jama.2019.13901	http://dx.doi.org/10.1001/jama.2019.13901			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31528992				2022-12-28	WOS:000488821100008
J	Spitzer, DL; Torres, S; Zwi, AB; Khalema, EN; Palaganas, E				Spitzer, Denise L.; Torres, Sara; Zwi, Anthony B.; Khalema, Ernest Nene; Palaganas, Erlinda			Towards inclusive migrant healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOMESTIC VIOLENCE; WOMENS HEALTH; GENDER; MIGRATION; INEQUALITIES; IMMIGRANTS; IMPACT		[Spitzer, Denise L.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Torres, Sara] Laurentian Univ, Sch Social Work, Sudbury, ON, Canada; [Zwi, Anthony B.] Univ New South Wales, Sch Social Sci, Sydney, NSW, Australia; [Khalema, Ernest Nene] Univ KwaZulu Natal, Sch Built Environm & Dev Studies, Durban, South Africa; [Palaganas, Erlinda] Univ Philippines Baguio, Coll Social Sci, Inst Management, Baguio, Philippines	University of Alberta; Laurentian University; University of New South Wales Sydney; University of Kwazulu Natal; University of the Philippines System; University of the Philippines Baguio	Spitzer, DL (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	spitzer@ualberta.ca	Zwi, Anthony/AAP-8731-2020; Zwi, Anthony/AAP-7026-2021	Zwi, Anthony/0000-0001-6902-6602; Palaganas, Erlinda/0000-0002-6145-5741				Anitha S, 2011, VIOLENCE AGAINST WOM, V17, P1260, DOI 10.1177/1077801211424571; Avato J, 2010, WORLD DEV, V38, P455, DOI 10.1016/j.worlddev.2009.10.003; Bell D, 2015, SOC SCI MED, V124, P284, DOI 10.1016/j.socscimed.2014.11.014; Benach J, 2001, J EPIDEMIOL COMMUN H, V55, P239, DOI 10.1136/jech.55.4.239; Bourgois P, 2017, ACAD MED, V92, P299, DOI 10.1097/ACM.0000000000001294; Castles S, 2011, GLOBALIZATIONS, V8, P311, DOI 10.1080/14747731.2011.576847; Dejardin AK, 2008, GENDER DIMENSIONS GL; Diaz E, 2017, EUR J PUBLIC HEALTH, V27, P433, DOI 10.1093/eurpub/ckx001; Fisher C, 2013, VIOLENCE AGAINST WOM, V19, P833, DOI 10.1177/1077801213497535; Flynn MA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101248; Gamlin JB, 2018, SOC POLIT, V25, P50, DOI 10.1093/sp/jxx010; Grove NJ, 2006, SOC SCI MED, V62, P1931, DOI 10.1016/j.socscimed.2005.08.061; Hacker K, 2015, RISK MANAG HEALTHC P, V8, P175, DOI 10.2147/RMHP.S70173; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Hankivsky O, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-5; International Organization for Migration, 2010, MIGR RES CTR IN ASS; Javanparast S, 2018, INT J HEALTH POLICY, V7, P943, DOI 10.15171/ijhpm.2018.53; Jones CP, 2014, MED CARE, V52, pS71, DOI 10.1097/MLR.0000000000000216; Krieger N, 2001, PUBLIC HEALTH, V115, P175, DOI 10.1016/S0033-3506(01)00440-1; Lutz H, 2016, FRAMING INTERSECTION, P17; McLaughlin J., 2013, PRODUCING NEGOTIATIN, P175; Metzl JM, 2014, SOC SCI MED, V103, P126, DOI 10.1016/j.socscimed.2013.06.032; Ozdemir V, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2710; Raman S, 2007, J PAEDIATR CHILD H, V43, P581, DOI 10.1111/j.1440-1754.2007.01147.x; Sangaramoorthy T, 2008, STUD ETHN NATL, V8, P248, DOI 10.1111/j.1754-9469.2008.00014.x; Sirvio A, 2012, SCAND J PUBLIC HEALT, V40, P360, DOI 10.1177/1403494812450092; Sobritchea C, 2006, LIFE DEATH MOVE SEXU; Spitzer DL, 2004, MED ANTHROPOL Q, V18, P490, DOI 10.1525/maq.2004.18.4.490; Spitzer DL, 2011, ENGENDERING MIGRANT, P23; Spitzer DL, 2016, HDB GENDER HLTH, P251, DOI [10.4337/9781784710866.00027, DOI 10.4337/9781784710866.00027]; Spitzer DL, 2008, 71 CERIS; Steele LS, 2002, CAN J PUBLIC HEALTH, V93, P118, DOI 10.1007/BF03404551; Torres S, 2017, CRIT PUBLIC HEALTH, V27, P533, DOI 10.1080/09581596.2016.1275523; UNDESA, 2017, POP FACTS; United Nations High Commissioner for Refugees, 2018, GLOB TRENDS FORC DIS; WARMINGTON R, 2014, U OTTAWA J MED, V4, P45, DOI DOI 10.18192/U0JM.V4I1.1040; World Health Organization, 2018, HLTH REF MIGR	37	14	14	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2019	366								l4256	10.1136/bmj.l4256	http://dx.doi.org/10.1136/bmj.l4256			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JA3VP	31527055	Green Published, hybrid			2022-12-28	WOS:000487758000003
J	Christie, B				Christie, Bryan			Scotland strikes deal to offer cystic fibrosis drugs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		CHRISTIE B, 2019, BMJ-BRIT MED J, V366, DOI DOI 10.1136/BMJ.L5137	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5556	10.1136/bmj.l5556	http://dx.doi.org/10.1136/bmj.l5556			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519651				2022-12-28	WOS:000486649800010
J	Enserink, M				Enserink, Martin			HYPOXIA CITY	SCIENCE			English	Editorial Material																			0	8	9	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1098	1103		10.1126/science.365.6458.1098	http://dx.doi.org/10.1126/science.365.6458.1098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515381				2022-12-28	WOS:000485780800034
J	Mahase, E				Mahase, Elisabeth			BMA calls for legislation to stop doctors being blamed when under "unmanageable pressure"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2019, CAR SUPP COLL FUT VI; DYER C, 2019, BMJ-BRIT MED J, V365, P71513, DOI DOI 10.1136/BMJ.L4106	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2019	366								l5557	10.1136/bmj.l5557	http://dx.doi.org/10.1136/bmj.l5557			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MX	31519729				2022-12-28	WOS:000486649800011
J	Eisenstein, M				Eisenstein, Michael			Easing the pain	NATURE			English	Editorial Material							DISCONTINUATION											Cheatle MD, 2019, J PAIN, V20, P842, DOI 10.1016/j.jpain.2019.01.011; Demidenko MI, 2017, GEN HOSP PSYCHIAT, V47, P29, DOI 10.1016/j.genhosppsych.2017.04.011; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Fink DS, 2018, ANN INTERN MED, V168, P783, DOI 10.7326/M17-3074; Frank JW, 2017, ANN INTERN MED, V167, P181, DOI 10.7326/M17-0598; Glanz JM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2613; Ilgen MA, 2016, PAIN, V157, P1079, DOI 10.1097/j.pain.0000000000000484; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Martin J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2270; Rodgers J, 2012, J HAND SURG-AM, V37A, P645, DOI 10.1016/j.jhsa.2012.01.035; Zhu WJ, 2019, NEW ENGL J MED, V380, P1043, DOI 10.1056/NEJMsa1807069	11	4	4	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2019	573	7773					S13	S15		10.1038/d41586-019-02687-1	http://dx.doi.org/10.1038/d41586-019-02687-1			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX0XA	31511673				2022-12-28	WOS:000485415400008
J	Jiang, J; Bai, G				Jiang, John (Xuefeng); Bai, Ge			Types of Information Compromised in Breaches of Protected Health Information	ANNALS OF INTERNAL MEDICINE			English	Letter									[Jiang, John (Xuefeng)] Michigan State Univ, Eli Broad Coll Business, E Lansing, MI 48824 USA; [Bai, Ge] Johns Hopkins Carey Business Sch, Baltimore, MD USA; [Bai, Ge] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Michigan State University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jiang, J (corresponding author), Michigan State Univ, Eli Broad Coll Business, E Lansing, MI 48824 USA.	jiangj@msu.edu	Jiang, John/AAT-7192-2020; jiang, john X/M-5342-2017	Jiang, John/0000-0001-6459-6411; jiang, john X/0000-0001-6459-6411	Johns Hopkins Carey Business School	Johns Hopkins Carey Business School	Dr. Bai thanks The Johns Hopkins Carey Business School for its supplementary research support.	Jiang J, 2019, JAMA INTERN MED, V179, P265, DOI 10.1001/jamainternmed.2018.5295; U.S. Department of Health and Human Services, 2019, BREACH PORT NOT SECR; U.S. Department of Health and Human Services, 2019, SUMM HIPAA PRIV RUL	3	7	7	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2020	172	2					159	160		10.7326/M19-1759	http://dx.doi.org/10.7326/M19-1759			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KE3DL	31546251				2022-12-28	WOS:000508439500025
J	Thomas, E; Milton, J; Cigarroa, FG				Thomas, Elizabeth; Milton, Jennifer; Cigarroa, Francisco G.			The Advancing American Kidney Health Executive Order: An Opportunity to Enhance Organ Donation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION; RISK	This Viewpoint uses provisions in President Trump's 2019 American Kidney Health Executive order calling for an increase in access to kidney transplantation to discuss strategies to increase deceased and living donor pools, improve allocation of organs from higher-risk donors, and support the long-term medical needs of living donors.	[Thomas, Elizabeth; Milton, Jennifer; Cigarroa, Francisco G.] Univ Texas Hlth Sci Ctr San Antonio, Transplant Ctr, Teresa Lozano & Joe Long Sch Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Cigarroa, FG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Transplant Ctr, Teresa Lozano & Joe Long Sch Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	cigarroa@uthscsa.edu						Glazier A, 2019, JAMA-J AM MED ASSOC, V322, P719, DOI 10.1001/jama.2019.9187; Gruessner RWG, 2018, TRANSPL P, V50, P3025, DOI 10.1016/j.transproceed.2018.07.024; Kucirka LM, 2011, AM J TRANSPLANT, V11, P1176, DOI 10.1111/j.1600-6143.2010.03329.x; Kucirka LM, 2011, AM J TRANSPLANT, V11, P1188, DOI 10.1111/j.1600-6143.2011.03460.x; Matas AJ, 2018, AM J TRANSPLANT, V18, P1140, DOI 10.1111/ajt.14671; National Institute of Diabetes and Digestive and Kidney Diseases, 2018, US REN DAT SYST 2018; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Wainright JL, 2018, AM J TRANSPLANT, V18, P1129, DOI 10.1111/ajt.14678; Whitehouse.gov website, EX ORD ADV AM KIDN H	9	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2019	322	17					1645	1646		10.1001/jama.2019.14500	http://dx.doi.org/10.1001/jama.2019.14500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JQ0WD	31539017				2022-12-28	WOS:000498674400006
J	Dunne, J; Rebay-Salisbury, K; Salisbury, RB; Frisch, A; Walton-Doyle, C; Evershed, RP				Dunne, J.; Rebay-Salisbury, K.; Salisbury, R. B.; Frisch, A.; Walton-Doyle, C.; Evershed, R. P.			Milk of ruminants in ceramic baby bottles from prehistoric child graves	NATURE			English	Article							INFANT	The study of childhood diet, including breastfeeding and weaning, has important implications for our understanding of infant mortality and fertility in past societies(1). Stable isotope analyses of nitrogen from bone collagen and dentine samples of infants have provided information on the timing of weaning(2); however, little is known about which foods were consumed by infants in prehistory. The earliest known clay vessels that were possibly used for feeding infants appear in Neolithic Europe, and become more common throughout the Bronze and Iron Ages. However, these vesselswhich include a spout through which liquid could be poured-have also been suggested to be feeding vessels for the sick or infirm(3,4). Here we report evidence for the foods that were contained in such vessels, based on analyses of the lipid `fingerprints' and the compound-specific delta C-13 and Delta C-13 values of the major fatty acids of residues from three small, spouted vessels that were found in Bronze and Iron Age graves of infants in Bavaria. The results suggest that the vessels were used to feed infants with milk products derived from ruminants. This evidence of the foodstuffs that were used to either feed or wean prehistoric infants confirms the importance of milk from domesticated animals for these early communities, and provides information on the infant-feeding behaviours that were practised by prehistoric human groups.	[Dunne, J.; Walton-Doyle, C.; Evershed, R. P.] Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol, Avon, England; [Rebay-Salisbury, K.; Salisbury, R. B.] Austrian Acad Sci, Inst Oriental & European Archaeol, Vienna, Austria; [Frisch, A.] Museen Stadt Regensburg, Abt Archaol, Regensburg, Germany	University of Bristol; Austrian Academy of Sciences	Dunne, J; Evershed, RP (corresponding author), Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol, Avon, England.	julie.dunne@bristol.ac.uk; r.p.evershed@bristol.ac.uk	Salisbury, Roderick B./B-8957-2013	Salisbury, Roderick B./0000-0003-3773-5337; Walton-Doyle, Caitlin/0000-0001-7123-3336; Rebay-Salisbury, Katharina/0000-0003-0126-8693	European Research Council (ERC) under the EU Horizon 2020 research and innovation programme [676828]; NERC; Leverhulme Trust [RPG-2016-115]; NERC [lsmsf010001] Funding Source: UKRI	European Research Council (ERC) under the EU Horizon 2020 research and innovation programme(European Research Council (ERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Background research and travel for this study was funded as part of the framework of the project 'The value of mothers to society: responses to motherhood and child rearing practices in prehistoric Europe' which received funding from the European Research Council (ERC) under the EU Horizon 2020 research and innovation programme (676828). We thank the NERC for partial funding of the National Environmental Isotope Facility (NEIF; Bristol laboratory). J.D. thanks The Leverhulme Trust (RPG-2016-115) for funding and I. Bull and A. Kuhl for technical help. We thank H. Grant of the NEIF (Lancaster laboratory) for stable isotopic characterization of reference standards and derivatizing agents. G. Almstadter, S. Gairhos, K. Gromer, A. Kern, D. Kern, D. Pany-Kucera, K. Wiltschke-Schrotta and M. Berner provided practical support for sampling.	Augstein M., 2015, BEITRAG ANAL MIKRORE, V262; Bocquet-Appel JP, 2011, SCIENCE, V333, P560, DOI 10.1126/science.1208880; Correa-Ascencio M, 2014, ANAL METHODS-UK, V6, P1330, DOI 10.1039/c3ay41678j; Dudd SN, 1998, SCIENCE, V282, P1478, DOI 10.1126/science.282.5393.1478; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; Evershed RP, 2002, ACCOUNTS CHEM RES, V35, P660, DOI 10.1021/ar000200f; Fildes V.A., 1986, BREASTS BOTTLES BABI; Fontecha J, 2005, INT DAIRY J, V15, P1217, DOI 10.1016/j.idairyj.2004.11.013; Fulminante F., 2015, CHILDHOOD, V8, P24, DOI DOI 10.1179/1758571615Z.00000000026; GURR MI, 1981, J DAIRY RES, V48, P519, DOI 10.1017/S0022029900022020; Halcrow SE, 2018, BREASTFEEDING: NEW ANTHROPOLOGICAL APPROACHES, P155; Howcroft R, 2012, ANTHROPOZOOLOGICA, V47, P31, DOI 10.5252/az2012n2a3; Humphrey LT, 2010, SEMIN CELL DEV BIOL, V21, P453, DOI 10.1016/j.semcdb.2009.11.003; Jay M., 2009, CHILDHOOD, V2, P163, DOI [DOI 10.1179/CIP.2009.2.1.163, 10.1179/cip.2009.2.1.163]; Knott C, 2001, FOUND HUM B, P429; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Mays S., 2017, CHILDHOOD, V10, P38, DOI DOI 10.1080/17585716.2017.1301066; Meller H. E, 2011, BRONZERAUSCH SPATNEO, V4; Rebay-Salisbury Katharina, 2017, MITTEILUNGEN ANTHR G, V147, P13; Robinson SM, 2015, J DEV ORIG HLTH DIS, V6, P384, DOI 10.1017/S2040174415001257; Rohrig K-H, 1994, HALLSTATTZEITLICHE G; Sellen DW, 2007, ANNU REV NUTR, V27, P123, DOI 10.1146/annurev.nutr.25.050304.092557; Sellen DW, 2001, HUM NATURE-INT BIOS, V12, P47, DOI 10.1007/s12110-001-1013-y; SHEPPARD JJ, 1984, CHILD DEV, V55, P831, DOI 10.1111/j.1467-8624.1984.tb03820.x; Wirth S., AUGSBURGER BEITRAGE, V1	25	30	32	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2019	574	7777					246	+		10.1038/s41586-019-1572-x	http://dx.doi.org/10.1038/s41586-019-1572-x			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JD2DB	31554964	Green Submitted			2022-12-28	WOS:000489784200047
J	Slomski, A				Slomski, Anita			Mediterranean Diet During Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2019	322	12					1134	1134		10.1001/jama.2019.13918	http://dx.doi.org/10.1001/jama.2019.13918			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LY	31550027				2022-12-28	WOS:000488822800007
J	Di Lorenzo, C; Kaj, B; Krishnan, K; Moran, CJ; Goldstein, AM; Gee, MS; Masia, R				Di Lorenzo, Carlo; Kaj, Batul; Krishnan, Kumar; Moran, Christopher J.; Goldstein, Allan M.; Gee, Michael S.; Masia, Ricard			Case 29-2019: A 14-Month-Old Boy with Vomiting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL ESOPHAGEAL STENOSIS; GASTROESOPHAGEAL-REFLUX; MANAGEMENT	A 14-month-old boy was evaluated in the pediatric gastroenterology clinic because of vomiting. Beginning at 26 days of age, frequent episodes of emesis occurred, and the boy's parents once reported blood in the vomitus. He had difficulty gaining weight but was otherwise healthy. Diagnostic studies were performed.	[Di Lorenzo, Carlo] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Di Lorenzo, Carlo] Ohio State Univ, Dept Pediat, Sch Med, Columbus, OH 43210 USA; [Kaj, Batul; Moran, Christopher J.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Krishnan, Kumar] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Goldstein, Allan M.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA; [Gee, Michael S.] Massachusetts Gen Hosp, Dept Radiol, 32 Fruit St, Boston, MA 02114 USA; [Masia, Ricard] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kaj, Batul; Moran, Christopher J.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Krishnan, Kumar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Goldstein, Allan M.] Harvard Med Sch, Dept Pediat Surg, Boston, MA 02115 USA; [Gee, Michael S.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Masia, Ricard] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Di Lorenzo, C (corresponding author), Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA.; Di Lorenzo, C (corresponding author), Ohio State Univ, Dept Pediat, Sch Med, Columbus, OH 43210 USA.			Kaj-Carbaidwala, Batul/0000-0001-6045-9559				Amae S, 2003, J PEDIATR SURG, V38, P565, DOI 10.1053/jpsu.2003.50123; BLUESTONE CD, 1969, LARYNGOSCOPE, V79, P1095, DOI 10.1288/00005537-196906000-00004; Chen IL, 2012, J PEDIATR GASTR NUTR, V54, P8, DOI 10.1097/MPG.0b013e31823890b4; Kawahara H, 2003, J PEDIATR SURG, V38, P1716, DOI 10.1016/j.jpedsurg.2003.08.020; Michaud L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-186; Mousa Hayat, 2017, Curr Gastroenterol Rep, V19, P65, DOI 10.1007/s11894-017-0605-6; Nelson SP, 1997, ARCH PEDIAT ADOL MED, V151, P569, DOI 10.1001/archpedi.1997.02170430035007; ROSEN R, 2018, J PEDIATR GASTR NUTR, V66, P516, DOI [DOI 10.1097/MPG.0000000000001889, 10.1097/MPG.0000000000001889]; SMITH PM, 1994, GASTROENTEROLOGY, V107, P1312, DOI 10.1016/0016-5085(94)90532-0; Staelens S, 2008, CLIN NUTR, V27, P264, DOI 10.1016/j.clnu.2007.12.009; Suzuhigashi M, 2017, PEDIATR SURG INT, V33, P1035, DOI 10.1007/s00383-017-4133-0; Terui K, 2015, WORLD J GASTRO ENDOS, V7, P183, DOI 10.4253/wjge.v7.i3.183	12	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2019	381	12					1159	1167		10.1056/NEJMcpc1904049	http://dx.doi.org/10.1056/NEJMcpc1904049			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ4PY	31532965				2022-12-28	WOS:000487066900011
J	Kopf, A; Sixt, M				Kopf, Aglaja; Sixt, Michael			The Neural Crest Pitches In to Remove Apoptotic Debris	CELL			English	Editorial Material								In this issue of Cell, Zhu et al. show that in the developing zebrafish, neural crest cells can act as professional phagocytes and directionally approach apoptotic cells to clear the larval nervous system from cell debris.	[Kopf, Aglaja; Sixt, Michael] Inst Sci & Technol Austria IST Austria, Campus 1, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Sixt, M (corresponding author), Inst Sci & Technol Austria IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	sixt@ist.ac.at		Sixt, Michael/0000-0002-6620-9179; Kopf, Aglaja/0000-0002-2187-6656				Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Hong Yuxiao, 2015, J Investig Dermatol Symp Proc, V17, P37, DOI 10.1038/jidsymp.2015.14; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Shklover J, 2015, CURR TOP DEV BIOL, V114, P297, DOI 10.1016/bs.ctdb.2015.07.024; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Zhu YL, 2019, CELL, V179, P74, DOI 10.1016/j.cell.2019.08.001	7	0	0	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2019	179	1					51	53		10.1016/j.cell.2019.08.047	http://dx.doi.org/10.1016/j.cell.2019.08.047			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IY8BG	31539498	Bronze			2022-12-28	WOS:000486618500011
J	Svoboda, E				Svoboda, Elizabeth			A sticking point for rapid flu tests?	NATURE			English	Editorial Material																		Allen A J, 2018, Diagn Progn Res, V2, P15, DOI 10.1186/s41512-018-0031-8; Anselem O, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217651; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Koul PA, 2016, INDIAN J MED MICROBI, V33, P26; Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848	5	4	4	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2019	573	7774					S56	S57		10.1038/d41586-019-02754-7	http://dx.doi.org/10.1038/d41586-019-02754-7			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IY8MD	31534257				2022-12-28	WOS:000486647800007
J	Haseler, C; Crooke, R; Haseler, T				Haseler, Christine; Crooke, Ranulf; Haseler, Tobias			Promoting physical activity to patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; ADULTS		[Haseler, Christine] Hucclecote Surg, Gloucester, England; [Crooke, Ranulf] Hilary Cottage Surg, Fairford, England; [Haseler, Tobias] Bloomsbury Surg, London, England		Haseler, C (corresponding author), Hucclecote Surg, Gloucester, England.	christine.haseler@nhs.net	Haseler, Tobias/AAE-7061-2022	Crooke, Ranulf/0000-0001-8571-7315				[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2015, EXERCISE MIRACLE CUR; Bickerdike L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013384; Calfas KJ, 1996, PREV MED, V25, P225, DOI 10.1006/pmed.1996.0050; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; CMO U, 2017, PHYS ACT PREGN INF G; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Department of Health Chief Medical Officers, 2011, HLTH IMPR PROT START; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Gill JMR, 2006, CLIN SCI, V110, P409, DOI 10.1042/CS20050207; Haseler C, 2016, INT MUSCULOSKELET ME, V38, P3, DOI [10.1080/17536146.2015.1110964, DOI 10.1080/17536146.2015.1110964]; Hausenblas HA, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1745; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Jacome C, 2016, J CARDIOPULM REHABIL, V36, P445, DOI 10.1097/HCR.0000000000000219; Kjaer T, 2019, HEALTH POLICY, V123, P790, DOI 10.1016/j.healthpol.2019.05.015; Koshoedo SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1893-0; Macintyre S, 2000, BRIT J SPORT MED, V34, P6, DOI 10.1136/bjsm.34.1.6; McNally S, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4609; Milton K, 2013, BRIT J SPORT MED, V47, P44, DOI 10.1136/bjsports-2011-090899; Naci H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5577; National Institute for Health and Care Excellence, 2013, PHYS ACT BRIEF ADV A; National Institute for Health and Care Excellence, 2014, OST CAR MAN CG177; National Institute for Health and Care Excellence, 2014, BEH CHANG IND APPR P; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Public Health England, 2019, MUSCL BON STRENGTH B; Public Health England, 2017, 10 MIN BRISK WALK EA; Richards J, 2013, COCHRANE DB SYST REV, V9; Riebe D, 2015, MED SCI SPORT EXER, V47, P2473, DOI 10.1249/MSS.0000000000000664; Rollnick S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1900; Silsbury Z, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008430; Silverman MN, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0040; Varney JBM, 2014, EVERYBODY ACTIVE EVE; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wheeler PC, 2017, BJGP OPEN; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	36	21	23	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5230	10.1136/bmj.l5230	http://dx.doi.org/10.1136/bmj.l5230			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530549				2022-12-28	WOS:000487758600002
J	Kuehn, B				Kuehn, Bridget			Global Effect of Childhood Cancers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1035	1035		10.1001/jama.2019.13826	http://dx.doi.org/10.1001/jama.2019.13826			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31529015				2022-12-28	WOS:000488821100006
J	Morgan, M				Morgan, Matt			Matt Morgan: When bullet points miss the heart	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, S Glam, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, S Glam, Wales.	mmorgan@bmj.com		Morgan, Matt/0000-0002-2357-7190				Fins JJ, 1920, T AM CLIN CLIMAT ASS, P126	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2019	366								l5500	10.1136/bmj.l5500	http://dx.doi.org/10.1136/bmj.l5500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JA3VV	31530546	Bronze			2022-12-28	WOS:000487758600005
J	Sung, VW; Borello-France, D; Newman, DK; Richter, HE; Lukacz, ES; Moalli, P; Weidner, AC; Smith, AL; Dunivan, G; Ridgeway, B; Nguyen, JN; Mazloomdoost, D; Carper, B; Gantz, MG; Myers, DL; Rardin, CR; Hampton, BS; Carberry, C; Wohlrab, K; Korbly, N; Meers, A; Lynch, A; Rhodes, K; Fox, W; Choquette, L; Clark, M; Nassaney, M; Varner, RE; Ballard, A; Ellington, DR; Holley, RL; Willis, V; Saxon, N; Carter, K; Willingham, R; Burge, J; Johnson, R; Nager, C; Albo, M; Alperin, M; Columbo, J; Furey, C; Riley, P; Hall, L; Doan, C; VandeVegte, K; Luber, KM; Tan-Kim, J; Dyer, KY; Diwadkar, GB; Menefee, SA; Mackinnon, LM; Zazueta-Damian, G; Jakus-Waldman, S; Liao, C; Flores, N; Simmons, M; Patel, A; Zyczynski, H; Sutkin, G; Bonidie, M; Ackenbom, M; Gruss, J; Noel, J; Baranski, L; Geraci, L; Eline, E; Mislanovich, K; Amundsen, C; Visco, A; Siddiqui, N; Kawasaki, A; McLean, S; Raynor, M; Clark, D; Cook, W; Longoria, N; Hayes, A; Harm-Ernandes, I; Arya, L; Harvie, H; Andy, U; Flick, L; Kinglee, M; Wang, M; Thompson, D; Carney, T; Rogers, R; Komesu, Y; Jeppson, P; Cichowski, S; Taylor, K; Castaneda, C; Beynon, R; Summers, A; Lee, S; Hopkins, K; Middendorf, J; Miller, C; Yane, E; White, B; Barber, M; Paraiso, M; Tarr, M; Jelovsek, E; Unger, C; Pung, L; Graham, A; Dastoli, K; Edington, M; O'Dougherty, E; Dubbs, J; Edgehouse, M; Wallace, D; Huitema, C; Nolen, T; Wilson, KA; Hair, B; Glass, K; Matthews, D; Bearden, M; Pickett, JW; Tang, Y; Shaffer, A; Zaterka-Baxter, K; Morris, L; Cleffi, K; Bann, C				Sung, Vivian W.; Borello-France, Diane; Newman, Diane K.; Richter, Holly E.; Lukacz, Emily S.; Moalli, Pamela; Weidner, Alison C.; Smith, Ariana L.; Dunivan, Gena; Ridgeway, Beri; Nguyen, John N.; Mazloomdoost, Donna; Carper, Benjamin; Gantz, Marie G.; Myers, Deborah L.; Rardin, Charles R.; Hampton, B. Star; Carberry, Cassandra; Wohlrab, Kyle; Korbly, Nicole; Meers, Ann; Lynch, Alexandra; Rhodes, Kathryn; Fox, Wendy; Choquette, Leslie; Clark, Michelle; Nassaney, Melissa; Varner, R. Edward; Ballard, Alicia; Ellington, David R.; Holley, Robert L.; Willis, Velria; Saxon, Nancy; Carter, Kathy; Willingham, Robin; Burge, Julie; Johnson, Ryanne; Nager, Charles; Albo, Mike; Alperin, Marianna; Columbo, JoAnn; Furey, Cindy; Riley, Patricia; Hall, Lynn; Doan, Christine; VandeVegte, Karen; Luber, Karl M.; Tan-Kim, Jasmine; Dyer, Keisha Y.; Diwadkar, Gouri B.; Menefee, Shawn A.; Mackinnon, Linda M.; Zazueta-Damian, Gisselle; Jakus-Waldman, Sharon; Liao, Christina; Flores, Nancy; Simmons, Mary; Patel, Arty; Zyczynski, Halina; Sutkin, Gary; Bonidie, Michael; Ackenbom, Mary; Gruss, Judy; Noel, Jaqueline; Baranski, Lindsay; Geraci, Lori; Eline, Ellen; Mislanovich, Karen; Amundsen, Cindy; Visco, Anthony; Siddiqui, Nazema; Kawasaki, Amie; McLean, Shantae; Raynor, Mary; Clark, Dominique; Cook, Weatherly; Longoria, Nicole; Hayes, Akira; Harm-Ernandes, Ingrid; Arya, Lily; Harvie, Heidi; Andy, Uduak; Flick, Lorraine; Kinglee, Michelle; Wang, Mary; Thompson, Donna; Carney, Teresa; Rogers, Rebecca; Komesu, Yuko; Jeppson, Peter; Cichowski, Sara; Taylor, Karen; Castaneda, Cassandra; Beynon, Reynette; Summers, Amanda; Lee, Sue; Hopkins, Kathleen; Middendorf, Julia; Miller, Christy; Yane, Erin; White, Barbara; Barber, Matthew; Paraiso, Marie; Tarr, Megan; Jelovsek, Eric; Unger, Cecile; Pung, Ly; Graham, Annette; Dastoli, Kathleen; Edington, Maryori; O'Dougherty, Elizabeth; Dubbs, Jill; Edgehouse, Megan; Wallace, Dennis; Huitema, Carolyn; Nolen, Tracy; Wilson, Kevin A.; Hair, Brenda; Glass, Kendra; Matthews, Daryl; Bearden, Maura; Pickett, James W., II; Tang, Yan; Shaffer, Amanda; Zaterka-Baxter, Kristin; Morris, Lindsay; Cleffi, Kathryn; Bann, Carla		NICHD Pelvic Floor Disorders	Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MIDURETHRAL SLINGS; PROLAPSE SURGERY; QUESTIONNAIRE; DEFINITIONS; ASSOCIATION; VALIDATION; OUTCOMES	Key PointsQuestionDoes combining perioperative behavioral and pelvic floor muscle therapy with midurethral sling result in greater improvement in mixed urinary incontinence symptoms than does a sling alone? FindingsIn this randomized clinical trial that included 480 women, incontinence symptoms (measured by the Urogenital Distress Inventory Long Form; range, 0-300 points; minimal clinically important difference, 35 points) decreased by 128.2 points in the combined therapy group and 114.7 points in the surgery alone group, resulting in a statistically significant between-group difference that did not meet the threshold for clinical importance. MeaningAmong women with mixed urinary incontinence, the addition of perioperative behavioral and pelvic floor muscle therapy to midurethral sling surgery resulted in a difference in urinary incontinence symptoms that may not be clinically important. ImportanceMixed urinary incontinence, including both stress and urgency incontinence, has adverse effects on a woman's quality of life. Studies evaluating treatments to simultaneously improve both components are lacking. ObjectiveTo determine whether combining behavioral and pelvic floor muscle therapy with midurethral sling is more effective than sling alone for improving mixed urinary incontinence symptoms. Design, Setting, and ParticipantsRandomized clinical trial involving women 21 years or older with moderate or severe stress and urgency urinary incontinence symptoms for at least 3 months, and at least 1 stress and 1 urgency incontinence episode on a 3-day bladder diary. The trial was conducted across 9 sites in the United States, enrollment between October 2013 and April 2016; final follow-up October 2017. InterventionsBehavioral and pelvic floor muscle therapy (included 1 preoperative and 5 postoperative sessions through 6 months) combined with midurethral sling (n=209) vs sling alone (n=207). Main Outcomes and MeasuresThe primary outcome was change between baseline and 12 months in mixed incontinence symptoms measured by the Urogenital Distress Inventory (UDI) long form; range, 0 to 300 points; minimal clinically important difference, 35 points, with higher scores indicating worse symptoms. ResultsAmong 480 women randomized (mean [SD] age, 54.0 years [10.7]), 464 were eligible and 416 (86.7%) had postbaseline outcome data and were included in primary analyses. The UDI score in the combined group significantly decreased from 178.0 points at baseline to 30.7 points at 12 months, adjusted mean change -128.1 points (95% CI, -146.5 to -109.8). The UDI score in the sling-only group significantly decreased from 176.8 to 34.5 points, adjusted mean change -114.7 points (95% CI, -133.3 to -96.2). The model-estimated between-group difference (-13.4 points; 95% CI, -25.9 to -1.0; P=.04) did not meet the minimal clinically important difference threshold. Related and unrelated serious adverse events occurred in 10.2% of the participants (8.7% combined and 11.8% sling only). Conclusions and RelevanceAmong women with mixed urinary incontinence, behavioral and pelvic floor muscle therapy combined with midurethral sling surgery compared with surgery alone resulted in a small statistically significant difference in urinary incontinence symptoms at 12 months that did not meet the prespecified threshold for clinical importance. Trial RegistrationClinicalTrials.gov Identifier: NCT01959347 This superiority trial compared behavioral and pelvic floor muscle therapy plus midurethral sling surgery with midurethral sling surgery alone in treating women with mixed urinary incontinence.	[Sung, Vivian W.] Brown Univ, Alpert Med Sch, Dept Obstet & Gynecol, Div Urogynecol & Reconstruct Pelv Surg, Providence, RI 02912 USA; [Borello-France, Diane] Duquesne Univ, Rangos Sch Hlth Sci, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Newman, Diane K.] Univ Penn, Dept Surg, Perelman Sch Med, Div Urol, Philadelphia, PA 19104 USA; [Richter, Holly E.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Urogynecol & Pelv Reconstruct Surg, Birmingham, AL 35294 USA; [Lukacz, Emily S.] Univ Calif San Diego, Dept Obstet Gynecol & Reprod Sci, Div Female Pelv Med & Reconstruct Surg, La Jolla, CA 92093 USA; [Moalli, Pamela] Univ Pittsburgh, Med Ctr, Dept Obstet Gynecol & Reprod Sci, Womens Ctr Bladder & Pelv Hlth,Div Urogynecol & R, Pittsburgh, PA USA; [Weidner, Alison C.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Urogynecol, Durham, NC 27710 USA; [Smith, Ariana L.] Univ Penn Hlth Syst, Perelman Sch Med, Dept Surg, Div Urol, Philadelphia, PA USA; [Dunivan, Gena] Univ New Mexico, Dept Obstet & Gynecol, Div Urogynecol, Albuquerque, NM 87131 USA; [Ridgeway, Beri] Cleveland Clin, Ctr Urogynecol & Reconstruct Pelv Surg, Obstet Gynecol & Womens Hlth Inst, Cleveland, OH 44106 USA; [Nguyen, John N.] Kaiser Permanente, Dept Obstet & Gynecol, Div Female Pelv Med & Reconstruct Surg, Downey, CA USA; [Mazloomdoost, Donna] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Carper, Benjamin; Gantz, Marie G.] RTI Int, Social Stat & Environm Sci, Res Triangle Pk, NC USA; [NICHD Pelvic Floor Disorders] Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA; [Rardin, Charles R.; Hampton, B. Star; Carberry, Cassandra; Wohlrab, Kyle; Korbly, Nicole; Meers, Ann; Lynch, Alexandra; Rhodes, Kathryn; Fox, Wendy; Choquette, Leslie; Clark, Michelle; Nassaney, Melissa] Univ Alabama Birmingham, Birmingham, AL USA; [Varner, R. Edward; Ballard, Alicia; Ellington, David R.; Holley, Robert L.; Willis, Velria; Saxon, Nancy; Carter, Kathy; Willingham, Robin; Burge, Julie; Johnson, Ryanne] Univ Calif San Diego, La Jolla, CA 92093 USA; [Varner, R. Edward; Ballard, Alicia; Ellington, David R.; Holley, Robert L.; Willis, Velria; Saxon, Nancy; Carter, Kathy; Willingham, Robin; Burge, Julie; Johnson, Ryanne] Kaiser Permanente, Oakland, CA USA; [Nager, Charles; Albo, Mike; Alperin, Marianna; Columbo, JoAnn; Furey, Cindy; Riley, Patricia; Hall, Lynn; Doan, Christine; VandeVegte, Karen; Luber, Karl M.; Tan-Kim, Jasmine; Dyer, Keisha Y.; Diwadkar, Gouri B.; Menefee, Shawn A.; Mackinnon, Linda M.; Zazueta-Damian, Gisselle] Kaiser Permanente Downey, Downey, CA USA; [Jakus-Waldman, Sharon; Liao, Christina; Flores, Nancy; Simmons, Mary; Patel, Arty] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Zyczynski, Halina; Sutkin, Gary; Bonidie, Michael; Ackenbom, Mary; Gruss, Judy; Noel, Jaqueline; Baranski, Lindsay; Geraci, Lori; Eline, Ellen; Mislanovich, Karen] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Visco, Anthony; Siddiqui, Nazema; Kawasaki, Amie; McLean, Shantae; Raynor, Mary; Clark, Dominique; Cook, Weatherly; Longoria, Nicole; Hayes, Akira; Harm-Ernandes, Ingrid] Univ Penn Hlth Syst, Philadelphia, PA USA; [Arya, Lily; Harvie, Heidi; Andy, Uduak; Flick, Lorraine; Kinglee, Michelle; Wang, Mary; Thompson, Donna; Carney, Teresa] Univ New Mexico, Albuquerque, NM 87131 USA; [Rogers, Rebecca; Komesu, Yuko; Jeppson, Peter; Cichowski, Sara; Taylor, Karen; Summers, Amanda; Lee, Sue; Hopkins, Kathleen; Middendorf, Julia; Miller, Christy; Yane, Erin; White, Barbara] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Barber, Matthew; Paraiso, Marie; Tarr, Megan; Jelovsek, Eric; Unger, Cecile; Pung, Ly; Graham, Annette; Dastoli, Kathleen; Edington, Maryori; O'Dougherty, Elizabeth; Dubbs, Jill; Edgehouse, Megan; Wallace, Dennis; Huitema, Carolyn; Nolen, Tracy; Wilson, Kevin A.; Hair, Brenda; Glass, Kendra; Matthews, Daryl; Bearden, Maura; Pickett, James W., II; Tang, Yan; Shaffer, Amanda; Zaterka-Baxter, Kristin; Morris, Lindsay; Cleffi, Kathryn; Bann, Carla] Res Triangle Inst, POB 12194, Res Triangle Pk, NC 27709 USA	Brown University; Duquesne University; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of New Mexico; Cleveland Clinic Foundation; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Research Triangle Institute; Women & Infants Hospital Rhode Island; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Kaiser Permanente; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; University of Pennsylvania; University of New Mexico; Cleveland Clinic Foundation; Research Triangle Institute	Sung, VW (corresponding author), Women & Infants Hosp Rhode Isl, Div Urogynecol & Reconstruct Pelv Surg, 101 Plain St,Fifth Floor, Providence, RI 02903 USA.	vsung@wihri.org	Wallace, Dennis/AAR-7005-2021; Cichowski, Sara/AAD-9400-2020; Carper, Benjamin/L-3433-2017	Smith, Ariana/0000-0002-9784-2559; Richter, Holly E/0000-0001-7741-5771; Gantz, Marie/0000-0001-8528-0184; Carper, Benjamin/0000-0001-5882-2232	NICHD; NIH Office of Research onWomen's Health [U10 HD041261, U10 HD069013, U10 HD054214, U10 HD054215, U10 HD041267, U10 HD069025, U10 HD069010, U10 HD069006, U01 HD069031]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD054214, UG1HD069010] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Office of Research onWomen's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the NICHD and NIH Office of Research onWomen's Health (U10 HD041261, U10 HD069013, U10 HD054214, U10 HD054215, U10 HD041267, U10 HD069025, U10 HD069010, U10 HD069006, and U01 HD069031).	Abdel-Fattah M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.018; Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Barber MD, 2008, OBSTET GYNECOL, V111, P611, DOI 10.1097/AOG.0b013e318162f22e; Barber MD, 2014, JAMA-J AM MED ASSOC, V311, P1023, DOI 10.1001/jama.2014.1719; Barber MD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.007; Brubaker L, 2011, NEUROUROL URODYNAM, V30, P47, DOI 10.1002/nau.20922; Brubaker L, 2009, NEUROUROL URODYNAM, V28, P268, DOI 10.1002/nau.20698; Coyne KS, 2006, J UROLOGY, V176, P627, DOI 10.1016/j.juro.2006.03.088; Coyne KS, 2005, QUAL LIFE RES, V14, P849, DOI 10.1007/s11136-004-0706-1; Dmochowski R, 2005, CURR OPIN UROL, V15, P374, DOI 10.1097/01.mou.0000183946.96411.76; Dooley Y, 2008, INT UROGYNECOL J, V19, P1359, DOI 10.1007/s00192-008-0637-4; Dyer KY, 2011, NEUROUROL URODYNAM, V30, P1319, DOI 10.1002/nau.21028; Ford AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006375.pub4; Goode PS, 2011, JAMA-J AM MED ASSOC, V305, P151, DOI 10.1001/jama.2010.1972; Husby VS, 2010, AM J PHYS MED REHAB, V89, P304, DOI 10.1097/PHM.0b013e3181cf5623; Jain P, 2011, INT UROGYNECOL J, V22, P923, DOI 10.1007/s00192-011-1406-3; Jarvis SK, 2005, AUST NZ J OBSTET GYN, V45, P300, DOI 10.1111/j.1479-828X.2005.00415.x; Kammerer-Doak D, 2014, INT UROGYNECOL J, V25, P1303, DOI 10.1007/s00192-014-2485-8; Kobashi KC, 2017, J UROLOGY, V198, P875, DOI 10.1016/j.juro.2017.06.061; MacDonald R, 2007, BJU INT, V100, P76, DOI 10.1111/j.1464-410X.2007.06913.x; Margolis MK, 2009, NEUROUROL URODYNAM, V28, P416, DOI 10.1002/nau.20672; McClurg D, 2014, INT UROGYNECOL J, V25, P883, DOI 10.1007/s00192-013-2301-x; Minassian VA, 2017, INT UROGYNECOL J, V28, P687, DOI 10.1007/s00192-017-3314-7; Moalli PA, 2008, INT UROGYNECOL J, V19, P655, DOI 10.1007/s00192-007-0499-1; Myers DL, 2014, JAMA-J AM MED ASSOC, V311, P2007, DOI 10.1001/jama.2014.4299; Newman DK, 2018, NEUROUROL URODYNAM, V37, P14, DOI 10.1002/nau.23244; Pocock SJ, 2016, NEW ENGL J MED, V375, P861, DOI 10.1056/NEJMra1510064; Richter HE, 2010, NEW ENGL J MED, V362, P2066, DOI 10.1056/NEJMoa0912658; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Sung VW, 2016, INT UROGYNECOL J, V27, P1479, DOI 10.1007/s00192-016-3031-7; Thomas TN, 2017, FEMALE PELVIC MED RE, V23, P177, DOI 10.1097/SPV.0000000000000423; Welk B, 2017, CUAJ-CAN UROL ASSOC, V11, pS121, DOI 10.5489/cuaj.4584; Yalcin I, 2003, AM J OBSTET GYNECOL, V189, P98, DOI 10.1067/mob.2003.379	33	31	31	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2019	322	11					1066	1076		10.1001/jama.2019.12467	http://dx.doi.org/10.1001/jama.2019.12467			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB8LM	31529007	Bronze, Green Published			2022-12-28	WOS:000488821100019
J	Siskind, D; Kisely, S				Siskind, Dan; Kisely, Steve			Balancing body and mind: selecting the optimal antipsychotic	LANCET			English	Editorial Material							SCHIZOPHRENIA; PEOPLE		[Siskind, Dan; Kisely, Steve] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Kisely, Steve] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Kisely, Steve] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada	University of Queensland; Dalhousie University; Dalhousie University	Siskind, D (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia.	d.siskind@uq.edu.au	Siskind, Dan/A-9812-2014	Siskind, Dan/0000-0002-2072-9216	National Health and Medical Research Council Early Career Fellowship [APP1111136]	National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	DS is partially supported by an National Health and Medical Research Council Early Career Fellowship (APP1111136). SK has received speaker's honoraria from Janssen, outside the area of work commented on here.	Dixon LB, 2010, SCHIZOPHRENIA BULL, V36, P48, DOI 10.1093/schbul/sbp115; Firth J, 2019, LANCET PSYCHIAT, V6, P675, DOI 10.1016/S2215-0366(19)30132-4; Galletly C, 2016, AUST NZ J PSYCHIAT, V50, P410, DOI 10.1177/0004867416641195; Huhn M, 2019, LANCET, V394, P939, DOI [10.1016/S0140-6736(19)31135-3, 10.1176/appi.focus.18306]; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Oakley P, 2018, J PSYCHIATR RES, V102, P245, DOI 10.1016/j.jpsychires.2018.04.019; Siskind D, 2016, BRIT J PSYCHIAT, V209, P387, DOI 10.1192/bjp.bp.115.177261; Vancampfort D, 2019, WORLD PSYCHIATRY, V18, P53, DOI 10.1002/wps.20614; Vermeulen J, 2017, PSYCHOL MED, V47, P2217, DOI 10.1017/S0033291717000873; Wilder, 2010, EVID-BASED MENT HEAL, V13, P108, DOI 10.1136/ebmh.13.4.108	11	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2019	394	10202					900	902		10.1016/S0140-6736(19)32096-3	http://dx.doi.org/10.1016/S0140-6736(19)32096-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IX7CE	31526722	hybrid, Green Published			2022-12-28	WOS:000485840600006
J	Jackson, ST				Jackson, Stephen T.			Humboldt for the Anthropocene	SCIENCE			English	Editorial Material									[Jackson, Stephen T.] US Geol Survey, Southwest Climate Adaptat Sci Ctr, Tucson, AZ 85721 USA; [Jackson, Stephen T.] Univ Arizona, Tucson, AZ 85721 USA	United States Department of the Interior; United States Geological Survey; University of Arizona	Jackson, ST (corresponding author), US Geol Survey, Southwest Climate Adaptat Sci Ctr, Tucson, AZ 85721 USA.; Jackson, ST (corresponding author), Univ Arizona, Tucson, AZ 85721 USA.	stjackson@usgs.gov		Jackson, Stephen/0000-0002-1487-4652				Black J., 1814, POLITICAL ESSAY KING; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Holt P., 1817, DISTRIBUTIONE GEOGRA; Humboldt Alexander von, 1818, PERSONAL NARRATIVE T; Humboldt Alexander Von, 2012, VIEWS CORDILLERAS MO; Humboldt Alexandre de, 1915, ASIE CENTRALE RECHER; Jackson ST, 2009, SCIENCE, V324, P596, DOI 10.1126/science.1171659; Kutzinski Vera, 2011, POLITICAL ESSAY ISLA; Lack H.W., 2009, A VONHUMBOLDT BOT EX; Morueta-Holme N, 2018, ANN MO BOT GARD, V103, P315, DOI 10.3417/2018110; Otte E.C., 1997, COSMOS SKETCH PHYS D; Person M. W., 1845, KOSMOS, V1, P65; Sachs Aaron, 2006, HUMBOLDT CURRENT 19; von Humboldt A., 1829, PERSONAL NARRATIVE T; von Humboldt Alexander, 2009, ESSAY GEOGRAPHY PLAN; Von Humboldt Alexander, 2009, PERSONAL NARRATIVE T; Von Humboldt Alexander, 1826, PERSONAL NARRATIVE T; VONHUMBOLDT A, 2014, VIEWS NATURE; Walls Laura Dassow, 2009, PASSAGE COSMOS A VON; [No title captured]	20	5	5	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1074	1076		10.1126/science.aax7212	http://dx.doi.org/10.1126/science.aax7212			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515369				2022-12-28	WOS:000485780800020
J	Makino, Y; Manuelli, S; Hook, L				Makino, Yuka; Manuelli, Sara; Hook, Lindsey			Accelerating the movement for mountain peoples and policies	SCIENCE			English	Editorial Material									[Makino, Yuka; Manuelli, Sara; Hook, Lindsey] Food & Agr Org United Nations FAO, Mt Partnership Secretariat, Forestry Policy & Resources Div, Dept Forestry, Rome, Italy	Food & Agriculture Organization of the United Nations (FAO)	Makino, Y (corresponding author), Food & Agr Org United Nations FAO, Mt Partnership Secretariat, Forestry Policy & Resources Div, Dept Forestry, Rome, Italy.	yuka.makino@fao.org						FAO, 2017, IND 15 4 2 MOUNT GRE; Gioli G., 2019, HINDU KUSH HIMALAYA; graCheva r, 2019, MIGRATION SUSTAINABL, P34; Grita F., 2019, VULNERABILITY FOOD I; GROOMBRIDGE BRIAN, 2002, UNEP WCMC BIODIVERSI, V12; Guha Ramachandra, 2000, UNQUIET WOODS ECOLOG; Krecek J, 2019, LAND USE POLICY, V80, P439, DOI 10.1016/j.landusepol.2017.10.018; Schoolmeester T., 2016, OUTLOOK ON CLIMATE C; U. N. Environment, 2016, WAST MAN OUTL MOUNT; Wester P., 2019, HINDU KUSH HIMALAYA	10	8	8	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1084	1086		10.1126/science.aay8855	http://dx.doi.org/10.1126/science.aay8855			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515375				2022-12-28	WOS:000485780800026
J	Servick, K				Servick, Kelly			WAR OF NERVES	SCIENCE			English	Editorial Material																			0	7	8	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2019	365	6458			SI		1071	1073		10.1126/science.365.6458.1071	http://dx.doi.org/10.1126/science.365.6458.1071			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IX6GK	31515368				2022-12-28	WOS:000485780800019
J	Tanne, JH				Tanne, Janice Hopkins			Don't vape, CDC says, as US lung disease epidemic grows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		CDC, 2019, EM PREP RESP HLTH AD; Christiani DC, 2019, NEW ENGL J MED, P6; Food and Drug Administration, 2018, 2018 NYTS DAT STARTL; Layden JE, 2019, NEW ENGL J MED, P6; New York State Department of Health, GET FACTS EL CIG SIM	5	1	1	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2019	366								l5479	10.1136/bmj.l5479	http://dx.doi.org/10.1136/bmj.l5479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IY8MK	31501087				2022-12-28	WOS:000486648500008
